Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.6899723954060827,-2.275981022358041,0.0,0.0009705893125297585,0.001,15/35,5.11%,KSR1;IRAG1;APOE;PDE7B;ADCY1;AKAP6;GUCY1B1;RAPGEF3;HTR2C;CAP2;RAPGEF2;RIMS2;EPHA5;PDE4D;AHR
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.6040411600614328,-2.0386083341283987,0.0,0.06114712668937478,0.109,21/41,19.93%,IL34;TGFA;GRM5;NEDD9;ACE;EPHA4;GPRC5B;DOCK3;LRP8;NTRK2;GAS6;ADRA2A;NOX4;ERBB3;HBEGF;CSF1R;RELN;FBXW7;BDNF;FCGR1A;PRNP
prerank,cAMP-mediated signaling (GO:0019933),-0.6719628294233324,-2.027175285222015,0.0,0.04885299539733118,0.132,12/24,7.74%,KSR1;PDE7B;ADCY1;AKAP6;RAPGEF3;CAP2;RAPGEF2;RIMS2;EPHA5;PDE4D;AHR;PDE2A
prerank,bicarbonate transport (GO:0015701),0.8368330056934712,1.9902593737910501,0.0,0.023239331166858404,0.02,5/25,4.19%,SLC26A7;SLC4A10;SLC4A4;SLC26A6;SLC4A2
prerank,organic anion transport (GO:0015711),0.7159012780534393,1.9841231719224353,0.0,0.015156085543603308,0.027,10/76,2.44%,SLC26A7;SLC4A10;SLC4A4;SLC23A1;SLCO3A1;SLCO2A1;LRRC8D;SLCO4A1;ABCG2;SLC26A6
prerank,cGMP-mediated signaling (GO:0019934),-0.7882875484328441,-1.9785707696612693,0.0,0.07983097095557264,0.252,6/13,7.74%,IRAG1;APOE;GUCY1B1;HTR2C;KCNC2;PDE2A
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.7110783285682549,-1.9672566363369894,0.0,0.07939420576493425,0.305,6/19,3.74%,TJP1;OCLN;CLDN5;PRKCH;ROCK2;F11R
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.7430119069595249,-1.945788694665495,0.0,0.09479422285707309,0.411,4/15,4.23%,PLTP;APOE;ABCA5;ABCG1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5626843001998375,-1.9435329661792236,0.0,0.08430261457401332,0.419,18/46,12.12%,ATP1A2;GRM7;CDH2;SHANK3;DGKI;GRM5;GRM3;NRXN1;GRM1;SYT1;MEF2C;OPHN1;CACNG7;CACNG4;GRM8;TPRG1L;CACNG3;CACNG2
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.7846924097714891,-1.9327389870886909,0.0,0.08468391751822144,0.459,7/12,15.77%,IL34;LYN;CSF1;MAPK1;BST2;PTK2;CSF1R
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.49689837657034364,-1.9294760271249785,0.0,0.07883342082880596,0.47,46/91,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;SSR1;RPS16;RPL4;ARL6IP1;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,inorganic anion transport (GO:0015698),0.7153793121429194,1.9273331067359318,0.0,0.058603530768599456,0.134,8/53,3.71%,SLC26A7;SLC4A10;CLIC4;ANO9;SLC26A6;SLC34A2;ANO6;CLIC1
prerank,positive regulation of blood coagulation (GO:0030194),0.8738338799823141,1.9217091183712989,0.0,0.05380410367979174,0.154,5/17,3.59%,F3;THBS1;ST3GAL4;THBD;ANO6
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.6906162216887567,1.9187763973157854,0.0,0.04708490575546094,0.166,17/79,5.95%,SLIT2;BMPER;THBS1;CRIM1;HTRA3;VWC2;NEDD4;SMAD6;FGF2;SKIL;SMAD9;BMPR1A;NOG;SKI;EMILIN1;ATP2B4;NBL1
prerank,response to ketone (GO:1901654),0.8085953968191284,1.917723858675025,0.0,0.040247827165791006,0.169,4/24,3.17%,SLIT3;SLIT2;THBS1;TGFB3
prerank,ion homeostasis (GO:0050801),0.7700894030501558,1.9103946320010894,0.0,0.04084925913180701,0.197,7/30,5.28%,SLC4A10;SLC4A4;FHL1;WNK1;CAMK2D;SLC4A2;RANGRF
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.49381576356428314,-1.909857475233775,0.0,0.09288539720909789,0.572,46/87,19.74%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9;SRP14;SEC61A2
prerank,response to glucocorticoid (GO:0051384),0.779048039345028,1.904198851652506,0.0,0.041679235244909095,0.228,5/26,7.82%,SLIT3;SLIT2;ADAM9;ANXA1;FAM107A
prerank,regulation of cell junction assembly (GO:1901888),-0.6221529569881381,-1.8932188592385308,0.0,0.10817659065104401,0.66,8/27,5.75%,TJP1;OCLN;CLDN5;PRKCH;RAPGEF2;ROCK2;F11R;MEF2C
prerank,cellular component maintenance (GO:0043954),-0.747119280127512,-1.8826286341201024,0.002631578947368421,0.11307365490971688,0.697,4/12,8.97%,IGF1R;INSR;ITGA3;CLDN1
prerank,regulation of intracellular pH (GO:0051453),0.7521440461727658,1.8784962420805973,0.0,0.06848305319702234,0.38,6/34,4.19%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2
prerank,regulation of cellular pH (GO:0030641),0.767095190221408,1.8734786331109485,0.0,0.06840446608679626,0.405,11/29,11.45%,SLC4A10;SLC4A4;SLC9A2;SLC9B1;SLC26A6;SLC4A2;ATP1A4;SLC9A1;TM9SF4;SLC9A8;CHP1
prerank,carboxylic acid transmembrane transport (GO:1905039),0.712811380972534,1.8341122411404396,0.0,0.14476358070738676,0.703,8/40,5.00%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;SLC16A1;SLC38A6;SLC7A9
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.6384429967432348,-1.826806551956474,0.0030959752321981426,0.20218121987158358,0.886,11/20,27.12%,PLCB1;CHRM2;CHRM3;GNA11;GRK2;LYPD1;RGS10;CHRM1;GNB1;LY6G6D;CHRNB2
prerank,embryonic skeletal system development (GO:0048706),0.7309715369419516,1.8264393620787087,0.002583979328165375,0.15400266921805808,0.749,12/35,7.76%,SIX1;KIAA1217;PCSK5;WNT9A;WNT11;HOXA3;XYLT1;HOXC4;HOXB3;NOG;HOXB4;SULF1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.6231015593076545,-1.821822579898047,0.0,0.19938677591682755,0.897,9/21,9.75%,ITGA1;PDGFRB;MEF2C;PPP1R15B;CALM1;BMP2;HSP90AB1;CD300A;MAGI2
prerank,collagen fibril organization (GO:0030199),0.6499921151162732,1.8196991385487984,0.0,0.16485157660503905,0.799,21/88,5.44%,COL25A1;COL8A1;COL12A1;COL6A2;COL8A2;TLL1;PLOD2;ADAMTS2;COL6A1;BMP1;DDR2;COL5A2;CYP1B1;LOXL1;COL3A1;OPTC;COL6A3;COL11A1;ADAMTS3;TGFBR1;NF1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.8062327955616796,1.8138647832202772,0.001392757660167131,0.17176896949417084,0.838,9/20,13.14%,SMOC2;THBS1;FGF2;LRIT3;NOG;SULF1;FGFBP3;CREB3L1;NPTN
prerank,sulfate transport (GO:0008272),0.8614486074481278,1.8118060904654478,0.0,0.16705374288060534,0.843,3/14,2.44%,SLC26A7;SLC26A2;SLC26A6
prerank,regulation of BMP signaling pathway (GO:0030510),0.6602729104333608,1.8117980549922863,0.0,0.15661288395056752,0.843,19/73,7.92%,BMPER;BMP4;CRIM1;HTRA3;FSTL1;VWC2;FOXD1;CCN1;SMAD6;SKIL;SMAD9;SFRP4;ZNF423;BMPR1A;NOG;SKI;NBL1;SULF1;SMAD2
prerank,cation transport (GO:0006812),0.6087388910069446,1.8071836014509914,0.0,0.16219983313134678,0.865,19/167,4.76%,SLC47A1;SLC4A4;PIEZO2;SLC23A1;KCNK5;SLC9B2;KCNJ2;KCNB2;SLC5A6;SLC12A2;KCNJ15;KCNMB3;KCNMB2;ATP1B1;FGF13;KCNS3;ANO6;TRPM7;TRPM6
prerank,sulfur compound transport (GO:0072348),0.757237930558059,1.8064880941806034,0.0013679890560875513,0.15476047349523825,0.868,5/27,2.44%,SLC26A7;SLC5A6;LRRC8D;ABCG2;SLC26A6
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.8028231837491128,1.805888826982121,0.0015151515151515152,0.14837010058474817,0.87,7/18,8.35%,BMP4;EGFR;DDX5;ESR1;NCOR1;ZC3H12A;NCOR2
prerank,carbohydrate transport (GO:0008643),0.8706743519317824,1.8048609809340805,0.0,0.14322500838705127,0.871,3/11,2.44%,SLC23A1;SLC23A2;SLC26A6
prerank,chloride transport (GO:0006821),0.6518925129523364,1.8030162067984417,0.0,0.1402058199176509,0.876,11/74,4.12%,SLC26A7;SLC4A10;SLC12A7;SLC12A2;CLIC4;ANO9;SLC26A6;GABRA3;ANO6;CLIC1;GLRB
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.6858115347001006,-1.8007266472630197,0.0,0.23501202554053888,0.934,6/16,7.58%,APOE;NOS3;GUCY1B1;KCNC2;NDNF;GUCY1A1
prerank,cytoplasmic translation (GO:0002181),-0.46178683415303,-1.7961524046849606,0.0,0.23148555103834742,0.941,44/91,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;EIF3I;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.6971973276453034,1.7890407619462152,0.0025673940949935813,0.17365199830413366,0.929,12/39,6.61%,SLIT2;SIX1;BMP4;LRP6;MET;PKD1;SEMA3E;FGF2;NRP1;VEGFA;GLI2;TGFBR2
prerank,endodermal cell differentiation (GO:0035987),0.7237231829327265,1.7812397044479493,0.0,0.19083488580119642,0.948,8/31,7.38%,COL8A1;COL12A1;COL6A1;ITGB5;COL11A1;SETD2;INHBA;FN1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.543541404924048,-1.7800447176737464,0.0,0.2603463097138647,0.966,13/37,5.95%,PLCB1;GRM7;GRID2;GRIK2;GRIA4;GRM5;GRM3;APP;GRM1;GRIN2A;GRIN2B;CPEB4;GRIN1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.8811282606532748,1.7790374701329201,0.0016420361247947454,0.19058777571081162,0.951,3/11,1.66%,BMP4;EGFR;DDX5
prerank,vasculature development (GO:0001944),-0.6538381815366253,-1.7788560436480796,0.015479876160990712,0.24890223703540923,0.97,13/16,23.65%,ERRFI1;PDGFRB;NOTCH4;CDH5;SOX18;PIK3CA;ACVRL1;APLNR;FBXW7;PDGFRA;ACVR2B;FOXF1;FLT4
prerank,monosaccharide transmembrane transport (GO:0015749),0.8106500589108889,1.775263586966925,0.0015408320493066256,0.1951699655734943,0.964,2/16,0.14%,SLC23A1;SLC23A2
prerank,protein targeting to ER (GO:0045047),-0.4650463307751047,-1.7748867113356617,0.0,0.24576343066214046,0.974,46/99,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;ZFAND2A;RPL11;RPS5;RPS16;RPL4;RPS7;RPS23;RPS15;RPL36;RPS18;SGTA;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;RPL23;RPL17;RPL9
prerank,positive regulation of chemotaxis (GO:0050921),0.6892740286575778,1.7746293934037207,0.0012853470437017994,0.18972310159967012,0.965,8/43,3.17%,SMOC2;F3;THBS1;MET;NTRK3;FGF2;NRP1;VEGFA
prerank,ion transport (GO:0006811),0.6149035201702109,1.7720556203363826,0.0,0.19167770408478058,0.969,12/111,4.19%,SLC26A7;PIEZO2;SLC26A2;SLC9A2;SLC12A7;SLC12A2;SLC24A3;WNK1;SLC26A6;ANO6;GLRB;SLC4A2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.6709546217169743,1.7665251311329087,0.0,0.2034884913818549,0.976,12/51,5.95%,BMPER;CRIM1;HTRA3;FSTL1;VWC2;SMAD6;SKIL;SMAD9;BMPR1A;NOG;SKI;NBL1
prerank,hippo signaling (GO:0035329),-0.5742481515834319,-1.763046509719215,0.015384615384615385,0.26482529392374465,0.985,6/26,6.89%,TJP1;AMOTL2;AMOTL1;YWHAB;TEAD4;TEAD2
prerank,cellular response to copper ion (GO:0071280),-0.6788256708900662,-1.76214336970963,0.011764705882352941,0.2549876779631752,0.986,12/16,21.08%,MT3;MT2A;PRNP;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;SNCA
prerank,central nervous system neuron development (GO:0021954),-0.6789501412193056,-1.761705199026823,0.0030581039755351682,0.24423556518930656,0.987,7/15,9.51%,MAP2;RAPGEF2;LHX6;B4GALT6;NTRK2;MAPT;HSP90AB1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7733372670043217,1.7554651599998847,0.0015313935681470138,0.23448380622632242,0.986,5/17,3.08%,BMP4;TMEM100;FGF2;SOX9;SFRP4
prerank,ureteric bud morphogenesis (GO:0060675),0.8026334884411884,1.7546822916450282,0.004545454545454545,0.22916001341928202,0.986,4/16,2.22%,SIX1;BMP4;WNT11;FGF2
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.8139301344047801,1.7540667174012805,0.008995502248875561,0.22356041020123674,0.986,6/15,4.74%,SIX1;BMP4;SOX9;VEGFA;SMO;NOG
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.839699264698755,1.7468283967349614,0.0077279752704791345,0.245844337588532,0.995,3/11,5.95%,SLIT2;CCN3;NBL1
prerank,positive regulation of hemostasis (GO:1900048),0.8760549996494006,1.7465597536725257,0.00338409475465313,0.23218528696504442,0.995,2/10,0.22%,THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.8760549996494006,1.7465597536725257,0.00338409475465313,0.23218528696504442,0.995,2/10,0.22%,THBS1;ST3GAL4
prerank,regulation of sensory perception of pain (GO:0051930),0.8570240712510199,1.7390572915743903,0.003048780487804878,0.25433354978884787,0.998,5/11,5.46%,CCN3;MGLL;TMEM100;CCL3;ACP3
prerank,organic acid transport (GO:0015849),0.610778628301276,1.7383684937471147,0.0,0.2498508768688086,0.998,18/94,8.76%,SLC26A7;SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC5A6;LRRC8D;ABCG2;SLC16A1;SLC26A6;SLC10A2;FOLR2;SLC7A9;SLC27A3;SLC51A;SLC25A32;SLC38A3;RXRA
prerank,mesonephric tubule development (GO:0072164),0.81579440712102,1.7373847157305708,0.0030303030303030303,0.2465936080337619,0.998,5/15,1.87%,SLIT2;SIX1;BMP4;PKD1;WNT11
prerank,response to amyloid-beta (GO:1904645),-0.5157754073785992,-1.7371775094931285,0.01,0.29560774496830255,0.996,14/44,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;SNX6;GJA1;CASP4;EPHA4;CACNA1B;GRIN1;LGMN;CACNA2D1
prerank,cellular response to drug (GO:0035690),-0.5864644182579787,-1.7355737510175309,0.011538461538461539,0.2876988487223626,0.997,10/25,13.12%,PDE4B;ACER2;PPM1E;TFRC;RAP2A;MEF2C;AIM2;GAS6;KCNQ1;CERS1
prerank,positive regulation of heart contraction (GO:0045823),-0.619976050505672,-1.7348333742205693,0.0,0.27813207339852763,0.997,7/19,13.08%,ATP1A2;RYR2;ATP2A2;EDN1;ADM;KCNQ1;CHGA
prerank,response to copper ion (GO:0046688),-0.6340673000639452,-1.729323796532372,0.009554140127388535,0.2825161506625082,0.997,16/20,31.84%,MT3;MT2A;PRNP;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;SNCA;AQP1;IL1A;ATP5F1D;HSF1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.6668276102196893,1.7256779609106858,0.0,0.2868488611305131,0.998,6/45,5.14%,SLC38A2;BMP4;EGFR;DDX5;U2AF2;ZC3H18
prerank,aorta development (GO:0035904),-0.6748420069937002,-1.71902158205954,0.006349206349206349,0.30016373183790684,0.999,9/14,15.37%,ROBO1;ROBO2;PDGFRB;ADAMTS9;TBX1;PDE2A;TBX2;EFEMP2;APLNR
prerank,regulation of phagocytosis (GO:0050764),-0.4886408597333537,-1.7164162472785758,0.006060606060606061,0.295336462241198,0.999,20/53,19.27%,CAMK1D;MERTK;TGM2;DYSF;IL15RA;SIRPA;DOCK2;SYT7;GATA2;SYT11;SPHK1;GAS6;RACK1;SNX3;TULP1;CD47;LYAR;HCK;PYCARD;CALR
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.7808671818105386,1.7144091400248427,0.004545454545454545,0.32833003776766617,0.999,4/16,2.22%,SIX1;BMP4;FOXD1;FGF2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7161457659733573,-1.7138668952237024,0.01366120218579235,0.2923481946533601,0.999,5/11,6.47%,PLCB1;IGF1R;IGF1;PIK3R1;GHR
prerank,regulation of fibrinolysis (GO:0051917),0.8072310638029198,1.7135450498354785,0.0032520325203252032,0.32449179148854684,0.999,2/13,2.68%,THBS1;THBD
prerank,response to interferon-alpha (GO:0035455),-0.6300841960065349,-1.7130628724227133,0.02608695652173913,0.28493266918165283,0.999,10/16,17.42%,IFNAR1;IFITM1;IFITM3;AXL;IFNAR2;BST2;IFITM2;GAS6;ADAR;PDE12
prerank,ureteric bud development (GO:0001657),0.7888208426885163,1.7115399236870217,0.0044444444444444444,0.3255724327098265,0.999,5/17,2.08%,SLIT2;SIX1;BMP4;WNT11;GPC3
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5576256717378695,-1.710138901434173,0.011673151750972763,0.2835060072566763,0.999,18/30,13.15%,TJP1;GJB6;LAMA2;PECAM1;OCLN;CLDN5;ESAM;MBP;SLC1A1;F11R;GJA1;ACTB;JAM3;JAM2;CLDN1;CDH5;LAMC1;WNK3
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.7363977682897922,-1.709891889459404,0.011111111111111112,0.27522273193421964,0.999,6/10,16.26%,LYN;RAPGEF2;CXCL12;AXL;GAS6;CCL19
prerank,regulation of muscle cell differentiation (GO:0051147),0.6929613837890515,1.7093880902713803,0.002635046113306983,0.3264332138748465,0.999,8/31,6.54%,CDON;BOC;HDAC9;ID2;ABL1;CTNNA1;MEF2A;MAPK12
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.7198034176848513,-1.7077979244999137,0.010101010101010102,0.27285324401025973,0.999,3/10,11.55%,ATP1A2;BIN1;ADRA2A
prerank,cell differentiation in spinal cord (GO:0021515),-0.7208038514553299,-1.706535078340147,0.014124293785310734,0.26802538398064424,0.999,4/10,10.06%,SOX6;SOX13;MDGA2;ZC4H2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4217936907456312,-1.7049597386126345,0.0,0.26408348637773976,1.0,48/110,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;MAGOH;RPS5;CTIF;RPS16;RPL4;SMG7;RPS7;RPS23;RPS15;RPL36;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;HELZ2;RPL23;RPL17;RPL9
prerank,digestive tract development (GO:0048565),0.6841550195702089,1.701160813956969,0.013192612137203167,0.35660271970499813,1.0,12/32,8.40%,PCSK5;PKD1;RARB;COBL;SMO;GLI3;CLMP;EPHB3;NIPBL;GLI2;AGR2;GATA4
prerank,negative regulation of calcium ion transport (GO:0051926),-0.6528447675264015,-1.700761131494483,0.015479876160990712,0.26699294338839447,1.0,3/15,11.55%,ATP1A2;SLC30A1;ADRA2A
prerank,sprouting angiogenesis (GO:0002040),0.6532966126133678,1.700041952715622,0.0024752475247524753,0.3540783075709385,1.0,11/51,3.17%,SLIT2;BMPER;RSPO3;THBS1;BMP4;PGF;SEMA3E;PTK2B;FGF2;NRP1;VEGFA
prerank,response to hexose (GO:0009746),0.7178490625234761,1.6990386300405342,0.005449591280653951,0.35112720849017565,1.0,2/25,0.67%,THBS1;TCF7L2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.711557143644381,-1.6954558895399516,0.01871657754010695,0.27192240036982374,1.0,9/11,21.82%,MERTK;CXCL12;AXL;GAS6;CCL19;NOD2;SELENOS;HCLS1;IRF7
prerank,melanocyte differentiation (GO:0030318),-0.7189585418166586,-1.69211285529907,0.0169971671388102,0.2728633059409319,1.0,7/11,12.19%,LRMDA;KIT;MITF;ENPP1;MEF2C;SLC24A5;MREG
prerank,cellular response to zinc ion (GO:0071294),-0.6389424991454371,-1.6916483739243984,0.02556818181818182,0.26713604309472894,1.0,13/15,24.76%,GLRA1;ATP13A2;MT3;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;HVCN1
prerank,transepithelial transport (GO:0070633),0.7846868375216173,1.6891058247610642,0.009259259259259259,0.39245475421385545,1.0,5/15,2.44%,SLC23A1;SLC23A2;SLC12A2;ABCG2;SLC26A6
prerank,pharyngeal system development (GO:0060037),0.7619624408560647,1.6886756790139503,0.01355421686746988,0.38608246847882527,1.0,6/15,4.74%,BMP4;HES1;BMP5;BMPR1A;TGFBR1;NOG
prerank,endoderm formation (GO:0001706),0.680613183760471,1.687327831340416,0.003931847968545216,0.38502772316395567,1.0,8/35,7.38%,COL8A1;COL12A1;COL6A1;ITGB5;COL11A1;SETD2;INHBA;FN1
prerank,cellular response to amyloid-beta (GO:1904646),-0.5325365055990816,-1.6869802107593177,0.013824884792626729,0.27166794857707943,1.0,13/35,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;SNX6;GJA1;CASP4;EPHA4;GRIN1;LGMN;CACNA2D1
prerank,positive regulation of wound healing (GO:0090303),0.6747328682334067,1.6866867973604769,0.004043126684636119,0.38015999058757904,1.0,9/36,7.87%,SMOC2;THBS1;ST3GAL4;PRKCE;PLPP3;FOXC2;ANXA1;ITGB1;DMTN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.6054506293176841,1.6844230010957393,0.00468384074941452,0.38312563442823344,1.0,10/68,5.71%,SLC23A1;SLC23A2;AOX1;SLC5A6;MMACHC;VNN1;RFK;PNPO;FOLR2;NNMT
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5763165383265227,-1.6825214563167876,0.014285714285714285,0.27581307512888337,1.0,7/23,10.17%,IGF1;EFNB2;AKAP6;PIEZO1;MEF2C;PROX1;EDN1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.653780467495725,1.6792823456671941,0.0051813471502590676,0.40063576714084453,1.0,14/43,11.50%,BMP4;KLF5;NFIB;DDX5;FGF2;SOX9;KLF4;STAT3;FOXO3;NFATC4;NFATC3;EGR1;ATOH8;TEAD1
prerank,negative regulation of cartilage development (GO:0061037),0.7974249738741306,1.6764667374038993,0.010736196319018405,0.40626081608417686,1.0,5/13,4.57%,WNT9A;WNT11;SOX9;TGFBR1;PTHLH
prerank,amino acid transmembrane transport (GO:0003333),0.6426542458448468,1.6740558748720142,0.002466091245376079,0.40995781576056045,1.0,7/45,5.00%,SLC47A1;SLC38A2;SLC38A1;LRRC8D;SFXN3;SLC38A6;SLC7A9
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7772823078532349,1.6721087105473746,0.020123839009287926,0.4126758847705814,1.0,3/14,4.62%,THBS1;CMKLR1;IRAK3
prerank,primary neural tube formation (GO:0014020),0.6871368547512929,1.6712405460260866,0.010282776349614395,0.40971032702235266,1.0,6/30,5.66%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,regulation of T cell migration (GO:2000404),-0.6168030906923292,-1.67049117864495,0.006666666666666667,0.29792470040794405,1.0,9/18,18.38%,APOD;LRCH1;APP;RIPOR2;CXCL12;CD200;DOCK8;CD200R1;PYCARD
prerank,extracellular matrix organization (GO:0030198),0.5450551460808165,1.6699786211348586,0.0,0.40894366529258214,1.0,54/276,8.79%,COL25A1;COL8A1;ADAMTSL3;COL12A1;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;TLL1;ADAMTSL1;VIT;THSD4;PLOD2;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;BMP1;DDR2;COL5A2;CYP1B1;GSN;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;OPTC;DSPP;MMP28;COL6A3;HTRA1;COL11A1;ELN;CAPN2;ADAMTS3;TIMP1;TGFBR1;HAS1;NF1;BGN;CD44;FN1;ITGB1;TIMP2;KIF9;ADAMTS6;COL17A1;ADAMTSL5;MMP16;P3H1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7789913260335903,1.6686059207441306,0.0045045045045045045,0.40831026246942526,1.0,4/14,10.85%,THBS1;FGF2;SULF1;CREB3L1
prerank,motor neuron axon guidance (GO:0008045),0.7668528279619801,1.6677470531278746,0.011851851851851851,0.40590435996087015,1.0,4/15,4.51%,SLIT2;NTN1;SLIT1;TMEFF1
prerank,carboxylic acid transport (GO:0046942),0.6206932662049941,1.6650045530119044,0.0036991368680641184,0.41313605384619906,1.0,8/55,5.58%,SLC38A2;SLC23A1;SLC23A2;SLC38A1;SLC16A9;SLC16A1;SLC38A6;SLC6A7
prerank,axon extension (GO:0048675),0.7263014341735086,1.6646360282783226,0.005797101449275362,0.4082375841644793,1.0,5/23,3.11%,SLIT3;SLIT2;ULK2;SLIT1;NRP1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.749405729337524,1.6642450871036252,0.018518518518518517,0.40320156754359754,1.0,4/15,2.22%,SMOC2;THBS1;MET;FGF2
prerank,detection of mechanical stimulus (GO:0050982),0.7329186662176901,1.6636609169512933,0.01002865329512894,0.3992895181761555,1.0,3/19,1.53%,PIEZO2;PKD1;CSRP3
prerank,tube closure (GO:0060606),0.6824841006032412,1.6631883796234384,0.011688311688311689,0.3947318279356239,1.0,6/31,5.66%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,anterior/posterior pattern specification (GO:0009952),0.6337477625260058,1.6627867043711413,0.004819277108433735,0.39045865381708017,1.0,19/53,13.42%,PCSK5;HES1;HOXA5;HOXA3;HOXB6;HOXC6;HOXC4;TGFBR1;HOXA6;HOXB3;SKI;BHLHE40;HOXB4;SMAD2;GATA4;HES3;HOXB5;LRP5;HOXA7
prerank,neutral amino acid transport (GO:0015804),0.6827853600482792,1.6597370242227636,0.012482662968099861,0.399436691413775,1.0,5/28,5.58%,SLC38A2;SLC38A1;SLC38A6;SLC7A9;SLC6A7
prerank,regulation of dendrite extension (GO:1903859),-0.6068939920619871,-1.6591887274763568,0.013071895424836602,0.3190530216885613,1.0,9/18,19.82%,NEDD4L;RIMS1;RIMS2;SYT1;SYT4;RNF157;RASAL1;CPNE5;SYT2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.578649339575231,1.6576501001712463,0.0011098779134295228,0.40359584160203427,1.0,34/104,17.26%,BMPER;CCN3;CRIM1;HTRA3;VWC2;SMAD6;SKIL;HTRA4;SMAD9;PMEPA1;BMPR1A;CD109;TGFBR1;NOG;SPRED2;SKI;EMILIN1;NBL1;TGFBR2;IL17RD;SMAD2;CHRD;LEMD2;TGFB1I1;LDLRAD4;SORL1;ACVR1;WFIKKN1;FAM89B;UBE2D3;SMAD4;PIN1;BCL9L;SMAD7
prerank,chemokine-mediated signaling pathway (GO:0070098),0.6456752464635067,1.6551207387863298,0.003865979381443299,0.4086864858026365,1.0,9/42,9.92%,STK39;WNK1;PTK2B;CXCL2;CCL3;CCL1;FOXC1;CIB1;CCL7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.7702711079832668,1.6542756002829722,0.0091324200913242,0.40682202558658326,1.0,4/14,4.14%,STK39;WNK1;PTK2B;CCL3
prerank,regulation of acrosome reaction (GO:0060046),-0.7061762409922254,-1.6536773427302656,0.021220159151193633,0.32675771560234806,1.0,2/10,10.12%,PLCB1;GLRA1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.7693210788331843,1.6516488213747291,0.02108433734939759,0.4131680711234467,1.0,6/14,13.66%,ME1;NMNAT2;NMNAT1;AK4;AK3;AK1
prerank,ventricular septum morphogenesis (GO:0060412),0.685631384272422,1.650864601520372,0.008298755186721992,0.41123512108310306,1.0,9/27,6.61%,SLIT3;SLIT2;BMP4;ZFPM2;HES1;BMPR1A;TGFBR1;NOG;TGFBR2
prerank,regulation of T cell chemotaxis (GO:0010819),0.7947165265077751,1.6489491533425944,0.01393188854489164,0.4147217323114437,1.0,2/11,1.59%,STK39;WNK1
prerank,organic cation transport (GO:0015695),0.729898710865493,1.6482719083490096,0.010248901903367497,0.41193679171012176,1.0,1/20,0.01%,SLC47A1
prerank,acute inflammatory response (GO:0002526),0.7148576874814352,1.6458610236112672,0.016304347826086956,0.41818339043733954,1.0,4/23,3.91%,F3;LBP;ANO6;VNN1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.7183117944080206,1.6445270012462248,0.018518518518518517,0.41955048693540437,1.0,9/23,9.60%,SIX1;BMP4;FGF2;SOX9;VEGFA;SMO;NOG;SIRT6;SIX4
prerank,positive regulation of dendrite extension (GO:1903861),-0.6148609426315498,-1.643890206015458,0.01910828025477707,0.3468886202981357,1.0,9/17,19.82%,NEDD4L;RIMS1;RIMS2;SYT1;SYT4;RNF157;RASAL1;CPNE5;SYT2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.6074483871973129,-1.6425667172105194,0.00909090909090909,0.34333541942357026,1.0,6/18,14.26%,PLCB1;CHRM2;CHRM3;GNA11;GRK2;OPRM1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5571565279210277,-1.6424524709126074,0.00749063670411985,0.3363195222097798,1.0,9/24,8.25%,PEX5L;RAPGEF2;PRKAR2B;PDE4D;PRKAR1B;PRKAR1A;MGRN1;PDE2A;RNF157
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.8050136647122167,1.6408205615079434,0.014084507042253521,0.43250752914830276,1.0,2/10,1.59%,STK39;WNK1
prerank,vitamin transport (GO:0051180),0.6777567484781045,1.640670202111547,0.008119079837618403,0.4276409189434597,1.0,7/29,10.17%,SLC23A1;SLC5A6;ABCG2;FOLR2;GC;SLC25A32;SLC52A3
prerank,embryonic digestive tract development (GO:0048566),0.7340619334316173,1.639451178833497,0.025373134328358207,0.4281889414487615,1.0,6/18,6.46%,PCSK5;RARB;ID2;GLI3;NIPBL;GLI2
prerank,response to alcohol (GO:0097305),0.689943212288119,1.637050120833661,0.0111731843575419,0.4338267562865596,1.0,7/27,7.92%,SLIT3;SLIT2;ADH7;CCL3;TGFBR1;TGFBR2;SMAD2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6932679966829843,1.6362260334692293,0.008426966292134831,0.43260712019142467,1.0,6/24,6.54%,CDON;BOC;ABL1;CTNNA1;MEF2A;MAPK12
prerank,positive regulation of potassium ion transport (GO:0043268),0.6504868518499796,1.6342963747128714,0.005128205128205128,0.43701309657851506,1.0,6/38,1.84%,KCNJ2;FHL1;KCNJ15;KCNMB3;KCNMB2;ANK2
prerank,peptide cross-linking (GO:0018149),0.6910300245011428,1.6335826851166242,0.0223463687150838,0.4348237282954108,1.0,8/25,8.84%,THBS1;COL3A1;DSP;ANXA1;ABCA7;FN1;TGM5;TGM6
prerank,nucleotide biosynthetic process (GO:0009165),0.7339392327012835,1.631719536557819,0.01394700139470014,0.4383928548539175,1.0,4/18,8.41%,ME1;PRPS2;NMNAT2;NMNAT1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6652541426588858,1.6312488325885302,0.011842105263157895,0.4353874694513834,1.0,9/31,6.61%,SIX1;HOXA3;HOXC4;TGFBR1;HOXB3;NOG;TWIST1;HOXB4;TGFBR2
prerank,circulatory system development (GO:0072359),0.5603196616875762,1.6310214235677845,0.0,0.43132294874803767,1.0,35/118,13.65%,MICAL2;PLCE1;NXN;ZFPM2;PCSK5;CACNA1C;PKD1;NTRK3;HDAC9;FOXL1;COL3A1;AKAP13;SOX9;ID2;PDLIM7;FOXC2;TGFBR1;DNAAF4;NF1;MEF2A;ECE1;GLI2;TCF25;TGFBR2;FN1;FOXC1;ALPK3;POU4F1;TAB2;BCOR;ZFPM1;CDKN1B;NCOA6;PDLIM4;ACVR1
prerank,heart development (GO:0007507),0.551882578931946,1.6310038919611693,0.0,0.42633177099712366,1.0,37/150,10.56%,MICAL2;BMP4;PLCE1;ZFPM2;PCSK5;CACNA1C;PKD1;NTRK3;SGCD;CSRP3;BMP5;GPC3;HDAC9;FOXL1;COL3A1;AKAP13;SOX9;VEGFA;ID2;PDLIM7;FOXC2;TGFBR1;NIPBL;DNAAF4;NF1;MEF2A;ECE1;GLI2;TCF25;TGFBR2;FN1;GATA4;FOXC1;ALPK3;POU4F1;TAB2;BCOR
prerank,regulation of mononuclear cell migration (GO:0071675),0.6888772232605503,1.630680335367159,0.017955801104972375,0.4229605267982318,1.0,4/23,2.28%,SLIT2;THBS1;BMP5;CMKLR1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.577130812548739,1.629715774713442,0.0011376564277588168,0.4227676827266265,1.0,17/92,4.52%,SMOC2;THBS1;FOXP1;BMP4;DOCK5;ADAM9;PRKCE;PTK2B;FGF2;SOX9;NRP1;VEGFA;RAB25;FOXC2;BCAS3;PLCG2;ABL1
prerank,regulation of endothelial cell migration (GO:0010594),0.5773209785577603,1.6295299606119922,0.005707762557077625,0.4188361276208799,1.0,20/85,9.66%,SLIT2;BMPER;SMOC2;THBS1;FOXP1;BMP4;RHOJ;PTK2B;FGF2;NRP1;VEGFA;FOXC2;BCAS3;ABL1;NF1;ZC3H12A;ANXA3;GPI;KRIT1;AAMP
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.6522745558656925,1.6287916012560206,0.01699346405228758,0.4175132598888054,1.0,8/35,5.68%,NR3C2;NEDD4;DDX5;RBFOX2;PMEPA1;ESR1;DDX17;UBR5
prerank,gastrulation (GO:0007369),0.7546880527601219,1.6272406136692155,0.013313609467455622,0.41990215666803776,1.0,8/15,18.74%,GPC3;NR4A3;SMAD2;LRP5;MEGF8;NPHP3;MKKS;TASOR
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.7016466719433493,-1.626270468235332,0.017994858611825194,0.37351512043853546,1.0,5/10,14.46%,PDE4B;CACNB2;CACNA2D1;CALM1;NOS1AP
prerank,protein deacetylation (GO:0006476),0.62932730244125,1.6251189778502955,0.01288659793814433,0.42472570272081595,1.0,15/41,16.42%,HDAC4;HDAC9;RBM14;RCOR3;SIRT6;MIER1;MTA1;BRMS1L;BRMS1;TBL1X;RCOR1;SIRT3;MSL3;MORF4L1;PRDM5
prerank,histone deacetylation (GO:0016575),0.6272812254793273,1.6229850847297693,0.015523932729624839,0.4300154879523506,1.0,16/43,16.42%,HDAC4;HDAC9;RBM14;HDAC8;RCOR3;PER1;SIRT6;MIER1;MTA1;BRMS1L;BRMS1;TBL1X;RCOR1;MSL3;MORF4L1;PRDM5
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.7812716521873615,1.6227667025601527,0.02556390977443609,0.42641293578160766,1.0,6/12,9.60%,SIX1;SOX9;VEGFA;SMO;NOG;SIX4
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5981005794941967,-1.6227478947836587,0.03273809523809524,0.37648961353577803,1.0,7/18,13.57%,IGF1;IGFBP2;RPS3;IL18;HMGB1;ICOSLG;CD24
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.7517309211261521,1.6223764580400297,0.019402985074626865,0.4235964674484533,1.0,5/15,6.61%,SIX1;TGFBR1;TWIST1;NIPBL;TGFBR2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7524299017753511,1.621913401962913,0.016516516516516516,0.4210520101755564,1.0,4/17,3.08%,SLIT2;FSTL1;LRIT3;SFRP4
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.608785663431849,1.6214282822633177,0.009535160905840286,0.4189078893895523,1.0,13/56,6.79%,BMPER;BMP4;SMAD6;BMP5;PMEPA1;TGFB3;BMPR1A;GDF10;TGFBR1;NOG;EMILIN1;BMP6;INHBA
prerank,regulation of multicellular organism growth (GO:0040014),-0.6138841901056081,-1.6213150107888195,0.02881844380403458,0.37299747280518625,1.0,4/15,6.47%,IGF1;APP;PTCH1;GHR
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6786119661985317,-1.6208586807853198,0.023076923076923078,0.3668827601362487,1.0,6/10,21.97%,LYN;KIT;CD24;CD40;BTLA;BAG6
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.6465735112714242,-1.6195490601076084,0.04285714285714286,0.36356035825874305,1.0,9/12,23.95%,MAP2;STMN1;DYRK1A;CDH5;CLIP3;STMN2;ARHGEF7;SNCA;TUBB4A
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.7596422779530061,1.6176767963793053,0.018209408194233688,0.431307819943944,1.0,3/13,3.20%,BMP4;NR3C2;ESR1
prerank,skeletal system development (GO:0001501),0.5476703820863492,1.6170972073515002,0.0010706638115631692,0.4294121134731525,1.0,37/148,9.25%,KIAA1217;CDH11;TLL1;PCSK5;EXT1;PKD1;ALPL;BMP1;TNFRSF11B;BMP5;WNT11;GNAS;CMKLR1;AKAP13;SOX9;PAPSS2;ITGB8;NPR3;DSPP;XYLT1;GDF10;TGFBR1;PTHLH;NOG;FGFR1;ZBTB16;BMP6;MYOC;GLI2;CD44;SLC10A7;SULF1;EVC;PHEX;MMP16;P3H1;CHRD
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6724351506236619,1.6170408876015419,0.020833333333333332,0.4253399764509548,1.0,4/25,3.82%,THBS1;EGFR;NRP1;FZD7
prerank,histone H3 deacetylation (GO:0070932),0.7437095446924294,1.615812698651721,0.029940119760479042,0.4265124553110552,1.0,5/15,6.65%,HDAC4;HDAC9;HDAC8;PER1;SIRT6
prerank,secretion (GO:0046903),-0.6321650353429191,-1.614371200097895,0.028011204481792718,0.3715892026517233,1.0,6/14,13.40%,RIMS1;SLC22A6;NPR1;SLC22A4;SLC22A2;FBLN5
prerank,positive regulation of positive chemotaxis (GO:0050927),0.747042903249009,1.6132427772478755,0.021406727828746176,0.43381418713717085,1.0,4/15,3.17%,F3;PGF;NTRK3;VEGFA
prerank,cellular response to chemokine (GO:1990869),0.6212796412145515,1.6130880513202668,0.017994858611825194,0.4304427353765977,1.0,11/46,10.43%,STK39;SLC12A2;WNK1;PTK2B;CXCL2;CCL3;CCL1;ZC3H12A;FOXC1;CCL7;RHOA
prerank,positive regulation of cell communication (GO:0010647),-0.5184310090856296,-1.6118087514118937,0.003816793893129771,0.3720592364697408,1.0,9/28,10.17%,WLS;GRIK2;ANK3;RIMS1;RIMS2;SYT1;LGI1;KCTD13;EDN1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.39387118954138006,-1.6112356176116507,0.0,0.36712981923398363,1.0,31/107,11.18%,ATP1A2;GRM7;LRRC4C;CDH2;GRID2;GRIK2;NRG3;DGKI;MCTP1;GRM5;GRM3;APP;DLGAP1;RIMS1;GRM1;RIMS2;MCTP2;EIF4EBP2;SYT1;MEF2C;CACNA1B;OPHN1;ABR;LGI1;TMEM108;LRP8;KCTD13;GRM8;IQSEC2;SLC8A3;TPRG1L
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.5864017324797257,-1.6103055384937004,0.019933554817275746,0.3631563904542149,1.0,7/17,9.75%,ITGA1;PDGFRB;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.697811964165612,1.6092425662593952,0.020028612303290415,0.4447158459765128,1.0,7/21,6.38%,BMP4;CCN3;TGFB3;BMPR1A;TGFBR1;BMP6;NUP93
prerank,limb morphogenesis (GO:0035108),0.6966857948009062,1.6087578294979115,0.0344311377245509,0.44272286034388403,1.0,6/20,5.66%,PCSK5;LRP6;MBNL1;GLI3;NIPBL;SKI
prerank,regulation of monocyte chemotaxis (GO:0090025),0.6748619428389263,1.607166234964302,0.029085872576177285,0.4459642085287312,1.0,5/24,5.95%,SLIT2;CCN3;ANO6;CCL1;NBL1
prerank,neural tube closure (GO:0001843),0.6439377137495975,1.604858238446377,0.01875,0.4524425159290132,1.0,6/34,5.66%,LRP6;COBL;LMO4;PRICKLE1;GRHL2;SKI
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6340466304590896,1.6040608070804248,0.016414141414141416,0.4520290709574746,1.0,8/39,5.28%,STK39;FHL1;FXYD5;NEDD4;PTPN3;ANK2;WWP2;RANGRF
prerank,B cell receptor signaling pathway (GO:0050853),-0.5074568711758951,-1.6038503705884617,0.008298755186721992,0.37503911593803396,1.0,11/32,13.75%,PRKCB;BCL2;RFTN1;TEC;MEF2C;VAV3;CD38;BMX;NFATC2;SH2B2;BLNK
prerank,negative regulation of leukocyte migration (GO:0002686),0.7928740887383382,1.6029969218043978,0.03201219512195122,0.4527646665942482,1.0,3/10,5.81%,SLIT2;BMP5;EMILIN1
prerank,cardiac muscle cell contraction (GO:0086003),0.7000281784578583,1.596896175133402,0.027298850574712645,0.4760215931713255,1.0,5/19,1.97%,KCNJ2;CACNA1C;CACNA1G;CAMK2D;GSN
prerank,ganglioside biosynthetic process (GO:0001574),-0.5992488247067186,-1.595958144328567,0.03215434083601286,0.3894573288018116,1.0,5/15,8.98%,ST6GALNAC3;ST8SIA4;ST3GAL1;ST8SIA6;B4GALT6
prerank,response to cholesterol (GO:0070723),0.7086673614784913,1.5953666603019887,0.02359882005899705,0.478858819126744,1.0,8/17,9.97%,LRP6;SMO;CCL3;TGFBR1;TGFBR2;SMAD2;GRAMD1A;GRAMD1C
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.7808488258513308,1.5953062080927571,0.03727714748784441,0.4747905500713543,1.0,5/11,12.02%,BMP4;ZFPM2;BMPR1A;GATA4;JAG1
prerank,negative regulation of T cell differentiation (GO:0045581),0.8034518106476348,1.5942207950163227,0.022082018927444796,0.47551316245106356,1.0,3/10,7.74%,BMP4;GLI3;IRF1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6101979104976682,1.5927460377580036,0.009650180940892641,0.47838686293116256,1.0,15/46,14.46%,TCF7L2;NEDD4;CDH1;PRKCD;GSK3B;ZIC1;EMD;UBR5;BAG3;ZC3H12A;MAVS;XPO4;JUP;DMAP1;KHDRBS1
prerank,negative regulation of myotube differentiation (GO:0010832),0.7606534787775876,1.5920221976436855,0.0243531202435312,0.4775939587819089,1.0,4/12,9.62%,CCN3;HDAC4;CEACAM5;TMEM119
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.7447967622326024,1.5918245642048052,0.02945736434108527,0.4743107953541339,1.0,5/13,7.63%,BMP4;NFIB;SOX9;NFATC4;NFATC3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.6873867738263147,1.591306087507161,0.021337126600284494,0.4723733765029603,1.0,5/23,12.22%,SLC12A7;SLC12A2;ATP6V0A4;SLC9A1;SLC12A8
prerank,ceramide transport (GO:0035627),-0.6467094968743693,-1.5905696444121864,0.036931818181818184,0.3977113088088042,1.0,7/12,25.15%,PLTP;CERT1;ABCB4;ABCA2;PLEKHA3;GLTP;CPTP
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.7442966955940715,1.5900564808064328,0.026033690658499236,0.4737334635782923,1.0,1/13,0.02%,SLC4A10
prerank,chordate embryonic development (GO:0043009),0.5986877943788527,1.5896795998473983,0.009580838323353293,0.4715083900895571,1.0,15/55,5.88%,KIAA1217;PCSK5;PKD1;MBNL1;BMP5;FUT8;WNT11;GRHL2;VEGFA;TGFB3;XYLT1;TGFBR1;NOG;FGFR1;DACT1
prerank,purine nucleotide metabolic process (GO:0006163),0.6626450098234601,1.5878124116841539,0.022222222222222223,0.4761303377832487,1.0,7/24,11.50%,NT5C1A;PRPS2;FHIT;NT5E;DNPH1;XDH;NUDT15
prerank,epithelial tube morphogenesis (GO:0060562),0.6418864856536592,1.5854365137835487,0.03087248322147651,0.4831170667974039,1.0,5/32,1.09%,SLIT2;BMP4;MET;PKD1;HES1
prerank,spinal cord development (GO:0021510),0.7427069007139401,1.5850495912023195,0.0350076103500761,0.48087796044048686,1.0,4/12,6.46%,VIT;PKD1;NF1;GLI2
prerank,regulation of protein import into nucleus (GO:0042306),0.6257470485692134,1.582893241295453,0.01918158567774936,0.487288855261742,1.0,12/36,13.59%,BMP4;CDH1;PRKCD;ZIC1;MDFIC;UBR5;BAG3;ZC3H12A;MAVS;CHP1;JUP;DMAP1
prerank,regulation of cardiac conduction (GO:1903779),-0.44065115370601554,-1.58061134134571,0.0,0.4206048785847709,1.0,17/54,12.19%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ABCC9;NPR1;ATP2A2;TRPC1;ATP1B2;ATP2A3;DMPK;SLC8A3;FXYD6;ATP2B1;AHCYL1;ACE2
prerank,thymus development (GO:0048538),0.7534684746562852,1.580459471724882,0.03048780487804878,0.49476199252340575,1.0,4/13,4.69%,SIX1;HES1;TGFBR1;EPHB3
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.6678767255313998,-1.5796364339014288,0.01971830985915493,0.4169397105824556,1.0,6/11,12.57%,NEDD4L;ACTN2;PICALM;LEPROTL1;GPM6B;TAX1BP3
prerank,skeletal system morphogenesis (GO:0048705),0.6116453674478187,1.5794801719893823,0.01277139208173691,0.4951232397236386,1.0,16/42,16.78%,SIX1;LRP6;HOXA3;SFRP4;HOXC4;TGFBR1;HOXB3;FGFR1;SKI;HOXB4;LRP5;DYNC2I1;HOXD3;MEGF8;HHIP;FGFR3
prerank,extracellular structure organization (GO:0043062),0.518758513446913,1.5789755322268995,0.00205761316872428,0.4935063950365935,1.0,39/204,8.49%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;ADAMTSL1;VIT;THSD4;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;DDR2;COL5A2;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;DSPP;MMP28;COL6A3;COL11A1;ELN;ADAMTS3;TGFBR1;NF1;BGN;CD44;FN1;ITGB1;ADAMTS6;COL17A1;ADAMTSL5;MMP16
prerank,negative regulation of cellular protein localization (GO:1903828),-0.4896290240555411,-1.578423051124127,0.021645021645021644,0.4138467591296242,1.0,12/34,12.57%,MFHAS1;NEDD4L;ACTN2;RIPOR2;PICALM;ROCK2;ANKRD13A;MAPT;LEPROTL1;GPM6B;MAP1A;TAX1BP3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.43064227584508713,-1.5745872972171207,0.0,0.41877077290768094,1.0,12/57,14.46%,ADCY5;GRM7;LPAR1;ADCY1;CHRM2;ADCY7;PDE2A;CHRM3;GRM8;ADRA2A;OPRM1;GNAI1
prerank,BMP signaling pathway (GO:0030509),0.5903258961504669,1.5731498380989197,0.002403846153846154,0.5173277198883262,1.0,15/62,9.27%,BMP4;DDX5;SMAD6;BMP5;TMEM100;SMAD9;TGFB3;BMPR1A;NOG;USP15;BMP6;SMAD2;RUNX2;CHRD;PDCD4
prerank,activation of protein kinase A activity (GO:0034199),-0.5885108630466742,-1.5730301683782504,0.04819277108433735,0.4170045988536058,1.0,6/16,6.42%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A
prerank,regulation of sequestering of calcium ion (GO:0051282),0.7475783534298025,1.572971483619283,0.0401854714064915,0.513978264762942,1.0,4/12,6.07%,UBASH3B;ANK2;PTK2B;DIAPH1
prerank,B cell homeostasis (GO:0001782),-0.673787503868124,-1.5712448347340608,0.04132231404958678,0.4157258007714002,1.0,4/10,5.75%,DOCK10;LYN;DOCK11;MEF2C
prerank,external encapsulating structure organization (GO:0045229),0.5166222950533192,1.570645901882869,0.0020639834881320948,0.521527218591033,1.0,29/205,4.10%,COL8A1;ADAMTSL3;SH3PXD2A;SMOC2;THBS1;ADAMTS17;COL6A2;COL8A2;ADAMTSL1;VIT;THSD4;ADAMTS2;MFAP5;COL6A1;SMOC1;CDH1;DDR2;COL5A2;FGF2;LOXL1;COL3A1;ITGB8;ITGB5;DSPP;MMP28;COL6A3;COL11A1;ELN;ADAMTS3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6131657926471463,1.5699027986011838,0.016581632653061226,0.5209698799801998,1.0,10/39,5.28%,STK39;FXYD5;NEDD4;PTPN3;WNK1;CAMK2D;PRKCE;FGF13;SLMAP;RANGRF
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.6110142269834581,1.5698020552823526,0.018158236057068743,0.5174132157554954,1.0,8/43,4.96%,THBS1;FOXP1;BMP4;IGFBP5;FGF2;BMPR1A;ID2;NR4A3
prerank,xenobiotic transport (GO:0042908),0.7130477888931679,1.5691714584818344,0.03654970760233918,0.5163250272060522,1.0,2/17,2.16%,SLC47A1;ABCG2
prerank,import into cell (GO:0098657),0.6149234240100829,1.5690399730623494,0.017654476670870115,0.5130564594169471,1.0,6/41,3.32%,SLC47A1;SLC38A1;SLC12A7;SLC5A6;LRRC8D;SLC39A14
prerank,gland development (GO:0048732),0.5871447191288035,1.5677266293013292,0.00853658536585366,0.515815909851646,1.0,15/59,7.70%,SIX1;MET;HES1;COBL;WNT11;EZR;IGSF3;SOX9;TGFB3;TGFBR1;EPHB3;ANXA1;NF1;GLI2;DKK3
prerank,positive regulation of leukocyte activation (GO:0002696),0.6991689062805702,1.5664320529251943,0.041176470588235294,0.5181043750181725,1.0,5/18,8.34%,THBS1;LBP;CD2;IL33;TLR4
prerank,regulation of fibroblast migration (GO:0010762),0.6745897022909766,1.5634411953247935,0.034532374100719423,0.5285993568407541,1.0,8/20,8.58%,THBS1;DDR2;PRKCE;FGF2;HAS1;ITGB1;DMTN;CORO1C
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.7008042927050038,1.563269332559224,0.03,0.5255892724003296,1.0,2/19,3.01%,SLC26A2;PAPSS2
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.5652663971219415,-1.5620485109331057,0.0486322188449848,0.4362946018808012,1.0,6/18,21.04%,APOE;TMCC2;ABCG1;APH1B;NSG1;ADAM19
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6692017989567627,-1.5604412001691714,0.038929440389294405,0.43427352852264334,1.0,4/10,7.11%,SEMA6A;DCN;CADM4;DAB2IP
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5885943059069483,-1.5602671001070465,0.03571428571428571,0.4284580879929162,1.0,8/15,26.85%,PRKCH;CSF1;IL18;LPL;MSR1;CD36;AGT;PLA2G5
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.648016790913163,1.5579089497996912,0.03899721448467967,0.5466884870654964,1.0,16/27,23.55%,USP2;ID2;ATOH7;PER1;BHLHE40;CRY2;PER3;MTA1;CRTC1;PDE6B;SIK1;FBXL6;PPP1CC;PML;FBXL8;TP53
prerank,regulation of interleukin-1 production (GO:0032652),0.7109468411642832,1.5577593068959643,0.03994082840236687,0.5435323721398027,1.0,4/15,8.34%,FOXP1;ANXA1;NLRP12;TLR4
prerank,aortic valve morphogenesis (GO:0003180),0.6305462648397019,1.55586925221052,0.022606382978723406,0.5492754397752023,1.0,8/30,5.81%,SLIT3;SLIT2;BMP4;SMAD6;SOX9;ELN;TWIST1;EMILIN1
prerank,inorganic anion transmembrane transport (GO:0098661),0.5711145312849557,1.5555798473606797,0.017605633802816902,0.5468676523311683,1.0,8/63,4.12%,SLC26A2;SLC12A7;SLC5A6;SLC12A2;ANO9;GABRA3;ANO6;GLRB
prerank,negative regulation of protein processing (GO:0010955),0.7444516240344745,1.5546667489375117,0.0379746835443038,0.5473460850619216,1.0,3/12,6.06%,THBS1;GAS1;ACP4
prerank,embryonic limb morphogenesis (GO:0030326),0.6271610553181116,1.5541520909951065,0.03609625668449198,0.5460246649575057,1.0,11/34,7.03%,LRP6;CACNA1C;MBNL1;AFF3;GLI3;NOG;TWIST1;NIPBL;SKI;ECE1;CREBBP
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.6478571169093199,1.5534328843586316,0.03867403314917127,0.5456049480214267,1.0,5/27,6.49%,BMP4;EGFR;DDX5;STAT3;AGO2
prerank,regulation of cell killing (GO:0031341),0.7012614482487236,1.5523905599400456,0.03875968992248062,0.5470925878864583,1.0,3/16,3.82%,CFH;CD55;FZD7
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7181152793471777,1.5513606470167802,0.04078549848942598,0.5481625146149675,1.0,4/14,4.57%,WNT9A;SOX9;TGFBR1;PTHLH
prerank,positive regulation of macrophage activation (GO:0043032),0.7047453384853068,1.5499789722983364,0.039755351681957186,0.5511209462396573,1.0,5/17,8.34%,THBS1;LBP;CCL3;IL33;TLR4
prerank,negative chemotaxis (GO:0050919),0.6259158290133477,1.5497572319271333,0.027308192457737322,0.5482653802201896,1.0,8/33,5.78%,SLIT3;SLIT2;NTN1;SEMA3E;UNC5C;SLIT1;SEMA3C;SEMA3D
prerank,cellular response to BMP stimulus (GO:0071773),0.5712384939850139,1.5477131575512357,0.0071174377224199285,0.5540641596676638,1.0,14/66,9.27%,BMP4;DDX5;SMAD6;BMP5;TMEM100;SMAD9;SOX9;TGFB3;BMPR1A;USP15;BMP6;SMAD2;RUNX2;PDCD4
prerank,photoperiodism (GO:0009648),0.6382728208307346,1.546900775123779,0.043596730245231606,0.5542244811602483,1.0,16/28,23.55%,USP2;ID2;ATOH7;PER1;BHLHE40;CRY2;PER3;MTA1;CRTC1;PDE6B;SIK1;FBXL6;PPP1CC;PML;FBXL8;TP53
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.5549247647311345,1.5463641641419306,0.01652892561983471,0.5530017772389587,1.0,18/76,13.19%,RASSF2;EGFR;CCN3;NR3C2;TCIM;NFAT5;EZR;LIMS1;NLRP12;ZC3H12A;TLR4;PDCD4;RHOA;EIF2AK2;TRIM44;IFI35;CPNE1;DLG1
prerank,response to purine-containing compound (GO:0014074),-0.5775534559255223,-1.5441988398167783,0.03293413173652695,0.4713969426303952,1.0,6/17,10.41%,RYR2;ABCC9;TRPC3;P2RY1;STAT1;P2RX7
prerank,aortic valve development (GO:0003176),0.6161097703643449,1.5429569736530606,0.020942408376963352,0.5660413193397311,1.0,8/34,5.81%,SLIT3;SLIT2;BMP4;SMAD6;SOX9;ELN;TWIST1;EMILIN1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6766126076574775,1.5427160472073211,0.03945371775417299,0.5634939541428547,1.0,8/19,13.65%,SLIT3;SMAD6;BMPR1A;TGFBR2;GATA4;ZFPM1;MDM4;ACVR1
prerank,glycine transport (GO:0015816),-0.659694671679746,-1.541298917459854,0.053164556962025315,0.47432699703329306,1.0,5/10,22.43%,SLC6A9;SLC38A5;SLC6A17;SLC6A5;SLC36A2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6932093445452681,1.5384952471032138,0.03901734104046243,0.5801379724396165,1.0,4/17,10.91%,EGFR;PKD1;CCND1;CCNYL1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.5737121764202895,-1.5384670391725248,0.043343653250773995,0.47657302272411894,1.0,12/18,26.40%,MSRA;ASPA;SLC25A13;ASPG;GOT2;ASNS;FOLH1;ADI1;SMS;GOT1;ASS1;NAT8L
prerank,atrioventricular valve development (GO:0003171),0.7126465034263092,1.537927287691416,0.04510108864696734,0.5793102047932701,1.0,6/14,13.65%,SLIT3;BMPR1A;TGFBR2;ZFPM1;MDM4;ACVR1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6551311697923475,1.5364863335245251,0.037138927097661624,0.5827628969578703,1.0,2/27,0.16%,SLC47A1;SLC38A1
prerank,regulation of membrane depolarization (GO:0003254),0.6792626624506016,1.5364858754492765,0.049107142857142856,0.5790337143216205,1.0,9/18,17.76%,FHL1;PTPN3;CAMK2D;RANGRF;ABCD1;SCN1B;SCN3B;SMAD7;LRRK2
prerank,regulation of ossification (GO:0030278),0.6076215244716365,1.5362853411937143,0.022427440633245383,0.5762594716177426,1.0,9/36,5.85%,BMP4;LRP6;DDR2;SMAD6;SOX9;SGMS2;TXLNG;TWIST1;ZBTB16
prerank,L-glutamate transmembrane transport (GO:0015813),-0.6793294464377344,-1.53622845964488,0.039473684210526314,0.4770446471083764,1.0,4/10,5.34%,SLC1A3;SLC1A1;SLC1A2;SLC25A13
prerank,odontogenesis (GO:0042476),0.6079145888083742,1.5360226194519602,0.038314176245210725,0.5738017247134574,1.0,11/35,11.99%,BMP4;LRP6;EDA;PITX2;TGFB3;ACP4;GLI2;INHBA;FOXC1;BCOR;COL1A2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6712669722133855,1.5354498964119754,0.03328509406657019,0.572900033548205,1.0,3/22,1.97%,SLIT2;PRKCD;GSN
prerank,negative regulation of myoblast differentiation (GO:0045662),0.7199532428681842,1.5352117830605456,0.04732824427480916,0.5704876899325149,1.0,3/13,2.75%,BMP4;PRICKLE1;SOX9
prerank,positive regulation of locomotion (GO:0040017),0.6308129015029834,1.5344376409318419,0.040787623066104076,0.570684671975993,1.0,4/27,4.99%,THBS1;NTN1;CCDC25;TWIST1
prerank,cartilage development (GO:0051216),0.5911581847432485,1.533361701425882,0.023543990086741014,0.5724073048412319,1.0,12/49,8.73%,BMP4;CCN3;NFIB;PKD1;FGF2;SOX9;ITGB8;SLC39A14;ZBTB16;CD44;SULF1;RUNX2
prerank,vesicle transport along actin filament (GO:0030050),-0.542716580167345,-1.5326409167242117,0.049079754601226995,0.48252914151136983,1.0,13/19,33.40%,MYO1B;FNBP1L;MYO5A;ACTN4;MYO6;MYO5C;MYO1F;MYO1G;MYO15A;MYO7A;MYO1H;MYO1D;MYO1A
prerank,negative regulation of endocytosis (GO:0045806),-0.5069231022044393,-1.5317127015250238,0.030927835051546393,0.4791956828820909,1.0,8/24,11.17%,PRKD1;MCTP1;PICALM;NR1H3;SYT11;RAC1;CD300A;NR1H2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5727018261610852,-1.5312858564106933,0.05105105105105105,0.47417817333870516,1.0,4/15,3.26%,GRM7;GRM5;GRM3;GRM1
prerank,alcohol catabolic process (GO:0046164),-0.6506073004359184,-1.5311389897311938,0.08994708994708994,0.46829657238360156,1.0,2/10,1.77%,APOE;CYP27A1
prerank,regulation of response to stress (GO:0080134),0.754229582809879,1.5310489868227695,0.03542673107890499,0.5800286627404929,1.0,1/10,0.06%,SLC38A2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6417479029119069,-1.530354622546995,0.05604719764011799,0.4646601795816167,1.0,7/11,22.48%,MECOM;WNT5A;ETV6;CD34;YJEFN3;WNT2B;WNT10B
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.583431786568697,1.53004670668896,0.02392947103274559,0.5812851686802555,1.0,8/46,4.96%,THBS1;FOXP1;BMP4;TCF7L2;IGFBP5;ID2;ELN;NR4A3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5751623657582494,-1.5290251827545274,0.03323262839879154,0.46280933719127326,1.0,10/15,23.12%,IL31RA;NR1H3;LRFN5;CD200;CD300A;CD84;GRN;MILR1;CD300LF;GPER1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6673259736792734,1.5279910924019036,0.030791788856304986,0.5872722892131896,1.0,4/20,3.59%,THBS1;GSN;SFRP4;ANO6
prerank,response to progesterone (GO:0032570),0.685857878994689,1.5268832827739924,0.05057803468208093,0.589267388579028,1.0,2/18,3.17%,THBS1;TGFB3
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.5026820136801642,-1.526833937725101,0.0375,0.46352396940661683,1.0,14/26,23.84%,LYN;PICALM;ROCK2;MBP;GRIN2B;EPHA4;GRIN1;AIM2;APH1B;PYCARD;PSME2;AGER;TTBK1;VSIR
prerank,response to sterol (GO:0036314),0.7455218033818556,1.5264171040531231,0.041990668740279936,0.5881771257628152,1.0,5/11,7.92%,CCL3;TGFBR1;TGFBR2;RORA;SMAD2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.7019933038964979,1.5257424940092852,0.071875,0.5877133028711792,1.0,6/14,12.97%,THBS1;MEOX2;KLF4;STARD13;RHOA;ITGB1BP1
prerank,sodium ion transport (GO:0006814),0.5356790308764631,1.5245037634186438,0.013498312710911136,0.5897959300950385,1.0,9/85,3.59%,SLC4A4;SLC23A1;SLC9B2;SLC5A6;SLC12A2;SLC24A3;ATP1B1;FGF13;ANO6
prerank,regulation of MAPK cascade (GO:0043408),-0.3606595539475375,-1.5241909894119767,0.0,0.4660769878767901,1.0,41/157,10.41%,FLT1;IGF1R;IGF1;PHLPP1;KSR1;LYN;TEK;TNIK;KIT;LPAR1;TGFBR3;JCAD;PAK1;EPHB1;PELI2;ROCK2;KDR;EPHA7;INSR;RIT2;PAK3;SPRED1;ROR2;RYK;LBH;DAG1;TBX1;EPHA8;MAP4K4;ZDHHC17;MAPK1;DAB2IP;NRK;BMP2;NTRK2;PAK5;PTPRJ;FAS;MAP2K1;FLT3;P2RX7
prerank,nucleotide metabolic process (GO:0009117),0.6619613113555636,1.5240009156871022,0.04827586206896552,0.5885553783803035,1.0,9/23,14.97%,ME1;FHIT;NUDT5;NMNAT2;NMNAT1;CTPS2;AK4;AK1;REXO2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.5887750450083516,1.5227603811817378,0.029925187032418952,0.5908864368210036,1.0,8/44,3.59%,KCNJ2;KCNJ15;KCNMB3;KCNMB2;WNK1;ANK2;ATP1B1;ANO6
prerank,cellular response to estradiol stimulus (GO:0071392),0.6631221833221149,1.5222235902847276,0.0410958904109589,0.5899653159141615,1.0,4/18,10.40%,EGFR;ESR1;LCOR;POU4F1
prerank,chemical homeostasis (GO:0048878),0.554447327098584,1.5220336091727742,0.018648018648018648,0.5875421554972662,1.0,9/61,11.47%,SLC4A10;SLC4A4;WNK1;SLC4A2;ACOX3;PNPLA3;TLCD1;RBP1;ANGPTL3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6184838074574251,1.5208661426337489,0.03633916554508748,0.5896414107980933,1.0,13/32,10.83%,THBS1;RHOJ;MEOX2;HDAC9;FGF2;VEGFA;FOXC2;KLF4;ANXA1;STARD13;CIB1;RHOA;MAP3K3
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5651905016214569,1.5205530879813411,0.0208078335373317,0.5880099291168183,1.0,20/61,14.63%,SMOC2;EGFR;EYA2;FGF2;EYA4;RAD51;SIRT6;WRN;UIMC1;STPG4;PARP3;DHX36;MECP2;RAD50;EYA3;BRCA1;TIGAR;RNF8;ATRX;BRCC3
prerank,catecholamine biosynthetic process (GO:0042423),-0.6525543253192667,-1.518656553705787,0.04736842105263158,0.47787743670369515,1.0,4/11,21.08%,MOXD1;GCH1;DDC;SNCA
prerank,inositol phosphate-mediated signaling (GO:0048016),0.6757727143787462,1.516492918480286,0.04538799414348463,0.6036599980719272,1.0,8/19,15.76%,PLCE1;PPP3CA;NFAT5;NFATC4;NFATC3;NMUR2;NFATC1;PPP3CC
prerank,regulation of cholesterol storage (GO:0010885),-0.5749625222349317,-1.5154109866666554,0.06382978723404255,0.48215799568170387,1.0,9/15,24.13%,PPARA;ABCG1;NR1H3;PPARD;NR1H2;LPL;MSR1;ABCA1;TREM2
prerank,cellular response to peptide (GO:1901653),-0.4275544384836285,-1.5142212916902171,0.01282051282051282,0.48012597582947986,1.0,14/56,6.07%,IGF1R;IGF1;GRM5;APP;VCAM1;GRIN2A;NOD1;SNX6;GJA1;CASP4;EPHA4;GRIN1;LGMN;CACNA2D1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.7319469614544649,1.5140426315156794,0.060842433697347896,0.6124314431110875,1.0,4/12,5.95%,SLIT2;CCN3;BMP5;NBL1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6142999435484133,1.5127455564805075,0.04900662251655629,0.615484660420157,1.0,6/33,5.34%,MAP3K5;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1
prerank,negative regulation of insulin secretion (GO:0046676),0.6909218546172182,1.5125298237032463,0.053857350800582245,0.6129606440148541,1.0,4/17,4.72%,CCN3;KCNB1;IRS1;KLF7
prerank,negative regulation of phosphorylation (GO:0042326),0.530559660751954,1.5102752662509606,0.02127659574468085,0.6202656075544735,1.0,22/85,12.33%,SLIT2;BMP4;LRP6;HDAC4;NTRK3;PID1;PLPP3;NIBAN1;KLHL31;IBTK;PFKFB1;INHBA;NCOR1;ZC3H12A;CORO1C;CDKN2C;CIB1;XDH;EPHB2;CHP1;CDKN1C;CDKN1B
prerank,in utero embryonic development (GO:0001701),0.6399798364217637,1.5099682366916662,0.05138888888888889,0.6182343137322206,1.0,6/25,4.49%,PKD1;MBNL1;FUT8;VEGFA;TGFB3;TGFBR1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.6733822636205463,1.5064545172292791,0.05945121951219512,0.632508418340025,1.0,5/16,9.37%,DDX5;RBFOX2;ESR1;DDX17;TADA3
prerank,cellular response to reactive oxygen species (GO:0034614),0.5658414181781546,1.5059954615645275,0.027058823529411764,0.6310508142204201,1.0,8/59,6.13%,EGFR;MAP3K5;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1;PRDX5
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5330714207511783,1.5050794356417538,0.0223463687150838,0.6324096346482154,1.0,19/86,10.44%,THBS1;BMP4;FOXD1;CCN1;BMP5;TGFB3;ZNF423;GIPC1;BMPR1A;GDF10;TGFBR1;BMP6;NUP93;INHBA;CREBBP;SULF1;SMAD2;TTK;TGFB1I1
prerank,actin filament depolymerization (GO:0030042),0.7266224317728127,1.504851981624514,0.06134969325153374,0.6298923768446016,1.0,2/11,1.97%,MICAL2;GSN
prerank,metanephros development (GO:0001656),0.6345921766993972,1.5048192214413478,0.058091286307053944,0.6266470981963811,1.0,6/26,5.44%,SIX1;BMP4;PKD1;FOXD1;NIPBL;NF1
prerank,T cell migration (GO:0072678),0.7133687166640678,1.504752218301596,0.06584992343032159,0.6236850774071453,1.0,2/13,4.14%,SLC12A2;CCL3
prerank,endothelial cell proliferation (GO:0001935),0.6755557068139967,1.5035138471171736,0.06628242074927954,0.6263064243449377,1.0,6/17,13.19%,BMPER;BMP4;PROK2;NRARP;ITGB1BP1;DLG1
prerank,mesenchyme development (GO:0060485),0.7006942258785426,1.503359872198287,0.06006006006006006,0.6236822757276363,1.0,4/15,8.40%,BMP4;WNT11;TGFBR1;GATA4
prerank,nucleotide catabolic process (GO:0009166),0.6793654964247857,1.503260262284169,0.043674698795180725,0.6208464431135129,1.0,7/16,11.50%,NT5C1A;NT5E;DNPH1;DERA;VCP;XDH;NUDT15
prerank,positive regulation of cell cycle (GO:0045787),0.5572661517977711,1.5030795772191643,0.027842227378190254,0.6184476414122275,1.0,11/62,12.33%,SMOC2;EGFR;LRP6;PKD1;USP2;RARA;CCND1;CCNB1;CCNYL1;ANKRD17;CDKN1B
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.5182123788995379,1.5024081041973656,0.005376344086021506,0.61855774124831,1.0,40/128,18.32%,BMP4;ADAM9;DDX5;SMAD6;BMP5;TMEM100;COL3A1;SMAD9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;TGFBR1;USP15;LTBP2;SKI;BMP6;TGFBR2;INHBA;ITGB1;SMAD2;RUNX2;NLK;PDCD4;RHOA;TGFB1I1;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A;INHBB;RNF111;MEGF8;SMAD4;SMAD7;TWSG1;SMURF1;RGMB
prerank,osteoclast differentiation (GO:0030316),0.6508762954174023,1.501888129833502,0.04405286343612335,0.6179180575860098,1.0,3/22,2.25%,FOXP1;ANXA2;GAB2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.44989076694326424,-1.5014707533942164,0.027777777777777776,0.5163650689005046,1.0,17/38,19.93%,IL34;GRM5;NEDD9;APP;ACE;EPHA4;GPRC5B;LRP8;GAS6;NOX4;ERBB3;CSF1R;RELN;HYAL2;THY1;FCGR1A;PRNP
prerank,muscle cell differentiation (GO:0042692),-0.4769980750549733,-1.501457924086468,0.036734693877551024,0.5103130231325581,1.0,11/32,9.05%,WNT5B;SPEG;SGCZ;TBX18;MRTFB;TBX1;MEF2C;SYNE1;TMEM204;HEY2;GATA6
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4787684862581245,-1.5010791727346557,0.03278688524590164,0.5055754585278558,1.0,14/32,23.44%,CEMIP;AKAP6;TRPC3;GRIN1;TRPC1;P2RX7;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1;CAV1
prerank,epithelial cell differentiation (GO:0030855),0.530872137934252,1.501071636204996,0.014722536806342015,0.61880578543182,1.0,18/88,12.59%,SIX1;BMP4;FSTL1;CASP6;ANXA4;BDH2;EHF;GRHL2;VEGFA;FZD7;ANXA1;TDRD7;GSTA2;DNPH1;ANXA7;RHCG;JAG1;PTER
prerank,regulation of dopamine secretion (GO:0014059),-0.4934273457822137,-1.500698727105816,0.038461538461538464,0.5009579596532907,1.0,15/25,27.12%,SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;SYT2;KCNA2;SYT15;SNCA;CHRNA4;DRD2;CHRNB2
prerank,negative regulation of cellular component movement (GO:0051271),-0.5906653259108832,-1.5004560104805138,0.04477611940298507,0.496158638910809,1.0,4/15,1.83%,FRMD5;SPOCK3;TGFBR3;FBLN1
prerank,basement membrane organization (GO:0071711),-0.5839844333508736,-1.500290792442733,0.0621301775147929,0.49104185365480274,1.0,9/14,23.20%,NID1;NID2;LAMB1;COL4A1;LAMB2;CTSS;LAMB3;NTNG1;NTNG2
prerank,AMP metabolic process (GO:0046033),0.7091278518712298,1.4997541235647947,0.05279034690799397,0.6219435718969931,1.0,10/13,23.13%,NT5C1A;NT5E;AMPD3;XDH;AK4;AK3;AMPD2;NUDT2;ADSS2;ADSL
prerank,regulation of osteoblast proliferation (GO:0033688),0.663328921553326,1.499495921713495,0.06033182503770739,0.620100414241141,1.0,7/17,13.39%,CCN1;NELL1;NPR3;TMEM119;RHOA;EIF2AK2;PLXNB1
prerank,negative regulation of heart contraction (GO:0045822),-0.6313343787329335,-1.4991988905262257,0.07102272727272728,0.48926328812055647,1.0,4/11,12.14%,ATP1A2;PDE4D;SPTBN4;GRK2
prerank,renal water homeostasis (GO:0003091),-0.5130629742586235,-1.4975351957969283,0.05474452554744526,0.4889850288158167,1.0,9/23,14.73%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;WFS1;AQP4;PRKACB
prerank,amino sugar metabolic process (GO:0006040),-0.6504441441023446,-1.4973870787403192,0.07466666666666667,0.48401812032122604,1.0,3/10,2.05%,ST6GAL1;ST3GAL1;CSGALNACT1
prerank,establishment of endothelial barrier (GO:0061028),-0.4946202453060794,-1.4973214767763006,0.04980842911877394,0.4789806075113255,1.0,9/29,7.74%,TJP1;PECAM1;PPP1R16B;RAPGEF3;RAPGEF2;F11R;PDE4D;ROBO4;PDE2A
prerank,regulation of telomere maintenance (GO:0032204),0.631905768927406,1.4967857955599337,0.0403899721448468,0.6298776830588274,1.0,13/26,24.90%,HDAC8;SMG6;SIRT6;DHX36;RAD50;ATRX;YLPM1;XRCC5;ERCC4;PML;NBN;USP7;GNL3
prerank,regulation of B cell activation (GO:0050864),-0.49070228674466626,-1.4963785274663841,0.044673539518900345,0.47672455914360595,1.0,15/25,39.02%,AHR;SH3KBP1;TNIP2;SAMSN1;NOD2;ZFP36L1;BANK1;IL4I1;IKZF3;THEMIS2;LAPTM5;FOXJ1;CD22;TNFAIP3;IL6
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.7336528022603829,1.496259572747656,0.06060606060606061,0.6294878559700963,1.0,3/11,2.70%,RSPO3;MLLT3;PLEKHA4
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6872845810711403,1.4951794911092342,0.05873715124816446,0.631478177238842,1.0,3/15,3.95%,PIEZO2;TMEM120A;COL11A1
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5320928205689752,1.4947588512670227,0.013824884792626729,0.6304274822432087,1.0,14/84,5.15%,SMOC2;THBS1;FOXP1;BMP4;MET;PTK2B;PLPP3;FGF2;NRP1;VEGFA;FOXC2;BCAS3;ABL1;FGFR1
prerank,regulation of interleukin-12 production (GO:0032655),0.5690707751983399,1.4944932286798709,0.03647798742138365,0.6283868900093305,1.0,9/47,11.28%,THBS1;FOXP1;CMKLR1;PLCG2;IRAK3;TLR4;MAST2;RIPK2;TLR8
prerank,ventricular septum development (GO:0003281),0.5938435596003842,1.4938336224454445,0.030463576158940398,0.6282872728961653,1.0,8/37,6.61%,SLIT3;SLIT2;ZFPM2;HES1;BMPR1A;TGFBR1;NOG;TGFBR2
prerank,hexose transmembrane transport (GO:0008645),-0.5180346550050852,-1.4935916532187368,0.059375,0.4801352078140632,1.0,5/21,12.63%,SLC2A1;SLC2A12;SLC5A3;PPARD;SLC50A1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5636534876905447,1.492864448279684,0.026347305389221556,0.6295922550068722,1.0,8/54,3.49%,KCNJ2;STK39;FHL1;NEDD4;KCNJ15;KCNMB3;KCNMB2;WWP2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6165103639329693,1.4923995123073421,0.05533596837944664,0.6287299016029424,1.0,9/28,13.59%,CDH1;PRKCD;ZIC1;UBR5;BAG3;ZC3H12A;MAVS;JUP;DMAP1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6517758610826776,1.492383945857601,0.05065123010130246,0.6257664314476161,1.0,1/21,0.09%,SLIT2
prerank,cellular response to organic substance (GO:0071310),0.5098733378988916,1.4920512411632143,0.008733624454148471,0.6242296242322855,1.0,19/116,6.94%,SLIT3;SLIT2;RAMP1;DPYSL3;PID1;CYP1B1;NFAT5;IGFBP5;BMPR1A;KLF4;CCL3;TGFBR1;EMD;PTPN2;STAT3;SHC1;ERBB2;TGFBR2;NLRP12
prerank,response to zinc ion (GO:0010043),-0.504546698155906,-1.4913058071334964,0.039525691699604744,0.48170549786958694,1.0,18/25,27.63%,PAM;CRIP1;GLRA1;ATP13A2;MT3;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;KHK;HVCN1;SLC30A4;HAAO
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5554922733955762,1.4911901511286407,0.028605482717520857,0.6252654073684228,1.0,32/57,27.83%,FZR1;FOXN3;CHEK2;TICRR;WAC;TOPBP1;TRIM39;CCND1;UIMC1;CLSPN;FBXO31;RAD17;BRCA1;BRCC3;PRKDC;CDK2;CDKN1A;MDC1;DTL;DONSON;ATF2;NBN;CHEK1;TAOK1;ABRAXAS1;ATM;TP53;RAD9A;RAD9B;MRNIP;RPS27L;PLK1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6968318792320539,1.4895172594690673,0.048458149779735685,0.630269703506524,1.0,5/15,5.15%,SMOC2;MET;FGF2;VEGFA;FGFR1
prerank,positive regulation of phagocytosis (GO:0050766),-0.43805780774103614,-1.489140858633168,0.02564102564102564,0.48322339865979,1.0,23/47,26.85%,CAMK1D;MERTK;IL15RA;SIRPA;DOCK2;GATA2;RAB31;PTPRJ;C2;GAS6;TULP1;CD47;LYAR;C4B;PYCARD;CALR;C3;CD300LF;CCL2;TREM2;TUB;AHSG;PLA2G5
prerank,regulation of regulated secretory pathway (GO:1903305),-0.46474945217982394,-1.4890492147894068,0.023809523809523808,0.47852033902232466,1.0,15/34,20.93%,RIMS1;RIMS2;SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;RAB3A;RIMS4;RAB15;SYT2;SYT15
prerank,response to laminar fluid shear stress (GO:0034616),0.7201483758518696,1.4886288335209383,0.07570977917981073,0.6315180677479468,1.0,3/10,4.13%,SMAD6;NFE2L2;KLF4
prerank,embryonic organ morphogenesis (GO:0048562),0.5771143236975697,1.488409616138258,0.03176620076238882,0.6295597362026407,1.0,9/42,6.56%,SIX1;MFAP5;HES1;HOXA3;ID2;HOXC4;HOXB3;NIPBL;HOXB4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4886867147275087,-1.4882956509676437,0.04316546762589928,0.47598092043757356,1.0,10/27,16.28%,PRKCH;PPARA;ABCA5;CSF1;ABCG1;NR1H3;IL18;NR1H2;LPL;MSR1
prerank,lung epithelium development (GO:0060428),0.742114984512084,1.4879498337377757,0.058084772370486655,0.6286591046602799,1.0,3/10,3.07%,BMP4;PKD1;GRHL2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.6441157320793022,1.487894664539188,0.0617816091954023,0.6259796954032711,1.0,4/21,3.24%,THBS1;PTK2B;CMKLR1;MTUS1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5766582680096595,1.4873359354307965,0.04218362282878412,0.6254980543643156,1.0,6/41,2.83%,KCNJ2;KCNJ15;KCNMB3;KCNMB2;ANK2;CLTRN
prerank,transition metal ion transport (GO:0000041),-0.4592447758093283,-1.4870314965585107,0.037815126050420166,0.47498699776581327,1.0,15/35,17.33%,CP;SLC30A10;TRPC3;ATP2C1;TFRC;SLC39A8;TRPC4;TRPC6;TRPC1;SLC30A1;ATOX1;FTH1;SLC31A1;MT3;TRPC7
prerank,response to hydrogen peroxide (GO:0042542),0.576518152472551,1.4869404684445058,0.036991368680641186,0.6244637750502897,1.0,7/45,5.34%,MAP3K5;ADAM9;PRKCD;CYP1B1;NFE2L2;ABL1;ANXA1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.6021099175742867,-1.4862621009337014,0.07608695652173914,0.4724655797081741,1.0,4/11,15.39%,LYN;TNFRSF21;CD300A;TYROBP
prerank,cellular response to mechanical stimulus (GO:0071260),0.5675213798467285,1.4854951778786516,0.037082818294190356,0.6281339787866453,1.0,11/46,12.32%,PIEZO2;CRADD;SOX9;CASP2;IRF1;TLR4;SLC9A1;MAP2K4;TLR8;MAP3K1;MYD88
prerank,sensory perception of sound (GO:0007605),-0.3782327235437119,-1.4848987216844265,0.0,0.47168737472647193,1.0,21/88,12.33%,GRM7;COL4A3;KIT;DCDC2;CEMIP;CACNA1D;USP53;RIPOR2;ADGRV1;PCDH15;EYA1;TBX1;CLIC5;EPS8L2;NDUFB9;WFS1;GRAP;CCDC50;KCNQ1;SPTBN4;WHRN
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6165907624422182,1.484033063182502,0.0625,0.6318918220637547,1.0,11/25,13.19%,CACNA1C;CAMK2D;ANK2;FGF13;DSP;DSG2;RANGRF;AKAP9;TRPM4;JUP;DLG1
prerank,positive regulation of glucose import (GO:0046326),-0.5196314446723804,-1.4840027808710132,0.0425531914893617,0.46974638086998516,1.0,5/21,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;INSR
prerank,positive regulation of nervous system development (GO:0051962),-0.42945627755644034,-1.4818991583864354,0.038834951456310676,0.4711277853377623,1.0,11/42,11.08%,IL1RAPL1;GRID2;EPHB1;NRXN1;TGM2;SYNDIG1;MME;CUX2;SRPX2;LRRC4B;PTPRD
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4801423382548356,-1.481814510394907,0.043824701195219126,0.4667887533726452,1.0,12/30,21.92%,IGF1;IGFBP2;RPS3;PRKAR1A;IL18;HMGB1;ICOSLG;CD24;PYCARD;PRNP;AGER;CD274
prerank,neurotransmitter secretion (GO:0007269),-0.43146104662794643,-1.4796437093155765,0.02336448598130841,0.46851994286342163,1.0,10/44,7.00%,NRXN1;SYN2;RIMS1;RIMS2;LIN7A;SNAP25;SYT1;HSPA8;SYT10;PTPRN2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.7152969692884511,1.4792068501986844,0.07936507936507936,0.6516325221678021,1.0,2/11,3.28%,THBS1;BMPR1A
prerank,negative regulation of cell growth (GO:0030308),0.5126319580308005,1.477874891477279,0.015102481121898598,0.6552110192267527,1.0,9/121,2.21%,SLIT3;SLIT2;FHL1;CCN3;NDRG3;OSGIN2;ULK2;WNT11;FGF13
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6128216089371682,-1.4763434992039264,0.07754010695187166,0.47338452759804217,1.0,3/11,3.74%,TJP1;RAPGEF2;F11R
prerank,epiboly involved in wound healing (GO:0090505),0.6845206784179058,1.4761103523607828,0.055639097744360905,0.6607868748024209,1.0,5/16,10.43%,TMEFF2;CCN1;MRTFA;CD44;RHOA
prerank,regulation of myotube differentiation (GO:0010830),0.6238035464349735,1.4752754433741064,0.054016620498614956,0.6618800339487415,1.0,6/24,11.90%,CCN3;HDAC4;HDAC9;CEACAM5;TMEM119;ATP11A
prerank,mesenchymal to epithelial transition (GO:0060231),0.7271479510596078,1.4751790925894406,0.08173076923076923,0.6593377268475608,1.0,2/10,3.82%,BMP4;FZD7
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.6257477391496217,-1.4750623164020402,0.07407407407407407,0.4726680082639134,1.0,6/10,14.55%,SHANK3;APP;SYP;NETO1;SYNGR1;CAMK2B
prerank,aminoglycan biosynthetic process (GO:0006023),0.555378164416121,1.474103116330556,0.0422360248447205,0.6615107931423229,1.0,13/49,11.62%,GPC6;EXT1;GPC3;HS6ST2;B3GNT2;HEXA;HS3ST1;XYLT1;HAS1;SLC35D2;B4GAT1;B3GALT6;B3GNT9
prerank,response to prostaglandin E (GO:0034695),-0.6375854494767533,-1.4733316602874558,0.06648936170212766,0.473015365788012,1.0,6/10,25.42%,TGFBR3;GNG2;CCL19;SFRP1;GNB1;PTGER4
prerank,inositol phosphate biosynthetic process (GO:0032958),0.7322549090760526,1.4727691595297911,0.059282371294851796,0.6648877312182302,1.0,4/11,7.90%,FGF2;IP6K1;IP6K2;PPIP5K1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6950961778839025,1.4727370947122171,0.06870229007633588,0.6620999120079536,1.0,4/14,5.02%,SLIT2;IGFBP5;BMPR1A;LRP1
prerank,anion transport (GO:0006820),0.5898981341797713,1.472261288302867,0.05660377358490566,0.6614160638148613,1.0,4/33,4.19%,SLC26A7;LRRC8D;ABCG2;SLC4A2
prerank,sodium ion import across plasma membrane (GO:0098719),0.6541298711914716,1.4720642348533892,0.07994186046511628,0.6593746667589352,1.0,2/17,0.50%,SLC9A2;SLC12A2
prerank,purine nucleotide catabolic process (GO:0006195),0.6866160051665805,1.4707177669342035,0.07044410413476264,0.6626347426698035,1.0,5/13,11.50%,NT5C1A;NT5E;DNPH1;XDH;NUDT15
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6208218602293141,-1.4704111244644196,0.06925207756232687,0.47692994109871373,1.0,5/10,10.31%,LYN;MAPK1;RNF13;FAS;MAP2K1
prerank,regulation of smooth muscle contraction (GO:0006940),0.6468058930368782,1.4700753428014388,0.06694560669456066,0.6627685302554365,1.0,6/20,12.40%,KCNB2;PLCE1;ADRB2;PROK2;NMUR2;CTTN
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6102408045578774,1.4699779239817679,0.052,0.6603596922513505,1.0,12/27,16.62%,FXYD5;PTPN3;CAMK2D;SLMAP;SNTA1;RANGRF;ATP2B4;DLG1;SCN1B;COMMD1;SCN3B;FXYD2
prerank,smooth muscle contraction (GO:0006939),-0.5694122906271399,-1.469724931538822,0.07536231884057971,0.47460942977919135,1.0,7/14,8.26%,MYLK;SLC8A1;ROCK2;PIK3C2A;MYH11;BDKRB2;ACTA2
prerank,signal peptide processing (GO:0006465),0.7165418386534618,1.4697120568500321,0.07174887892376682,0.6587933044318375,1.0,1/11,0.66%,PCSK5
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.6231325110675234,1.469487926538332,0.06703146374829001,0.6569211727133064,1.0,7/25,7.92%,BMP4;FOXD1;CCN1;ZNF423;BMPR1A;SULF1;SMAD2
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.6349851799616464,-1.4689381902252716,0.07880434782608696,0.472624999345964,1.0,4/10,8.83%,APOD;LRCH1;RIPOR2;CD200
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6605774457862229,1.4686197899999882,0.07604017216642754,0.6579613860631809,1.0,3/18,3.09%,CCN3;KCNB1;IRS1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.5973505466542963,1.46826568183797,0.07152317880794702,0.6569024750546828,1.0,5/30,8.64%,FOXP1;DDX5;NCOR1;NCOR2;KDM1A
prerank,response to interleukin-4 (GO:0070670),-0.6273395418063639,-1.4680082656056264,0.05013192612137203,0.4711566915885609,1.0,4/10,18.29%,LEF1;TCF7;XBP1;JAK3
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5494783262621203,-1.4675421812375193,0.06230529595015576,0.4685136778877201,1.0,8/17,14.73%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;CYSLTR2;PRKACB
prerank,axon development (GO:0061564),-0.3850255207715479,-1.4671644106233963,0.007692307692307693,0.4654186751256829,1.0,24/78,12.24%,GRM7;NREP;ANK3;CTNNA2;APP;CNTN4;DCC;PAK3;DSCAML1;BAIAP2;RYK;ACTB;PLP1;RTN4;ZDHHC17;RTN4RL1;LMTK2;MAPT;CAMSAP2;SEMA5A;PLPPR4;SPTBN4;MAP1A;SLITRK5
prerank,embryonic eye morphogenesis (GO:0048048),0.7056032932519217,1.4671631345610152,0.08186195826645265,0.659104048303902,1.0,2/11,0.98%,LRP6;MFAP5
prerank,negative regulation of locomotion (GO:0040013),-0.5908633761989426,-1.4668825582482075,0.07458563535911603,0.4621260200028543,1.0,3/12,1.83%,FRMD5;SPOCK3;FBLN1
prerank,regulation of blood coagulation (GO:0030193),0.6114598935886991,1.4653833645587875,0.056010928961748634,0.6647007661557154,1.0,3/27,2.68%,THBS1;ST3GAL4;THBD
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7391322211453941,1.4642662586505806,0.08837209302325581,0.6670903956835929,1.0,3/11,1.65%,MAP3K5;PRKCD;CYP1B1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.6624104710863472,1.463640111798115,0.08395802098950525,0.6670553497874396,1.0,2/16,1.93%,ST3GAL4;NFAT5
prerank,response to UV (GO:0009411),0.5121579532022612,1.4633701904471812,0.020089285714285716,0.665500744438142,1.0,28/95,20.10%,EGFR;SCARA3;NEDD4;PRKCD;UBE4B;ERCC5;UBE2A;CREBBP;WRN;UVSSA;CCND1;KDM1A;USP1;PARP1;DHX36;EIF2S1;ZBTB1;PRIMPOL;UBE2B;USP28;CIRBP;PCLAF;USP47;MAP3K4;DTL;CAT;ATR;ERCC4
prerank,response to chemokine (GO:1990868),0.6764427208685897,1.462868343116783,0.0837138508371385,0.6648384972348831,1.0,6/13,10.43%,STK39;SLC12A2;WNK1;ZC3H12A;FOXC1;RHOA
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.7359493831945227,1.4623513434299493,0.07213114754098361,0.6645143606355249,1.0,4/10,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5218390771753976,-1.4612940065126765,0.08940397350993377,0.473655880149672,1.0,7/19,9.74%,IGF1;APOE;RTN1;PICALM;RTN4;NTRK2;BIN1
prerank,defense response to symbiont (GO:0140546),-0.3732774012106386,-1.4610899914755406,0.008928571428571428,0.470242296587511,1.0,32/92,19.43%,SERINC3;AGBL4;BCL2;ABCC9;BCL2L1;TRIM56;SERINC5;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;NDUFAF4;STAT1;RNASEL;IFITM2;IRF2;IFIT3;EXOSC5;RTP4;TLR7;SHFL;CD40;MLKL;NLRC5;PDE12;PYCARD;ZBP1;STAT2
prerank,histone H4 deacetylation (GO:0070933),0.732640687041119,1.4590018596964025,0.07981220657276995,0.6779948043148729,1.0,4/10,10.93%,HDAC4;HDAC9;HDAC8;RCOR1
prerank,actin filament-based transport (GO:0099515),-0.5110433784724019,-1.4585442822328414,0.05396825396825397,0.47345999162218455,1.0,13/21,33.40%,MYO1B;FNBP1L;MYO5A;ACTN4;MYO6;MYO5C;MYO1F;MYO1G;MYO15A;MYO7A;MYO1H;MYO1D;MYO1A
prerank,androgen receptor signaling pathway (GO:0030521),0.7314299451201003,1.4585437536948522,0.07631160572337042,0.6773392412032169,1.0,3/11,3.36%,DDX5;PMEPA1;DDX17
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6635398438804584,1.4584715145046072,0.08383233532934131,0.6749343773491602,1.0,3/14,9.27%,THBS1;ANO6;PDCD4
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.5900498041097368,1.4583108354670566,0.05305039787798409,0.6729094931010913,1.0,17/32,23.47%,FZR1;FOXN3;TICRR;TOPBP1;TRIM39;UIMC1;CLSPN;BRCA1;BRCC3;CDKN1A;DTL;DONSON;NBN;CHEK1;TAOK1;ABRAXAS1;ATM
prerank,aorta morphogenesis (GO:0035909),-0.5492346128523277,-1.4582109567700496,0.03724928366762178,0.4705497869586981,1.0,11/17,15.34%,ENG;MYLK;PDGFRB;ADAMTS9;RBPJ;TBX1;PROX1;HEY2;TBX2;EFEMP2;ACVRL1
prerank,regulation of ion transmembrane transport (GO:0034765),0.5895459518136406,1.457943404239168,0.0651890482398957,0.6720228950558255,1.0,6/33,3.59%,KCNJ2;NEDD4;KCNJ15;WNK1;WWP2;ANO6
prerank,negative regulation of vascular permeability (GO:0043116),0.6917003407725861,1.457861033132025,0.0779816513761468,0.6696566479521788,1.0,2/12,3.17%,SLIT2;VEGFA
prerank,positive regulation of synapse assembly (GO:0051965),-0.47332761809024804,-1.4568260186108937,0.05426356589147287,0.4703187038145235,1.0,9/27,11.08%,IL1RAPL1;GRID2;EPHB1;NRXN1;SYNDIG1;CUX2;SRPX2;LRRC4B;PTPRD
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4933546499212894,1.456662990413134,0.021436227224008574,0.6728688374657699,1.0,27/136,11.45%,TCF7L2;PKD1;HES1;HDAC4;CYP1B1;ANXA4;CMKLR1;MDFI;PTGIS;SFRP4;ESR1;ID2;ID1;WWP2;KLF4;IRAK3;TAX1BP1;BHLHE40;GLIS2;NLRP12;ZC3H12A;KDM1A;SFRP5;BRMS1;ERBIN;KEAP1;CHP1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.6164830365856591,1.4554358744725528,0.08263305322128851,0.6757617786340524,1.0,5/25,7.30%,SLIT2;PRKCD;CDK10;ARHGAP44;LIMK2
prerank,dendritic spine organization (GO:0097061),-0.4964153575635571,-1.4551673543318049,0.08333333333333333,0.47105404258104105,1.0,8/26,7.72%,IGF1R;DOCK10;SHANK3;EPHB1;INSR;PAK3;LGMN;ITGA3
prerank,cellular response to fatty acid (GO:0071398),0.6979906741306664,1.4546385608055534,0.09389671361502347,0.6765903826501315,1.0,4/12,10.80%,PID1;IRS1;ZC3H12A;PDK3
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6719387030894166,1.4541673999807956,0.09544787077826726,0.6759977898500122,1.0,7/14,19.06%,SEC31A;SEC24B;SEC23A;MIA3;SEC24D;RAB1A;SEC23B
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5605462903575454,1.4540608132366752,0.04677623261694058,0.6738600934243194,1.0,20/43,23.47%,FZR1;FOXN3;NABP1;TICRR;TOPBP1;TRIM39;UIMC1;CLSPN;RAD17;BRCA1;BRCC3;CDKN1A;DTL;DONSON;CHFR;NBN;CHEK1;TAOK1;ABRAXAS1;ATM
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6110348620062529,-1.4538352092492923,0.0782122905027933,0.47063323396666557,1.0,7/11,17.39%,EFNB2;SOX6;MEF2C;FRS2;BMP2;MYOCD;GREM1
prerank,defense response to virus (GO:0051607),-0.3656105205202991,-1.4536248293998737,0.009615384615384616,0.46758922864437685,1.0,34/100,19.43%,SERINC3;AGBL4;BCL2;ABCC9;BCL2L1;TRIM56;SERINC5;IFIT2;IFIT1;ZDHHC1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;NDUFAF4;STAT1;AKAP1;RNASEL;IFITM2;IRF2;IFIT3;EXOSC5;RTP4;TLR7;SHFL;CD40;MLKL;NLRC5;PDE12;PYCARD;ZBP1;STAT2
prerank,neuron remodeling (GO:0016322),-0.6291791564482924,-1.4535568381325394,0.08100558659217877,0.46404263267772766,1.0,7/10,23.07%,ADGRB3;APP;EPHA8;C1QA;CX3CL1;C3;RND1
prerank,regulation of B cell proliferation (GO:0030888),-0.42298140123094174,-1.4530438547029934,0.02830188679245283,0.4617925293400516,1.0,15/44,15.88%,LYN;BCL2;TFRC;TNFRSF21;AHR;MEF2C;VAV3;CD38;CD300A;NFATC2;CD81;MIF;CD40;TYROBP;CD74
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.32321358134606304,-1.4526426267223689,0.0,0.45913459943976626,1.0,55/224,10.12%,SLC1A3;UNC13C;GRM7;DTNA;NOVA1;GRIK2;KCND2;PDE7B;GRIA4;GRM5;GRM3;GABRG3;NRXN1;CACNA1E;DLGAP1;APBA1;HTR2C;SLC6A1;SYN2;GRM1;MBP;GRIN2A;KCNQ3;SLC1A1;GABRB3;RIT2;PRKAR2B;GABRB1;GRIN2B;CACNB4;CHRM2;SNAP25;CACNB2;GABRA2;SLC1A2;PRKAR1B;PLP1;GABRB2;SYT1;GRIA1;CACNA1B;GRIN1;APBA2;GPR176;PRKAR1A;SYT10;MAPK1;GABBR2;CALM1;CHRM3;RPS6KA1;GLRA3;CACNB1;GRIA3;GLRA1
prerank,glucose transmembrane transport (GO:1904659),-0.5292366702862087,-1.4500877803214538,0.07453416149068323,0.462379649214372,1.0,4/18,7.36%,SLC2A1;SORT1;SLC5A3;PPARD
prerank,positive regulation of DNA replication (GO:0045740),0.6681696281653358,1.4497210974854606,0.08394698085419734,0.6910653766845894,1.0,7/16,21.28%,EGFR;GLI2;STN1;BCAR3;DHX9;EGF;BRPF3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5698919919605894,1.4486166087208023,0.04791929382093316,0.6935416757356012,1.0,9/38,8.51%,KCNJ2;CACNA1C;CACNA1G;CAMK2D;ANK2;DSP;DSG2;AKAP9;TRPM4
prerank,regulation of axon guidance (GO:1902667),0.719360118247237,1.4485551194959962,0.08346456692913386,0.6910737430610194,1.0,2/10,3.17%,NRP1;VEGFA
prerank,response to estradiol (GO:0032355),0.5809927413081594,1.4475077486495274,0.061898211829436035,0.6932611458285955,1.0,7/31,12.77%,EGFR;ESR1;STAT3;ANXA1;LCOR;POU4F1;STRN3
prerank,skeletal muscle organ development (GO:0060538),0.6118203425814572,1.447218911656542,0.0681198910081744,0.6918516236818292,1.0,4/26,4.64%,SIX1;CSRP3;DISP1;LARGE1
prerank,"phagocytosis, engulfment (GO:0006911)",0.5716307273664986,1.4453465329244681,0.057180851063829786,0.6980920522161584,1.0,4/36,1.97%,THBS1;GULP1;RHOBTB1;GSN
prerank,response to glucagon (GO:0033762),-0.5181245040844195,-1.445003014478276,0.05466237942122187,0.47249642044617296,1.0,9/19,16.43%,ADCY5;ADCY1;PRKAR2B;PRKAR1B;ADCY7;PRKAR1A;CYSLTR2;PRKACB;CRY1
prerank,entry into host (GO:0044409),0.6816715504242319,1.4446903863966571,0.08144796380090498,0.6985114774049317,1.0,2/13,1.25%,MET;CDH1
prerank,cellular response to heat (GO:0034605),0.5650882168443663,1.44413468293996,0.06985769728331177,0.6985414469374683,1.0,7/35,10.54%,THBS1;TCIM;BAG3;CLPB;VCP;RBBP7;DHX36
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.6990908367323464,1.4437486332912028,0.09105180533751962,0.6976929102087664,1.0,3/12,8.35%,FOXP1;NCOR1;NCOR2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6857457097837647,1.4433341660271573,0.09803921568627451,0.6969708855499782,1.0,3/12,7.62%,BMP4;NEDD4;NUP214
prerank,water transport (GO:0006833),-0.5886131621378579,-1.4422651751077027,0.06149732620320856,0.4762084470852738,1.0,3/12,13.89%,AQP11;PDPN;AQP4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5516364923134678,-1.442124773932801,0.07602339181286549,0.472906676642362,1.0,8/17,8.68%,MAML3;MAML2;NOTCH3;RBPJ;PLXND1;NOTCH1;NOTCH4;STAT1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.6073466826199283,1.4420070173373245,0.06955380577427822,0.7004695383056743,1.0,3/26,1.81%,SMOC2;HES1;USP2
prerank,positive regulation of chromosome organization (GO:2001252),0.676087392655818,1.4419457356433139,0.08124076809453472,0.6980942945391813,1.0,10/15,27.46%,SIRT6;DHX36;RAD50;DDX11;ATRX;PML;NBN;RAD21;GNL3;SHCBP1L
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.6906540352206213,1.441763336818824,0.0882800608828006,0.6963532394306464,1.0,3/13,6.46%,BMP4;VNN1;GLI2
prerank,endothelial tube morphogenesis (GO:0061154),0.7071749952792413,1.4414516581002104,0.08064516129032258,0.6950790537140475,1.0,3/10,10.43%,BMP4;STARD13;RHOA
prerank,regulation of vasculature development (GO:1901342),0.6082784583173914,1.439557722582894,0.06460674157303371,0.7017533502925939,1.0,5/26,6.57%,BMPER;FGF2;NF1;PROK2;ERBB2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5920939558210021,1.4394504238167416,0.07361111111111111,0.6995640383496897,1.0,11/27,13.19%,CACNA1C;CAMK2D;ANK2;FGF13;DSP;DSG2;RANGRF;AKAP9;TRPM4;JUP;DLG1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.6533033671065357,1.4374406116354144,0.07010014306151645,0.7061491707043174,1.0,8/16,18.46%,DDX5;DDX17;SRSF6;CDK13;CELF4;SRSF1;HNRNPM;DHX9
prerank,positive regulation of synaptic transmission (GO:0050806),-0.3899386460572035,-1.43730482959859,0.006944444444444444,0.48223582934054315,1.0,22/72,12.12%,GRIK2;ADCY1;SHANK3;SLC24A2;NRXN1;APP;RIMS1;GRIN2A;RIMS2;PRKCZ;GRIN2B;SYT1;LGMN;CACNG7;CACNG4;LGI1;SHANK2;KCTD13;SLC8A3;PLK2;CACNG3;CACNG2
prerank,histone modification (GO:0016570),0.4985298064981315,1.437148182954547,0.027382256297918947,0.7049702005367146,1.0,34/109,19.38%,EYA2;HDAC4;CCNA2;PRKCD;HDAC9;EYA4;RBM14;RCOR3;PRMT8;MIER1;UBE2A;CREBBP;EHMT1;MTA1;BRMS1L;BRMS1;NSD1;TBL1X;RCOR1;EYA3;MSL3;MORF4L1;UBE2B;KAT6B;CDK2;PRDM5;PHF20L1;TRRAP;PARP2;PHF20;PRMT6;USP21;USP16;HDAC2
prerank,positive regulation of protein import (GO:1904591),0.5893352517995747,1.4368773704486384,0.0728476821192053,0.7036128513142593,1.0,9/30,13.59%,CDH1;PRKCD;ZIC1;UBR5;BAG3;ZC3H12A;MAVS;JUP;DMAP1
prerank,regulation of glycogen metabolic process (GO:0070873),0.6827573111816057,1.4368228399871896,0.08895705521472393,0.7013110402412533,1.0,2/12,5.50%,PPP1R3B;PPP1R3C
prerank,membrane repolarization during action potential (GO:0086011),0.6930584323814938,1.4367936744483203,0.10029940119760479,0.6988701357220118,1.0,2/13,1.98%,KCNJ2;ATP1B1
prerank,regulation of viral entry into host cell (GO:0046596),-0.45185609061864995,-1.4366156236376628,0.05172413793103448,0.4806314489663341,1.0,12/30,16.12%,HS3ST5;LY6E;LGALS1;TRIM14;IFITM1;IFITM3;IFITM2;TRIM62;NECTIN2;SNX3;CD74;P4HB
prerank,endothelial cell migration (GO:0043542),0.5644439199746416,1.4357434446885304,0.06233766233766234,0.701214155577798,1.0,12/37,13.12%,CCN3;FSTL1;CYP1B1;NRP1;VEGFA;GIPC1;ID1;ABL1;STARD13;RHOA;S100A2;NR4A1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5978457863069129,1.4356246419027558,0.08458390177353342,0.6992339349200556,1.0,8/26,8.37%,STK39;FHL1;NEDD4;ANK2;ATP1B1;WWP2;ITGB1;AKAP9
prerank,base conversion or substitution editing (GO:0016553),-0.6124356055538592,-1.4355824990689658,0.06860158311345646,0.4795870116508983,1.0,3/11,12.79%,APOBEC1;ADARB2;ADAR
prerank,embryonic appendage morphogenesis (GO:0035113),0.6762668444144903,1.435124534590966,0.10696920583468396,0.6990023394735406,1.0,3/12,5.66%,LRP6;MBNL1;SKI
prerank,positive regulation of organelle organization (GO:0010638),0.572507831603145,1.4347918785614535,0.06657608695652174,0.6980439050995422,1.0,6/32,5.34%,ANXA2;SORBS3;ATL3;ADRB2;GSK3B;ANXA1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6496374340608758,1.434702558607318,0.08431952662721894,0.6959141921216052,1.0,5/17,4.52%,NTRK3;BAIAP2L1;NRP1;BCAS3;ABL1
prerank,nuclear migration (GO:0007097),0.6672115522624169,1.4338051214650236,0.10631741140215717,0.6975433902945676,1.0,5/13,9.42%,CLMN;DOCK7;PCM1;PAFAH1B1;HOOK3
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.6481343122906672,1.4336646511733602,0.0907715582450832,0.6956661372143003,1.0,4/15,4.13%,BMPER;FGF2;VEGFA;KLF4
prerank,protein localization to cilium (GO:0061512),0.5800527355759569,1.4332195261500373,0.07055630936227951,0.6952890329045979,1.0,8/32,14.23%,BBS9;ZNF423;INVS;WDR35;TULP2;ARL3;EHD1;ROPN1
prerank,eye development (GO:0001654),0.5360752852087733,1.4326651899930913,0.05434782608695652,0.6953281238420616,1.0,12/54,10.06%,PBX3;CACNA1C;SMOC1;COL5A2;PBX1;PITX2;HIPK1;NIPBL;SKI;TSKU;FOXC1;ATF6
prerank,response to UV-A (GO:0070141),0.6584749587867346,1.4325296227190127,0.10149253731343283,0.6933998711172176,1.0,3/14,8.31%,EGFR;TIMP1;CCND1
prerank,lymphocyte proliferation (GO:0046651),-0.4999224531328488,-1.4321147787625024,0.08273381294964029,0.48570446064128076,1.0,9/22,22.73%,BCL2;MEF2C;FLT3;MSN;CD40;PPP3CB;HSPD1;CTPS1;PIK3CG
prerank,calcineurin-mediated signaling (GO:0097720),0.7154132811457554,1.4319245763188984,0.10737179487179487,0.6912776002834897,1.0,6/10,15.76%,PPP3CA;NFAT5;NFATC4;NFATC3;NFATC1;PPP3CC
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7154132811457554,1.4319245763188984,0.10737179487179487,0.6912776002834897,1.0,6/10,15.76%,PPP3CA;NFAT5;NFATC4;NFATC3;NFATC1;PPP3CC
prerank,regulation of plasminogen activation (GO:0010755),0.691024949977555,1.4315576548623294,0.11181102362204724,0.6905715271804244,1.0,1/12,0.19%,THBS1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6741216066479587,1.4304987636120747,0.0847457627118644,0.6928839443248613,1.0,3/13,4.96%,MET;NFE2L2;NR4A3
prerank,lymphocyte mediated immunity (GO:0002449),0.6969176049520135,1.4302828671437782,0.09672619047619048,0.6915188466075839,1.0,3/12,12.02%,CD55;CD46;JAG1
prerank,actin nucleation (GO:0045010),-0.5037478228072505,-1.427744091775473,0.07924528301886792,0.49492918252896156,1.0,6/21,11.91%,ARPC4;SPIRE1;ARPC5;IQGAP2;LMOD1;ARPC3
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.5392446511079773,1.4277037389596285,0.05218446601941747,0.7010391234543549,1.0,15/55,18.97%,FBXL7;FHL1;PSMB2;AURKA;PSMD11;PSMC1;CUL1;PSMC6;PSMD1;PSMD4;USP47;PSMA6;PSMD14;PSMD12;PSMD7
prerank,neuron differentiation (GO:0030182),0.4800254223458959,1.427654543573937,0.014705882352941176,0.6988581174880889,1.0,25/165,7.26%,VSX1;PBX3;WNT9A;LRP6;MET;WNK1;WNT11;PBX1;PITX2;VEGFA;ID2;FZD1;FZD7;ITM2C;TGFBR1;ATOH7;THOC2;ACSL3;CTF1;GLI2;ERBB2;NRBP2;NR4A2;INHBA;TENM1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5319121161735817,1.4271717437175322,0.06982543640897755,0.69868857524492,1.0,10/49,13.32%,F3;LBP;CD2;TLR1;STAT3;TLR4;MAVS;TLR8;MYD88;TIRAP
prerank,regulation of cell death (GO:0010941),0.4995180603069429,1.4263376016405578,0.026018099547511313,0.7000549038098997,1.0,20/94,12.69%,BMP4;CCN3;ACER3;CCN5;CCN1;WNT11;FGF2;SRGAP2;LRP1;SRSF6;AGR2;ZC3H12A;NOA1;BECN1;RIPK2;CHP1;ATG5;CLU;CDKN1B;CELF1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5261573070725558,1.4262896398744447,0.046706586826347304,0.6978685334128703,1.0,18/65,18.97%,FBXL7;FHL1;PSMB2;NABP1;AURKA;PSMD11;PSMC1;CUL1;PSMC6;PSMD1;PSMD4;USP47;ZFYVE19;PSMA6;PSMD14;PSMD12;CHFR;PSMD7
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.627595284856363,1.4262750861508775,0.08085106382978724,0.6955350083153542,1.0,4/20,10.91%,EGFR;PKD1;CCND1;CCNYL1
prerank,reverse cholesterol transport (GO:0043691),-0.580342619812256,-1.4256133048500959,0.08259587020648967,0.4975439184646162,1.0,3/13,4.23%,APOE;ABCA5;ABCG1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6750057683465907,1.4255606777696264,0.0941358024691358,0.6963379302533298,1.0,6/13,6.38%,BMP4;TGFB3;BMPR1A;TGFBR1;BMP6;NUP93
prerank,positive regulation of RNA splicing (GO:0033120),0.5861989609428083,1.425344588522733,0.08677685950413223,0.6949433420430464,1.0,9/29,15.49%,SLC38A2;CELF3;U2AF2;DAZAP1;THRAP3;RBM3;CELF4;RBMX;CIRBP
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5384570929586696,-1.424927586445878,0.08441558441558442,0.4957601410260698,1.0,10/18,16.76%,CAMK1D;PRKD1;ADCY1;RPS6KA5;EPHA5;CD200;LRP8;RPS6KA4;RELN;CRTC3
prerank,regulation of peptide hormone secretion (GO:0090276),-0.38450886839124543,-1.4245926454920537,0.013071895424836602,0.4930384227943434,1.0,12/67,6.47%,ITPR1;RAPGEF4;SLC2A1;CHD7;CACNA1D;CACNA1E;RAPGEF3;HTR2C;DPP4;SNAP25;KCNC2;SYT7
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4791713495414266,-1.424312131718818,0.0625,0.4902654601011924,1.0,9/23,11.74%,ACSL1;ELOVL7;FAR2;ACSL4;HACD1;HACD2;ACSBG1;DGAT1;ACSL5
prerank,pancreas development (GO:0031016),0.6817832027007913,1.424273440588099,0.10153846153846154,0.6973062357186155,1.0,2/12,0.88%,TCF7L2;MET
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3938906482397349,-1.4236847899357887,0.029585798816568046,0.48859879009476787,1.0,13/62,9.45%,ROBO1;AUTS2;IGF1;LYN;ARHGEF3;LPAR1;RASGRF1;F11R;MAP4K4;NOTCH1;ADGRG1;RAC1;MMD2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5708152378236633,1.4227046400611025,0.07894736842105263,0.7019904187226219,1.0,6/33,4.13%,BMPER;THBS1;RHOJ;FGF2;VEGFA;KLF4
prerank,carboxylic acid metabolic process (GO:0019752),0.5644357307343921,1.4223658852396248,0.09305373525557012,0.7011978234552309,1.0,4/33,4.91%,SLC23A1;SLC23A2;PTGIS;CYP2S1
prerank,regulation of heart contraction (GO:0008016),-0.35916569285839833,-1.4218694146758062,0.0,0.4900040649714497,1.0,22/90,12.55%,ATP1A2;ITPR1;ATP1B3;SLC8A1;RYR2;ABCC9;NPR1;PDE4D;ATP2A2;TRPC1;CALM1;ATP1B2;DES;ATP2A3;DMPK;SLC8A3;FXYD6;KCNQ1;ATP2B1;AHCYL1;ACE2;TBX2
prerank,early endosome to Golgi transport (GO:0034498),0.6796956545039599,1.4214821224185141,0.11363636363636363,0.7030632672089657,1.0,6/11,17.53%,SNX2;RAB6A;STX5;TRAPPC10;SNX8;SURF4
prerank,regulation of interleukin-8 production (GO:0032677),0.515582300244019,1.4213695958706318,0.05137395459976105,0.7011946136653021,1.0,14/69,13.32%,F3;LBP;ANXA4;CD2;KLF4;TLR1;STAT3;ANXA1;C5AR2;TLR4;MAVS;TLR8;MYD88;TIRAP
prerank,muscle cell migration (GO:0014812),0.7184660912479041,1.420904248492754,0.09667194928684628,0.7010637868272248,1.0,5/10,13.74%,SIX1;CCN3;AAMP;ITGB1BP1;ITGB3
prerank,protein localization to organelle (GO:0033365),0.4877869676135843,1.4206791895098043,0.0183585313174946,0.6997126406915155,1.0,45/133,23.42%,SIX1;BMP4;BBS9;CSRP3;ANK2;ZNF423;TRAM2;EMD;GBF1;CNTLN;RAB6A;WDR35;LMNA;TULP2;ABCA7;TSPAN17;GAK;SIX4;RAB35;ARL3;STX5;TIA1;EHD1;SORL1;DCP1A;ROPN1;BICD1;TOR1B;DVL1;VAMP2;SSB;LRRK2;COG3;DHX9;ZBTB7A;RAB33B;RAB11A;TOR1AIP1;BICD2;MTCH2;FAM83H;PAQR3;YWHAE;BBS2;GCC2
prerank,engulfment of apoptotic cell (GO:0043652),0.650030893963593,1.4202591565295941,0.08333333333333333,0.6992407624790078,1.0,2/15,1.89%,THBS1;RHOBTB1
prerank,neuron maturation (GO:0042551),-0.5184010836144805,-1.4202378754155158,0.10443037974683544,0.4910435314237094,1.0,11/18,28.60%,ADGRB3;APP;EPHA8;B4GALT6;C1QA;CX3CL1;C3;ACTL6B;RND1;SRRM4;SCARF1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7096943824927602,1.42003110184923,0.09569377990430622,0.6979078259562015,1.0,2/10,1.82%,LRP6;BMP5
prerank,negative regulation of growth (GO:0045926),0.4955508648605633,1.41976652068116,0.021953896816684963,0.6967360190575898,1.0,12/121,7.53%,SLIT3;SLIT2;FHL1;CCN3;NDRG3;OSGIN2;WNT11;NOTCH2;NDUFS3;INHBA;SERTAD3;IP6K2
prerank,regulation of osteoblast differentiation (GO:0045667),0.49978709616974937,1.4194724390253586,0.040632054176072234,0.6957798957311361,1.0,20/82,9.62%,BMP4;CRIM1;SMOC1;DDR2;TWIST2;CCN1;DDX5;SMAD6;SOX9;NELL1;BMPR1A;GDF10;NOG;TWIST1;SKI;BMP6;TRPM4;RUNX2;CHRD;TMEM119
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5343417927120626,1.418426123444657,0.06532663316582915,0.6982166704989629,1.0,12/50,12.13%,EGFR;NR3C2;TCIM;NFAT5;LIMS1;NLRP12;TLR4;PDCD4;RHOA;EIF2AK2;TRIM44;IFI35
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6650024540511592,1.4183389278171414,0.08952959028831563,0.6963598005066395,1.0,7/14,13.10%,ENTPD6;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;NUDT1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.5309908826050247,-1.4179555309180516,0.07741935483870968,0.4938142735637517,1.0,10/17,25.08%,COX7B;NDUFA4;COX4I1;AFG1L;COX5B;CYCS;COX7C;COX6C;COX6B1;COX4I2
prerank,potassium ion homeostasis (GO:0055075),0.6222126694773147,1.4175803252609755,0.09116809116809117,0.6973728603665014,1.0,8/23,9.71%,SLC12A7;KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.61928224808519,1.4168964889291547,0.09631728045325778,0.6983337531310071,1.0,4/21,7.93%,LRP6;GSK3B;FZD1;CSNK1A1
prerank,hyaluronan metabolic process (GO:0030212),0.5971432985828277,1.4155063334684725,0.0921595598349381,0.7021669856615788,1.0,8/23,11.45%,FGF2;SPAM1;HEXA;HAS1;LYVE1;CD44;SLC9A1;CHP1
prerank,cellular response to interleukin-4 (GO:0071353),-0.6102131373219213,-1.4154975440602586,0.0962566844919786,0.4973768197760256,1.0,4/10,18.29%,LEF1;TCF7;XBP1;JAK3
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4978292727989746,1.4151643450457185,0.029180695847362513,0.7014191050862173,1.0,23/108,9.08%,RSPO3;NXN;TCF7L1;TRABD2B;CTNND2;GPC3;MDFI;FOXL1;RSPO4;SFRP4;ESR1;FZD7;GRB10;EMD;MDFIC;LRP1;SKI;DACT1;TSKU;TIAM1;SULF1;NLK;SFRP5
prerank,regulation of neuron projection development (GO:0010975),-0.32963602459465674,-1.4150786496523684,0.0,0.49497395790216236,1.0,47/163,10.36%,CAMK1D;EFNB2;IL1RAPL1;LYN;PTK7;CSMD3;LRRC4C;CDH2;APOE;PRKD1;LPAR1;SHANK3;ITGA6;SPOCK1;PAK1;TENM3;PPFIA2;CTNNA2;TOX;WNT5A;RAPGEF2;DCC;SERPINI1;LRRC7;RIT2;PAK3;ROR2;FUT9;NDNF;EPHA4;CFL1;MAG;DAB2IP;RTN4RL1;PTPRO;PLPPR5;DENND5A;KIF1A;TWF2;ATP1B2;NTRK2;CRMP1;RUFY3;MAGI2;PLK5;CAMSAP2;NDRG4
prerank,glycosaminoglycan metabolic process (GO:0030203),0.5213902103765701,1.4150691303710539,0.06642066420664207,0.6995332441348867,1.0,14/54,15.34%,GPC6;EXT1;GPC3;HS6ST2;HEXA;HS3ST1;XYLT1;HAS1;SLC35D2;B3GALT6;GPC4;NAGLU;HS2ST1;IDUA
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5253378656774211,1.4142260411492158,0.07021791767554479,0.7012987862787484,1.0,10/59,6.61%,STK39;CIT;WNK1;PRKCD;CAMK2D;GSK3B;CDK10;HIPK1;TGFBR1;TGFBR2
prerank,negative regulation of nuclear division (GO:0051784),0.6770640926546274,1.4138648392568285,0.11287758346581876,0.7008173955362169,1.0,3/11,11.60%,BMP4;TOM1L1;FBXO5
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.6225402079423552,1.4135142380595522,0.10548523206751055,0.7002239420600792,1.0,6/19,17.40%,LBP;PRKCE;PIK3AP1;TLR4;TIRAP;SCIMP
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.6027400852338869,1.4125492928141015,0.08044382801664356,0.7022988989138546,1.0,9/22,17.25%,NEDD4;RNF126;RNF115;MVB12B;TOM1L1;VPS37A;VPS37B;SNF8;PTPN23
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6405691566161117,1.4121867908015309,0.1006006006006006,0.7016695678931969,1.0,3/16,3.17%,THBS1;FGF2;VEGFA
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5621290459758971,1.4115117197800755,0.0793010752688172,0.7023871669041187,1.0,8/34,9.62%,DOCK5;NRP1;LIMS1;ABL1;MYOC;DMTN;S100A10;CIB1
prerank,lipid phosphorylation (GO:0046834),-0.6085443151357482,-1.410912302461905,0.11688311688311688,0.5030161645290282,1.0,4/10,7.53%,DGKB;DGKI;DGKD;DGKG
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.642052028181147,1.4100189243132677,0.11094452773613193,0.7066935362021848,1.0,4/14,11.33%,PKD1;MDFI;G3BP2;KEAP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5855326022160534,1.4099246684687698,0.10618279569892473,0.7049421171346255,1.0,12/27,15.83%,IRAK3;TLR1;TAB3;IRAK4;TLR4;MAP3K7;TAB2;MAP3K1;MYD88;TIRAP;TRAF6;TNIP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.6416380532686558,1.4093314845871732,0.12386706948640483,0.7054294896422186,1.0,9/16,23.47%,SMG6;SLX4;PARP1;DHX36;NAF1;HNRNPA2B1;ERCC4;TNKS2;ATM
prerank,vascular transport (GO:0010232),0.5069497138019216,1.4078896291792378,0.05092592592592592,0.7096207507347326,1.0,10/81,2.30%,SLC4A4;SLC38A2;SLC38A1;SLC5A6;SLCO3A1;SLC12A2;SLC24A3;SLC2A13;ABCG2;SLC16A1
prerank,regulation of astrocyte differentiation (GO:0048710),0.6714031191793491,1.4078719464194263,0.12238805970149254,0.7075334749244276,1.0,4/12,4.74%,HES1;ID2;CLCF1;NOG
prerank,artery morphogenesis (GO:0048844),0.5867161060492229,1.4071819147531806,0.08948863636363637,0.7083285960845955,1.0,9/30,5.44%,BMP4;HES1;NRP1;VEGFA;BMPR1A;TGFBR1;NOG;LRP1;NF1
prerank,negative regulation of complement activation (GO:0045916),0.7006073225424778,1.407084360693424,0.1370309951060359,0.7065370356716291,1.0,4/10,13.88%,CD55;SERPING1;CD46;CR1L
prerank,dendrite self-avoidance (GO:0070593),-0.510866905522267,-1.4064571850990932,0.10091743119266056,0.5122612998670575,1.0,6/16,13.47%,BSG;CNTN4;DSCAML1;ROBO4;NEXN;PALLD
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6361531661387624,1.4055307117460605,0.11560693641618497,0.7112607264068124,1.0,5/15,10.49%,TCF7L2;GSK3B;EMD;BAG3;XPO4
prerank,positive regulation of angiogenesis (GO:0045766),0.4888905187558614,1.4047393332159008,0.04471101417666303,0.7124284357051092,1.0,20/108,8.52%,BMPER;SMOC2;F3;THBS1;PGF;CYP1B1;FGF2;PTGIS;ITGB8;VEGFA;FOXC2;KLF4;HIPK1;TWIST1;AGO2;SIRT6;ITGB1;ZC3H12A;GATA4;ANXA3
prerank,neuromuscular junction development (GO:0007528),-0.48446300999277647,-1.40452520613755,0.09655172413793103,0.5145556441298704,1.0,9/24,10.06%,PDZRN3;UNC13C;ANK3;PPFIBP2;PPFIBP1;CACNB4;CACNB2;CACNB1;ZC4H2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6045711665590515,-1.4036902719329878,0.09809264305177112,0.5133899815649074,1.0,3/10,3.63%,ENG;ERRFI1;ENPP1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5611146124510334,1.4030909522147947,0.07723577235772358,0.7174310450512477,1.0,10/33,12.97%,THBS1;MEOX2;FGF2;KLF4;ATP2B4;STARD13;RHOA;MECP2;JUP;ITGB1BP1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.4333861995258227,-1.4030200954769665,0.054945054945054944,0.511841238124137,1.0,11/35,16.41%,VTN;SGIP1;B2M;PICALM;HIP1R;SNAP91;RAC1;TNK2;HIP1;CCL19;BMP2K
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.4487540029537789,-1.402737135108175,0.05622489959839357,0.5092720435579664,1.0,12/32,23.12%,CEMIP;AKAP6;TRPC1;CALM1;JPH2;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1
prerank,canonical Wnt signaling pathway (GO:0060070),0.512383483050798,1.4019159689922085,0.05620608899297424,0.7206917695288491,1.0,13/68,9.08%,TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;SFRP4;GSK3B;FZD1;FZD7;NR4A2;CSNK1A1;SFRP5
prerank,transport across blood-brain barrier (GO:0150104),0.5036271320265776,1.4014060195367064,0.04519119351100811,0.7208618910273583,1.0,10/83,2.30%,SLC4A4;SLC38A2;SLC38A1;SLC5A6;SLCO3A1;SLC12A2;SLC24A3;SLC2A13;ABCG2;SLC16A1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5045181200019051,-1.401125744032496,0.08223684210526316,0.5106441653685978,1.0,4/18,1.74%,UNC13C;GRID2;GRIK2;CDH8
prerank,skeletal muscle tissue development (GO:0007519),0.5751016166710049,1.4010308260544933,0.08485639686684072,0.720242749513669,1.0,6/32,10.12%,SIX1;CSRP3;SKI;SIX4;MYORG;LEMD2
prerank,B cell proliferation (GO:0042100),-0.5215659439566868,-1.400983311498607,0.08307692307692308,0.5077190509011188,1.0,6/17,22.37%,BCL2;MEF2C;CD40;CD180;HSPD1;CTPS1
prerank,monocarboxylic acid transport (GO:0015718),0.5319189119823715,1.4003583547624336,0.07891491985203453,0.7210868014718282,1.0,8/51,2.91%,SLC5A6;SLCO3A1;SLC16A9;SLCO2A1;ABCG2;SLC16A1;SLC26A6;SLC10A2
prerank,ceramide biosynthetic process (GO:0046513),-0.4160308212061061,-1.3996979798697164,0.06086956521739131,0.5078185901821022,1.0,13/40,15.96%,ST6GALNAC3;ST8SIA4;CERS4;SGMS1;DEGS2;ST8SIA6;B4GALT6;ASAH1;CERS2;CERS1;SMPD1;SPTLC2;CLN8
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5826647037297479,1.3983141267612265,0.08310249307479224,0.72804873677959,1.0,16/25,29.51%,CDK12;CDK13;WDR43;NELFE;RNF8;RECQL5;BRD4;HEXIM1;TCERG1;LARP7;EAPP;SUPT4H1;ELL;NELFA;EAF1;RNF168
prerank,polyamine metabolic process (GO:0006595),0.6585998524474975,1.3977363936728109,0.11509715994020926,0.7283788502023756,1.0,5/13,17.07%,SRM;SMOX;ODC1;PAOX;OAZ2
prerank,regulation of cell growth (GO:0001558),0.46823961655336144,1.3972562145927616,0.01652892561983471,0.7283491466445317,1.0,34/204,12.60%,SLIT3;SLIT2;FHL1;EGFR;CCN3;PLCE1;NDRG3;OSGIN2;CAMK2D;WNT11;DCUN1D5;TGFBR1;DDX49;NDUFS3;ERBB2;INHBA;SERTAD3;CDK11B;LTBP4;IP6K2;FAM107A;DNPH1;CEP43;EIF4G2;TMC8;CDKN2C;CIB1;KLHL22;RBBP7;SGK3;FXN;CDKN1B;RPS6KA3;BRAT1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6692208404420343,1.3971911873366911,0.11042944785276074,0.726484698626559,1.0,5/12,8.35%,ESR1;STAT3;NCOR1;ZC3H12A;NCOR2
prerank,organic substance transport (GO:0071702),0.4780143929754077,1.3965638353335066,0.030434782608695653,0.7271244140768122,1.0,17/121,11.38%,SLC47A1;SLC23A1;RAMP1;ABCD3;SLCO2A1;ABCG2;DISP1;LMAN2L;RUFY1;ABCA7;ABCD1;SLC6A2;SCAMP2;MIA3;CMTM6;SLC22A18;RHCG
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5349081960304178,1.3957473865967895,0.07078507078507079,0.7285770254907703,1.0,14/44,17.51%,THBS1;NGF;VEGFA;KLF4;CAST;CD44;IGBP1;RPS6KA3;RAF1;DPEP1;CARD16;USP47;CST7;PCID2
prerank,regulation of mitotic cell cycle (GO:0007346),0.46511480994002286,1.3952324314811064,0.01791359325605901,0.7286273266179895,1.0,54/171,19.14%,SMOC2;FZR1;PTPN3;USP2;CCDC8;TTC28;CDK10;PSMB2;GAS1;GBF1;ANAPC5;NEK7;CDK11B;PSMD11;ANAPC10;FOXC1;PSMC1;CDC16;CUL1;ANAPC11;CDC20;CDK13;CCNB1;ANGEL2;PSMC6;BTG3;MAD2L1;FBXO5;CDKN1C;ANAPC16;RPRM;CDKN1B;PRMT5;PIM2;SRA1;PRKCA;PSMD1;PSMD4;SCRIB;PIN1;SIK1;RPS6KB1;IQGAP1;RB1;RNF20;PSMA6;UBE2S;TMEM8B;PSMD14;PSMD12;TTL;TRIM35;PSMD7;BORA
prerank,retina homeostasis (GO:0001895),-0.4801207305873657,-1.395193784269929,0.08653846153846154,0.5165588312357898,1.0,8/23,18.05%,B2M;ACTB;POTEF;ATP1B2;HSPB1;WHRN;TULP1;SOD1
prerank,skin development (GO:0043588),0.5135595129798802,1.3951765277727208,0.06779661016949153,0.726745413315444,1.0,10/65,6.24%,CLIC4;MET;PKD1;ADAM9;COL5A2;COL3A1;ASPRV1;DSP;ANXA1;BCR
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5789921212500247,-1.3950120935780126,0.136,0.5137075765221198,1.0,3/11,5.75%,LYN;RAPGEF2;MEF2C
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5003529865384669,1.3938921957973416,0.0574052812858783,0.7302899253931132,1.0,8/74,4.49%,THBS1;BMP4;EYA2;TCF7L2;BMP5;EYA4;GSK3B;TGFBR1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6343556348039634,1.3935169353383918,0.12794117647058822,0.7298929243083206,1.0,5/16,12.29%,DPYSL3;NT5C1A;NT5E;DPYSL2;UPP2
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5654997733642504,-1.3931887187259795,0.12256267409470752,0.5152969233686473,1.0,2/12,8.02%,IL1R1;IL18
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.6194400678401121,1.3926061242105563,0.10838150289017341,0.7316864646503746,1.0,5/18,9.62%,CCN3;HDAC4;FZD7;CEACAM5;TMEM119
prerank,protein deacylation (GO:0035601),0.6014022143964582,1.3923685983905738,0.10626702997275204,0.7306111845671496,1.0,6/23,13.62%,HDAC4;LYPLA2;SIRT6;ABHD17B;LYPLAL1;SIRT3
prerank,peptidyl-threonine modification (GO:0018210),0.5091157245056401,1.3923321038185874,0.07478890229191798,0.7286543646760714,1.0,18/66,16.38%,STK39;CIT;WNK1;PRKCD;CAMK2D;GSK3B;CDK10;HIPK1;TGFBR1;GALNT13;TGFBR2;NLK;GALNT11;MARK2;ACVR1;PRKCA;PRKDC;MAP3K10
prerank,renal system development (GO:0072001),0.5285776321226481,1.392274756774329,0.06840796019900497,0.7268107374056959,1.0,12/52,10.41%,SIX1;BMP4;PCSK5;PKD1;VEGFA;TGFBR1;GLI2;PYGO2;SULF1;FOXC1;PYGO1;ARL3
prerank,endocrine system development (GO:0035270),0.6061962621853155,1.391934004494303,0.1091703056768559,0.7262958786515863,1.0,6/21,7.70%,SIX1;WNT11;TGFBR1;NF1;GLI2;DKK3
prerank,protein modification by small protein removal (GO:0070646),0.46160956403520176,1.3914275771523883,0.01120162932790224,0.7264266926297217,1.0,112/252,26.92%,CCNA2;USP2;USP46;OTUD1;ADRB2;ESR1;PSMB2;TGFBR1;IL33;USP24;USP15;USP25;USP13;MYSM1;BARD1;IKBKG;ADRM1;PSMD11;SMAD2;ZC3H12A;BECN1;UIMC1;PSMC1;VCP;SENP5;USP1;TADA3;IFIH1;CLSPN;USP34;CDC20;DESI1;DESI2;RHOA;MAP3K7;RAD23B;WDR48;PSMC6;KEAP1;TRAF2;MDM4;BRCA1;USP40;COPS7B;RNF123;COPS5;ZRANB1;USP4;BRCC3;PSMD1;USP28;INO80E;ABRAXAS2;TRAF6;PSMD4;TNIP1;SMAD4;FOXK1;USP47;OTUD5;HCFC1;POLB;SMAD7;PSMA6;OTUD4;TRRAP;ACTR5;COPS8;OTUD3;USP49;PSMD14;PSMD12;COPS3;PSMD7;VCPIP1;USP21;USP16;MBD5;COPS2;USP19;USP10;USP32;FOXK2;TRAF3;YY1;PSME3;USP30;USP36;USP9X;SENP1;SUDS3;TADA2B;ABRAXAS1;TP53;OGT;PSMD3;USP7;USP33;PSMB6;USP42;UBB;INO80;SENP7;KDM1B;SENP6;RHOT1;UBA52;RPS27A;FOXO4;MCRS1;TOMM20;SENP2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.5771115229102924,-1.3914142030763381,0.11081081081081082,0.5168723827662406,1.0,6/12,21.58%,SERINC3;SERINC5;CBS;SEPHS2;GGT1;CTH
prerank,cellular component disassembly (GO:0022411),0.5190092178484265,1.3913912686204755,0.0625,0.7245013052123543,1.0,10/53,8.49%,TLL1;BMP1;GSN;HTRA1;CAPN2;TIMP1;CD44;TIMP2;KIF9;MMP16
prerank,regulation of amyloid-beta formation (GO:1902003),-0.42894109767357325,-1.3893746826855433,0.0635593220338983,0.5192228189209976,1.0,11/34,9.74%,IGF1;APOE;RTN1;PICALM;ROCK2;ABCG1;EPHA4;RTN4;LRRTM3;NTRK2;BIN1
prerank,polyol biosynthetic process (GO:0046173),0.6354427411116474,1.3892512901707317,0.09406657018813314,0.7318935599953652,1.0,5/16,7.90%,ACER3;FGF2;IP6K1;IP6K2;PPIP5K1
prerank,Golgi to endosome transport (GO:0006895),0.6380216607510414,1.3885710045813067,0.10391566265060241,0.732851274977411,1.0,4/16,5.52%,VPS13A;VPS13C;GBF1;KIF16B
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.6729425505852836,1.3879115330732443,0.10584518167456557,0.7336175117706379,1.0,5/12,12.65%,CHEK2;TICRR;TOPBP1;CLSPN;RAD17
prerank,extracellular matrix disassembly (GO:0022617),0.5184340689744288,1.3873637090804942,0.06993865030674846,0.7340454718948635,1.0,10/53,8.49%,TLL1;BMP1;GSN;HTRA1;CAPN2;TIMP1;CD44;TIMP2;KIF9;MMP16
prerank,chemical synaptic transmission (GO:0007268),-0.30600784862096425,-1.387234476314461,0.0,0.5222132211712908,1.0,54/284,7.00%,SLC1A3;UNC13C;GRM7;DTNA;NOVA1;GRID2;GRIK2;APOE;KCND2;PDE7B;CDH8;GRIA4;GRM5;GRM3;GABRG3;NRXN1;CACNA1E;DLGAP1;APBA1;HTR2C;SLC6A1;SYN2;RIMS1;GRM1;MBP;GRIN2A;KCNQ3;SLC1A1;GABRB3;RIT2;PRKAR2B;LIN7A;GABRB1;GRIN2B;CACNB4;CHRM2;SNAP25;CACNB2;GABRA2;SLC1A2;PRKAR1B;PLP1;GABRB2;SYT1;GRIA1;CACNA1B;GRIN1;APBA2;GPR176;HSPA8;PRKAR1A;SYT10;MAPK1;PTPRN2
prerank,positive regulation of immune system process (GO:0002684),0.6469522675115918,1.387205045946399,0.11244377811094453,0.7326266747916743,1.0,4/16,18.03%,VEGFA;ANXA1;MIA3;NCKAP1L
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.5196564394295632,1.3867615495306749,0.08131067961165049,0.7326945601756226,1.0,13/53,14.63%,EGFR;EYA2;PRKCD;DDX5;EYA4;SPRED2;UIMC1;NSMCE1;EYA3;BRCA1;TIGAR;RNF8;BRCC3
prerank,ear morphogenesis (GO:0042471),0.6066672298029463,1.3867514792683515,0.11494252873563218,0.7306959695542771,1.0,5/20,5.18%,SIX1;ZIC1;NOG;TWIST1;NIPBL
prerank,neuron cell-cell adhesion (GO:0007158),-0.5417099509773157,-1.3866607478636854,0.12352941176470589,0.5205294448265306,1.0,6/14,10.38%,ASTN2;NRXN1;CNTN4;NRXN3;NCAM2;ASTN1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.6124275655835918,1.3863398753110712,0.11271676300578035,0.7304273628835263,1.0,7/17,13.65%,BMP4;BMPR1A;NOTCH2;NOG;GALNT11;JAG1;ACVR1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.5829966260765613,1.3863217260863983,0.11944444444444445,0.7284828102919092,1.0,12/26,23.60%,FOXP1;PER1;CRY2;NCOR1;NCOR2;BRCA1;STRN3;PIAS2;ZBTB7A;HEYL;CNOT1;DAB2
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6196621454285729,1.386091668162912,0.13114754098360656,0.7274387791253053,1.0,3/18,3.24%,SLIT2;PTK2B;MTUS1
prerank,protein hydroxylation (GO:0018126),0.6398339493886999,1.3857573522636053,0.11544227886056972,0.7269323245401018,1.0,8/15,21.65%,PLOD2;EGLN3;P3H3;P3H1;JMJD4;ASPH;HIF1AN;P3H4
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.48024843849790555,1.3855459860119723,0.03399122807017544,0.7259011357872766,1.0,18/113,7.32%,F3;BMP4;EGFR;TCF7L2;PGF;BMP5;FGF2;SOX9;NRAS;NRP1;VEGFA;FZD7;NOTCH2;TGFBR1;NR4A3;BMP6;ERBB2;SRSF6
prerank,kidney development (GO:0001822),0.5134112792639629,1.385356675127521,0.06698564593301436,0.7247726395041433,1.0,15/65,10.41%,SIX1;BMP4;PCSK5;PKD1;VEGFA;TGFBR1;NIPBL;NF1;ZBTB16;GLI2;PYGO2;SULF1;FOXC1;PYGO1;ARL3
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5236929847181018,1.3844824250484675,0.08445532435740515,0.7264678211908361,1.0,8/47,10.33%,THBS1;PID1;PRKCD;PLCG2;TGFBR2;ZC3H12A;TLR4;XDH
prerank,purine-containing compound catabolic process (GO:0072523),0.6497381239950725,1.3843452354015602,0.10819165378670788,0.7250726688755872,1.0,5/13,11.50%,NT5C1A;NT5E;DNPH1;XDH;NUDT15
prerank,regulation of RNA splicing (GO:0043484),0.5010870034554831,1.3821883161508006,0.07838479809976247,0.7323122382166621,1.0,17/69,15.38%,SLC38A2;AHNAK2;MBNL1;AHNAK;CLK2;CLK1;U2AF2;SON;RBM39;CLK4;CELF1;TIA1;FUS;HNRNPH1;RRP1B;KHDRBS1;SNRNP70
prerank,acylglycerol catabolic process (GO:0046464),0.5717308289816627,1.3821585836728874,0.1,0.7304572476243776,1.0,6/30,12.98%,MGLL;LYPLA2;FABP12;PNPLA3;ABHD6;PNPLA2
prerank,metal ion export (GO:0070839),0.5709848637866723,1.3820326578230127,0.10403120936280884,0.7290434083270413,1.0,9/31,9.77%,SLC4A4;KCNK5;ATP1B1;ATP2B4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,atrial septum development (GO:0003283),0.6501619773689532,1.381526805174343,0.12459546925566344,0.7293650532495667,1.0,6/13,16.72%,ANK2;NOTCH2;GATA4;ZFPM1;MDM4;NPHP3
prerank,actin polymerization or depolymerization (GO:0008154),0.5271988318214984,1.3814780332590595,0.09202453987730061,0.7275603767485606,1.0,9/50,7.82%,MICAL2;VILL;COBL;ABI1;GSN;PSTPIP1;DIAPH1;FLII;FAM107A
prerank,histone deubiquitination (GO:0016578),0.6162407337850567,1.3813555204335004,0.12389380530973451,0.7261821191843382,1.0,10/18,25.01%,USP15;UIMC1;BRCC3;TRRAP;USP49;USP21;USP16;USP36;USP7;ENY2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5124448043897684,-1.381245870300303,0.10862619808306709,0.5331095776122042,1.0,3/17,3.85%,ANK3;AKAP6;KCNAB1
prerank,negative regulation of phagocytosis (GO:0050765),-0.5041837362921874,-1.3808916948535876,0.08978328173374613,0.530953781546386,1.0,10/17,23.65%,DYSF;SIRPA;SYT11;CD300A;RACK1;HMGB1;SNX3;CD47;CD300LF;PRTN3
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5914740972781084,1.380820536798545,0.11560693641618497,0.7245936232454778,1.0,7/23,16.42%,THBS1;GIPC1;CREBBP;TGFB1I1;CDKN1C;RNF111;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5914740972781084,1.380820536798545,0.11560693641618497,0.7245936232454778,1.0,7/23,16.42%,THBS1;GIPC1;CREBBP;TGFB1I1;CDKN1C;RNF111;SMAD4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6122727606888025,1.3807426466986328,0.10794602698650675,0.7230182241570929,1.0,4/20,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,negative regulation of protein modification process (GO:0031400),0.49047653349672804,1.380044324860447,0.06971428571428571,0.7241294759136846,1.0,19/79,11.45%,SLIT2;LRP6;NTRK3;PID1;PLPP3;NIBAN1;KLHL31;GSK3B;SNTA1;IBTK;ATP2B4;ZC3H12A;CORO1C;P3H1;PTPA;CIB1;XDH;EPHB2;CHP1
prerank,negative regulation of coagulation (GO:0050819),-0.5419955289647419,-1.3799459242650294,0.11016949152542373,0.530482941712477,1.0,6/14,11.41%,VTN;APOE;HS3ST5;CD34;EDN1;TFPI
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.5191956214183993,-1.3796832688246101,0.09770114942528736,0.5280707490990222,1.0,6/17,18.05%,APOE;FGF1;ABCG1;KPNB1;ABCA2;SOD1
prerank,visual perception (GO:0007601),0.487223331874739,1.3796224070248941,0.059684684684684686,0.7240927358424873,1.0,15/84,16.03%,SLC4A10;EYA4;CACNA1F;PITPNA;COL11A1;RDH12;TULP2;CRYBB3;SFRP5;ATF6;DHRS3;EYA3;MYO9A;EFEMP1;PAX6
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.576165164305222,1.3782678653636165,0.10714285714285714,0.7279691676715195,1.0,7/26,10.68%,EGFR;SOX9;ERBB2;KNSTRN;FOXC1;SYAP1;GAREM1
prerank,peptidyl-proline modification (GO:0018208),0.5908144317089105,1.3779453559465096,0.08767123287671233,0.7273718196997556,1.0,6/25,17.88%,FKBP5;NKTR;FKBP10;PPIC;PIN1;PPIL6
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6688234444958545,1.3775780023816335,0.1321928460342146,0.7271348650264956,1.0,1/12,0.48%,TMEFF2
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5194523311752693,1.3773554765652767,0.07107843137254902,0.7261679428296756,1.0,15/55,16.26%,THBS1;PID1;CYP1B1;COQ7;TGFBR2;ZC3H12A;XDH;EIF6;PDK3;ARF4;BRCA1;AATF;RNF41;ALOX5;CDKN1A
prerank,Wnt signaling pathway (GO:0016055),0.4837611822862323,1.376815991270944,0.0550561797752809,0.7265479999768568,1.0,18/92,9.72%,NXN;TCF7L1;TCF7L2;WNT9A;LRP6;WNT11;PLPP3;SFRP4;GSK3B;FZD1;FZD7;PLCG2;NR4A2;STRN;CSNK1A1;SFRP5;CUL1;USP34
prerank,hyaluronan catabolic process (GO:0030214),0.6059186215353121,1.376596392453475,0.12005856515373353,0.7256485124413198,1.0,7/18,11.45%,FGF2;SPAM1;HEXA;LYVE1;CD44;SLC9A1;CHP1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5026883417732126,1.3764070446431254,0.060786650774731825,0.7244978228741616,1.0,15/69,13.32%,THBS1;LBP;CD2;CCL3;PLCG2;TLR1;IL33;TWIST1;STAT3;TLR4;MAVS;IFIH1;EPHB2;CLU;TIRAP
prerank,cell junction organization (GO:0034330),-0.3618013504147804,-1.3751836243982702,0.02962962962962963,0.5374623788353411,1.0,20/71,11.59%,TJP1;OCLN;GRM5;PPFIBP2;PPFIBP1;PPFIA2;APP;SLC6A1;PAK3;VASP;ACTB;SDK2;OPHN1;FLNC;FBLIM1;CLDN1;MAPT;SLC8A3;C1QA;VMP1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.46756590597805947,-1.3750890841501637,0.09803921568627451,0.5345867277797836,1.0,8/24,11.65%,TEK;KDR;NDNF;GATA2;TNIP2;SEMA5A;GAS6;CDH5
prerank,striated muscle tissue development (GO:0014706),0.5754031802696682,1.3750694000950865,0.10650069156293222,0.7284577802933933,1.0,4/29,1.82%,SIX1;SGCD;CSRP3;BMP5
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4802982538771357,1.3749850458674848,0.05636978579481398,0.7269540978615407,1.0,28/95,17.26%,THBS1;HTRA3;SMAD6;SKIL;HTRA4;PMEPA1;GIPC1;CD109;TGFBR1;SPRED2;SKI;EMILIN1;TGFBR2;CREBBP;LTBP4;DKK3;IL17RD;SMAD2;TGFB1I1;LDLRAD4;CDKN1C;WFIKKN1;FAM89B;RNF111;SMAD4;PIN1;BCL9L;SMAD7
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.6374719799288092,1.3748039637423464,0.11866859623733719,0.7259346154369236,1.0,4/17,5.21%,ADRA1B;ADRB2;AKAP13;ADCY9
prerank,negative regulation of ATP metabolic process (GO:1903579),0.6126475981620721,1.3728571876545945,0.13623188405797101,0.7323378760789928,1.0,7/17,14.05%,HDAC4;PID1;PFKFB1;NCOR1;MLXIPL;PARP1;TIGAR
prerank,vasculogenesis (GO:0001570),-0.4461528192857623,-1.372539439699994,0.07114624505928854,0.538648352793882,1.0,11/32,11.66%,ENG;PDGFRB;TGFBR3;KDR;SPRED1;RASIP1;SOX17;NOTCH1;HEY2;ADM;SOX18
prerank,negative regulation of protein phosphorylation (GO:0001933),0.4667035485724545,1.3720087619808574,0.03400637619553666,0.7342889073418942,1.0,33/150,11.45%,SLIT2;RASSF2;LRP6;UBASH3B;NTRK3;PID1;PRKCD;SMAD6;PLPP3;NIBAN1;PMEPA1;KLHL31;NOG;TWIST1;SPRED2;NF1;IBTK;EMILIN1;NCK2;NLRP12;DMTN;CEP43;ZC3H12A;MLXIPL;CORO1C;CIB1;XDH;DUSP19;QARS1;DNAJC3;LDLRAD4;EPHB2;CHP1
prerank,signal release from synapse (GO:0099643),-0.4020566177994962,-1.3713972907644247,0.056338028169014086,0.5385628814760713,1.0,9/43,7.00%,NRXN1;SYN2;RIMS1;LIN7A;SNAP25;SYT1;HSPA8;SYT10;PTPRN2
prerank,potassium ion transmembrane transport (GO:0071805),0.4707938883052233,1.3712763013915872,0.03536977491961415,0.7355831440481129,1.0,11/135,3.07%,SLC9A2;KCNK5;SLC12A7;KCNJ2;KCNB2;SLC12A2;SLC24A3;KCNJ15;ATP1B1;KCNB1;KCNS3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5322249243166587,1.3709948671262535,0.10282776349614396,0.7349483820236409,1.0,11/45,10.68%,EGFR;PLCE1;REPS2;PTK2B;SOX9;SHC1;KIF16B;NCK2;AAMP;ERBIN;GAREM1
prerank,potassium ion import across plasma membrane (GO:1990573),0.5452710055256555,1.3705662832928756,0.10855683269476372,0.734993916209426,1.0,5/41,1.98%,SLC12A7;KCNJ2;SLC12A2;KCNJ15;ATP1B1
prerank,regulation of nervous system process (GO:0031644),-0.5160159207197625,-1.3703464026265206,0.11746031746031746,0.5382456954262251,1.0,13/18,26.28%,NOS3;APP;DLGAP1;HTR2C;ROCK2;TMEM108;SLC8A3;SLC8A2;NPTXR;NPTX1;DLGAP2;NPTX2;BEGAIN
prerank,regulation of DNA metabolic process (GO:0051052),0.5223268024413902,1.3703298670125308,0.08740359897172237,0.7340623207274222,1.0,20/44,29.04%,GRHL2;HDAC8;SMG6;TICRR;HELB;USP1;KPNA1;TOM1L1;KPNA2;WDR18;YLPM1;XRCC5;WDR70;NBN;KDM1B;MPV17;UBE2V1;PDGFA;THOC1;UBE2N
prerank,nitrogen compound transport (GO:0071705),0.46896581333049603,1.370276712341003,0.030042918454935622,0.7324130132567344,1.0,20/141,11.53%,SLC38A2;SLC23A1;SLC38A1;SLC12A2;RAMP1;LRRC8D;ABCG2;TMEM30B;SCARB2;SLC7A9;LMAN2L;RUFY1;SLC6A2;SLC38A3;SCAMP2;MIA3;CMTM6;SLC52A3;RHCG;SLC25A45
prerank,positive regulation of lipid catabolic process (GO:0050996),0.614182366352637,1.3702766970038844,0.10595065312046444,0.730554096979433,1.0,6/19,12.98%,PRKCD;IRS1;TWIST1;ABCD1;ANGPTL3;PNPLA2
prerank,regulation of protein catabolic process (GO:0042176),0.47995164219301645,1.3696806161223523,0.0593505039193729,0.7312625820577303,1.0,31/99,18.62%,WWP1;EGFR;NEDD4;FZR1;GPC3;WWP2;GSK3B;IRAK3;CHEK2;DACT1;BARD1;ZDHHC2;VCP;IDE;ODC1;MAD2L1;NSF;STX5;CDKN1B;MDM4;SORL1;RNF41;AZIN1;PIN1;SNF8;SNX12;OAZ2;AREL1;DTL;SMURF1;HMGCR
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.5207402779547152,1.3687219286678438,0.1018867924528302,0.7335111643080026,1.0,20/45,22.78%,BMP4;PTPN3;GAS1;NABP1;FOXC1;ANGEL2;TOM1L1;BTG3;MAD2L1;CDKN1C;ZW10;CDKN1B;SCRIB;ZWILCH;CHFR;TRIM35;WEE1;AURKAIP1;CHEK1;PRCC
prerank,inorganic cation import across plasma membrane (GO:0098659),0.49584107799193133,1.3673409107338277,0.073512252042007,0.737481633508348,1.0,14/75,9.77%,SLC9A2;SLC12A7;KCNJ2;SLC12A2;KCNJ15;ATP1B1;SLC39A14;ATP2B4;TRPM4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,sodium-independent organic anion transport (GO:0043252),0.6863661926358722,1.3671479208084683,0.1494435612082671,0.7364689768604933,1.0,3/10,1.29%,SLCO3A1;SLCO2A1;SLCO4A1
prerank,myotube differentiation (GO:0014902),-0.5050788840511297,-1.3665307804973663,0.1289308176100629,0.5455896958252309,1.0,5/17,7.65%,IGF1;ADGRB3;SORT1;MEF2C;JAM2
prerank,organophosphate ester transport (GO:0015748),0.5774579654221907,1.366225116051117,0.12083333333333333,0.7384520957726105,1.0,4/24,3.78%,TNFAIP8L3;PITPNC1;LDLR;PITPNA
prerank,negative regulation of telomere maintenance (GO:0032205),0.6358828597578403,1.3652799598402172,0.1273006134969325,0.7404985535036276,1.0,8/15,23.47%,SMG6;SLX4;PARP1;RAD50;ERCC4;NBN;TNKS2;ATM
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.5841726193109954,-1.363879377427572,0.15300546448087432,0.5497967679767558,1.0,6/10,19.35%,PDE4D;MGRN1;PDE2A;RNF157;APLNR;CDC34
prerank,cell-cell junction maintenance (GO:0045217),-0.5687759803321539,-1.363683401047124,0.14363143631436315,0.5471725139884002,1.0,1/11,0.05%,TJP1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5600668557684981,1.3624398542637488,0.11290322580645161,0.7504492291831948,1.0,17/29,31.09%,ERCC5;MNAT1;CHD1L;PARP1;RAD23B;CDK7;GTF2H3;CETN2;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5434332944889193,-1.3624350891664168,0.11864406779661017,0.5477784230932237,1.0,7/12,16.03%,PODXL;PROM1;PTPRO;MAGI2;BASP1;CD24;KLF15
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5454873882735479,1.3622024990778394,0.10252996005326231,0.7495450902653593,1.0,8/33,11.50%,KLF5;FGF2;KLF4;STAT3;FOXO3;EGR1;ATOH8;TEAD1
prerank,establishment of epithelial cell polarity (GO:0090162),0.6073358052740216,1.3621527272215759,0.1326676176890157,0.7478882609146646,1.0,8/19,16.49%,CYTH3;EZR;SYNE4;RHOA;PARD3;MYO9A;GOLPH3;CAMSAP3
prerank,regulation of NMDA receptor activity (GO:2000310),-0.4312932623048066,-1.3619565416224602,0.08677685950413223,0.5459840618580043,1.0,15/32,15.97%,GRIA4;ACTN2;APP;GRIN2A;LRRC7;GRIN2B;SLC6A9;MEF2C;GRIA1;GRIN1;GRIA3;OPRM1;CAMK2B;CAMK2A;RELN
prerank,response to glucose (GO:0009749),0.5247305673316973,1.3617522630719539,0.08470290771175727,0.7477902563028407,1.0,5/46,3.32%,THBS1;TCF7L2;UNC13B;KCNB1;SLC39A14
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.49306927253337185,1.3615849177081885,0.07962529274004684,0.7466898144481896,1.0,15/73,13.32%,THBS1;LBP;CD2;CCL3;PLCG2;TLR1;IL33;TWIST1;STAT3;TLR4;MAVS;IFIH1;EPHB2;CLU;TIRAP
prerank,cardiac muscle tissue development (GO:0048738),0.522771261010068,1.3609640749290144,0.08849557522123894,0.7474986367473145,1.0,8/50,3.87%,BMP4;SGCD;CACNA1G;CSRP3;BMP5;AKAP13;BMPR1A;NOTCH2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4755421955709431,1.360718008887754,0.058758314855875834,0.7467667740963225,1.0,19/95,7.98%,ST3GAL4;GPC6;EXT1;DSE;GPC3;HS6ST2;UST;B3GNT2;CHST13;HEXA;HS3ST1;XYLT1;HAS1;BGN;CHST11;B4GALT1;SLC10A7;SLC35D2;CHST5
prerank,regulation of filopodium assembly (GO:0051489),0.5421958503763944,1.360682880389538,0.10927573062261753,0.7451122937796806,1.0,11/38,7.87%,DPYSL3;PRKCD;ARAP1;NRP1;TGFB3;PALM;BCAS3;ARHGAP44;TENM1;RHOQ;DMTN
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.48463246507188346,-1.360532099880895,0.11217948717948718,0.5467159607261551,1.0,7/18,7.10%,SHANK3;NRXN1;RIMS1;RIMS2;PRKCZ;GRIN1;CUX2
prerank,autophagy of nucleus (GO:0044804),0.622369299026575,1.3585701672192174,0.13561847988077497,0.7523619207901803,1.0,6/16,13.99%,ULK2;WDR45B;ATG3;RB1CC1;ATG5;WIPI2
prerank,protein deubiquitination (GO:0016579),0.45217644655255124,1.358351690740278,0.015384615384615385,0.7514584364850795,1.0,95/242,24.41%,CCNA2;USP2;USP46;OTUD1;ADRB2;ESR1;PSMB2;TGFBR1;IL33;USP24;USP15;USP25;USP13;MYSM1;BARD1;IKBKG;ADRM1;PSMD11;SMAD2;ZC3H12A;BECN1;UIMC1;PSMC1;VCP;USP1;TADA3;IFIH1;CLSPN;USP34;CDC20;DESI2;RHOA;MAP3K7;RAD23B;WDR48;PSMC6;KEAP1;TRAF2;MDM4;BRCA1;USP40;RNF123;COPS5;ZRANB1;USP4;BRCC3;PSMD1;USP28;INO80E;ABRAXAS2;TRAF6;PSMD4;TNIP1;SMAD4;FOXK1;USP47;OTUD5;HCFC1;POLB;SMAD7;PSMA6;OTUD4;TRRAP;ACTR5;OTUD3;USP49;PSMD14;PSMD12;PSMD7;VCPIP1;USP21;USP16;MBD5;USP19;USP10;USP32;FOXK2;TRAF3;YY1;PSME3;USP30;USP36;USP9X;SUDS3;TADA2B;ABRAXAS1;TP53;OGT;PSMD3;USP7;USP33;PSMB6;USP42;UBB;INO80
prerank,dopaminergic neuron differentiation (GO:0071542),0.6085298495592733,1.3565992151854056,0.1417910447761194,0.7569979193442689,1.0,3/19,6.71%,LRP6;VEGFA;NR4A2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6269761233745367,1.3564232319106715,0.1361573373676248,0.7558864682974634,1.0,5/15,6.59%,RSPO3;GPC3;SFRP4;DACT1;TIAM1
prerank,regulation of cell morphogenesis (GO:0022604),0.5464510172489274,1.3561911496296286,0.11957950065703023,0.7550788729355207,1.0,13/30,19.57%,FMNL2;EFNA5;CD44;ZMYM4;PDZD8;ZRANB1;MYO9A;MOV10;BCL9L;LARP4;SH3D19;FITM2;FERMT2
prerank,regulation of DNA replication (GO:0006275),0.5164828043644795,1.355415605346479,0.09245742092457421,0.7565156438199363,1.0,19/49,21.92%,EGFR;CCNA2;GLI2;DSCC1;STN1;ANKRD17;FBXO5;ESCO1;ORC3;BCAR3;RAD17;TSPYL2;DHX9;ATR;S100A11;WAPL;EGF;BRPF3;GTPBP4
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.45274421919942937,-1.3554020095753876,0.10486891385767791,0.5584051141435254,1.0,6/26,18.37%,ATP1A2;CALM1;ADRA2A;UBQLN1;CASQ2;GNB5
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.6418102931340147,1.3549436984398049,0.13901345291479822,0.7566672664253281,1.0,6/14,18.10%,CARD14;MAP3K7;TRAF2;TIRAP;TRAF6;COPS8
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6820831157189584,1.354840125319728,0.12845528455284552,0.7552928360820748,1.0,2/10,3.09%,PRKCE;IRS1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5438586697204082,-1.354383477270186,0.13529411764705881,0.5582786347377875,1.0,4/13,8.02%,LEF1;PRKCZ;TNFRSF21;IL18
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5820968254480083,-1.3542599626187932,0.15072463768115943,0.5555383616777969,1.0,2/10,3.85%,ANK3;KCNAB1
prerank,protein localization to nucleus (GO:0034504),0.4741107705664329,1.3536124767467284,0.0683090705487122,0.7586499164854759,1.0,23/102,16.18%,SIX1;BMP4;PRICKLE1;TBRG1;STAT3;LMNA;NUP93;ABCA7;E2F3;WRN;NUP214;NUP153;TNPO2;SIX4;TNPO3;IPO7;NUP155;NUTF2;MORC3;NUP88;TOR1B;DVL1;CSE1L
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.49732907016444533,-1.3533861510779748,0.1461038961038961,0.5548928810567232,1.0,6/17,9.74%,IGF1;APOE;RTN1;RTN4;NTRK2;BIN1
prerank,type I interferon signaling pathway (GO:0060337),-0.4141763716645382,-1.3533487696165574,0.05825242718446602,0.548945160853238,1.0,22/41,21.82%,IFNAR1;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;STAT1;RNASEL;IFITM2;IRF2;IFIT3;ADAR;PSMB8;IRF9;IRF8;STAT2;XAF1;JAK1;IRF7
prerank,cellular response to type I interferon (GO:0071357),-0.4141763716645382,-1.3533487696165574,0.05825242718446602,0.548945160853238,1.0,22/41,21.82%,IFNAR1;IFIT2;IFIT1;SAMHD1;IFITM1;OAS2;IFITM3;IFNAR2;BST2;STAT1;RNASEL;IFITM2;IRF2;IFIT3;ADAR;PSMB8;IRF9;IRF8;STAT2;XAF1;JAK1;IRF7
prerank,myoblast differentiation (GO:0045445),0.6420489084451717,1.3533240529020594,0.14393939393939395,0.758154776766102,1.0,5/14,6.54%,TCF7L2;MBNL1;DDX5;DDX17;MAPK12
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.3591709854533421,-1.3514990100691409,0.06896551724137931,0.5511997805624163,1.0,13/72,4.28%,FLT1;IGF1R;IGF1;PDGFD;LYN;TEK;PDGFRB;KIT;PIK3R1;DCN;KDR;INSR;ROR2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5219994641775629,1.3506073169638757,0.10591133004926108,0.7683737478146305,1.0,6/48,8.24%,SLIT3;SLIT2;IRAK3;PTPN2;PALM3;ARG1
prerank,DNA replication (GO:0006260),0.46771398401090925,1.3498996609819223,0.06562847608453838,0.7694961145995165,1.0,44/105,25.29%,REV3L;EXO1;TBRG1;CDC45;MCM2;TICRR;BARD1;WRN;TOPBP1;HELB;TOP1;CLSPN;POLE2;KIN;RAD50;ORC3;RAD17;BRCA1;RNASEH2A;BRIP1;MCM7;PCLAF;FAM111A;CDK2;CDC7;POLG2;POLB;RECQL5;DONSON;MCM9;RMI2;POLA2;RFC1;ATR;BAZ1A;NAP1L1;NBN;CHEK1;ATM;CDK2AP1;RBBP8;RAD9A;CDC6;RAD9B
prerank,cellular response to purine-containing compound (GO:0071415),-0.5807030179978776,-1.3495824474885945,0.1477832512315271,0.5536451295818399,1.0,4/10,15.71%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,negative regulation of transmembrane transport (GO:0034763),0.6751950985864099,1.3494674244879794,0.1629032258064516,0.7695499434747647,1.0,1/10,0.19%,THBS1
prerank,activin receptor signaling pathway (GO:0032924),0.6320938606885378,1.3491315330666178,0.1355421686746988,0.7691821158062638,1.0,5/15,15.32%,TGFBR1;INHBA;SMAD2;ACVR1;INHBB
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5095408467411823,1.3488576579108713,0.11028500619578686,0.7684529500490989,1.0,6/51,4.34%,THBS1;PGF;CMKLR1;VEGFA;ANO6;CCL1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4716199966734774,-1.3484384816460186,0.11564625850340136,0.5539299316826423,1.0,4/21,5.77%,OSBPL8;PLA1A;OSBPL10;PLAAT3
prerank,regulation of autophagosome maturation (GO:1901096),0.6191359832345086,1.3472112251615624,0.1580547112462006,0.7734917789307221,1.0,3/13,5.22%,ADRB2;CLEC16A;TMEM39A
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.6385523962057098,1.346748291749413,0.14930015552099535,0.7735666061455128,1.0,4/12,8.35%,ESR1;NCOR1;ZC3H12A;NCOR2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.6125356494894602,1.3463547800727378,0.15038759689922482,0.773460821886476,1.0,13/16,31.68%,CELF3;DAZAP1;THRAP3;RBM3;CELF4;RBMX;CIRBP;NUP98;RBMXL1;TRA2A;TRA2B;PRDX6;SNW1
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4565799718210797,-1.3462771989712405,0.07482993197278912,0.5572272620528469,1.0,8/25,12.19%,ERRFI1;PPARA;CBLB;SNX6;SLC6A9;ZFYVE28;CNRIP1;ACE2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.45303242269655514,-1.3462512761976817,0.10980392156862745,0.5543458906004406,1.0,10/26,10.70%,SHANK3;NRXN1;APP;RIMS1;RIMS2;PRKCZ;GRIN1;CUX2;TMEM108;SLC8A3
prerank,regulation of B cell apoptotic process (GO:0002902),0.6515639597913775,1.3459229329706426,0.1523809523809524,0.7735188070935253,1.0,1/12,0.23%,FOXP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6250041675349632,1.3450668598196256,0.14985163204747776,0.7753518136047142,1.0,7/14,18.57%,EHHADH;ACOX3;ABCD1;ACOT8;ACOX1;CROT;CRAT
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5514315893528278,1.3445295482735693,0.12125340599455041,0.7759067905427348,1.0,17/29,23.97%,RAB6A;COG5;TRAPPC3L;COPG1;COPA;NSF;COG8;TRAPPC3;TRAPPC10;COPB2;GOSR2;COG3;VTI1A;RAB33B;VTI1B;COG2;COPZ1
prerank,acidic amino acid transport (GO:0015800),-0.4952487021662111,-1.3444730378437195,0.1414790996784566,0.5562452485501234,1.0,7/17,5.34%,SLC1A3;SLC6A13;SLC6A1;SLC1A1;GJA1;SLC1A2;SLC25A13
prerank,sulfur compound biosynthetic process (GO:0044272),0.46522373170322684,1.3443054701170025,0.051648351648351645,0.7750328693050801,1.0,16/104,7.98%,SLC26A2;ST3GAL4;DSE;GCLC;UST;B3GNT2;PAPSS2;CHST13;BGN;GSTT1;CHST11;B4GALT1;SLC10A7;GSTA2;SLC35D2;CHST5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6675710779978874,1.3442387587854345,0.15132605304212168,0.7717207446160357,1.0,2/10,4.13%,WNK1;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6675710779978874,1.3442387587854345,0.15132605304212168,0.7717207446160357,1.0,2/10,4.13%,WNK1;KLF4
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5982621947416609,1.3441305342954455,0.12973760932944606,0.7703491756993973,1.0,4/19,10.85%,BMP4;TGFB3;EMILIN1;CREB3L1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.593243500305549,1.3440081789231872,0.14693295292439373,0.7690491148415485,1.0,5/20,17.88%,FKBP5;NKTR;PPIC;PIN1;PPIL6
prerank,protein localization to cell surface (GO:0034394),0.5618638264407537,1.3437524553867446,0.12618724559023067,0.7683775340988599,1.0,9/26,18.27%,PTPRU;ANK2;WNT11;RIC3;VCL;PIGU;USP4;PIGK;SMURF1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5618018998395117,-1.3427529823109707,0.11014492753623188,0.5581195048934279,1.0,5/12,6.47%,UNC13C;RIMS1;RIMS2;SYT1;SYT7
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5087171571583818,-1.3426352190360837,0.12835820895522387,0.5554972287915737,1.0,5/16,10.38%,AUTS2;ARHGAP24;RASGRF1;CADM4;STMN3
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4809233646438848,1.3424628503555955,0.08934707903780069,0.7720055756834072,1.0,14/77,12.19%,THBS1;BMP4;TCF7L2;TGFBR1;NDUFS3;NR4A2;MPV17L;GATA4;ITGAV;QARS1;MCL1;FXN;HERPUD1;CLU
prerank,chondrocyte differentiation (GO:0002062),0.5456772483962425,1.3411949253512148,0.1392081736909323,0.7756678800649677,1.0,7/32,8.73%,BMP4;CCN3;NFIB;SOX9;SLC39A14;SULF1;RUNX2
prerank,regulation of DNA repair (GO:0006282),0.5124585375811348,1.3410238213933254,0.1159235668789809,0.774607462431247,1.0,12/44,14.63%,EGFR;EYA2;EYA4;UBR5;UIMC1;USP1;EYA3;BRCA1;TRIP12;TIGAR;RNF8;BRCC3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.5629323571404516,-1.3406011913316167,0.15384615384615385,0.5582809505060494,1.0,7/11,26.08%,UQCRH;UQCR10;UQCRC1;CYCS;CYC1;UQCC3;UQCRQ
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.640121478633659,1.3402435871862908,0.16591251885369532,0.7760284055528687,1.0,4/12,13.32%,FOXP1;KLF4;TLR4;TIRAP
prerank,detection of calcium ion (GO:0005513),0.637069293337699,1.3400567040166749,0.16338880484114976,0.775054658180703,1.0,3/13,2.38%,KCNMB3;KCNMB2;CASR
prerank,positive regulation of catabolic process (GO:0009896),0.4963620178456111,1.3400025180788366,0.09027777777777778,0.7735423197499326,1.0,21/65,18.27%,WWP1;NEDD4;FZR1;GPC3;WWP2;GSK3B;DACT1;BARD1;VCP;IDE;ANGPTL3;NSF;STX5;CDKN1B;SORL1;RNF41;SNF8;OAZ2;AREL1;DTL;SMURF1
prerank,pulmonary valve morphogenesis (GO:0003184),0.605278092942272,1.339886417198299,0.15922619047619047,0.7722654230548012,1.0,4/17,3.87%,SLIT2;BMP4;SMAD6;NOTCH2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4293595706807792,-1.339153840666558,0.07777777777777778,0.5592857472247257,1.0,15/28,26.04%,MITF;PRKAA2;SIRPA;FGFR4;RAC1;MED1;AVIL;PRKAG2;NOS1AP;CD47;PDK4;C3;NR1H4;MFSD12;SIRT5
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4127488798457808,-1.3391254923956049,0.09502262443438914,0.5564978887180934,1.0,13/39,10.12%,ROBO1;ROBO2;MAML3;MAML2;TSPAN5;NOS3;EPN2;RBPJ;NOTCH1;NOTCH4;TSPAN14;JAG2;TM2D3
prerank,negative regulation of chemotaxis (GO:0050922),0.5433433792382147,1.338769430080409,0.13968668407310705,0.7752457498892601,1.0,6/31,5.78%,SLIT2;THBS1;SEMA3E;SEMA3C;PTPN2;SEMA3D
prerank,regulation of cartilage development (GO:0061035),0.6008314921416037,1.3384145364263034,0.15138282387190685,0.775038066342584,1.0,6/18,5.85%,BMP4;BMP1;WNT11;SOX9;PTHLH;ZBTB16
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.49550866353292894,1.3380811983879703,0.09334889148191365,0.7746178821914587,1.0,22/63,17.54%,PLAGL1;CRADD;CNOT8;CHEK2;AURKA;WAC;CASP2;CCND1;CCNB1;FBXO31;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;PIDD1;PRKDC;CDK2;CDKN1A;CNOT4;PLK3;PCBP4
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5672106131148806,1.3372741534832007,0.1573816155988858,0.7762339865818414,1.0,6/23,6.07%,UBASH3B;CAMK2D;ANK2;PTK2B;CACNG6;DIAPH1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.473007354574474,-1.3372019674897169,0.10631229235880399,0.5590743761604107,1.0,7/20,18.63%,RPS6KA5;PRKAA2;PPARGC1A;RPS6KA4;BRD7;SOX4;GLYR1
prerank,Rac protein signal transduction (GO:0016601),-0.4947364166922975,-1.3368538892235362,0.1498371335504886,0.5571133134057931,1.0,7/18,12.18%,EPS8;ELMO1;CDH13;HACD3;RAC1;RHOH;HACE1
prerank,regulation of chromatin organization (GO:1902275),0.6234956686769012,1.3360938960696125,0.15970149253731344,0.7793460363495226,1.0,3/14,6.66%,MLLT3;TLK1;ALKBH4
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5709689627234698,1.336080030925374,0.14664804469273743,0.7776537874285662,1.0,15/22,33.01%,CHD1L;PARP1;RAD23B;GTF2H3;CETN2;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1
prerank,pulmonary valve development (GO:0003177),0.6035788263683868,1.3360640728320647,0.1487481590574374,0.7759960805260434,1.0,4/18,3.87%,SLIT2;BMP4;SMAD6;NOTCH2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4598332751474802,1.3353827673400536,0.06637649619151251,0.7771075167977,1.0,17/112,9.54%,THBS1;FOXP1;LBP;CD2;RARA;CCL3;PLCG2;IRAK3;TLR1;IL33;TWIST1;STAT3;C5AR2;ZC3H12A;TLR4;MAVS;IFIH1
prerank,glucose import (GO:0046323),-0.5302042015272087,-1.3349258739364582,0.14484679665738162,0.5597294955222377,1.0,2/13,2.40%,SLC2A1;SORT1
prerank,outflow tract septum morphogenesis (GO:0003148),0.567482910476077,1.3341628615499288,0.1522633744855967,0.7803670173885363,1.0,8/24,6.61%,BMP4;ZFPM2;SMAD6;NRP1;BMPR1A;SEMA3C;PARVA;TGFBR2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.6588283388602532,1.3340323844629314,0.16903633491311215,0.7791323320727198,1.0,2/11,1.98%,KCNJ2;ATP1B1
prerank,central nervous system neuron differentiation (GO:0021953),-0.4137279658372799,-1.3339849853453847,0.07661290322580645,0.5595055229436067,1.0,12/33,10.06%,GRID2;MDGA2;SPOCK1;MAP2;TOX;RYK;OPHN1;PROX1;FAIM2;NTRK2;MAPT;ZC4H2
prerank,RNA biosynthetic process (GO:0032774),0.5434389573152484,1.3335629727238114,0.15649867374005305,0.7794131302701476,1.0,18/31,26.45%,HELB;PRIM1;NCOA6;PRMT5;TAF4;PRIM2;SMARCA5;TAF5;POLA2;TTF1;TBP;TAF12;TAF13;GTF2B;TAF7;RSF1;SMN1;TTF2
prerank,actin crosslink formation (GO:0051764),0.6288842767152387,1.3333600904683478,0.1582089552238806,0.778546526411646,1.0,3/12,3.04%,DPYSL3;BAIAP2L1;GAS2
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5386873105381382,1.3333275550980013,0.12813738441215325,0.7769509100822821,1.0,10/31,9.25%,CRIM1;TWIST2;SMAD6;SOX9;GDF10;NOG;TWIST1;SKI;TRPM4;CHRD
prerank,regulation of cell cycle (GO:0051726),0.4349894988177703,1.3325075717033665,0.0194672131147541,0.7786682686244006,1.0,78/271,22.80%,THBS1;BMP4;PLAGL1;TCF7L2;LRP6;PKD1;GRK5;SOX9;TTC28;ID2;GADD45G;CDK10;NOTCH2;TXLNG;RARA;SON;TGFBR1;ABL1;TBRG1;GBF1;STAT3;NEK7;MAPK12;CDC14A;INHBA;BARD1;CDK11B;SMIM22;IRF1;MLXIPL;CCND1;EIF4G2;CDKN2C;PDCD4;CDC123;CCNB1;POU4F1;ANKRD17;GAS2L1;FBXO5;RPRM;CDKN1B;BRCA1;CDKN3;NR4A1;RRP8;PIM2;SRA1;CDK7;PCLAF;CDKN1A;SIK1;E4F1;FAP;HCFC1;IQGAP1;RB1;RNF20;TSPYL2;DTL;TMEM8B;PRDM11;MED25;FBXL6;WDR12;LIN9;NEK6;GADD45GIP1;PML;PUM1;PES1;NBN;TARDBP;ZBTB17;CHEK1;RPS6KA2;PRCC;SRPK2
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6368546783216125,1.3322393259895364,0.15890850722311398,0.7781163060480112,1.0,2/12,2.11%,GCLC;BDH2
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6054645105124926,1.3321724927729948,0.17040358744394618,0.7767151891568418,1.0,6/15,13.66%,ENTPD6;ENTPD2;ENTPD5;ENTPD7;AK4;AK1
prerank,potassium ion export across plasma membrane (GO:0097623),0.6386714515546272,1.3315003065418967,0.16812865497076024,0.7777944605964997,1.0,1/13,0.18%,KCNK5
prerank,fatty acid beta-oxidation (GO:0006635),0.5099564780266168,1.3305745297197487,0.09090909090909091,0.7799716996882878,1.0,20/51,23.66%,ABCD3;EHHADH;BDH2;AUH;ACOX3;ABCD1;ECHDC1;DECR1;ETFDH;ACOT8;ETFA;ACOX1;ECHDC2;ACADL;CROT;CRAT;ACADS;ACADVL;ECI1;HADHA
prerank,DNA duplex unwinding (GO:0032508),0.5086149060384156,1.330317616341644,0.11439114391143912,0.7793340281989384,1.0,27/50,31.09%,ANXA1;MCM2;RAD51;WRN;CHD1L;PARP1;RAD23B;RAD50;DDX11;MCM7;GTF2H3;RECQL5;MCM9;DHX9;CETN2;NBN;HMGA1;UBB;RECQL;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5
prerank,positive regulation of mRNA processing (GO:0050685),0.5774623886148595,1.329318150626781,0.15797317436661698,0.7816865937943283,1.0,8/21,15.49%,CELF3;DAZAP1;THRAP3;DHX36;RBM3;CELF4;RBMX;CIRBP
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.47463412720939135,1.3290785470876108,0.08154020385050963,0.7810981658903773,1.0,24/87,19.03%,FBXL7;FHL1;PSMB2;KLF4;DACT1;AURKA;FAM107A;PSMD11;CDKN2C;PSMC1;CUL1;PSMC6;FBXO5;DLG1;PSMD1;PSMD4;CDKN1A;USP47;RB1;PSMA6;PSMD14;PSMD12;PSMD7;WEE1
prerank,visual system development (GO:0150063),0.5191568563223407,1.328877660745585,0.1364795918367347,0.7802248313119096,1.0,7/37,12.37%,PBX3;SMOC1;PBX1;HIPK1;FOXC1;ATF6;SCO2
prerank,positive regulation of embryonic development (GO:0040019),-0.4917406274256782,-1.328841404163952,0.13529411764705881,0.570945505095709,1.0,5/19,7.15%,PLCB1;WNT4;OSR1;CFL1;TENM4
prerank,positive regulation of cholesterol transport (GO:0032376),-0.43411580334325356,-1.3286931620209117,0.08300395256916997,0.5685081309746183,1.0,6/27,6.89%,PLTP;APOE;ABCA5;PTCH1;NR1H3;EEPD1
prerank,positive regulation of cytokinesis (GO:0032467),0.5444631745154714,1.3279733566553902,0.12698412698412698,0.7824342742607021,1.0,7/32,12.02%,CIT;PRKCE;GIPC1;CDC14A;CUL3;RHOA;DRD3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6477401833269054,1.327741886139151,0.15233785822021115,0.7817244396575662,1.0,4/12,5.44%,DOCK5;IGFBP5;NR4A3;DOCK7
prerank,positive regulation of protein catabolic process (GO:0045732),0.4742501141003789,1.3276780772261805,0.08879023307436182,0.7802928358011807,1.0,25/84,18.27%,WWP1;NEDD4;FZR1;ADAM9;EZR;GPC3;WWP2;GSK3B;DACT1;BARD1;RDX;VCP;IDE;NSF;STX5;CDKN1B;SORL1;RNF41;SNF8;PLK3;OAZ2;AREL1;DTL;SH3D19;SMURF1
prerank,integrin-mediated signaling pathway (GO:0007229),0.47492185049560676,1.3265795007876222,0.10273972602739725,0.7831917999589734,1.0,23/73,18.39%,ITGBL1;ADAM9;PTK2B;PLPP3;COL3A1;NRP1;ITGB8;ITGB5;ABL1;FN1;PTPRA;ITGB1;CUL3;ITGAV;ERBIN;ANGPTL3;ITGB1BP1;ITGB3;ADAM15;PTN;ADAMTS1;LAT;ITGA5
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4304586214321289,1.3265165311161906,0.005,0.7818105687526418,1.0,139/572,17.61%,FOXP2;FOXP1;KLF12;BMP4;ZFHX3;ZFPM2;TCF7L2;NFIB;HES1;HDAC4;FOXP4;NEDD4;CUX1;RARB;DDX5;USP2;PRDM6;EZR;HDAC9;SKIL;MDFI;SOX9;SOX14;JDP2;VEGFA;ESR1;ID2;ID1;WWP2;ZNF148;FOXC2;GLIS1;RARA;KLF4;GLI3;HDAC8;KLF7;NOG;IL33;NR4A3;TWIST1;NIPBL;STAT3;FOXO3;KLF10;SKI;NFIX;FRK;ZBTB16;PER1;MEF2A;DACT1;NFIL3;NFATC4;BMP6;LCOR;BHLHE40;GLI2;TCF25;GLIS2;SIRT6;BAG3;NR4A2;MIER1;CREBBP;CRY2;NCOR1;PHF21A;NFATC3;SMAD2;CHD3;EED;MLX;CBX5;CCND1;NCOR2;NFIC;PER3;KDM1A;DNMT3A;RXRA;MXD4;FOXC1;MTA1;BRMS1L;BRMS1;NSD1;TBL1X;POU4F1;PARP1;BCOR;ERF;ZNF25;MECP2;IGBP1;ZFPM1;ZBTB1;PHF12;ZBTB32;NR2F1;MDM4;NR1D1;BATF3;GTF2IRD1;EZH1;DLG1;E2F1;HOXA7;MTDH;DMAP1;PRDM2;ATRX;NR3C1;NKAP;THAP7;URI1;FOSB;UBE2D3;ZNF219;TRAF6;KMT5A;PAX6;MZF1;PRDM5;SMAD4;NCOA5;ZMYM5;PLK3;YAP1;E4F1;CHD8;ESR2;VPS72;HCFC1;RB1;SMAD7;ZBTB7B;TLE6;POU6F1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.6255286609761577,1.3262625919439484,0.15267175572519084,0.7812069930989831,1.0,3/13,3.04%,CACNA1G;CLTRN;KCNB1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.5372896210904988,1.3258680223397474,0.11859838274932614,0.7811101106332023,1.0,8/33,13.24%,PKD1;TCIM;ID2;PLCG2;ATP2B4;TRIM39;CDKN1B;E2F1
prerank,organophosphate biosynthetic process (GO:0090407),0.5244819505613045,1.325274077478369,0.13119143239625167,0.7817478953729906,1.0,11/37,12.66%,FGF2;PNPO;IP6K1;IP6K2;PPIP5K1;MBOAT1;TKT;LPCAT1;PIP5K1A;GNPAT;MOCOS
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5473748330731474,-1.3248960948980568,0.1742857142857143,0.5765397092477764,1.0,3/11,9.00%,NOS3;CALM1;GCH1
prerank,tyrosine metabolic process (GO:0006570),0.648879044226144,1.3243503682170548,0.15472312703583063,0.7839786980632903,1.0,1/11,1.78%,IYD
prerank,amino acid transport (GO:0006865),0.5018224180050348,1.3240253835102225,0.10098522167487685,0.7836783371419455,1.0,4/49,5.00%,SLC38A2;SLC38A1;SLC38A6;SLC7A9
prerank,positive regulation of intracellular protein transport (GO:0090316),0.44868516372511397,1.3230061260806814,0.04665959703075292,0.78634877007976,1.0,44/144,17.07%,TCF7L2;CDH1;ABLIM3;PRKCD;KCNB1;GSK3B;ZIC1;TMEM30B;BCAS3;HPS4;SEC16A;EMD;UBR5;ERBB2;BAG3;PCM1;NPEPPS;SAE1;TENM1;ZDHHC2;ZC3H12A;HSPA1L;MAVS;CIB1;MIEF1;C2CD5;XPO4;TM9SF4;PCNT;CHP1;TFDP1;JUP;SH3GLB1;ITGB1BP1;E2F1;SORL1;DMAP1;UBE2D3;PPP3CC;MIEF2;UBL5;VAMP2;PLK3;OAZ2
prerank,neuron projection development (GO:0031175),-0.3234379978868372,-1.322303835244154,0.0196078431372549,0.5807727762118042,1.0,50/168,12.54%,DOCK10;PTPRM;GRM7;LYN;APOE;TNIK;CNTNAP2;SHANK3;FRYL;PAK1;EPHB1;MAP2;APP;CNTN4;RASGRF1;ADGRV1;RAPGEF2;MYO16;PAK3;GPM6A;RYK;EPB41L3;SH3GL2;PLP1;EPHA8;MAP4K4;EPHA4;BMP7;LAMB1;OPHN1;SGK1;DAB2IP;STMN1;NRK;BICDL1;LGI1;TMEM108;STMN4;MAPT;GPM6B;CAMSAP2;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;WHRN;HMGB1
prerank,ganglion development (GO:0061548),0.6387316456368641,1.3222442257906946,0.1695447409733124,0.787761957190932,1.0,2/11,3.11%,UNC5C;NRP1
prerank,regulation of cholesterol efflux (GO:0010874),-0.41786823196764633,-1.321832944842212,0.10975609756097561,0.5793175076486119,1.0,6/30,6.89%,PLTP;APOE;ABCA5;PTCH1;NR1H3;EEPD1
prerank,thyroid hormone generation (GO:0006590),0.658799267096432,1.3216933745692452,0.16108452950558214,0.7884278311569471,1.0,2/10,2.54%,IYD;CPQ
prerank,potassium ion transport (GO:0006813),0.4542881020914181,1.3214491387652663,0.06956521739130435,0.787845879376217,1.0,10/120,3.07%,SLC9A2;KCNK5;KCNJ2;KCNB2;SLC24A3;KCNJ15;KCNMB3;KCNMB2;KCNB1;KCNS3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.462233536322593,-1.3208916575568654,0.0975609756097561,0.5791420787631611,1.0,6/19,16.26%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,muscle tissue development (GO:0060537),0.6201483743731474,1.3205347467319082,0.165402124430956,0.7898946779282291,1.0,4/13,5.44%,BMP4;CSRP3;SMO;NF1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6214054183260993,1.320417127131277,0.16797488226059654,0.7887753169861426,1.0,5/13,16.18%,PKD1;MDFI;KEAP1;DBN1;GOPC
prerank,activation of protein kinase B activity (GO:0032148),-0.42898591292143196,-1.3203923055834703,0.13953488372093023,0.5777421046378357,1.0,12/29,17.34%,IGF1;OSBPL8;WNT5A;FGF1;INSR;IL18;GAS6;PINK1;ADRA2A;CCDC88A;MT3;NTF3
prerank,negative regulation of cell death (GO:0060548),0.46709357278475755,1.3200193478611346,0.08040770101925254,0.7886773179610853,1.0,19/88,14.05%,BMP4;CCN3;CCN5;CCN1;WNT11;FGF2;SRGAP2;GSK3B;SRSF6;IKBKG;AGR2;GATA4;BECN1;POU4F1;ATG5;CLU;TRAF2;SORL1;TIGAR
prerank,regulation of lamellipodium assembly (GO:0010591),0.5228120604908371,1.3194918680762586,0.1394736842105263,0.789206512511172,1.0,2/34,0.50%,SLIT2;PLCE1
prerank,positive regulation of telomere maintenance (GO:0032206),0.5368195935629768,1.3194338969681023,0.1437994722955145,0.7877921979900417,1.0,15/31,24.90%,NEK7;SLX4;SIRT6;DHX36;RAD50;ATRX;NAF1;MAP3K4;HNRNPA2B1;PML;NBN;TNKS2;ATM;MAPKAPK5;GNL3
prerank,response to fatty acid (GO:0070542),0.5852761273474618,1.3192863197059546,0.175,0.786778286995547,1.0,7/17,18.40%,PID1;SOX9;IRS1;FOXO3;PDK3;PPP5C;SCD
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.4686456092750148,-1.3190377562169073,0.12,0.5786408478174987,1.0,6/19,9.75%,GRM5;RYR2;VCAM1;KDR;PTGFR;PTPRJ
prerank,respiratory tube development (GO:0030323),0.5518621196077567,1.3188808079930985,0.15279672578444747,0.7868977114917008,1.0,5/28,6.46%,BMP4;PCSK5;FGF2;VEGFA;GLI2
prerank,cellular response to hormone stimulus (GO:0032870),0.4805836401994397,1.3184518449627018,0.10093896713615023,0.7870540669624638,1.0,12/69,9.71%,SLIT3;SLIT2;RAMP1;RARA;BCAS3;NR4A3;SERPINB9;STAT3;KLF9;RDX;ATP1A3;ATP1A1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.5347856058062292,-1.3182329383484386,0.15803108808290156,0.5779976577046178,1.0,4/12,7.11%,SEMA6A;DCN;CADM4;DAB2IP
prerank,supramolecular fiber organization (GO:0097435),0.4319548841949292,1.3181145458540262,0.021148036253776436,0.7867782312686554,1.0,41/333,7.24%,COL25A1;COL8A1;COL12A1;COL6A2;COL8A2;TLL1;PLOD2;ADAMTS2;COL6A1;BMP1;DDR2;SNCAIP;COL5A2;CYP1B1;RHOBTB1;GSN;FGF13;NLRP5;LOXL1;MAP7D3;COL3A1;OPTC;DSP;COL6A3;CLIP4;COL11A1;ADAMTS3;TGFBR1;SHROOM4;KATNB1;SHROOM3;CLIP1;NF1;LTBP2;LTBP3;FAT1;EMILIN1;ARHGAP17;PCM1;FLII;KATNAL2
prerank,regulation of trophoblast cell migration (GO:1901163),0.6209070843192838,1.3169017167608401,0.1753846153846154,0.7900420165126659,1.0,4/14,6.49%,ARHGDIB;VEGFA;TIMP1;AGO2
prerank,cellular response to sterol (GO:0036315),0.6293848346746198,1.3162376075196998,0.18167202572347266,0.7912840391519451,1.0,5/13,9.97%,LRP6;SMO;RORA;GRAMD1A;GRAMD1C
prerank,eye morphogenesis (GO:0048592),0.573016889606983,1.3151236369309722,0.1577424023154848,0.7944160185171281,1.0,7/19,5.66%,MFAP5;COL5A2;VEGFA;NIPBL;STAT3;NF1;SKI
prerank,cytosolic transport (GO:0016482),0.4556400114240976,1.3150755012477746,0.08633879781420765,0.7930017907087182,1.0,46/108,27.05%,VPS13A;VPS13C;SNX2;ERC1;RNF126;GBF1;KIF16B;EEA1;RAB6A;PHETA2;BECN1;WDR81;RGP1;SNX32;HOOK3;GAK;DOP1B;STX5;ANKRD27;EVI5;GOSR2;UBE2O;SNF8;PTPN23;ANKFY1;MON2;TBC1D5;TBC1D17;AP2A1;VPS52;VTI1A;BET1L;VTI1B;STX8;TBC1D23;GCC2;TMEM87A;VPS54;RIC1;GGA1;RAB14;CCDC91;VPS26B;TBC1D10A;AP4M1;CLN3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.6081909233196743,1.313500454185759,0.1858678955453149,0.7979124547772619,1.0,2/14,2.28%,THBS1;CMKLR1
prerank,regulation of microtubule-based process (GO:0032886),0.5214647100015565,1.3132293636343881,0.13881748071979436,0.7974007035090924,1.0,14/36,17.52%,EFNA5;GSK3B;PHLDB2;DIAPH1;ERBB2;AURKA;FAM107A;PHLDB1;IGBP1;MARK2;MAP6;BICD1;CAMSAP3;MEMO1
prerank,regulation of protein kinase activity (GO:0045859),0.45313788534114424,1.313186564691134,0.08881578947368421,0.7959501604984113,1.0,27/106,19.72%,RASSF2;PLCE1;LRP6;UBASH3B;DDR2;CCN1;PTK2B;NF1;CEP43;DUSP19;QARS1;TAB2;RAP1A;CHP1;ITGB1BP1;RAP2C;DVL1;CDKN1A;CEP85;IQGAP1;RB1;TSPYL2;TRAF4;LAT;RAP2B;XRCC5;ANKRD54
prerank,response to estrogen (GO:0043627),0.5355142619869757,1.3128006336618552,0.1362397820163488,0.7959935303027612,1.0,8/31,17.23%,SLC34A2;ESR1;RARA;BCAS3;SERPINB9;BRCA1;SRA1;KMT2D
prerank,global genome nucleotide-excision repair (GO:0070911),0.553801771939148,1.3120886002796475,0.15342465753424658,0.797387328013197,1.0,17/26,33.01%,CHD1L;PARP1;RAD23B;RNF111;GTF2H3;CETN2;ERCC4;UBB;UBA52;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.46528724134351124,1.3114043946165113,0.10762331838565023,0.7985986450564825,1.0,23/87,13.80%,ADAM9;SMAD6;COL3A1;SMAD9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;TGFBR1;USP15;LTBP2;SKI;TGFBR2;ITGB1;SMAD2;NLK;RHOA;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.6350121294227402,1.3112489158529526,0.18209876543209877,0.7960478293060218,1.0,5/12,13.71%,GSK3B;ATP2B4;RCAN1;CHP1;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.6350121294227402,1.3112489158529526,0.18209876543209877,0.7960478293060218,1.0,5/12,13.71%,GSK3B;ATP2B4;RCAN1;CHP1;HOMER2
prerank,negative regulation of wound healing (GO:0061045),0.5464055056596062,1.311129484367336,0.1589310829817159,0.7949083954023121,1.0,5/28,4.30%,SLC12A2;FGF2;THBD;CD109;PHLDB2
prerank,cellular response to osmotic stress (GO:0071470),0.5714128502578187,1.3110335202532741,0.1546242774566474,0.7937049396900366,1.0,3/21,3.02%,STK39;LRRC8D;YBX3
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6037932480362508,1.3107275273545411,0.18277945619335348,0.7933234593299618,1.0,3/15,9.04%,BMP4;SFRP4;FOXC1
prerank,regulation of lipase activity (GO:0060191),0.6300270566832681,1.310431181034456,0.17896389324960754,0.7929495220669625,1.0,3/13,11.47%,PCSK5;RHOA;ANGPTL3
prerank,postsynaptic membrane organization (GO:0001941),-0.47673973590673957,-1.310329050725222,0.1345565749235474,0.5976870321379166,1.0,3/17,2.68%,APOE;SHANK3;NRXN1
prerank,regulation of bone mineralization (GO:0030500),0.49186341397368427,1.310304736128766,0.12622549019607843,0.7918774028281921,1.0,16/55,10.56%,BMP4;DDR2;CCN1;PTK2B;NELL1;TGFB3;BMPR1A;SGMS2;ANO6;TXLNG;CCL3;TWIST1;BMP6;TRPM4;TMEM119;BCOR
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.48431759849189154,1.3094876542284788,0.12038140643623362,0.7936026511136505,1.0,8/63,9.88%,THBS1;BMP4;TCF7L2;TGFBR1;FGFR1;FEM1B;TMC8;ITGAV
prerank,retinol metabolic process (GO:0042572),0.6123297240488678,1.3090613013779568,0.190625,0.7937335851098167,1.0,4/14,11.78%,CYP1B1;ADH7;RDH12;DHRS3
prerank,sensory perception of light stimulus (GO:0050953),0.4622503771475937,1.3088465627815224,0.1021566401816118,0.7931146681941776,1.0,12/87,12.25%,SLC4A10;EYA4;CACNA1F;PITPNA;COL11A1;RDH12;TULP2;CRYBB3;SFRP5;ATF6;DHRS3;EYA3
prerank,protein localization to Golgi apparatus (GO:0034067),0.5388400812771841,1.3086195497045965,0.1685082872928177,0.7924703421328507,1.0,14/27,24.51%,VPS13A;VPS13C;GBF1;RAB6A;GAK;VPS13D;ZDHHC15;SORL1;GOLPH3;RAB33B;BICD2;PAQR3;GCC2;ARL5C
prerank,T cell proliferation (GO:0042098),-0.5119937871613904,-1.3085877908695578,0.16574585635359115,0.5999170745034416,1.0,6/13,22.73%,CADM1;DOCK8;MSN;PPP3CB;CTPS1;PIK3CG
prerank,early endosome to late endosome transport (GO:0045022),0.5802040253869631,1.307938013713757,0.15384615384615385,0.793631000414082,1.0,8/20,17.25%,KIF16B;EEA1;BECN1;WDR81;HOOK3;ANKRD27;SNF8;PTPN23
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5245996387468704,1.307318081610452,0.13838120104438642,0.7946068190178092,1.0,10/37,13.33%,ENTPD6;SIDT2;NUDT5;ENTPD2;ENTPD5;NUDT15;ENTPD7;RNASE3;NUDT1;RNASEH2A
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5198206981511668,1.3070168940148068,0.15119363395225463,0.7943093849826447,1.0,9/35,4.52%,NTRK3;BAIAP2L1;SEMA3E;PTK2B;NRP1;ARHGDIB;NOTCH2;BCAS3;ABL1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4582765944851252,1.3066683207753897,0.09739524348810873,0.7941512542038744,1.0,39/95,25.86%,REV3L;ERCC5;NIPBL;NABP1;CDC45;MCM2;RAD51;SLX4;SPIDR;WRN;SMC6;SMC5;PARP1;NSMCE1;RAD50;RNF138;BRCA1;MCM7;MORF4L1;CDC7;RECQL5;RAD21L1;REC8;MCM9;BRCA2;PSMD14;ERCC4;YY1;NBN;AP5Z1;RAD52;RAD51D;RBBP8;INO80;RECQL;RAD21;KDM4D;RAD54L;POLQ
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5616674212153773,1.3066388772727433,0.1752136752136752,0.7927253163858946,1.0,5/20,5.02%,SLIT2;IGFBP5;NRP1;BMPR1A;LRP1
prerank,cardiac conduction system development (GO:0003161),0.558769601312708,1.30629802359447,0.1649782923299566,0.7925708827475024,1.0,4/24,3.87%,BMP4;CACNA1G;BMPR1A;NOTCH2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6042192650095816,1.3050389200028458,0.17956656346749225,0.7961074821080317,1.0,2/15,4.18%,CD55;GLI3
prerank,cell cycle G1/S phase transition (GO:0044843),0.4857492511774429,1.3046289128625934,0.13007159904534607,0.7962917269682174,1.0,23/61,17.24%,CCNA2;MNAT1;INHBA;E2F3;CCND1;CUL3;CDKN2C;CUL1;GSPT1;CDKN1B;CDKN3;E2F1;ACVR1;HINFP;PIM2;KHDRBS1;CDK7;CDK2;CDKN1A;CDC7;PLK3;RPS6KB1;RB1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.47962376043725274,-1.304161024249311,0.14046822742474915,0.609788912085363,1.0,5/16,8.98%,ST6GALNAC3;ST8SIA4;ST8SIA1;ST8SIA6;B4GALT6
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.5053009669288593,-1.303232884782497,0.1686746987951807,0.609658886850446,1.0,5/14,12.19%,NOS3;ACE;ENPEP;EDN1;ACE2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.47948230258984403,-1.3026680438338405,0.13496932515337423,0.6083443211368714,1.0,6/17,16.26%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,positive regulation of calcium ion transport (GO:0051928),-0.4003771050319199,-1.3025726702977791,0.0947867298578199,0.60573430940795,1.0,13/36,13.23%,MYLK;PDGFRB;CACNA1D;CXCL12;TRPC3;CACNB2;GRIN1;TRPC6;WFS1;P2RX7;ATP2B1;WNK3;ORAI1
prerank,negative regulation of cell migration (GO:0030336),0.442671322269035,1.3023126060614123,0.07790821771611527,0.8042262629850925,1.0,23/137,5.44%,SLIT2;TMEFF2;CLIC4;DPYSL3;CDH1;CYP1B1;PTPRU;WNT11;IGFBP5;FGF2;SLURP1;COL3A1;SRGAP2;SRGAP3;ARHGDIB;BMPR1A;PHLDB2;TIMP1;NOG;LRP1;HAS1;FOXO3;NF1
prerank,DNA repair (GO:0006281),0.4295327718148926,1.3021260098934604,0.024489795918367346,0.803487098728581,1.0,115/284,26.95%,EXO1;MPG;ABL1;ERCC5;NABP1;HERC2;RAD51;CHEK2;FANCL;SMUG1;TICRR;SLX4;SETD2;MNAT1;APEX2;UBE2A;BARD1;APEX1;WRN;TOPBP1;CHD1L;SMARCAL1;UIMC1;VCP;TEX264;MTA1;MLH3;USP1;PARP3;NEIL3;CIB1;POLE2;PARP1;RAD23B;NSMCE1;WDR48;ZBTB1;RAD50;POLI;EYA3;KPNA2;RAD17;BRCA1;KMT5B;NUDT1;RNASEH2A;TNKS1BP1;HINFP;RNF8;COMMD1;PRIMPOL;BRIP1;BRCC3;UBE2B;SLC30A9;PRKDC;SMC1A;FAM111A;SMARCA5;PPP5C;USP47;FTO;GTF2H3;POLB;ASCC2;RECQL5;MDC1;TRRAP;ACTR5;BRCA2;APLF;PARP2;RMI2;CETN2;PRMT6;VCPIP1;ATR;PARP4;XRCC5;ERCC4;NBN;TDP2;CHEK1;DCLRE1A;KMT5C;SPRTN;RAD52;ALKBH1;ABRAXAS1;RAD51D;ATM;TP53;RBBP8;XRCC4;ASF1A;UBB;INO80;RECQL;RAD21;RAD9A;TDG;CSNK1E;RAD9B;ERCC8;RAD54L;UBE2V1;UBA52;POLK;POLQ;GTF2H4;MGME1;RPS27A;NEIL1;SUMO1;PARP9
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.39111937010139586,-1.3016705644460154,0.08755760368663594,0.6054527060632481,1.0,8/39,7.95%,MYO1B;PPFIA2;FNBP1L;MYO5A;BICDL1;SYT4;ACTN4;KIF1A
prerank,regulation of endopeptidase activity (GO:0052548),-0.35817333652115607,-1.3014082575673271,0.07006369426751592,0.6033950609397214,1.0,12/59,13.61%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;PICALM;SERPINI1;SERPIND1;BIRC2;GAPDH;APH1B;PSMB8
prerank,monoacylglycerol metabolic process (GO:0046462),0.6257649057252825,1.3007337290363659,0.17262830482115085,0.8075555637654938,1.0,2/13,9.44%,MGLL;ABHD6
prerank,positive regulation of vasculature development (GO:1904018),0.4599371439833061,1.300565737718411,0.11173184357541899,0.8067603765738944,1.0,16/94,8.52%,SMOC2;F3;THBS1;PGF;CYP1B1;FGF2;PTGIS;ITGB8;VEGFA;HIPK1;TWIST1;AGO2;ITGB1;ZC3H12A;GATA4;ANXA3
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.594130246412163,1.3004067023089694,0.1683748169838946,0.8042984246587543,1.0,6/16,8.58%,THBS1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.594130246412163,1.3004067023089694,0.1683748169838946,0.8042984246587543,1.0,6/16,8.58%,THBS1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.5373991393832114,-1.3000421382129395,0.15469613259668508,0.6045198702896575,1.0,3/11,5.74%,LYN;ANK3;PRKCQ
prerank,negative regulation of protein polymerization (GO:0032272),0.537022829729213,1.2992004567046762,0.16598639455782313,0.8076773617318695,1.0,2/27,1.64%,SLIT2;PRKCD
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5759712569000451,1.29856741204177,0.17812061711079943,0.8086388679162995,1.0,13/20,28.95%,PAICS;AMPD3;GMPR2;AK4;AK3;AMPD2;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC;NT5C2
prerank,neuron projection regeneration (GO:0031102),-0.5706995692385839,-1.2982457989407277,0.17708333333333334,0.606833012897926,1.0,2/10,7.28%,NREP;RTN4RL1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.5982407659925985,1.2974540909661265,0.1712121212121212,0.8115694080685593,1.0,2/16,3.17%,BMP4;TGFB3
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.5368770627572534,1.2970309404883824,0.1499330655957162,0.8117322804185835,1.0,5/30,4.31%,KCNJ2;CACNA1C;CACNA1G;ANK2;SNTA1
prerank,T cell differentiation (GO:0030217),-0.3859226909102135,-1.2966628662007347,0.1031390134529148,0.6085594989561587,1.0,10/40,13.51%,LEPR;KIT;CHD7;SOX13;TCF7;RHOH;JAG2;LFNG;MR1;PTPN22
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.3179200405861842,-1.2961062423273932,0.034482758620689655,0.6074027692275272,1.0,35/124,12.54%,PTPRM;LYN;APOE;CNTNAP2;FRYL;MAP2;APP;CNTN4;RASGRF1;RAPGEF2;GPM6A;RYK;SH3GL2;PLP1;EPHA8;LAMB1;OPHN1;STMN1;BICDL1;WDPCP;LGI1;ATP1B2;TMEM108;STMN4;RAC1;MAPT;GPM6B;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;HMGB1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.44464225360678283,-1.2958898008001805,0.12582781456953643,0.6052506717543527,1.0,8/22,23.99%,APOD;CCDC3;ALK;ADRA2A;PPP2R5A;ASXL3;GPER1;APOC1
prerank,negative regulation of cell differentiation (GO:0045596),0.4298396200353243,1.2953363784380953,0.061139896373056994,0.817025171585076,1.0,40/181,14.65%,BMP4;EGFR;CRIM1;ZFPM2;WNT9A;HES1;TWIST2;COL5A2;SMAD6;BMP5;PTK2B;SOX9;ID2;GDF10;TGFBR1;PTHLH;NOG;TWIST1;SPRED2;SKI;ZBTB16;TSKU;RORA;IL17RD;TRPM4;CHRD;PDCD4;HES3;ITGAV;XDH;NEPRO;ZFPM1;LDLRAD4;JAG1;TRIO;E2F1;LRP5;ITGB3;NBR1;SRA1
prerank,histone mRNA catabolic process (GO:0071044),0.5846571133065698,1.2950896398245946,0.19089574155653452,0.816482440188184,1.0,8/15,25.44%,TUT7;TUT4;TENT2;ERI1;SSB;TENT4B;ATM;LSM1
prerank,proteolysis (GO:0006508),0.4252087791919705,1.2945299859291426,0.04183673469387755,0.8173322623158857,1.0,55/252,17.77%,F3;CAPN5;HTRA3;PCSK5;TRABD2B;BMP1;CASP6;HTRA4;CPQ;CNDP1;ASPRV1;HTRA1;CAPN2;ADAMTS3;CAPN12;USP25;ECE1;XPNPEP3;XPNPEP1;BACE2;SPPL2A;NPEPPS;CASP2;PHEX;TINAGL1;MMP16;LONP2;TASP1;DESI1;DESI2;TBL1X;IDE;MMEL1;DDI2;PCSK7;ECE2;CTRC;CPNE1;RNF123;CLPP;RET;ATG4C;TYSND1;CTSE;ATG4B;PGPEP1;YME1L1;NLN;FAM111A;DPP3;ATG4A;FAP;CPZ;PSMA6;APEH
prerank,muscle organ development (GO:0007517),0.4939885570219973,1.2945143755559825,0.13038130381303814,0.8158682894319297,1.0,12/54,7.90%,FHL1;MKX;SGCD;COL6A3;MRAS;EMD;LARGE1;MEF2A;CTF1;MAPK12;EVC;COPRS
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.598236021997928,1.2942020511991794,0.2012012012012012,0.8156866332568595,1.0,2/15,1.98%,KCNJ2;ATP1B1
prerank,regulation of protein localization to membrane (GO:1905475),0.529607956889998,1.2941781777954797,0.1584553928095872,0.8142426528711073,1.0,4/28,7.41%,GPC6;GSN;GPC3;ZDHHC2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.47278134528444116,-1.2931315840298667,0.11708860759493671,0.6098638655888343,1.0,6/18,16.26%,CAMK1D;RIPOR2;DAPK2;RAC1;CD74;CCL19
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4430019840710501,1.2930197421788967,0.08478260869565217,0.8175243725998196,1.0,19/122,12.21%,SMOC2;THBS1;EGFR;SAMD4A;FGF2;NIBAN1;IRS1;KLF4;IL33;GLI2;ERBB2;NLRP12;TLR4;EIF3E;STN1;EIF6;RBM3;BCAR3;NAT10
prerank,regulation of protein phosphorylation (GO:0001932),0.4266853999065831,1.292492649895662,0.04405737704918033,0.8182923848777821,1.0,36/256,10.33%,SLIT2;BMPER;BMP4;CARD14;EGFR;SLCO3A1;PLCE1;LRP6;PGF;NTRK3;PID1;CCN1;PLPP3;EFNA5;FGF2;NIBAN1;SOX9;KRAS;KLHL31;VEGFA;ABL1;IBTK;FAM20A;ERBB2;LIMK2;FN1;ZC3H12A;CCND1;CORO1C;MAVS;PPP2R5C;CIB1;TMEM119;PIK3R3;NSD1;XDH
prerank,response to ionizing radiation (GO:0010212),0.46970978483887726,1.2918448663214877,0.1303827751196172,0.8194522453190188,1.0,31/70,26.12%,TANK;CLK2;ANXA1;NABP1;RAD51;TICRR;SPIDR;TOPBP1;UIMC1;MTA1;EYA3;BRAT1;BRCA1;COP1;TNKS1BP1;RNF8;BRCC3;USP28;CDKN1A;INTS7;ABRAXAS1;ATM;TP53;XRCC4;INO80;AEN;RAD9A;RAD9B;KDM4D;IKBIP;MRNIP
prerank,positive chemotaxis (GO:0050918),0.5864308486006942,1.2914932167648023,0.19581464872944693,0.8194164040342861,1.0,3/17,3.17%,MET;NRP1;VEGFA
prerank,response to organophosphorus (GO:0046683),-0.47943419021363537,-1.2910532652067344,0.1743119266055046,0.6129971032454276,1.0,4/16,10.41%,ABCC9;TRPC3;STAT1;P2RX7
prerank,regulation of platelet activation (GO:0010543),-0.45060054286936746,-1.2901853657394322,0.11746031746031746,0.6126986488943461,1.0,5/21,5.74%,LYN;APOE;NOS3;TEC;PRKCQ
prerank,protein kinase B signaling (GO:0043491),-0.43835186685011474,-1.2901640974081878,0.1434108527131783,0.6100110499369509,1.0,13/23,23.82%,IGF1;KDR;GAS6;SIRT2;THEM4;TSC2;TYRO3;MT3;ZFP36L1;EPHA2;AKT1;CCL2;PAX2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.5558913125202349,-1.2897467800488616,0.1721311475409836,0.6085810676075482,1.0,4/10,18.06%,TGFA;ADRA2A;HBEGF;FBXW7
prerank,response to calcium ion (GO:0051592),0.45076540953035416,1.2896388009821014,0.10733844468784227,0.8253133017883519,1.0,13/102,7.87%,THBS1;CLIC4;NEDD4;ADAM9;PPP3CA;KCNMB3;KCNMB2;CAMK2D;CASR;PLCG2;MEF2A;SEC31A;DMTN
prerank,lung development (GO:0030324),0.5220290146242229,1.2890212864726347,0.17437252311756934,0.8262094944979677,1.0,6/33,6.46%,BMP4;PKD1;WNT11;FGF2;VEGFA;GLI2
prerank,clathrin coat assembly (GO:0048268),-0.495036025880243,-1.2885397448843734,0.17592592592592593,0.609014731111593,1.0,4/15,5.56%,SGIP1;PICALM;PIK3C2A;HIP1R
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.554122295018102,1.287450345140287,0.17937853107344634,0.8310352582266544,1.0,15/22,33.50%,CDK12;SCAF8;CDK13;CCNT2;BRD4;CCNT1;TCERG1;HMGN1;EAPP;SUPT4H1;ELL;THOC1;THOC5;DDX39B;ALYREF
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.4698443852025073,1.286793166401905,0.12056737588652482,0.8320054782069718,1.0,21/65,18.27%,HTRA3;SMAD6;SKIL;HTRA4;PMEPA1;CD109;TGFBR1;SPRED2;SKI;EMILIN1;TGFBR2;IL17RD;SMAD2;TGFB1I1;LDLRAD4;WFIKKN1;FAM89B;PIN1;BCL9L;SMAD7;SMURF1
prerank,regulation of chromatin binding (GO:0035561),0.6336401120515677,1.286792810476514,0.20904836193447737,0.8304694429528054,1.0,7/10,29.80%,BTAF1;DDX11;MED25;WAPL;KDM4D;PARP9;DTX3L
prerank,relaxation of muscle (GO:0090075),0.6073668928001297,1.2867164345976327,0.1858678955453149,0.8292429431231447,1.0,4/13,1.98%,KCNJ2;CAMK2D;GSN;ATP1B1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.593848606751215,1.2863934034801292,0.18313953488372092,0.8290239233552265,1.0,5/17,12.02%,CD55;STAT3;TLR4;CD46;JAG1
prerank,superoxide anion generation (GO:0042554),-0.5177054855146722,-1.2861229514137271,0.16138328530259366,0.6135278900625886,1.0,9/13,37.29%,NOX1;ALOX12;NOX4;NCF2;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.46483455356768444,1.2855040522569325,0.13801169590643275,0.8311236983607708,1.0,13/67,9.62%,DOCK5;VIT;PTK2B;NRP1;GSK3B;LIMS1;ABL1;MYOC;FN1;AGR2;DMTN;S100A10;CIB1
prerank,cellular defense response (GO:0006968),0.5012814282719774,1.2853325642733209,0.1568627450980392,0.8302308995466984,1.0,8/40,10.90%,LBP;PTK2B;ZNF148;TCIRG1;CLEC5A;ITGB1;BECN1;TRAT1
prerank,regulation of epithelial cell migration (GO:0010632),0.4859468934406838,1.2847679162629317,0.14373464373464373,0.8310586906409148,1.0,7/51,4.45%,BMPER;DOCK5;RHOJ;PRKCE;SOX9;RAB25;PLCG2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.3557464115840456,-1.2845738978873862,0.0972972972972973,0.6156047854133374,1.0,21/57,16.08%,GRIA4;ACTN2;APP;DLGAP1;GRIN2A;LRRC7;GRIN2B;MEF2C;GRIA1;GRIN1;CACNG7;CACNG4;GRIA3;CACNG3;CACNG2;NETO1;OPRM1;CAMK2B;CAMK2A;RELN;GSG1L
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.49665395103149335,1.2845510715745014,0.14549938347718866,0.830431574121469,1.0,8/45,6.79%,BMP4;BMP5;TGFB3;BMPR1A;GDF10;TGFBR1;BMP6;INHBA
prerank,nuclear export (GO:0051168),0.4528891625301732,1.2842103877279176,0.1187214611872146,0.8302658540492177,1.0,26/80,19.29%,PKD1;SRSF11;U2AF2;THOC2;SRSF5;STRADA;SRSF6;NUP214;WASHC4;RANBP3;NUP153;XPO1;DESI1;XPO4;CHP1;CDC40;SRSF2;NUP155;NUTF2;SRSF1;XPO7;RNPS1;CSE1L;CHTOP;SMURF1;SARNP
prerank,positive regulation of T cell migration (GO:2000406),0.5580874082126474,1.28389758686793,0.18142235123367198,0.8300050344206703,1.0,2/20,1.59%,STK39;WNK1
prerank,protein K63-linked deubiquitination (GO:0070536),0.5299784555204382,1.2835202913018446,0.16914749661705006,0.8300795156597341,1.0,14/31,23.91%,OTUD1;USP25;USP13;UIMC1;ZRANB1;BRCC3;ABRAXAS2;OTUD5;OTUD4;PSMD14;USP16;ABRAXAS1;USP7;USP33
prerank,positive regulation of filopodium assembly (GO:0051491),0.548938132025657,1.283398992339769,0.16826265389876882,0.8290644688588615,1.0,8/24,7.72%,DPYSL3;ARAP1;NRP1;TGFB3;PALM;BCAS3;TENM1;RHOQ
prerank,positive regulation of collagen metabolic process (GO:0010714),0.5846727552755,1.2831204390165343,0.18181818181818182,0.8286955859987901,1.0,2/17,3.17%,BMP4;TGFB3
prerank,cell-cell junction assembly (GO:0007043),-0.3537238424300903,-1.2829250729073094,0.052941176470588235,0.6176465884149526,1.0,16/63,6.95%,TJP1;GJB6;TLN2;CDH2;CDH8;CLDN5;CDH10;GJB2;ARVCF;GJA1;ACTB;GJC1;GJD3;EPB41L3;JAM3;PKP4
prerank,telomere maintenance via telomere trimming (GO:0090737),0.640320911054463,1.282334502834464,0.20915032679738563,0.8273383950483197,1.0,4/10,8.81%,EXO1;SLX4;WRN;SMARCAL1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.640320911054463,1.282334502834464,0.20915032679738563,0.8273383950483197,1.0,4/10,8.81%,EXO1;SLX4;WRN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.640320911054463,1.282334502834464,0.20915032679738563,0.8273383950483197,1.0,4/10,8.81%,EXO1;SLX4;WRN;SMARCAL1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6159457008058857,1.2817387784475942,0.18935837245696402,0.82831096865747,1.0,6/12,11.41%,NFIB;TSKU;GLI2;PAFAH1B1;SZT2;EPHB2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4495920580635133,1.281723812894333,0.11607142857142858,0.8268728537298596,1.0,21/93,15.53%,RASSF2;EGFR;NTRK3;NGF;VEGFA;DOCK7;ATP2B4;NCK2;CD44;TENM1;DMTN;MLXIPL;AKAP9;RIPK2;NSD1;BCAR3;RAF1;TNKS1BP1;DMD;NCK1;CAPRIN2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.6048812385252221,1.2816040875500234,0.17905918057663125,0.8259088809293248,1.0,4/14,9.04%,PGF;NRP1;VEGFA;FOXC1
prerank,action potential (GO:0001508),0.49705354412504327,1.281586598326492,0.15980024968789014,0.824500091190114,1.0,5/44,3.04%,KCNJ2;CACNA1G;KCNMB3;KCNMB2;KCNB1
prerank,UV protection (GO:0009650),0.649715746483686,1.2815826131753165,0.22815533980582525,0.8230403996699893,1.0,2/10,4.67%,SCARA3;ERCC5
prerank,integrated stress response signaling (GO:0140467),0.5848839777470345,1.2813028104968194,0.2033898305084746,0.822679167409588,1.0,4/14,11.99%,NFE2L2;EIF2AK1;EIF2S1;HERPUD1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.4714217950776934,1.2812659883637227,0.14456391875746716,0.8213501660934107,1.0,17/62,19.87%,MLLT3;ELOF1;CDK12;AFF4;SETD2;MNAT1;ADRM1;CDK13;ELOA;NELFE;CDK7;CCNT2;GTF2H3;PCID2;POLR2C;ELP4;CCNT1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.4987284968520024,-1.2810745268887846,0.1873198847262248,0.6200588723328699,1.0,6/13,26.60%,ADHFE1;GOT2;GPT2;PHYH;GOT1;IDH2
prerank,regulation of actin filament polymerization (GO:0030833),0.4688110149110773,1.2806037767710163,0.13773148148148148,0.8226443262748775,1.0,19/69,16.45%,SLIT2;CDC42EP5;BAIAP2L1;PRKCD;PRKCE;PTK2B;ARHGAP40;NCK2;TENM1;KANK4;WASHC5;CTTN;DBN1;GBA2;NCK1;FCHSD2;CDC42EP2;ARFGEF1;PLEKHG2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.4191238791823207,-1.2805186318157626,0.1482889733840304,0.6188746364551221,1.0,6/30,9.24%,ROBO1;ARHGEF3;LPAR1;F11R;ADGRG1;RAC1
prerank,positive regulation of binding (GO:0051099),0.45336805144015996,1.2802222717796563,0.1275626423690205,0.8227138860945667,1.0,31/84,19.85%,BMP4;TCF7L2;MET;PKD1;HES1;NGF;GSK3B;RARA;LRP1;SKI;DACT1;TIAM1;FOXC1;DPH3;RIPK2;IDE;DDX11;NMD3;MARK3;CAPRIN2;FLOT1;ADD1;PIN1;LRRK2;STK3;RALB;DHX9;PPARG;MED25;CEBPG;GPSM1
prerank,negative regulation of peptidase activity (GO:0010466),-0.37276368950102823,-1.2796905809004553,0.1044776119402985,0.6184787543872279,1.0,7/47,3.61%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;SERPINI1;CST3
prerank,sodium ion transmembrane transport (GO:0035725),0.45253643450188236,1.2796574619734586,0.1156930126002291,0.8235235677573781,1.0,14/84,9.77%,SLC4A4;SLC9A2;SLC12A2;SLC24A3;ATP1B1;ANO6;SLC6A7;TRPM4;SLC6A2;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5695451769788376,1.2788600220244477,0.2011577424023155,0.8253193720281131,1.0,5/18,9.14%,EZR;NELL1;DACT1;RDX;RGP1
prerank,keratinocyte differentiation (GO:0030216),0.5353148276881604,1.278699009611356,0.18014184397163122,0.8244981816545801,1.0,7/29,12.38%,CLIC4;ADAM9;DSP;ANXA1;BCR;JAG1;PIP5K1A
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4661365369724705,1.2781768557865958,0.14685314685314685,0.8251332304360153,1.0,22/66,19.43%,FHL1;EGFR;PKD1;ID2;KLF4;ANXA1;DACT1;LSM11;FAM107A;CCND1;RDX;CDKN2C;ANKRD17;TFDP1;DLG1;E2F1;CDKN1A;ADAMTS1;RB1;KMT2E;WEE1;EIF4G1
prerank,fatty acid oxidation (GO:0019395),0.4829131948994831,1.2781454482763144,0.14009661835748793,0.8238322477446413,1.0,15/57,17.71%,ABCD3;EHHADH;ADH7;BDH2;AUH;ABCD1;ECHDC1;DECR1;PEX13;ADH5;ACOX1;ECHDC2;ACADL;PECR;CROT
prerank,positive regulation of nuclear division (GO:0051785),-0.43957684331861563,-1.2778751244057718,0.14396887159533073,0.6210396945799318,1.0,4/25,3.89%,IGF1;TGFA;PDGFRB;INSR
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4293250189406785,1.2772538982282358,0.08851422550052687,0.82599779891846,1.0,19/150,7.67%,F3;THBS1;EGFR;TNFAIP8L3;TCF7L2;MET;FGF2;GAB2;PIK3AP1;IRS1;ESR1;CCL3;TGFBR1;FGFR1;MYOC;ERBB2;STRN;ITGB1;KITLG
prerank,regulation of transferase activity (GO:0051338),0.5739563414595321,1.2770847529391542,0.19765739385065886,0.8252130247222581,1.0,6/17,23.47%,SMG6;FEM1B;SPTSSB;BAG5;PARP4;ATM
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4095826426798973,-1.2770701599418164,0.1660377358490566,0.6206586828221814,1.0,14/27,20.93%,RIMS1;RIMS2;SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;SYT13;SDF4;PPP3CB;SYT2;SYT15
prerank,pyroptosis (GO:0070269),-0.5031403851948146,-1.2769515330953274,0.18313953488372092,0.6183851669327898,1.0,8/15,25.40%,CASP4;GSDMD;AIM2;ZBP1;CASP1;APIP;TREM2;NLRC4
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3832956241363403,-1.2768933622858751,0.11627906976744186,0.6159417354645947,1.0,10/41,7.67%,ITPR1;SLC24A2;SLC8A1;RYR2;HTR2C;GRIN2A;GRIN2B;GRIN1;CACNA2D1;TRPV2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.49815824208387327,-1.2766691420812617,0.1928374655647383,0.6140144566113892,1.0,4/14,6.97%,ZEB1;SPRED1;OSR1;NOTCH4
prerank,cation transmembrane transport (GO:0098655),-0.3737395297674264,-1.2766217032389726,0.10328638497652583,0.6116017662971133,1.0,6/44,6.71%,ATP1A2;TRPM3;ABCC9;SLC7A5;SLC6A9;SLC38A5
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.528310853371336,1.2754498567269361,0.18653576437587657,0.8289153256638059,1.0,10/29,20.97%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACOT8;ACOT13;CROT;GLYAT;ACOT6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.528310853371336,1.2754498567269361,0.18653576437587657,0.8289153256638059,1.0,10/29,20.97%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACOT8;ACOT13;CROT;GLYAT;ACOT6
prerank,positive regulation of DNA repair (GO:0045739),0.4918744749373677,1.275404139699789,0.15228426395939088,0.8276542923318172,1.0,12/46,14.63%,EGFR;EYA2;EYA4;SPIDR;UIMC1;PARP1;EYA3;BRCA1;DDX11;TIGAR;RNF8;BRCC3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.416578799918518,1.2752494297755195,0.019095477386934675,0.826822894211598,1.0,101/417,16.53%,FOXP2;FOXP1;WWP1;BMP4;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;TWIST2;RBFOX2;WNT11;SAMD7;FOXN3;GCLC;HDAC9;PRICKLE1;SOX9;DMBX1;SOX14;ZNF423;ID2;ID1;WWP2;ZNF148;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;TWIST1;RCOR3;NIPBL;SHC1;KLF10;SPINDOC;ZBTB16;PER1;NFIL3;BHLHE40;L3MBTL3;GLIS2;MBD1;EHMT1;CRY2;NCOR1;DKK3;IRF1;SMAD2;EED;BTAF1;MLX;MLXIPL;CBX5;NCOR2;CIPC;KDM1A;RUNX2;UIMC1;ELF3;PDCD4;SIX4;BRMS1;QARS1;BCOR;ARID4A;CREB3L1;RCOR1;MECP2;SCMH1;ATOH8;PHF12;CDKN1C;NIBAN2;CDKN1B;BRCA1;NR1D1;E2F1;HOXA7;PATZ1;DMAP1;HINFP;SP3;ATF7IP;KHDRBS1;NR3C1;NKAP;THAP7;POU2F1;MBTD1;KAT6B;ZNF219;TRAF6;KMT5A;MAP3K10;PRDM5;SMAD4;FOXK1;USP47
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5357541223697739,1.2749734518626439,0.19268635724331926,0.8264873065058881,1.0,4/26,8.86%,ST3GAL4;LARGE1;GAL3ST4;TKT
prerank,purine nucleotide biosynthetic process (GO:0006164),0.6200751760881487,1.273905825369264,0.19940029985007496,0.8292541445805238,1.0,2/12,4.17%,PRPS2;ADA
prerank,positive regulation of protein sumoylation (GO:0033235),0.6331307705827404,1.2738500810698064,0.2129032258064516,0.8280589394537379,1.0,2/10,7.23%,HDAC4;SAE1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5753591963803385,1.2735131690905253,0.19280575539568345,0.8280021697624322,1.0,4/20,5.21%,ADRA1B;ADRB2;AKAP13;ADCY9
prerank,DNA alkylation (GO:0006305),0.565504523970738,1.2734357945142736,0.18063583815028902,0.8254718949084047,1.0,9/19,26.10%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E;PPM1D;BAZ2A
prerank,DNA methylation or demethylation (GO:0044728),0.565504523970738,1.2734357945142736,0.18063583815028902,0.8254718949084047,1.0,9/19,26.10%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E;PPM1D;BAZ2A
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4748966294867746,-1.2733098215931091,0.16819571865443425,0.6181110724418072,1.0,6/17,4.94%,ATP1A2;SLC8A1;RYR2;GJA1;GJC1;GJD3
prerank,regulation of angiogenesis (GO:0045765),0.4267679114987646,1.2732474965466047,0.07556935817805382,0.8248278554729889,1.0,41/192,14.08%,BMPER;SMOC2;F3;THBS1;RHOJ;PGF;HOXA5;SEMA3E;CYP1B1;FGF2;PTGIS;ISM1;ITGB8;VEGFA;KLF4;HIPK1;TWIST1;NF1;EMILIN1;ATP2B4;PROK2;AGO2;ERBB2;ITGB1;SULF1;ZC3H12A;GATA4;ANXA3;KRIT1;FOXC1;ADAM12;MECP2;ANGPTL3;JUP;NIBAN2;SYNJ2BP;BRCA1;MTDH;EFNA3;CD160;HTATIP2
prerank,regulation of DNA recombination (GO:0000018),0.5145640870229148,1.273219403248782,0.18241469816272965,0.8235603711321211,1.0,9/32,16.00%,RAD51;SETD2;SIRT6;SPIDR;KDM1A;KPNA1;RAD50;KPNA2;PPP4R2
prerank,protein targeting to peroxisome (GO:0006625),0.5293387618505397,1.2722285265010176,0.16927083333333334,0.8259928209523679,1.0,7/29,10.08%,ABCD3;PXMP2;ABCD1;ZFAND6;LONP2;ACBD5;PEX13
prerank,apoptotic mitochondrial changes (GO:0008637),-0.4023419708770927,-1.272196996886243,0.10460251046025104,0.618532304142402,1.0,13/32,22.54%,BCL2;ERBB4;BCL2L1;IFIT2;THEM4;BOK;CAMK2A;HK2;FIS1;HSPD1;BIK;SFN;MFF
prerank,epidermal cell differentiation (GO:0009913),0.5006896042648374,1.2718068760493164,0.16687898089171974,0.8263356916757885,1.0,6/41,6.24%,CLIC4;ADAM9;PITX2;DSP;ANXA1;BCR
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.41958521343612254,-1.2708693597505945,0.11721611721611722,0.6198400826258509,1.0,5/26,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;INSR
prerank,blood vessel morphogenesis (GO:0048514),-0.36152323730763747,-1.2706557490552437,0.11538461538461539,0.617972611007842,1.0,16/54,8.55%,FLT1;EFNB2;ENG;LAMA1;CDH2;TGFBR3;CCBE1;KDR;SLC1A1;RASIP1;RBPJ;TBX1;SOX17;COL4A1;PROX1;HEY2
prerank,positive regulation of macrophage migration (GO:1905523),0.567781139360299,1.2700788529561262,0.2026431718061674,0.8318001146208635,1.0,3/19,4.14%,THBS1;CMKLR1;CCL3
prerank,protein K11-linked ubiquitination (GO:0070979),0.5309587820816946,1.2683581011782061,0.1904127829560586,0.8373388698692892,1.0,9/27,17.68%,FZR1;ANAPC5;UBE2A;ANAPC10;CDC16;ANAPC11;UBE2B;UBE2D3;UBE2S
prerank,protein localization to synapse (GO:0035418),0.6057574517848392,1.2680233709898616,0.2006079027355623,0.8371743945467746,1.0,7/12,14.20%,SHANK1;BSN;PCLO;ZDHHC12;NLGN1;ZDHHC15;NRXN2
prerank,regulation of viral life cycle (GO:1903900),-0.4441411891290959,-1.2673516875582076,0.18411552346570398,0.6244164519221799,1.0,6/21,16.32%,HS3ST5;TRIM14;AXL;TRIM62;NECTIN2;TYRO3
prerank,protein depolymerization (GO:0051261),0.5279205265703972,1.267138175719621,0.17796610169491525,0.8391427939939685,1.0,3/27,4.74%,MICAL2;GSN;KATNB1
prerank,negative regulation of hemostasis (GO:1900047),-0.5194346776057488,-1.2671172773202772,0.1931216931216931,0.6224977979360943,1.0,5/12,11.41%,VTN;APOE;CD34;EDN1;TFPI
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5260467027656699,-1.2670062871580632,0.18361581920903955,0.6202224170626388,1.0,3/12,3.31%,APOE;PICALM;ROCK2
prerank,negative regulation of protein catabolic process (GO:0042177),0.49522920101207457,1.2668876097725639,0.1744340878828229,0.8387925756482495,1.0,14/40,18.62%,EGFR;PTPN3;NELL1;TIMP1;IRAK3;TIMP2;RGP1;MAD2L1;MDM4;AZIN1;SNRNP70;PIN1;SNX12;HMGCR
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.49122910660635094,1.266828772553057,0.1601513240857503,0.8376263277098095,1.0,19/42,28.74%,RAD51;SETD2;SIRT6;SPIDR;KDM1A;HELB;PARP1;CGAS;WDR48;FUS;PPP4R2;ACTR2;RMI2;CHEK1;POLQ;KLHL15;MRNIP;SMCHD1;PPP4C
prerank,macrophage differentiation (GO:0030225),0.6027508958869985,1.2667162334990292,0.21428571428571427,0.8366295761380229,1.0,2/13,3.17%,BMP4;VEGFA
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5557915429800009,-1.2664908769064753,0.20540540540540542,0.6191373442687289,1.0,9/10,43.93%,UBAC2;ERLEC1;UBE2J1;SVIP;DERL2;DERL3;INSIG1;OS9;YOD1
prerank,regulation of actin nucleation (GO:0051125),0.6145741566091081,1.266266005183303,0.21638330757341576,0.8370623407154382,1.0,4/12,16.38%,GSN;ARFIP2;WASHC5;ARPIN
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.632093982309981,1.2662508429597692,0.20583468395461912,0.8356956703481945,1.0,2/10,3.80%,LRP6;FZD1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4259591752474343,1.2650663694983961,0.08891213389121339,0.8389814600642963,1.0,39/166,17.75%,SMOC2;THBS1;EGFR;SAMD4A;FGF2;NIBAN1;IRS1;GIPC1;LDLR;KLF4;PTPN2;NNMT;GLI2;ERBB2;MLXIPL;TLR4;EGR1;EIF3E;STN1;ARNT;EIF6;CHP1;RBM3;BCAR3;CLU;NAT10;STARD4;NR1D1;SREBF1;PAOX;NMD3;ELOVL5;CIRBP;PRKDC;ARPP19;RPS6KB1;SLC25A37;LARP4;P2RX4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.46783283189853836,1.2649368241605854,0.16339066339066338,0.83810440557595,1.0,8/60,7.80%,SMOC2;FGF2;GRHL2;KLF4;CHTF18;NEK7;CHTF8;DSCC1
prerank,negative regulation of mRNA processing (GO:0050686),0.5840426514429985,1.2648301515681888,0.21139430284857572,0.8371067388475106,1.0,6/15,17.54%,U2AF2;BARD1;SRSF6;RBMX;RNPS1;PCBP4
prerank,relaxation of cardiac muscle (GO:0055119),0.5980132322316238,1.2643461385605261,0.2117465224111283,0.8377141890752796,1.0,4/13,1.98%,KCNJ2;CAMK2D;GSN;ATP1B1
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.498529308305517,1.2640371638007655,0.16243654822335024,0.8375166843530667,1.0,9/39,12.02%,FXYD5;CDH1;WNK1;VEGFA;KLF4;BMP6;RDX;MIA3;JAG1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.49629544587867336,-1.2639415167948664,0.19648093841642228,0.6237981441140146,1.0,3/13,9.00%,NOS3;CALM1;GCH1
prerank,monocyte differentiation (GO:0030224),0.6263782676575411,1.2634147730951792,0.208130081300813,0.8387445100210265,1.0,2/10,3.17%,BMP4;VEGFA
prerank,negative regulation of signal transduction (GO:0009968),0.4183956166644591,1.2630728038085821,0.06282183316168898,0.8386787636000252,1.0,40/249,9.12%,THBS1;EGFR;NXN;NTN1;TRABD2B;UBASH3B;NEDD4;PID1;TCIM;PRKCD;BMP5;IGFBP5;GPC3;FGF2;MDFI;SFRP4;IRS1;SRMS;WWP2;PALM;GRB10;GLI3;IRAK3;PTPN2;NOG;LRP1;EMILIN1;DACT1;TSKU;ERBB2;GLIS2;NR4A2;NLRP12;PALM3;DKK3;SULF1;GATA4;NLK;SFRP5;VCP
prerank,morphogenesis of an epithelium (GO:0002009),0.5370462660226127,1.2630115077646953,0.18588873812754408,0.8375541558738876,1.0,4/25,7.45%,LRP6;SOX9;RIPK4;VCL
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5554573311169654,1.2626089168750534,0.21052631578947367,0.8364034691521522,1.0,13/21,33.97%,ERCC5;CHD1L;PARP1;GTF2H3;ERCC4;GTF2H4;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1;RPA1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5554573311169654,1.2626089168750534,0.21052631578947367,0.8364034691521522,1.0,13/21,33.97%,ERCC5;CHD1L;PARP1;GTF2H3;ERCC4;GTF2H4;DDB1;ERCC2;DDB2;XPA;GTF2H5;GTF2H1;RPA1
prerank,actin filament bundle assembly (GO:0051017),0.5066227323219393,1.2621158427135524,0.1773142112125163,0.8369332395003775,1.0,9/33,7.87%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;PLS1;LIMA1;FAM107A;DMTN
prerank,exit from mitosis (GO:0010458),-0.5049101333563764,-1.2619857882119279,0.19491525423728814,0.6266484659017738,1.0,2/12,2.71%,EPS8;CLASP2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.47620153044262503,1.2616382109311948,0.1687192118226601,0.8375012774990537,1.0,10/50,13.46%,THBS1;NGF;VEGFA;KLF4;CD44;IGBP1;RPS6KA3;RAF1;DPEP1;CARD16
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5854537346576436,1.2614489176250068,0.20583717357910905,0.836897237597992,1.0,10/13,29.51%,NELFE;RNF8;RECQL5;HEXIM1;TCERG1;LARP7;EAPP;SUPT4H1;NELFA;RNF168
prerank,regulation of DNA biosynthetic process (GO:2000278),0.53175034517777,1.261152982590063,0.1927877947295423,0.8367388990167959,1.0,3/27,4.77%,SMOC2;FGF2;SMG6
prerank,regulation of cellular metabolic process (GO:0031323),0.4897175295508992,1.2611443266277387,0.16811955168119552,0.8353997850935516,1.0,12/45,16.22%,PID1;CYP1B1;CNDP1;COQ7;KIF16B;NCOR2;ACACA;EIF6;PDK3;ARF4;RNF41;FLOT1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6169590101178766,1.260942149254524,0.2138364779874214,0.834735904838379,1.0,5/11,17.25%,EZR;RDX;SORL1;RAB21;PTPN23
prerank,regulation of cholesterol transport (GO:0032374),-0.4426751816979635,-1.2608198520500546,0.18394648829431437,0.6274372661874101,1.0,8/20,17.63%,ABCA5;NUS1;NR1H3;ARV1;NR1H2;ABCB4;ABCA2;YJEFN3
prerank,regulation of protein binding (GO:0043393),0.43313183455373305,1.2608098163527615,0.11675675675675676,0.8338526029732571,1.0,34/114,18.20%,BMP4;TCF7L2;PKD1;HDAC4;PRKCD;GSK3B;LRP1;DACT1;PRMT8;TIAM1;AURKA;KDM1A;TMC8;RIPK2;IDE;ZFPM1;MARK2;ITGB1BP1;DISC1;CARD16;SORL1;DDX11;NMD3;MARK3;DVL1;CAPRIN2;FLOT1;ADD1;CDKN1A;PSME3IP1;PIN1;LRRK2;STK3;RALB
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.45048998537682683,1.260720324309508,0.1283236994219653,0.832798833795921,1.0,27/84,18.97%,FZR1;ECRG4;PSMB2;ANAPC5;AURKA;PSMD11;CUL3;ANAPC10;PSMC1;CDC16;ANAPC11;CDC20;CCNB1;PSMC6;MAD2L1;FBXO5;FBXO31;ANAPC16;PSMD1;PSMD4;CDK2;RB1;PSMA6;UBE2S;PSMD14;PSMD12;PSMD7
prerank,spliceosomal complex assembly (GO:0000245),0.4807242118022853,1.2606823014603499,0.18158890290037832,0.8315655417887841,1.0,24/46,32.07%,CELF3;LUC7L2;SRSF5;SRSF6;CELF4;CELF1;SCAF11;SRSF1;LUC7L3;SRPK2;KHDC4;YTHDC1;USP39;SMN1;SNRNP200;CELF6;RBM5;GCFC2;ZRSR2;SRPK1;TXNL4A;SF3B1;NOL3;DDX39B
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4418960362621883,1.2603989929579238,0.1433370660694289,0.8312857850822847,1.0,19/88,13.74%,F3;THBS1;BMP4;PGF;FGF2;NRAS;NRP1;VEGFA;TGFBR1;NF1;SULF1;KRIT1;ARNT;XDH;ATOH8;SYNJ2BP;NRARP;NR4A1;ITGB3
prerank,response to X-ray (GO:0010165),0.5901590535945058,1.2602744674913375,0.21806853582554517,0.8304089094124599,1.0,7/14,25.68%,NIPBL;ANXA1;BRCC3;XRCC5;ATM;XRCC4;IKBIP
prerank,telomere maintenance via recombination (GO:0000722),0.604296509792391,1.2599654314516988,0.21405750798722045,0.8303140085157205,1.0,6/11,23.41%,RAD51;SMC6;SMC5;RAD50;ERCC4;RAD51D
prerank,chromatin assembly or disassembly (GO:0006333),0.6200294431673027,1.2599210722652425,0.2287878787878788,0.8291435051149023,1.0,3/11,8.07%,CHAF1B;HDAC8;CHAF1A
prerank,L-serine metabolic process (GO:0006563),-0.5502258236744414,-1.259320941027842,0.21052631578947367,0.6289535215910339,1.0,2/10,4.54%,SERINC3;SERINC5
prerank,fat cell differentiation (GO:0045444),0.46477358587756973,1.258890357146311,0.17759237187127533,0.8318189473591213,1.0,8/57,6.71%,TCF7L2;BBS9;PID1;SMAD6;TMEM120A;KLF4;NR4A3;NR4A2
prerank,inflammatory response (GO:0006954),0.4198015146328752,1.258766354263158,0.09410548086866598,0.83097789083107,1.0,30/195,10.00%,THBS1;MGLL;HDAC4;PTGDR;HDAC9;CMKLR1;CXCL2;VNN1;CCL3;CCL1;TRAF3IP2;ABCF1;TLR1;FOLR2;STAT3;ANXA1;C5AR2;PROK2;NFATC4;PRDX5;REL;CD44;PTGER1;IKBKG;NFATC3;AOC3;TLR4;ELF3;CCL7;RIPK2
prerank,central nervous system development (GO:0007417),0.4147518457995288,1.2586914055705827,0.061037639877924724,0.8299390959346292,1.0,30/250,6.71%,SLC23A1;WWP1;PBX3;DCLK1;ZFHX3;VIT;NFIB;PKD1;ADGRL2;ZIC4;GSN;PBX1;ECRG4;SOX9;DMBX1;GRHL2;ELP3;SMO;ZIC1;S100B;SHROOM4;PDGFC;NIPBL;STAT3;NF1;ZBTB16;SNTG2;GLIS2;TGFBR2;NR4A2
prerank,response to interleukin-6 (GO:0070741),0.6284284955646813,1.258552797993414,0.21746031746031746,0.8291330623810269,1.0,2/10,2.55%,PID1;PTGIS
prerank,cellular potassium ion homeostasis (GO:0030007),0.6062535396822304,1.258454436613675,0.20793650793650795,0.8281915426254314,1.0,7/13,9.71%,KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5674719651399078,1.258372952064637,0.21842496285289748,0.8271751971327115,1.0,4/17,9.58%,MPG;ERCC5;SMUG1;NEIL3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4324471698048343,-1.258138099517288,0.16666666666666666,0.6298815287142826,1.0,6/21,11.17%,PLTP;APOE;PTCH1;NR1H3;EEPD1;NR1H2
prerank,positive regulation of developmental growth (GO:0048639),-0.36480117165354614,-1.2578945770647734,0.13186813186813187,0.6280983861881565,1.0,13/49,9.60%,PLCB1;NEDD4L;SEMA7A;RIMS1;RIMS2;INSR;SYT1;GHR;SYT4;RNF157;TWF2;MAPT;RUFY3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.45688730833995417,-1.257775528781629,0.16307692307692306,0.6259648891180065,1.0,9/18,18.30%,ACSL1;ELOVL7;ACSL4;HACD1;HACD2;ACSBG1;ACSL5;ELOVL6;HSD17B12
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5718645725275865,1.2576608852791193,0.21052631578947367,0.8285925882602622,1.0,6/16,24.12%,SOX9;NCOR1;BRCA1;ACADL;ACADVL;APPL2
prerank,bone morphogenesis (GO:0060349),0.5844668101276,1.2576389109653268,0.1975867269984917,0.8273751556103973,1.0,3/14,5.66%,LRP6;SFRP4;SKI
prerank,double-strand break repair (GO:0006302),0.42518989411296637,1.2571871048165373,0.10283315844700944,0.8278063464055195,1.0,76/158,30.15%,REV3L;ERCC5;NABP1;HERC2;RAD51;CHEK2;SLX4;BARD1;SPIDR;WRN;SMARCAL1;UIMC1;VCP;SMC6;MTA1;PARP3;CIB1;SMC5;PARP1;NSMCE1;RAD50;RNF138;EYA3;KPNA2;BRCA1;TNKS1BP1;RNF8;BRIP1;BRCC3;MORF4L1;PRKDC;SMARCA5;PPP5C;POLB;RECQL5;MDC1;MCM9;ACTR5;BRCA2;APLF;PARP2;PSMD14;KDM2A;XRCC5;ERCC4;YY1;NBN;AP5Z1;TDP2;DCLRE1A;RAD52;ABRAXAS1;RAD51D;ATM;RBBP8;XRCC4;POLM;INO80;RECQL;RAD21;KDM4D;POLQ;SUMO1;PARP9;SETMAR;RAD51B;PALB2;UBE2N;PAXIP1;PIAS4;RNF168;DTX3L;MAPK8;MMS22L;POLA1;GEN1
prerank,peptide biosynthetic process (GO:0043043),-0.2981286303158453,-1.2570449328236837,0.03508771929824561,0.625644163587342,1.0,52/153,17.54%,EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;GGT5;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;MRPL3;CARNS1;RPL4;RPS7;RPS23;RPS15;MRPS14;RPL36;MRPS33;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;MRPL51;HARS1;RPL23;RPL17
prerank,mitochondrion localization (GO:0051646),0.5612910424206163,1.256767618374002,0.18301610541727673,0.8281443067275063,1.0,6/19,17.76%,MARK1;MEF2A;BRAT1;MARK2;TLE6;LRRK2
prerank,protein localization to centrosome (GO:0071539),0.5685315381551127,1.2566627298802941,0.21407185628742514,0.827213356835266,1.0,10/17,32.27%,PCM1;GOLGB1;HOOK3;NUDCD3;C2CD3;PIBF1;CCDC14;BBS4;CEP131;CSNK1D
prerank,ERBB signaling pathway (GO:0038127),0.4613892059236304,1.2562374114816381,0.1592505854800937,0.8275399407327787,1.0,12/64,10.68%,EGFR;PLCE1;REPS2;PTK2B;SOX9;SHC1;KIF16B;ERBB2;NCK2;AAMP;ERBIN;GAREM1
prerank,protein maturation (GO:0051604),0.43590670674018017,1.2557695892816871,0.1425364758698092,0.8280499269922585,1.0,27/95,19.23%,F3;PCSK5;ASPRV1;ADAMTS3;ECE1;XPNPEP3;CASP2;GLRX3;PHEX;TSPAN17;MMP16;LONP2;TASP1;MMEL1;DDI2;PCSK7;NAA15;ECE2;SORL1;TYSND1;NAA40;CCS;ISCA1;CPZ;NFU1;NDUFAB1;NAA60
prerank,positive regulation of vasoconstriction (GO:0045907),0.595828140504898,1.255582291590533,0.20827178729689808,0.8274293966224703,1.0,2/13,8.51%,ADRA1B;TRPM4
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4476958232776541,1.2555661038017336,0.15375854214123008,0.8261729314192636,1.0,10/75,6.65%,F3;BMP4;PGF;FGF2;NRAS;NRP1;VEGFA;TGFBR1;FGFR1;SIRT6
prerank,cellular response to ketone (GO:1901655),-0.39205948780433025,-1.2552382609753978,0.12857142857142856,0.6284889328401031,1.0,10/35,15.07%,ADCY5;ADCY1;ROCK2;AHR;GNG2;PTGFR;SPP1;PCK2;GNAI1;MSN
prerank,regulation of mast cell activation (GO:0033003),-0.5394333403414012,-1.2544494161375546,0.20460358056265984,0.6281456879738491,1.0,6/10,23.10%,LYN;NECTIN2;CD84;CRLF2;MILR1;CD300LF
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.4611202810921244,1.2537108826321743,0.16864608076009502,0.832085856627993,1.0,17/64,19.87%,MLLT3;ELOF1;CDK12;AFF4;SETD2;MNAT1;ADRM1;CDK13;ELOA;NELFE;CDK7;CCNT2;GTF2H3;PCID2;POLR2C;ELP4;CCNT1
prerank,intracellular cholesterol transport (GO:0032367),0.5894590650544538,1.2535139826779653,0.21638330757341576,0.8315256446960436,1.0,8/15,24.55%,LRP6;LDLR;NPC1;STARD4;STAR;SERAC1;RELCH;OSBP
prerank,negative regulation of cell motility (GO:2000146),0.43577139545100063,1.2534136879431785,0.13472070098576122,0.8306028146820441,1.0,15/108,5.44%,SLIT2;TMEFF2;CLIC4;DPYSL3;CDH1;CYP1B1;PTPRU;WNT11;IGFBP5;SLURP1;SRGAP2;SRGAP3;NOG;FOXO3;NF1
prerank,regulation of catecholamine secretion (GO:0050433),-0.4021367556640047,-1.2531681435700102,0.13545816733067728,0.6293950679726049,1.0,15/29,22.11%,SYT1;SYT7;SYT10;SYT4;SYT11;SYT12;SYT6;GRK2;CHGA;SYT13;SYT2;KCNA2;SYT15;SNCA;CHRNA4
prerank,regulation of response to biotic stimulus (GO:0002831),0.5193716662488869,1.253055974480097,0.22612359550561797,0.8306599298996731,1.0,2/28,1.19%,FOXP1;CD55
prerank,camera-type eye morphogenesis (GO:0048593),0.621515035056234,1.2529849703758233,0.23510466988727857,0.8296239779905548,1.0,4/10,5.66%,LRP6;VEGFA;NF1;SKI
prerank,embryonic organ development (GO:0048568),0.4636941747648365,1.2528890510625437,0.1652892561983471,0.828657789315512,1.0,10/61,7.67%,PBX3;PCSK5;RARB;COBL;PBX1;BMPR1A;GLI3;GLI2;TGFBR2;KITLG
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.5980520740949313,1.252875942614522,0.222052067381317,0.8274084221508355,1.0,3/12,11.51%,SOAT1;ACSL3;SOAT2
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4947490429882452,-1.2525398330477653,0.19559228650137742,0.628806443452419,1.0,7/14,19.56%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;SLC8A3;TRPV4;SLC8A2
prerank,metal ion homeostasis (GO:0055065),0.4971013581281927,1.252399443227664,0.17838541666666666,0.8279280117208142,1.0,4/40,6.19%,SLC12A7;SLC12A2;CNNM2;FAM20A
prerank,actin filament bundle organization (GO:0061572),0.5058659825999225,1.2521953313070522,0.19143239625167335,0.827393014412974,1.0,9/33,7.87%,DPYSL3;BAIAP2L1;EZR;PAWR;CALD1;PLS1;LIMA1;FAM107A;DMTN
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6092575212370774,1.251851813629282,0.20775193798449612,0.827478203142296,1.0,1/12,0.19%,F3
prerank,apoptotic cell clearance (GO:0043277),0.5133543509638981,1.2515494021161226,0.18328840970350405,0.8274012734192727,1.0,5/30,5.34%,THBS1;RHOBTB1;RARA;LRP1;ANXA1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.44880661078801715,1.2508338301160002,0.14600231749710313,0.8288872597514377,1.0,36/80,24.22%,PLPP3;GBF1;TMED3;RAB6A;ARFGAP3;ARFGAP1;COPG1;ERGIC1;COPA;ERGIC2;KIF3B;NSF;ZW10;ARF4;ATP9B;KIF1C;ARCN1;COPB2;BNIP1;KLC1;GOLPH3;RAB1A;KDELR2;SURF4;COG3;RER1;TMED2;BICD2;GOLPH3L;KDELR3;ARF3;KIF23;KIF15;RAB1B;COPZ1;KIFAP3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.47516182083539504,1.2502774622107538,0.17699115044247787,0.8296950345721078,1.0,10/48,10.24%,DOCK5;CUX1;NRP1;LIMS1;ABL1;MYOC;DMTN;S100A10;CIB1;FBXW8
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5650415111949135,1.250237558403586,0.22351233671988388,0.8285889838221996,1.0,8/18,10.83%,RHOJ;HDAC9;FGF2;VEGFA;FOXC2;ANXA1;CIB1;MAP3K3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4773258927856513,1.2501321168048904,0.18766066838046272,0.8277221654720421,1.0,10/47,9.62%,DOCK5;EFNA5;NRP1;LIMS1;ABL1;MYOC;DMTN;CORO1C;S100A10;CIB1
prerank,regulation of focal adhesion assembly (GO:0051893),0.4736372248667807,1.2492494014891442,0.173053152039555,0.8296709420674778,1.0,17/54,10.43%,THBS1;EFNA5;NRP1;VEGFA;BCAS3;PHLDB2;LIMS1;ABL1;MYOC;PTPRA;VCL;FAM107A;DMTN;CORO1C;S100A10;SLC9A1;RHOA
prerank,regulation of protein export from nucleus (GO:0046825),0.5326049266698234,1.2490633067066608,0.2198100407055631,0.829105602883909,1.0,6/23,10.49%,TCF7L2;GSK3B;EMD;BAG3;BARD1;XPO4
prerank,cell junction assembly (GO:0034329),-0.31748223266645953,-1.2489750274509488,0.041666666666666664,0.636481742074534,1.0,32/100,11.65%,TJP1;TLN2;SPOCK2;CDH2;DNM3;CDH8;SHANK3;ITGA6;CLDN5;ADGRL3;NRXN1;CDH10;KIRREL3;VASP;ARVCF;GPM6A;RYK;ACTB;GJC1;SDK2;PLXND1;OPHN1;PKP4;FLNC;FBLIM1;SHANK2;CDH7;CDH19;CDH20;DNER;VMP1;CDH5
prerank,T-helper cell differentiation (GO:0042093),0.5801641437932726,1.2489156161362813,0.2375776397515528,0.8283321497133782,1.0,1/14,0.23%,FOXP1
prerank,camera-type eye development (GO:0043010),0.526675768153818,1.2484167861596926,0.2097902097902098,0.8287779054175327,1.0,7/25,6.03%,CACNA1C;CYP1B1;PITX2;VEGFA;NF1;SKI;TSKU
prerank,negative regulation of potassium ion transport (GO:0043267),0.5947498813399833,1.2476249002165978,0.21100917431192662,0.8305689848094445,1.0,2/13,2.10%,STK39;PTK2B
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4688568881990397,-1.2476160437928216,0.1867816091954023,0.6378451649438355,1.0,6/16,8.07%,PLCB1;RANBP3L;IGFBP3;RIPOR2;MEF2C;BTG1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5441490319994255,1.2474397992910964,0.2222222222222222,0.8300598899039677,1.0,5/22,12.33%,BMP4;INHBA;CDKN2C;CDKN1C;CDKN1B
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6015571559608269,1.247281073147284,0.2343032159264931,0.8280853211869406,1.0,2/11,5.34%,PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.6015571559608269,1.247281073147284,0.2343032159264931,0.8280853211869406,1.0,2/11,5.34%,PTK2B;SHC1
prerank,acylglycerol biosynthetic process (GO:0046463),0.5356012662248782,1.2466894507979416,0.1985611510791367,0.8289747288786692,1.0,7/23,14.41%,PLCE1;PLA2G15;PNPLA3;LPIN2;AGMO;PNPLA2;MOGAT1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.5441234476283564,1.245809728532453,0.1966053748231966,0.8298348405721963,1.0,5/20,9.52%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.5441234476283564,1.245809728532453,0.1966053748231966,0.8298348405721963,1.0,5/20,9.52%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4018551549347459,1.2448362021771808,0.004,0.832315181496047,1.0,198/834,17.36%,MICAL2;SIX1;BMP4;EGFR;PLAGL1;ZFHX3;KLF5;ZFPM2;TCF7L2;LRP6;NFIB;MET;PKD1;HES1;HDAC4;PID1;RARB;HOXA5;PPP3CA;CCN1;CSRP3;MEOX2;BMP5;NFAT5;TCF20;NFIA;FGF2;PBX1;SMAD9;EHF;SOX9;GRHL2;PITX2;VEGFA;TGFB3;ESR1;NFE2L2;BMPR1A;GRHL1;DDX17;DCAF6;FOXC2;GLIS1;MLXIP;HOXC4;RARA;ELF1;BCAS3;KLF4;GLI3;CDK12;ABL1;RBM14;HDAC8;KLF7;HOXB3;IL33;MLLT10;MED13;NR4A3;TWIST1;KMT2C;STAT3;FOXO3;KLF10;SKI;NFIX;MRTFA;PER1;MEF2A;BMP6;MYSM1;GLI2;AGO2;HOXB4;GLIS2;REL;NR4A2;NCK2;INHBA;NRF1;CREBBP;RORA;APEX1;E2F3;IKBKG;MED24;NFATC3;RHOQ;IRF1;SMAD2;KANSL3;ZC3H12A;MLX;MLXIPL;TLR4;EGR1;NFIC;GATA4;THRAP3;KDM1A;RUNX2;RXRA;GABPB1;GABPB2;FOXC1;ELF3;PPRC1;MAVS;ZFP64;ARNT;SLC9A1;RIPK2;ATF6;CDK13;TBL1X;POU4F1;PARP1;DHX36;CRTC2;LPIN2;POGZ;ZFPM1;ATOH8;TEAD1;TFDP1;JUP;RXRB;ARF4;JAG1;THAP3;CRTC1;RPS6KA3;NCOA6;NR2F1;HSF2;BRCA1;NR1D1;ITGB1BP1;LMX1A;SREBF1;NR4A1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;SSBP3;NFATC1;RBMX;ACVR1;AATF;PRDM2;COPS5;HTATIP2;METTL23;RFXANK;HINFP;SP3;PPP1R12A;ATRX;NR3C1;AKIRIN2;BCL11B;POU2F1;CDK7;CCNT2;PLSCR1;DVL1;E2F2;MEF2D;NCK1;SLC30A9;KAT6B;CAPRIN2;PRKDC;RNF111;HOXD3;TRAF6;TNIP1;PAX6;SMARCA5;MZF1;GDNF;ATF1;SMAD4;PIN1;IKBKB;ACTR2;PRDM10;YAP1;E4F1;CHD8;BCL9L;HCFC1;KMT2D;SMAD7;CAMTA2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.40003887032816376,1.244483818403518,0.0,0.8323262905227433,1.0,378/1668,17.61%,FOXP2;TBX15;FOXP1;KLF12;ZBTB7C;SIX1;BMP4;PBX3;EGFR;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;ZFPM2;TCF7L2;TFCP2L1;LRP6;ZFHX4;PRRX2;NFIB;SLTM;MET;MKX;PKD1;FOXD1;HES1;HDAC4;FOXP4;PID1;ZIC4;CUX1;RARB;TWIST2;HOXA5;PPP3CA;CCN1;CSRP3;KLF3;MEOX2;DDX5;CAMK2D;SMAD6;USP2;BMP5;NFAT5;PRDM6;TCF20;EZR;ANXA4;HOXA3;NFIA;HDAC9;FGF2;SKIL;JMJD1C;HOXB6;PBX1;MDFI;PURG;FOXL1;SMAD9;EHF;PRRX1;SOX9;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;ELP3;JDP2;VEGFA;TGFB3;ESR1;HOXC6;NFE2L2;BMPR1A;ID2;GRHL1;DDX17;ID1;DCAF6;WWP2;ZNF148;FOXC2;ZIC1;GLIS1;BRD3;MLXIP;HOXC4;RARA;ELF1;BCAS3;KLF4;GLI3;SP110;CDK12;ABL1;ATOH7;RBM14;HDAC8;HOXA6;KLF7;HOXB3;NOG;IL33;MLLT10;MED13;NR4A3;TWIST1;ARID4B;RCOR3;NIPBL;KMT2C;STAT3;FOXO3;KLF10;CC2D1B;CCNL1;SKI;NFIX;MRTFA;FRK;ZBTB16;PER1;MEF2A;DACT1;ATP2B4;NFIL3;SRCAP;NFATC4;BMP6;LCOR;BHLHE40;MYSM1;KLF9;GLI2;CCNL2;TCF25;AGO2;MNAT1;HOXB4;ERBB2;GLIS2;REL;SIRT6;NR4A2;NCK2;INHBA;MIER1;NFE2L1;NRF1;CREBBP;RORA;CRY2;NCOR1;ZNF691;APEX1;E2F3;POU3F4;IKBKG;MED24;PHF21A;NFATC3;RHOQ;IRF1;SMAD2;FOXO6;CHD3;KANSL3;EED;ZC3H12A;MLX;MLXIPL;CBX5;CCND1;TLR4;EGR1;NCOR2;NFIC;GATA4;PER3;THRAP3;KDM1A;DNMT3A;RUNX2;RXRA;HOXA2;HIF3A;SMARCAL1;GABPB1;GABPB2;MED27;MXD4;IFRD1;FOXC1;ELF3;PPRC1;MAVS;MTA1;TADA3;ZFP64;ARNT;HES3;SIX4;BRMS1L;BRMS1;SLC9A1;SMARCC1;ATF7;RIPK2;ATF6;HDGFL3;CDK13;NSD1;TBL1X;CCNB1;POU4F1;PARP1;DHX36;BCOR;CRTC2;ARID4A;LPIN2;ERF;ZNF25;CREB3L1;RCOR1;MECP2;IGBP1;RFX2;POGZ;ZFPM1;ATOH8;HOXB5;TEAD1;ZBTB1;TFDP1;PHF12;JUP;RXRB;ZBTB32;MYNN;ARF4;JAG1;ZBTB8B;THAP3;CRTC1;RPS6KA3;NCOA6;NR2F1;ETV3;MDM4;HSF2;BRCA1;NR1D1;CEBPD;ZBTB8A;FUS;ZFP3;BATF3;ITGB1BP1;GTF2IRD1;EZH1;LMX1A;ELOA;SREBF1;NR4A1;ZBTB24;DLG1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;MTDH;NFYA;SSBP3;HIRA;NFATC1;PATZ1;DMAP1;RBMX;ACVR1;AATF;MED15;PRDM2;COPS5;HTATIP2;METTL23;RFX7;HR;RFXANK;HINFP;SP3;PPP1R12A;BRIP1;MED31;ZBTB34;ATRX;SRA1;NR3C1;SP140;AKIRIN2;BCL11B;NKAP;CHD1;TARBP1;THAP7;POU2F1;CDK7;CCNT2;URI1;PLSCR1;FOSB;GMEB1;DVL1;E2F2;MEF2D;NCK1;ZNF394;UBE2D3;SLC30A9;KAT6B;CAPRIN2;PRKDC;TOX4;ZNF219;RNF111;HOXD3;TRAF6;KMT5A;TNIP1;HIVEP3;KDM5B;PAX6;SSU72;SMARCA5;ZBTB3;MZF1;CDKN1A;MOV10;GDNF;ATF1;PRDM5;SMAD4;FOXK1;NCOA5;PIN1;ZFP1;ZMYM5;IKBKB;ACTR2;TSHZ2;SNF8;PHF20L1;PRDM10;PLK3;GTF2H3;YAP1;E4F1;CHD8;ESR2;VPS72;BCL9L;HCFC1;KMT2D;RB1;SMAD7;ZBTB7B;CAMTA2;TLE6;RNF14;KDM3B;MED20;POU6F1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5397508575969425,1.2441214839279586,0.2170767004341534,0.8323816953850386,1.0,5/21,7.76%,EXT1;HS3ST4;HS6ST2;XYLT1;SULF1
prerank,striated muscle contraction (GO:0006941),-0.35887935542752525,-1.2440626358339824,0.11052631578947368,0.6452894247793635,1.0,5/53,2.92%,ATP1A2;DTNA;SLC8A1;RYR2;RCSD1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.6091763916636718,1.2440226307369788,0.2286634460547504,0.8314952103252521,1.0,4/11,13.02%,LRP6;FZD1;NR4A2;LMX1A
prerank,ncRNA 3'-end processing (GO:0043628),0.5739529989395095,1.2437144345155713,0.22137404580152673,0.8314008265086411,1.0,9/14,24.95%,INTS5;INTS6;ERI1;SSB;INTS7;PTCD1;INTS14;INTS8;INTS2
prerank,acyl-CoA metabolic process (GO:0006637),0.4898373949501184,1.2436673464431371,0.20742637644046094,0.8303282768797772,1.0,13/35,21.18%,ACSM2A;ACSM2B;ACOT12;ACOT9;ACOT11;ACACA;ACOT8;SUCLA2;ACOT13;HMGCS2;GLYAT;ACOT6;OGDH
prerank,positive regulation of cell adhesion (GO:0045785),0.44739764002113885,1.243482083392537,0.1602787456445993,0.8297740319615045,1.0,12/74,9.88%,ZFHX3;VIT;ADAM9;PPP3CA;VEGFA;FOXC2;LIMS1;ERBB2;AGR2;CHRD;CIB1;ITGAV
prerank,epithelium development (GO:0060429),0.43060338041420654,1.2430765999295779,0.15443592552026286,0.830014908173047,1.0,16/107,7.97%,SIX1;PKD1;MEOX2;CASP6;ANXA4;BDH2;EHF;SOX9;GRHL2;VEGFA;SMO;RIPK4;DACT1;VCL;GSTA2;DNPH1
prerank,endocardial cushion morphogenesis (GO:0003203),0.552019232467731,1.2430538161154503,0.21282798833819241,0.8288462505673083,1.0,5/18,6.61%,BMP4;SOX9;BMPR1A;NOG;TGFBR2
prerank,NAD biosynthetic process (GO:0009435),0.5486972662688931,1.2429404124962025,0.22535211267605634,0.8280395741992947,1.0,5/20,8.86%,PTGIS;NMNAT2;NNMT;NMNAT1;NUDT12
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5225131163127436,1.2423933447020412,0.2111888111888112,0.8288830711864492,1.0,3/23,2.10%,HES1;CYP1B1;PTK2B
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.4687865452511464,-1.2413193325462697,0.18037974683544303,0.6505689753076375,1.0,4/15,11.91%,ARPC4;ARPC5;IQGAP2;ARPC3
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.3942136773033305,-1.2412788462550641,0.1457286432160804,0.6481912808088472,1.0,12/32,15.31%,ITGA1;PDGFRB;PPP1R16B;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2;ANKLE2;CDH5;SMPD1;PPP2R5A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.4281136946319704,1.2412347748482329,0.1573157315731573,0.8320344107749158,1.0,15/101,12.21%,THBS1;PERP;SAMD4A;CYFIP2;EZR;NIBAN1;KLF4;DACT1;ERBB2;INHBA;EIF3E;RDX;EIF6;RBM3;NAT10
prerank,calcium ion import into cytosol (GO:1902656),-0.480843928269474,-1.241119596720851,0.20113314447592068,0.6461624818673495,1.0,7/15,19.56%,SLC24A2;SLC8A1;CACNA2D1;TRPV2;SLC8A3;TRPV4;SLC8A2
prerank,nucleoside catabolic process (GO:0009164),0.6154224684226354,1.2409065980076168,0.2370486656200942,0.8319493835966068,1.0,4/11,12.29%,NT5C1A;NT5E;DERA;UPP2
prerank,inorganic cation transmembrane transport (GO:0098662),0.4045148951290775,1.240633619369377,0.07574206755373593,0.8316646333466758,1.0,40/268,11.38%,SLC4A4;SLC9A2;KCNK5;KCNJ2;KCNB2;SLC12A2;SLC24A3;CACNA1C;PKD1;SCARA5;CACNA1G;ATP2C2;ATP1B1;KCNB1;KCNS3;SLC39A14;ANO6;TRPM7;TRPM6;SLC6A7;ATP2B4;ATP6V0A4;SLC39A13;SLC39A11;SLC30A3;TRPM4;SLC6A2;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;ITGAV;COX15;KCNG4;TRPM8;TRPC4AP;SLC9A8;NALCN;RHCG
prerank,protein stabilization (GO:0050821),0.41869288435069935,1.2404355739275692,0.11554621848739496,0.831151023405742,1.0,52/168,20.00%,RASSF2;PRKCD;USP2;ANK2;ATP1B1;PLPP3;TELO2;HPS4;SEC16A;TBRG1;IFT46;PARVA;CHEK2;USP13;BAG3;TRIM39;PER3;NLK;P3H1;WDR81;TBL1X;AAK1;CHP1;TRIM44;NAA15;CLU;STX12;MDM4;COA8;RAB21;MORC3;PIM2;ATF7IP;SEL1L;CDK7;UBE2B;DVL1;CCT5;FLOT1;CDKN1A;PIN1;HCFC1;SMAD7;GOLGA7;STK3;BAG5;COG3;OTUD3;FKBPL;CREBL2;USP19;BAG2
prerank,blood vessel endothelial cell migration (GO:0043534),0.5433496968870369,1.2398365739163923,0.2297111416781293,0.8322759746628143,1.0,5/22,3.37%,SLIT2;FGF2;NRP1;VEGFA;ID1
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.5273640081484655,-1.2395689439095539,0.21487603305785125,0.6482034941215251,1.0,4/10,13.35%,ST6GAL1;ST3GAL1;NPL;GNPDA2
prerank,somite development (GO:0061053),0.5954473189362905,1.2390773242064543,0.23222748815165878,0.8339050409284368,1.0,2/11,3.51%,MEOX2;SMO
prerank,primary miRNA processing (GO:0031053),0.6273552714344712,1.2390067084199428,0.22990353697749197,0.832927044381497,1.0,8/10,34.16%,DGCR8;SMAD2;HNRNPA2B1;MRPL44;DROSHA;SMAD1;PUS10;SRRT
prerank,positive regulation of ATP metabolic process (GO:1903580),0.4990381105027145,1.2389040592606686,0.21204188481675393,0.8320683501062272,1.0,7/32,9.52%,SLC4A4;PID1;PFKFB1;ENTPD5;MLXIPL;VCP;ARNT
prerank,sphingosine metabolic process (GO:0006670),0.5598859373330405,1.2386117977748794,0.21911764705882353,0.8319305008712989,1.0,2/17,2.14%,ACER3;PLPP3
prerank,negative regulation of transposition (GO:0010529),0.5646216303192484,1.2384920694228145,0.21714285714285714,0.8311249101604719,1.0,4/16,16.33%,TEX15;TUT7;TUT4;MOV10
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5354646775693181,1.2384112002007401,0.20754716981132076,0.8301879586675274,1.0,7/21,17.26%,RASSF2;NCK2;DMTN;MLXIPL;DMD;NCK1;SMAD7
prerank,sodium ion export across plasma membrane (GO:0036376),0.5922068460123554,1.2383074392832176,0.2398753894080997,0.8293323954348469,1.0,7/13,9.77%,SLC4A4;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.43876927755515566,1.2380669734897782,0.1543700340522134,0.829021582368925,1.0,18/86,12.56%,ARHGEF28;PLCE1;AKAP13;NGF;ARHGDIB;NOTCH2;ARHGAP44;SHOC2;SHC1;BCR;ARHGAP17;STARD13;ARFGAP1;RDX;ERBIN;DENND4A;EPHB2;RAF1
prerank,adherens junction organization (GO:0034332),-0.35194647320448297,-1.2374158663026789,0.13043478260869565,0.6520389810918903,1.0,19/48,15.16%,TJP1;CADM1;CDH2;CDH8;CDH13;CADM2;CDH4;CDH10;ACTB;JAM3;CADM3;CDH7;CDH19;CDH20;CDH5;CDH12;CDH22;NECTIN2;CTNNB1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5909257059012726,1.2371631228772761,0.22036474164133737,0.8311541096274997,1.0,4/13,16.13%,LARGE1;RENBP;CHST5;OGA
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.586713947998105,1.2369292786201964,0.23384615384615384,0.8308415420468689,1.0,5/13,13.58%,TMEM30B;SEC16A;TM9SF4;BCAP31;SORL1
prerank,positive regulation of histone methylation (GO:0031062),-0.417758596471689,-1.2367113233079066,0.1962962962962963,0.6514617276695527,1.0,2/24,2.65%,AUTS2;JARID2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5188936361964537,1.2362698662237646,0.2273342354533153,0.832035907835332,1.0,15/23,31.90%,PARP1;RAD23B;COPS7B;COPS5;COPS8;CETN2;COPS3;COPS2;UBB;UBA52;RPS27A;DDB1;DDB2;XPA;COPS7A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.4413765249903276,1.2358690049833527,0.1782065834279228,0.8322664642216488,1.0,24/78,17.76%,FZR1;RNF144A;PRICKLE1;NFE2L2;GSK3B;ZYG11B;SIRT6;CSNK1A1;ARIH1;VCP;CDC20;ANKIB1;DDA1;DET1;KEAP1;HERPUD1;CLU;BCAP31;COP1;DVL1;PLK3;SMAD7;RNF14;LRRK2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5581302613740491,1.235626806597984,0.23969465648854962,0.8319859989315738,1.0,4/15,4.52%,EGFR;PTK2B;SRMS;ABL1
prerank,protein import into peroxisome membrane (GO:0045046),0.5358842257906088,1.2351171806432337,0.2,0.8326242320352442,1.0,5/22,10.08%,ABCD3;PXMP2;ABCD1;ACBD5;PEX13
prerank,positive regulation of transporter activity (GO:0032411),0.5804045966814485,1.235036375045574,0.23124042879019907,0.8317002762650392,1.0,3/13,11.01%,STK39;RXRA;SYNGR3
prerank,regulation of postsynapse organization (GO:0099175),-0.39707341960528897,-1.2349949349215128,0.1701388888888889,0.6539997381513485,1.0,8/28,7.95%,IL1RAPL1;SHANK3;PPFIA2;WNT5A;ARHGAP22;EPHA4;CFL1;KIF1A
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6111474462727184,1.2349022385380906,0.24183006535947713,0.8310220817386355,1.0,3/10,11.99%,NFE2L2;EIF2S1;HERPUD1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3980636120639884,1.234675657681106,0.001,0.8306616933205975,1.0,411/1646,20.29%,FOXP2;BNC2;TBX15;FOXP1;WWP1;KLF12;ZBTB7C;VSX1;SIX1;BMP4;PBX3;EGFR;NR3C2;PLAGL1;ZFHX3;TCF7L1;KLF5;ZFPM2;TCF7L2;TFCP2L1;LRP6;ZFHX4;PRRX2;NFIB;SLTM;MKX;MAP3K5;FOXD1;HES1;HDAC4;FOXP4;CDH1;ZIC4;CUX1;TWIST2;HOXA5;TCIM;MLLT3;KLF3;MEOX2;DDX5;CAMK2D;RBFOX2;SMAD6;WNT11;SAMD7;NFAT5;TCF20;FOXN3;GCLC;ANXA4;HOXA3;NFIA;HDAC9;FGF2;JMJD1C;PRICKLE1;HOXB6;PBX1;PURG;FOXL1;SMAD9;EHF;PRRX1;ERC1;SOX9;DMRT3;DMBX1;SOX14;SP8;GRHL2;PITX2;ELP3;JDP2;VEGFA;TGFB3;ZNF423;ESR1;HOXC6;NFE2L2;ID2;GRHL1;DDX17;ID1;WWP2;ZNF148;FZD1;FZD7;FOXC2;ZIC1;GLIS1;BRD3;MLXIP;HOXC4;RARA;ELF1;KLF4;GLI3;PHC2;SP110;LIMS1;TLE2;TGFBR1;ABL1;ATOH7;MDFIC;HOXA6;KLF7;HOXB3;MED13;NR4A3;TWIST1;ARID4B;RCOR3;NIPBL;STAT3;SHC1;FOXO3;CDC45;KLF10;CC2D1B;SPINDOC;CCNL1;NFIX;CHEK2;USP13;ZBTB16;PER1;MEF2A;ATP2B4;NFIL3;SRCAP;NFATC4;LCOR;BHLHE40;HMG20A;KLF9;GLI2;CCNL2;MNAT1;HOXB4;ERBB2;L3MBTL3;GLIS2;REL;NR4A2;MBD1;INHBA;NFE2L1;NRF1;WAC;CREBBP;EHMT1;RORA;CRY2;NCOR1;ZNF691;TENM1;SERTAD3;CDK11B;E2F3;POU3F4;MED24;NFATC3;DKK3;IRF1;SMAD2;FOXO6;CHD3;EED;BTAF1;MLX;MLXIPL;GPBP1;CBX5;EGR1;NCOR2;NFIC;GATA4;THRAP3;CIPC;KDM1A;RUNX2;RXRA;NLK;HOXA2;HIF3A;SMARCAL1;MED27;MXD4;UIMC1;IFRD1;CD80;FOXC1;ELF3;PDCD4;ILF2;TADA3;ARNT;HES3;SIX4;GPATCH3;BRMS1;SMARCC1;ATF7;CDK16;TASP1;ATF6;HDGFL3;NSD1;TBL1X;POU4F1;TGFB1I1;QARS1;DHX36;BCOR;ARID4A;ERF;ZNF25;CREB3L1;RCOR1;DENND4A;MECP2;SCMH1;RFX2;ATOH8;HOXB5;TRIM44;TEAD1;ZBTB1;NAA15;FBXO5;POLR3F;TP53INP2;TFDP1;PHF12;CDKN1C;RXRB;ZBTB32;MYNN;ZBTB8B;NIBAN2;CDKN1B;RPS6KA3;NCOA6;NFXL1;NR2F1;APBB3;ETV3;MDM4;HSF2;BRCA1;POFUT1;NR1D1;CEBPD;ZBTB8A;FUS;ZFP3;BATF3;GTF2IRD1;RET;LMX1A;ELOA;SREBF1;NR4A1;ZBTB24;E2F1;PRMT5;LRP5;HOXA7;RRP8;MTDH;NFYA;HIRA;NFATC1;PATZ1;DMAP1;ACVR1;AATF;PRDM2;HTATIP2;RFX7;HR;RFXANK;HINFP;SP3;PIM2;ATF7IP;BRIP1;KHDRBS1;MED31;MSL3;PITHD1;ZBTB34;ATRX;SRA1;NR3C1;SP140;BCL11B;NKAP;CHD1;TARBP1;THAP7;POU2F1;CCNT2;URI1;FOSB;GMEB1;DVL1;E2F2;MEF2D;MBTD1;ZNF394;KAT6B;TOX4;ZNF219;RNF111;HOXD3;TRAF6;KMT5A;EFEMP1;HIVEP3;KDM5B;PAX6;SMARCA5;ZBTB3;MZF1;CDKN1A;ATF1;MAP3K10;PRDM5;SMAD4;FOXK1;USP47;ZFP1;IKBKB;TSHZ2;SNF8;PHF20L1;YAP1;E4F1;CHD8;ESR2;ERN2;HCFC1;KMT2D;RB1;SMAD7;ASCC2;ZBTB7B;NEK4;CAMTA2;RNF20;PCID2;RNF14;KDM3B;MED20;POU6F1;PRDM15;UBP1;NUP35;TAF5;TRRAP;DEK;ACTR5;ATF2;BRCA2;RGMB;KMT2E;DHX9;KDM2A;PRDM11;NONO;PIAS2;PHF20;GON4L;MED16;NFX1;PPARG;PRMT6;COMMD7;BRD4;ZBTB2;ZNF260;USP21;USP16;ELP4;HDAC2;CARF;EPC1;MAFF;CEBPG;HEXIM1;XRCC5;CHUK;SATB2;CREBL2;LIN9;CCNT1;ZBTB25;NR1D2;ZBTB7A;TCF12;IKZF2;BRD9;PHF14;FOXK2;E2F5;BCL7A;PCGF1;ZBTB48
prerank,oligosaccharide biosynthetic process (GO:0009312),0.5523479424692725,1.234399950484327,0.23469387755102042,0.8304439785008515,1.0,3/20,7.09%,ST3GAL4;FUT8;B4GALT1
prerank,negative regulation of response to stimulus (GO:0048585),0.45622190961939657,1.2342406835633355,0.2023391812865497,0.8298565557173263,1.0,9/60,6.94%,SLIT2;UBASH3B;VPS13C;COL3A1;SRMS;KLF4;KLF7;TWIST1;NLRP12
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.5139814047948326,-1.2342240575418755,0.1853932584269663,0.6537297874452296,1.0,4/13,5.98%,ADCY1;SHANK3;APP;LGMN
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5146713699532706,1.2339319296600377,0.2239221140472879,0.829771660898307,1.0,4/25,1.98%,STK39;WNK1;ANK2;ATP1B1
prerank,amino acid import across plasma membrane (GO:0089718),0.5193184437990225,1.2334180184149997,0.23537604456824512,0.8304473588451272,1.0,1/24,0.01%,SLC47A1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.400485764753142,1.2333765793464795,0.027054108216432865,0.8293935536563829,1.0,145/497,21.27%,FOXP2;FOXP1;WWP1;BMP4;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;TWIST2;RBFOX2;SAMD4A;WNT11;SAMD7;IGFBP5;FOXN3;GCLC;HDAC9;PRICKLE1;SOX9;DMBX1;SOX14;ZNF423;ID2;ID1;WWP2;ZNF148;GSK3B;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;PAIP2;TWIST1;RCOR3;NIPBL;SHC1;KLF10;SPINDOC;CNOT8;ZBTB16;PER1;NFIL3;BHLHE40;L3MBTL3;GLIS2;MBD1;EHMT1;CRY2;NCOR1;DKK3;IRF1;SMAD2;EED;BTAF1;MLX;MLXIPL;CBX5;NCOR2;CIPC;KDM1A;RUNX2;UIMC1;ELF3;EPRS1;PDCD4;SIX4;BRMS1;QARS1;DHX36;BCOR;ARID4A;EIF2AK2;EIF2AK1;CREB3L1;RCOR1;MECP2;SCMH1;ATOH8;PHF12;CDKN1C;NIBAN2;CDKN1B;RAD17;BRCA1;NR1D1;E2F1;HOXA7;PATZ1;DMAP1;HINFP;SP3;ATF7IP;KHDRBS1;NR3C1;NKAP;THAP7;POU2F1;MBTD1;KAT6B;ZNF219;TRAF6;KMT5A;CDKN1A;MAP3K10;PRDM5;SMAD4;FOXK1;USP47;CHD8;ERN2;RB1;TSPYL2;TOB1;PRDM11;NONO;SYNCRIP;ENC1;DAPK1;IGF2BP3;PPARG;PRMT6;COMMD7;ATR;HDAC2;EPC1;HEXIM1;XRCC5;S100A11;NR1D2;ZBTB7A;FOXK2;BCL7A;WAPL;CAPRIN1;NKX2-1;PML;CBFA2T2;NPAS1;ID3;SAMD4B;DAP
prerank,peptidyl-lysine monomethylation (GO:0018026),0.6147021564726592,1.2330891890916653,0.2554858934169279,0.8292893934237011,1.0,6/10,26.83%,SETD2;EHMT1;KMT5A;SETD6;SMYD2;SETD7
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.47743649068852595,1.2330343526525136,0.19672131147540983,0.828292379325363,1.0,4/48,5.21%,SLC26A2;GUCY2C;PAPSS2;ADCY9
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.5263360817292181,1.2326737304496365,0.2268326417704011,0.8284343822666265,1.0,5/23,9.52%,SLC4A4;PFKFB1;ENTPD5;MLXIPL;ARNT
prerank,neuron development (GO:0048666),-0.29232912812284834,-1.2326236715116763,0.015873015873015872,0.6558667410039054,1.0,45/141,13.25%,PTPRM;LYN;APOE;CNTNAP2;FRYL;TENM3;MAP2;APP;CNTN4;TENM2;RASGRF1;MYT1L;RAPGEF2;UGCG;GPM6A;EPHA5;RYK;SH3GL2;PLP1;EPHA8;MEF2C;DCX;LAMB1;OPHN1;TENM4;STMN1;BICDL1;LGI1;TMEM108;B4GALT6;STMN4;NTRK2;MAPT;ALK;GPM6B;ATCAY;STMN3;MICALL1;VAPA;BTG2;UHMK1;FRY;HMGB1;ATP8A2;ATXN10
prerank,negative regulation of endothelial cell migration (GO:0010596),0.485058827245712,1.2325441401900104,0.20253164556962025,0.8277055871439822,1.0,8/36,12.63%,SLIT2;THBS1;FGF2;ATP2B4;KRIT1;MECP2;JUP;SYNJ2BP
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5026760463752203,1.232475256042309,0.22294654498044328,0.8267871681008797,1.0,11/32,13.42%,THBS1;SEMA3E;BCAS3;PHLDB2;MYOC;FAM107A;DMTN;CORO1C;JAG1;ITGB1BP1;HOXA7
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5448626829911604,1.2318120584299137,0.24486803519061584,0.8280188375860155,1.0,3/17,3.04%,CACNA1G;CLTRN;KCNB1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4606237410338947,1.2316646847073718,0.19833729216152018,0.8273943530312972,1.0,26/59,26.46%,TANK;ERC1;TAB3;REL;IKBKG;TLR4;RIPK2;MAP3K7;TAB2;IRAK1BP1;TLR8;TRAF2;TRAF6;IKBKB;MAP3K14;RBCK1;FAIM;TICAM1;CHUK;RELB;TRADD;UBB;NLRC3;UBA52;SHARPIN;RPS27A
prerank,protein localization to chromatin (GO:0071168),0.5518226742048034,1.2312837038062125,0.2276064610866373,0.827526576386861,1.0,11/18,27.83%,ESR1;NIPBL;LEMD2;MCM9;TASOR;WAPL;PPHLN1;RAD21;SGF29;MRNIP;PLK1
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5120664968497795,-1.2305655928631916,0.20215633423180593,0.6593238270587299,1.0,4/11,26.85%,ABCG1;PLA2G7;AGT;PLA2G5
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5919864943986307,1.2305283571292798,0.23839009287925697,0.8290729926247764,1.0,8/12,27.11%,WAC;CCND1;FBXO31;PRKDC;CDK2;PLK3;TP53;RPS27L
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5908472854904792,1.2303119589056184,0.2530487804878049,0.828690105034242,1.0,6/12,13.19%,CACNA1C;DSP;DSG2;TRPM4;JUP;DLG1
prerank,lipid catabolic process (GO:0016042),-0.45743852581420896,-1.2301718614023487,0.17252396166134185,0.6579417985741709,1.0,8/18,26.94%,PLA1A;PLAAT3;SIRT2;LPL;MT3;LIPE;LIPH;PPT1
prerank,dicarboxylic acid transport (GO:0006835),0.5148602952847213,1.2300415830142688,0.20133333333333334,0.8284383527961059,1.0,4/28,4.90%,SLC26A7;SLC26A6;GIPC1;FOLR2
prerank,tRNA wobble uridine modification (GO:0002098),0.5695181949204597,1.2295610063591267,0.2468553459119497,0.8290164723346157,1.0,4/14,9.90%,ELP3;DPH3;ALKBH8;MTO1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.4457710441983887,-1.2293059659203374,0.2108626198083067,0.6581022171616612,1.0,9/19,7.11%,ROBO1;SEMA6A;JCAD;CCBE1;DCN;CD63;TSPAN12;CADM4;DAB2IP
prerank,blood circulation (GO:0008015),-0.3400314726154979,-1.2291140357282164,0.15469613259668508,0.6562636094373202,1.0,17/49,12.71%,COL4A3;NOS3;GUCY1B1;ROCK2;SGCZ;CXCL12;NPR1;ACE;TBC1D8;GUCY1A1;ADORA2A;BDKRB2;MYOF;STAT1;F5;ACE2;CYB5R3
prerank,regulation of macrophage migration (GO:1905521),0.5991222858434899,1.228673383033098,0.23255813953488372,0.8310679538807862,1.0,3/10,5.81%,PTK2B;MTUS1;EMILIN1
prerank,generation of neurons (GO:0048699),0.40957670471099766,1.2285783196637992,0.11570247933884298,0.8302389812255987,1.0,33/190,10.22%,SIX1;WNT9A;MET;HES1;MARK1;CIT;WNT11;FGF13;NRP1;ELP3;FZD1;FZD7;ITM2C;ATOH7;FGFR1;THOC2;DNAAF4;DOCK7;ACSL3;CTF1;BHLHE40;ERBB2;NRBP2;NR4A2;PAFAH1B1;RUNX2;SDCCAG8;MAP1B;HES3;SIX4;LRP12;PEX13;NAV1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4620323289107823,-1.2284163272406572,0.1590909090909091,0.6559383750703387,1.0,4/16,17.65%,CLDN5;CLDN1;CLDN14;CLDN10
prerank,double-strand break repair via break-induced replication (GO:0000727),0.5831816478825274,1.2280338356513796,0.2571428571428571,0.8310906655049307,1.0,4/12,16.33%,CDC45;MCM2;MCM7;CDC7
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.5115574674418294,-1.2277417455358735,0.23173803526448364,0.6553201007268405,1.0,3/11,8.56%,NOVA1;NOVA2;PCBP3
prerank,mesonephros development (GO:0001823),0.5895988063812982,1.2274842608150216,0.2372611464968153,0.8319825306866905,1.0,2/11,5.85%,BMP4;ZBTB16
prerank,glycerolipid catabolic process (GO:0046503),0.5456330063486168,1.2272787718601992,0.2217391304347826,0.8315908187495283,1.0,4/19,9.44%,MGLL;PLA2G4F;LYPLA2;ABHD6
prerank,organelle disassembly (GO:1903008),0.4952566958175422,1.2272518211719572,0.21986754966887417,0.8305294305108206,1.0,16/33,22.73%,ULK2;GBF1;MTIF3;KIF9;VCP;TEX264;RB1CC1;STX5;UBA5;KLC1;KIF5B;PLK3;EIF2D;MRRF;ZFAND1;MTIF2
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4167892294066672,-1.227226908528534,0.16544117647058823,0.6544680230455626,1.0,16/26,20.31%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC39A12;ATP13A2;MT3;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,regulation of synapse maturation (GO:0090128),-0.5255130462745149,-1.2267734237019081,0.24456521739130435,0.653304364529473,1.0,5/10,15.97%,NRXN1;ARHGEF15;DAB2IP;CAMK2B;RELN
prerank,cellular response to tumor necrosis factor (GO:0071356),0.41039072065902127,1.224951874574127,0.13955928646379853,0.8379400480819008,1.0,46/175,21.82%,CARD14;PID1;TANK;TNFRSF11B;PTK2B;EDA;YBX3;NFE2L2;PSMB2;CCL3;LIMS1;CCL1;FOXO3;ZFAND6;PSMD11;ZC3H12A;PSMC1;CIB1;CCL7;ERBIN;PSMC6;TRAF2;BRCA1;NR1D1;PSMD1;GSDME;TRAF6;PSMD4;TRAF5;IKBKB;TNFRSF12A;MAP3K14;PSMA6;TNFSF13B;PSMD14;DHX9;PSMD12;PSMD7;JAK2;COMMD7;CHUK;CDIP1;TRAF3;PSME3;TXNDC17;TRADD
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.5869570906616189,1.224799706982801,0.24183976261127596,0.8373215125815582,1.0,3/12,5.88%,DSE;UST;BGN
prerank,regulation of phosphorylation (GO:0042325),0.41947545489045523,1.2247348552978932,0.16021505376344086,0.8363932663568896,1.0,28/120,18.03%,THBS1;BMP4;EGFR;NRP1;FZD7;NUP93;INHBA;BARD1;FN1;NUP214;CORO1C;NUP153;CDKN2C;EIF6;CDKN1C;CDKN1B;NUP155;RAD17;RANBP2;ROPN1;NUP88;MCM7;CDKN1A;PIN1;IKBKB;GLMN;NUP35;NCKAP1L
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.46413948190920434,1.224216836664404,0.16985645933014354,0.8371436408628775,1.0,17/54,17.54%,PLAGL1;CRADD;CNOT8;CHEK2;AURKA;CASP2;CCNB1;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;PIDD1;CDKN1A;CNOT4;PLK3;PCBP4
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.570213420574504,1.224089884732412,0.26339285714285715,0.8364697715297088,1.0,10/16,27.04%,PAICS;AMPD3;AMPD2;NUDT2;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,digestive tract morphogenesis (GO:0048546),0.5739275513617934,1.2238509084075433,0.24499229583975346,0.8361387859805299,1.0,4/14,7.51%,ID2;EPHB3;NIPBL;AGR2
prerank,regulation of protein sumoylation (GO:0033233),0.5559395968380606,1.22374367870909,0.24925373134328357,0.8353364484885198,1.0,3/17,8.34%,HDAC4;SAE1;EGR1
prerank,epithelial cell morphogenesis (GO:0003382),0.556523707451924,1.2234761861525887,0.23703703703703705,0.835206671947585,1.0,3/17,3.31%,MET;GRHL2;RAB25
prerank,amino acid import (GO:0043090),0.5379004542618979,1.223346553855319,0.2276064610866373,0.8345014768775829,1.0,2/21,3.81%,SLC47A1;SFXN3
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.47778652983834446,1.2227310946195042,0.20546163849154747,0.83561947218387,1.0,7/38,12.66%,THBS1;BMP5;GSK3B;FEM1B;TMC8;TRAF2;BRCA1
prerank,stabilization of membrane potential (GO:0030322),0.5681156529001421,1.222578473144289,0.25329428989751096,0.8350424764364447,1.0,1/16,0.18%,KCNK5
prerank,negative regulation of cell projection organization (GO:0031345),-0.35211895878349986,-1.222041709638433,0.11398963730569948,0.664356208575029,1.0,14/48,9.42%,EFNB2;APOE;LPAR1;SPOCK1;RAPGEF2;DCC;GRIN2B;EPHA4;MAG;RTN4RL1;PTPRO;DENND5A;YWHAH;CRMP1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.57838566217521,1.2219178994003348,0.25949367088607594,0.8362721613889714,1.0,2/13,1.74%,PERP;CYFIP2
prerank,response to interferon-beta (GO:0035456),-0.42117878132925807,-1.2213536304916786,0.19333333333333333,0.6638206947431208,1.0,11/22,19.64%,IFITM1;IFITM3;IFNAR2;NDUFA13;BST2;STAT1;AIM2;IFITM2;SHFL;CDC34;XAF1
prerank,O-glycan processing (GO:0016266),0.45804790701583287,1.2213508207406127,0.20239520958083831,0.8371218197728697,1.0,5/54,5.27%,ST3GAL4;GXYLT2;B3GNT2;GALNT15;GALNT13
prerank,regulation of pseudopodium assembly (GO:0031272),0.6010047159298015,1.2204832094089946,0.264,0.8379603575786717,1.0,1/10,0.77%,CDC42EP5
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6010047159298015,1.2204832094089946,0.264,0.8379603575786717,1.0,1/10,0.77%,CDC42EP5
prerank,negative regulation of ion transport (GO:0043271),0.5181076808397924,1.2204217780189537,0.24279835390946503,0.8370103954662566,1.0,3/24,2.10%,NEDD4;WNK1;PTK2B
prerank,positive regulation of cartilage development (GO:0061036),0.5531380091923889,1.2202582365447243,0.24550898203592814,0.8364749351646366,1.0,4/17,5.85%,BMP4;BMP1;SOX9;ZBTB16
prerank,mRNA splice site selection (GO:0006376),0.4990361918784305,1.2199573507914299,0.24166666666666667,0.8364378587068002,1.0,13/30,27.87%,CELF3;LUC7L2;SRSF5;SRSF6;CELF4;CELF1;SRSF1;LUC7L3;KHDC4;YTHDC1;PRPF39;SFSWAP;CELF6
prerank,"DNA-templated transcription, termination (GO:0006353)",0.44446146029416,1.219823646726299,0.19184652278177458,0.8358026350154769,1.0,36/68,34.15%,POLR1G;POLR1A;MNAT1;LSM11;SCAF8;TAF1D;PRMT5;POLR3K;CDK7;SSU72;GTF2H3;CPSF3;POLR1F;UBTF;MTERF2;CSTF3;CLP1;TTF1;TBP;MAZ;FIP1L1;SMN1;GTF2H4;TTF2;CSTF1;WDR33;SNRPB;ERCC2;CSTF2T;GTF2H5;NUDT21;TAF1C;GTF2H1;MED18;SNRPF;TAF1A
prerank,triglyceride biosynthetic process (GO:0019432),-0.4441942740728987,-1.2197732180175775,0.17378048780487804,0.6659831549020918,1.0,6/18,11.56%,LPGAT1;GK;LPIN3;GPAM;PCK2;DGAT1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.5061970626888591,-1.2192056939469889,0.26795580110497236,0.6651909760780191,1.0,6/11,8.91%,KDR;NDNF;GATA2;PRCP;CD34;MCAM
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5451241245156938,1.219103605241552,0.22056631892697467,0.8371693049668053,1.0,4/17,1.84%,KCNJ2;CACNA1C;CACNA1G;ANK2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.4012911355964278,-1.2189318887529355,0.17437722419928825,0.6635847107237468,1.0,11/25,20.62%,EPHA4;OPHN1;HSP90AB1;RPL11;RPS7;HIPK2;SGTA;RPL23;GABARAPL2;TAF1;ALAD
prerank,cardiac muscle cell action potential (GO:0086001),0.5027662526565028,1.2182395056545614,0.22482758620689655,0.8392127333984551,1.0,5/30,1.98%,KCNJ2;CACNA1C;CACNA1G;ANK2;ATP1B1
prerank,inositol lipid-mediated signaling (GO:0048017),0.46210970762569387,1.218031309459887,0.2046285018270402,0.8388110833098211,1.0,10/50,5.15%,PLCE1;TNFAIP8L3;PLCZ1;EZR;PIK3C2B;GAB2;NGF;PLCB3;IRS1;FGFR1
prerank,regulation of leukocyte activation (GO:0002694),-0.48008651181382683,-1.2180260011818183,0.23006134969325154,0.6638215735463212,1.0,5/14,15.88%,LYN;MFHAS1;CD200;MIF;CD74
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5883941956482183,1.2169100944925102,0.2519561815336463,0.8416405310993772,1.0,4/12,7.52%,IRS1;NR4A3;TWIST1;ABCD1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.45457879489871794,1.2168769152042704,0.2034313725490196,0.8406383772306703,1.0,33/58,30.60%,HERC2;BARD1;SMARCAL1;UIMC1;SMC5;RAD50;BRCA1;RNF8;BRCC3;PRKDC;POLB;MDC1;PSMD14;KDM2A;XRCC5;ZBTB7A;ERCC4;NBN;DCLRE1A;ABRAXAS1;ATM;XRCC4;POLM;ERCC8;POLQ;SUMO1;SETMAR;UBE2N;PAXIP1;PIAS4;RNF168;POLA1;XRCC6
prerank,negative regulation of cell adhesion (GO:0007162),-0.32262131212655315,-1.2168035997351723,0.13114754098360656,0.664823028894068,1.0,19/72,10.23%,SEMA6A;FBLN1;SPOCK1;ACER2;CDH13;RIPOR2;CORO2B;PODXL;NEXMIF;SIPA1;PLXND1;NOTCH1;JAM3;PLXNC1;ADAM22;PTPRO;NF2;ARHGDIA;SEMA5A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5046624625459724,1.2165174166316797,0.21680216802168023,0.8408079435023187,1.0,12/28,24.39%,EGFR;TCIM;WWP2;NIBAN2;NRARP;ZBTB7A;HIF1AN;DLK2;EGF;DLK1;MMP14;RITA1
prerank,regulation of glycolytic process (GO:0006110),0.44165521518150147,1.2162114460430633,0.19929660023446658,0.8407517583232607,1.0,15/68,14.40%,SLC4A4;HDAC4;PFKFB1;NUP93;NCOR1;ENTPD5;NUP214;MLXIPL;NUP153;ARNT;EIF6;NUP155;RANBP2;TIGAR;NUP88
prerank,proteoglycan metabolic process (GO:0006029),0.5022081208599104,1.216179422197345,0.2111888111888112,0.8397262262016807,1.0,8/26,11.17%,HS3ST4;FOXL1;CHST13;XYLT1;CHST11;GAL3ST4;SULF1;B3GALT6
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5736625895777725,1.216038104906469,0.2750373692077728,0.839076573092014,1.0,5/13,17.76%,RHOQ;ENTPD7;AK4;AK3;LRRK2
prerank,endoplasmic reticulum organization (GO:0007029),0.44429513287608713,1.2160112306399071,0.19607843137254902,0.8380274982109637,1.0,23/72,19.10%,ATL3;TRAM2;ATL2;SEC16A;EMD;LMAN2L;SEC31A;SEC61A1;SHTN1;MIA3;GAK;DOP1B;STX5;RTN3;SPTSSB;TMEM33;TOR1B;ATL1;BNIP1;VAMP2;TLE6;LRRK2;VCPIP1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5773204488946028,1.216000308207639,0.2539432176656151,0.8369554400522342,1.0,9/12,29.51%,NELFE;RNF8;RECQL5;HEXIM1;TCERG1;LARP7;EAPP;NELFA;RNF168
prerank,regulation of T cell cytokine production (GO:0002724),0.5683478494362422,1.215967543190256,0.2548435171385991,0.8359608536115952,1.0,6/15,17.26%,CD55;TRPM4;MAP3K7;TRAF2;TRAF6;SMAD7
prerank,regulation of striated muscle contraction (GO:0006942),-0.4002598050590471,-1.2158999330269953,0.17045454545454544,0.6650063941845065,1.0,5/27,12.14%,ATP1A2;RYR2;CALM1;SLC8A3;GRK2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3967280652383361,1.215884066527441,0.07265388496468214,0.8351328198022336,1.0,133/336,26.18%,FOXP1;TANK;EXO1;DCUN1D5;ABL1;NIPBL;NABP1;HERC2;UBR5;RAD51;CHEK2;FANCL;TICRR;SLX4;MAPK12;MNAT1;UBE2A;WAC;CASP2;BARD1;SPIDR;APEX1;IKBKG;WRN;TOPBP1;IKBKE;ZC3H12A;CBX5;CCND1;CHD1L;HELB;SMARCAL1;VCP;SMC6;PARP3;ALKBH8;CIB1;POLE2;SMC5;CEP63;PARP1;KIN;CGAS;WDR48;MCL1;ZBTB1;FBXO31;RAD50;SUSD6;POLI;NCOA6;BRAT1;RAD17;BRCA1;KMT5B;NUDT1;E2F1;TRIP12;DDX11;AATF;TIGAR;HINFP;RNF8;FBXO45;PIDD1;MCM7;UBE2B;USP28;PRKDC;SMC1A;PCLAF;FAM111A;CDKN1A;USP47;PLK3;GTF2H3;YAP1;POLB;NEK4;RECQL5;DTL;TRRAP;MCM9;MAPKAPK2;ATF2;APLF;PARP2;RMI2;VCPIP1;ATR;USP16;TLK2;PARP4;XRCC5;USP10;ERCC4;CDKN2AIP;PML;YY1;IRF3;NBN;FMR1;SPDYA;CHEK1;TAOK1;KMT5C;SPRTN;RAD52;WDR76;BOD1L1;ALKBH1;RAD51D;ATM;TP53;RBBP8;DDIT3;SLF1;ASF1A;INO80;RECQL;RAD9A;BID;CSNK1E;RAD9B;ALKBH7;ERCC8;RAD54L;MACROD2;POLK;POLQ;GTF2H4;MRNIP;TOPORS
prerank,response to organic cyclic compound (GO:0014070),0.4590329016891444,1.2157933139725234,0.20074349442379183,0.8343245869858527,1.0,7/52,5.34%,ALPL;CYP1B1;IGFBP5;ESR1;CCL3;STAT3;ANXA1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.5552648382293203,1.2156913770375248,0.2727272727272727,0.833602265425104,1.0,4/17,3.17%,SLIT2;FGF2;NRP1;VEGFA
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6116347718549042,1.2154824892661844,0.2523961661341853,0.8332488023347323,1.0,3/10,7.06%,KLF4;IRAK3;PALM3
prerank,regulation of transmembrane transport (GO:0034762),0.4914463625195902,1.2154376337000439,0.22506738544474394,0.8322940800136689,1.0,5/31,3.49%,KCNJ2;NEDD4;KCNJ15;CLTRN;WWP2
prerank,calcium ion transport (GO:0006816),0.4166322270621395,1.21537829449952,0.16868798235942667,0.8313916805363467,1.0,22/113,11.26%,SLC24A3;RAMP1;CACNA1C;PKD1;CACNA1G;ATP2C2;ANK2;CASR;CACNG6;CACNA1F;ANO6;CCL3;ORAI3;TRPM7;TRPM6;ATP2B4;CRACR2A;TRPM4;ITGAV;TRPM8;TRPC4AP;NALCN
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4808170955892114,-1.2150460182022604,0.24293785310734464,0.6626833335368112,1.0,2/12,2.09%,IGF1;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4808170955892114,-1.2150460182022604,0.24293785310734464,0.6626833335368112,1.0,2/12,2.09%,IGF1;AKAP6
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.6120149783199876,1.2149526747248856,0.24423963133640553,0.8317721553061322,1.0,4/10,11.86%,RARB;RARA;RXRA;RXRB
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.39616917124293544,-1.2149059111788696,0.2,0.6607362309958207,1.0,6/26,7.27%,ERRFI1;TGFA;APP;CBLB;SNX6;ZFYVE28
prerank,nucleic acid metabolic process (GO:0090304),0.4397840868065527,1.2148945705668084,0.20754716981132076,0.8308755294477582,1.0,18/69,18.58%,RBFOX2;NT5E;DDX24;WRN;TOPBP1;DUSP11;ATXN2;RAD50;KPNA2;HNRNPH1;WTAP;RBMX;DNASE2;HNRNPM;LSM8;RECQL5;HNRNPA2B1;POLR2C
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.40050233765440796,-1.21482962770283,0.1976284584980237,0.6586452543423925,1.0,13/28,24.38%,SIRPA;SH3KBP1;PRKCQ;TNIP2;TYROBP;CD47;NOD2;THY1;PYCARD;HSPD1;FGF10;CCL2;CYRIB
prerank,neutrophil activation (GO:0042119),0.5842702743157312,1.2146146575205883,0.2772585669781931,0.8307960387605834,1.0,1/12,1.64%,PRKCD
prerank,modification-dependent protein catabolic process (GO:0019941),0.40937977083570315,1.2145609794812209,0.12655601659751037,0.8298937129397486,1.0,55/193,19.04%,FBXL7;NEDD4;FZR1;RNF144A;FBXO10;CBLC;RNF126;UBE4B;RNF114;ANAPC5;SPSB2;UBE2A;AURKA;ADRM1;PSMD11;RNF185;ARIH1;WDR81;CUL3;ANAPC10;CDC16;UBE4A;ANAPC11;CDC20;ANKIB1;UBR4;TRPC4AP;UBE3C;MAD2L1;KEAP1;ANAPC16;HERPUD1;RNF130;RNF146;UBE2K;UBR3;TRIP12;MIB1;RNF8;FBXO45;UBE2B;RNF111;NTAN1;RNF11;CNOT4;RNF20;AREL1;RNF14;UBE2S;DTL;SMURF1;PSMD14;CHFR;COPS3;PCYOX1L
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4605209638771621,1.214441753863965,0.1980074719800747,0.8292396930725864,1.0,16/50,16.28%,GPC3;SMO;ZIC1;GLI3;GAS1;GLIS2;TEDC2;CREBBP;RORA;EVC;VCP;ULK3;KIF7;MEGF8;HHIP;DLG5
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.37365155555983864,-1.2141685258718928,0.168141592920354,0.6582696814783013,1.0,14/33,18.16%,LRRC4C;GRID2;GRIK2;NRG3;EIF4EBP2;CACNA1B;ABR;LRP8;IQSEC2;FABP5;GRIK1;RELN;NTF3;BDNF
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3927860166016301,1.2141004001556503,0.017,0.8294242893420911,1.0,185/807,17.32%,FOXP2;FOXP1;WWP1;KLF12;BMP4;ZFHX3;ZFPM2;TCF7L2;FOXD1;HES1;HDAC4;FOXP4;CUX1;RARB;TWIST2;DDX5;RBFOX2;USP2;WNT11;SAMD7;PRDM6;FOXN3;GCLC;EZR;HDAC9;SKIL;PRICKLE1;MDFI;SOX9;DMBX1;SOX14;JDP2;VEGFA;ZNF423;ESR1;ID2;ID1;WWP2;ZNF148;FOXC2;GLIS1;RARA;KLF4;GLI3;PHC2;LIMS1;TLE2;MDFIC;HDAC8;KLF7;NOG;IL33;NR4A3;TWIST1;RCOR3;NIPBL;STAT3;SHC1;FOXO3;KLF10;SPINDOC;SKI;NFIX;FRK;ZBTB16;PER1;MEF2A;DACT1;NFIL3;BMP6;PRDX5;LCOR;BHLHE40;GLI2;TCF25;L3MBTL3;GLIS2;SIRT6;NR4A2;MBD1;MIER1;CREBBP;EHMT1;CRY2;NCOR1;PHF21A;DKK3;IRF1;SMAD2;CHD3;EED;BTAF1;MLX;MLXIPL;CBX5;CCND1;NCOR2;NFIC;PER3;CIPC;KDM1A;DNMT3A;RUNX2;RXRA;MXD4;UIMC1;FOXC1;ELF3;MTA1;PDCD4;SIX4;BRMS1L;BRMS1;NSD1;TBL1X;POU4F1;PARP1;QARS1;BCOR;ARID4A;ERF;ZNF25;CREB3L1;RCOR1;MECP2;SCMH1;IGBP1;ZFPM1;ATOH8;ZBTB1;PHF12;CDKN1C;ZBTB32;NIBAN2;CDKN1B;NR2F1;MDM4;BRCA1;NR1D1;BATF3;GTF2IRD1;EZH1;DLG1;E2F1;HOXA7;MTDH;PATZ1;DMAP1;PRDM2;HINFP;SP3;ATF7IP;KHDRBS1;NR3C1;NKAP;THAP7;POU2F1;URI1;FOSB;MBTD1;UBE2D3;KAT6B;ZNF219;TRAF6;KMT5A;PAX6;MZF1;MAP3K10;PRDM5;SMAD4;FOXK1;NCOA5;USP47;ZMYM5;PLK3;YAP1;E4F1;CHD8;ESR2;VPS72;ERN2;HCFC1;RB1;SMAD7;ZBTB7B
prerank,endothelial cell development (GO:0001885),-0.41059982771339554,-1.2137964555260738,0.19202898550724637,0.657045753414623,1.0,9/25,7.74%,COL22A1;PECAM1;PPP1R16B;COL18A1;RAPGEF3;RAPGEF2;PDE4D;ROBO4;PDE2A
prerank,macrophage activation (GO:0042116),0.487648089536387,1.2137042958354625,0.22250639386189258,0.8297017077839763,1.0,7/34,12.19%,FOXP1;LBP;PLCG2;TLR1;TLR4;IFI35;CLU
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5750804548390372,1.213676630591987,0.2770167427701674,0.8287004117177268,1.0,8/14,27.04%,RFK;PAICS;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.5649887179286728,1.2134357238952347,0.23970588235294119,0.8284289768509808,1.0,4/15,9.04%,LRP6;EDA;GLI2;FOXC1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.48384167810066914,-1.212902293573407,0.2225705329153605,0.6573539719034738,1.0,4/13,7.27%,ERRFI1;CBLB;SNX6;ZFYVE28
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3415512249778367,-1.2128136998558727,0.16393442622950818,0.6553854812994311,1.0,17/56,12.19%,IL1RAPL1;TEK;GRID2;CNTNAP2;CLDN5;EPHB1;NRXN1;KDR;SYNDIG1;MAP4K4;CUX2;RAC1;SRPX2;LRRC4B;PTPRJ;PTPRD;ACE2
prerank,gliogenesis (GO:0042063),0.5614704189122174,1.2127264750951976,0.25076923076923074,0.8299228140590004,1.0,3/15,5.34%,NFIB;CD9;ANXA1
prerank,synaptic vesicle transport (GO:0048489),0.5828064027032436,1.212656593521125,0.25955414012738853,0.8290935708880172,1.0,4/11,17.62%,TMEM230;SPG11;KIF5B;SYNJ1
prerank,calcium-mediated signaling (GO:0019722),0.4197634013023866,1.2124397270485496,0.1707865168539326,0.8288769823898805,1.0,16/93,12.45%,EGFR;PLCE1;CACNA1C;PPP3CA;ANK2;ATP1B1;CCL3;PLCG2;DMTN;TRPM4;SLC9A1;RCAN1;SAMD14;MCU;NMUR2;BCAP31
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.5662814413392258,1.211397963519058,0.2585139318885449,0.8313033569433201,1.0,2/14,6.61%,CD55;TGFBR2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.413190868972704,1.2112888656939038,0.15952890792291222,0.8306089610437385,1.0,16/142,6.83%,PLCE1;SLC35G1;CACNA1C;CD55;PTGDR;ADRA1B;PLCZ1;EDNRA;CMKLR1;ESR1;CCL1;ABL1;C5AR2;ATP2B4;PROK2;PTGER1
prerank,telomere maintenance (GO:0000723),0.4550644307209323,1.2112743827802575,0.21393034825870647,0.8295773778414834,1.0,18/50,23.47%,RAD51;TEN1;APEX1;WRN;STN1;SMC6;PARP3;SMC5;PARP1;RAD50;PRKDC;ATR;XRCC5;ERCC4;ZBTB48;NBN;RAD51D;ATM
prerank,response to tumor necrosis factor (GO:0034612),0.42784124937004325,1.2112571331466635,0.20112359550561798,0.8285603406858132,1.0,16/91,12.71%,PID1;ADAM9;TANK;AFF3;YBX3;NFE2L2;CCL3;CCL1;ZFAND6;ZC3H12A;CIB1;CCL7;ERBIN;IGBP1;BRCA1;NR1D1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.30987260228240654,-1.2109471799798885,0.10891089108910891,0.6583326349559898,1.0,19/100,7.11%,FLT1;IGF1R;IGF1;PDGFD;LYN;TEK;PIP5K1B;PDGFRB;PPP1R16B;KIT;PIK3R1;DCN;KDR;INSR;ROR2;IER3;PTPN13;MAPK1;DAB2IP
prerank,neuronal action potential (GO:0019228),0.520757998603313,1.210719592524336,0.25251076040172166,0.8293523153848338,1.0,3/22,1.57%,CACNA1G;KCNMB3;KCNMB2
prerank,regulation of epidermal cell differentiation (GO:0045604),0.5357075688530559,1.2103674389227845,0.2626865671641791,0.8295693605183594,1.0,3/21,4.72%,BMP4;SFRP4;KLF7
prerank,cellular response to hydroxyurea (GO:0072711),0.6137743826367015,1.2098492875127436,0.24328593996840442,0.8302844836737523,1.0,7/10,22.05%,SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,positive regulation of DNA binding (GO:0043388),0.4918124528583452,1.2096516779277147,0.2220744680851064,0.82989036809339,1.0,12/31,21.00%,HES1;NGF;TWIST1;SKI;FOXC1;POU4F1;NIBAN2;TRAF6;RB1;PPARG;CEBPG;EGF
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.46047449586901484,1.2094663108427919,0.2176039119804401,0.8294226710442392,1.0,13/49,19.08%,THBS1;RAB7B;NR4A3;KMT2C;CIB1;EIF6;ZFPM1;PITHD1;MOV10;CNOT4;KMT2D;KMT2E;PRMT6
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4738169115204841,1.2092426098895828,0.2233375156838143,0.8291980017430002,1.0,7/44,7.26%,CDC42EP5;BAIAP2L1;PRKCE;GSN;PTK2B;NCK2;TENM1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.4538538137389554,-1.208757903886559,0.22839506172839505,0.6621845584734277,1.0,4/18,15.60%,BCL2;BCL2L1;THEM4;CAMK2A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5932902213205186,1.2079679247686739,0.2476489028213166,0.8325729937615504,1.0,7/11,32.75%,SIRT6;ATF7IP;TASOR;PPHLN1;RESF1;SETDB1;TPR
prerank,regulation of protein kinase B signaling (GO:0051896),0.4006677472538172,1.2079105861010797,0.14107883817427386,0.8316694971851881,1.0,34/193,13.46%,F3;THBS1;EGFR;TNFAIP8L3;TCF7L2;MET;NTRK3;FGF2;GAB2;PIK3AP1;IRS1;ESR1;PHLPP2;CCL3;TGFBR1;FGFR1;MYOC;ERBB2;STRN;ITGB1;KITLG;GATA4;CD80;SFRP5;PPP2R5C;CIB1;MYORG;XDH;TRAT1;DRD3;CPNE1;ITGB1BP1;RET;MTDH
prerank,DNA geometric change (GO:0032392),0.5082568971889665,1.207849713205687,0.24861878453038674,0.8307956726615497,1.0,11/24,24.42%,ANXA1;WRN;DHX36;RAD50;DDX11;RECQL5;HNRNPA2B1;MCM9;DHX9;NBN;RECQL
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.5526119496123599,1.207653354258385,0.24631268436578171,0.8304169464782576,1.0,6/14,16.62%,WNK1;ATP1B1;SLC9A1;CHP1;DMD;FXYD2
prerank,regulation of synapse assembly (GO:0051963),-0.3452744443276785,-1.2076453888684515,0.1696969696969697,0.6631151150617876,1.0,14/46,11.90%,IL1RAPL1;ROBO2;GRID2;EPHB1;NRXN1;APP;SYNDIG1;LRFN5;MEF2C;CUX2;SRPX2;LRRC4B;PTPRD;IL1RAPL2
prerank,DNA replication checkpoint signaling (GO:0000076),0.550505608994992,1.207474818784084,0.2657856093979442,0.8300015309466137,1.0,5/16,12.65%,CDC45;TICRR;TOPBP1;CLSPN;RAD17
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.5108308910119679,1.206981769547935,0.2452054794520548,0.8306131523110707,1.0,15/25,33.50%,SCAF8;WDR43;CCNT2;CCNT1;TSFM;SETD5;HMGN1;SUPT4H1;ELL;THOC1;EAF1;THOC5;HTATSF1;DDX39B;ALYREF
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5074450937064521,1.206856091550254,0.23949579831932774,0.8300107185721305,1.0,8/26,13.42%,RARA;CCL3;PTPN2;INHBA;TLR4;TCTA;ZFPM1;HOXA7
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4179407465802736,1.206535773304675,0.18151815181518152,0.8300786876704256,1.0,47/96,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,regulation of interleukin-4 production (GO:0032673),-0.4419149221491365,-1.206396784665684,0.2397003745318352,0.6641762207707833,1.0,4/21,5.74%,LEF1;SLC7A5;PRKCZ;PRKCQ
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.32823622919898604,-1.2061694193460841,0.15286624203821655,0.662604119238125,1.0,13/66,7.11%,ROBO1;FLT1;IL34;SASH1;PDGFD;PDGFRB;KIT;PAK1;FGF1;RPS3;TNFRSF11A;PIK3R6;DAB2IP
prerank,toll-like receptor signaling pathway (GO:0002224),0.4367043576458998,1.2060579844857267,0.197459584295612,0.8306930323110904,1.0,27/84,19.76%,SCARA3;LBP;PIK3AP1;PLCG2;IRAK3;TLR1;TAB3;IRAK4;IKBKG;TLR4;RIPK2;MAP3K7;TAB2;TLR8;MAP3K1;MYD88;RPS6KA3;TIRAP;UBE2D3;TRAF6;TNIP1;IKBKB;SCIMP;MAPKAPK2;TICAM1;COLEC12;CHUK
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.493959600002719,-1.2058705282157955,0.24507042253521127,0.6613013221990258,1.0,5/12,11.17%,PPARA;ABCA5;ABCG1;NR1H3;NR1H2
prerank,regulation of cellular protein localization (GO:1903827),0.4637082514491317,1.2055679789395086,0.2312579415501906,0.8313367780342434,1.0,16/45,19.10%,GPC6;GPC3;NDEL1;GBF1;SETD2;SPIDR;KDM1A;VCP;PARP1;RAB11B;GPC4;DVL1;CCDC66;PIN1;RALB;VCPIP1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3936406702495462,1.2054282281865842,0.07669021190716448,0.8307661369488741,1.0,89/341,18.97%,WWP1;FBXL7;NEDD4;FZR1;RNF144A;FBXO10;CBLC;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;RNF114;ANAPC5;SPSB2;UBE2A;RNF115;AURKA;MVB12B;ADRM1;PSMD11;FEM1B;RNF185;ARIH1;WDR81;CUL3;ANAPC10;PSMC1;VCP;MTA1;CDC16;UBE4A;PPP2R5C;ANAPC11;CDC20;KLHL22;ANKIB1;TBL1X;UBR4;TGFB1I1;RAD23B;TRPC4AP;TOM1L1;UBE3C;PSMC6;MAD2L1;KEAP1;ANAPC16;VPS37A;HERPUD1;RNF130;RNF146;UBE2K;VPS37B;UBR3;TRIP12;COP1;SPOPL;MIB1;ZRANB1;RNF122;RNF8;FBXO45;PSMD1;UBE2B;NHLRC1;UBE2D3;RNF111;PSMD4;NTAN1;RNF11;CNOT4;PTPN23;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;CHFR;COPS3;RMND5A;PSMD7
prerank,regulation of receptor recycling (GO:0001919),0.5465528379433573,1.2052375636330999,0.25801749271137026,0.8303668523411536,1.0,6/16,16.29%,ANXA2;KIF16B;ECE1;TRAT1;NSF;SCRIB
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6002240452950232,1.2051947673900498,0.2852664576802508,0.8294299577839388,1.0,2/10,2.99%,NT5C1A;NT5E
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.583950084283329,1.2051365772580918,0.24807395993836673,0.8285814634442706,1.0,5/13,18.03%,GLI3;TGFBR2;NKAP;ZBTB7B;NCKAP1L
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4919993438153942,-1.2051059654693483,0.22959183673469388,0.6612583067125501,1.0,6/12,16.15%,PLEKHH2;SEMA5A;PIK3CA;CFL2;MTPN;PLEK
prerank,cellular response to misfolded protein (GO:0071218),0.5360194426549908,1.2048609036291058,0.24962852897473997,0.8284877979577568,1.0,4/20,9.12%,RNF126;RNF185;CUL3;VCP
prerank,homeostasis of number of cells (GO:0048872),0.5770898478911891,1.2041069838173648,0.25801282051282054,0.8300822212512232,1.0,1/12,0.43%,CCN3
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.519771646089139,1.2039876352505203,0.252112676056338,0.8294343675488999,1.0,4/22,7.88%,ADAM9;PTPN3;TIMP1;TIMP2
prerank,protein homotrimerization (GO:0070207),0.5535029274247978,1.2036075780724302,0.25297619047619047,0.8287125592171195,1.0,2/14,2.21%,SCARA5;DISP1
prerank,protein trimerization (GO:0070206),0.5535029274247978,1.2036075780724302,0.25297619047619047,0.8287125592171195,1.0,2/14,2.21%,SCARA5;DISP1
prerank,stem cell development (GO:0048864),-0.45024195929663935,-1.2035675256499838,0.2476489028213166,0.6633399454199657,1.0,9/16,33.55%,CDH2;TAPT1;SNAI2;NRG1;SHH;WNT7A;NOLC1;CYP26C1;TCOF1
prerank,anion transmembrane transport (GO:0098656),0.4388962057989657,1.2034384243302039,0.21107266435986158,0.828244717129099,1.0,4/67,1.13%,SLC23A1;SLC23A2;SLC5A6;LRRC8D
prerank,gonad development (GO:0008406),-0.36254116136472464,-1.2033130207256297,0.18181818181818182,0.6618778458441383,1.0,8/41,10.09%,NR2F2;WNT4;KIT;WNT5A;MAMLD1;SALL1;GATA6;BASP1
prerank,steroid catabolic process (GO:0006706),-0.5176303151236094,-1.2029726988849934,0.25405405405405407,0.6606360853925827,1.0,2/10,9.37%,YWHAH;SPP1
prerank,positive regulation of protein modification process (GO:0031401),0.4039093945835378,1.2028475063576791,0.14507772020725387,0.8292682110137233,1.0,29/203,9.83%,BMP4;CARD14;EGFR;SLCO3A1;RAMP1;PGF;TRABD2B;NTRK3;CCN1;PRKCD;EFNA5;FGF2;NIBAN1;SOX9;KRAS;VEGFA;ABL1;FAM161A;NNMT;FAM20A;ERBB2;LIMK2;CCND1;MAVS;PTPA;CIB1;TMEM119;BRMS1;PIK3R3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4006614698644228,1.2024208561796155,0.15932914046121593,0.8296650933412452,1.0,57/173,22.55%,CD55;ANK2;ATL3;ATL2;SEC16A;SPTAN1;TMED5;GBF1;TMED3;RANGRF;COG5;LMAN2L;NRBP2;TRAPPC3L;GOLGB1;SEC31A;SEC24B;SEC23A;ARFGAP3;ARFGAP1;COPG1;CUL3;ERGIC1;COPA;MIA3;ERGIC2;SEC24D;DCTN5;DCTN4;NSF;STX5;ZW10;ARF4;BCAP31;TRAPPC11;COG8;ARCN1;TRAPPC3;COPB2;CAPZA1;GOSR2;RAB1A;GOPC;KDELR2;PROZ;COG3;VTI1A;BET1L;SPTBN1;TMED2;MPPE1;STX17;VTI1B;KDELR3;COG2;MCFD2;BET1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5252982415641703,1.2020728702416077,0.2594670406732118,0.8297702964343187,1.0,4/21,10.33%,NT5C1A;NT5E;AMPD3;XDH
prerank,positive regulation of phosphorylation (GO:0042327),0.3993285662749095,1.2019761386611574,0.12603305785123967,0.8290626005791495,1.0,36/240,9.83%,SLC4A4;THBS1;BMP4;CARD14;EGFR;SLCO3A1;MET;PGF;NTRK3;DDR2;CCN1;LMO4;EFNA5;FGF2;NIBAN1;SOX9;KRAS;NRP1;VEGFA;FZD7;ABL1;EPHB3;FGFR1;PFKFB1;FAM20A;ERBB2;ROR1;LIMK2;ENTPD5;MLXIPL;CCND1;MAVS;ARNT;CIB1;TMEM119;PIK3R3
prerank,regulation of cell cycle phase transition (GO:1901987),0.42551606607656783,1.2019605583664201,0.1926605504587156,0.8280717895717952,1.0,27/91,18.97%,FZR1;TCIM;PSMB2;ANAPC5;ATP2B4;TRIM39;PSMD11;ANAPC10;PSMC1;CDC16;CUL1;ANAPC11;CDC20;CCNB1;PSMC6;MAD2L1;FBXO5;ANAPC16;CDKN1B;PSMD1;PSMD4;CDKN1A;PSMA6;UBE2S;PSMD14;PSMD12;PSMD7
prerank,phosphate ion homeostasis (GO:0055062),0.5948481597661626,1.2018302534149399,0.2682119205298013,0.8274527183482501,1.0,2/10,3.08%,SLC34A2;SFRP4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39485297848369044,1.2018284785741085,0.08953722334004025,0.8264247174859579,1.0,59/348,12.69%,SLC38A2;F3;BMP4;SLC24A3;FOXD1;NTRK3;PID1;HOXA5;ANXA2;ANK2;WNT11;GSN;EZR;FGF2;SOX9;KRAS;PKP1;NGF;SFRP4;ITGB8;VEGFA;NFE2L2;ID2;SMO;GSK3B;KLF4;CCL3;LIMS1;PLCG2;TGFBR1;NOG;IL33;SERPINB9;TWIST1;STAT3;UBR5;EMILIN1;BMP6;ECE1;AGO2;INHBA;FN1;AGR2;ZC3H12A;TLR4;EGR1;RDX;TADA3;TMEM119;PIK3R3;POU4F1;DHX36;EPHB2;CD46;NSF;CLU;MYD88;BRCA1;CELF1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5302769989156821,1.2017875211263396,0.2633863965267728,0.8255292107424225,1.0,3/21,7.09%,ST3GAL4;FUT8;B4GALT1
prerank,positive regulation of gene expression (GO:0010628),0.3926586125444167,1.201721272680696,0.05905905905905906,0.8247241272067304,1.0,94/442,17.50%,SLC38A2;F3;THBS1;BMP4;EGFR;SLC24A3;FOXD1;NTRK3;PID1;HOXA5;DDX5;SAMD4A;ANK2;WNT11;GSN;EZR;FGF2;NIBAN1;SOX9;KRAS;PKP1;NGF;SFRP4;ITGB8;VEGFA;NFE2L2;ID2;SMO;GSK3B;KLF4;CCL3;LIMS1;U2AF2;PLCG2;TGFBR1;NOG;IL33;POLR1G;SERPINB9;TWIST1;STAT3;UBR5;EMILIN1;BMP6;POLR1A;AGO2;ERBB2;INHBA;FN1;AGR2;ZC3H12A;TLR4;EGR1;EIF3E;RDX;TADA3;TMEM119;PIK3R3;EIF6;POU4F1;DHX36;EIF2AK2;EPHB2;RBM3;CD46;TAF1D;CLU;NAT10;MYD88;BRCA1;CELF1;E2F1;DDX21;HINFP;CNTF;AFDN;PLSCR1;CIRBP;PRKDC;HOXD3;PAX6;RBMS3;SMARCA5;FLOT1;MOV10;SNF8;YAP1;GLMN;HCFC1;RPS6KB1;TENT4B;POLR1F;ZBTB7B;LARP4
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4749533450164668,1.201583511588354,0.23822341857335128,0.8241840311666534,1.0,3/35,3.03%,PCDHB16;CDH11;PCDHB9
prerank,mRNA export from nucleus (GO:0006406),0.41389018820921,1.2010995562048703,0.19609967497291442,0.8248567601137438,1.0,49/102,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;PCID2;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;ENY2;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,regulation of dendritic spine development (GO:0060998),-0.43707730769383335,-1.200997631228203,0.19805194805194806,0.6639212768908478,1.0,6/19,7.95%,APOE;SHANK3;PPFIA2;MEF2C;CPEB3;KIF1A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5120982408230216,1.2009222359132237,0.25,0.8244207644796439,1.0,11/24,19.28%,ABCG2;NFE2L1;UROS;RSAD1;COX15;FXN;SUCLA2;TSPO;PPOX;ATP5IF1;FLVCR1
prerank,response to molecule of bacterial origin (GO:0002237),0.438083631676542,1.2008412321447455,0.22247706422018348,0.8236987751548522,1.0,17/69,20.79%,FOXP1;LBP;SMAD6;CXCL2;IRAK3;PALM3;TLR4;ERBIN;TAB2;RPS6KA3;TIRAP;OTUD5;MAPKAPK2;SRR;JAK2;SLPI;FER
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4119141686646146,-1.2008059122556962,0.2152777777777778,0.6623637685915911,1.0,3/23,1.78%,ENG;NREP;TGFBR3
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5251240996286303,1.2002054741649624,0.2544704264099037,0.8248591567649006,1.0,2/20,6.90%,ADAM9;SPPL2A
prerank,ceramide catabolic process (GO:0046514),0.5574905648687742,1.1998879031371885,0.2721804511278195,0.8248612021958571,1.0,2/14,3.41%,ACER3;HEXA
prerank,SNARE complex assembly (GO:0035493),0.6058657884525686,1.199881859902664,0.28298887122416533,0.8238565837363256,1.0,4/10,17.26%,CLTRN;STXBP6;VAMP2;STXBP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.5306552753669538,1.1991536241922371,0.25,0.8254465730392133,1.0,8/20,9.77%,KCNJ2;SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,negative regulation of neuron projection development (GO:0010977),-0.3322052465217056,-1.1990275405395243,0.13253012048192772,0.6652931315729226,1.0,26/56,19.26%,EFNB2;APOE;LPAR1;SPOCK1;DCC;EPHA4;RTN4;NGEF;MAG;RTN4RL1;PTPRO;DENND5A;CRMP1;RUFY3;ARHGDIA;FKBP4;STMN2;MCF2;TRPV4;MT3;PRAG1;THY1;MYLIP;LINGO1;BCL11A;SEMA3A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.4332025058722197,1.19873400624163,0.2066590126291619,0.8259013855765706,1.0,11/76,7.26%,CDC42EP5;NTRK3;BAIAP2L1;SORBS3;PRKCE;PTK2B;NRP1;BCAS3;ABL1;NCK2;TENM1
prerank,miRNA metabolic process (GO:0010586),0.5295432565915401,1.1986992306230533,0.2611190817790531,0.8250024781334666,1.0,12/20,29.56%,DDX17;AGO2;TUT7;DGCR8;TUT4;TENT4B;TRIM71;PARN;DICER1;PRKRA;DROSHA;SND1
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.4826633123780801,-1.1986806847773606,0.2621082621082621,0.6641730060585131,1.0,4/12,11.26%,APP;CXCL12;JAM2;DOCK8
prerank,protein export from nucleus (GO:0006611),0.4937187890032856,1.1986114835623596,0.24794520547945206,0.8243021462327311,1.0,12/27,18.27%,PKD1;STRADA;NUP214;RANBP3;XPO1;DESI1;XPO4;CHP1;NUTF2;XPO7;CSE1L;SMURF1
prerank,regulation of histone deacetylation (GO:0031063),0.5711359821332458,1.1982677892448286,0.26275115919629055,0.8244364370475384,1.0,5/13,19.08%,CAMK2D;NIPBL;SAP30BP;ZBTB7B;PRMT6
prerank,RNA 3'-end processing (GO:0031123),0.43323486448317916,1.1977613183477245,0.19358669833729217,0.8251506067425064,1.0,23/69,23.79%,SRSF11;U2AF2;THOC2;SRSF5;TUT7;SRSF6;TUT4;CDC40;SRSF2;TENT2;SRSF1;RNPS1;CPSF3;CHTOP;TENT4B;CSTF3;SARNP;CLP1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5576391320036006,1.197568301714572,0.26548672566371684,0.8248389996535357,1.0,5/15,18.55%,LARGE1;RENBP;CHST5;OGA;GNPDA1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.48912512918169604,1.197567540265747,0.2313937753721245,0.8238306415214052,1.0,6/29,13.51%,SLC4A10;ACP4;ZDHHC2;EPHB2;NSMF;DBN1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.40514698735066323,1.197513589242834,0.15154749199573106,0.8230112662467357,1.0,37/145,20.40%,FBXL7;FHL1;PSMB2;PCM1;AURKA;PAFAH1B1;PSMD11;CEP43;CCND1;AKAP9;PSMC1;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;MECP2;PSMC6;PCNT;FBXO5;PSMD1;OFD1;PSMD4;CDK2;CDC7;USP47;PSMA6;DTL;CEP164;PSMD14;PSMD12;CETN2;PSMD7;BRD4;RAB11A;SFI1
prerank,superoxide metabolic process (GO:0006801),0.4924330110153432,1.1974826093689408,0.24279835390946503,0.822112467253089,1.0,1/29,0.13%,SH3PXD2A
prerank,microglial cell activation (GO:0001774),-0.4173314071904819,-1.197481119057447,0.21299638989169675,0.6654944564930985,1.0,10/21,24.13%,APP;MAPT;C1QA;IFNGR1;CX3CL1;TYROBP;GRN;SNCA;AGER;TREM2
prerank,myotube cell development (GO:0014904),0.6004233601043942,1.1973321384164584,0.28125,0.8216840972412616,1.0,3/10,9.95%,SIX1;SKI;MYORG
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.42632868738651286,1.1973164549173108,0.19885714285714284,0.8207472604560117,1.0,16/78,16.26%,EGFR;PKD1;CCNA2;MNAT1;CCND1;CDKN2C;CCNB1;CCNYL1;CDKN1C;IPO7;CDKN1B;CDKN3;CCNG1;CDK7;CCNT2;CDKN1A
prerank,urogenital system development (GO:0001655),0.5789684312446267,1.1972532065054375,0.2721804511278195,0.8199835624375192,1.0,4/11,11.41%,SOX9;EPHB3;ANXA1;EPHB2
prerank,"wound healing, spreading of cells (GO:0044319)",0.5187029618470758,1.1971136742956376,0.25738396624472576,0.8194304310843137,1.0,5/24,10.43%,TMEFF2;CCN1;MRTFA;CD44;RHOA
prerank,myelination in peripheral nervous system (GO:0022011),0.5691232835036953,1.1969358221844608,0.27202472952086554,0.81904295583171,1.0,4/13,12.46%,NF1;SKI;MYOC;PARD3
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5849459112688755,1.1965420457834912,0.2857142857142857,0.8194035077661107,1.0,3/10,9.14%,ANXA2;NELL1;RGP1
prerank,sensory perception (GO:0007600),-0.35277282977785185,-1.1963433714156764,0.1651376146788991,0.6663847054500687,1.0,24/45,28.95%,RETREG1;ADGRV1;PCDH15;MME;ADORA2A;TRPV2;P2RX7;TMEM150C;SCN9A;WHRN;OPRM1;TTC8;TRPA1;USH2A;KCNA2;PENK;CHRNA4;NTSR2;CCL2;KCNK4;CHRNB2;ALOXE3;CLRN1;PNOC
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3803760352427596,-1.1962948356729861,0.2109090909090909,0.6643668239936413,1.0,5/29,8.78%,ENG;TGFBR3;NOTCH1;PROX1;BMP2
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5411046401259112,1.1954168852065652,0.2673559822747415,0.8222292616293143,1.0,2/17,2.18%,PCSK5;HDAC9
prerank,regulation of gene expression (GO:0010468),0.3863961455398563,1.195290579051082,0.019,0.8216944167474082,1.0,207/903,19.03%,SLC38A2;BNC2;F3;FOXP1;VSX1;SIX1;BMP4;ZFHX3;TCF7L1;SLC24A3;PRRX2;AHNAK2;MBNL1;FOXD1;HDAC4;NTRK3;CDH1;PID1;HOXA5;AFF3;ANK2;WNT11;PRDM6;GSN;ATP1B1;FOXN3;EZR;NFIA;AHNAK;FGF2;JMJD1C;ERC1;SOX9;KRAS;PKP1;NGF;SOX14;YBX3;SFRP4;NELL1;ITGB8;VEGFA;ZNF423;ESR1;NFE2L2;BMPR1A;ID2;WWP2;SMO;ZNF148;CLK2;COQ7;CLK1;GSK3B;FZD7;NOTCH2;KLF4;CCL3;LIMS1;PLCG2;SON;TGFBR1;ABL1;PTHLH;NOG;IL33;SERPINB9;TWIST1;AFF4;C1D;STAT3;ZC3H7A;UBR5;CHEK2;EMILIN1;USP13;PER1;ATP2B4;NFIL3;TSKU;BMP6;BHLHE40;HMG20A;AGO2;TCF19;REL;INHBA;AURKA;CREBBP;RORA;SERTAD3;TDRD7;CDK11B;FN1;AGR2;TRIM39;CHD3;ZC3H12A;MLX;MLXIPL;GPBP1;TLR4;EGR1;GATA4;NLK;RDX;FOXC1;MTA1;TADA3;ZFP64;TMEM119;PIK3R3;ANXA7;ATF7;NSD1;XDH;POU4F1;ANKRA2;DHX36;CREB3L1;DENND4A;MECP2;POGZ;ATOH8;EPHB2;TRIM44;CD46;PHF12;CLK4;CLU;MYD88;NFXL1;APBB3;BRCA1;POFUT1;CELF1;HMG20B;FUS;CPNE1;HNRNPH1;GTF2IRD1;RRP1B;E2F1;PRMT5;NFYA;PATZ1;PRDM2;RFXANK;HINFP;SP3;MSL3;ATRX;CNTF;NR3C1;NKAP;THAP7;AFDN;PLSCR1;DVL1;SNRNP70;TOB2;KAT6B;ZNF219;HOXD3;MEGF8;EFEMP1;PAX6;RBMS3;CDK2;MZF1;MOV10;GDNF;PRDM5;PIN1;MBNL2;SNF8;PRDM10;YAP1;ESR2;GLMN;SNX12;HCFC1;KMT2D;RB1;ASCC2;ZBTB7B;RNF20;LARP4;PCBP4;RNF14;NUP35;TAF5;TRRAP;TOB1;ACTR5;ATF2;PRDM4;BRCA2;TICAM1;CCN4;PUM2;PRDM11;NONO;GON4L;IGF2BP3;NFX1;ZUP1
prerank,substrate-dependent cell migration (GO:0006929),0.5601020710026388,1.1951907800609163,0.2731411229135053,0.8210327326033748,1.0,4/14,12.97%,NTN1;NRP1;SHTN1;ITGB1BP1
prerank,cAMP biosynthetic process (GO:0006171),-0.5182201597780456,-1.1950685205018639,0.24661246612466126,0.6657496076790661,1.0,3/10,5.92%,ADCY5;ADCY1;ADCY7
prerank,negative regulation of secretion by cell (GO:1903531),-0.3638039008862514,-1.1949910808960307,0.18636363636363637,0.6638427777541795,1.0,9/38,13.15%,GRM7;IL1RAPL1;APOE;NOTCH1;SYT4;SYT11;SLC30A1;CHGA;RHBDF2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.442442457572375,-1.1948647811188533,0.22151898734177214,0.6621428293150866,1.0,4/18,5.75%,FLT1;COL4A3;AKT3;MEF2C
prerank,purine-containing compound biosynthetic process (GO:0072522),0.508010919750889,1.1948193038217576,0.2637215528781794,0.8212745751040207,1.0,9/25,23.13%,PRPS2;ADA;PAICS;AMPD3;DGUOK;GMPR2;AMPD2;GMPS;ADSL
prerank,recombinational repair (GO:0000725),0.4250900893096455,1.1943345082353816,0.20813953488372092,0.82194190954565,1.0,30/77,25.86%,REV3L;ERCC5;NABP1;RAD51;SLX4;SPIDR;WRN;SMC6;SMC5;PARP1;NSMCE1;RAD50;RNF138;BRCA1;MORF4L1;RECQL5;MCM9;BRCA2;PSMD14;ERCC4;YY1;NBN;AP5Z1;RAD52;RAD51D;RBBP8;INO80;RECQL;KDM4D;POLQ
prerank,NIK/NF-kappaB signaling (GO:0038061),0.43490653810682295,1.1941956408617358,0.21301775147928995,0.8214306550711576,1.0,23/72,21.15%,CARD14;PSMB2;REL;PSMD11;PSMC1;CUL1;MAP3K7;PSMC6;TRAF2;TIRAP;PSMD1;TRAF6;PSMD4;MAP3K14;PSMA6;COPS8;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;NFKB2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.32671065792486226,-1.1939397832441783,0.15527950310559005,0.6626690828207146,1.0,9/66,3.88%,ROBO1;MCC;MTSS1;PTPRM;NR2F2;APOE;TGFBR3;B2M;CDK6
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.4001002938437469,-1.1939231767121326,0.2049469964664311,0.6606058150979839,1.0,9/23,15.82%,CEMIP;APP;BMP7;MAPK1;CALM1;SPHK1;WNK3;PRKAG2;STOX1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.5122864379967471,1.1935622632538676,0.25504322766570603,0.8225516089716086,1.0,5/22,11.07%,ESR1;MED13;MED24;DHX36;PSMC6
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5395565248418481,1.1934456713581567,0.26725403817914833,0.8219692847168658,1.0,5/19,4.74%,ZFPM2;FGF2;BMPR1A;TGFBR1;NOG
prerank,ether lipid metabolic process (GO:0046485),0.554683882444966,1.193242097217966,0.26656626506024095,0.8216972939186586,1.0,6/14,13.45%,NCEH1;AGPS;PAFAH1B1;AGMO;GNPAT;PEDS1
prerank,negative regulation of interleukin-8 production (GO:0032717),0.5416479278214588,1.1929008245243855,0.28193832599118945,0.821883359811823,1.0,3/17,5.34%,ANXA4;KLF4;ANXA1
prerank,regulation of mRNA metabolic process (GO:1903311),0.5906065048597212,1.192589086512662,0.267741935483871,0.8219807513651569,1.0,2/11,7.36%,SLTM;CDK11B
prerank,positive regulation of axon extension (GO:0045773),0.5123638674976132,1.1923961039485453,0.2618343195266272,0.8216215979497863,1.0,7/22,17.38%,NTN1;NRP1;VEGFA;SHTN1;DBN1;MEGF8;GOLGA4
prerank,negative regulation of axon extension (GO:0030517),-0.3840957876200295,-1.192165704781175,0.17796610169491525,0.6632982867460862,1.0,17/30,20.82%,SEMA6A;MAP2;SEMA7A;SEMA6D;RTN4;MAG;SEMA3B;SEMA5A;SEMA3G;SEMA5B;MT3;SEMA6B;TRIM46;SEMA4G;SEMA3A;SEMA3F;SEMA4D
prerank,DNA metabolic process (GO:0006259),0.3906219566130942,1.191822732380452,0.1079429735234216,0.8226113131294999,1.0,91/270,26.51%,TCF7L2;NT5E;EXO1;MPG;ERCC5;NABP1;CDC45;MCM2;RAD51;FANCL;SMUG1;TICRR;SLX4;MNAT1;UBE2A;BARD1;APEX1;WRN;TOPBP1;CHD1L;HELB;SMARCAL1;STN1;VCP;TOP1;PARP3;PRIM1;NEIL3;POLE2;PARP1;NUDT15;ZBTB1;RAD50;ORC3;POLI;KPNA2;RAD17;BRCA1;KMT5B;NUDT1;RNASEH2A;DDX21;HINFP;PRIMPOL;PRIM2;MCM7;UBE2B;DNASE2;PRKDC;SMC1A;CDK2;CDC7;GTF2H3;POLB;RECQL5;TRRAP;PARP2;RMI2;POLA2;RFC1;ATR;PARP4;XRCC5;ERCC4;NBN;CHEK1;KMT5C;SRPK2;RAD52;ALKBH1;RAD51D;ATM;RBBP8;USP7;ASF1A;UBB;INO80;RECQL;RAD21;RAD9A;TDG;CSNK1E;CDC6;RAD9B;RAD54L;UBA52;POLK;POLQ;GTF2H4;RPS27A;NEIL1
prerank,mitotic recombination (GO:0006312),0.5449085389131979,1.1917293291152047,0.2727272727272727,0.8219572113802248,1.0,6/15,23.41%,RAD51;SMC6;SMC5;RAD50;RAD52;RAD51D
prerank,aromatic amino acid family metabolic process (GO:0009072),0.5926589409108639,1.1909466175204466,0.273015873015873,0.8236899461932865,1.0,1/10,1.78%,IYD
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.4418990605585034,1.1902668981232791,0.22981366459627328,0.8250136772114545,1.0,14/52,14.14%,EGFR;PRKCE;LRP1;RANGRF;ACSL3;ATP2B4;PLS1;ZDHHC2;AGR2;ITGB1;CIB1;EPHB2;DLG1;PTPN9
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5689304193246365,1.1900318218945578,0.29376854599406527,0.8247718551569133,1.0,5/13,19.18%,SAE1;DESI1;DESI2;UBA5;UBA3
prerank,phospholipid biosynthetic process (GO:0008654),0.46930056264500536,1.1896436796658094,0.26666666666666666,0.8251514729579057,1.0,10/36,12.86%,DHDDS;SGMS2;MBOAT1;LPCAT1;DPAGT1;HDHD5;PIP5K1A;AGK;GNPAT;CPNE1
prerank,RNA export from nucleus (GO:0006405),0.4093967610104846,1.1894938525018408,0.1956521739130435,0.8246849940031467,1.0,47/100,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,protein localization to kinetochore (GO:0034501),0.5603373182618447,1.1894424492492748,0.2773497688751926,0.823878831418306,1.0,8/14,27.57%,TTK;CENPT;ZW10;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,negative regulation of ossification (GO:0030279),0.5007101192932256,1.1892403548461334,0.28372739916550765,0.8235881378375073,1.0,6/23,10.56%,SMAD6;PTK2B;SOX9;CCL3;TRPM4;BCOR
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4394705910444039,-1.189234817195904,0.1903323262839879,0.6692488004981137,1.0,3/18,1.73%,PRKCB;SLC2A1;OCLN
prerank,positive regulation of glucose metabolic process (GO:0010907),0.558320407396149,1.1891880733215212,0.2797527047913447,0.822817382732376,1.0,3/14,5.71%,IRS1;PTPN2;NNMT
prerank,cilium organization (GO:0044782),0.39432020003149837,1.188242944681632,0.1533678756476684,0.825043917069837,1.0,67/209,22.22%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PTPDC1;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;CFAP43;EHD2;IFT52;MAK;DYNC2I2;TSGA10IP;ARL3;PLK4;RFX2;PCNT;GALNT11;KIF3B;ARF4;OCRL;DISC1;EXOC7;EHD1;DYNC2I1;ROPN1;TMEM231;CEP19;TRAPPC14;OFD1;ATAT1;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;PTPN23;CEP164;MKKS;ATP6V0D1;CLUAP1;IQCB1;NUDCD3;RAB11A;LZTFL1;HYLS1;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2;DYNC2H1;TCTN1;ARMC2
prerank,regulation of vacuole organization (GO:0044088),0.5153697553701383,1.1879009917602867,0.27375886524822696,0.8252146421083774,1.0,3/20,4.87%,ANXA2;NPRL3;SCARB2
prerank,positive regulation of ossification (GO:0045778),0.4617466312021815,1.187687530639809,0.24643320363164722,0.8249522740575821,1.0,8/39,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;ZBTB16;BMP6
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5966655026299189,1.1875029989833754,0.2993527508090615,0.8245943500422349,1.0,4/10,1.91%,STK39;NEDD4;CAMK2D;PRKCE
prerank,arachidonic acid metabolic process (GO:0019369),0.46764283123780204,1.1872466482698913,0.25432756324900135,0.8244934254163929,1.0,5/35,5.09%,MGLL;CYP1B1;PTGIS;CYP2S1;PTGES2
prerank,regulation of cytokinesis (GO:0032465),0.42388752575687805,1.1868833287272254,0.21305841924398625,0.8248049545230987,1.0,28/78,25.26%,CIT;PRKCE;GIPC1;KIF13A;SETD2;CDC14A;AURKA;RAB11FIP3;BECN1;CUL3;AHCTF1;RHOA;PLK4;DRD3;SH3GLB1;ZFYVE19;PIN1;CXCR5;PLK3;CETN2;RAB11A;BIRC6;KIF23;CALM2;ENTR1;PKN2;PDXP;CDC6
prerank,barbed-end actin filament capping (GO:0051016),0.5372784005761871,1.1866444021530922,0.2727272727272727,0.8236874560539186,1.0,4/18,7.03%,VILL;GSN;ADD3;FLII
prerank,actin filament capping (GO:0051693),0.5372784005761871,1.1866444021530922,0.2727272727272727,0.8236874560539186,1.0,4/18,7.03%,VILL;GSN;ADD3;FLII
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.54084448637816,1.1863068663251357,0.27522935779816515,0.8237910879390483,1.0,6/16,19.64%,RAET1E;PLEKHM2;LYST;KIF5B;VAMP2;CEBPG
prerank,regulation of muscle contraction (GO:0006937),0.5054970131106983,1.1861508784542891,0.27900552486187846,0.8233651055600292,1.0,3/26,4.23%,KCNB2;PLCE1;PPP1R12B
prerank,inner ear morphogenesis (GO:0042472),0.5132686197297852,1.1860500040273851,0.25604551920341395,0.8227634717932735,1.0,5/22,11.41%,SIX1;SOX9;ZIC1;POU3F4;EPHB2
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.5149643876091763,1.1859869608196631,0.27615062761506276,0.8220314978970744,1.0,11/21,25.90%,SAMD4A;CNOT8;TUT7;TUT4;TNKS1BP1;CNOT4;SAMD4B;CNOT1;CNOT11;PAN3;PARN
prerank,heart trabecula morphogenesis (GO:0061384),-0.4352541815815295,-1.1858936130673112,0.25688073394495414,0.6765920288250157,1.0,7/18,6.27%,ENG;TEK;TGFBR3;RBP4;RBPJ;BMP7;NOTCH1
prerank,endocardial cushion development (GO:0003197),0.5144260576707936,1.1858379785163433,0.26483357452966716,0.82156087703359,1.0,7/21,13.65%,BMP4;SOX9;BMPR1A;NOG;GATA4;MDM4;ACVR1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4382495598150752,1.1855910693333225,0.2266355140186916,0.821462183514874,1.0,16/64,13.42%,THBS1;SEMA3E;PTK2B;EFNA5;GSK3B;NF1;MYOC;PTPRA;VCL;CORO1C;CIB1;SLC9A1;RHOA;JUP;JAG1;HOXA7
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.48876507607596736,1.1855773564938883,0.25869262865090403,0.8205678193636332,1.0,4/29,13.02%,THBS1;INHBA;TRAF2;RET
prerank,dorsal/ventral pattern formation (GO:0009953),0.5271955787541495,1.1854049301788825,0.27050359712230215,0.8202140987253005,1.0,5/20,6.46%,MDFI;BMPR1A;NOG;NBL1;GLI2
prerank,carnitine metabolic process (GO:0009437),0.571504242076469,1.1847271114685385,0.27416798732171155,0.8214481419528489,1.0,9/12,27.10%,TMLHE;CPT1B;CPT1C;ACADL;CROT;CRAT;ACADM;SHMT1;CPT1A
prerank,termination of RNA polymerase I transcription (GO:0006363),0.4793908424579281,1.1837317697371454,0.25371120107962214,0.8237423020626983,1.0,10/30,22.37%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF;TTF1;TBP
prerank,regulation of hippo signaling (GO:0035330),0.523198501397313,1.1836161489347923,0.28695652173913044,0.8231784595584285,1.0,2/17,1.26%,CIT;MOB3B
prerank,cellular response to estrogen stimulus (GO:0071391),0.5578297803129247,1.1834016704694863,0.29102167182662536,0.8229911779784316,1.0,3/14,4.97%,RARA;BCAS3;SERPINB9
prerank,sensory organ development (GO:0007423),0.4437304949826799,1.1829521623356833,0.24447174447174447,0.8235749368805595,1.0,9/51,12.37%,PBX3;SMOC1;PBX1;HIPK1;ECE1;FOXC1;SIX4;ATF6;SCO2
prerank,GTP metabolic process (GO:0046039),0.5442959593995327,1.1827762861207363,0.29850746268656714,0.8232201980676732,1.0,5/15,17.76%,RHOQ;ENTPD7;AK4;AK3;LRRK2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.45702276585987867,1.1826452591379413,0.23172242874845106,0.8227129718120768,1.0,8/48,5.34%,THBS1;RHOJ;HDAC9;FGF2;VEGFA;FOXC2;FGFR1;ANXA1
prerank,positive regulation of vacuole organization (GO:0044090),0.5813590317238347,1.1826386726575273,0.2816,0.821786971260337,1.0,6/10,24.14%,ANXA2;SH3GLB1;PIP4K2A;RALB;LRSAM1;RAB3GAP1
prerank,chloride transmembrane transport (GO:1902476),0.4570038466383753,1.1821060379569763,0.23833543505674654,0.8226475266530694,1.0,6/48,4.12%,SLC12A7;SLC12A2;ANO9;GABRA3;ANO6;GLRB
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5894114268776796,1.1820196048055152,0.2846153846153846,0.821995710278243,1.0,6/10,26.46%,TUT7;TUT4;CHFR;UBB;UBA52;RPS27A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.40292684520028127,1.1818554465335394,0.19656283566058003,0.8216297788412482,1.0,17/140,8.89%,PLCE1;CACNA1C;CD55;PTGDR;ADRA1B;PLCZ1;EDNRA;CMKLR1;ESR1;CCL1;ABL1;C5AR2;PROK2;GPR65;PTGER1;TRPM4;GPR4
prerank,cellular response to interleukin-15 (GO:0071350),-0.46644971802476864,-1.1812639730467496,0.22910216718266255,0.6852935038576548,1.0,2/13,3.72%,PLCB1;IL15RA
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.46644971802476864,-1.1812639730467496,0.22910216718266255,0.6852935038576548,1.0,2/13,3.72%,PLCB1;IL15RA
prerank,Golgi organization (GO:0007030),0.4072492213851108,1.1807852904706622,0.21397379912663755,0.8241965924814584,1.0,42/112,22.55%,ATL3;ARHGAP21;GORASP2;BCAS3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;RAB43;LMAN2L;GOLGB1;CSNK1A1;PLEKHM2;GAK;FBXW8;SEC23IP;STX5;ZW10;TRAPPC11;PRMT5;GOSR2;GOLPH3;ARFGEF1;RAB1A;PLK3;SURF4;LRRK2;BAG5;COG3;UBXN2B;ATP8B4;VCPIP1;VTI1A;TMED2;STX17;GOLPH3L;VTI1B;DYNC2H1;COG2;BET1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.42129584728971015,1.1804360507068539,0.22753792298716452,0.8244333820136347,1.0,30/80,24.03%,SGSM2;SNX2;ERC1;RNF126;RAB7B;GBF1;RAB6A;PHETA2;RGP1;SNX32;STX5;EVI5;TRAPPC10;GOSR2;SNX8;UBE2O;SNX12;ANKFY1;SURF4;TBC1D5;TBC1D17;VPS52;VTI1A;BET1L;VTI1B;TBC1D23;GCC2;TMEM87A;VPS54;RIC1
prerank,protein import into nucleus (GO:0006606),0.4305122255482707,1.1804170889284251,0.24675324675324675,0.8235693607985587,1.0,19/66,17.81%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;NUP153;TNPO2;RGPD1;KPNA1;TNPO3;IPO7;NUP155;KPNA2;RANBP2;NUTF2;NUP88;KPNA4;CSE1L;NUP35
prerank,protein targeting to lysosome (GO:0006622),0.5169459512914403,1.1803512009624746,0.29985855728429983,0.8228419517812847,1.0,6/20,17.13%,NEDD4;SCARB2;CLU;AP3M1;SORL1;GNPTAB
prerank,cellular metal ion homeostasis (GO:0006875),0.4088450756737209,1.1801024549466672,0.19933554817275748,0.8227645127691006,1.0,22/102,13.14%,KCNJ2;SLC12A2;SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;SLC10A7;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;CCL7;DRD3;SLC8B1;CTRC;NPTN
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4407101116497186,-1.1800147873699471,0.24458204334365324,0.6868456654934969,1.0,7/15,15.43%,LPGAT1;PPARA;NR1H3;PPARGC1A;PPARD;NR1H2;MID1IP1
prerank,epithelial cell-cell adhesion (GO:0090136),0.5796813609644252,1.179983994196662,0.2796352583586626,0.8222061588574919,1.0,5/11,11.81%,CCN3;ITGB5;DSP;VCL;JUP
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5550044016356239,1.1797225885878504,0.2824773413897281,0.8221789333710434,1.0,7/14,16.49%,EZR;SYNE4;PATJ;RHOA;MYO9A;SCRIB;CAMSAP3
prerank,peptidyl-serine modification (GO:0018209),0.3963244033252349,1.1791575081925805,0.16877637130801687,0.8231621753232987,1.0,50/166,20.09%,STK39;PKD1;MARK1;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;TLK1;GSK3B;MBOAT4;HIPK1;TGFBR1;GALNT13;VRK3;MAPK12;TGFBR2;AURKA;IKBKE;CSNK1A1;MAST2;TOP1;CLSPN;TTK;PARP1;PDK3;CSNK1G3;POGLUT3;CAB39;ULK3;SGK3;RPS6KA3;MARK2;CSNK1G1;MORC3;PRKCA;MARK3;PRKDC;CDK2;CDC7;MAP3K10;IKBKB;RPS6KB1;LRRK2;MAPKAPK2;PARP2;ATR;TLK2;CHUK;NEK6
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3681167341627258,-1.1788728141135363,0.22466960352422907,0.6881959013111545,1.0,17/36,26.50%,WNT5A;CSF1;CASP4;PARP14;AXL;EDN1;GAS6;CD74;NLRC5;HIF1A;HSPA1A;ZBP1;CASP1;IL7;CD300LF;FADD;C1QTNF4
prerank,catecholamine metabolic process (GO:0006584),0.5624544624840274,1.1785055150299182,0.26777609682299547,0.8243537390937088,1.0,3/14,14.57%,SNCAIP;DRD3;LRTOMT
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5643527709212471,1.1783884214417115,0.29339477726574503,0.8238201167534608,1.0,3/13,3.28%,ZFPM2;FGF2;BMPR1A
prerank,negative regulation of catabolic process (GO:0009895),0.44499543539791764,1.1783764009217654,0.2572877059569075,0.8229292061126113,1.0,12/47,18.62%,EGFR;HDAC4;IRAK3;PFKFB1;NCOR1;MAD2L1;MDM4;TIGAR;AZIN1;PIN1;SNX12;HMGCR
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.595121123808044,1.1778660847923261,0.3074484944532488,0.8236289015275532,1.0,4/10,18.03%,CD55;TGFBR2;ZBTB7B;NCKAP1L
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5648681171250037,1.177690464236788,0.2981366459627329,0.8232163703910134,1.0,5/12,14.79%,NIN;PCM1;HOOK3;BICD1;CEP19
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3148576434481908,-1.1776899575227098,0.11904761904761904,0.689259207259366,1.0,20/75,12.24%,DCDC2;ANK3;CTNNA2;MAP2;APP;CNTN4;DCC;PAK3;DSCAML1;BAIAP2;RYK;ACTB;MEF2C;ZDHHC17;OPHN1;LMTK2;PLPPR4;SPTBN4;MAP1A;SLITRK5
prerank,ameboidal-type cell migration (GO:0001667),0.4441408684376208,1.1775199747219167,0.24129651860744297,0.8229231041816981,1.0,9/51,8.58%,CCN3;FAT2;SEMA3E;GPC3;SRGAP2;SEMA3C;SEMA3D;PDXDC1;CORO1C
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.41696166025982834,1.177367950015996,0.22359550561797753,0.822483880938349,1.0,18/87,8.70%,SEMA3E;PRKCD;RHOBTB1;EZR;PTK2B;EFNA5;ARHGDIB;CDK10;NOTCH2;ABL1;ARHGAP44;LRP1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3
prerank,wound healing (GO:0042060),0.4441051015635269,1.1772647425728426,0.25211097708082025,0.8219366571320867,1.0,14/62,9.51%,AHNAK2;PPP3CA;FGF2;COL3A1;DSP;SYTL4;FZD7;TGFBR1;NOG;NF1;TSKU;ERBB2;GATA4;MIA3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4975876792633729,-1.1772263540402572,0.25067385444743934,0.6884255604484151,1.0,2/11,1.42%,LYN;MFHAS1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.459259820832963,1.177163231929147,0.27284595300261094,0.8213668473862641,1.0,11/38,18.67%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;SH3GLB1;SREBF1;UBE2D3;UBL5;LRRK2;ATP5IF1
prerank,error-prone translesion synthesis (GO:0042276),0.5122687136569359,1.1771493759676936,0.3066104078762307,0.8204947404331685,1.0,9/21,26.46%,REV3L;POLE2;POLI;PRIMPOL;RFC1;UBB;UBA52;POLK;RPS27A
prerank,atrial septum morphogenesis (GO:0060413),0.5745296863738749,1.1770907798609425,0.292259083728278,0.8197909132698081,1.0,4/10,13.65%,NOTCH2;GATA4;ZFPM1;ACVR1
prerank,tRNA wobble base modification (GO:0002097),0.5469653326867632,1.176881989429873,0.28414442700156983,0.8196142072542982,1.0,4/14,9.90%,ELP3;DPH3;ALKBH8;MTO1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.5385878662614622,1.176857296308704,0.27802690582959644,0.8187627870507356,1.0,7/16,17.63%,NIPBL;DSCC1;POGZ;SMC1A;RB1;RAD21L1;REC8
prerank,DNA modification (GO:0006304),0.5077980984273756,1.1762425499270914,0.2808988764044944,0.8198912267169338,1.0,6/22,11.97%,MPG;SMUG1;PARP3;NEIL3;PARP1;EXOSC3
prerank,regulation of signal transduction (GO:0009966),0.3970302828979937,1.1759820860664865,0.1671858774662513,0.8198163783579023,1.0,34/190,12.97%,RSPO3;PLCE1;TCF7L1;UBASH3B;MGLL;CD55;GRK5;IGFBP5;FOXL1;LRIT3;SRMS;ESR1;ZIC1;ELF1;TIMP1;GAS1;MDFIC;PTPN2;NCK2;NLRP12;CREBBP;RORA;SULF1;GRK4;CD80;RGS6;GALNT11;CD46;DHRS3;CLU;SYNJ2BP;POFUT1;IGFBP6;ITGB1BP1
prerank,regulation of nuclear division (GO:0051783),0.5109165343392735,1.1758161347348042,0.2915451895043732,0.8194615285252562,1.0,9/20,27.64%,CCDC8;CDK13;FBXO5;PRMT5;PIN1;BORA;PDXP;CUL7;KIF20B
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.36587312230984004,-1.17577736411006,0.2151394422310757,0.6904403188125802,1.0,3/33,3.58%,IL34;LEF1;CSF1
prerank,microtubule polymerization (GO:0046785),0.4839388553575435,1.1756510003271505,0.2766531713900135,0.8190771222361996,1.0,8/28,16.61%,FGF13;MAP7D3;NDEL1;AKAP9;HDGFL3;TUBGCP6;TUBGCP2;PIN1
prerank,natural killer cell mediated immunity (GO:0002228),0.5374740429875637,1.1755591380362636,0.2870229007633588,0.8184185152975496,1.0,5/15,19.64%,RAET1E;PLEKHM2;LYST;KIF5B;CEBPG
prerank,epithelial to mesenchymal transition (GO:0001837),-0.3469822356749284,-1.1753626361872098,0.2127659574468085,0.6895428592101708,1.0,14/47,8.78%,LEF1;WNT4;ENG;TGFBR3;WNT5A;ROCK2;TBX3;RBPJ;BMP7;NOTCH1;LOXL3;NOTCH4;HEY2;BMP2
prerank,regulation of complement activation (GO:0030449),0.45783938463351254,1.1753457379231007,0.2705128205128205,0.8182704981513491,1.0,8/40,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.3447736612856046,-1.1752639032022536,0.19047619047619047,0.6877128328612151,1.0,10/40,10.06%,TCF4;ZEB1;BRINP3;MEF2C;GPRC5B;PROX1;BMP2;BRINP1;MMD2;ZC4H2
prerank,positive regulation of translation (GO:0045727),0.41303488069386785,1.1752465660100142,0.2330316742081448,0.8176960192107858,1.0,24/94,20.27%,THBS1;SAMD4A;NIBAN1;YBX3;AGO2;ERBB2;EIF3E;MRPS27;CDC123;RPUSD4;EIF6;DHX36;JMJD4;RBM3;NAT10;KHDRBS1;CIRBP;PRKDC;RPS6KB1;LARP4;DHX9;USP16;FASTKD3;LARP4B
prerank,mitochondrion morphogenesis (GO:0070584),0.5838957048458976,1.173885366093977,0.2836990595611285,0.8212606645750186,1.0,1/11,1.27%,PID1
prerank,regulation of macrophage activation (GO:0043030),0.4789936770893628,1.1734320350411196,0.26366120218579236,0.8218532687723958,1.0,5/30,8.34%,THBS1;LBP;IL33;ZC3H12A;TLR4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.5283223357939475,1.17341666606785,0.2821997105643994,0.8209920353699092,1.0,7/18,25.01%,THOC2;NUP93;PCID2;DDX19B;SARNP;ZC3H11A;ENY2
prerank,regulation of immune effector process (GO:0002697),0.45512430783343616,1.173187386037269,0.26913265306122447,0.820808537423015,1.0,8/41,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.5696110458135277,1.1728404976982816,0.30655737704918035,0.821072161507829,1.0,4/12,17.68%,FZR1;CDC20;RAB1A;UBE2S
prerank,dermatan sulfate metabolic process (GO:0030205),0.5535678541661778,1.172585395768897,0.2897473997028232,0.820946844140568,1.0,5/13,16.84%,DSE;UST;BGN;IDUA;CHST12
prerank,myeloid cell development (GO:0061515),0.5252338961720556,1.1724845443466205,0.2817919075144509,0.8203805141997981,1.0,2/18,1.69%,FOXP1;ANXA2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5709007400941051,1.1724484580039212,0.3020030816640986,0.819594472088702,1.0,7/12,19.69%,MAVS;IFIH1;CGAS;FLOT1;RALB;DHX9;COLEC12
prerank,cellular response to organonitrogen compound (GO:0071417),0.40991011410536765,1.1724379756370735,0.2245810055865922,0.8187302992131852,1.0,17/99,12.66%,SLIT2;CDH1;IGFBP5;EZR;SLC26A6;SOX9;CAPN2;CTNNA1;RRAGB;DIAPH1;DMTN;EGR1;AKAP9;RAP1A;JUP;NSMF;BRCA1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3422790123155235,-1.1715146368785994,0.2198952879581152,0.6963137533346091,1.0,9/47,10.21%,VTN;SPOCK3;SPOCK2;SPOCK1;TIMP3;SERPINI1;SERPIND1;BIN1;GAPDH
prerank,embryonic axis specification (GO:0000578),0.534492282506674,1.1714408184349905,0.30627871362940273,0.8210875817306493,1.0,3/15,7.92%,COBL;SMAD6;SMAD2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4677232190891716,1.171326684938855,0.25412960609911056,0.8205578861370462,1.0,8/39,6.84%,EGFR;PTPN3;CBLC;RNF126;PTPN2;ACP4;ERBB2;RNF115
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4877844219585921,-1.1709997833176047,0.27807486631016043,0.6956037132116685,1.0,2/10,1.41%,SOX5;SOX6
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5656759925316656,1.1702956434724852,0.30094043887147337,0.8230815707807658,1.0,5/11,7.33%,SOAT1;ITM2C;AGO2;BACE2;ABCA7
prerank,muscle contraction (GO:0006936),-0.2773682002813459,-1.1702020353418758,0.1076923076923077,0.6956838181521834,1.0,20/126,10.51%,ITGA1;MYLK;DTNA;SNTB1;SLC8A1;ACTN2;ROCK2;DYSF;GJC1;MYH11;MYL9;BDKRB2;LMOD1;ACTA2;TPM2;MYOF;CALM1;DES;GLRA1;TMOD1
prerank,apical protein localization (GO:0045176),-0.5061728869280784,-1.1698845898073695,0.26356589147286824,0.6945385100450147,1.0,4/10,6.49%,SHROOM2;ACTB;JAM3;MAL
prerank,regulation of calcium ion import (GO:0090279),-0.4016360490006747,-1.1698692593950986,0.2642857142857143,0.6925227611965333,1.0,10/21,26.31%,PDGFRB;CXCL12;PLPP4;SLC30A1;WNK3;CTNNB1;PRNP;STC1;CCL2;SPHK2
prerank,regulation of glucose import (GO:0046324),-0.37037508161802685,-1.169868043784523,0.20967741935483872,0.6904493397558251,1.0,6/30,3.89%,IGF1;OSBPL8;OCLN;PIK3R1;ENPP1;INSR
prerank,hemidesmosome assembly (GO:0031581),-0.4885624493120898,-1.1698182225549063,0.27941176470588236,0.6885157773379011,1.0,6/11,19.01%,ITGA6;DST;LAMC2;LAMC1;CD151;LAMB3
prerank,lymphocyte chemotaxis (GO:0048247),0.46798936230451904,1.1694199244176453,0.2701298701298701,0.8250873585770142,1.0,3/34,4.34%,SLC12A2;CCL3;CCL1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3963874336016643,1.1693604062888516,0.202991452991453,0.8243719227686204,1.0,33/140,14.62%,SLIT2;PLCE1;RHOJ;ARHGAP20;VAV2;ARAP1;ARHGAP21;ARHGAP10;SRGAP2;SRGAP3;AKAP13;ARHGDIB;ARHGAP44;ARHGAP40;BCR;ARHGAP17;TIAM1;SOS2;RHOQ;TIAM2;ARHGAP31;STARD13;ARHGAP5;ITGAV;RHOA;FGD1;TRIO;OCRL;FGD3;TRIP10;MYO9A;GNA13;DEPDC1B
prerank,positive regulation of bone mineralization (GO:0030501),0.4639669513831318,1.1691902398842007,0.27989487516425754,0.8240745504578445,1.0,7/35,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;BMP6
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45954305792387656,1.1691622937872623,0.24487179487179486,0.8232638178871168,1.0,6/40,5.15%,EGFR;NTRK3;EDNRA;FGF2;ESR1;FGFR1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5532107737685534,1.1690853269017736,0.308868501529052,0.822616470630283,1.0,6/13,11.57%,ENTPD6;ENTPD2;ENTPD5;SMPDL3A;NUDT15;ENTPD7
prerank,glycosaminoglycan catabolic process (GO:0006027),0.43036000774431926,1.1690020472902023,0.24334140435835352,0.8219793167866416,1.0,14/55,15.34%,GPC6;GPC3;FGF2;SPAM1;HEXA;BGN;LYVE1;CD44;ARSB;SLC9A1;CHP1;GPC4;NAGLU;IDUA
prerank,regulation of cation channel activity (GO:2001257),-0.30290606117857266,-1.1689236832193661,0.13513513513513514,0.6890317521360814,1.0,33/89,16.08%,FGF14;GRIA4;ANK3;ACTN2;APP;FGF12;GRIN2A;KCNAB1;LRRC7;GRIN2B;CACNB4;CACNB2;PDE4D;MEF2C;GRIA1;GRIN1;CACNG7;JPH1;CALM1;CACNG4;CACNB1;GRIA3;CACNG3;JPH2;CACNG2;FGF11;NETO1;OPRM1;CTSS;CAMK2B;CAMK2A;RELN;GSG1L
prerank,regulation of mitochondrial fusion (GO:0010635),0.5690174926542388,1.1685530056610196,0.30389221556886226,0.8225569110592893,1.0,1/11,1.27%,PID1
prerank,regulation of integrin activation (GO:0033623),-0.4502681448836573,-1.1681595523929527,0.2515923566878981,0.6891126517221671,1.0,9/15,28.25%,RASIP1;PIEZO1;JAM3;FBLIM1;PLEK;KIF14;SELP;PTGER4;RAP1B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.55180280937882,1.1680288253590967,0.3029850746268657,0.8233557170121375,1.0,3/12,12.09%,DPYSL3;DPYSL2;CTPS2
prerank,lipid transport (GO:0006869),0.41472040324213655,1.16796334429856,0.2340909090909091,0.8226848028571808,1.0,14/97,8.76%,SLCO3A1;TNFAIP8L3;ABCD3;SLCO2A1;LBP;PITPNC1;SLC10A2;LDLR;PITPNA;SLC27A3;ABCA7;ABCD1;SLC51A;RXRA
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.5371161791648795,1.1678014928124396,0.3029871977240398,0.8223532363109994,1.0,7/15,27.05%,USP46;ZDHHC12;NLGN1;STXBP1;ZDHHC3;NLGN2;CLN3
prerank,regulation of RNA export from nucleus (GO:0046831),0.5947587719308263,1.1675379402264836,0.3218210361067504,0.8222725303475834,1.0,5/11,24.47%,SETD2;NUP153;KHDRBS1;DHX9;AKAP8L
prerank,bile acid biosynthetic process (GO:0006699),-0.39531687900424717,-1.16740970134534,0.21708185053380782,0.6889978061235658,1.0,8/24,21.99%,CYP7B1;CYP27A1;OSBPL1A;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H
prerank,clathrin-dependent endocytosis (GO:0072583),-0.40350068797118455,-1.167372127411513,0.24344569288389514,0.6870798880302845,1.0,5/26,6.04%,DNAJC6;SGIP1;PICALM;FNBP1L;SNAP91
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.43739184397363906,-1.1671908998835583,0.2524271844660194,0.6855443594864602,1.0,11/16,35.89%,CXCL12;BCL2L1;RPS3;TPT1;CDKN2D;SNAI2;CCAR2;DDIAS;SFRP2;ACKR3;NACC2
prerank,positive regulation of ERAD pathway (GO:1904294),0.5552546878815716,1.1671158116998772,0.30551181102362207,0.8227877670685234,1.0,5/13,12.45%,NFE2L2;USP13;RNF185;HERPUD1;BCAP31
prerank,regulation of interferon-alpha production (GO:0032647),0.496495112861027,1.16669814805522,0.288135593220339,0.8232724628753101,1.0,13/23,26.18%,SETD2;TLR4;MAVS;IFIH1;RIPK2;DHX36;TLR8;PTPRS;DHX9;CHUK;IRF3;NLRC3;IRF5
prerank,response to hydroxyurea (GO:0072710),0.5765929500935482,1.166350205500377,0.29339477726574503,0.8235307326345588,1.0,7/11,22.05%,SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.4755389851242796,-1.1662579552155787,0.2594594594594595,0.6860387120833509,1.0,4/12,11.67%,EPHB1;B4GALT6;HSP90AB1;SPTBN4
prerank,response to ATP (GO:0033198),-0.4251827545399137,-1.1661320439307632,0.2727272727272727,0.6843931744535496,1.0,7/18,21.56%,ABCC9;TRPC3;P2RY1;P2RX7;CIB2;TAF1;HSP90B1
prerank,amide transport (GO:0042886),0.4883184566445968,1.1658219579961324,0.2907303370786517,0.8243181208413826,1.0,5/26,8.49%,SLC5A6;ABCG2;DISP1;FOLR2;SLC25A32
prerank,fatty acid catabolic process (GO:0009062),0.43174042728221707,1.1657580609644544,0.2549476135040745,0.823641443615382,1.0,19/67,18.73%,ABCD3;EHHADH;BDH2;PLA2G15;AUH;ABCD1;ECHDC1;ACBD5;DECR1;PEX13;LPIN2;ACOT8;ACOX1;ECHDC2;ACADL;CEL;PECR;CROT;PCCB
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.4759434849829032,1.1651043397785685,0.2938775510204082,0.8248806729569218,1.0,6/29,10.27%,TCF7L1;TCF7L2;TLE2;PYGO2;CREBBP;PYGO1
prerank,regulation of calcium ion transport (GO:0051924),-0.3263030459972993,-1.1650967384020783,0.19895287958115182,0.685275670536317,1.0,18/54,15.60%,MYLK;EPB41;BCL2;CACNA1D;CACNB2;CACNA2D1;TRPC6;WFS1;PLPP4;ADRA2A;ATP2B1;WNK3;ORAI1;CAMK2G;CD84;CAMK2B;CTNNB1;CAMK2A
prerank,regulation of feeding behavior (GO:0060259),-0.4878853338871672,-1.1650367046381362,0.26666666666666666,0.6834500574517325,1.0,2/11,1.21%,LEPR;SGIP1
prerank,bone development (GO:0060348),0.458006572824243,1.1650025586357418,0.2667525773195876,0.8243425282701977,1.0,9/39,8.79%,LRP6;GNAS;AKAP13;SFRP4;SKI;MYOC;SLC10A7;SULF1;P3H1
prerank,protein localization to cell-cell junction (GO:0150105),-0.44368794468598477,-1.1649909311972584,0.24390243902439024,0.6815900147937239,1.0,4/15,4.83%,TJP1;F11R;CGNL1;ACTB
prerank,mRNA transport (GO:0051028),0.4023701273722536,1.164905188545523,0.24035281146637266,0.8237427252325679,1.0,48/101,33.50%,SRSF11;U2AF2;SMG6;THOC2;SRSF5;NUP93;SRSF6;NUP214;NUP153;CDC40;SRSF2;NUP155;FYTTD1;RANBP2;NUP88;SRSF1;RNPS1;CPSF3;CHTOP;UPF2;HNRNPA2B1;NUP35;DDX19B;SARNP;FMR1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;YTHDC1;NUP98;POM121;WDR33;THOC1;ALKBH5;SEC13;UPF3B;THOC5;SEH1L;DDX39A;DDX39B;NUP54;SRSF7;TPR;AAAS;NXT1;ALYREF
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.4435507179879803,-1.164817877758321,0.23563218390804597,0.6800885650838937,1.0,3/14,6.47%,LYN;PIK3R1;GHR
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.4984902830317392,1.1643660630337294,0.30404463040446306,0.8245916614203821,1.0,10/24,24.68%,SLX4;TEN1;STN1;PARP1;NAT10;TENT4B;ERCC4;TNKS2;GNL3L;SRC
prerank,positive regulation of protein binding (GO:0032092),0.4378490939744134,1.1643576249306118,0.2660098522167488,0.8237313581611714,1.0,19/56,18.20%,BMP4;TCF7L2;PKD1;GSK3B;ABL1;LRP1;DACT1;TIAM1;RIPK2;IDE;NMD3;MARK3;CAPRIN2;FLOT1;ADD1;PIN1;LRRK2;STK3;RALB
prerank,cellular copper ion homeostasis (GO:0006878),-0.453759279380351,-1.1623139108397755,0.2781065088757396,0.6849759255219021,1.0,6/14,19.93%,APP;ATOX1;SLC31A1;COX19;MT2A;PRNP
prerank,positive regulation of T cell proliferation (GO:0042102),-0.31943926261867817,-1.162305474041886,0.15757575757575756,0.6830299162948286,1.0,17/55,21.92%,IGF1;IGFBP2;VCAM1;TFRC;RPS3;IL18;HMGB1;ICOSLG;CD24;CCL19;CD86;SLC7A1;JAK3;PYCARD;CD276;AGER;CD274
prerank,calcium ion transmembrane transport (GO:0070588),0.4071633064650179,1.1622976949602475,0.2408675799086758,0.8293412168446275,1.0,17/86,12.50%,SLC35G1;SLC24A3;CACNA1C;PKD1;CACNA1G;ATP2C2;ANO6;TRPM7;TRPM6;ATP2B4;TRPM4;ITGAV;TRPM8;TRPC4AP;NALCN;MCU;SLC8B1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.36618441872017693,-1.1619346058682616,0.23949579831932774,0.6820600861792216,1.0,5/32,5.77%,OSBPL8;PLA1A;OSBPL10;SERINC5;PLAAT3
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.38190631442628775,1.1619098276363686,0.16328600405679514,0.8296821881011488,1.0,87/259,21.36%,NTN1;FXYD5;PKD1;BBS9;ABLIM3;EXOC4;GSN;EZR;SRGAP2;NRP1;PTPDC1;ANO6;EMP1;PMP22;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;ARFIP2;VCL;ITGB1;DMTN;ABLIM2;SHTN1;CFAP43;EHD2;IFT52;MAK;DYNC2I2;ARL3;PLK4;RAP1A;RFX2;PCNT;GALNT11;KIF3B;FGD1;ARF4;PIP5K1A;OCRL;DISC1;EXOC7;EHD1;FGD3;EMP3;DYNC2I1;TMEM231;RAP2C;CYFIP1;FGD6;CEP19;TRAPPC14;OFD1;ATAT1;GOLPH3;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;PTPN23;S1PR2;CEP164;MKKS;ATP6V0D1;RAP2B;CLUAP1;IQCB1;NUDCD3;RAB11A;LZTFL1;HYLS1;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.40390764361214,1.161605020251047,0.23008849557522124,0.8297003520573693,1.0,31/114,21.82%,CARD14;TNFRSF11B;PTK2B;EDA;PSMB2;LIMS1;FOXO3;PSMD11;PSMC1;PSMC6;TRAF2;PSMD1;TRAF6;PSMD4;TRAF5;IKBKB;TNFRSF12A;MAP3K14;PSMA6;TNFSF13B;PSMD14;PSMD12;PSMD7;JAK2;COMMD7;CHUK;CDIP1;TRAF3;PSME3;TXNDC17;TRADD
prerank,positive regulation of cellular component movement (GO:0051272),0.4958431007810157,1.161360599635193,0.29124820659971307,0.8296453063056982,1.0,5/24,4.99%,NTN1;VEGFA;TGFBR1;CCDC25;TWIST1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.26862474516459917,-1.1612682780105623,0.0625,0.6818944542985856,1.0,57/168,18.17%,RPL37;RPL27A;RPL19;RPS13;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;DCP2;RPS29;RPL35A;RPL10A;PAN2;RPL11;MAGOH;RPS5;CNOT6L;CTIF;RPS16;EXOSC5;RPL4;SMG7;POLR2G;RPS7;RPS23;RPS15;RPL36;RPS18;EXOSC9;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;PELO;PDE12;HELZ2;RPL23;RPL17;RPL9;CNOT9
prerank,response to lipid (GO:0033993),0.4078811545604197,1.1611568822484941,0.23304157549234136,0.8294087196260613,1.0,20/105,13.32%,FOXP1;ALPL;LBP;SMAD6;SOX9;ESR1;RARA;IRAK3;STAT3;ANXA1;FOXO3;PALM3;TLR4;RXRA;ERBIN;TAB2;RXRB;RPS6KA3;STRN3;TIRAP
prerank,estrogen metabolic process (GO:0008210),0.5398934200292018,1.160888742041459,0.2981366459627329,0.8293519532713393,1.0,4/15,26.31%,CYP1B1;SULT1A1;HSD17B2;HSD17B4
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.48742540701798887,1.1601897525500358,0.2896174863387978,0.8306940006844514,1.0,7/26,13.02%,EYA2;EYA4;FGFR1;INHBA;MCL1;EYA3;RET
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5170075029877487,1.1600218683164978,0.2907303370786517,0.8303231195751187,1.0,9/19,16.29%,CLIC4;DLG2;ERBIN;PATJ;PARD3;SYNJ2BP;MARK2;DLG1;SCRIB
prerank,positive regulation of lipid localization (GO:1905954),0.5688462109273528,1.159940995144889,0.32272727272727275,0.8297121966003883,1.0,3/11,8.15%,LRP1;IKBKE;ZC3H12A
prerank,endochondral bone morphogenesis (GO:0060350),0.5652039969397371,1.1598850230740612,0.3183279742765273,0.829004199045004,1.0,5/11,16.78%,BMP4;FOXC1;TMEM119;INPPL1;FGFR3
prerank,glial cell differentiation (GO:0010001),0.4854787221666019,1.159609039798885,0.29132791327913277,0.8290037006066727,1.0,3/28,5.26%,NFIB;SOX9;STAT3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3935556833314631,1.1594423657710426,0.2017075773745998,0.8287033890684047,1.0,42/153,18.03%,STK39;PKD1;MARK1;WNK1;PRKCD;CAMK2D;ULK2;PRKCE;TLK1;GSK3B;HIPK1;TGFBR1;VRK3;MAPK12;TGFBR2;AURKA;IKBKE;CSNK1A1;NLK;MAST2;TOP1;CLSPN;TTK;PDK3;CSNK1G3;CAB39;ULK3;SGK3;RPS6KA3;MARK2;CSNK1G1;MORC3;PRKCA;MARK3;PRKDC;CDK2;CDC7;MAP3K10;IKBKB;RPS6KB1;LRRK2;MAPKAPK2
prerank,negative regulation of cell aging (GO:0090344),-0.4305912628221482,-1.1593118805328122,0.2948328267477204,0.6854240890427391,1.0,6/16,15.84%,AKT3;SLC30A10;CDK6;RBL1;MIF;TERT
prerank,response to metal ion (GO:0010038),0.42528463980661735,1.159261646485154,0.2531356898517674,0.82837813120757,1.0,7/67,8.45%,THBS1;NEDD4;ADAM9;PPP3CA;NDRG1;SEC31A;SLC30A3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.5413371522135577,1.1591554766681211,0.2933130699088146,0.8278416823887197,1.0,5/14,17.54%,U2AF2;SRSF6;RBMX;RNPS1;PCBP4
prerank,positive regulation of secretion by cell (GO:1903532),0.41728999123415383,1.1588889253298156,0.267816091954023,0.8278126293722075,1.0,8/70,6.10%,SLC12A2;ADAM9;EZR;UNC13B;KCNB1;TGFB3;SYTL4;BMP6
prerank,positive regulation of protein polymerization (GO:0032273),0.4246549965984064,1.1588770603783063,0.25415676959619954,0.8269878499987614,1.0,10/65,8.37%,CDC42EP5;MET;BAIAP2L1;PRKCE;PTK2B;CLIP1;NCK2;TENM1;TOGARAM1;AKAP9
prerank,protein neddylation (GO:0045116),0.5598507203436908,1.1587640976369102,0.3076923076923077,0.8264492452966661,1.0,6/13,19.53%,DCUN1D5;UBE2M;DCUN1D2;DCUN1D1;UBA3;UBE2F
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4543463739877498,1.1586703796391742,0.2928660826032541,0.8258598193248562,1.0,11/39,13.42%,THBS1;SEMA3E;EFNA5;FZD7;MYOC;DMTN;CORO1C;RHOA;JAG1;ITGB1BP1;HOXA7
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5136377182034871,1.1586519220287321,0.28263988522238165,0.8250735725831297,1.0,10/19,21.43%,SETD2;TLR4;MAVS;IFIH1;RIPK2;DHX36;TLR8;DHX9;CHUK;IRF3
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5711865409566762,1.1583548839178335,0.29797191887675506,0.8251512558323486,1.0,2/10,1.65%,WNK1;CYP1B1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4893845914451665,-1.158283080045462,0.275,0.6863169381985995,1.0,5/11,27.43%,AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,ephrin receptor signaling pathway (GO:0048013),-0.3045926346688134,-1.1581175697203827,0.203125,0.6848208733820096,1.0,19/82,6.57%,EFNB2;LYN;PAK1;EPHB1;EPHA6;ROCK2;EPHA7;PAK3;ARPC4;GRIN2B;EPHA5;DNM1;ACTB;EPHA8;ARPC5;EPHA4;VAV3;GRIN1;NGEF
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4555041954336734,-1.1572569315815393,0.26262626262626265,0.6851757355361914,1.0,2/15,4.43%,IGF1;BCL2L1
prerank,organelle transport along microtubule (GO:0072384),0.4759663999067312,1.1566627014881492,0.2921195652173913,0.8297153583727194,1.0,14/31,27.05%,ARHGAP21;NDEL1;RAB6A;PAFAH1B1;COPG1;MAP1S;BICD1;KIF5B;RAB1A;BICD2;UBB;FBXW11;RHOT1;CLN3
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.37900687051572257,1.1566243024625045,0.12663316582914572,0.8289771704284999,1.0,109/366,23.55%,BNC2;VSX1;SIX1;ZFHX3;TCF7L1;PRRX2;CCNA2;FOXN3;NFIA;JMJD1C;ERC1;SOX14;ZNF423;ESR1;FZD7;TGFBR1;ABL1;STAT3;FOXO3;CHEK2;USP13;NFIL3;BHLHE40;HMG20A;CREBBP;RORA;SERTAD3;CDK11B;DSCC1;CHD3;MLX;MLXIPL;GPBP1;GATA4;NLK;FOXC1;ATXN2;ATF7;NSD1;TOM1L1;DENND4A;ANKRD17;RBM3;FBXO5;PHF12;ESCO1;ORC3;NFXL1;APBB3;POFUT1;FUS;GTF2IRD1;E2F1;PRMT5;NFYA;PATZ1;PRDM2;HINFP;SP3;MSL3;ATRX;CYFIP1;NR3C1;THAP7;DVL1;KAT6B;ZNF219;EFEMP1;MZF1;ESR2;HCFC1;KMT2D;RB1;ASCC2;RNF20;RNF14;NUP35;TAF5;TRRAP;ACTR5;ATF2;BRCA2;NONO;GON4L;NFX1;GEMIN5;CREBL2;NR1D2;FOXK2;PCGF1;UTP4;PUM3;ZKSCAN5;PML;NFKB2;IGF2;POU6F2;HOXB7;WWC2;ATXN1L;ZNF35;RPL10;SBNO1;CCAR1;RABL3;HMGA1;MYCBP;MAPKAPK5;TP53
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3767824864629308,1.156592111435699,0.14213197969543148,0.8282162654119649,1.0,99/314,26.23%,WWP1;FBXL7;NEDD4;FZR1;ECRG4;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;ANAPC5;SPSB2;AMN1;UBE2A;AURKA;FBXL20;PSMD11;FEM1B;RNF185;CUL3;ANAPC10;PSMC1;MAN1B1;VCP;MTA1;CDC16;UBE4A;PPP2R5C;CUL1;ANAPC11;CDC20;KLHL22;TBL1X;CCNB1;FBXO27;RAD23B;PSMC6;MAD2L1;FBXO5;FBXO31;ANAPC16;HERPUD1;UBE2K;UBR3;FBXO48;COP1;SPOPL;RNF122;FBXO45;SEL1L;PSMD1;UBE2B;NHLRC1;UBE2D3;PSMD4;CDK2;FBXO17;TMEM129;RB1;AREL1;PSMA6;UBE2S;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;RMND5A;PSMD7;FBXL6;ANKZF1;USP19;UBXN4;DNAJB2;PML;PSME3;BUB3;ANKRD9;RHBDD2;FBXL8;TRIM71;PSMD3;DDIT3;FBXW4;PSMB6;SEC61B;UBB;FBXW11;APPBP2;LTN1;HECTD3;ERCC8;UBA52;SHARPIN;KLHL15;RNF103-CHMP3;TOPORS;ANAPC4
prerank,cell differentiation in hindbrain (GO:0021533),-0.4826988231139844,-1.1563044205582529,0.2922636103151863,0.6858457487775423,1.0,5/11,12.76%,GRID2;OPHN1;PROX1;FAIM2;KNDC1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.4667617697657117,1.1559976426401546,0.29517241379310344,0.8292227866395433,1.0,5/31,4.74%,ZFPM2;BMPR1A;DSP;TGFBR1;NOG
prerank,calcium ion import (GO:0070509),0.4701830058571712,1.1559886097294643,0.29708222811671087,0.8284032181529626,1.0,4/28,2.89%,CACNA1C;CACNA1G;CASR;CACNA1F
prerank,mitochondrial RNA metabolic process (GO:0000959),0.542620831274309,1.1559664086180668,0.3066465256797583,0.8276042807169807,1.0,5/14,18.35%,FASTKD1;FOXO3;EARS2;FASTKD5;MTERF2
prerank,oligodendrocyte development (GO:0014003),-0.43519042216252996,-1.1556888173359814,0.24629080118694363,0.6855686723317642,1.0,4/15,17.16%,PLP1;B4GALT6;EIF2B1;NSUN5
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.48287014644501325,1.1549773557365655,0.2967479674796748,0.8299180455334751,1.0,6/26,12.66%,CYP1B1;RORA;SULF1;GATA4;ARNT;BRCA1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.49333257493383764,1.1546732438652478,0.29680998613037446,0.8299963481962694,1.0,6/24,12.66%,CYP1B1;RORA;SULF1;GATA4;ARNT;BRCA1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.56201170913761,1.1543143676659045,0.31781701444622795,0.8302830680059032,1.0,2/11,13.55%,EGLN3;P4HA1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.28267784539454943,-1.1537232226210505,0.18072289156626506,0.6891102556834183,1.0,34/121,15.97%,IGF1;IL34;VTN;LYN;IL31RA;ENPP2;PECAM1;KIT;GRM5;NEDD9;TEC;ERBB4;IL6R;ACE;PARP14;EPHA4;GHR;GPRC5B;IL18;LRP8;PTPRJ;TNK2;FLT3;GAS6;CD81;NOX4;ERBB3;ARL2BP;MIF;CD40;FGF7;CSF1R;CD74;RELN
prerank,positive regulation of programmed cell death (GO:0043068),0.37715921238149486,1.1536233623908627,0.17599186164801628,0.8316843045346836,1.0,47/272,16.83%,SLIT2;RASSF2;BMP4;MAP3K5;HOXA5;CYP1B1;VAV2;UNC13B;CRADD;AKAP13;NGF;SFRP4;PAWR;TGFB3;ANO6;GADD45G;ABL1;FOXO3;NF1;TIAM1;SOS2;CASP2;BARD1;IP6K2;ITGB1;TIAM2;PTPA;ATF6;PDCD2;FGD1;CLU;TRIO;ARL6IP5;FGD3;RRP1B;E2F1;HTATIP2;RNF122;GNA13;PIDD1;RNPS1;TRAF6;MTCH1;SCRIB;MAP3K10;PLEKHG2;TNFRSF12A
prerank,homotypic cell-cell adhesion (GO:0034109),0.4516440959464292,1.1535345642458226,0.29177057356608477,0.8310994834177402,1.0,7/39,7.45%,UBASH3B;PLPP3;GNAS;CLIC1;CEACAM5;FN1;VCL
prerank,response to growth factor (GO:0070848),0.44265163982738936,1.1535313427013252,0.2795425667090216,0.8302504705672864,1.0,12/41,17.19%,BMPR1A;KLF4;TGFBR1;EMD;SHC1;ERBB2;TGFBR2;CIB1;ACVR1;URI1;CPNE3;RPS6KB1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4090313953852273,1.1534850576449664,0.2502857142857143,0.8295368192412883,1.0,38/84,26.48%,MBNL1;DDX5;RBFOX2;DDX17;CELF3;U2AF2;SON;RBM39;SRSF6;DAZAP1;THRAP3;RBM3;CELF4;RBM25;CELF1;TIA1;WTAP;RBMX;KHDRBS1;CIRBP;RNPS1;MBNL2;PCBP4;ZBTB7A;FMR1;SRSF3;SRPK2;JMJD6;LARP7;REST;YTHDC1;NUP98;RBM11;RBM4;SFSWAP;ZC3H10;RBMXL1;METTL16
prerank,activation of phospholipase C activity (GO:0007202),0.47489047079847624,1.153139152255259,0.2682602921646746,0.8297151325932413,1.0,2/29,1.94%,EGFR;EDNRA
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.5220156633178623,1.1529180322027384,0.296411856474259,0.8294889160076356,1.0,7/17,24.12%,DHDDS;ALG13;ALG12;DPAGT1;ALG14;ALG8;MVD
prerank,protein processing (GO:0016485),0.40620478668176374,1.1525616814438486,0.2323008849557522,0.8297959436579307,1.0,20/102,15.95%,F3;PCSK5;ASPRV1;PRSS12;ADAMTS3;ECE1;XPNPEP3;CASP2;PHEX;MMP16;LONP2;MMEL1;DDI2;PCSK7;FXN;ECE2;TYSND1;PIDD1;YME1L1;FAM111A
prerank,protein import (GO:0017038),0.41406402004552245,1.152450928714443,0.2508551881413911,0.8292821645645073,1.0,18/84,14.40%,ABCD3;PRICKLE1;PXMP2;STAT3;NUP93;E2F3;ABCD1;NUP214;NUP153;TNPO2;ACBD5;PEX13;TNPO3;CLU;IPO7;NUP155;NUTF2;NUP88
prerank,protein insertion into membrane (GO:0051205),0.46554025637018354,1.152174495670476,0.28063241106719367,0.8293094322580302,1.0,3/32,4.59%,EGFR;TRAM2;EMD
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4328664190780806,1.152118348965823,0.2707317073170732,0.828666498083519,1.0,22/56,20.15%,EGFR;ANXA1;ANAPC5;LSM11;CCND1;RDX;CUL3;CDC16;ANAPC11;CCNB1;ANKRD17;MECP2;FBXO5;TFDP1;ADAMTS1;CDC7;RB1;DTL;KMT2E;BRD4;EIF4G1;RAB11A
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.49612749152626867,1.1518463100371228,0.2962962962962963,0.8287223217617314,1.0,7/22,14.37%,RASSF2;VEGFA;PDGFC;TOM1L1;RAD50;TNKS1BP1;RAP2C
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5102380891823362,1.1517564081086293,0.28699551569506726,0.8281589505037814,1.0,4/18,8.35%,ESR1;NCOR1;ZC3H12A;NCOR2
prerank,intestinal lipid absorption (GO:0098856),0.5618287778461106,1.1514656457574095,0.326984126984127,0.8282441367816915,1.0,4/11,16.98%,LDLR;LIMA1;SOAT2;CEL
prerank,positive regulation of cell population proliferation (GO:0008284),0.37654645877138726,1.1513835609538872,0.1372745490981964,0.8276483131099376,1.0,62/423,10.17%,THBS1;FOXP1;BMP4;EGFR;ZFPM2;TCF7L2;ACER3;PGF;HES1;HDAC4;NTRK3;PID1;GRK5;DDR2;CCN1;BMP5;PTK2B;FGF2;GAB2;SOX9;KRAS;IRS1;VEGFA;TGFB3;BMPR1A;ID2;RAB25;CLCF1;RARA;TIMP1;S100B;TGFBR1;PTHLH;FOLR2;NR4A3;PDGFC;FGFR1;SHC1;TCIRG1;CNOT8;PROK2;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;SIRT6;UBE2A;FN1;KITLG;CEP43;MLXIPL;TRPM4;KDM1A;CUL3;CHRD;CIB1;TMEM119;CDC123;ITGAV;CDK13;TTK
prerank,glycogen catabolic process (GO:0005980),0.5344122712990671,1.150823359430887,0.310192023633678,0.8286565259080079,1.0,5/15,15.09%,PYGB;PHKA2;PHKB;RB1CC1;PGM2
prerank,positive regulation of apoptotic process (GO:0043065),0.3760915461547405,1.1506749541038115,0.16361788617886178,0.8282852300890581,1.0,54/293,16.99%,SLIT2;RASSF2;BMP4;MAP3K5;HOXA5;CYP1B1;VAV2;UNC13B;CRADD;PTGIS;AKAP13;NGF;SFRP4;PAWR;TGFB3;ANO6;GADD45G;CCL3;TGFBR1;ABL1;FOXO3;NF1;TIAM1;SOS2;CASP2;BARD1;IP6K2;ITGB1;TIAM2;TRIM39;ZC3H12A;PTPA;BRMS1;ATF6;PDCD2;FGD1;CLU;TRIO;ARL6IP5;FGD3;RRP1B;E2F1;RNF122;GNA13;PIDD1;RNPS1;TRAF6;MTCH1;SCRIB;MAP3K10;PLEKHG2;SIK1;TNFRSF12A;FAP
prerank,cellular response to alcohol (GO:0097306),0.4423098413020854,1.1506561983169576,0.2765151515151515,0.8275119709284173,1.0,15/42,16.93%,LRP6;CDH1;SMO;CTNNA1;RAD51;KLF9;SPIDR;GRAMD1A;GRAMD1C;JUP;BRCA1;ADAM15;GOLPH3;ADCY8;ADCY3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4251328268149297,1.150651444976238,0.25146198830409355,0.8266867824620436,1.0,23/68,23.57%,PTHLH;ACSM2A;ACSM2B;ACOT12;RHOQ;ACOT9;ACOT11;AMPD3;ENTPD7;ACOT8;ACOT13;GMPR2;AK4;AK3;SULT1A1;CROT;LRRK2;GLYAT;AMPD2;ADSS2;ACOT6;ABHD14B;SULT6B1
prerank,microtubule anchoring at centrosome (GO:0034454),0.5817561864605193,1.1504938138941996,0.3262295081967213,0.8263258187599027,1.0,4/10,14.79%,NIN;PCM1;HOOK3;CEP19
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3909406450733779,-1.1501227872033486,0.2709030100334448,0.6971705075894621,1.0,11/23,30.46%,LTA4H;GSTM1;ACSBG1;ALOX12;GPX4;ELOVL6;PTGS2;GSTM2;ALOXE3;ACOT7;CYP2E1
prerank,cognition (GO:0050890),0.4501583620628481,1.1496796987121547,0.29259259259259257,0.8280890836360298,1.0,12/42,16.94%,ST3GAL4;SOBP;SHROOM4;CBR3;NIPBL;NF1;FAM107A;DOP1B;METTL23;CYFIP1;CHMP2B;STRA6
prerank,negative regulation of cell junction assembly (GO:1901889),0.4903301951204133,1.1491223135058783,0.2937062937062937,0.829028134205479,1.0,7/25,8.58%,THBS1;SLIT1;BCAS3;PHLDB2;FAM107A;DMTN;CORO1C
prerank,protein localization to condensed chromosome (GO:1903083),0.5560230580049467,1.1489000376311385,0.3129890453834116,0.8288759683820996,1.0,7/12,27.57%,TTK;ZW10;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,response to nitric oxide (GO:0071731),-0.47117418059897564,-1.148714431307756,0.3343195266272189,0.6991649575378016,1.0,8/13,28.13%,GUCY1B1;FOXO1;KCNC2;CCL19;MT3;EGLN1;MMP3;AQP1
prerank,regulation of tube diameter (GO:0035296),-0.4404420849267511,-1.1485205582294211,0.3057142857142857,0.6958480103705387,1.0,4/13,4.44%,NOS3;ROCK2;NPR1;ACE
prerank,vascular process in circulatory system (GO:0003018),-0.4404420849267511,-1.1485205582294211,0.3057142857142857,0.6958480103705387,1.0,4/13,4.44%,NOS3;ROCK2;NPR1;ACE
prerank,response to interleukin-1 (GO:0070555),0.41852566237232597,1.1482933585279158,0.2764976958525346,0.8299699708181775,1.0,16/73,15.75%,HDAC4;TANK;PTGIS;SOX9;CCL3;CCL1;IRAK3;ANXA1;ZC3H12A;CCL7;IGBP1;MYD88;NR1D1;RBMX;PRKCA;TRAF6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.44134568825180265,-1.1477864932169843,0.2967032967032967,0.6959125370838368,1.0,1/14,0.16%,AUTS2
prerank,positive regulation of axonogenesis (GO:0050772),0.44368031082486714,1.1475164712336505,0.287515762925599,0.8315321904794228,1.0,10/43,13.51%,SLIT2;NTN1;NGF;TIAM1;TIAM2;SHTN1;RHOA;MAP6;PLXNB1;DBN1
prerank,heterochromatin organization (GO:0070828),-0.4419952031742691,-1.1475145169009273,0.3003003003003003,0.6948162791826324,1.0,3/14,13.17%,MECOM;PRDM16;HP1BP3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5325319085065365,1.1472825359944854,0.31666666666666665,0.8314658156890526,1.0,5/14,13.75%,IRS1;TWIST1;ABCD1;LONP2;TYSND1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5385360600244029,1.1468736693637123,0.30966767371601206,0.8318976335578737,1.0,3/15,7.40%,EGFR;ERBB2;MVB12B
prerank,lipoprotein biosynthetic process (GO:0042158),-0.48112995904582767,-1.1467376716981545,0.3109919571045576,0.6950272743042769,1.0,2/11,3.64%,APOE;UGCG
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.3573630126288915,-1.1463742415806717,0.24110671936758893,0.6940511329228211,1.0,15/34,18.97%,GRID2;GABRG3;GRIN2A;GRIN2B;GABRA2;MEF2C;GRIN1;GLRA1;GABRG1;GABRA5;GABRA1;GABRG2;GSK3A;ARRB2;GABRA4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.49875555335487587,1.14630436360452,0.29515418502202645,0.8328679387941016,1.0,4/20,9.62%,HOXA5;PTK2B;ZBTB16;CIB1
prerank,epithelial cell migration (GO:0010631),0.4472050751793703,1.1459670749767799,0.2892670157068063,0.8330937618046322,1.0,9/37,12.16%,FAT2;FSTL1;CYP1B1;NRP1;GIPC1;ABL1;STARD13;RHOA;S100A2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.41154015552857465,1.14567247124249,0.271889400921659,0.8332234823155719,1.0,14/73,15.53%,EGFR;NTRK3;NGF;VEGFA;DOCK7;ATP2B4;CD44;TENM1;AKAP9;RIPK2;BCAR3;RAF1;TNKS1BP1;CAPRIN2
prerank,base-excision repair (GO:0006284),0.4441759434670754,1.1453300487981464,0.28957528957528955,0.8334718728730083,1.0,12/48,19.19%,MPG;ERCC5;SMUG1;APEX2;APEX1;WRN;NEIL3;PARP1;USP47;POLB;PRMT6;RFC1
prerank,histone H2A acetylation (GO:0043968),0.526540000505342,1.145227897482231,0.3261802575107296,0.8329347957023424,1.0,7/16,19.60%,EP400;DMAP1;MSL3;MORF4L1;NAA40;TRRAP;EPC1
prerank,aminoglycan metabolic process (GO:0006022),0.5608390414499558,1.1452026543684948,0.3257042253521127,0.832162426991078,1.0,2/10,11.17%,XYLT1;B3GALT6
prerank,regulation of cellular response to stress (GO:0080135),0.3919308018853123,1.1445170122571606,0.2510775862068966,0.8334448493445198,1.0,29/115,20.09%,SLC38A2;CAMK2D;GSK3B;ABL1;HSPB8;NUP93;BAG3;CREBBP;ABCD1;NUP214;HSPA1L;NUP153;MCL1;CHORDC1;NUP155;RANBP2;NUP88;ALOX5;MLST8;ADCY8;NEK4;NUP35;BAG5;MAPKAPK2;ATR;EIF4G1;USP19;BAG2;NEK6
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.36589474859241017,-1.143906020806391,0.2320675105485232,0.6989118171725559,1.0,13/33,16.32%,IGF1R;IGF1;PIK3R1;MYO16;PIK3C2A;EDN1;PIK3CA;SIRT2;ERBB3;HTR2A;PIK3R5;NYAP2;TYRO3
prerank,mitochondrion disassembly (GO:0061726),0.46465208930984625,1.1438953979344166,0.3051519154557464,0.8346042224761651,1.0,9/34,13.99%,ULK2;CISD2;BECN1;WDR45B;ATG3;RB1CC1;ATG5;MARK2;WIPI2
prerank,positive regulation of dendrite development (GO:1900006),0.5643758858123016,1.1434138584776203,0.3200636942675159,0.8352960226652675,1.0,2/10,1.82%,COBL;BMP5
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.5147610785906663,1.1434028760964419,0.3057142857142857,0.8345001324650155,1.0,5/17,5.44%,DOCK5;IGFBP5;NRP1;NR4A3;DOCK7
prerank,negative regulation of programmed cell death (GO:0043069),0.3732076953381754,1.1433159088297427,0.14919354838709678,0.8339390030017986,1.0,75/355,17.51%,THBS1;BMP4;CARD14;EGFR;MET;FSTL1;GRK5;TCIM;SMAD6;WNT11;GCLC;ANXA4;PTK2B;ARHGAP10;ERC1;SOX9;NGF;VEGFA;NTSR1;GSK3B;NOTCH2;KRT18;SON;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;PROK2;CEACAM5;CLEC5A;PRDX5;BAG3;CD44;CASP2;BARD1;ZFAND6;SIX4;CIB1;RIPK2;POU4F1;DNAJC3;MCL1;MAD2L1;NAA15;FXN;ARF4;NIBAN2;MYD88;RPS6KA3;RAF1;DPEP1;TMBIM4;MTDH;AATF;COPS5;TIGAR;HTATIP2;PIM2;PIDD1;BNIP1;NAA38;YME1L1;PRKDC;TRAF6;GOLPH3;FFAR4;UBE2O;GDNF;USP47;IKBKB;PLK3;RPS6KB1;AREL1;PCID2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4602140035316252,1.1432683355731577,0.29499323410013534,0.833249919775063,1.0,8/30,16.60%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;SH3GLB1;UBE2D3;UBL5
prerank,positive regulation of cell division (GO:0051781),0.4519163218766216,1.1430091690685438,0.28410513141426785,0.8332613347779096,1.0,7/38,12.02%,CIT;PRKCE;GIPC1;CDC14A;CUL3;RHOA;DRD3
prerank,protein localization to microtubule organizing center (GO:1905508),0.5315195328077003,1.142993094828422,0.3195718654434251,0.8324937887807008,1.0,8/15,32.27%,PCM1;HOOK3;C2CD3;PIBF1;CCDC14;BBS4;CEP131;CSNK1D
prerank,negative regulation of MAP kinase activity (GO:0043407),0.44210604796827535,1.1424100352997055,0.2794486215538847,0.833451994895412,1.0,7/44,10.44%,BMP4;PRKCD;CBLC;IRAK3;NF1;PDCD4;DUSP19
prerank,polarized epithelial cell differentiation (GO:0030859),0.5450880899219552,1.1421883945193507,0.3220858895705521,0.8333295925238894,1.0,6/13,16.49%,EZR;SYNE4;RHOA;MYO9A;SCRIB;CAMSAP3
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.37695164514782964,1.142107974194821,0.16347124117053483,0.8327789891291311,1.0,85/327,21.37%,BNC2;VSX1;SIX1;ZFHX3;TCF7L1;PRRX2;FOXN3;NFIA;JMJD1C;ERC1;SOX14;ZNF423;ESR1;FZD7;TGFBR1;ABL1;STAT3;CHEK2;USP13;NFIL3;BHLHE40;HMG20A;CREBBP;RORA;SERTAD3;CDK11B;CHD3;MLX;MLXIPL;GPBP1;GATA4;NLK;FOXC1;ATF7;NSD1;DENND4A;PHF12;NFXL1;APBB3;POFUT1;FUS;GTF2IRD1;E2F1;PRMT5;NFYA;PATZ1;PRDM2;HINFP;SP3;MSL3;ATRX;NR3C1;THAP7;DVL1;KAT6B;ZNF219;EFEMP1;MZF1;ESR2;HCFC1;KMT2D;RB1;ASCC2;RNF20;RNF14;NUP35;TAF5;TRRAP;ACTR5;ATF2;BRCA2;NONO;GON4L;NFX1;COPS2;CREBL2;NR1D2;FOXK2;PCGF1;UTP4;ZKSCAN5;PML;NFKB2;IGF2;POU6F2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.49154066120120915,1.1420734777667858,0.29645390070921984,0.8320650867973814,1.0,9/21,23.47%,CDC20;KLHL22;TTK;MAD2L1;FBXO5;ZW10;MAD1L1;BUB3;ATM
prerank,cell projection assembly (GO:0030031),0.49853381467463764,1.1416642951309481,0.3370473537604457,0.8325232281438892,1.0,4/22,7.72%,RHOJ;GSN;PARVA;RHOQ
prerank,regulation of cell communication (GO:0010646),0.45933732925030796,1.1416592901509637,0.2855245683930943,0.8317129533435891,1.0,6/35,8.04%,MGLL;GRK5;CAMK2D;ANK2;ANXA1;GRK4
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5068434113509569,1.1411278498841513,0.30896551724137933,0.8325403191815275,1.0,4/20,8.34%,LBP;PRKCE;CCL3;TLR4
prerank,negative regulation of lipid storage (GO:0010888),-0.4008395541547526,-1.140616417608103,0.2532051282051282,0.7057665310306649,1.0,6/19,11.17%,OSBPL8;PPARA;ABCG1;NR1H3;PPARD;NR1H2
prerank,regulation of cholesterol esterification (GO:0010872),-0.49402007982883217,-1.1400810676467936,0.3142857142857143,0.7052702840426837,1.0,2/10,4.23%,APOE;ABCG1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4241357076933816,1.1397736643301644,0.28287841191067,0.835978927107244,1.0,13/52,14.14%,EGFR;PRKCE;EPB41L2;LRP1;RANGRF;ATP2B4;PLS1;AGR2;ITGB1;CIB1;EPHB2;DLG1;PTPN9
prerank,positive regulation of cell migration (GO:0030335),0.3754261961091317,1.1392080263155582,0.2041025641025641,0.8369351024856095,1.0,43/253,9.92%,F3;THBS1;EGFR;DOCK5;NTRK3;ADAM9;DDR2;TWIST2;PPP3CA;CCN1;SEMA3E;WNT11;PRKCE;PTK2B;SOX9;NRP1;ELP3;VEGFA;RAB25;SMO;CCL3;SEMA3C;PLCG2;TGFBR1;PDGFC;NIPBL;STAT3;SEMA3D;MYOC;AGO2;TIAM1;FN1;SMIM22;ITGB1;FAM107A;DMTN;CEP43;SHTN1;RDX;MIA3;CIB1;PIK3R3;CCL7
prerank,cellular senescence (GO:0090398),0.46951444680524185,1.1392031174805575,0.29763560500695413,0.8361286553513587,1.0,11/27,23.60%,PRKCD;ECRG4;ID2;SMC6;SMC5;ULK3;CDKN1A;PML;HMGA1;MAPKAPK5;KAT6A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5028123209390102,1.138912433129404,0.3180428134556575,0.8362237054089269,1.0,2/20,1.99%,PLOD2;GCLC
prerank,regulation of neuroblast proliferation (GO:1902692),0.5255969503223424,1.1388989150598767,0.32293291731669266,0.8354414248266535,1.0,7/15,19.29%,VEGFA;NF1;KDM1A;DISC1;PTN;LRRK2;TAFA3
prerank,histone H4 acetylation (GO:0043967),0.43539188966806963,1.1385823525822196,0.29484029484029484,0.8356631402280553,1.0,19/47,20.09%,EP400;PER1;KANSL3;TADA3;KANSL2;ZZZ3;JADE2;DMAP1;MSL3;MORF4L1;NAA40;HCFC1;TRRAP;ATF2;BRCA2;PHF20;NAA60;EPC1;KANSL1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.47027386286452,1.1384510734280466,0.30831099195710454,0.8352541571499398,1.0,9/31,19.03%,FHL1;KLF4;DACT1;FAM107A;CDKN2C;DLG1;CDKN1A;RB1;WEE1
prerank,Golgi localization (GO:0051645),0.5665398612582457,1.1384227626545629,0.3369397217928903,0.8345197515888995,1.0,4/11,14.22%,ARHGAP21;COPG1;HOOK3;ARCN1
prerank,negative regulation of glycolytic process (GO:0045820),0.5543471751402254,1.138162618246108,0.3296875,0.8336975219893977,1.0,4/10,14.05%,HDAC4;PFKFB1;NCOR1;TIGAR
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5543471751402254,1.138162618246108,0.3296875,0.8336975219893977,1.0,4/10,14.05%,HDAC4;PFKFB1;NCOR1;TIGAR
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4896856127592303,-1.1380687952969468,0.30446194225721784,0.7088353156541857,1.0,4/10,16.15%,ACTN2;SEMA5A;CFL2;PLEK
prerank,regulation of humoral immune response (GO:0002920),0.43864532133520473,1.1378968325817043,0.3105196451204056,0.8337191620171598,1.0,8/44,15.67%,CFH;CD55;C5AR2;SERPING1;CD46;CLU;CR1L;C3AR1
prerank,mRNA 3'-end processing (GO:0031124),0.40221849186917513,1.1377167709424507,0.2632794457274827,0.8334760591236758,1.0,26/78,23.87%,SRSF11;U2AF2;THOC2;SRSF5;SRSF6;LSM11;SCAF8;PABPC1;CDC40;SRSF2;TENT2;SRSF1;RNPS1;SSU72;CPSF3;CHTOP;TENT4B;CSTF3;SARNP;CLP1;DHX38;SRSF3;SRRM1;ZC3H11A;FIP1L1;PAPOLG
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.4103320672100823,1.1374972014156408,0.28554778554778554,0.8333577583047556,1.0,13/76,11.45%,CYP1B1;ANXA4;CMKLR1;PTGIS;KLF4;IRAK3;TAX1BP1;G3BP2;NLRP12;ZC3H12A;BRMS1;ERBIN;CHP1
prerank,regulation of cellular senescence (GO:2000772),-0.3734228046937007,-1.1374834194642904,0.27626459143968873,0.7085013427887838,1.0,9/28,15.84%,AKT3;SLC30A10;B2M;CDK6;NUAK1;YPEL3;RBL1;ABI3;TERT
prerank,regulation of translation (GO:0006417),0.3771315619977725,1.1374552928033068,0.24710830704521555,0.8326787899313806,1.0,54/173,25.56%,THBS1;SAMD4A;IGFBP5;NIBAN1;EIF4G3;PAIP2;FOXO3;CNOT8;ERBB2;EIF4G2;EIF3E;EPRS1;ATXN2;GSPT1;EIF6;DHX36;EIF2AK2;ETF1;RBM3;NAT10;EIF5B;RPS6KA3;CYFIP1;CIRBP;PRKDC;RPS6KB1;LARP4;EIF4B;TOB1;DHX9;SYNCRIP;ENC1;DAPK1;IGF2BP3;EIF4G1;GEMIN5;LARP4B;PUM3;CAPRIN1;SAMD4B;FMR1;MALSU1;RPL10;MTIF2;TSFM;ALKBH1;CNOT1;MAPKAPK5;TRIM71;MTOR;LTN1;DDX6;TSC1;RBM4
prerank,myeloid leukocyte differentiation (GO:0002573),0.4128036366515583,1.1374404497052315,0.28205128205128205,0.8319115282030173,1.0,15/65,19.02%,FOXP1;BMP4;GAB2;VEGFA;RARA;TGFBR2;RXRA;PARP1;BATF3;E2F1;CDK2;CDKN1A;FARP2;DEK;PPARG
prerank,aminoglycan catabolic process (GO:0006026),0.4690458942642198,1.1374309340822897,0.29958391123439665,0.8311280514997802,1.0,2/28,2.08%,GPC6;GPC3
prerank,regulation of cell development (GO:0060284),0.4529811399620946,1.1366449258835247,0.3037135278514589,0.8327531842516264,1.0,6/36,9.52%,HES1;HDAC9;NOTCH2;DOCK7;BHLHE40;HES3
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3774181761041592,1.1365835822026449,0.24713242961418144,0.8321245753741562,1.0,43/170,19.46%,FOXP1;CDH1;AFF3;PRDM6;ATP1B1;YBX3;NELL1;LDLR;COQ7;PTHLH;SCARB2;AFF4;C1D;KIF16B;TSKU;HMG20A;TCF19;TRIM39;ZC3H12A;ZFP64;ANKRA2;POGZ;TRIM44;HMG20B;PRDM2;RFXANK;HINFP;NKAP;TOB2;MEGF8;CDK2;FLOT1;GDNF;PRDM5;PIN1;PRDM10;PCBP4;TOB1;PRDM4;PRDM11;IGF2BP3;ZUP1;EDN3
prerank,nucleotide-excision repair (GO:0006289),0.39890224215759945,1.1364705804070818,0.26666666666666666,0.8316786677324072,1.0,43/101,31.90%,ERCC5;SLX4;MNAT1;UVSSA;CHD1L;PARP1;RAD23B;COPS7B;COPS5;COMMD1;BRIP1;CDK7;SLC30A9;RNF111;GTF2H3;POLB;COPS8;BRCA2;POLR2C;CETN2;COPS3;RFC1;COPS2;ERCC4;TP53;USP7;UBB;HMGN1;ERCC8;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;POLA1;DDB2;POLD1;XPA;HUS1;GTF2H5;ATXN3;COPS7A
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5158985899370145,1.1364558802275615,0.3142857142857143,0.8309131569387986,1.0,2/15,4.62%,TGFB3;IRAK3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5527078715945889,1.136285380594612,0.3449367088607595,0.8306190858341267,1.0,2/11,2.89%,CAMK2D;CACNG6
prerank,cytoplasmic microtubule organization (GO:0031122),0.4270411780760994,1.1355771808414479,0.3008423586040915,0.8320686072800737,1.0,17/54,16.88%,EZR;CLIP4;CLIP1;PCM1;KATNAL2;LIMK2;HOOK3;CIB1;RHOA;CHP1;TUBGCP6;DLG1;FIGNL2;TUBGCP2;CAMSAP3;CRIPT;PLK3
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5433349749719603,1.1353839195249116,0.34579439252336447,0.8318853862160205,1.0,1/13,0.35%,SIX1
prerank,central nervous system myelination (GO:0022010),-0.4740702395267618,-1.1351475614486166,0.328804347826087,0.7131686209260103,1.0,4/11,16.62%,PLP1;TENM4;B4GALT6;ABCA2
prerank,establishment of vesicle localization (GO:0051650),0.5015560686500273,1.1351046118751327,0.32991202346041054,0.8319260775655841,1.0,7/18,20.15%,LIMK2;IKBKG;TMEM230;SPG11;KIF5B;SYNJ1;RAB11A
prerank,negative regulation of dephosphorylation (GO:0035305),-0.41145364172169696,-1.1348070228854557,0.26517571884984026,0.7122403540672003,1.0,4/18,9.55%,MFHAS1;PPP1R16B;YWHAB;SH3RF2
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.453100388637718,1.134600399824045,0.3103448275862069,0.8326923098999581,1.0,8/32,17.38%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF
prerank,regulation of phospholipase activity (GO:0010517),0.5749713089691948,1.1344025827438318,0.33695652173913043,0.8324768637369426,1.0,4/10,16.78%,LRP1;FGFR1;ANGPTL3;FGFR3
prerank,peptidyl-lysine modification (GO:0018205),0.3967295016329331,1.133914698266413,0.26460859977949286,0.8331836575478951,1.0,19/99,14.40%,PLOD2;HDAC4;HDAC9;LOXL1;NUP93;SAE1;NUP214;P3H3;TRPM4;NUP153;SENP5;IFIH1;ETFBKMT;LOX;ESCO1;NUP155;RANBP2;SIRT3;NUP88
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.534543630795558,1.133849678171203,0.33766233766233766,0.8325723542372329,1.0,5/13,21.51%,ALG13;ALG12;DPAGT1;ALG14;ALG8
prerank,regulation of tissue remodeling (GO:0034103),-0.4046388398524534,-1.1336121768587566,0.28013029315960913,0.7136277436245946,1.0,4/18,8.02%,LEPR;CST3;SYT7;IL18
prerank,peroxisomal membrane transport (GO:0015919),0.4748839087309364,1.1328324399233198,0.310935441370224,0.8348729721693882,1.0,5/27,10.08%,ABCD3;PXMP2;ABCD1;ACBD5;PEX13
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.5598617468637365,1.1327923062827654,0.34717607973421927,0.8341981308388515,1.0,3/10,13.01%,VEGFA;KDM1A;DISC1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.4748148841633547,1.1317915683552076,0.3223593964334705,0.8364821062804139,1.0,8/26,10.55%,ALPK1;TAB3;IKBKG;IFIH1;AAMP;RIPK2;MAP3K7;TAB2
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.47657480020378895,1.131524243825738,0.30567081604426005,0.8364715783350588,1.0,4/24,5.50%,PPP1R3B;IRS1;GSK3B;PPP1R3C
prerank,membrane raft organization (GO:0031579),0.5253829512118777,1.1310855787468008,0.32592592592592595,0.8370156323089146,1.0,5/15,16.22%,ANXA2;ABCA7;S100A10;NPC1;FLOT1
prerank,negative regulation of protein metabolic process (GO:0051248),0.42606932769184097,1.1305335150385398,0.3056234718826406,0.8378806212025027,1.0,16/48,21.26%,EGFR;LDLR;IRAK3;ITGAV;EIF2AK1;MAD2L1;CLU;MDM4;ITGB3;AZIN1;INHBB;PIN1;SNX12;HMGCR;SF3B3;IAPP
prerank,anterograde axonal transport (GO:0008089),0.44622845389723537,1.1304557291460675,0.3209242618741977,0.8373471620806126,1.0,11/37,18.54%,DLG2;KIF1B;AP3B1;KIF3B;AP3M1;KIF1C;RAB21;AP3D1;KIF5B;BLOC1S5;AP3S1
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4294722971504289,1.1301559747112893,0.30788804071246817,0.8374680597678069,1.0,11/43,13.65%,BMP4;DDR2;CCN1;NELL1;BMPR1A;BMP6;RUNX2;TMEM119;FBXO5;LRP5;ACVR1
prerank,negative regulation of protein secretion (GO:0050709),0.44532435295896183,1.1296682240971794,0.3248730964467005,0.8381826293229556,1.0,7/38,12.02%,CCN3;KCNB1;IRS1;RAB11FIP3;DPH3;SERGEF;DRD3
prerank,autonomic nervous system development (GO:0048483),0.5079504763723217,1.1292987932003424,0.3382352941176471,0.8384691351359711,1.0,3/17,7.38%,NRP1;NF1;FN1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3879078005525747,1.1288917257686766,0.2754880694143167,0.8389321567944233,1.0,45/121,24.31%,PRKCD;SAMD4A;PKP1;PSMB2;CNOT8;ZC3H14;APEX1;NUP214;PSMD11;ZC3H12A;XPO1;PSMC1;PABPC1;DHX36;PSMC6;EXOSC3;DCP1A;PRKCA;PSMD1;PSMD4;MOV10;EXOSC1;PCID2;PCBP4;PSMA6;MAPKAPK2;PSMD14;PSMD12;DIS3;PUM2;SERBP1;IGF2BP3;PSMD7;EIF4G1;EXOSC2;EXOSC7;PSME3;SAMD4B;PUM1;FMR1;CNOT1;PSMD3;PSMB6;UBB;EXOSC8
prerank,protein O-linked glycosylation (GO:0006493),0.3924758979574254,1.1288161795754525,0.3063973063973064,0.8383838916431021,1.0,8/96,5.27%,ST3GAL4;PLOD2;TMTC1;GXYLT2;B3GNT2;LARGE1;GALNT15;GALNT13
prerank,DNA damage checkpoint signaling (GO:0000077),0.464162619961055,1.1283689877689327,0.2923076923076923,0.8389508043869089,1.0,15/28,24.90%,CHEK2;CLSPN;CEP63;RAD17;E2F1;HINFP;BRIP1;USP28;INTS7;DONSON;ATR;NBN;CHEK1;ATM;RAD9A
prerank,regulation of protein transport (GO:0051223),0.4709107949908806,1.1277893531595695,0.3169705469845722,0.8398822287615987,1.0,9/27,19.09%,DISP1;WWP2;NDEL1;DNAJC1;P3H1;CHP1;GAPVD1;SNX12;STXBP5
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5573641376656073,1.1277420430687972,0.3487261146496815,0.8384260326974182,1.0,1/10,2.89%,CACNA1F
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5573641376656073,1.1277420430687972,0.3487261146496815,0.8384260326974182,1.0,1/10,2.89%,CACNA1F
prerank,regulation of intracellular protein transport (GO:0033157),0.45225860125648004,1.1275147345846448,0.324254215304799,0.8383085429239879,1.0,9/32,17.07%,BMP4;BCAS3;NDEL1;PCM1;TENM1;PCNT;VAMP2;PLK3;OAZ2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.36331386117832554,1.1274225133038236,0.069,0.8378031726057772,1.0,244/1082,17.72%,SIX1;BMP4;EGFR;PLAGL1;ZFHX3;KLF5;ZFPM2;TCF7L2;LRP6;NFIB;MET;MAP3K5;PKD1;HES1;HDAC4;CDH1;PID1;RARB;HOXA5;MLLT3;PPP3CA;CCN1;CSRP3;MEOX2;BMP5;WNT11;NFAT5;TCF20;NFIA;FGF2;PBX1;EHF;SOX9;GRHL2;PITX2;VEGFA;TGFB3;ZNF423;ESR1;NFE2L2;BMPR1A;ID2;GRHL1;DDX17;DCAF6;FZD1;FZD7;FOXC2;ZIC1;GLIS1;MLXIP;HOXC4;RARA;ELOF1;ELF1;BCAS3;KLF4;GLI3;TGFBR1;ABL1;RBM14;MDFIC;HDAC8;KLF7;HOXB3;IL33;MLLT10;MED13;NR4A3;TWIST1;KMT2C;STAT3;SHC1;FOXO3;KLF10;SKI;NFIX;MRTFA;CHEK2;ZBTB16;PER1;MEF2A;NFIL3;BMP6;MYSM1;GLI2;AGO2;HOXB4;ERBB2;GLIS2;REL;NR4A2;NCK2;INHBA;NRF1;WAC;CREBBP;RORA;SERTAD3;APEX1;E2F3;IKBKG;MED24;NFATC3;RHOQ;IRF1;SMAD2;KANSL3;ZC3H12A;MLX;MLXIPL;TLR4;EGR1;NFIC;GATA4;THRAP3;KDM1A;RUNX2;RXRA;GABPB1;GABPB2;CD80;FOXC1;ELF3;PPRC1;MAVS;ILF2;TADA3;ZFP64;ARNT;SIX4;GPATCH3;SLC9A1;SMARCC1;SCAF8;TASP1;RIPK2;ATF6;NSD1;TBL1X;POU4F1;TGFB1I1;PARP1;DHX36;CRTC2;WDR43;LPIN2;POGZ;ZFPM1;ATOH8;TRIM44;TEAD1;NAA15;TP53INP2;TFDP1;CDKN1C;JUP;RXRB;ARF4;JAG1;THAP3;NIBAN2;CRTC1;RPS6KA3;NCOA6;NR2F1;HSF2;BRCA1;NR1D1;ITGB1BP1;RET;LMX1A;SREBF1;NR4A1;RRP1B;E2F1;LRP5;HOXA7;PAXBP1;NFYA;SSBP3;NFATC1;RBMX;ACVR1;AATF;PRDM2;COPS5;HTATIP2;METTL23;RFXANK;HINFP;SP3;PIM2;ATF7IP;PPP1R12A;PITHD1;ATRX;NR3C1;AKIRIN2;BCL11B;POU2F1;CDK7;CCNT2;PLSCR1;DVL1;E2F2;MEF2D;NCK1;SLC30A9;KAT6B;CAPRIN2;PRKDC;RNF111;HOXD3;TRAF6;TNIP1;HIVEP3;PAX6;SMARCA5;MZF1;GDNF;ATF1;SMAD4;FOXK1;PIN1;IKBKB;ACTR2;PRDM10;YAP1;E4F1;CHD8;ESR2;BCL9L;HCFC1;KMT2D;SMAD7;NEK4;CAMTA2;UBTF;RNF20;PCID2;RNF14;PRDM15;UBP1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.42414343908670266,1.1273811200934063,0.2979242979242979,0.8371507303184601,1.0,15/52,16.75%,MBNL1;DDX5;RBFOX2;DDX17;CELF3;SRSF6;THRAP3;CELF4;RBM25;CELF1;WTAP;RBMX;KHDRBS1;RNPS1;MBNL2
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.5582275504876262,1.127309322963551,0.3560126582278481,0.8358037845928681,1.0,3/10,18.59%,AP2A2;AP2B1;AP2A1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.5582275504876262,1.127309322963551,0.3560126582278481,0.8358037845928681,1.0,3/10,18.59%,AP2A2;AP2B1;AP2A1
prerank,glycolipid biosynthetic process (GO:0009247),0.4443741108958007,1.1271650131285547,0.3124215809284818,0.8354293381182862,1.0,13/38,25.83%,ST3GAL4;LARGE1;PGAP2;PIGU;ST6GALNAC5;PIGO;DPM1;MPPE1;PIGG;PGAP3;PIGB;ST3GAL2;PIGQ
prerank,negative regulation of cell cycle process (GO:0010948),0.41340626620889553,1.1264757805997399,0.3026315789473684,0.8366606386434718,1.0,21/61,23.71%,BMP4;RAD51;EHMT1;EED;CBX5;RBBP7;TOM1L1;FBXO5;TFDP1;BRCA1;E2F1;CDC7;ZFYVE19;EPC1;SUZ12;WAPL;AURKAIP1;CHEK1;PCGF6;APAF1;RBBP8
prerank,mitotic DNA replication (GO:1902969),0.566524101793269,1.1255715457201594,0.3471337579617834,0.838566394727848,1.0,2/10,5.63%,CDC45;MCM2
prerank,DNA double-strand break processing (GO:0000729),0.5045936022871301,1.1254168768312955,0.3157894736842105,0.8382340905386256,1.0,11/18,29.04%,SLX4;BARD1;RAD50;RNF138;BRCA1;NBN;RAD52;ATM;RBBP8;SETMAR;UBE2N
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.43754217057635236,-1.125271779823595,0.3025210084033613,0.7352810928888541,1.0,7/15,23.24%,GGT5;GOT2;CHAC2;ALDH4A1;SARDH;GGT1;ABHD12
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5189336767401443,1.1250601407311325,0.35068912710566613,0.8377789311977719,1.0,5/15,18.54%,AP3B1;AP3M1;AP3D1;BLOC1S5;AP3S1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5189336767401443,1.1250601407311325,0.35068912710566613,0.8377789311977719,1.0,5/15,18.54%,AP3B1;AP3M1;AP3D1;BLOC1S5;AP3S1
prerank,androgen metabolic process (GO:0008209),-0.4120472397159134,-1.1249851672123736,0.28619528619528617,0.7340735206143403,1.0,12/18,46.51%,SPP1;MED1;SRD5A1;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,protein localization to chromosome (GO:0034502),0.45467399782720047,1.1249448965569442,0.31545338441890164,0.8373507625181076,1.0,15/34,27.83%,ESR1;PARP3;LEMD2;ATRX;RB1;MCM9;ATR;XRCC5;WAPL;TNKS2;XRCC4;SLF1;RAD21;MRNIP;PLK1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5089966757295826,1.1248405238685972,0.3465491923641703,0.8369082584883615,1.0,3/17,4.65%,EZR;UBASH3A;PTPN2
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.39558272406557377,1.1236472089626512,0.2917620137299771,0.8397832461513751,1.0,25/88,24.34%,FBXL7;PSMB2;AMN1;FBXL20;PSMD11;PSMC1;CUL1;FBXO27;PSMC6;FBXO31;FBXO48;PSMD1;PSMD4;FBXO17;PSMA6;PSMD14;PSMD12;PSMD7;FBXL6;PSME3;FBXL8;PSMD3;FBXW4;PSMB6;FBXW11
prerank,iron-sulfur cluster assembly (GO:0016226),0.4774189695975087,1.123471309649055,0.3210227272727273,0.8395196580222658,1.0,8/24,20.90%,GLRX3;HSCB;FXN;NUBP2;NUBPL;ISCA1;NFU1;IBA57
prerank,cAMP metabolic process (GO:0046058),-0.45417960014805275,-1.123088479937094,0.3211267605633803,0.7374542759310215,1.0,4/13,5.92%,ADCY5;ADCY1;PDE4D;ADCY7
prerank,positive regulation of vascular permeability (GO:0043117),-0.45182254829805046,-1.1230433178756916,0.2947976878612717,0.7356474852259703,1.0,2/12,1.73%,TJP1;OCLN
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5608937914262377,1.1227627012848524,0.3382352941176471,0.8408207569442098,1.0,4/10,17.24%,EGR1;CLU;SORL1;RB1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4611322288204539,1.122737249494483,0.3152317880794702,0.8400986170369781,1.0,10/33,19.03%,FHL1;KLF4;DACT1;FAM107A;CDKN2C;DLG1;CDKN1A;PLK3;RB1;WEE1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4575035130595014,1.1226102309689572,0.32669322709163345,0.8389180288551458,1.0,11/31,29.39%,RNMT;MNAT1;CDK7;GTF2H3;POLR2C;RNGTT;GTF2H4;CMTR2;RAMAC;CMTR1;ERCC2
prerank,7-methylguanosine RNA capping (GO:0009452),0.4575035130595014,1.1226102309689572,0.32669322709163345,0.8389180288551458,1.0,11/31,29.39%,RNMT;MNAT1;CDK7;GTF2H3;POLR2C;RNGTT;GTF2H4;CMTR2;RAMAC;CMTR1;ERCC2
prerank,regulation of cytoskeleton organization (GO:0051493),0.39060112692471893,1.122263473438407,0.28335170893054024,0.8391941013958083,1.0,22/108,10.43%,CLIC4;PRKCD;SORBS3;RHOBTB1;EZR;EFNA5;GSK3B;CDK10;CAPN2;PHLDB2;ABL1;ARHGAP44;LRP1;DIAPH1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3;PHLDB1;RHOA
prerank,synapse assembly (GO:0007416),-0.3082478805684106,-1.1222225131370367,0.17073170731707318,0.7358941407489186,1.0,16/67,5.97%,SPOCK2;CDH2;DNM3;GRID2;SHANK3;ADGRL3;NRXN1;WNT5A;KIRREL3;GABRB3;GPM6A;RYK;GABRA2;SDK2;GABRB2;PLXND1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.5454073453989953,1.121756552932415,0.34937888198757766,0.8399222774715264,1.0,2/12,12.02%,HES1;JAG1
prerank,transcription by RNA polymerase II (GO:0006366),0.36816859205032476,1.1215703280432787,0.22681451612903225,0.8396837276229708,1.0,81/305,19.88%,NR3C2;RNMT;RARB;MLLT3;DDX5;HDAC9;PRRX1;ESR1;NOTCH2;RARA;ELOF1;CDK12;NR4A3;AFF4;NABP1;NFIX;SETD2;MNAT1;NR4A2;MBD1;CREBBP;RORA;SNAPC2;NCOR1;E2F3;LSM11;ADRM1;INTS5;NCOR2;NFIC;RXRA;MED27;SCAF8;CDK13;TBL1X;PARP1;TEAD1;ZBTB1;TFDP1;RXRB;NR2F1;NR1D1;CEBPD;GTF2E1;INTS6;ELOA;NR4A1;NFYA;RBMX;NELFE;DDX21;GTF2A2;TAF4;NR3C1;POU2F1;CDK7;CCNT2;E2F2;SSU72;HSF2BP;GTF2H3;YAP1;ESR2;CPSF3;ZBTB7B;PCID2;INTS7;MED20;TAF5;DEK;ELL2;POLR2C;MED16;NFX1;PPARG;CSTF3;ELP4;CLP1;COPS2;CCNT1;NR1D2
prerank,response to acidic pH (GO:0010447),0.5302025958985275,1.1215539608090288,0.34276729559748426,0.8389610380260798,1.0,5/13,14.80%,GPR65;GPR4;SLC9A1;CHP1;RAB11B
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.48296423775091407,1.121303138753588,0.33751743375174337,0.8389391996240593,1.0,7/22,13.15%,NTRK3;NGF;KIDINS220;CIB1;RAB35;RAP1A;EHD1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3982336727233857,1.121251922812195,0.30221703617269546,0.8383149004851238,1.0,14/80,13.46%,THBS1;MAP3K5;NGF;VEGFA;KLF4;CD44;NLRP12;IGBP1;RPS6KA3;BCAP31;RAF1;DPEP1;ARL6IP5;CARD16
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.461240008795451,1.120868172475205,0.32407407407407407,0.8387199213012998,1.0,16/29,29.09%,ZC3H7A;AGO2;TUT7;DGCR8;TUT4;SMAD2;HNRNPA2B1;PUM2;MRPL44;PUM1;TRIM71;DICER1;PRKRA;DROSHA;AGO1;SMAD1
prerank,regulation of vasoconstriction (GO:0019229),0.4647465507128816,1.1208285883446039,0.3208053691275168,0.838070831512567,1.0,4/27,8.51%,KCNMB2;ADRA1B;ECE1;TRPM4
prerank,intraciliary retrograde transport (GO:0035721),0.5377970054827175,1.1207486689180006,0.36037441497659906,0.8375292989073143,1.0,5/12,21.80%,WDR35;DYNC2I2;DYNC2I1;IFT43;DYNC2H1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3885057803443026,-1.120585463480855,0.27702702702702703,0.7384852989083612,1.0,6/22,8.39%,SLC16A2;TOX;NES;TAFA1;GATA2;PROX1
prerank,regulation of B cell differentiation (GO:0045577),0.5000069773131697,1.1205132569212686,0.32507739938080493,0.8374221959303476,1.0,3/17,6.79%,ID2;PPP2R3C;INHBA
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.5351183273007172,1.120377500317995,0.34915773353751917,0.8370247405355441,1.0,2/14,2.99%,NT5C1A;NT5E
prerank,respiratory system development (GO:0060541),0.4541405635483577,1.1196357089610525,0.3293492695883134,0.838520434413763,1.0,5/32,6.46%,BMP4;DISP1;FGF2;VEGFA;GLI2
prerank,microtubule depolymerization (GO:0007019),-0.417415960339627,-1.119401645200199,0.3037249283667622,0.7398981122182448,1.0,10/17,26.36%,STMN1;STMN4;STMN3;NCKAP5;STMN2;CKAP5;KIF2A;NCKAP5L;KIF14;KIF19
prerank,protein methylation (GO:0006479),0.4396918061553059,1.1192131230437505,0.3241551939924906,0.8390206318076571,1.0,10/40,13.30%,PCMT1;RAB6A;PRMT8;EHMT1;GSPT1;ETFBKMT;NSD1;ETF1;EEF2KMT;PRMT5
prerank,zinc ion homeostasis (GO:0055069),-0.37109428673028777,-1.1191625466152009,0.2723735408560311,0.738656679012805,1.0,16/28,20.31%,SLC30A10;SLC39A10;SLC39A8;SLC30A1;SLC39A12;ATP13A2;MT3;MT2A;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G
prerank,glycoprotein metabolic process (GO:0009100),0.4167720780324676,1.1182377175633489,0.3108108108108108,0.8411098128123865,1.0,14/53,16.72%,ST3GAL4;FUT8;LARGE1;MAN2A1;ST8SIA2;GAL3ST4;MAN1B1;FBXO27;GANAB;MAN2B1;TNIP1;GOLPH3;OGA;FBXO17
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4138739544133816,1.1177755059099441,0.304029304029304,0.84178021782176,1.0,18/60,19.08%,TCF7L2;SOX9;MED13;MED24;CCND1;RUNX2;MED27;CCNB1;DHX36;MECP2;MED15;ATF7IP;MED31;CDKN1A;MOV10;MED20;MED16;MED25
prerank,cellular response to light stimulus (GO:0071482),0.40597614555725525,1.1174609830510271,0.2986857825567503,0.8419321391685274,1.0,19/66,24.41%,NEDD4;PRKCD;PDE6A;CREBBP;KDM1A;PARP1;DHX36;EIF2S1;ZBTB1;PDE6B;USP28;USP47;ATR;ERCC4;YY1;FMR1;TP53;CNGB1;INO80
prerank,sphingolipid biosynthetic process (GO:0030148),-0.30554961232982963,-1.1172470356769655,0.20270270270270271,0.7421984677287443,1.0,25/71,16.95%,PRKD1;CERS4;ACER2;CERT1;SGMS1;ELOVL7;DEGS2;ST8SIA1;HACD3;HACD1;B4GALT6;SPHK1;CSNK1G2;ASAH1;HACD2;VAPA;CERS2;SPNS2;ALDH3B1;CERS1;SMPD1;SPTLC2;ELOVL6;CLN8;ST8SIA5
prerank,prostanoid biosynthetic process (GO:0046457),-0.42561146242558834,-1.1172096892526233,0.2883435582822086,0.7403822531576547,1.0,9/15,24.51%,PTGDS;PTGS1;EDN1;TBXAS1;MIF;CD74;PNPLA8;PTGS2;PRXL2B
prerank,regulation of chromosome organization (GO:0033044),0.476229051398994,1.117031858912349,0.330028328611898,0.842395887168994,1.0,7/22,20.35%,HDAC8;SMG6;YLPM1;RB1;RMI2;XRCC5;WAPL
prerank,regulation of cell differentiation (GO:0045595),0.38048645302795225,1.1167640365925702,0.286480686695279,0.8424202031189308,1.0,26/148,12.72%,SIX1;ZFHX3;SMOC1;DDX5;NGF;ID2;DDX17;KLF4;PHLDB2;TGFBR1;PTHLH;FGFR1;NF1;TIAM1;CREBBP;LTBP4;RUNX2;ST7;PHLDB1;EIF2AK2;PDCD2;NLGN1;RPS6KA3;RAF1;NR1D1;CEBPD
prerank,negative regulation of cellular process (GO:0048523),0.3629949953009814,1.1165963236141336,0.173,0.842164371255619,1.0,78/521,13.12%,SLIT3;SLIT2;ZBTB7C;FHL1;BMP4;CCN3;WNT9A;CCN5;NDRG3;OSGIN2;CCN1;CYP1B1;SMAD6;PTPRU;BMP5;WNT11;ABI1;VPS13C;PTK2B;FGF2;SLURP1;SRGAP2;TES;NGF;CLMN;CD9;SFRP4;ARHGDIB;TGFB3;CDK10;KLF4;PTHLH;TBRG1;PTPN2;KLF10;TEX15;NDUFS3;SKI;FRK;EMILIN1;LMNA;NCK2;INHBA;STRN;TENM1;SERTAD3;SRSF6;AGR2;IP6K2;IRF1;P3H3;BECN1;P3H1;CDKN2C;SFRP5;PDCD4;MIA3;PPP2R5C;CIB1;RBBP7;TGFB1I1;EIF2AK2;BTG3;EPHB2;FBXO5;ATG5;GNRH1;IFI35;NIBAN2;CLU;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1;NR4A1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.4435334881185749,1.1165176001079633,0.3390052356020942,0.8416263890437123,1.0,11/33,22.26%,TELO2;RAD51;STN1;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;ZBTB48;PPP6C
prerank,skeletal muscle contraction (GO:0003009),-0.40129466821217297,-1.1163633670776874,0.3118279569892473,0.7408250409753507,1.0,7/19,30.41%,RCSD1;STAC;STAC2;MYH14;STAC3;CCDC78;TCAP
prerank,eosinophil migration (GO:0072677),0.5273053499423755,1.1158563038111162,0.3787878787878788,0.8421030887438566,1.0,3/14,9.92%,CCL3;CCL1;CCL7
prerank,eosinophil chemotaxis (GO:0048245),0.5273053499423755,1.1158563038111162,0.3787878787878788,0.8421030887438566,1.0,3/14,9.92%,CCL3;CCL1;CCL7
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.44779743972875297,-1.1158055713780326,0.32558139534883723,0.7405344353481921,1.0,2/13,3.89%,IGF1;INSR
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4830685459861384,1.11568475593068,0.34173669467787116,0.8418291364813355,1.0,4/21,4.96%,IGFBP5;FGF2;BMPR1A;NR4A3
prerank,transcription by RNA polymerase I (GO:0006360),0.44110478219066335,1.1155579408427274,0.3363994743758213,0.8414636608438001,1.0,10/34,22.37%,POLR1G;POLR1A;MNAT1;TAF1D;CDK7;GTF2H3;POLR1F;UBTF;TTF1;TBP
prerank,adipose tissue development (GO:0060612),-0.46374218661423205,-1.1153501283226506,0.32954545454545453,0.7398958227179575,1.0,6/11,25.44%,ARID5B;SPTLC2;XBP1;DYRK1B;RORC;NAMPT
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4567233480516832,1.1153034712981154,0.3328729281767956,0.8414803956866845,1.0,15/29,29.80%,DCUN1D5;ABL1;FEM1B;FBXO5;DCUN1D2;PIN1;SMAD7;DCUN1D1;BAG5;AXIN1;TOPORS;PLK1;ARRDC3;UBE2N;DTX3L
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43438152018096554,1.1152524660556906,0.3333333333333333,0.8408789155225307,1.0,5/39,9.27%,THBS1;NFE2L2;ANO6;KRIT1;PDCD4
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.4436857588550114,-1.1144725088677028,0.3285302593659942,0.7403865946525454,1.0,3/12,9.60%,IGF1R;INSR;FYCO1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.4558612009387984,1.1144484126307208,0.33201058201058203,0.8425599708150115,1.0,3/27,2.15%,CAMK2D;ANK2;AHNAK
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4537647303496989,-1.1142285975824897,0.32320441988950277,0.7392038222452803,1.0,2/12,3.89%,IGF1;INSR
prerank,regulation of Notch signaling pathway (GO:0008593),0.4019584334856636,1.1139926339257946,0.31206496519721577,0.8430735330464426,1.0,17/76,12.97%,EGFR;CCN3;TCIM;WWP2;STAT3;CREBBP;ELF3;AAK1;NEPRO;GALNT11;CD46;JAG1;NIBAN2;SYNJ2BP;POFUT1;NRARP;ITGB1BP1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5050073716493605,1.1139202498263885,0.34841628959276016,0.84253545206328,1.0,5/16,8.90%,GSN;PTK2B;BCAS3;SHTN1;KRIT1
prerank,regulation of neuron death (GO:1901214),-0.2907642746020105,-1.1138904998947956,0.25833333333333336,0.73814689516402,1.0,24/82,16.93%,EFNB2;GRID2;EPHB1;WNT5A;PICALM;DCC;CSF1;GRIN2B;TRIM2;RRAS2;MEF2C;PPARGC1A;CD34;FAIM2;CD200;MAPT;C1QA;CHGA;SARM1;BTBD10;TYROBP;CTSZ;CD200R1;ATP13A2
prerank,neuron projection morphogenesis (GO:0048812),-0.2747558897034723,-1.1137298151737312,0.2153846153846154,0.7367071524966262,1.0,28/137,8.14%,DOCK10;TNIK;CNTNAP2;DCDC2;SHANK3;ANK3;PAK1;EPHB1;CTNNA2;MAP2;APP;CNTN4;DCC;MYO16;PAK3;GPM6A;DSCAML1;BAIAP2;RYK;ACTB;EPB41L3;MAP4K4;BMP7;ZDHHC17;SGK1;DAB2IP;NRK;LMTK2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.4757824715832595,1.1136558936827263,0.34225352112676055,0.8424998878257327,1.0,13/22,27.86%,ERI3;URB1;EXOSC3;ERI1;KRI1;WDR12;EXOSC2;EXOSC7;PES1;NOP14;EXOSC8;FTSJ3;ERI2
prerank,cytosolic calcium ion transport (GO:0060401),0.4621001570790891,1.11318837066393,0.3324468085106383,0.8430861760827119,1.0,2/28,0.97%,SLC35G1;CACNA1C
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.46654823736461426,1.1128065245939636,0.325452016689847,0.8434713328519416,1.0,5/27,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.45806664728323604,-1.1126788387107915,0.3372093023255814,0.7378861807809359,1.0,4/12,5.53%,NKD1;PROM1;RORB;SDK2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5527300861829605,1.1122227078873432,0.3624382207578254,0.8444426870497449,1.0,4/10,18.39%,GSK3B;PARD6A;BICD1;UBXN2B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.44915773434457806,1.1118545732574256,0.32313829787234044,0.8447812402955562,1.0,2/33,0.19%,SLIT2;THBS1
prerank,negative regulation of cellular senescence (GO:2000773),-0.43985278818298895,-1.111618412701747,0.3342776203966006,0.7389923417999219,1.0,3/13,3.88%,AKT3;SLC30A10;CDK6
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.39401656331436913,1.1115456846718526,0.3249714937286203,0.8449305860688757,1.0,16/80,17.50%,THBS1;SLC2A13;PRKCD;SAMD4A;NIBAN1;ERBB2;EIF3E;EIF6;RBM3;CLU;NAT10;SIRT3;CIRBP;PRKDC;RPS6KB1;LARP4
prerank,cellular response to ionizing radiation (GO:0071479),0.42113158327486183,1.110405858727172,0.32138442521631644,0.8475110083655445,1.0,19/47,25.37%,TANK;NIPBL;RAD51;SPIDR;WRN;KDM1A;TNKS1BP1;CDKN1A;YAP1;INTS7;ATR;TLK2;XRCC5;ATM;TP53;INO80;RAD9A;RAD9B;KDM4D
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.44317362090369083,1.110203963904922,0.33419354838709675,0.8473629644832759,1.0,9/36,13.19%,EZR;KLHL31;PER1;DACT1;NCOR1;DUSP19;QARS1;IGBP1;DLG1
prerank,hepaticobiliary system development (GO:0061008),0.48260220506725077,1.1102023963612486,0.34852941176470587,0.8466045819817726,1.0,4/20,5.44%,MET;COBL;NIPBL;NF1
prerank,limb development (GO:0060173),0.46356319339342583,1.110181590046405,0.33520336605890605,0.8459011237403541,1.0,4/28,4.74%,PCSK5;SMOC1;GLI3;NOG
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.489094602784526,1.110160443802935,0.34649122807017546,0.8452116265369282,1.0,2/19,2.28%,THBS1;CMKLR1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3965462317861539,1.1098120894951233,0.3174061433447099,0.8454594639393405,1.0,12/85,7.32%,BMP4;EGFR;TCF7L2;BMP5;FGF2;SOX9;VEGFA;LIMS1;NR4A3;BMP6;ERBB2;SRSF6
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.4025647262275318,1.1098049690165577,0.3244803695150115,0.8447290452181468,1.0,19/76,18.27%,HDAC4;TANK;PRICKLE1;DCUN1D5;SAE1;FAM107A;ZC3H12A;CUL3;RIPK2;WDR48;BRCA1;COMMD1;DCUN1D2;TRAF6;TNIP1;SMAD7;DCUN1D1;LRRK2;MYCBP2
prerank,protein-containing complex assembly (GO:0065003),0.3655238932690677,1.1093153436657721,0.24721377912867273,0.8454662437591327,1.0,63/259,18.09%,FBXL7;TCF7L1;TCF7L2;HES1;REPS2;PTK2B;SOX9;ANO6;GSK3B;TLE2;SEC16A;SLC7A9;MNAT1;TIAM1;PYGO2;CREBBP;SHANK1;SEC31A;FN1;SEC24B;IKBKG;DMTN;CSNK1A1;ZC3H12A;SEC23A;CUL3;EPRS1;ANKRD28;CUL1;SLC9A1;CDC123;SEC24D;PYGO1;SEC23IP;PPP6R3;DET1;TEAD1;MCU;NSF;STX5;ZW10;TRAF2;PARD3;MDM4;ITGB1BP1;DMD;TRAPPC3;TRAPPC10;CAPZA1;GOSR2;AFDN;RAB1A;TUBGCP2;VAMP2;YAP1;ADCY8;BCL9L;KMT2D;FARP2;LRRK2;TRRAP;NCKAP1L;TRAPPC9
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.31464253879801984,-1.1089249311642304,0.24873096446700507,0.7444790481039328,1.0,9/49,8.02%,IGF1;LYN;IL31RA;KIT;ERBB4;IL6R;PARP14;GHR;IL18
prerank,positive regulation of tissue remodeling (GO:0034105),-0.47810881733517074,-1.1088743954093188,0.33678756476683935,0.7427471665503744,1.0,2/10,8.02%,ROCK2;IL18
prerank,histone mRNA metabolic process (GO:0008334),0.455817742707634,1.108447115616096,0.34864864864864864,0.8473218844010305,1.0,8/27,17.28%,TUT7;LSM11;TUT4;TENT2;ERI1;SSB;CPSF3;TENT4B
prerank,long-chain fatty acid import into cell (GO:0044539),-0.47065400292457227,-1.1084320514907011,0.3481675392670157,0.7420708161619928,1.0,2/10,1.44%,ACSL1;SLC2A1
prerank,cellular response to cadmium ion (GO:0071276),0.4743291690050592,1.1082411928215792,0.34691011235955055,0.8471479793069079,1.0,1/24,0.41%,EGFR
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.46664871260654067,1.1081629068567207,0.35935397039030953,0.8466180363177317,1.0,8/26,11.72%,EGFR;CDK10;ANXA1;LSM11;CCND1;RDX;ANKRD17;TFDP1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5403989244765953,1.1081254673293632,0.37767584097859325,0.8459637521093533,1.0,7/12,27.04%,PAICS;LHPP;ADSS2;GMPS;ADSL;PFAS;ATIC
prerank,endomembrane system organization (GO:0010256),0.3730131940695135,1.1076109642067167,0.28722280887011614,0.8467316860539196,1.0,50/178,18.40%,ATL3;ARHGAP21;GORASP2;BCAS3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;RAB43;NUP93;LMAN2L;GOLGB1;SEC31A;SEC61A1;CSNK1A1;PLEKHM2;WASHC4;PHETA2;HOOK3;MIA3;GAK;TLCD1;LEMD2;FBXW8;PLEKHF1;SEC23IP;WASHC5;DOP1B;ZW10;NUP155;SPTSSB;TRAPPC11;AP3D1;TOR1B;ATL1;ANXA8;ANXA8L1;BNIP1;CHMP2B;GOLPH3;ARFGEF1;RAB1A;SURF4;LRRK2;BAG5;COG3;UBXN2B;ATP8B4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4587052694817044,1.1075502737942913,0.3351724137931035,0.8461639409910948,1.0,5/28,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.44847142006670476,-1.1070723810611973,0.33242506811989103,0.7439125903580358,1.0,6/13,15.51%,ELOVL7;HACD3;HACD1;HACD2;TECRL;ELOVL6
prerank,protein polymerization (GO:0051258),0.4139377188446814,1.1069963190531864,0.33292383292383293,0.847120006204827,1.0,10/55,12.73%,COBL;GSN;FGF13;MAP7D3;PSTPIP1;DIAPH1;FAM107A;HDGFL3;WASHC5;UBE2K
prerank,glial cell development (GO:0021782),-0.3784785572827643,-1.1064954620638008,0.31970260223048325,0.7436474396711003,1.0,8/25,17.26%,APP;CDK6;NRROS;CSPG5;EIF2B1;SOX4;NSUN5;MT3
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4645302397164781,-1.106486144300527,0.33080808080808083,0.7418204360998487,1.0,2/11,3.58%,IL34;CSF1
prerank,lipid droplet formation (GO:0140042),0.541312677169656,1.1064065016256388,0.361198738170347,0.8481695744177419,1.0,5/10,19.00%,ZFYVE1;SMIM22;SQLE;CDS1;FITM2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.47315066303698006,-1.105779154155543,0.3359173126614987,0.7419243086289508,1.0,4/10,14.65%,APOE;DBI;TMEM30A;ABCB4
prerank,Rap protein signal transduction (GO:0032486),-0.4791784773964921,-1.1056814188519948,0.34444444444444444,0.7403169981320734,1.0,4/10,11.28%,RAPGEF3;RAPGEF2;RAP2A;PLK2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5408034147356127,1.1048020821875288,0.3617363344051447,0.8522296513413429,1.0,6/11,15.90%,THBS1;CREB3L1;SYNJ2BP;EPN1;E2F2;ALOX5
prerank,DNA integrity checkpoint signaling (GO:0031570),0.4396618483268614,1.104601342378988,0.3257978723404255,0.8521019359432919,1.0,18/36,25.29%,CDC45;CHEK2;CLSPN;CEP63;RAD17;E2F1;HINFP;BRIP1;USP28;INTS7;DONSON;ATR;NBN;CHEK1;ATM;RAD9A;CDC6;RAD9B
prerank,metallo-sulfur cluster assembly (GO:0031163),0.4718665519685689,1.1038541984215453,0.34285714285714286,0.8536011285126831,1.0,7/22,20.90%,HSCB;FXN;NUBP2;NUBPL;ISCA1;NFU1;IBA57
prerank,negative regulation of neuron differentiation (GO:0045665),0.4762279333200541,1.1037956764909738,0.3588317107093185,0.8530258413766995,1.0,5/22,11.00%,HES1;SOX9;GSK3B;HES3;NEPRO
prerank,negative regulation of binding (GO:0051100),0.3925545275492535,1.1031989322753755,0.32994350282485874,0.8539957942612398,1.0,36/81,25.27%,PRKCD;MDFI;SMO;GSK3B;DACT1;AURKA;BTAF1;KDM1A;TMC8;ZFPM1;CPNE1;ITGB1BP1;DISC1;E2F1;CARD16;SORL1;DDX11;DVL1;CDKN1A;PSME3IP1;PIN1;LRRK2;RALB;JAK2;BAG2;WAPL;SLPI;DNAJB2;GTPBP4;STYX;DAB2;GNL3L;USP33;RSF1;CSNK1E;JUN
prerank,protein deneddylation (GO:0000338),0.5491295516966456,1.1031398317343768,0.3619344773790952,0.8534310025905572,1.0,5/10,19.75%,COPS7B;COPS5;COPS8;COPS3;COPS2
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.5262246951409282,1.1028408655438426,0.3683409436834094,0.8535571766369138,1.0,1/13,2.25%,GAB2
prerank,aerobic electron transport chain (GO:0019646),-0.2986976126018701,-1.1026677101424356,0.29931972789115646,0.7468091756471181,1.0,29/68,26.08%,COX7B;NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;AFG1L;COX5B;NDUFC1;NDUFV3;UQCR10;SDHA;NDUFB11;UQCRC1;CYCS;COX7C;CYC1;SDHC;NDUFA7;COX6C;COX6B1;NDUFA11;NDUFB6;NDUFB8;NDUFA3;COX4I2;UQCC3;NDUFA1;UQCRQ
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.41755130007340446,1.1023769955852543,0.3312421580928482,0.8542342583410848,1.0,5/48,6.07%,UBASH3B;CAMK2D;ANK2;PTK2B;DIAPH1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4015371926466278,1.1023173293419037,0.3321637426900585,0.8536654044805564,1.0,14/68,13.32%,LBP;RAB7B;PLCG2;TLR1;IL33;TWIST1;STAT3;IL17RA;TLR4;MAVS;IFIH1;TLR8;MYD88;TIRAP
prerank,excitatory postsynaptic potential (GO:0060079),-0.39375495829000895,-1.1018579049446364,0.30094043887147337,0.7472040777688672,1.0,5/19,5.95%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3709241480023843,-1.1018407538387827,0.3041958041958042,0.7453885079208068,1.0,9/26,16.60%,SHANK3;ROCK2;SYNPO2;FHOD1;RAC1;SYNPO;CX3CL1;PLEK;ALMS1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.26240036182826126,-1.1017793724077225,0.16923076923076924,0.7437092558283408,1.0,34/163,14.36%,PRKCB;PDE4B;BCL2;RFTN1;PAK1;PIK3R1;TEC;FYB1;INPP5D;PAK3;TNFRSF21;PDE4D;PRKCQ;MEF2C;VAV3;THEMIS;CD38;BTRC;PSMD8;PSMC3;PSMB4;BMX;PTPRJ;PAG1;NFATC2;MOG;PSMB3;SH2B2;PIK3CA;ICOSLG;PTPN22;PSMB8;BLNK;BTN3A3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.5434063952659134,1.1017435529675033,0.395,0.8546002532933563,1.0,2/10,3.78%,DSE;XYLT1
prerank,DNA-dependent DNA replication (GO:0006261),0.38035744240966246,1.1016490560897483,0.31106243154435925,0.8541103496217579,1.0,44/128,26.46%,REV3L;PSMB2;CDC45;MCM2;RAD51;WRN;TOPBP1;PSMD11;HELB;PSMC1;PRIM1;POLE2;PSMC6;ORC3;DDX21;PRIMPOL;PRIM2;PSMD1;MCM7;PSMD4;CDK2;CDC7;POLG2;POLB;RECQL5;PSMA6;PSMD14;PSMD12;POLA2;PSMD7;RFC1;BAZ1A;PSME3;SRPK2;HMGA1;CDK2AP1;PSMD3;PSMB6;UBB;RECQL;CDC6;UBA52;MGME1;RPS27A
prerank,regulation of brown fat cell differentiation (GO:0090335),0.5046455857099766,1.101629316257545,0.3684210526315789,0.853425802636794,1.0,1/16,0.35%,SIX1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.38094909948852373,1.1009143421578527,0.3134160090191657,0.8548307488919068,1.0,23/107,16.22%,THBS1;MAP3K5;TMEM117;NIBAN1;GSK3B;ERP27;GORASP2;SEC16A;AGR2;RNF185;VCP;ATF6;CREB3L1;EIF2S1;HERPUD1;TRAF2;BCAP31;UBA5;TMEM33;SEL1L;NCK1;TMTC3;FLOT1
prerank,response to cadmium ion (GO:0046686),0.4655286214316885,1.100851180835116,0.35465924895688455,0.8542754007845736,1.0,1/26,0.41%,EGFR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.29852159870520184,-1.1004206282651423,0.30201342281879195,0.7457097601086662,1.0,29/69,26.08%,COX7B;NDUFB9;NDUFA4;UQCRH;NDUFA13;COX4I1;AFG1L;COX5B;NDUFC1;NDUFV3;UQCR10;SDHA;NDUFB11;UQCRC1;CYCS;COX7C;CYC1;SDHC;NDUFA7;COX6C;COX6B1;NDUFA11;NDUFB6;NDUFB8;NDUFA3;COX4I2;UQCC3;NDUFA1;UQCRQ
prerank,positive regulation of cell motility (GO:2000147),0.3653229226828051,1.0998911318287856,0.2851196670135276,0.8564420318036782,1.0,33/205,9.92%,F3;THBS1;EGFR;NTN1;NTRK3;ADAM9;TWIST2;PPP3CA;CCN1;SEMA3E;WNT11;PTK2B;ELP3;VEGFA;SMO;CCL3;SEMA3C;TGFBR1;CCDC25;TWIST1;PDGFC;STAT3;SEMA3D;MYOC;TIAM1;SMIM22;ITGB1;FAM107A;CEP43;RDX;CIB1;PIK3R3;CCL7
prerank,ubiquinone metabolic process (GO:0006743),0.5108095512998303,1.0998567322391428,0.36950146627565983,0.8557968050261516,1.0,3/15,7.56%,COQ7;COQ10B;PDSS2
prerank,metal ion transport (GO:0030001),-0.28532441958530924,-1.0997858975429493,0.25806451612903225,0.7456731689565141,1.0,22/86,11.85%,ITPR1;CACNA1D;SLC8A1;CACNA1E;RYR2;TRPC3;ATP2C1;CALCRL;SLC39A8;CACNA1B;CACNA2D1;TRPC4;CACNG7;TRPC1;ATP2A3;NIPA1;SLC8A3;SLC30A1;NIPAL4;CACNG3;MMGT1;TPT1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3423334056817097,-1.0996605102708983,0.2988505747126437,0.7441868354954828,1.0,9/39,7.73%,TJP1;APOE;TIE1;RAPGEF2;ROCK2;NOTCH1;HSPA8;DAB2IP;GFAP
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3338280244530327,-1.0992431482087583,0.3058252427184466,0.7435285068867674,1.0,9/35,9.75%,ITGA1;PDGFRB;PPP4R4;NUAK1;PPP1R15B;CALM1;HSP90AB1;CD300A;MAGI2
prerank,regulation of DNA binding (GO:0051101),0.4277633600107839,1.0991886678965532,0.3486590038314176,0.8570257632981951,1.0,15/44,21.00%,HES1;MDFI;NGF;SMO;SKI;KDM1A;FOXC1;HJURP;CPNE1;E2F1;PPARG;JAK2;CEBPG;ZBTB7A;EGF
prerank,B cell differentiation (GO:0030183),0.41998562969683617,1.0989905920377059,0.3515527950310559,0.8568461359273086,1.0,6/46,7.67%,HDAC4;HDAC9;CLCF1;PLCG2;PTPN2;ITGB1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.42032139742618724,-1.0985096045158147,0.3313953488372093,0.7437229597721916,1.0,3/13,8.59%,DDO;ASPA;GOT2
prerank,regulation of protein modification process (GO:0031399),-0.3152097977356819,-1.0984079376082485,0.25824175824175827,0.7422285856195557,1.0,16/50,19.80%,LYN;PPP1R16B;GRM5;SPRED1;CADM4;HSPB1;CDH5;PTK2;FNIP2;CCDC88A;ABCA2;MT3;CCDC88C;STAT2;PPIB;FNIP1
prerank,protein localization to plasma membrane (GO:0072659),0.375623976145908,1.0983025384208924,0.31896551724137934,0.8581541680480629,1.0,29/129,13.19%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;NECTIN3;GORASP2;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;PLEKHF1;RAP1A;JUP;PIP5K1A;ITGB1BP1;EHD1;DLG1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4689979053623955,1.0982926567158375,0.3641791044776119,0.8574320443875756,1.0,4/20,1.98%,CACNA1C;CAMK2D;ANK2;ATP1B1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.46920283940688345,1.0981792926058844,0.3497191011235955,0.8570030171799532,1.0,7/23,17.53%,SEC16A;RANGRF;VCP;HERPUD1;SEL1L;TMEM129;SURF4
prerank,cytoskeleton organization (GO:0007010),0.3743382373336188,1.0979677513743147,0.31788793103448276,0.8568821762362625,1.0,21/114,11.72%,MICAL2;PLCE1;MARK1;FMNL2;RHOBTB1;STRIP2;ARHGAP10;CCL3;PPP2R3C;DIAPH1;SPRYD3;ZMYM4;DMTN;PCLO;RND3;MAST2;PDZD8;CCL7;RHOA;DPYSL2;FGD1
prerank,actin-myosin filament sliding (GO:0033275),-0.3237472728002491,-1.0979571092081184,0.2943722943722944,0.7399400702437123,1.0,15/38,31.18%,ACTN2;TPM2;DES;TMOD1;MYBPC1;TTN;VIM;MYL1;TPM1;MYL6;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,muscle filament sliding (GO:0030049),-0.3237472728002491,-1.0979571092081184,0.2943722943722944,0.7399400702437123,1.0,15/38,31.18%,ACTN2;TPM2;DES;TMOD1;MYBPC1;TTN;VIM;MYL1;TPM1;MYL6;MYBPC2;TCAP;MYL3;ACTA1;MYH6
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3922534653564777,1.0976182555304868,0.34902411021814006,0.857186655533331,1.0,11/80,7.72%,PLCE1;CDC42EP5;DPYSL3;ARAP1;NRP1;TGFB3;PALM;BCAS3;NDEL1;TENM1;RHOQ
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5391873717105949,1.097370953953598,0.3655737704918033,0.8571564410743517,1.0,2/10,7.33%,BMP1;ABCA7
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5542174129679004,1.0973085791622905,0.3633440514469453,0.8565955965148179,1.0,6/10,26.36%,ETFDH;ETFA;ACADL;ACADS;ACADVL;ACADM
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4310208690500706,1.0972229190628673,0.3453145057766367,0.8561191222688334,1.0,18/40,24.23%,TCF7L2;TGFB3;TGFBR1;TWIST1;TIAM1;TGFBR2;SMAD2;FOXC1;TGFB1I1;JAG1;SMAD4;BCL9L;FERMT2;GCNT2;SNAI1;CRB2;DAB2;MTOR
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4551991825886438,-1.096994875793835,0.3258426966292135,0.7407782043126642,1.0,4/11,17.39%,EFNB2;MEF2C;MYOCD;GREM1
prerank,translesion synthesis (GO:0019985),0.43162753183459546,1.0969768908356143,0.35199004975124376,0.8561153487317515,1.0,15/42,26.46%,REV3L;VCP;POLE2;ZBTB1;POLI;PRIMPOL;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBA52;POLK;RPS27A
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3626631321096692,1.0966340280948335,0.29025641025641025,0.8564165437390632,1.0,56/234,18.46%,CARD14;SLCO3A1;LRP6;HDAC4;DDR2;PLPP3;EDA;ERC1;VEGFA;ESR1;SMO;FZD1;RAB7B;RIPK4;PLCG2;IRAK3;STAT3;TAB3;ROR1;IKBKG;IKBKE;TLR4;ANXA3;KDM1A;PPRC1;MAVS;CIB1;RIPK2;MAP3K7;TAB2;CRTC2;EIF2AK2;TRIM41;TFDP1;JUP;CLU;MYD88;CRTC1;TRAF2;TIRAP;MTDH;CARD16;COPS5;PIDD1;TRAF6;FLOT1;TRAF5;IKBKB;ADCY8;ESR2;PSMA6;STK3;RBCK1;ATF2;TICAM1;DHX9
prerank,protein heterooligomerization (GO:0051291),0.49318453636162624,1.0965090366209724,0.362406015037594,0.8560535360489588,1.0,2/17,2.72%,PKD1;TMEM120A
prerank,protein K63-linked ubiquitination (GO:0070534),0.4281265730498119,1.0963617716306868,0.33374844333748444,0.8557305233995566,1.0,12/41,17.68%,NEDD4;WWP2;RNF126;TRAF3IP2;RNF115;TRAF2;RNF8;UBE2B;TRAF6;UBE2O;TRAF5;UBE2S
prerank,DNA packaging (GO:0006323),0.5045191970888241,1.0960066101325288,0.3716417910447761,0.8560478766669597,1.0,6/16,27.27%,CHAF1B;CHAF1A;AIFM1;TP53;KAT6A;HAT1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3696455030716384,1.0958576421516368,0.304257528556594,0.855734160250669,1.0,29/186,9.09%,NXN;TCF7L2;LRP6;TRABD2B;MLLT3;PTPRU;WNT11;PRICKLE1;MDFI;SOX9;SFRP4;GSK3B;GRB10;PSMB2;GLI3;INVS;TLE2;EMD;NOG;LRP1;DACT1;TSKU;DKK3;PSMD11;CSNK1A1;NLK;CUL3;SFRP5;PSMC1
prerank,ncRNA metabolic process (GO:0034660),0.4310495043415929,1.0956717898831738,0.3708010335917313,0.855579788627782,1.0,6/37,9.20%,DDX17;AGO2;TUT7;DGCR8;TUT4;DTD2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4120301333865227,1.0956350286341747,0.35984848484848486,0.8549636341927338,1.0,22/45,26.95%,ZC3H7A;FOXO3;PER1;TDRD7;ATXN2;RBM3;CYFIP1;MEX3D;LARP4;PUM2;GEMIN5;PUM3;GCNT2;PUM1;RPL10;MAPKAPK5;TRIM71;YTHDC1;TSC1;ZC3H10;METTL16;PARP9
prerank,positive regulation of proteolysis (GO:0045862),0.4116118691977085,1.0954775988425285,0.349009900990099,0.8546821501827575,1.0,7/55,8.15%,PERP;ADAM9;TANK;CYFIP2;TNP2;MAPK12;ZC3H12A
prerank,mitotic chromosome condensation (GO:0007076),0.4592079143163787,1.0952402985610457,0.34184397163120567,0.854610020467973,1.0,8/26,24.47%,SMC4;CCNB1;KMT5A;RB1;NCAPH2;SMC2;PHF8;AKAP8L
prerank,regulation of apoptotic process (GO:0042981),0.3523800999296172,1.0949882981232895,0.177,0.8546075781160648,1.0,127/676,16.88%,SLIT2;THBS1;RASSF2;BMP4;CARD14;EGFR;MAP3K5;PERP;FSTL1;GRK5;HOXA5;TCIM;CYP1B1;SMAD6;VAV2;WNT11;CASP6;GCLC;ANXA4;PTK2B;UNC13B;CRADD;ARHGAP10;AKAP13;ERC1;SOX9;FBXO10;NGF;SFRP4;PAWR;VEGFA;TGFB3;NTSR1;EGLN3;ANO6;GADD45G;GSK3B;NOTCH2;NDRG1;KRT18;SON;GAS1;ABL1;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;FOXO3;NF1;PROK2;CEACAM5;CLEC5A;PRDX5;TIAM1;BAG3;PLSCR3;CD44;SOS2;CREBBP;CASP2;BARD1;APEX1;WRN;IP6K2;ITGB1;TIAM2;ZFAND6;VCP;PTPA;SIX4;CIB1;BRMS1;RIPK2;ATF6;ANKRD13C;DNAJC3;MCL1;MAD2L1;PDCD2;NAA15;FGD1;FXN;ARF4;NIBAN2;CLU;MYD88;RPS6KA3;TRAF2;TRIO;RAF1;NSMF;RBM25;DPEP1;TMBIM4;ARL6IP5;FGD3;RRP1B;E2F1;MTDH;AATF;COPS5;HTATIP2;RNF122;PIM2;GNA13;SRA1;PIDD1;TMEM219;BNIP1;NAA38;YME1L1;PRKDC;RNPS1;TRAF6;GOLPH3;MTCH1;FFAR4;UBE2O;SCRIB;GDNF;MAP3K10;PLEKHG2;USP47;IKBKB;TNFRSF12A;PLK3
prerank,histone H3-K4 trimethylation (GO:0080182),0.5319739072914822,1.094850079755272,0.37972768532526474,0.8543227823946458,1.0,7/11,34.73%,WDR82;KMT2D;OGT;CTR9;TET3;PRDM9;TET2
prerank,small GTPase mediated signal transduction (GO:0007264),0.37978132546880883,1.0948004776141036,0.3115124153498871,0.8537372640035825,1.0,18/103,8.90%,PLCE1;NTN1;CCNA2;FGF2;NRAS;KRAS;MRAS;SHOC2;G3BP2;SHC1;NF1;BCR;TIAM1;ARFIP2;TIAM2;ARHGAP31;SHTN1;KRIT1
prerank,purine-containing compound salvage (GO:0043101),0.5445496713367025,1.0947804003440111,0.37402190923317685,0.8530651533900202,1.0,5/12,18.91%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4873491026917387,1.0947231257617556,0.3624454148471616,0.8525129139621571,1.0,8/18,20.15%,CCND1;CCNB1;MECP2;FBXO5;CDC7;DTL;BRD4;RAB11A
prerank,positive regulation of protein deacetylation (GO:0090312),0.5097120980991339,1.0943891759783697,0.3755725190839695,0.8527763525508246,1.0,7/14,24.47%,NIPBL;NNMT;BRMS1;SAP30BP;ZBTB7B;FNTA;AKAP8L
prerank,cholesterol transport (GO:0030301),0.4263244990393658,1.0943449470075384,0.36375321336760924,0.8521647508631084,1.0,17/45,24.55%,SOAT1;LDLR;TSKU;LIMA1;ABCA7;NPC1;SOAT2;CLU;STX12;STARD4;LCAT;CEL;STAR;STARD5;SERAC1;RELCH;OSBP
prerank,iron ion transmembrane transport (GO:0034755),0.5552682973358427,1.0941649101342388,0.3933649289099526,0.8519638895573881,1.0,2/10,3.32%,SCARA5;SLC39A14
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.36373898008274386,-1.0941552637561491,0.3088803088803089,0.7469434973877869,1.0,4/28,4.20%,ARHGAP28;ESAM;CXCL12;PAK3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.537633970598164,1.0941002257601764,0.3820395738203957,0.8514455687849514,1.0,3/10,9.02%,PRKCD;CD9;RDX
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3856106201168068,1.0940027459256207,0.30734966592427615,0.8510230475589404,1.0,36/100,24.14%,RNF144A;PRICKLE1;FHIT;GIPC1;GSK3B;ZYG11B;WAC;TRIM39;CSNK1A1;XPO1;ARIH1;VCP;DESI1;ANKIB1;RAD23B;DDA1;DET1;KEAP1;HERPUD1;CLU;COP1;COMMD1;DVL1;GLMN;SMAD7;RNF14;LRRK2;BAG5;TLK2;BAG2;DNAJB2;PIAS1;DAB2;OGT;USP7;ARIH2
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.40511052076188353,-1.0937319156146914,0.3072100313479624,0.7463130182525509,1.0,7/16,23.84%,TNFRSF21;TRIB2;TYROBP;JAK3;AGER;CD274;VSIR
prerank,sensory perception of pain (GO:0019233),-0.3876299327232959,-1.0937093539245195,0.3180327868852459,0.7445936572904076,1.0,12/21,27.61%,RETREG1;MME;P2RX7;SCN9A;OPRM1;TRPA1;KCNA2;CHRNA4;CCL2;KCNK4;CHRNB2;ALOXE3
prerank,synaptic membrane adhesion (GO:0099560),0.5172610101527028,1.0936277250685107,0.3806646525679758,0.85139612283509,1.0,5/14,14.92%,GPC6;PTPRF;SLITRK2;PTPRS;GPC4
prerank,positive regulation of cellular catabolic process (GO:0031331),0.37896744870302557,1.0931564146294512,0.3233082706766917,0.8519890768063733,1.0,21/132,10.46%,SLC4A4;ADAM9;PRKCD;EZR;IRS1;GSK3B;TPCN1;TWIST1;ZC3H18;FOXO3;CNOT8;DACT1;PFKFB1;ENTPD5;ABCD1;ZC3H12A;MLXIPL;RDX;ARNT;ATF6;PLEKHF1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.36017400038670433,1.092951194279546,0.280040733197556,0.8519209003840689,1.0,46/291,13.46%,SLIT2;EGFR;WNT9A;PID1;ADAM9;LBP;PRKCD;WNT11;IGFBP5;EZR;PTK2B;SLC26A6;SOX9;IRS1;ESR1;CXCL2;FZD7;CAPN2;NR4A3;RRAGB;ATP2B4;PRDX5;LCOR;RORA;IP6K2;DMTN;ZC3H12A;TLR4;EGR1;AKAP9;CD80;VCP;PDCD4;POU4F1;RHOA;DHX36;PDK3;RAP1A;TRIM41;MYD88;NSMF;NR1D1;DPEP1;RET;TIRAP;CARD16
prerank,epidermis development (GO:0008544),0.40979384084846954,1.0929483820576917,0.3181818181818182,0.8512070402766252,1.0,8/56,8.84%,KRTDAP;GRHL2;GRHL1;DSP;EMP1;PTHLH;COL17A1;TGM5
prerank,fatty acid transport (GO:0015908),-0.3985390668386567,-1.0928884534831649,0.3185840707964602,0.7450681142812374,1.0,5/17,12.52%,ACSL1;APOE;PPARD;GOT2;FABP5
prerank,protein autoubiquitination (GO:0051865),0.40561092442662616,1.0925395769507118,0.3517406962785114,0.851721315427656,1.0,20/61,19.40%,SH3RF3;WWP2;UBE2A;RNF115;RNF185;CUL3;RNF146;TRAF2;BRCA1;RNF122;RNF8;RNF41;UBE2B;UBE2D3;TRAF6;RNF141;RNF11;CNOT4;NFX1;LRSAM1
prerank,regulation of neuron differentiation (GO:0045664),0.39495995127365835,1.0922366574475444,0.344,0.851880173326688,1.0,13/76,11.39%,SIX1;ZFHX3;VWC2;HES1;NGF;ID2;FGFR1;NBL1;TIAM1;HES3;RHOA;NEPRO;NLGN1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.34179022305404716,-1.0921984185627118,0.3007518796992481,0.7451734276707241,1.0,7/33,6.74%,DNAJC6;DNM3;PICALM;DNM1;SYT1;SNAP91;OPHN1
prerank,L-amino acid transport (GO:0015807),0.4573436905399081,1.0918982947354037,0.36388508891928867,0.8521142417402001,1.0,3/28,8.54%,SLC38A2;SLC7A9;SLC38A3
prerank,histone H3-K9 demethylation (GO:0033169),0.5287467489947916,1.0917567492551536,0.3745928338762215,0.8518088586490852,1.0,7/11,25.37%,JMJD1C;KDM1A;HR;KDM3B;PHF8;KDM3A;KDM4D
prerank,protein monoubiquitination (GO:0006513),0.4292165458852646,1.0917051844332828,0.33766233766233766,0.8512419726944894,1.0,10/36,17.80%,RNF126;FANCL;WAC;CUL3;KLHL22;UBE2B;UBE2D3;UBE2O;RNF20;DTL
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3421982074711534,-1.091277868220093,0.3254901960784314,0.7459847532643699,1.0,13/32,23.12%,APOE;PPARA;PRKAA2;ASAH1;AVIL;PRKAG2;ZBTB20;MID1IP1;PDK4;ASXL3;C3;AKT1;GPER1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.38957054085793663,1.0907664917285123,0.34371395617070355,0.8532461218825199,1.0,15/78,14.14%,EGFR;PID1;PRKCE;LRP1;RANGRF;ATP2B4;PLS1;ZDHHC2;AGR2;ITGB1;RHOQ;CIB1;EPHB2;DLG1;PTPN9
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.35946874567656784,-1.090701522689526,0.30656934306569344,0.745849357213493,1.0,11/29,19.43%,WNT5A;SAMHD1;IFNAR2;RNASEL;HSP90AB1;USP18;NLRC5;PTPN6;CACTIN;ZBP1;STAT2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.39118202761004683,-1.0905836577628611,0.3415384615384615,0.7443843667654003,1.0,6/19,16.74%,IGF1;IL18;CD200;SPHK1;NUPR1;CD200R1
prerank,organelle assembly (GO:0070925),0.35399447687490987,1.0899613522231315,0.29819277108433734,0.8549203359801218,1.0,106/384,21.36%,PKD1;BBS9;ABLIM3;EXOC4;ULK2;GSN;PTPDC1;GORASP2;HPS4;RBM14;IFT46;PDE6D;GBF1;FAM161A;RAB43;PARVA;DZIP1;NEK7;WDR35;CDC14A;PCM1;FLII;RAB11FIP3;ZFYVE1;NCOR1;SMIM22;BECN1;CFAP43;EHD2;WDR45B;ATXN2;IFT52;MAK;DYNC2I2;HAUS2;ARL3;CEP63;PLK4;ATG3;CENPT;RFX2;POGZ;PCNT;GALNT11;EIF2S1;KIF3B;TP53INP2;UBAP2L;TUBGCP6;RB1CC1;ATG5;VPS37A;ARF4;STX12;OCRL;VTA1;VPS37B;DISC1;EXOC7;EHD1;PDCD6IP;DYNC2I1;WIPI2;TMEM231;BICD1;CEP19;TRAPPC14;CIRBP;OFD1;ATAT1;CHMP2B;RAB1A;CCDC66;TUBGCP2;IFT43;SQLE;NPHP3;ACTR2;SNF8;CPLANE2;CEP20;PTPN23;FARP2;UBXN2B;CEP164;CDS1;MKKS;ATP6V0D1;FITM2;CLUAP1;IQCB1;NUDCD3;NEK6;RAB11A;LZTFL1;HYLS1;CCDC61;EXOC2;TXNDC15;PIBF1;TMOD3;LSM4;CEP89;ACTR3;EXOC5;TEKT2
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4694785795013517,-1.0897309341093484,0.3506172839506173,0.7448927977464762,1.0,7/10,14.15%,GABRG3;GABRA2;GABRB2;GABRG1;GABRA5;GABRA1;GABRG2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.3740606724581339,-1.089638898406732,0.3150684931506849,0.7434301117249216,1.0,5/22,9.52%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,regulation of chemokine production (GO:0032642),0.42887556590122194,1.0895562076805227,0.35096774193548386,0.8554147635292869,1.0,5/36,10.76%,FOXP1;IL33;TLR4;EGR1;EIF2AK2
prerank,ubiquinone biosynthetic process (GO:0006744),0.5079966266057938,1.089529907477103,0.3810930576070901,0.8547699427146206,1.0,7/15,25.54%,COQ7;COQ10B;PDSS2;NDUFA9;COQ10A;UBIAD1;PDSS1
prerank,ERBB2 signaling pathway (GO:0038128),0.44663221171748096,1.0891089484378593,0.3562913907284768,0.8553003272117959,1.0,5/31,10.04%,EGFR;SHC1;MYOC;ERBB2;ERBIN
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3684737834613555,1.08852897909229,0.3322818086225026,0.8561978571513502,1.0,41/166,19.02%,NR3C2;RARB;HDAC9;ESR1;NOTCH2;RARA;POLR1G;NR4A3;POLR1A;MNAT1;NR4A2;CREBBP;RORA;NCOR1;E2F3;NCOR2;RXRA;MED27;TBL1X;TEAD1;RXRB;TAF1D;NCOA6;NR2F1;NR1D1;GTF2E1;NR4A1;GTF2A2;TAF4;NR3C1;CDK7;E2F2;SMARCA5;GTF2H3;YAP1;ESR2;POLR1F;UBTF;TAF5;POLR2C;PPARG
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5377382386524902,1.0885200401216935,0.37267080745341613,0.8554918667937267,1.0,4/10,13.32%,SOX9;TGFBR2;CHRD;LRP5
prerank,keratan sulfate metabolic process (GO:0042339),0.4478117337677253,1.0884599798362076,0.3675675675675676,0.8549733266294128,1.0,7/31,10.81%,ST3GAL4;B3GNT2;HEXA;B4GALT1;SLC35D2;CHST5;B4GAT1
prerank,cellular protein metabolic process (GO:0044267),-0.24831785484463959,-1.0883781575962748,0.0,0.7450966926711351,1.0,84/396,12.59%,CP;IGF1;LTBP1;IGFBP2;IGFBP7;SPARCL1;CDH2;APOE;ST8SIA4;ST3GAL1;PAPPA;ST3GAL6;MSRA;APP;IGFBP3;CSF1;CST3;CTSH;EEF1A1;ITIH2;RPL37;IGFBP4;RPL27A;TNC;LGALS1;PLAT;QSOX1;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPN2;RPS14;RPL18A;NOTUM;RPL38;LGMN;LAMB1;RPS19;RPS8;RPS11;RPL34;DAB2IP;VWA1;RPL18;RPL7;SERPIND1;ADORA2A;FAM20C;LTA4H;RPS25;RPL21;RPL23A;CHRM3;RPLP2;RPS21;RPL26;RPS4X;RPL41;GATA6;RPS29;RPL35A;RPL10A;SPP1;WFS1;RPL11;F5;SIAH2;RPS5;PDIA6;GAS6;RPS16;MFGE8;MRPL3;CHGB;RPL4;SERP1;RPS7;RPS23;APH1B;RPS15;LAMB2;LAMC1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.45609994914961705,1.0880817188591736,0.3607681755829904,0.8554218750811914,1.0,16/27,29.25%,CREBBP;MSL3;MORF4L1;KAT6B;ATAT1;PHF20L1;TRRAP;PHF20;KAT6A;MRGBP;CPA4;SGF29;KAT8;KAT2B;NAA50;BRD8
prerank,nucleosome assembly (GO:0006334),0.4478139445121228,1.0878685389903766,0.3647214854111406,0.8552922949826504,1.0,13/31,24.63%,CHAF1B;SOX9;CHAF1A;HIRA;ATRX;KAT6B;SMARCA5;NAA60;CABIN1;NAP1L1;IPO4;ASF1A;RSF1
prerank,quinone biosynthetic process (GO:1901663),0.512398512606194,1.087864903381432,0.38450074515648286,0.8545877393120072,1.0,3/14,7.56%,COQ7;COQ10B;PDSS2
prerank,regulation of myoblast differentiation (GO:0045661),0.4393792551081322,1.0877759296451164,0.35841313269493846,0.8541615492254174,1.0,3/32,2.75%,BOC;BMP4;SOX9
prerank,negative regulation of angiogenesis (GO:0016525),0.3878107525338559,1.0876610083049643,0.34443168771526983,0.8537767269962566,1.0,21/84,16.30%,THBS1;SLC12A2;HOXA5;SEMA3E;ISM1;KLF4;EMILIN1;ATP2B4;SULF1;KRIT1;FOXC1;CREB3L1;MECP2;NIBAN2;SYNJ2BP;EFNA3;EPN1;CD160;E2F2;ALOX5;ADAMTS1
prerank,chromosome organization (GO:0051276),0.3865051336768539,1.087618482820584,0.34301675977653634,0.853194530152337,1.0,19/99,19.88%,TCF7L1;TCF7L2;ABL1;HDAC8;HMG20A;EHMT1;PARP1;RAD23B;CENPT;NUP155;COPS7B;EZH1;COPS5;COPS8;CETN2;COPS3;HDAC2;COPS2;ZBTB7A
prerank,histone H4-K16 acetylation (GO:0043984),0.4803478454677785,1.087485597953274,0.36103151862464183,0.8528627383929743,1.0,10/19,27.20%,KANSL3;KANSL2;JADE2;MSL3;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4343741910103919,-1.0870896553746996,0.36694677871148457,0.7470089259745213,1.0,3/13,19.18%,TMSB4X;HEY2;TAF1
prerank,cell part morphogenesis (GO:0032990),0.5224069775053442,1.0870001931323323,0.364741641337386,0.8534650284774501,1.0,1/13,1.27%,PID1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3649096139014284,1.0869138138798127,0.33472803347280333,0.8530255183849393,1.0,43/151,18.03%,BMP4;EGFR;NTRK3;TMEM100;SMAD9;SOX9;NRP1;VEGFA;BMPR1A;KIDINS220;KLF4;LIMS1;TGFBR1;GAS1;EMD;HAS1;SHC1;ANXA1;BMP6;ERBB2;TGFBR2;CD44;KNSTRN;RUNX2;FOXC1;SYAP1;CIB1;RAB35;GAREM1;RAP1A;ITGB1BP1;NR4A1;EHD1;ACVR1;NR3C1;URI1;SMAD4;CPNE3;RPS6KB1;IQGAP1;SMAD7;MTSS2;MAPKAPK2
prerank,negative regulation of chemokine production (GO:0032682),-0.41757893041851146,-1.08655500681558,0.3654390934844193,0.7466884840768844,1.0,4/14,15.93%,APOD;SIRPA;C1QTNF3;SIGIRR
prerank,neural crest cell development (GO:0014032),-0.31355904940621215,-1.0865019605427813,0.28654970760233917,0.7451170964476115,1.0,20/44,24.15%,SEMA6A;CDH2;SEMA7A;RADIL;ERBB4;TBX1;SEMA6D;SEMA3B;SEMA5A;SEMA3G;TAPT1;SEMA5B;SEMA6B;SEMA4G;SEMA3A;SEMA3F;SEMA4D;SNAI2;NRTN;NRG1
prerank,receptor catabolic process (GO:0032801),0.46498850192868985,1.086482801354792,0.361997226074896,0.8536013647872379,1.0,8/24,18.59%,NEDD4;AP2A2;KIF16B;BECN1;SH3GLB1;AP2B1;SMURF1;AP2A1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5290333645763822,1.0859052437017052,0.3719806763285024,0.8545487271427312,1.0,5/11,17.26%,TGFBR1;USP15;TGFBR2;ACVR1;SMAD7
prerank,positive regulation of signal transduction (GO:0009967),0.3579845530828457,1.0855817461188622,0.328879753340185,0.8547080781222027,1.0,50/238,14.70%,SMOC2;RSPO3;F3;CCN3;NTRK3;PTK2B;CRADD;PTGIS;RSPO4;IRS1;NRP1;SLC39A14;SMO;GRB10;ADAMTS3;LIMS1;TGFBR1;STAT3;SKI;DACT1;BMP6;TEDC2;CREBBP;SHANK1;SULF1;EVC;TRIM39;DMTN;CD80;ELF3;ARNT;FGFBP3;ITGAV;MYORG;AAK1;NEPRO;NLGN1;TRIM44;ULK3;DRD3;JAG1;KIF7;ITGB1BP1;DISC1;NPTN;SORL1;ITGB3;ZRANB1;DEPDC1B;PRKCA
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.539453987609119,1.084293999232389,0.3871473354231975,0.8576072897781181,1.0,1/11,0.32%,STK39
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3654505155109833,1.084217510288713,0.33049946865037194,0.8571148849612181,1.0,39/152,18.97%,RSPO3;EGFR;WNK1;GPC3;PLEKHA4;RSPO4;SFRP4;PSMB2;SKI;UBR5;DACT1;SULF1;PSMD11;TRPM4;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;DISC1;CSNK1G1;ZRANB1;DEPDC1B;PSMD1;UBE2B;CAPRIN2;PSMD4;USP47;PIN1;PSMA6;PRDM15;LRRK2;PSMD14;PSMD12;PSMD7
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.39715702974427536,1.0841831354182274,0.3693181818181818,0.8564947933089809,1.0,26/72,23.55%,PLAGL1;CRADD;NDRG1;CNOT8;CHEK2;AURKA;CASP2;CCNB1;TFDP1;CDKN1B;MDM4;E2F1;TNKS1BP1;ATRX;PIDD1;CDKN1A;CNOT4;PLK3;PCBP4;USP10;PML;NBN;CNOT1;ATM;CNOT11;TP53
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.41408062979235133,1.0836966423440557,0.36573511543134873,0.8572545494583886,1.0,10/49,13.89%,SMAD6;PMEPA1;GSK3B;DACT1;TMC8;LDLRAD4;CLU;RAF1;SORL1;ANKRD27
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.379053886680277,-1.0836420723949471,0.3219178082191781,0.7510932607796001,1.0,6/22,8.01%,LYN;PICALM;ROCK2;ABCG1;EPHA4;LRRTM3
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.4583750856636599,-1.0835844945347404,0.366120218579235,0.7495076191922693,1.0,4/10,13.42%,DPP4;CST3;NOTCH1;CHADL
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.37353765777947145,-1.0834008957267296,0.3333333333333333,0.7482747019025936,1.0,15/21,39.96%,PAG1;PTPN22;SAMSN1;JAK3;BANK1;LST1;LAX1;IL4I1;DUSP3;LAPTM5;VTCN1;FOXJ1;TNFAIP3;FGL1;TNFAIP8L2
prerank,heme biosynthetic process (GO:0006783),0.47333819517817205,1.0833303046026983,0.39557399723374825,0.8575963046562247,1.0,9/22,19.28%,ABCG2;NFE2L1;UROS;COX15;FXN;TSPO;PPOX;ATP5IF1;FLVCR1
prerank,proteasomal protein catabolic process (GO:0010498),0.36067460203967566,1.0829065743206008,0.32746113989637304,0.858120136912799,1.0,47/201,18.97%,WWP1;NEDD4;NFE2L2;WWP2;RNF126;PSMB2;UBE4B;SPSB2;UBE2A;PSMD11;FEM1B;RNF185;CUL3;PSMC1;VCP;MTA1;PPP2R5C;KLHL22;TBL1X;RAD23B;PSMC6;DDI2;NR1D1;UBE2K;COP1;SPOPL;RNF122;FBXO45;RNF41;SEL1L;PSMD1;UBE2B;NHLRC1;UBE2D3;PSMD4;AREL1;PSMA6;RBCK1;SMURF1;UBXN2B;PSMD14;SPOP;PSMD12;DDI1;RMND5A;ENC1;PSMD7
prerank,secondary palate development (GO:0062009),-0.41849739402513475,-1.082790896487077,0.33620689655172414,0.7481802353293491,1.0,4/14,3.01%,LEF1;CHD7;TGFBR3;WNT5A
prerank,regulation of membrane repolarization (GO:0060306),0.5199773499838372,1.0825222484679178,0.4039938556067588,0.8585501806875705,1.0,1/13,0.23%,KCNJ2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.48283130829951915,1.0824750646677679,0.37412095639943743,0.8579674339093066,1.0,4/17,13.02%,ADAM9;FOXC2;CIB1;RET
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3850798287912132,-1.0820697972892213,0.33444816053511706,0.7484344499519113,1.0,9/22,14.42%,AEBP1;APOE;MAP2;HSPA8;MAPT;CAMSAP2;MAP1A;PIK3CA;EFEMP2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.4248450713115314,1.0820676930924835,0.37435897435897436,0.858373491956843,1.0,7/40,6.10%,BMP4;CCN1;NELL1;TGFB3;BMPR1A;ANO6;BMP6
prerank,sphingosine biosynthetic process (GO:0046512),0.5300425378338525,1.0814709421919348,0.38170347003154576,0.8586437675580543,1.0,1/11,0.70%,ACER3
prerank,sphingoid biosynthetic process (GO:0046520),0.5300425378338525,1.0814709421919348,0.38170347003154576,0.8586437675580543,1.0,1/11,0.70%,ACER3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37957912478586714,1.0814488146398678,0.3469387755102041,0.8579928387015712,1.0,19/94,13.44%,MAP3K5;PRKCD;CYP1B1;DDX5;TMEM117;FHIT;ABL1;CHEK2;CASP2;IKBKE;CUL3;CUL1;POU4F1;MCL1;TRAF2;BRCA1;ARL6IP5;E2F1;RRP8
prerank,negative regulation of protein binding (GO:0032091),0.3908902990152829,1.0811968173178643,0.36964078794901506,0.8579593888870206,1.0,28/71,23.91%,PRKCD;PTPRF;ADRB2;GSK3B;DACT1;AURKA;KDM1A;TMC8;ZFPM1;ITGB1BP1;DISC1;CARD16;SORL1;DDX11;DVL1;ADAM15;CDKN1A;PSME3IP1;PIN1;LRRK2;RALB;BAG2;SLPI;DNAJB2;STYX;DAB2;GNL3L;USP33
prerank,regulation of stem cell proliferation (GO:0072091),-0.4033362757737575,-1.0810544163692533,0.35093167701863354,0.7495482439434491,1.0,3/17,4.44%,FBLN1;GJA1;ACE
prerank,ether lipid biosynthetic process (GO:0008611),0.5396459938023912,1.0806342312176513,0.39346811819595645,0.8587940774973143,1.0,4/10,16.44%,AGPS;GNPAT;PEDS1;LPCAT2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.45956867897715936,1.0804803388137734,0.3668555240793201,0.8585280042010538,1.0,9/25,26.09%,ZYG11B;RNF185;CUL3;VCP;CLPP;YME1L1;POMT2;OMA1;KLHL15
prerank,regulation of monocyte differentiation (GO:0045655),0.5031825124552388,1.0803795188942544,0.3996865203761755,0.8581144637431771,1.0,1/14,0.23%,FOXP1
prerank,cholesterol efflux (GO:0033344),0.47382503258909037,1.0801027262567935,0.386066763425254,0.8582205047522132,1.0,6/20,12.36%,SOAT1;TSKU;ABCA7;NPC1;SOAT2;STX12
prerank,reticulophagy (GO:0061709),0.5152474317126726,1.0798171897639872,0.38193343898573695,0.8583338376900735,1.0,4/12,12.46%,ULK2;TEX264;RB1CC1;UBA5
prerank,signal transduction in response to DNA damage (GO:0042770),0.41173887775787466,1.0797714366203142,0.34566326530612246,0.8577648157802161,1.0,22/49,24.93%,NDRG1;ABL1;CHEK2;CLSPN;CEP63;MDM4;RAD17;E2F1;HINFP;BRIP1;ATRX;USP28;INTS7;DONSON;ATR;USP10;NBN;CHEK1;ATM;TP53;RAD9A;BID
prerank,regulation of cell population proliferation (GO:0042127),0.3497530477647208,1.0794287827557414,0.248,0.8580497741308617,1.0,115/691,12.97%,THBS1;ZBTB7C;SIX1;BMP4;EGFR;TCF7L2;ACER3;WNT9A;PGF;HES1;HDAC4;NTRK3;GRK5;CYP1B1;RBFOX2;SMAD6;PTPRU;BMP5;ABI1;PTK2B;FGF2;GAB2;SLURP1;ECRG4;SOX9;TES;KRAS;NGF;CLMN;SFRP4;IRS1;VEGFA;TGFB3;BMPR1A;ID2;RAB25;NPR3;EGLN3;CLCF1;RNF126;CDK10;ELN;RARA;KLF4;LIMS1;TIMP1;S100B;TGFBR1;PTHLH;TBRG1;PTPN2;FOLR2;NR4A3;PDGFC;FGFR1;STAT3;SHC1;TCIRG1;KLF10;SKI;CNOT8;FRK;PROK2;LMNA;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;NCK2;INHBA;UBE2A;STRN;TENM1;FN1;SMIM22;KITLG;IRF1;CEP43;MLXIPL;P3H3;TRPM4;P3H1;CUL3;CDKN2C;SFRP5;PPP2R5C;SIX4;CIB1;CDC123;ITGAV;CDK13;TTK;RHOA;TGFB1I1;GAREM1;EIF2AK2;MECP2;BTG3;FBXO5;JUP;SGK3;FXN;JAG1;GNRH1;IFI35;NIBAN2;CLU;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3638449560762833,1.0793968041287525,0.34994697773064687,0.8574306104960238,1.0,20/151,11.12%,BMPER;EGFR;TNFAIP8L3;NTRK3;PTK2B;FGF2;NRP1;NOTCH2;CCL3;CCL1;PDGFC;SHC1;CD44;ROR1;ABCA7;GATA4;CIB1;CCL7;GAREM1;RAP1A
prerank,hemopoiesis (GO:0030097),-0.27853353129845343,-1.0793805358467945,0.26666666666666666,0.7524035187301542,1.0,15/87,8.17%,FLT1;MECOM;TEK;KIT;TGFBR3;SNRK;TOX;WNT5A;KDR;KIRREL3;ETV6;MEIS1;NOTCH4;CD34;FLT3LG
prerank,neurogenesis (GO:0022008),0.41550881686509306,1.079310472716922,0.3582089552238806,0.8570059421653999,1.0,4/43,5.34%,SIX1;CIT;THOC2;ANXA1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5444632121897728,1.0792838950195196,0.4030612244897959,0.8563836875452944,1.0,2/10,6.56%,MLLT3;HOXB4
prerank,positive regulation of B cell proliferation (GO:0030890),-0.35058269649658524,-1.0791478002991883,0.33579335793357934,0.7513320712093866,1.0,10/29,15.88%,BCL2;TFRC;MEF2C;VAV3;CD38;NFATC2;CD81;MIF;CD40;CD74
prerank,negative regulation of translational initiation (GO:0045947),0.5113385898001339,1.0789476309475916,0.38484848484848483,0.8566019779489603,1.0,4/13,10.77%,PAIP2;AGO2;EIF3E;EIF2AK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.35504602787674605,1.0789253716691798,0.3360995850622407,0.8559719959906706,1.0,30/199,9.73%,BMP4;EGFR;NFIB;SMAD6;BMP5;WNT11;HDAC9;SOX9;GRHL2;ARHGDIB;ZNF423;NPR3;ID1;GSK3B;FOXC2;TIMP1;KLF7;SPRED2;DOCK7;ATP2B4;IP6K1;NLRP12;RAB11FIP3;SRSF6;IL17RD;TLR4;CORO1C;PARP3;ABHD6;ACOT11
prerank,platelet aggregation (GO:0070527),0.4343415354192305,1.0788684365297931,0.3708010335917313,0.8554534775952735,1.0,5/33,7.45%,UBASH3B;GNAS;CLIC1;FN1;VCL
prerank,regulation of double-strand break repair (GO:2000779),0.4255655917546772,1.0783345081388478,0.36942675159235666,0.8562533668294132,1.0,17/39,26.12%,TWIST1;UBR5;RAD51;SETD2;SIRT6;SPIDR;KDM1A;TRIP12;DDX11;PPP4R2;ACTR2;DEK;PML;CHEK1;SLF1;ZCWPW1;MRNIP
prerank,glycogen metabolic process (GO:0005977),0.4537794042561062,1.0783245911698756,0.3795423956931359,0.8555881815326575,1.0,8/27,15.40%,PYGB;GSK3B;PHKA2;PPP1R3C;PHKB;NR1D1;PGM2;NHLRC1
prerank,protein polyubiquitination (GO:0000209),0.3524685261938186,1.0781021494299745,0.3228744939271255,0.8555324596946037,1.0,69/297,18.97%,WWP1;FBXL7;NEDD4;FZR1;RNF144A;MKRN3;FBXO10;WWP2;RNF126;PSMB2;UBE4B;TRAF3IP2;RNF114;ANAPC5;UBR5;UBE2A;RNF115;NPEPPS;BARD1;FBXL20;PSMD11;ARIH1;CUL3;ANAPC10;PSMC1;CDC16;UBE4A;CUL1;ANAPC11;ANKIB1;FBXW8;FBXO27;HECTD2;UBE3C;PSMC6;DDA1;FBXO31;RNF146;TRAF2;BRCA1;UBE2K;TRIP12;RNF8;RNF41;PSMD1;UBE2B;NHLRC1;HERC6;UBE2D3;TRAF6;PSMD4;UBE2O;TRAF5;FBXO17;TMEM129;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;PSMD14;SPOP;PSMD12;CHFR;RMND5A;PSMD7
prerank,membrane depolarization during action potential (GO:0086010),0.4558479838503788,1.0780751090708027,0.38048090523338046,0.8549264448668981,1.0,3/26,1.48%,KCNJ2;CACNA1C;CACNA1G
prerank,spindle assembly checkpoint signaling (GO:0071173),0.46404906005792906,1.0780123825736634,0.3845070422535211,0.8530241567103127,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.46404906005792906,1.0780123825736634,0.3845070422535211,0.8530241567103127,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.46404906005792906,1.0780123825736634,0.3845070422535211,0.8530241567103127,1.0,8/20,23.47%,CDC20;KLHL22;TTK;MAD2L1;ZW10;MAD1L1;BUB3;ATM
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4840707942907496,1.0779761060029547,0.37517433751743373,0.8524311457926778,1.0,9/19,27.62%,PRDX5;TENM1;DHX36;POLR3F;CHD8;ICE2;MTOR;ELL;ZNF76
prerank,DNA replication initiation (GO:0006270),0.4249400316342055,1.0779473749857698,0.38471337579617837,0.8518366407898011,1.0,11/37,18.52%,CDC45;MCM2;TOPBP1;PRIM1;POLE2;ORC3;PRIM2;MCM7;CDK2;CDC7;POLA2
prerank,DNA methylation (GO:0006306),0.4600462175216654,1.0777721708224048,0.3793584379358438,0.8516011541589948,1.0,7/23,18.45%,TEX15;EHMT1;DNMT3A;DMAP1;ATF7IP;ATRX;KMT2E
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4255186259058619,1.0775432648119252,0.3790931989924433,0.8515375803583197,1.0,20/40,33.96%,RAD51;WRN;SMARCAL1;DDX11;PRIMPOL;ATRX;FAM111A;DONSON;MCM9;ATR;BOD1L1;SETMAR;THOC1;MMS22L;TIPIN;GEN1;POLD1;ALYREF;RFWD3;ZRANB3
prerank,regulation of actin filament-based process (GO:0032970),0.39366485316906064,1.0771518699377467,0.37327188940092165,0.8519482980447127,1.0,16/70,11.67%,PRKCD;RHOBTB1;EZR;EFNA5;CDK10;ABL1;ARHGAP44;LRP1;ARHGAP17;SMIM22;RHOQ;FAM107A;DMTN;RND3;RHOA;ABRACL
prerank,carbohydrate homeostasis (GO:0033500),0.3900678283115301,1.0771129146931786,0.3345280764635603,0.8513675190689548,1.0,20/67,19.34%,TCF7L2;KCNB1;IRS1;PTPN2;KLF7;STAT3;ACSM2A;BACE2;CRY2;MLXIPL;CRTC2;HECTD4;MCU;SLC8B1;ALOX5;PAX6;ADCY8;TENT4B;PPARG;MBD5
prerank,phospholipid metabolic process (GO:0006644),0.39316347092882387,1.0770574257521808,0.38207547169811323,0.8508178260359059,1.0,13/71,13.82%,TNFAIP8L3;PLPP3;PLPPR2;PLA2G4F;PLA2G15;PLA2G2C;MBOAT1;PNPLA3;LPCAT1;ANGPTL3;PIP5K1A;GNPAT;PIP4K2A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5414557838704307,1.0768772794649635,0.3818770226537217,0.8506345887213673,1.0,5/10,16.49%,EZR;SYNE4;RHOA;MYO9A;CAMSAP3
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.30700518655528064,-1.0768459022408703,0.33507853403141363,0.7559176630453958,1.0,11/47,10.31%,IGF1R;PHLPP1;TGFBR3;EPHB1;FOXO1;RAP2A;MAP4K4;MAPK1;DAB2IP;FAS;MAP2K1
prerank,nuclear envelope organization (GO:0006998),0.4680524770017437,1.0766749791541632,0.38472622478386165,0.8504817471279532,1.0,10/20,26.54%,EMD;NUP93;LEMD2;NUP155;TOR1B;TOR1AIP1;SUN1;REEP3;REEP4;SUN2
prerank,positive regulation of metabolic process (GO:0009893),-0.2771600649497198,-1.0763751547160905,0.3069306930693069,0.7555471435859514,1.0,15/103,8.02%,IGF1R;CAMK1D;LEPR;ACSL1;PPARGC1B;EBF2;ESRRG;GATM;INSR;GJA1;ACACB;PRDM16;PPARGC1A;TRPV2;IL18
prerank,presynaptic endocytosis (GO:0140238),0.4574125091189099,1.0763001212218566,0.3899018232819074,0.8508819075950086,1.0,8/24,17.62%,STON2;STON1;FCHO2;NLGN1;VAMP2;SYNJ2;CEL;SYNJ1
prerank,calcium ion transport into cytosol (GO:0060402),-0.38179869469218575,-1.0762061446401732,0.3402777777777778,0.7543118766783786,1.0,7/21,7.87%,SLC8A1;RYR2;GRIN2A;GRIN2B;GRIN1;CACNA2D1;JPH1
prerank,mitotic nuclear division (GO:0140014),0.38443230065615297,1.0761623460601135,0.35941043083900226,0.8505772271735155,1.0,21/71,20.70%,SMC4;NDEL1;CHEK2;SPICE1;STAG1;MISP;KNSTRN;TOGARAM1;KLHL22;RHOA;PPP2R2D;KIF3B;ZW10;OFD1;ABRAXAS2;SMC1A;UBE2S;STAG2;RAB11A;CCDC61;PIBF1
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.4359227429051425,-1.07606746820494,0.38461538461538464,0.7530534955857312,1.0,4/13,8.55%,RYR2;RBPJ;NOTCH1;HEY2
prerank,regulation of gastrulation (GO:0010470),-0.4244586278706358,-1.0759566741499218,0.37770897832817335,0.7516684813190692,1.0,5/14,11.14%,CLASP2;DAG1;OSR1;TENM4;RACK1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.4072323622293579,-1.0757825519922015,0.36684782608695654,0.7504504127402709,1.0,5/15,16.41%,DGKD;HIP1R;SNAP91;TNK2;BMP2K
prerank,autophagy of mitochondrion (GO:0000422),0.4255634955743067,1.0755545602728531,0.37242268041237114,0.8516218669440498,1.0,9/38,13.99%,ULK2;CISD2;BECN1;WDR45B;ATG3;RB1CC1;ATG5;MARK2;WIPI2
prerank,RNA transport (GO:0050658),0.3855406853653913,1.0755496155825852,0.34813084112149534,0.8509537897702225,1.0,24/71,23.27%,SIDT2;SRSF11;U2AF2;THOC2;SRSF5;TGFBR2;SRSF6;NUP214;NUP153;ATXN2;CDC40;SRSF2;NUP155;SRSF1;RNPS1;FLOT1;CHTOP;HNRNPA2B1;SARNP;FMR1;DHX38;SRSF3;SRRM1;ZC3H11A
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.34597972578709857,-1.075421483153775,0.36199095022624433,0.7497231504402662,1.0,13/32,13.14%,IL1RAPL1;TNIK;NEDD4L;ADGRB3;HECW2;RAPGEF2;RAP2A;HECW1;CUX2;YWHAH;PTPRD;KNDC1;SARM1
prerank,metanephric mesenchyme development (GO:0072075),0.5321963282440642,1.0754183298493007,0.3875598086124402,0.8506368203895015,1.0,1/10,0.35%,SIX1
prerank,regulation of sodium ion transport (GO:0002028),0.43450422850852616,1.07518714934287,0.36259541984732824,0.8506442069542324,1.0,13/34,17.75%,NEDD4;WNK1;SLMAP;SNTA1;RANGRF;PER1;ATP2B4;ATP1A1;DLG1;SCN1B;SCN3B;SIK1;P2RX4
prerank,cGMP biosynthetic process (GO:0006182),0.5378281147312177,1.0750374415933364,0.391304347826087,0.850395137649507,1.0,1/10,0.83%,GUCY2C
prerank,anterior/posterior axis specification (GO:0009948),-0.40491024959373434,-1.0750343408567933,0.38285714285714284,0.7491284373367383,1.0,2/15,3.34%,WLS;TBX3
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.4395016473743365,1.074432009690751,0.39917127071823205,0.8513726952167171,1.0,8/31,17.68%,FZR1;DCUN1D5;CDC20;DCUN1D2;RAB1A;PIN1;DCUN1D1;UBE2S
prerank,smooth muscle cell differentiation (GO:0051145),0.524769184330843,1.0738881934004172,0.39967637540453077,0.8522477301396444,1.0,2/12,5.73%,BMP4;MRTFA
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5061425724929681,1.073797150022695,0.3762962962962963,0.8518228506489749,1.0,1/13,1.64%,PRKCD
prerank,regulation of myeloid cell differentiation (GO:0045637),0.3966210652361195,1.0737404992854724,0.37695078031212487,0.8513204295827262,1.0,7/62,7.03%,THBS1;HOXA5;PTK2B;NR4A3;KMT2C;ZBTB16;CREBBP
prerank,smoothened signaling pathway (GO:0007224),0.43232075089973043,1.073247632532069,0.35514018691588783,0.85203387505724,1.0,7/32,16.38%,SMO;GLI3;HIPK1;GLI2;ULK3;TMEM231;MAP3K10
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.4528696052305681,1.07286834747485,0.3864942528735632,0.8524354133665978,1.0,1/23,0.09%,SLIT2
prerank,negative regulation of apoptotic process (GO:0043066),0.3480666680190989,1.0726476305891286,0.28714859437751006,0.8523906397045946,1.0,92/444,17.51%,THBS1;SIX1;BMP4;CARD14;EGFR;FSTL1;GRK5;TCIM;PRKCD;SMAD6;WNT11;GCLC;ANXA4;PTK2B;ARHGAP10;ERC1;SOX9;NGF;VEGFA;TGFB3;NTSR1;CLCF1;GSK3B;NOTCH2;KLF4;KRT18;SON;ERCC5;SERPINB9;TAX1BP1;SHC1;ANXA1;PROK2;CEACAM5;CLEC5A;NFATC4;PRDX5;BAG3;NRBP2;NR4A2;CD44;CASP2;BARD1;POU3F4;ITGB1;ZFAND6;ZC3H12A;GATA4;SIX4;CIB1;RIPK2;POU4F1;QARS1;DNAJC3;MCL1;IGBP1;MAD2L1;NAA15;FXN;ARF4;NIBAN2;MYD88;RPS6KA3;RAF1;DPEP1;TMBIM4;MTDH;CARD16;AATF;COPS5;HTATIP2;PIM2;PIDD1;PRKCA;CNTF;BNIP1;NAA38;YME1L1;PRKDC;TRAF6;GOLPH3;FFAR4;UBE2O;GDNF;USP47;IKBKB;PLK3;YAP1;RPS6KB1;RB1;AREL1;PCID2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.49106569786824056,1.0723703897755203,0.4014814814814815,0.8525083095583522,1.0,4/17,13.49%,ANK2;SNTA1;AKAP9;SCN1B
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4664402956400034,1.0722447286626176,0.39337175792507206,0.8521679773529964,1.0,7/21,20.00%,FZR1;CDC20;MAD2L1;FBXO5;RAB1A;UBE2S;BAG2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.33510130844453434,-1.071795342635988,0.3228346456692913,0.756368883992222,1.0,5/35,1.46%,FLT1;PTPRM;NR2F2;COL4A3;APOE
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.43593956674990036,1.0717225044989174,0.3944223107569721,0.852928476667177,1.0,8/33,11.72%,EGFR;PLCG2;ANXA1;LSM11;CCND1;RDX;ANKRD17;TFDP1
prerank,keratan sulfate catabolic process (GO:0042340),-0.4418849797952941,-1.0717215804223292,0.4155495978552279,0.7548632964974421,1.0,6/11,17.95%,FMOD;OGN;OMD;LUM;HEXB;GALNS
prerank,histone lysine demethylation (GO:0070076),0.4520424436774711,1.071564950411368,0.3785310734463277,0.8526685421345136,1.0,11/25,25.37%,JMJD1C;KDM1A;HR;KDM5B;KDM3B;KDM2A;RIOX2;PHF8;KDM3A;KDM1B;KDM4D
prerank,postreplication repair (GO:0006301),0.41386689503013524,1.0714883362761132,0.38461538461538464,0.8521886696960345,1.0,20/45,29.04%,UBE2A;VCP;NSMCE1;ZBTB1;POLI;BRCA1;PRIMPOL;UBE2B;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBE2V1;UBA52;POLK;RPS27A;WDR33;UBE2N
prerank,icosanoid metabolic process (GO:0006690),0.41695228486003777,1.0712184478780677,0.397172236503856,0.8522820142325596,1.0,10/40,19.06%,MGLL;CYP1B1;PTGIS;CYP2S1;DPEP1;ABCC1;ALOX5;DAGLB;MAPKAPK2;PON2
prerank,glucan catabolic process (GO:0009251),0.4991462443257593,1.0710660178317686,0.3793604651162791,0.8520176089367232,1.0,4/15,15.09%,PYGB;PHKA2;PHKB;PGM2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3607699914863275,-1.0710258082473485,0.33559322033898303,0.7550684323360711,1.0,11/24,18.13%,BCL2L1;NR1H3;AQP11;WFS1;CREB3;RACK1;NR1H2;XBP1;HSPA1A;UBXN1;SELENOS
prerank,protein alkylation (GO:0008213),0.46659992386091326,1.0710009741743722,0.3817427385892116,0.8515202054963795,1.0,6/22,12.34%,PCMT1;PRMT8;GSPT1;ETFBKMT;ETF1;EEF2KMT
prerank,regulation of lymphocyte differentiation (GO:0045619),0.47329150800774045,1.070508070099351,0.3981762917933131,0.8521857547079018,1.0,4/18,18.03%,CD2;ABL1;PRKDC;NCKAP1L
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.49269571971251863,1.0702306081107804,0.39002932551319647,0.852321106384313,1.0,3/15,5.88%,DSE;UST;BGN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3765668148360759,-1.069871563135038,0.36769759450171824,0.7566253956244288,1.0,6/21,7.58%,ADCY5;ADCY1;GUCY1B1;NPR1;ADCY7;GUCY1A1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.4000325965619711,1.0693846219934862,0.3954050785973398,0.8541389247772049,1.0,12/56,12.38%,LBP;ALPK1;PLCG2;TLR1;TAB3;IRAK4;TLR4;MAP3K7;TAB2;TLR8;MYD88;RPS6KA3
prerank,regulation of telomere capping (GO:1904353),0.4572540435414643,1.0685649258027798,0.4002808988764045,0.8557076493223175,1.0,9/23,23.82%,SMG6;NEK7;RAD50;MAP3K4;NBN;TNKS2;ATM;MAPKAPK5;USP7
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.4965300846240533,1.0684667493274769,0.3943452380952381,0.8553080293996859,1.0,7/16,24.42%,MCM2;RAD51;WRN;MCM7;RECQL5;HMGA1;RECQL
prerank,rRNA metabolic process (GO:0016072),-0.24993562007275064,-1.0680574960694689,0.24489795918367346,0.7597981121907065,1.0,46/160,18.59%,RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;MAPT;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17;RPL9;DDX27
prerank,I-kappaB phosphorylation (GO:0007252),0.5345626386895458,1.0670289497402707,0.4186413902053712,0.8586077601484398,1.0,3/10,10.52%,ERC1;TLR4;MAP3K7
prerank,regulation of ruffle assembly (GO:1900027),-0.36319791922019856,-1.066791013795547,0.3663003663003663,0.7614910849105971,1.0,4/23,6.29%,ARHGAP24;EPS8;EVL;EPS8L2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4759077963934224,1.0662445497255768,0.3930131004366812,0.860057175320526,1.0,3/17,4.72%,SOX9;DSPP;KLF7
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3653864671845879,1.0661159793256754,0.37339055793991416,0.8597321298373218,1.0,35/124,18.97%,TCF7L2;PPP3CA;WNT11;PDE6A;PRICKLE1;PLCB3;SFRP4;FZD1;FZD7;PSMB2;AP2A2;AGO2;TIAM1;PSMD11;NLK;SFRP5;PSMC1;RHOA;MAP3K7;PSMC6;NFATC1;PARD6A;PDE6B;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;MOV10;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,response to iron ion (GO:0010039),-0.426811296759879,-1.0660335645912633,0.3664772727272727,0.7619039828753047,1.0,2/12,2.14%,BCL2;B2M
prerank,neuron migration (GO:0001764),0.414388581647113,1.0658845167274913,0.3848069738480697,0.8597147647138911,1.0,16/48,13.01%,MARK1;FGF13;NRP1;ELP3;VEGFA;FGFR1;DNAAF4;NR4A2;PAFAH1B1;SDCCAG8;MAP1B;LRP12;PEX13;NAV1;MARK2;DISC1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.40424183045915196,1.065862251179231,0.37897310513447435,0.8590962592509338,1.0,22/52,26.46%,SAMD4A;CNOT8;TUT7;TUT4;EXOSC3;DCP1A;TNKS1BP1;EXOSC1;CNOT4;DIS3;EXOSC2;LSM4;EXOSC7;SAMD4B;CNOT1;CNOT11;EXOSC8;PAN3;DDX6;LSM1;PARN;PATL1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3942005327111335,1.0657370976786225,0.3884976525821596,0.8587640150146216,1.0,13/63,10.99%,MET;PTPN3;NELL1;EIF4G3;TIMP1;STAT3;TAB3;TIMP2;EIF4G2;RGP1;KLHL22;TAB2;MCL1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3693843122886704,1.06558258235816,0.3660130718954248,0.8585106850832156,1.0,25/112,13.80%,ADAM9;SMAD6;COL3A1;SMAD9;SOX9;TGFB3;ITGB5;BMPR1A;ID1;GDF10;LIMS1;TGFBR1;USP15;LTBP2;SKI;TGFBR2;ITGB1;SMAD2;NLK;RHOA;MAP3K7;COL1A2;PARD3;ACVR1;PARD6A
prerank,receptor internalization (GO:0031623),0.41444499460815687,1.0649425861171857,0.3879093198992443,0.8596534885267435,1.0,6/44,8.04%,RAMP1;NEDD4;CD9;LRP1;ITGB1;GRK4
prerank,intracellular protein transport (GO:0006886),0.34787989886137,1.0649369023489494,0.3444782168186423,0.8589990173551004,1.0,75/304,18.59%,PKD1;SGSM2;PRICKLE1;TLK1;GIPC1;STX11;KIF13A;HPS4;SEC16A;KATNB1;TMED5;TMED3;STAT3;RANGRF;LTBP2;HERC2;RAB43;RAB6A;NUP93;STRADA;BAG3;RAB24;ARFIP2;SEC31A;AP3B1;E2F3;NUP214;RANBP3;ARFGAP3;NUP153;XPO1;TNPO2;COPA;DESI1;C2CD5;SEC23IP;XPO4;TNPO3;NLGN1;CHP1;NSF;STX5;ARF4;IPO7;STX12;CTTN;NUP155;EHD1;NUTF2;TBC1D2B;SORL1;RAB21;EVI5;ARCN1;SCFD2;AP3D1;COPB2;NUP88;RABGAP1;XPO7;SNX8;RAB28;RAB1A;CSE1L;CAMSAP3;TBC1D8B;SNF8;RAB5B;STXBP1;SURF4;STX2;SMURF1;TBC1D5;TBC1D17;AP2A1
prerank,macromolecule catabolic process (GO:0009057),0.44661537339717855,1.064890440624641,0.3808864265927978,0.8584609091036823,1.0,7/26,19.40%,NEDD4;KIF16B;BECN1;IDE;SH3GLB1;SMURF1;LRSAM1
prerank,positive regulation of cell development (GO:0010720),0.42589699134740505,1.064787544175955,0.3862158647594278,0.8580988838855049,1.0,1/31,0.35%,BMP4
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.4366870272865775,1.0647643004202876,0.3912448700410397,0.8574905409978711,1.0,5/29,9.28%,SLIT2;PRKCD;LIMA1;SHANK1;KANK4
prerank,focal adhesion assembly (GO:0048041),-0.373605719594241,-1.064617806034239,0.35,0.7640797576478726,1.0,3/21,2.26%,PEAK1;THSD1;ACTN2
prerank,regulation of establishment of planar polarity (GO:0090175),0.3769034834647108,1.064313699294887,0.36302142051860203,0.8580921661555061,1.0,25/88,18.97%,WNT11;PRICKLE1;FZD1;FZD7;PSMB2;AP2A2;DACT1;TIAM1;PSMD11;PSMC1;RHOA;PSMC6;PARD6A;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;NPHP3;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4488978499677416,1.0640035378236254,0.3756906077348066,0.8582786107597161,1.0,5/24,5.85%,WNT9A;SOX9;TGFBR1;PTHLH;ZBTB16
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3612456024335249,-1.0638780800114926,0.35424354243542433,0.7644872487998499,1.0,6/28,5.98%,APOE;ADCY1;SHANK3;APP;EPHA4;LGMN
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4141322269948219,1.0637231989492786,0.41259640102827766,0.8584112543693729,1.0,20/42,29.09%,WARS2;NARS2;EPRS1;EARS2;QARS1;CARS2;YARS1;VARS1;VARS2;FARSA;RARS2;LARS1;AIMP2;YARS2;CARS1;EEF1E1;NARS1;FARS2;PPA2;GARS1
prerank,determination of left/right symmetry (GO:0007368),0.4199606018057264,1.0632598169929979,0.3989501312335958,0.8590021090588551,1.0,11/36,18.88%,PITX2;SMO;DNAAF4;GALNT11;KIF3B;OFD1;MEGF8;NPHP3;ODAD2;MKKS;ODAD3
prerank,regulation of primary metabolic process (GO:0080090),0.3659213976358941,1.0632079212669752,0.39021739130434785,0.8584794985969414,1.0,36/126,19.88%,TNFAIP8L3;ID2;LDLR;PSMB2;CREBBP;NCOR1;NQO1;ABCA7;CHD9;PSMD11;NCOR2;RXRA;PSMC1;ACACA;TBL1X;GGPS1;ODC1;PSMC6;NCOA6;NR1D1;SREBF1;NFYA;PSMD1;AZIN1;PSMD4;SQLE;OAZ2;PSMA6;SCD;PSMD14;PSMD12;HMGCR;PSMD7;PPARG;TGS1;NR1D2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.4244948993407643,1.063078289258858,0.38910505836575876,0.8581790945290787,1.0,5/33,12.46%,DDX5;ESR1;DNAAF4;KDM1A;UBA5
prerank,heterotypic cell-cell adhesion (GO:0034113),0.44734636093642155,1.0628051739761386,0.41536273115220484,0.8582313868655177,1.0,10/25,18.39%,CD2;DSP;DSG2;PARVA;ITGB1;ITGAV;JUP;ITGB3;CXADR;ITGA5
prerank,positive regulation of sodium ion transport (GO:0010765),-0.4324352111130854,-1.0627735058003458,0.3776435045317221,0.7658013953297712,1.0,8/12,31.16%,ANK3;CNKSR3;AHCYL1;WNK3;SCN5A;GPD1L;PKP2;SCN4B
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.3966920163107204,-1.061797868428253,0.3485342019543974,0.7667976248273374,1.0,4/16,4.29%,IGF1;IGFBP2;IGFBP3;IGFBP4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5339408941561037,1.061795686476586,0.42671009771986973,0.8602895159816821,1.0,3/10,13.32%,LBP;IFI35;TIRAP
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4487528016997312,1.0613423027607196,0.39775910364145656,0.8609150042714611,1.0,6/26,10.81%,ST3GAL4;B3GNT2;B4GALT1;SLC35D2;CHST5;B4GAT1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.37861473877051977,1.0613273680549082,0.3863109048723898,0.8602904085345792,1.0,13/72,9.03%,ARHGEF28;MET;COL3A1;AKAP13;NRP1;ARHGDIB;ABL1;MYOC;BCR;GPR65;STARD13;GPR4;CUL3
prerank,tRNA methylation (GO:0030488),0.43189656301996393,1.0612480494702852,0.398406374501992,0.8598325737887886,1.0,13/34,28.89%,TRMT10A;ALKBH8;MTO1;METTL2A;METTL2B;TARBP1;TRMT61B;TRDMT1;FTSJ1;DALRD3;THADA;TRMT44;THUMPD2
prerank,retinoid metabolic process (GO:0001523),0.3866347770128098,1.0611794059811652,0.3745583038869258,0.8593488781579189,1.0,11/71,12.07%,GPC6;CYP1B1;ADH7;GPC3;RDH12;CYP2S1;LRP1;RLBP1;RBP1;DHRS3;DHRS13
prerank,triglyceride metabolic process (GO:0006641),-0.30264335252074387,-1.0607773936278335,0.3489583333333333,0.7678748018271148,1.0,8/48,12.52%,APOE;LPGAT1;GK;PLAAT3;LPIN3;GPAM;DGAT1;FABP5
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.407472485886317,-1.0604886860010496,0.38323353293413176,0.7670252321093177,1.0,11/14,48.93%,PTGER3;OSMR;PTGS2;TNF;CREB3L3;IL6;OSM;FFAR2;IL1B;C2CD4B;IL6ST
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.27190588621259815,-1.0603901084471785,0.3238095238095238,0.7656080707380525,1.0,18/102,8.10%,TBC1D4;ADCY5;ADCY1;SLC30A10;PIK3R1;CPEB2;FOXO1;ENPP1;INSR;PRKAR2B;INSIG2;PRKAR1B;ADCY7;PRKAR1A;SLC25A33;MYO5A;LPIN3;RAB31
prerank,regulation of chemotaxis (GO:0050920),0.43162971974555114,1.0599784100858594,0.3871829105473965,0.8620455066487639,1.0,2/30,4.65%,THBS1;PTPN2
prerank,regulation of store-operated calcium entry (GO:2001256),0.532500253470583,1.059978271064572,0.41412520064205455,0.8613806146789216,1.0,4/10,17.48%,SLC8B1;HOMER2;GRAMD2A;HOMER1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.35984829427907533,-1.059883038056354,0.33986928104575165,0.7652121901603339,1.0,11/25,23.12%,CEMIP;AKAP6;CACNB2;TRPC1;CX3CL1;APLNR;PLCG1;THY1;SNCA;F2R;GPER1
prerank,protein heterotetramerization (GO:0051290),0.4944525320677557,1.059813677570432,0.40950920245398775,0.8612110367519671,1.0,1/13,1.00%,PKD1
prerank,smooth muscle tissue development (GO:0048745),0.5363232456546162,1.059808705554401,0.4324786324786325,0.8605610570032395,1.0,3/10,5.44%,BMP4;SMO;NF1
prerank,manganese ion transport (GO:0006828),-0.41462831193386074,-1.0595543468826412,0.3816155988857939,0.7643168805936956,1.0,7/14,8.38%,SLC30A10;TRPC3;ATP2C1;SLC39A8;TRPC4;TRPC6;TRPC1
prerank,axon guidance (GO:0007411),0.3515746338699137,1.0589512569942245,0.36251287332646753,0.8622115690926355,1.0,25/201,6.46%,SLIT3;SLIT2;NTN1;NFIB;SEMA3E;EZR;EFNA5;GAB2;UNC5C;SLIT1;NRP1;VEGFA;SMO;PDLIM7;NOTCH2;GRB10;SEMA3C;TMEFF1;EPHB3;KLF7;SPTAN1;LYPLA2;SHC1;SEMA3D;GLI2
prerank,cellular component assembly (GO:0022607),0.3520858183377249,1.0587377804947298,0.3595959595959596,0.8621770861400251,1.0,44/253,12.60%,DPYSL3;RHOJ;HES1;BAIAP2L1;REPS2;GSN;EZR;CHAF1B;PTK2B;SOX9;PKP1;GRHL2;PAWR;FZD1;GORASP2;LIMS1;SLC7A9;HAS1;PARVA;CALD1;PLS1;LIMA1;MNAT1;CREBBP;SHANK1;IKBKG;RHOQ;FAM107A;DMTN;BSN;CHAF1A;PCLO;TOGARAM1;EPRS1;TLCD1;RHOA;DET1;NLGN1;TEAD1;ZW10;RTN3;TRAF2;PARD3;MDM4
prerank,gluconeogenesis (GO:0006094),-0.31758834317340034,-1.0584264907482268,0.3440366972477064,0.7658540469354379,1.0,15/39,23.63%,RBP4;SLC25A13;PGM1;PPARGC1A;GOT2;PGAM1;GAPDH;PCK2;MDH1;CRY1;ENO1;GAPDHS;GOT1;G6PC3;ALDOC
prerank,synaptic vesicle localization (GO:0097479),0.49392614230601195,1.0580163916617429,0.3894080996884735,0.8635603331628049,1.0,5/13,17.62%,TMEM230;NLGN1;SPG11;KIF5B;SYNJ1
prerank,regulation of phosphate metabolic process (GO:0019220),0.48033287650616274,1.0576987622303369,0.4217585692995529,0.8637827102372506,1.0,7/16,16.73%,SMG6;BARD1;IGBP1;RAD17;TIGAR;MCM7;IKBKB
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3927067537197892,1.0574475058335833,0.3918269230769231,0.863815391654509,1.0,17/59,19.08%,TCF7L2;SOX9;MED13;TWIST1;MED24;CCND1;RUNX2;MED27;CCNB1;MECP2;MED15;MED31;CDKN1A;MOV10;MED20;MED16;MED25
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5242911188985997,1.0573239846821287,0.40672782874617736,0.863502174141352,1.0,7/11,28.77%,HIRA;ATRX;CABIN1;IPO4;ASF1A;HAT1;NASP
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.45365268348850807,1.0572711337299143,0.3843971631205674,0.8629903003163694,1.0,4/23,7.25%,HDAC4;CLK2;PFKFB1;NCOR1
prerank,negative regulation of bone mineralization (GO:0030502),0.5012375847352636,1.0571823158675355,0.4263565891472868,0.8625775416422825,1.0,4/13,10.56%,PTK2B;CCL3;TRPM4;BCOR
prerank,regulation of mRNA stability (GO:0043488),0.3601958457059578,1.056863037892991,0.3926645091693635,0.862747210690963,1.0,46/145,22.05%,PRKCD;SAMD4A;PSMB2;FASTKD1;ZC3H14;APEX1;NUP214;PSMD11;THRAP3;XPO1;PSMC1;PABPC1;DHX36;PSMC6;EXOSC3;CELF1;FUS;E2F1;DCP1A;PRKCA;PSMD1;CIRBP;PSMD4;MEX3D;EXOSC1;GDNF;FTO;PCID2;PCBP4;PSMA6;MAPKAPK2;PSMD14;PSMD12;DIS3;PUM2;SERBP1;IGF2BP3;PSMD7;EIF4G1;FASTKD3;EXOSC2;EXOSC7;PSME3;SAMD4B;PUM1;FMR1
prerank,protein localization to cell periphery (GO:1990778),0.36060184111450033,1.0567208354550495,0.3969795037756203,0.8624929764012425,1.0,28/133,13.19%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;ARL3;PLEKHF1;RAP1A;JUP;PIP5K1A;ITGB1BP1;EHD1;DLG1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.3529781187168234,1.0564207770724348,0.3839750260145682,0.8626554983366337,1.0,33/182,12.86%,FOXP1;BMP4;SLC24A3;FGF2;ITGB8;VEGFA;ESR1;BMPR1A;ID2;LDLR;WWP2;SMO;ZNF148;NOTCH2;KLF4;CCL3;EMILIN1;ATP2B4;AGO2;REL;AURKA;ZC3H12A;ATXN2;ANXA7;XDH;POU4F1;CREB3L1;TRAT1;MECP2;ATOH8;CD46;CELF1;CPNE1
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.3785147563010586,-1.0563325381062043,0.35563380281690143,0.7698731270184528,1.0,5/21,10.31%,IGF1;KDR;CTSH;MAPK1;MAP2K1
prerank,regulation of cell migration (GO:0030334),0.34367937135892906,1.056211922652958,0.3487437185929648,0.8625483818960239,1.0,55/382,9.92%,SLIT2;F3;THBS1;EGFR;TMEFF2;CLIC4;DPYSL3;NTRK3;CDH1;ADAM9;TWIST2;PPP3CA;CCN1;SEMA3E;LMO4;CYP1B1;PTPRU;WNT11;IGFBP5;PTK2B;FGF2;SLURP1;SRGAP2;SRGAP3;ELP3;VEGFA;SMO;PHACTR1;CCL3;SEMA3C;TGFBR1;NOG;PDGFC;STAT3;ANXA1;FOXO3;NF1;SEMA3D;LMNA;MYOC;TIAM1;VCL;SMIM22;ITGB1;SULF1;ARSB;FAM107A;CEP43;CORO1C;RDX;CHRD;MIA3;CIB1;PIK3R3;CCL7
prerank,negative regulation of bone remodeling (GO:0046851),0.5250650111830071,1.0553323916435684,0.42496050552922593,0.8642794418087792,1.0,2/11,9.62%,UBASH3B;TMEM119
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.4502751596577316,1.055189195972028,0.421875,0.8640248144649328,1.0,5/23,12.86%,CCN3;NLRP12;ZC3H12A;IFI35;CPNE1
prerank,cell projection organization (GO:0030030),0.44069102437258156,1.0550188337550517,0.41542625169147496,0.8638314152500629,1.0,5/30,7.72%,RHOJ;GSN;PARVA;ITGB1;RHOQ
prerank,cortical cytoskeleton organization (GO:0030865),0.41579438773609445,1.054655628180287,0.3968871595330739,0.8641323551514887,1.0,9/41,13.19%,FMNL2;RHOBTB1;EZR;PPP2R3C;RHOQ;RND3;RHOA;NLGN1;DLG1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.29297581837034253,-1.0544477739995572,0.3619631901840491,0.7732865725394019,1.0,10/57,8.28%,IGF1;LYN;IL31RA;KIT;ERBB4;IL6R;PARP14;GHR;IL18;NF2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.41787494961946003,1.0542946341775445,0.410761154855643,0.864502811825488,1.0,23/39,36.43%,ERCC5;CHD1L;PARP1;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;POLD1;XPA;GTF2H5;GTF2H1;RFC2;RPA1;POLD4;ERCC3;FAN1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.49952527021273807,1.0539899115702753,0.42750373692077726,0.8647367036913027,1.0,3/13,8.86%,PTGIS;NNMT;NUDT12
prerank,regulation of protein localization to nucleus (GO:1900180),0.4059161022285381,1.0539750520029727,0.400990099009901,0.8641210693480397,1.0,4/43,7.30%,BMP4;GSK3B;CTNNA1;LIMK2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5034204920693888,1.0538782821163786,0.4252336448598131,0.8637449698888239,1.0,4/13,10.92%,RANGRF;RIC3;ABCA7;TM9SF4
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4205540390268374,1.0537351909387171,0.4130718954248366,0.8635043663344869,1.0,20/37,33.97%,ERCC5;CHD1L;PARP1;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;DDB2;POLD1;XPA;GTF2H5;GTF2H1;RFC2;RPA1
prerank,dendritic cell differentiation (GO:0097028),-0.3667282716090984,-1.0526395649967664,0.3719298245614035,0.7765615911478647,1.0,9/22,24.13%,LYN;AXL;FLT3;GAS6;CAMK4;CCL19;IRF8;PRTN3;TREM2
prerank,regulation of cellular component movement (GO:0051270),0.39938487531059524,1.0525180608099856,0.39855072463768115,0.866198057737877,1.0,11/49,12.56%,EGFR;ARAP1;CD9;VEGFA;TGFBR1;ABL1;DIAPH1;ERBB2;RHOA;IGBP1;RAF1
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5060300861890273,1.0523303786316585,0.40965732087227413,0.86607077916437,1.0,1/11,3.02%,YBX3
prerank,negative regulation of blood pressure (GO:0045776),-0.41501973777741274,-1.0523175139847296,0.37091988130563797,0.7756912133566224,1.0,2/13,7.84%,NOS3;PRCP
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.4506411803090047,-1.0520117101504738,0.36246786632390743,0.7749644274783306,1.0,3/10,3.37%,BCL2;DCN;KDR
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.45184529821203523,-1.0514157842485128,0.4049586776859504,0.7748864318546327,1.0,3/10,16.44%,PRKAA2;KLF15;MYOCD
prerank,receptor metabolic process (GO:0043112),0.39956648533306083,1.0511792976652825,0.411619283065513,0.8685748784675827,1.0,9/53,8.69%,RAMP1;NEDD4;CD9;LRP1;KIF16B;ITGB1;GRK4;PHETA2;BECN1
prerank,brain development (GO:0007420),0.3584510822052918,1.0510133051950223,0.4047362755651238,0.8683695644675452,1.0,15/136,7.68%,SLC23A1;PBX3;ZFHX3;NFIB;ADGRL2;PBX1;DMBX1;GRHL2;ZIC1;SHROOM4;NIPBL;NF1;TGFBR2;PAFAH1B1;PAFAH1B2
prerank,positive regulation of cyclase activity (GO:0031281),0.49210877443592715,1.0507001709594288,0.4317507418397626,0.8686220309996628,1.0,2/14,5.44%,CACNA1C;NF1
prerank,actin filament network formation (GO:0051639),0.5099958178879975,1.0505545379214423,0.4290375203915171,0.8683544135312187,1.0,2/11,6.00%,COBL;PLS1
prerank,regulation of catabolic process (GO:0009894),0.4678057477126921,1.0504879086484875,0.42251461988304095,0.8678790183103545,1.0,6/18,16.99%,CHEK2;ZDHHC2;ITGB1;ODC1;SNF8;FAP
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.36300180422147194,1.0502837863551275,0.39742212674543503,0.8677502859700041,1.0,34/138,19.02%,NR3C2;RARB;HDAC9;ESR1;NOTCH2;RARA;NR4A3;MNAT1;NR4A2;CREBBP;RORA;NCOR1;E2F3;NCOR2;RXRA;MED27;TBL1X;TEAD1;RXRB;NR2F1;NR1D1;GTF2E1;NR4A1;GTF2A2;TAF4;NR3C1;CDK7;E2F2;GTF2H3;YAP1;ESR2;TAF5;POLR2C;PPARG
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3665123507992738,1.0499043125567558,0.3968609865470852,0.8681044885809149,1.0,20/98,16.29%,THBS1;PID1;ANXA2;SFRP4;VEGFA;KLF4;ECE1;TGFBR2;INHBA;ZC3H12A;ACACA;CCNB1;XDH;NSF;STARD4;IFNLR1;RNF41;RAB1A;CDKN1A;SCRIB
prerank,synaptic vesicle exocytosis (GO:0016079),-0.31344430433289444,-1.0498657623298902,0.329004329004329,0.7774170991398691,1.0,7/40,6.67%,UNC13C;RIMS1;RIMS2;SNAP25;SYT1;SYT7;SYT10
prerank,sensory perception of taste (GO:0050909),0.5153285804068184,1.0498312096653142,0.4072249589490969,0.8676448115972254,1.0,1/10,2.94%,TAS1R3
prerank,regulation of RNA metabolic process (GO:0051252),0.38909575761646203,1.0498127259965004,0.4123957091775924,0.8670482165712041,1.0,14/59,17.54%,AHNAK2;MBNL1;AHNAK;CLK2;CLK1;SON;CLK4;CELF1;FUS;HNRNPH1;RRP1B;SNRNP70;MBNL2;PCBP4
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4537194918680702,1.0495750280604412,0.4098591549295775,0.8670405292174401,1.0,4/20,8.73%,SMAD9;VEGFA;NFE2L2;RUNX2
prerank,diterpenoid metabolic process (GO:0016101),0.39518309961320447,1.0494709773710638,0.4099756690997567,0.8666912436731424,1.0,11/55,17.04%,GPC6;ADH7;GPC3;RDH12;LRP1;RLBP1;RBP1;DHRS3;GPC4;STRA6;PECR
prerank,protein polyglutamylation (GO:0018095),-0.4418609600837582,-1.0487858613938423,0.39617486338797814,0.7787112715142602,1.0,6/11,22.18%,TTLL7;TTLL11;TPGS1;TTLL5;TTLL6;TTLL1
prerank,positive regulation of cell differentiation (GO:0045597),0.34352363611709885,1.0487470076950614,0.41109969167523125,0.8680947627420602,1.0,39/237,10.54%,CDON;BOC;BMP4;VWC2;DDR2;HOXA5;CCN1;TMEM100;CMKLR1;SOX9;NGF;NELL1;TGFB3;BMPR1A;ID2;TGFBR1;ABL1;TWIST1;FGFR1;CTNNA1;ZBTB16;MEF2A;NBL1;BMP6;MAPK12;HOXB4;TIAM1;TGFBR2;KITLG;SMAD2;ZC3H12A;TRPM4;RUNX2;FOXC1;SYAP1;TMEM119;RHOA;TGFB1I1;DHX36
prerank,regulation of histone acetylation (GO:0035065),-0.32660410990405747,-1.0486543541705042,0.3537117903930131,0.7774213444682656,1.0,11/33,24.44%,RPS6KA5;RAPGEF3;PPARGC1A;RPS6KA4;BRD7;MYOCD;GLYR1;SNCA;CTBP1;NOC2L;SPI1
prerank,synaptic vesicle cycle (GO:0099504),-0.34336864928130756,-1.048651313005116,0.3840304182509506,0.775773451752243,1.0,11/30,24.07%,RIMS1;SNAP25;SYNDIG1;SYT7;SYT10;PLD2;RAB3A;BRSK1;SNCA;OTOF;SLC32A1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.37873288062263316,1.0485461893013843,0.39766081871345027,0.8679354668219136,1.0,13/66,16.91%,CDH1;PRKCD;ZIC1;UBR5;BAG3;LIMK2;ZC3H12A;MAVS;JUP;DMAP1;NMD3;CCT5;YAP1
prerank,body fluid secretion (GO:0007589),-0.4053411742886214,-1.0477418134803058,0.3768545994065282,0.7766837020390736,1.0,4/15,12.15%,ERBB4;NPR1;SLC22A4;SLC22A2
prerank,positive regulation of B cell activation (GO:0050871),-0.29938987726194466,-1.047709590829216,0.3553299492385787,0.7751389460523677,1.0,16/50,17.83%,BCL2;TFRC;SH3KBP1;MEF2C;VAV3;CD38;TNIP2;NFATC2;CD81;MIF;CD40;CD74;XBP1;NOD2;SHLD2;BTK
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.475454031581514,1.0470704208279904,0.43841642228739003,0.8713817554127693,1.0,6/18,19.46%,RFK;ABL1;FXN;SIRT3;GDNF;EDN3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.41416476802533486,-1.0468767642961654,0.39067055393586003,0.7758250744774077,1.0,1/14,0.81%,MOXD1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.4333326779085206,-1.0465789065578002,0.4157608695652174,0.774972565262685,1.0,4/12,16.62%,CLCN2;KPNB1;H6PD;ABCA2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.30646856818122575,-1.0463727049663043,0.3862433862433862,0.7739560911949139,1.0,10/46,10.11%,SEMA6A;LYN;FBLN1;TIMP3;SPRED1;SIRPA;DAB2IP;LMO3;CNKSR3;RPS6KA6
prerank,regulation of cellular component organization (GO:0051128),0.3577580844600812,1.0463177776689767,0.39847161572052403,0.8727672541412452,1.0,25/135,12.41%,PLCE1;NEDD4;SNCAIP;MLLT3;CAMK2D;STON2;DCUN1D5;ABL1;IRAK3;STON1;ALKBH4;RUFY1;AURKA;CDK11B;LTBP4;FAM107A;ARFGAP1;TMC8;SLITRK2;RAB4B;ANKRA2;RAP1A;HJURP;SGK3;TRAF2
prerank,protein localization to cell junction (GO:1902414),-0.360698602842736,-1.0461962624077608,0.375,0.7728623258994841,1.0,4/22,6.32%,TJP1;CGNL1;HEG1;JAM3
prerank,cell cycle checkpoint signaling (GO:0000075),0.5034431382233695,1.0459632537215293,0.4418960244648318,0.8730616187307669,1.0,6/12,22.78%,NABP1;ZW10;ZWILCH;CHFR;WEE1;PRCC
prerank,negative regulation of type I interferon production (GO:0032480),0.40720241351386505,1.0452860572137934,0.41656050955414015,0.8742420096182175,1.0,15/40,24.41%,TAX1BP1;REL;IKBKE;MAVS;IFIH1;GPATCH3;PTPRS;PIN1;OTUD5;NLRX1;RELB;YY1;IRF3;LILRB1;NLRC3
prerank,response to UV-B (GO:0010224),-0.4256877160314482,-1.0447138053114589,0.4166666666666667,0.7753665653347007,1.0,6/12,26.67%,MME;MFAP4;CRIP1;HYAL2;HYAL3;STK11
prerank,dendritic spine morphogenesis (GO:0060997),-0.4089132189436547,-1.0446219948252078,0.3930635838150289,0.773967816922658,1.0,4/15,4.20%,DOCK10;SHANK3;EPHB1;PAK3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4707744877481585,1.044609248868333,0.43002915451895046,0.8753949606135353,1.0,3/17,3.53%,HES1;ID2;CLCF1
prerank,actin filament polymerization (GO:0030041),0.4348711519912804,1.0444415246893277,0.4173441734417344,0.8751916874574649,1.0,6/29,11.19%,COBL;GSN;PSTPIP1;DIAPH1;FAM107A;WASHC5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3367828156267392,-1.0442400463799066,0.3948339483394834,0.7733712378146826,1.0,9/28,11.81%,MAP2;CLASP2;STMN1;STMN4;MAPT;CAMSAP2;STMN3;FKBP4;MAP1A
prerank,protein complex oligomerization (GO:0051259),0.37507974351384527,1.0442203630313558,0.40022935779816515,0.8751259519015746,1.0,20/85,17.48%,LRRC8D;ATL3;TMEM120A;MPP2;ATL2;G3BP2;PRMT8;ZC3H12A;CUTC;SLC9A1;MCU;ZBTB1;FUS;EHD1;PDCD6IP;RBMX;ATL1;YME1L1;ADCY8;HOMER1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5232325648313834,1.0441640938150887,0.4520766773162939,0.8746187799021409,1.0,6/11,30.42%,PRDX5;CAT;PRDX2;PRDX1;GPX1;PXDN
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3419792144697123,1.0441439325904112,0.3765182186234818,0.8740159912216542,1.0,55/348,12.73%,RASSF2;BMP4;CARD14;EGFR;SLCO3A1;PGF;NTRK3;DDR2;CCN1;BMP5;PTK2B;EFNA5;FGF2;NIBAN1;SOX9;KRAS;NGF;NRP1;VEGFA;TGFB3;BMPR1A;GDF10;PLCG2;TGFBR1;ABL1;PDGFC;DOCK7;ATP2B4;BMP6;FAM20A;ERBB2;CD44;INHBA;TENM1;LIMK2;CCND1;AKAP9;CD80;MAVS;CIB1;TMEM119;PIK3R3;RIPK2;TTK;DUSP19;TAB2;TOM1L1;RAP1A;CAB39;RAD50;RB1CC1;BCAR3;RAF1;BRAT1;UBE2K
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4953808742342373,1.0437065347148697,0.4143070044709389,0.8745230637350959,1.0,4/13,6.61%,SEMA3E;NRP1;VEGFA;TGFBR2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4575078096464821,1.043357280929751,0.4353448275862069,0.8748406823970072,1.0,5/22,15.75%,CD55;MAP3K7;ZBTB1;TRAF2;TRAF6
prerank,nucleosome organization (GO:0034728),0.39173696957549126,1.0433419516199807,0.43452380952380953,0.8742293072402445,1.0,18/55,24.63%,CHAF1B;SOX9;SRCAP;SETD2;CHAF1A;SMARCC1;DMAP1;RNF8;ATRX;KAT6B;SMARCA5;VPS72;NAA60;NAP1L1;HMGA1;ASF1A;INO80;RSF1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.35657476036029984,1.043329155191269,0.4017094017094017,0.873618840516107,1.0,24/118,14.18%,BMPER;FMNL2;NEDD4;PID1;SIPA1L1;EFNA5;FGF2;GSK3B;PHLDB2;EPHB3;ARHGAP44;NF1;PROK2;ERBB2;ZMYM4;LZTS1;PDZD8;PHLDB1;NSMF;MARK2;ZDHHC15;SRCIN1;HTATIP2;ZRANB1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.383467108076724,-1.0431139615173357,0.40412979351032446,0.7748295364367774,1.0,6/16,17.41%,APOE;NUS1;GCH1;NOS1AP;TERT;HIF1A
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4308915138138486,1.0418051964165276,0.4094488188976378,0.8771394166528853,1.0,14/29,27.96%,TANK;IKBKG;IKBKE;TLR4;UBE2D3;IKBKB;TICAM1;CHUK;TRAF3;IRF3;UBB;UBA52;RPS27A;LY96
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4098124893101544,1.0414370116472491,0.3984272608125819,0.8774916298678975,1.0,7/38,8.15%,TANK;ESR1;PER1;NLRP12;RORA;TRIM39;ZC3H12A
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3491239986727368,1.0411734472821101,0.4095139607032058,0.8775751776506855,1.0,35/198,14.05%,PLCE1;TNFAIP8L3;ALPL;PPP3CA;PLCZ1;PLPP3;PLPPR2;PLCB3;NUDT5;PLA2G4F;PLCG2;PLA2G15;STAT3;ACP3;PLA2G2C;IP6K1;PFKFB1;ACP4;NADK;LIMK2;IP6K2;PPIP5K1;GPI;TOP1;PFKP;INPP4A;DUSP28;EPHB2;ANGPTL3;DUSP5;AGK;OCRL;INPPL1;PIP4K2A;TIGAR
prerank,blood vessel diameter maintenance (GO:0097746),0.416872150600439,1.041134147071504,0.4315514993481095,0.8770381377125287,1.0,4/34,6.16%,KCNMB2;EDNRA;GCLC;ECE1
prerank,organelle organization (GO:0006996),0.33877007133771303,1.0410121405792603,0.39798994974874374,0.876722521728653,1.0,85/388,18.40%,MICAL2;PLCE1;ABCD3;MARK1;FMNL2;VPS13C;ATL3;STRIP2;ARHGAP21;ARHGAP10;GORASP2;BCAS3;CCL3;ATL2;SEC16A;RAB30;TMED5;GBF1;TMED3;FAM161A;RAB43;DIAPH1;LMAN2L;NRF1;SPRYD3;GOLGB1;SEC31A;SEC61A1;ZMYM4;ABCD1;DMTN;CSNK1A1;PLEKHM2;KIF9;PCLO;PNPLA3;GABPB1;MAST2;WDR81;PPRC1;LONP2;MIA3;GAK;VPS13D;PDZD8;CCL7;TSGA10IP;FBXW8;PLEKHF1;SEC23IP;PARP1;CENPT;DOP1B;DPYSL2;FGD1;ZW10;SPTSSB;FGD3;TRAPPC11;PDCD6IP;SIRT3;ZRANB1;ROPN1;MTFR1;TOR1B;FGD6;ATL1;BNIP1;YME1L1;CHMP2B;GOLPH3;ARFGEF1;RAB1A;MIEF2;HCFC1;POLG2;LARP4;SURF4;LRRK2;BAG5;COG3;CXADR;SH3D19;UBXN2B;ATP8B4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.43346268291206075,-1.0409269973174473,0.42337662337662335,0.7792803072442673,1.0,7/10,32.20%,RPS6KA6;HIPK2;KAT5;ING4;SP100;TFAP4;MUC1
prerank,positive regulation of TORC1 signaling (GO:1904263),0.474665512111785,1.0408957734340807,0.4375,0.8763961625098838,1.0,4/16,9.90%,TELO2;CLEC16A;RRAGB;KLHL22
prerank,oxoacid metabolic process (GO:0043436),-0.34420908224654495,-1.0408573544173647,0.38461538461538464,0.7778528281740048,1.0,9/27,26.80%,DDO;ENPP1;TPST1;MIF;SULT4A1;GRHPR;LIPT1;SULT2B1;AGXT
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3889025532804795,1.0405475210145796,0.4175824175824176,0.8766819060177358,1.0,11/52,22.34%,ME1;GCLC;FOLR2;SLC25A32;ACOT8;SLC46A1;SLC19A1;DGLUCY;MTHFS;OGDH;NIT2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5184238414496573,1.0402588376378348,0.45292207792207795,0.8768172336959719,1.0,2/10,14.48%,PDE6A;PDE6B
prerank,protein modification by small protein conjugation (GO:0032446),0.3379635144763756,1.0401141667673826,0.4074446680080483,0.8765907034987346,1.0,84/361,20.07%,WWP1;FBXL7;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;NFE2L2;WWP2;TRIM55;DCUN1D5;HERC2;SPSB2;TRIM47;NUP93;UBE2A;WAC;SAE1;BARD1;NUP214;TRIM39;UVSSA;TSPAN17;TRPM4;NUP153;HIF3A;ARIH1;CUL3;VCP;CDC16;IFIH1;CUL1;ANAPC11;PEX13;FBXW8;DTX2;ATG3;TRPC4AP;DET1;KEAP1;TRIM44;TRIM41;ANAPC16;RNF138;UBA5;NUP155;BRCA1;UBE2K;RANBP2;UBE2M;UBR3;MIB1;RNF8;COMMD1;NUP88;FBXO45;RNF41;UBE2B;DCUN1D2;UBE2D3;MKRN2;PRKDC;RNF111;CNOT4;TMEM129;DCUN1D1;RNF20;AREL1;RNF14;UBE2S;NUP35;SMURF1;MYCBP2;CHFR;PIAS2;TRIM35;ENC1;NFX1;VCPIP1;UBA3;UBE2F;TRAF7;UBE2Z;BRAP
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4453660522364004,1.0395343576475815,0.4217032967032967,0.8774211116105803,1.0,5/24,5.78%,SEMA3E;NRP1;VEGFA;SEMA3C;SEMA3D
prerank,negative regulation of cell communication (GO:0010648),0.4527250354769594,1.0394599716611905,0.4111111111111111,0.8769740722714265,1.0,5/21,16.08%,UBASH3B;SRMS;NLRP12;ACVR1;HHIP
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.4037822364481804,1.0393027335129639,0.4162371134020619,0.8767523912540374,1.0,13/40,25.65%,PRKCD;ABL1;FEM1B;USP1;NSMCE1;MCL1;FBXO5;KMT5A;NEK4;FMR1;WDR76;SMYD2;UBE2V1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3728142563313666,1.0390849760487728,0.40543735224586286,0.8766953482222091,1.0,11/72,10.11%,SLIT2;PRKCD;FGF13;LDLR;KATNB1;EMILIN1;LIMA1;SHANK1;KANK4;CIB1;HDGFL3
prerank,mRNA stabilization (GO:0048255),0.40498015371468904,1.0389636423344775,0.43376623376623374,0.8763805870338771,1.0,13/40,18.86%,YBX3;THRAP3;PABPC1;ANGEL2;MYD88;FUS;E2F1;TIRAP;CIRBP;GDNF;MAPKAPK2;DHX9;SYNCRIP
prerank,protein modification process (GO:0036211),0.3733555159828439,1.038901009586632,0.4136690647482014,0.8759133540950512,1.0,23/76,19.97%,PLOD2;WWP2;ABL1;PHKA2;USP25;ST8SIA2;PHEX;TGM5;PARP1;ATG3;LOX;CSNK1G3;UBE2M;MAN2B1;UBE2D3;PRKDC;GGCX;PPP4R2;UBL5;UBE2S;UBA3;PARP4;YES1
prerank,regulation of cell cycle process (GO:0010564),0.3603348623878635,1.038736966595792,0.42825361512791993,0.8757457745807108,1.0,27/104,21.06%,CCDC8;SOX9;TXLNG;KIF13A;SETD2;AURKA;RAB11FIP3;KNSTRN;BECN1;CDK13;AHCTF1;PLK4;FBXO5;SH3GLB1;PRMT5;CEP85;PIN1;PLK3;E4F1;RMI2;TTL;CETN2;BORA;MAD1L1;USP19;RAB11A;BIRC6
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3514681413339289,-1.0382974426562892,0.38372093023255816,0.7831349576021686,1.0,11/23,27.03%,ERRFI1;CBLB;SNX6;ZFYVE28;SOCS5;HYAL2;THY1;CAV1;GPRC5A;CHMP6;ZGPAT
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4468178395464423,1.0376204757055187,0.41713483146067415,0.8781174281488976,1.0,3/22,4.65%,EZR;UBASH3A;PTPN2
prerank,platelet degranulation (GO:0002576),0.35659574982887815,1.0375584287631021,0.4122222222222222,0.8776418010714863,1.0,15/118,9.60%,THBS1;PCDH7;LHFPL2;CD9;FAM3C;VEGFA;TGFB3;CD109;SYTL4;TIMP1;FN1;VCL;PHACTR2;TEX264;MAGED2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3609691583036033,1.0370676194735502,0.441834451901566,0.878286089508324,1.0,25/104,18.20%,LRP6;CCNA2;ADRB2;TELO2;CDK12;ABL1;MNAT1;CCND1;CDKN2C;SYAP1;CIB1;CCNB1;RHOA;DUSP19;CAB39;CDKN1B;CDKN3;LRP5;CCNG1;CDK7;CCNT2;CDKN1A;SNF8;RB1;RALB
prerank,actin filament organization (GO:0007015),0.35057937008856255,1.0370321764708565,0.41445270988310307,0.877730409994001,1.0,25/151,13.51%,DPYSL3;VILL;BAIAP2L1;COBL;RHOBTB1;ABI1;GSN;NLRP5;GAS2;SHROOM4;SHROOM3;FAT1;PLS1;ARHGAP17;FLII;DMTN;CORO1C;RND3;RHOA;SAMD14;GAS2L1;MCU;DLG1;INPPL1;DBN1
prerank,mismatch repair (GO:0006298),0.43183397985682714,1.03694610955319,0.430939226519337,0.8773034148583404,1.0,7/27,20.49%,EXO1;ABL1;SETD2;MLH3;RNASEH2A;MCM9;MSH4
prerank,tRNA aminoacylation (GO:0043039),0.4110401225211986,1.0366099728448057,0.4317295188556567,0.8775654197997123,1.0,17/37,29.09%,WARS2;EPRS1;QARS1;YARS1;VARS1;FARSA;RARS2;LARS1;AIMP2;YARS2;GATC;CARS1;EEF1E1;NARS1;FARS2;PPA2;GARS1
prerank,regulation of interferon-beta production (GO:0032648),0.3986416116657791,1.0365246010032787,0.4276729559748428,0.8771937855131976,1.0,22/46,26.88%,REL;IRF1;TLR4;MAVS;IFIH1;RIPK2;TLR8;POLR3F;POLR3A;PTPRS;TIRAP;FLOT1;POLR3D;DHX9;RELB;TRAF3;YY1;IRF3;LILRB1;NLRC3;IRF5;PPM1B
prerank,cellular lipid catabolic process (GO:0044242),0.44029067148427214,1.0363369661293078,0.4195323246217332,0.8770454255265738,1.0,9/27,16.98%,CYP1B1;PLA2G15;ACBD5;LPIN2;ANGPTL3;ACOT8;ACOX1;ACADL;CEL
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.36915664280941574,-1.0363281198812209,0.41818181818181815,0.7853568449673782,1.0,5/23,8.94%,BCL2;TFDP2;YWHAB;PPP1R13B;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.36915664280941574,-1.0363281198812209,0.41818181818181815,0.7853568449673782,1.0,5/23,8.94%,BCL2;TFDP2;YWHAB;PPP1R13B;YWHAH
prerank,mitotic spindle assembly (GO:0090307),0.39366547941477376,1.035788523167231,0.42698019801980197,0.8778782082901636,1.0,16/42,23.40%,CHEK2;SPICE1;STAG1;MISP;TOGARAM1;RHOA;KIF3B;OFD1;ABRAXAS2;SMC1A;STAG2;RAB11A;CCDC61;PIBF1;KIF23;ABRAXAS1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4546684957616907,1.0357006464776277,0.43023255813953487,0.8774821194267322,1.0,6/19,9.11%,NRP1;VEGFA;LIMS1;ABL1;MYOC;S100A10
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.3972152835267938,-1.0355771665998565,0.421875,0.7858178656259452,1.0,2/15,2.62%,OSBPL8;PPARA
prerank,snRNA 3'-end processing (GO:0034472),0.45441220259993154,1.0352895515506066,0.4291907514450867,0.877946151494635,1.0,11/19,24.95%,INTS5;EXOSC3;INTS6;INTS7;EXOSC2;EXOSC7;INTS1;INTS14;EXOSC8;INTS8;INTS2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.495326934290294,1.034237152368988,0.43601895734597157,0.8800949883710726,1.0,3/12,16.92%,CLTRN;TRPM4;ADCY8
prerank,embryonic heart tube morphogenesis (GO:0003143),0.39838875540275576,1.03419932910052,0.43640897755610975,0.8795511833955889,1.0,5/43,8.40%,MICAL2;HES1;SMO;TGFBR2;GATA4
prerank,cellular calcium ion homeostasis (GO:0006874),0.35107652187840255,1.0334859967017667,0.4411764705882353,0.8807550839267666,1.0,20/133,13.14%,SLC35G1;SLC24A3;CSRP3;ATP2C2;CAMK2D;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;SLC10A7;PDZD8;CCL7;MCU;HERPUD1;DRD3;SLC8B1;CTRC;NPTN
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4277919387629526,1.0334634274347172,0.4200792602377807,0.8801690305733791,1.0,7/29,16.35%,PKP1;THRAP3;PABPC1;FUS;E2F1;CIRBP;GDNF
prerank,regulation of monooxygenase activity (GO:0032768),0.44460415150336424,1.0329835662905422,0.45850914205344584,0.8808112727594496,1.0,2/23,6.12%,EGFR;CYGB
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.41300738557887173,1.0329605395273669,0.43699731903485256,0.8802355538455195,1.0,4/36,6.12%,EGFR;NPR3;ATP2B4;CYGB
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.3464218743352817,-1.0327987683785849,0.3689655172413793,0.7919410891282341,1.0,6/25,10.12%,GRID2;GRIN2A;GRIN2B;MEF2C;GRIN1;GLRA1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.37061848366984285,-1.0327096211986517,0.370253164556962,0.7905947178686302,1.0,11/18,24.51%,PTGDS;PTGS1;EDN1;TBXAS1;MIF;HPGDS;CD74;CBR1;PNPLA8;PTGS2;PRXL2B
prerank,regulation of cell size (GO:0008361),0.43963025162980846,1.0325112680098085,0.43001443001443,0.8807691868678424,1.0,5/23,10.43%,VAV2;EZR;RAP1GAP2;RDX;RHOA
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.4633961916283533,1.032394128111961,0.432510885341074,0.8804628469667192,1.0,5/18,11.45%,GSK3B;MDFIC;CTNNA1;POLR1A;CHP1
prerank,neural tube development (GO:0021915),0.4788182828697088,1.0323711612719908,0.44165435745937964,0.8798944788691118,1.0,3/15,5.88%,PKD1;GRHL2;DACT1
prerank,regulation of organelle assembly (GO:1902115),0.37081965986235826,1.032225470467894,0.4309327036599764,0.8796352416050705,1.0,21/72,21.06%,GSN;EZR;NPRL3;RABEP2;SPICE1;KIF9;RDX;SDCCAG8;ATXN2;ATG3;ATG5;PDCD6IP;TBC1D2B;EVI5;RABGAP1;TBC1D5;TBC1D17;ODAD3;CDKL1;TBC1D15;NPRL2
prerank,response to exogenous dsRNA (GO:0043330),0.4670482582255466,1.031978861687571,0.4279411764705882,0.8796151092105224,1.0,9/18,19.69%,IRAK3;MAVS;IFIH1;CGAS;FLOT1;RALB;TICAM1;DHX9;COLEC12
prerank,positive regulation of protein transport (GO:0051222),0.37518102216598104,1.0317575346090593,0.4325581395348837,0.8795599882174541,1.0,17/67,17.07%,ADAM9;EZR;UNC13B;TGFB3;SYTL4;BCAS3;ACSL3;BMP6;PCM1;TENM1;PCNT;CHP1;APBB3;GOLPH3;VAMP2;PLK3;OAZ2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4316840777019952,1.0312458449358106,0.43059490084985835,0.880228123140165,1.0,6/24,8.67%,TMEFF2;MET;ARAP1;PHLDB2;MYOC;RHPN2
prerank,stress fiber assembly (GO:0043149),0.47809394003327416,1.031017269803555,0.42048929663608564,0.879588010658413,1.0,5/15,10.43%,ITGB5;PHACTR1;ITGB1;CUL3;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.47809394003327416,1.031017269803555,0.42048929663608564,0.879588010658413,1.0,5/15,10.43%,ITGB5;PHACTR1;ITGB1;CUL3;RHOA
prerank,oligodendrocyte differentiation (GO:0048709),-0.3655895409313479,-1.030803921214402,0.3732394366197183,0.7942179511349083,1.0,5/19,17.16%,SOX6;SOX13;SLC8A3;EIF2B1;NSUN5
prerank,response to ethanol (GO:0045471),-0.41238509929848177,-1.030708702236504,0.40114613180515757,0.7928248895426757,1.0,8/14,18.05%,GRIN2A;GRIN2B;ADCY7;GRIN1;GOT2;GLRA1;SDF4;SOD1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.42361422431979434,1.03047250575588,0.44645340751043117,0.8803805284172604,1.0,7/27,8.67%,TMEFF2;MET;ARAP1;PHLDB2;MYOC;SHANK1;RHPN2
prerank,cell-matrix adhesion (GO:0007160),0.3640888826881258,1.0302104485409544,0.4160090191657272,0.8804028344716524,1.0,22/95,13.74%,ITGBL1;PKD1;ADAM9;COL3A1;ITGB8;ITGB5;MSLN;EMILIN1;LYVE1;BCR;TIAM1;CD44;FN1;VCL;ITGB1;COL17A1;ITGAV;ANGPTL3;PIP5K1A;CTTN;ITGB1BP1;ITGB3
prerank,positive regulation of intracellular transport (GO:0032388),0.4071413866346416,1.0296902130997987,0.4386422976501306,0.8811682033743297,1.0,11/38,17.07%,NEDD4;BCAS3;PCM1;TENM1;EHD2;PCNT;EHD1;SORL1;VAMP2;PLK3;OAZ2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.32476724479100993,-1.0295503425810428,0.38839285714285715,0.7943670611161325,1.0,5/33,10.72%,IGF1;TFRC;BCL2L1;MAPT;PINK1
prerank,myelin assembly (GO:0032288),0.5058125632523841,1.0293137029870265,0.4440944881889764,0.8815201806268227,1.0,2/10,4.27%,CD9;PMP22
prerank,regulation of cation transmembrane transport (GO:1904062),-0.34271515261951263,-1.0291090276548167,0.4008097165991903,0.7939400849068374,1.0,7/29,3.85%,KCNIP4;CACNA1D;DPP10;KCNIP3;FGF12;CD63;KCNAB1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4118809766850814,1.0289392545266014,0.43415906127770537,0.8818818073590973,1.0,11/37,16.49%,EFNA5;GSK3B;PHLDB2;FAM107A;PHLDB1;SKA3;GAS2L1;MARK2;MAP6;BICD1;CAMSAP3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5147262613196266,1.028785398848055,0.46515151515151515,0.8816507334366089,1.0,2/10,4.17%,WNK1;ADA
prerank,rRNA 3'-end processing (GO:0031125),0.5095496906021839,1.0286331902950212,0.45709828393135726,0.8814134720564282,1.0,7/10,27.86%,ERI3;EXOSC3;ERI1;EXOSC2;EXOSC7;EXOSC8;ERI2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3777189161891062,-1.028621028757779,0.403030303030303,0.7935778405645191,1.0,8/18,17.57%,SHANK3;NRXN1;CACNG7;CACNG4;CACNG3;CACNG2;RELN;CACNG8
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3844824851524026,-1.0284181597159727,0.44680851063829785,0.7925451163513493,1.0,4/16,5.92%,APOD;PPARA;SIRPA;ADCY7
prerank,regulation of phospholipase C activity (GO:1900274),0.47570832760418935,1.028398229457349,0.445468509984639,0.8814233617274303,1.0,5/15,5.15%,NTRK3;FGF2;ESR1;ABL1;FGFR1
prerank,proteoglycan biosynthetic process (GO:0030166),0.41275180828303415,1.0283182647551143,0.4125874125874126,0.881014464940791,1.0,8/31,12.48%,EXT1;FOXL1;CHST13;XYLT1;CHST11;GAL3ST4;B3GALT6;GLCE
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4393284235319628,1.0281320299471732,0.43061516452074394,0.8808938079705539,1.0,2/22,1.65%,HES1;CYP1B1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4476668509919709,1.0279711854626494,0.4563662374821173,0.880691711021412,1.0,5/22,16.55%,WNK1;KLF4;CD44;FLOT1;LCK
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.42331583503473763,1.0278406636378803,0.4375,0.8804119571994016,1.0,14/30,27.96%,TANK;IKBKG;IKBKE;TLR4;UBE2D3;IKBKB;TICAM1;CHUK;TRAF3;IRF3;UBB;UBA52;RPS27A;LY96
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.33916735331292835,1.02770740660885,0.4331941544885177,0.8801484692111585,1.0,60/184,26.46%,PKD1;FZR1;ID2;PSMB2;ANAPC5;CDC14A;PCM1;AURKA;PAFAH1B1;PSMD11;CEP43;AKAP9;CUL3;ANAPC10;PSMC1;SDCCAG8;CDC16;CUL1;ANAPC11;CDC20;HAUS2;CCNB1;CEP63;PLK4;PSMC6;MAD2L1;PCNT;FBXO5;ANAPC16;ZW10;E2F1;PSMD1;OFD1;PSMD4;CDK2;PSMA6;UBE2S;CEP164;PSMD14;PSMD12;CETN2;PSMD7;NEK6;SFI1;PSME3;BUB3;YWHAE;CEP76;PSMD3;PSMB6;APPL2;UBB;INO80;CSNK1E;CDC6;KLHL18;CEP290;UBA52;ANAPC4;RPS27A
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5065496917275137,1.0275779716957771,0.4607250755287009,0.8798413950803329,1.0,5/11,17.75%,CCL3;PLCG2;TRAT1;P2RX5;P2RX4
prerank,chromatin organization (GO:0006325),0.3541152815364525,1.0275091258420284,0.42548596112311016,0.8793820815619415,1.0,42/132,26.86%,TCF7L1;HDAC4;SOX9;ESR1;NUDT5;HDAC8;MYSM1;HMG20A;SETD2;EHMT1;CHD1L;TOP1;SMARCC1;NPM3;ZBTB1;EZH1;DDX11;ATRX;CHD1;KDM5B;SMARCA5;PBRM1;HCFC1;RB1;HDAC2;SATB2;ZBTB7A;HIRIP3;BAZ1A;SNAI1;BRWD1;TADA2B;INO80;SETD5;RSF1;KDM4D;HMGN1;SUPT4H1;BAZ2A;BAZ2B;SETD7;TADA2A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.48295511238359035,1.0273897164952583,0.45535714285714285,0.8790875053137067,1.0,2/13,1.84%,CACNA1C;ANK2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5238495413126731,1.0271730892499773,0.44855305466237944,0.8790421742794947,1.0,4/10,18.33%,TLR4;MIA3;MYD88;TICAM1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.44595892109755336,1.0271192233520867,0.45042492917847027,0.8785606941701788,1.0,10/21,26.17%,SMO;TEDC2;EVC;ULK3;KIF7;DLG5;TXNDC15;TUBD1;ARMC9;TTC23
prerank,regulation of leukocyte migration (GO:0002685),0.4718773352080659,1.0270305603608205,0.4362818590704648,0.8781876176256495,1.0,5/16,18.03%,VEGFA;ANXA1;MIA3;HOXA7;NCKAP1L
prerank,nucleocytoplasmic transport (GO:0006913),-0.30948817758218417,-1.0269967913069964,0.3798076923076923,0.7947714703345953,1.0,11/40,19.99%,ATXN1;ANP32A;BACH2;NPM1;GEMIN2;SNRPD3;DDX20;NXT2;SNRPG;RSRC1;LSG1
prerank,histone H4-K8 acetylation (GO:0043982),0.473869737310289,1.026930988974206,0.4308823529411765,0.8771942166163341,1.0,9/15,27.20%,KANSL3;KANSL2;JADE2;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),0.473869737310289,1.026930988974206,0.4308823529411765,0.8771942166163341,1.0,9/15,27.20%,KANSL3;KANSL2;JADE2;HCFC1;PHF20;KANSL1;OGT;MCRS1;KAT8
prerank,negative regulation of kinase activity (GO:0033673),0.374412869170948,1.026832343618011,0.42657342657342656,0.8768214697851251,1.0,13/62,17.24%,LRP6;UBASH3B;NF1;CEP43;DUSP19;QARS1;CHP1;CDKN1C;CDKN1B;ITGB1BP1;DVL1;CEP85;RB1
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.34422816864308614,1.0264571114188537,0.43703703703703706,0.8772040121846221,1.0,52/148,25.29%,USP2;EXO1;HIPK1;CHEK2;AURKA;EHMT1;BARD1;WRN;TOPBP1;CHD3;PPP2R5C;RBBP7;POU4F1;RAD50;MDM4;RAD17;BRCA1;MBD3;PRMT5;PIP4K2A;CCNG1;TAF4;BRIP1;KMT5A;CDK2;MLST8;PIN1;PLK3;TAF5;RMI2;PHF20;ATR;HDAC2;HEXIM1;PML;NBN;TBP;CHEK1;PRKAB1;TAF12;ATM;MAPKAPK5;TP53;TAF13;KAT6A;RBBP8;USP7;SMYD2;TAF7;MTOR;RAD9A;RAD9B
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.37581428583493715,1.026441405764366,0.43457943925233644,0.8766328538184882,1.0,11/69,6.57%,PLCE1;PLCZ1;EZR;PIK3C2B;GAB2;NGF;PLCB3;IRS1;FGFR1;NF1;ERBB2
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.3410754499915548,-1.0260740576674743,0.3954248366013072,0.795822574442369,1.0,8/23,15.18%,PDE4B;RYR2;TGM2;GNG2;MAPK1;KCNQ1;SIRT2;APLP1
prerank,calcium import into the mitochondrion (GO:0036444),0.5076987953259325,1.0258361382604584,0.444794952681388,0.8776378214822453,1.0,4/10,25.76%,MCU;MICU2;MCUB;MICU3
prerank,positive regulation of lipid transport (GO:0032370),-0.4246312276287466,-1.0258200298516613,0.4425287356321839,0.7949009295858659,1.0,4/12,14.65%,APOE;SPP1;DBI;ABCB4
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.4138189946527697,1.0256428377699562,0.4454664914586071,0.8769171852340134,1.0,9/32,17.81%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,tRNA export from nucleus (GO:0006409),0.4138189946527697,1.0256428377699562,0.4454664914586071,0.8769171852340134,1.0,9/32,17.81%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.34056475974031103,-1.0251064246975592,0.3971119133574007,0.7951932992932061,1.0,6/26,9.20%,SLC30A10;PPARA;SLC5A3;GRIN1;SLC25A33;ABCB7
prerank,respiratory electron transport chain (GO:0022904),-0.3969179148270029,-1.0249438611787212,0.41975308641975306,0.7940529265688099,1.0,4/14,13.54%,GPD2;SLC25A13;PPARGC1A;SDHA
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.33411798288881944,1.024883497517139,0.4338677354709419,0.8782345043671034,1.0,122/476,21.01%,SIX1;BMP4;EGFR;ZFHX3;LRP6;NFIB;MAP3K5;HES1;HDAC4;CDH1;MLLT3;WNT11;FGF2;EHF;SOX9;TGFB3;ZNF423;ESR1;ID2;FZD1;FZD7;FOXC2;ZIC1;RARA;ELF1;KLF4;GLI3;TGFBR1;MDFIC;MED13;STAT3;SHC1;FOXO3;CHEK2;ZBTB16;NFIL3;GLI2;GLIS2;INHBA;WAC;CREBBP;RORA;SERTAD3;MED24;IRF1;SMAD2;MLXIPL;EGR1;GATA4;THRAP3;RUNX2;RXRA;CD80;FOXC1;ILF2;TADA3;SIX4;GPATCH3;SMARCC1;TASP1;NSD1;TBL1X;TGFB1I1;ATOH8;TRIM44;TEAD1;NAA15;TP53INP2;CDKN1C;RXRB;NIBAN2;NCOA6;BRCA1;NR1D1;RET;E2F1;LRP5;NFYA;NFATC1;ACVR1;HINFP;SP3;PIM2;ATF7IP;PITHD1;KAT6B;RNF111;HIVEP3;PAX6;SMAD4;FOXK1;IKBKB;YAP1;CHD8;ESR2;HCFC1;NEK4;RNF20;PCID2;RNF14;BRCA2;RGMB;KMT2E;PRDM11;MED16;PPARG;BRD4;USP21;USP16;HDAC2;EPC1;CHUK;CREBL2;NR1D2;FOXK2;ZBTB48;NKX2-1;ZXDC;MAP2K2;PML;EGF;CREB1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.4378868904970372,1.0246790339903316,0.4375,0.8781808894226721,1.0,8/23,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4344846249478816,1.024621884945204,0.4297520661157025,0.877735443796499,1.0,3/26,7.28%,ACER3;CYP1B1;NQO1
prerank,regulation of oxidoreductase activity (GO:0051341),0.47752052496883235,1.0246157424060798,0.4578313253012048,0.8771353980632215,1.0,3/13,13.20%,ABL1;SZT2;ECSIT
prerank,glucose homeostasis (GO:0042593),0.36527184765535486,1.024562813272951,0.41924398625429554,0.876638661141694,1.0,20/83,16.92%,TCF7L2;LRRC8D;KCNB1;IRS1;PTPN2;KLF7;STAT3;ACSM2A;BACE2;CRY2;MLXIPL;CRTC2;HECTD4;MCU;SLC8B1;NR1D1;ALOX5;PAX6;FOXK1;ADCY8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5065630845611756,1.0245572390941966,0.4572784810126582,0.8760352544191137,1.0,1/11,1.97%,GSN
prerank,neuron fate commitment (GO:0048663),0.47904233829401743,1.0241307891373568,0.4345718901453958,0.8765404477698647,1.0,4/14,16.03%,ID2;TGFBR1;POU4F1;PAX6
prerank,cGMP metabolic process (GO:0046068),0.4948832998041261,1.0239846373221797,0.4528023598820059,0.8763114461256725,1.0,1/12,0.83%,GUCY2C
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.48947175590244363,1.023880476837345,0.4440944881889764,0.8759798807008389,1.0,5/13,21.00%,HES1;PIGU;MGAT5;JAK2;EGF
prerank,negative regulation of blood coagulation (GO:0030195),0.40590658761245146,1.0234214864099134,0.44993498049414826,0.8766272787853816,1.0,2/38,2.68%,F3;THBD
prerank,megakaryocyte differentiation (GO:0030219),-0.42240758827404523,-1.0232672086577692,0.4037433155080214,0.7969237080174338,1.0,4/11,15.44%,KIT;TAL1;MED1;SH2B3
prerank,nerve growth factor signaling pathway (GO:0038180),0.500647963445715,1.0227999173732218,0.45440494590417313,0.8776160030679152,1.0,3/10,11.12%,NGF;KIDINS220;RAP1A
prerank,positive regulation of protein metabolic process (GO:0051247),0.35391038748347764,1.0225622160939356,0.42934782608695654,0.8776007246007074,1.0,26/110,18.27%,WWP1;NEDD4;FZR1;GPC3;WWP2;GSK3B;KLF4;DACT1;INHBA;BARD1;CD80;VCP;IDE;NSF;STX5;CLU;CDKN1B;SORL1;RNF41;RAB1A;SNF8;OAZ2;SLC25A37;AREL1;DTL;SMURF1
prerank,telomere capping (GO:0016233),0.4704297000281512,1.0225086769947715,0.46050670640834573,0.8771085673612131,1.0,6/16,22.56%,TEN1;STN1;RAD50;PRKDC;NBN;DCLRE1A
prerank,negative regulation of cell population proliferation (GO:0008285),0.33164629866950995,1.0222684272981934,0.4462311557788945,0.8771233623944693,1.0,66/351,14.69%,ZBTB7C;BMP4;CCN3;WNT9A;HES1;CYP1B1;SMAD6;PTPRU;BMP5;ABI1;IGFBP5;PTK2B;SLURP1;SOX9;TES;NGF;CLMN;SFRP4;NELL1;TGFB3;CDK10;KLF4;PTHLH;EMD;TBRG1;PTPN2;NOG;KLF10;NF1;SKI;FRK;LMNA;NCK2;INHBA;STRN;TENM1;E2F3;IRF1;P3H3;P3H1;CDKN2C;SFRP5;PPP2R5C;CIB1;TGFB1I1;EIF2AK2;BTG3;TFDP1;CDKN1C;GNRH1;IFI35;NIBAN2;CDKN1B;RAF1;MDM4;CELF1;CDKN3;IGFBP6;ITGB1BP1;E2F1;PLXNB1;IFNLR1;MORC3;PIM2;CHERP;RNF41
prerank,neurotransmitter transport (GO:0006836),0.37311954152955285,1.0222423012516735,0.4502923976608187,0.876582060310065,1.0,3/73,2.16%,SLC38A2;SLC38A1;UNC13B
prerank,protein-containing complex disassembly (GO:0032984),0.38773474738025754,1.0222218600143942,0.4226190476190476,0.876022450503921,1.0,9/54,15.27%,LRP6;GSK3B;FZD1;LIX1L;CSNK1A1;VCP;SNX14;WIPI2;DVL1
prerank,cellular glucan metabolic process (GO:0006073),0.5097822397992637,1.0220579894895423,0.46923076923076923,0.8757903107117841,1.0,3/11,8.00%,GSK3B;PPP1R3C;PHKB
prerank,respiratory chain complex IV assembly (GO:0008535),0.4436506984225038,1.021766319545071,0.43802816901408453,0.8759343122450022,1.0,5/21,19.71%,COX16;COX15;SCO2;COA8;FASTKD3
prerank,cell proliferation in forebrain (GO:0021846),0.5136698729075885,1.021667171682427,0.4748427672955975,0.8755933436759424,1.0,3/10,9.42%,DOCK7;PCM1;HOOK3
prerank,vesicle transport along microtubule (GO:0047496),0.4408903965187895,1.0216392196774704,0.4684065934065934,0.8750578103385432,1.0,7/23,16.15%,KIF13A;NDEL1;PAFAH1B1;KIF3B;KIF1C;KIF5B;RAB1A
prerank,inositol phosphate metabolic process (GO:0043647),0.3910341770071054,1.0215706967250537,0.43036386449184444,0.8746250485147905,1.0,11/46,13.19%,PLCE1;PLCZ1;FGF2;PLCB3;PLCG2;IP6K1;IP6K2;PPIP5K1;INPP4A;OCRL;INPPL1
prerank,negative regulation of platelet activation (GO:0010544),0.46122796039084724,1.021321589065424,0.43171806167400884,0.8746323486868376,1.0,3/16,3.02%,PRKCD;THBD;CD9
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.33810883200949304,-1.021038913363356,0.40229885057471265,0.8014123019389928,1.0,3/27,3.26%,LPAR1;HTR2C;GRM1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.40440444809478543,-1.0209708376321855,0.4198250728862974,0.7999918065714653,1.0,5/13,15.52%,NR1H3;AQP11;WFS1;NR1H2;NUPR1
prerank,regulation of adaptive immune response (GO:0002819),-0.3744891342070533,-1.0205930826998428,0.4276729559748428,0.7994047581339783,1.0,8/18,29.73%,AHR;ADCY7;SAMSN1;PYCARD;IRF7;FADD;IL4I1;SASH3
prerank,diol biosynthetic process (GO:0034312),0.4764943262834942,1.0204686188024186,0.4457831325301205,0.8761714081300896,1.0,1/15,0.70%,ACER3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3278325417292406,-1.0203759823048564,0.4024896265560166,0.7984214043575653,1.0,10/34,10.26%,FLT1;SEMA6A;PRKD1;KDR;NUS1;NOTCH1;VEGFC;DAB2IP;SPHK1;HSPB1
prerank,peptide metabolic process (GO:0006518),0.36555816480133607,1.0202679444467448,0.4508670520231214,0.876091258085725,1.0,16/75,17.77%,PCSK5;CPQ;MMACHC;GSR;GSTT1;BACE2;NPEPPS;GSTA2;IDE;GSTT2;DPEP1;DMD;NLN;CPZ;GSTM4;APEH
prerank,regulation of ERAD pathway (GO:1904292),0.5023311905960107,1.0202482529331798,0.4470774091627172,0.8755200499219529,1.0,6/11,22.37%,USP25;USP13;RNF185;HERPUD1;USP19;TMEM259
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3593444586778519,-1.0202343249351256,0.42443729903536975,0.7972266856396661,1.0,1/19,0.24%,IGF1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33454333011828746,1.0201793212309767,0.44174265450861194,0.8751123091692856,1.0,45/308,11.60%,SIX1;BMP4;FOXD1;BMP1;LBP;ADRA1B;GNAS;FGF2;NLRP5;CMKLR1;ADRB2;SOX9;VEGFA;TGFB3;BMPR1A;SMO;GADD45G;GRB10;TGFBR1;NOG;IL33;TWIST1;LRP1;PDGFC;ZBTB16;TSKU;AGO2;TIAM1;TGFBR2;SIRT6;INHBA;EHMT1;ABCA7;SMAD2;TRPM4;KDM1A;FOXC1;SIX4;TMEM119;DECR1;TGFB1I1;TRPM8;EIF2AK2;NLGN1;FBXO5
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.3652649226841427,-1.0201653096291703,0.43558282208588955,0.7958755636316153,1.0,5/18,14.26%,VCAM1;SLC39A8;JAM2;GCNT1;ITGA4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34077024860290855,1.0200486650847433,0.4592901878914405,0.8748375657532028,1.0,28/190,12.86%,SLIT2;THBS1;CCN3;CIT;TANK;ESR1;NPRL3;PHLPP2;TWIST1;NF1;NDUFS3;PER1;ATP2B4;NLRP12;RORA;ABCA7;TRIM39;ZC3H12A;SFRP5;PPP2R5C;CIB1;XDH;MCL1;HERPUD1;DRD3;IFI35;NR1D1;CPNE1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3401894677409288,-1.019874599275443,0.4344569288389513,0.795117485337495,1.0,10/25,18.76%,TMTC2;SLC8A1;ANK3;GRIN1;WFS1;JPH2;ATP13A2;MT3;CIB2;KCNA1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.40798453627101305,1.0197405796950545,0.4497422680412371,0.8750092380818073,1.0,8/36,10.52%,TCF7L2;PPP3CA;WNT11;PDE6A;PLCB3;AGO2;NLK;MAP3K7
prerank,sphingolipid metabolic process (GO:0006665),-0.25671134393965095,-1.0196132694878137,0.42857142857142855,0.7943222688170462,1.0,33/108,16.80%,ST6GALNAC3;ENPP2;PRKD1;CERS4;ACER2;CERT1;SGMS1;ELOVL7;UGCG;DEGS2;ESYT1;SMPD3;HACD3;CTSA;GAL3ST1;HACD1;ARV1;SPHK1;CSNK1G2;ASAH1;HACD2;VAPA;CERS2;SPNS2;CERK;ALDH3B1;CERS1;SMPD1;SPTLC2;ELOVL6;CLN8;ABCA2;SERINC1
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.3066383598310135,-1.0195486261452587,0.43555555555555553,0.7929237969560402,1.0,16/38,23.12%,PHLPP1;PPARA;DAG1;MAGI2;PTPRJ;RACK1;THEM4;TSC2;SH2B3;HYAL2;PHLDA3;ARRB2;EPHA2;BANK1;AKT1;GPER1
prerank,extracellular matrix assembly (GO:0085029),-0.3403266443626767,-1.019387415333355,0.3870967741935484,0.7917706019520947,1.0,9/23,14.42%,QSOX1;LAMB1;MYH11;MFAP4;GPM6B;GAS6;LAMB2;FBLN5;EFEMP2
prerank,neural crest cell differentiation (GO:0014033),0.4607987530323472,1.0193349282526478,0.4469914040114613,0.8754388718783589,1.0,1/18,0.72%,LRP6
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.40628901372559406,1.0192221501698209,0.43593130779392336,0.8751099319382015,1.0,10/32,24.60%,DDX5;FHIT;HIPK1;POU4F1;RRP8;USP28;CDIP1;PML;TP53;AEN
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3918198253891402,1.018769887717111,0.43296432964329645,0.8756975201836537,1.0,14/50,23.75%,NXN;U2AF2;ABL1;HDAC8;CHP1;FBXO5;SPOPL;USP4;SMAD7;BAG5;BAG2;GTPBP4;OGT;GNL3L
prerank,negative regulation of cell cycle (GO:0045786),0.3636881633117473,1.0187234199409658,0.4507042253521127,0.8752124422712254,1.0,18/73,19.68%,BMP4;PTPN3;GAS1;INHBA;FOXC1;PDCD4;ANGEL2;BTG3;MAD2L1;CDKN1C;IPO7;CDKN1B;NR4A1;SCRIB;RB1;TSPYL2;TRIM35;HEXIM1
prerank,protein homooligomerization (GO:0051260),0.3533883674240002,1.018680027048107,0.45206971677559915,0.8747371056778321,1.0,19/114,13.63%,KCNJ2;SCARA5;DISP1;ATL3;TMEM120A;MPP2;ATL2;G3BP2;PRMT8;TRPM4;ACACA;TDO2;TK1;ZBTB1;FUS;ACOT13;EHD1;PDCD6IP;RBMX
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.3188423941050508,-1.0185710580863172,0.4424778761061947,0.7924187452645112,1.0,10/34,18.86%,RBP4;WNT5A;SLC7A5;LACC1;DNAJB9;PTPN22;XBP1;NOD2;CD86;STX4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4157432048950557,-1.018352249247619,0.42699724517906334,0.791458713900487,1.0,7/11,32.20%,RPS6KA6;HIPK2;KAT5;ING4;SP100;TFAP4;MUC1
prerank,negative regulation of MAPK cascade (GO:0043409),0.366038502696466,1.018155781062706,0.4699205448354143,0.8754478562950175,1.0,21/87,16.61%,BMP4;PRKCD;EZR;CBLC;IRAK3;PTPN2;SPRED2;NF1;EMILIN1;ABCA7;TLR4;QARS1;IGBP1;EPHB2;SYNJ2BP;ITGB1BP1;DLG1;SORL1;TNIP1;SMAD4;PIN1
prerank,glycolipid metabolic process (GO:0006664),0.39008341979123984,1.0176693311599165,0.46716232961586124,0.8760649479744643,1.0,3/47,3.41%,ST3GAL4;ESYT3;HEXA
prerank,rRNA processing (GO:0006364),-0.23459421027484587,-1.0172452249628252,0.4090909090909091,0.7929809282716328,1.0,46/172,18.59%,NSA2;RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17;RPL9;DDX27
prerank,negative regulation of cyclase activity (GO:0031280),-0.38869713355174995,-1.0172105688327209,0.4265129682997118,0.7915325791225177,1.0,3/14,8.27%,GRM3;ADGRV1;GABBR2
prerank,positive regulation of neurogenesis (GO:0050769),0.36859724537756916,1.0170836643381336,0.4755813953488372,0.8769576405365407,1.0,13/68,13.39%,SLIT2;CUX1;NGF;VEGFA;TIAM1;TIAM2;KDM1A;FBXW8;RHOA;DISC1;NPTN;MAP6;PLXNB1
prerank,regulation of receptor binding (GO:1900120),-0.44046277044368853,-1.016914481642556,0.42696629213483145,0.790781517305435,1.0,4/10,9.78%,GREM2;B2M;ATP2A2;ATP2A3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.48450350897708205,1.0169135492864116,0.4658385093167702,0.8755665754138034,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.48450350897708205,1.0169135492864116,0.4658385093167702,0.8755665754138034,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.48450350897708205,1.0169135492864116,0.4658385093167702,0.8755665754138034,1.0,5/12,17.24%,ANAPC5;CUL3;CDC16;ANAPC11;RB1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.3028515372336285,-1.0168458203308546,0.41037735849056606,0.7894276887538553,1.0,13/40,23.12%,IGF1;BCL2L1;PDCD5;PINK1;BCL2L11;TNFSF10;PYCARD;HGF;BIK;TRIAP1;MFF;AKT1;GPER1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.48836401628529374,1.0162889113332538,0.4506172839506173,0.8766217379098324,1.0,4/13,13.58%,TMEM30B;SEC16A;TM9SF4;SORL1
prerank,organic hydroxy compound transport (GO:0015850),-0.3170748726009235,-1.0161378948774207,0.41743119266055045,0.789697372087196,1.0,5/36,4.35%,SLCO2B1;SLCO1C1;NCOA1;RBP4;SLC5A3
prerank,endodermal cell fate commitment (GO:0001711),-0.44285105325659824,-1.0160231065534466,0.4716981132075472,0.7884932666824765,1.0,2/10,20.49%,SOX17;LEO1
prerank,protein phosphorylation (GO:0006468),0.32770958038893505,1.0159576666534198,0.44288577154308617,0.8769578964073738,1.0,109/479,18.17%,STK39;BMP4;EGFR;DCLK1;MAP3K5;PKD1;MARK1;CIT;GRK5;DDR2;CCNA2;WNK1;PRKCD;CAMK2D;ULK2;WNT11;PRKCE;ABI1;PTK2B;ERC1;TLK1;SRMS;BMPR1A;CLK2;GSK3B;CDK10;RARA;CDK12;HIPK1;TGFBR1;ABL1;IRAK3;EPHB3;USP15;FGFR1;FRK;CHEK2;STK16;NEK7;FAM20A;BCR;VRK3;STRADA;MAPK12;ERBB2;TGFBR2;NRBP2;AURKA;LIMK2;CDK11B;IKBKE;SMAD2;CSNK1A1;GRK4;TLR4;NLK;MAST2;TOP1;MAK;CLSPN;CDK16;CDK13;TTK;AAK1;PLK4;MAP3K7;EIF2AK2;EIF2AK1;PDK3;MAP3K3;CSNK1G3;EPHB2;CAB39;ULK3;SGK3;MAP3K1;RPS6KA3;MARK2;RET;CDKL2;CSNK1G1;ACVR1;MORC3;HTATIP2;PIM2;PRKCA;MARK3;CDK7;EEF2K;PRKDC;EFEMP1;CDK2;CDC7;MAP3K10;LCK;SIK1;IKBKB;FGFR3;GTF2H3;ERN2;RPS6KB1;SMAD7;NEK4;LRRK2;STK24;STK3;MAPKAPK2;COPS8;DDR1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.46271931006103095,1.0159189120124668,0.4631268436578171,0.876455865195851,1.0,2/15,3.09%,PRKCE;IRS1
prerank,phospholipid transport (GO:0015914),0.38401306988070977,1.0153643066761304,0.4601990049751244,0.8772760889485711,1.0,12/52,15.78%,TNFAIP8L3;PITPNC1;LDLR;PITPNA;TMEM30B;SCARB2;ABCA7;ATP11A;ATP9B;ATP10A;ABCC1;PCTP
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.4157625618097714,1.0153067020227426,0.46442953020134226,0.8768285454099123,1.0,4/30,6.79%,BMP4;MLLT3;HOXB4;INHBA
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3659890907239488,-1.0151879837929698,0.4294294294294294,0.7892779926292093,1.0,8/18,16.99%,PICALM;ROCK2;ABCG1;EPHA4;LRRTM3;IFNGR1;ABCA2;GSK3A
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.46979330784659007,1.0150961461380223,0.44113263785394935,0.8767234919427009,1.0,5/15,18.33%,STAT3;IL17RA;TLR4;MYD88;TICAM1
prerank,regulation of stress fiber assembly (GO:0051492),0.3649773845430201,1.0150559492120517,0.44749403341288785,0.8762223040738255,1.0,16/74,10.43%,TMEFF2;MET;ARAP1;WNT11;SORBS3;NRP1;TGFB3;PHLDB2;TGFBR1;ABL1;MYOC;GPR65;RHPN2;S100A10;SLC9A1;RHOA
prerank,positive regulation of innate immune response (GO:0045089),0.4092900228099918,1.015001132793242,0.46184738955823296,0.8757729441103899,1.0,10/30,18.46%,LBP;MAVS;TLR8;POLR3F;IFI35;UBE2K;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,cellular response to leucine starvation (GO:1990253),0.5049719776802065,1.0149607650656376,0.4603421461897356,0.8752751630362369,1.0,4/10,24.23%,RRAGB;SESN3;LARS1;MTOR
prerank,negative regulation of defense response (GO:0031348),0.3632993435221222,1.0146331263487558,0.4462242562929062,0.8755075693870298,1.0,9/77,7.12%,CCN3;PRKCD;PTGIS;KLF4;TRAFD1;IRAK3;PTPN2;NLRP12;RORA
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.406421249258493,1.0145223875589031,0.45395590142671854,0.8751630719969818,1.0,7/34,14.14%,UBASH3B;PTPRF;PTPN2;ACP4;DUSP5;PTPRS;PTPN9
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3640878738145785,1.0144881703181101,0.44760820045558086,0.8746577656439734,1.0,26/83,17.24%,CDC45;MNAT1;INHBA;E2F3;CCND1;CUL3;CDKN2C;CUL1;GSPT1;CDK16;FBXO5;TFDP1;CDKN1B;CDKN3;E2F1;ACVR1;HINFP;PIM2;KHDRBS1;CDK7;CDK2;CDKN1A;CDC7;PLK3;RPS6KB1;RB1
prerank,autophagosome organization (GO:1905037),0.3861181267310221,1.014476366127575,0.4445812807881773,0.8740835837877013,1.0,13/50,18.39%,ULK2;RAB43;BECN1;WDR45B;ATG3;TP53INP2;ULK3;RB1CC1;ATG5;STX12;WIPI2;RAB1A;UBXN2B
prerank,regulation of water loss via skin (GO:0033561),0.46726675532095674,1.0143691547480995,0.4606918238993711,0.8731762383665436,1.0,1/15,0.88%,MET
prerank,establishment of skin barrier (GO:0061436),0.46726675532095674,1.0143691547480995,0.4606918238993711,0.8731762383665436,1.0,1/15,0.88%,MET
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4347633406215074,1.0143247776229718,0.4482758620689655,0.8726901550039516,1.0,11/26,28.79%,SETD2;WDR82;ETFBKMT;EEF2KMT;KMT5B;KMT2D;KMT5C;OGT;SETD5;CTR9;TET3
prerank,monocyte chemotaxis (GO:0002548),-0.3194972959688294,-1.0142367180134935,0.42677824267782427,0.7903098137989909,1.0,5/32,7.45%,FLT1;IL6R;TNFRSF11A;RPS19;PTPRO
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4918134825545831,1.0141150047420533,0.45454545454545453,0.8726024381054713,1.0,3/12,11.62%,B3GNT2;B4GAT1;B3GNT9
prerank,stem cell differentiation (GO:0048863),0.40051625862272194,1.0135290004028885,0.4461738002594034,0.8735300510088907,1.0,5/39,7.88%,LRP6;MLLT3;SETD2;HOXB4;PSMD11
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.39460151002017335,-1.0133353389492255,0.4190751445086705,0.7913171817542285,1.0,3/13,8.27%,GRM3;ADGRV1;GABBR2
prerank,RNA stabilization (GO:0043489),0.4075491924860737,1.0132235595736667,0.4503225806451613,0.8737135195796182,1.0,10/33,20.56%,THRAP3;PABPC1;DHX36;TENT2;FUS;E2F1;CIRBP;GDNF;NAF1;TRDMT1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3712818412654124,1.0130322521877944,0.4573732718894009,0.8736492789265394,1.0,9/65,7.51%,EGFR;PTPN3;ARAP1;CBLC;RNF126;PTPN2;RNF115;MVB12B;AGR2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3439091690158704,1.0130222060291423,0.47096774193548385,0.873080265038385,1.0,27/141,13.09%,EGFR;CDH1;CYP1B1;CASP6;IGFBP5;EZR;SLC26A6;ESR1;CCL3;NR4A3;CTNNA1;RAD51;DIAPH1;LCOR;RORA;SPIDR;DMTN;ZC3H12A;EGR1;AKAP9;ATP1A3;ATP1A1;POU4F1;RAP1A;JUP;BRCA1;ARL6IP5
prerank,cellular polysaccharide catabolic process (GO:0044247),0.46786634846158204,1.0127862070774487,0.44573082489146165,0.8730945799313621,1.0,4/16,15.09%,PYGB;PHKA2;PHKB;PGM2
prerank,signal transduction by p53 class mediator (GO:0072331),0.4179839709979769,1.012726469103314,0.45308310991957107,0.8726477966025753,1.0,7/30,14.61%,DDX5;FHIT;NDRG1;POU4F1;MDM4;RRP8;ATRX
prerank,cell-substrate junction assembly (GO:0007044),-0.3264909279710636,-1.0127196554783418,0.41935483870967744,0.7914151785770668,1.0,13/33,21.55%,PEAK1;ITGA6;THSD1;ACTN2;DST;LAMC2;LAMC1;ARHGEF7;CD151;THY1;LAMB3;ACTN1;TESK2
prerank,response to light stimulus (GO:0009416),0.37885310698624614,1.0126070737762574,0.44752714113389624,0.8723581692092577,1.0,14/55,20.10%,UBE4B;ERCC5;UBE2A;CRY2;UVSSA;USP1;CPT1B;PRIMPOL;UBE2B;CIRBP;PCLAF;DTL;COPS3;ERCC4
prerank,cellular response to cytokine stimulus (GO:0071345),0.3275593805212649,1.0123500848039313,0.47738693467336685,0.8724303294235292,1.0,53/416,10.43%,F3;STK39;SLC12A2;DPYSL3;PID1;LBP;TANK;WNK1;NFAT5;FGF2;GAB2;IL22RA1;SLC26A6;PTGIS;SOX9;YBX3;VEGFA;IL20RB;NFE2L2;CXCL2;CLCF1;GSK3B;GRB10;CCL3;CCL1;TIMP1;IRAK3;PTPN2;TWIST1;STAT3;SHC1;ANXA1;FOXO3;CTF1;NLRP12;IRAK4;RORA;FN1;ITGB1;ZFAND6;IRF1;ZC3H12A;CCND1;TLR4;EGR1;CD80;FOXC1;EPRS1;CIB1;CCL7;ERBIN;POU4F1;RHOA
prerank,regulation of stem cell differentiation (GO:2000736),0.3595091397425945,1.0122867760021916,0.44769403824521936,0.8719814870217557,1.0,21/89,19.95%,HES1;BMPR1A;PSMB2;ABL1;HOXB4;PSMD11;PSMC1;EIF2AK2;PSMC6;JAG1;PSMD1;PRKDC;PTN;PSMD4;GDNF;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12
prerank,regulation of mitochondrial fission (GO:0090140),-0.33740077290993153,-1.0120498659412671,0.4222222222222222,0.7916538423102428,1.0,11/24,24.44%,DCN;KDR;SPIRE1;INF2;MAPT;PINK1;FIS1;STAT2;MFF;CYRIB;RALBP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.42289409516688736,1.0119139289423404,0.45260347129506007,0.8723601323963001,1.0,9/26,14.64%,GSK3B;PLCG2;ATP2B4;CIB1;SLC9A1;RCAN1;CHP1;HOMER2;CHERP
prerank,RNA splicing (GO:0008380),0.35446715834925235,1.0115118538027883,0.4644870349492672,0.8727430392750085,1.0,47/95,32.29%,MBNL1;CELF3;SRSF11;CDK12;DBR1;SNRNP48;PRPF18;SRSF2;FUS;SNRNP35;SCAF11;WBP4;RNPS1;PRPF8;RNPC3;WDR83;NONO;SYNCRIP;SNRNP40;PDCD7;SF3B3;DHX8;LSM4;TCERG1;LUC7L3;TARDBP;SRRM1;SRPK2;LSM1;USP39;SCNM1;PTBP1;ZCRB1;SMNDC1;SNRPB;DHX15;ZRSR2;HNRNPC;TRA2B;SRPK1;TXNL4A;PRPF3;SF3B2;SF3B1;NOL3;DDX39B;SRSF7
prerank,determination of bilateral symmetry (GO:0009855),0.4247636419353136,1.0113823829468513,0.46218487394957986,0.8724904344012783,1.0,10/24,24.73%,PITX2;DNAAF4;GALNT11;KIF3B;NPHP3;ODAD2;MKKS;ODAD3;CFAP53;DNAH11
prerank,nucleotide-sugar metabolic process (GO:0009225),0.49123772879795363,1.0112843555941027,0.463855421686747,0.8721326356770069,1.0,4/12,17.83%,FUT8;GMDS;SLC35A3;GFPT1
prerank,regulation of inclusion body assembly (GO:0090083),0.49415127538057835,1.0112724353557663,0.47303543913713403,0.8715786809590038,1.0,1/11,1.41%,SNCAIP
prerank,macrophage activation involved in immune response (GO:0002281),0.48125707592044753,1.0111967883516044,0.47685185185185186,0.8712117781064332,1.0,3/13,12.13%,LBP;PLCG2;IFI35
prerank,mesenchymal cell development (GO:0014031),-0.3699283195564437,-1.011076002761377,0.4126506024096386,0.7926602870305055,1.0,4/18,13.39%,CDH2;NOTCH1;HEY2;TAPT1
prerank,cellular response to nutrient levels (GO:0031669),0.3712350228901684,1.0109836686864708,0.47362250879249707,0.8711660893073104,1.0,17/62,19.43%,KCNB1;CLEC16A;RRAGB;KLF10;VPS41;ZFYVE1;WRN;FAM107A;WDR45B;GAS2L1;SREBF1;WIPI2;INHBB;LRRK2;STK24;RALB;EIF4G1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.4452169091783116,1.0109407143304054,0.4818941504178273,0.8706933482168369,1.0,6/20,28.87%,FDX1;TSPO;STAR;STARD3NL;FDX2;FDXR
prerank,sulfation (GO:0051923),0.49773017028801125,1.0107017820994189,0.46360759493670883,0.8707199984452467,1.0,3/11,13.77%,UST;CHST5;SULT1A1
prerank,sterol homeostasis (GO:0055092),0.3698113625073303,1.0104453142048087,0.4460260972716489,0.8708157816140858,1.0,13/65,13.32%,SOAT1;HDAC9;LDLR;TSKU;LIMA1;RORA;ABCD1;NPC1;ANGPTL3;SOAT2;NR1D1;EHD1;LRP5
prerank,establishment of spindle orientation (GO:0051294),0.4144132221355765,1.0099096688655402,0.4657718120805369,0.8715857177729013,1.0,8/28,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.4014464743661986,1.009720686409035,0.45253576072821844,0.8714837225602317,1.0,5/35,5.78%,MET;SEMA3E;NRP1;SEMA3C;SEMA3D
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3594697556690306,1.009678690681448,0.4600231749710313,0.8710035540069727,1.0,27/86,24.41%,VEGFA;NFE2L2;EGLN3;PSMB2;BAG3;CREBBP;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;PSMD1;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;HIF1AN;PSME3;CHEK1;TP53;PSMD3;DDIT3;PSMB6;KLF2;UBB;INO80
prerank,regulation of lipid storage (GO:0010883),0.4383389498910173,1.009562533333606,0.45161290322580644,0.8707201578706814,1.0,9/22,25.57%,PTPN2;IKBKE;ZC3H12A;ITGAV;ITGB3;FTO;MEST;CRP;ALKBH7
prerank,regulation of synapse organization (GO:0050807),-0.3349773251872076,-1.0090634205442157,0.4375,0.796818699497526,1.0,6/26,5.75%,IL1RAPL1;CTNNA2;WNT5A;ARHGAP22;EPHA4;MEF2C
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.50211003344315,1.008396579392599,0.4726134585289515,0.8730324304243131,1.0,2/10,3.88%,PID1;GRB10
prerank,RNA interference (GO:0016246),0.45204475063350935,1.0082957851533825,0.4666666666666667,0.872728470217481,1.0,11/17,29.69%,AGO2;CELF1;DHX9;MRPL44;CLP1;DICER1;PRKRA;DROSHA;AGO1;TSN;TSNAX
prerank,negative regulation of cytokine production (GO:0001818),0.34172882888890843,1.0082436764451665,0.46996838777660693,0.8722858756389823,1.0,24/163,11.28%,THBS1;EZR;ANXA4;HDAC9;CMKLR1;RARA;KLF4;IRAK3;TAX1BP1;ANXA1;C5AR2;INHBA;NLRP12;FN1;ABCD1;IKBKE;ZC3H12A;TLR4;MAVS;PDCD4;IFIH1;GPATCH3;ZFPM1;TLR8
prerank,cilium assembly (GO:0060271),0.32848399502292985,1.0079975647163923,0.4757085020242915,0.8723099536438382,1.0,78/296,21.89%,PKD1;BBS9;ABLIM3;EXOC4;GSN;PTPDC1;IFT46;PDE6D;GBF1;FAM161A;PARVA;DZIP1;WDR35;CDC14A;PCM1;RAB11FIP3;PAFAH1B1;CEP43;TOGARAM1;AKAP9;CFAP43;EHD2;SDCCAG8;IFT52;MAK;DYNC2I2;HAUS2;ARL3;CEP63;PLK4;RFX2;PCNT;GALNT11;KIF3B;ARF4;OCRL;DISC1;EXOC7;EHD1;DYNC2I1;TMEM231;NPHP1;CEP19;TRAPPC14;OFD1;ATAT1;RAB1A;CCDC66;IFT43;NPHP3;ACTR2;CPLANE2;CEP20;PTPN23;DNAAF3;CEP164;MKKS;CETN2;ATP6V0D1;CLUAP1;IQCB1;NUDCD3;C2CD3;RAB11A;LZTFL1;HYLS1;SFI1;IFT22;EXOC2;TXNDC15;PIBF1;CEP89;ACTR3;EXOC5;TEKT2;RSPH9;DYNC2H1;TCTN1
prerank,mRNA catabolic process (GO:0006402),0.3937486572078201,1.0079500971964965,0.47625,0.871840592602305,1.0,5/44,8.86%,DDX5;TUT7;TUT4;THRAP3;NUDT12
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3873673345687387,1.0078946721137878,0.4533001245330012,0.8713954335085615,1.0,17/50,23.94%,PSMB2;NQO1;PSMD11;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4772451318198577,1.0077569717870913,0.45603576751117736,0.871146082524099,1.0,5/14,22.84%,ATRX;BRCA2;ATR;XRCC5;TNKS2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4873431432329833,1.0075892013463335,0.4565868263473054,0.87096567966458,1.0,6/12,22.84%,PARP3;PARP1;PARP12;PARP6;PARP2;TNKS2
prerank,zymogen activation (GO:0031638),0.39681046930900293,1.0075778814734484,0.49122807017543857,0.8704191355526557,1.0,3/39,3.42%,PERP;CYFIP2;PRSS12
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4489835842514293,1.0074183885552424,0.46141975308641975,0.8702428149944699,1.0,3/16,1.84%,CACNA1C;CAMK2D;ANK2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.4325913261613732,1.007261855212541,0.46227709190672156,0.870025104062554,1.0,3/21,6.90%,ADAM9;BACE2;SPPL2A
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.46635699780080414,1.0071005801256774,0.47218045112781953,0.869858672184612,1.0,5/16,12.45%,ANK2;SEC16A;GBF1;MIA3;BCAP31
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4075568720406593,1.0067108585866134,0.45566166439290584,0.8702623648662099,1.0,7/29,20.79%,BMP5;SPRED2;IL17RD;LDLRAD4;SMAD7;SDHAF2;NKX2-1
prerank,positive regulation of cation channel activity (GO:2001259),-0.2991876910901802,-1.00664094428715,0.46153846153846156,0.8018506998423133,1.0,5/40,4.30%,SHANK3;ANK3;AKAP6;ACTN2;TMSB4X
prerank,negative regulation of lyase activity (GO:0051350),-0.37128322398316127,-1.0064589706471485,0.4375,0.8008466863640941,1.0,3/16,8.27%,GRM3;ADGRV1;GABBR2
prerank,transition metal ion homeostasis (GO:0055076),-0.32196785662630206,-1.0063922406082848,0.40329218106995884,0.7995505197564038,1.0,6/28,9.20%,CP;B2M;PICALM;SLC40A1;FTL;ABCB7
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.3082156443934334,-1.006213824419752,0.40825688073394495,0.7986005193970044,1.0,6/37,3.09%,IL1RAPL1;CADM1;GRID2;TENM3;TENM2;VCAM1
prerank,mitochondrial fission (GO:0000266),-0.382201052907011,-1.0058817930231065,0.4527687296416938,0.7979214738307145,1.0,6/16,22.54%,DNM3;DNM1;FIS1;MTFR2;MTFP1;MFF
prerank,dopamine metabolic process (GO:0042417),-0.3736087041596262,-1.0057538441964924,0.4519230769230769,0.7967606051444855,1.0,5/18,9.00%,MOXD1;MAOB;MAOA;COMT;GCH1
prerank,regulation of osteoclast differentiation (GO:0045670),0.3972413305754936,1.0057301451473186,0.4534731323722149,0.8721523193975342,1.0,5/33,10.40%,UBASH3B;CCL3;TLR4;TCTA;POU4F1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.490472326485929,1.00572721262545,0.4678624813153961,0.8715817177695254,1.0,3/13,12.18%,NEDD4;EMILIN1;NIBAN2
prerank,neuropeptide signaling pathway (GO:0007218),-0.28486090192694624,-1.0055733145441674,0.41208791208791207,0.7957281609143175,1.0,13/58,15.50%,SORT1;RAPGEF2;SORCS3;NXPH2;GLRA3;GLRA1;HCRTR2;CYSLTR2;SORCS1;CYSLTR1;NTS;OPRM1;NMU
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.39201196492438606,1.0053966487667787,0.45012468827930174,0.8717552896111757,1.0,6/43,6.84%,EGFR;PTPN3;CBLC;RNF126;PTPN2;RNF115
prerank,negative regulation of phosphatase activity (GO:0010923),0.4202595517311725,1.0053875144926772,0.45690834473324216,0.8711977426063928,1.0,6/25,15.16%,GSK3B;STYXL1;CRY2;PTPA;CHP1;URI1
prerank,GPI anchor biosynthetic process (GO:0006506),0.40810061257907826,1.0052237582999748,0.46153846153846156,0.871054584638719,1.0,16/30,33.00%,PGAP2;PIGT;PIGU;PIGO;PIGK;DPM1;MPPE1;GPAA1;PIGG;PGAP3;PIGB;PIGQ;PIGV;PIGA;PIGS;PIGP
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3789335291907562,-1.0049596882110468,0.46153846153846156,0.7959524340115055,1.0,5/17,17.99%,SLC7A5;PRKCZ;PRKCQ;CEBPB;CD86
prerank,positive regulation of macroautophagy (GO:0016239),0.3833868048401212,1.0044123996363845,0.4825436408977556,0.8725197169873276,1.0,16/48,20.20%,ADRB2;HSPB8;BAG3;WAC;IKBKG;PAFAH1B2;VPS13D;MAP3K7;SCOC;SH3GLB1;PIP4K2A;RALB;LRSAM1;GPSM1;EPM2A;SESN3
prerank,positive regulation of type I interferon production (GO:0032481),0.3635122937824404,1.0038216126910966,0.4657210401891253,0.8734049671672343,1.0,23/73,21.43%,SETD2;CREBBP;IRF1;TLR4;MAVS;IFIH1;RIPK2;DHX36;CGAS;TLR8;POLR3F;POLR3A;MYD88;POLR3K;POLR3E;PRKDC;FLOT1;POLR3D;DHX9;XRCC5;CHUK;NFKB2;IRF3
prerank,cellular response to UV (GO:0034644),0.3581213576954942,1.0036476849194014,0.45307068366164543,0.8732593018978683,1.0,22/76,24.41%,NEDD4;PRKCD;TIMP1;CREBBP;KDM1A;PARP1;DHX36;EIF2S1;ZBTB1;CARD16;USP28;CDKN1A;USP47;ACTR5;ATR;ERCC4;YY1;FMR1;CHEK1;HYAL1;TP53;INO80
prerank,negative regulation of transport (GO:0051051),-0.27844983923020405,-1.0036185020469628,0.44021739130434784,0.7981388567553935,1.0,12/51,14.63%,PRKD1;MCTP1;CTTNBP2NL;DYSF;SIRPA;NR1H3;BST2;SYT11;RACK1;NR1H2;ERBB3;SNX3
prerank,regulation of peptidase activity (GO:0052547),-0.36341409648822637,-1.003251776793066,0.4612676056338028,0.7976030842524923,1.0,6/19,16.93%,CST3;CTSH;NDUFA13;PINK1;PSMB8;ATP13A2
prerank,liver development (GO:0001889),0.40261448606543954,1.0032230834964886,0.4573333333333333,0.8737256707748132,1.0,5/32,6.92%,MET;COBL;ANXA1;NF1;AURKA
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.4776834790917851,1.0028852923047114,0.47449768160741884,0.8739756229177464,1.0,3/13,7.67%,CD9;LDLR;ITGB1
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.45069182322266726,1.002854054859138,0.4624277456647399,0.8734857459169277,1.0,9/18,26.14%,EZR;RDX;RAB21;SNX12;PTPN23;MAP2K2;DAB2;SRC;CHMP3
prerank,positive regulation of fat cell differentiation (GO:0045600),0.380655600183247,1.0027582802757777,0.4724602203182375,0.8731574870425772,1.0,7/47,9.13%,SIX1;CMKLR1;ID2;ZBTB16;ZC3H12A;TRPM4;SYAP1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.33893484815430075,-1.0026324385742587,0.4778156996587031,0.7977537936621694,1.0,7/21,17.26%,SLC30A10;PPARA;ABCB7;PINK1;SIRT2;ABCD2;MT3
prerank,protein kinase A signaling (GO:0010737),0.47532979312033474,1.0023951559138162,0.4765625,0.8734744584639954,1.0,2/12,9.02%,EZR;RDX
prerank,regulation of keratinocyte migration (GO:0051547),0.48441608754892196,1.00227758628662,0.45426829268292684,0.8731745393955119,1.0,1/12,1.31%,ADAM9
prerank,protein localization to vacuole (GO:0072665),-0.39879597377644915,-1.001867992937238,0.4542857142857143,0.7984100218589768,1.0,8/13,23.91%,RTN4;CD81;RNF128;ATP13A2;SH3BP4;GLMP;LAMTOR4;LAMTOR5
prerank,mRNA metabolic process (GO:0016071),0.353282076063486,1.0016981870890114,0.47678369195922987,0.8740181935586595,1.0,33/90,29.11%,DDX5;SRSF11;U2AF2;SON;SRSF5;LSM11;NUDT12;PRPF18;KIN;SRSF2;CELF1;SCAF11;SRSF1;PRPF8;SSB;CPSF3;HNRNPA2B1;NONO;CSTF3;TCERG1;AURKAIP1;TP53;AKAP8L;USP39;SUPT4H1;METTL16;PTBP1;DXO;SNRPB;ALKBH5;DHX15;YTHDF2;NUDT16L1
prerank,spindle assembly (GO:0051225),0.3649610887215129,1.001647462198142,0.4795673076923077,0.873555770685731,1.0,21/67,20.70%,CHEK2;NEK7;SPICE1;STAG1;MISP;NCOR1;TOGARAM1;HAUS2;RHOA;CEP63;KIF3B;TUBGCP6;OFD1;ABRAXAS2;SMC1A;TUBGCP2;STAG2;NEK6;RAB11A;CCDC61;PIBF1
prerank,sister chromatid segregation (GO:0000819),0.4116559789908709,1.0015963687765417,0.48010610079575594,0.8731118555554036,1.0,6/31,17.24%,SMC4;KNSTRN;KLHL22;ZW10;SMC1A;RB1
prerank,negative regulation of secretion (GO:0051048),-0.43599881738607393,-1.001253321921736,0.44327176781002636,0.7986164013459311,1.0,7/10,31.92%,NR1H3;PTGER3;ERBB3;CD74;NRG1;VAMP8;TIFAB
prerank,muscle cell development (GO:0055001),-0.32153393757889764,-1.0009895281653443,0.4358974358974359,0.7978496250114753,1.0,9/30,9.74%,IGF1;ENG;SLC8A1;SGCZ;DYSF;MYH11;MYOF;HEY2;BIN1
prerank,establishment of protein localization to membrane (GO:0090150),0.36928418419002784,1.0006910366991102,0.484375,0.8747078857259339,1.0,16/66,17.37%,EGFR;NECTIN3;GORASP2;ZDHHC2;ZDHHC20;ZDHHC12;ATG3;NPC1;VPS37A;PARD3;ZDHHC15;VPS37B;RAB11B;AFDN;ZDHHC24;GOLGA7
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3357172949395547,1.0005597475284724,0.47649572649572647,0.8744366125377292,1.0,30/128,19.14%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;PCNT;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;PLK3;ARPP19;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,regulation of protein secretion (GO:0050708),0.3445700435828376,1.0000928192701748,0.4956043956043956,0.8750378064502499,1.0,19/119,12.51%,SLC12A2;CACNA1C;ADAM9;EZR;UNC13B;DISP1;KCNB1;KCNS3;TGFB3;SYTL4;BMP6;DNAJC1;P3H1;DPH3;SERGEF;RAP1A;DRD3;SLC8B1;APBB3
prerank,apoptotic nuclear changes (GO:0030262),-0.3442737073128739,-0.999353508606918,0.4166666666666667,0.8007056272475824,1.0,10/24,23.56%,CECR2;KPNB1;BLCAP;HMGB1;CDK5RAP3;FOXL2;HMGB2;GPER1;ACVR1C;CASP3
prerank,histone H2A ubiquitination (GO:0033522),0.4476321378950824,0.9990512791938252,0.48191027496382055,0.8770500041506509,1.0,9/17,30.67%,UBE2A;BCOR;RNF8;UBE2B;PCGF1;DDB1;RNF168;DTX3L;DDB2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3322666521083506,0.9986340282289514,0.5015576323987538,0.8774603665361824,1.0,33/214,13.32%,BMPER;EGFR;TNFAIP8L3;NTRK3;CCN1;EZR;PTK2B;FGF2;NRP1;NOTCH2;CCL3;CCL1;PTPN2;PDGFC;SPRED2;SHC1;EMILIN1;ERBB2;CD44;ROR1;ABCA7;FN1;TLR4;GATA4;CIB1;CCL7;GAREM1;RAP1A;EPHB2;SYNJ2BP;ITGB1BP1;DLG1;TIRAP
prerank,amyloid fibril formation (GO:1990000),-0.28689035459511714,-0.9985610139247569,0.4810810810810811,0.8013049015284963,1.0,11/51,12.25%,B2M;TSPAN5;APP;CST3;ITM2B;HSPG2;TSPAN14;MAPT;SIAH2;MFGE8;APH1B
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3632379790998365,0.9985201689728624,0.48360655737704916,0.8771609273206074,1.0,12/67,10.43%,PGF;VAV2;CYFIP2;ABI1;PTK2B;NRP1;VEGFA;NCK2;SULF1;AAMP;ITGAV;RHOA
prerank,histone acetylation (GO:0016573),0.3689314480065247,0.9984076779095075,0.47107438016528924,0.8768598993795733,1.0,35/69,29.25%,EP400;PER1;CREBBP;TADA3;MAP3K7;ZZZ3;JADE2;DMAP1;MSL3;MORF4L1;NAA40;KAT6B;PHF20L1;TAF5;TRRAP;ATF2;BRCA2;PHF20;NAA60;EPC1;BRPF3;TAF12;YEATS2;KAT6A;TRIM16;MRGBP;CPA4;SGF29;TADA2A;KAT8;HAT1;KAT2B;BRD1;NAA50;BRD8
prerank,positive regulation of lyase activity (GO:0051349),0.4766288045036327,0.9983709476646156,0.48264984227129337,0.8763712973070471,1.0,3/14,11.92%,CACNA1C;NF1;FXN
prerank,regulation of neutrophil migration (GO:1902622),-0.43384247300910583,-0.9981747356997819,0.4733009708737864,0.8009224213767244,1.0,3/10,9.52%,JAM3;RAC1;RHOH
prerank,negative regulation of proteolysis (GO:0045861),0.4042484203339372,0.9981047762673867,0.47327249022164275,0.8764883897155472,1.0,6/34,7.88%,PTPN3;TIMP1;GAS1;ACP4;DNAJC1;TIMP2
prerank,pyruvate metabolic process (GO:0006090),0.37583325248551624,0.9979818865137281,0.47285886610373945,0.8761995863627646,1.0,6/52,10.47%,ME1;SLC16A1;NR4A3;PFKFB1;GPI;PDHA1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.3545287656480409,-0.9979320480027448,0.4533333333333333,0.8001052104110417,1.0,6/18,10.66%,IL34;DAAM2;TNFRSF21;NOTCH1;TENM4;OPALIN
prerank,plasma membrane organization (GO:0007009),0.3686154112403228,0.997927951469317,0.47759433962264153,0.8757637124752944,1.0,11/61,11.83%,AHNAK2;DMKN;ANK2;ANO6;SYTL4;PLSCR3;ABCA7;ABCD1;EHD2;TLCD1;NSF
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36364451014741955,0.9977367192539695,0.47205707491082044,0.8756553407897248,1.0,24/69,26.01%,NABP1;SNAPC2;INTS5;GTF2E1;INTS6;GTF2A2;POU2F1;CDK7;CCNT2;INTS7;TAF5;ELL2;POLR2C;CCNT1;ICE2;TAF8;TBP;INTS1;INTS14;TAF13;GTF2B;INTS8;INTS2;ELL
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3112410265533576,-0.9976357864518867,0.43023255813953487,0.7993106297842729,1.0,17/32,23.95%,MAP2;CLASP2;NAV3;STMN1;DYRK1A;CAMSAP2;APC2;FKBP4;CDH5;CLIP3;MID1IP1;STMN2;SPEF1;TPX2;SNCA;CAMSAP1;TUBB4A
prerank,aerobic respiration (GO:0009060),-0.3444496989421818,-0.9975503751066606,0.4560260586319218,0.7980559316162118,1.0,6/20,18.99%,UQCRH;UQCR10;UQCRC1;ME3;MTFR2;SDHC
prerank,regulation of protein-containing complex assembly (GO:0043254),0.34473179411194094,0.9973924854249899,0.48695652173913045,0.8758948684927104,1.0,25/110,18.20%,TRABD2B;GSN;MPP7;VEGFA;GSK3B;SPIDR;KIF9;TMC8;VCP;ANKRA2;EIF2AK2;HJURP;SH3GLB1;CLU;TRAF2;RAF1;TIRAP;SORL1;ATF7IP;CDC42EP2;HCFC1;RB1;STXBP1;FARP2;RALB
prerank,positive regulation of interferon-beta production (GO:0032728),0.40287558218978875,0.9972858173973574,0.47736093143596375,0.875584208530716,1.0,11/33,18.46%,IRF1;TLR4;MAVS;IFIH1;RIPK2;TLR8;POLR3F;POLR3A;FLOT1;POLR3D;DHX9
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4193750227380386,-0.9969477746980806,0.5040214477211796,0.7980963932233024,1.0,6/11,16.57%,NES;SEMA5A;CFL2;STMN2;PLEK;TRPV4
prerank,neuron apoptotic process (GO:0051402),-0.3605033350610362,-0.9968204425895417,0.4520547945205479,0.7969744838561312,1.0,7/19,13.95%,BCL2;APP;TNFRSF21;FAS;GAPDH;ATN1;ERBB3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4702282266691404,0.9963640700436138,0.48442367601246106,0.8772008793406225,1.0,4/13,15.75%,PIK3AP1;IRAK4;MYD88;TRAF6
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3792674058920621,0.9959873725440689,0.48711656441717793,0.8775117647782591,1.0,15/51,18.03%,DCLK1;SRGAP2;SNX2;NGF;NBL1;SHTN1;CTTN;TRIO;PLXNB1;DBN1;ANKRD27;MAP1S;LRRK2;NYAP1;NCKAP1L
prerank,response to lipopolysaccharide (GO:0032496),0.3412382203365488,0.9959327321425833,0.5031982942430704,0.877056410350957,1.0,27/138,19.05%,FOXP1;ADAM9;LBP;SMAD6;CXCL2;IRAK3;PALM3;ZC3H12A;TLR4;CD80;PDCD4;ERBIN;RHOA;TAB2;TRIM41;MYD88;RPS6KA3;NR1D1;TIRAP;CARD16;TRAF6;PDCD1LG2;OTUD5;MAPKAPK2;TICAM1;SRR;JAK2
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4120299537226517,-0.9957380151172832,0.4574468085106383,0.7982672019945938,1.0,1/11,0.96%,AGBL4
prerank,embryonic heart tube development (GO:0035050),0.46885222596939047,0.9955124853374452,0.4743975903614458,0.8775019691173311,1.0,2/14,3.09%,HES1;PITX2
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.30889652693088787,-0.9954551629894212,0.44223107569721115,0.7975592265627048,1.0,4/32,2.21%,AUTS2;ENPP2;OCLN;PIK3R1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.34080606635900074,0.9954213414685225,0.4978678038379531,0.8771441263870775,1.0,39/149,21.82%,CARD14;SLCO3A1;EDA;ERC1;RAB7B;RIPK4;IRAK3;STAT3;TAB3;ROR1;IKBKG;TLR4;CIB1;RIPK2;MAP3K7;TAB2;EIF2AK2;CLU;MYD88;TRAF2;TIRAP;MTDH;CARD16;PIDD1;TRAF6;FLOT1;TRAF5;IKBKB;PSMA6;RBCK1;TICAM1;DHX9;CHUK;ZBTB7A;MID2;FER;NFKB2;CRNN;TRADD
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3494529565668794,0.9953931671425558,0.4850828729281768,0.8766473583140401,1.0,31/109,21.13%,PPP3CA;VAV2;GAB2;PSMB2;PLCG2;NR4A3;SHC1;TAB3;IKBKG;NFATC3;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;MAP2K4;MAP3K1;NFATC1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;LAT;PSMD14;PSMD12;PSMD7;CHUK;FER;PSME3
prerank,regulation of biomineral tissue development (GO:0070167),0.4183877245390346,0.9953841471788303,0.4784366576819407,0.8760969526117497,1.0,5/26,4.99%,DDR2;SOX9;SGMS2;TXLNG;TWIST1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.49527277526945973,0.9951682391900897,0.4675925925925926,0.8760759900045799,1.0,1/10,1.31%,ADAM9
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.38329249164512086,0.9950722257871127,0.47341772151898737,0.875738935325663,1.0,10/42,11.81%,PTK2B;NRP1;VEGFA;GSK3B;LIMS1;ABL1;MYOC;S100A10;CIB1;JUP
prerank,glutathione metabolic process (GO:0006749),0.38788201145792095,0.9947665876761104,0.4880952380952381,0.8759009918007378,1.0,7/38,12.95%,GCLC;MMACHC;GSR;GSTT1;GSTA2;GSTT2;DPEP1
prerank,cellular response to superoxide (GO:0071451),-0.4272684854855343,-0.9946739530748847,0.47074468085106386,0.7982479447812929,1.0,4/10,18.05%,NOS3;SOD3;MT3;SOD1
prerank,positive regulation of response to external stimulus (GO:0032103),0.33906501152450863,0.9944345394991142,0.4911699779249448,0.8761515512213548,1.0,28/128,18.53%,THBS1;THBD;CCL3;CCL1;IL33;USP15;BMP6;IL17RA;NLRP12;TLR4;GPR4;PDCD4;ANKRD17;TLR8;POLR3F;IFI35;PRKCA;CNTF;AKIRIN2;PLSCR1;ABCC1;PTN;TNIP1;POLR3D;SCIMP;CCN4;DHX9;PUM2
prerank,protein localization to membrane (GO:0072657),0.3320712122293393,0.9941162927111616,0.5073068893528184,0.8763509411170247,1.0,46/187,16.73%,KCNB2;LRP6;RAMP1;CDH1;ANK2;ATP1B1;EZR;FGF13;SLMAP;KCNB1;DLG2;SEC16A;TTC7A;ZDHHC2;FCHO2;TSPAN17;RDX;EHD2;S100A10;GAK;C2CD5;ARL3;PLEKHF1;TM9SF4;RAP1A;NPC1;NLGN1;JUP;SH3GLB1;PIP5K1A;NUP155;SYNJ2BP;ZDHHC15;ITGB1BP1;EHD1;DLG1;NRXN2;AP3D1;RAB11B;SCN3B;RAB40B;DVL1;PTN;FLOT1;SCRIB;IKBKB
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3550524538937502,0.9940965343602266,0.49295774647887325,0.8758341255663464,1.0,14/74,11.27%,BMP5;TGFB3;PHLDB2;TGFBR1;TWIST1;SPRED2;TIAM1;TGFBR2;IL17RD;SMAD2;FOXC1;PHLDB1;TGFB1I1;LDLRAD4
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47947623912987003,0.9940862297200211,0.4640625,0.8752938877348009,1.0,3/13,6.65%,FGF2;FGFR1;SIRT6
prerank,cellular response to retinoic acid (GO:0071300),0.3829098253807523,0.9940692315416895,0.45879458794587946,0.8747673579455741,1.0,5/42,3.82%,WNT9A;WNT11;PTK2B;SOX9;FZD7
prerank,membrane fusion (GO:0061025),-0.3161149590506479,-0.9938085447581441,0.48717948717948717,0.7990786065338013,1.0,7/33,12.18%,DNM3;RIMS1;DYSF;DNM1;MYOF;VAPA;HACE1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3570242330136865,0.9935716173288693,0.49005847953216375,0.8754287650116154,1.0,7/75,5.44%,BMP4;LRP6;PRKCD;CBLC;ABL1;IRAK3;NF1
prerank,diol metabolic process (GO:0034311),-0.3500629796230258,-0.993533363491448,0.45364238410596025,0.7983659756028297,1.0,5/19,9.52%,NOS3;DEGS2;CALM1;GCH1;SPHK1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.431471614938489,0.9932642041652866,0.4762569832402235,0.8750379625180194,1.0,4/21,12.25%,EYA2;EYA4;MCL1;EYA3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.431471614938489,0.9932642041652866,0.4762569832402235,0.8750379625180194,1.0,4/21,12.25%,EYA2;EYA4;MCL1;EYA3
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4752640006888984,0.9932560112808905,0.4675118858954041,0.8744941304031596,1.0,2/12,4.80%,CCL3;IL33
prerank,endosome organization (GO:0007032),0.38463858128690265,0.9931855654099014,0.4818976279650437,0.8740969150709595,1.0,10/41,15.95%,EEA1;WASHC4;CORO1C;PHETA2;HOOK3;PLEKHF1;WASHC5;ANXA8;ANXA8L1;CHMP2B
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.42367458729443497,0.9931075863882581,0.48824343015214383,0.8737099309871289,1.0,5/25,11.62%,EXT1;B3GNT2;HAS1;B4GAT1;B3GNT9
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.4268804189188179,0.9930253602612888,0.48787446504992865,0.8733487031793117,1.0,2/21,4.09%,FOXP1;ELF1
prerank,positive regulation of protein acetylation (GO:1901985),-0.4066845018906359,-0.9928923690309012,0.479108635097493,0.7986703896709614,1.0,4/12,15.83%,RAPGEF3;PRKAA2;DDX3X;KAT5
prerank,sphingolipid catabolic process (GO:0030149),0.4601445881347149,0.9927471602369726,0.48,0.8734902282741668,1.0,3/15,8.26%,ACER3;SMPDL3A;PDXDC1
prerank,DNA recombination (GO:0006310),0.3903630452887523,0.9926646288342327,0.47381864623243936,0.8731250755741655,1.0,17/37,34.14%,EXO1;RAD51;WRN;RAD50;RECQL5;RAD52;RAD51D;RECQL;RAD21;RAD54L;RAD51B;TSN;GEN1;RPAIN;ENDOG;RPA1;DMC1
prerank,regulation of protein autophosphorylation (GO:0031952),0.3927134455484871,0.9924492445936978,0.4675324675324675,0.8730984849266403,1.0,10/36,14.37%,RASSF2;VEGFA;PDGFC;NLRP12;PPP2R5C;TOM1L1;CHP1;RAD50;TNKS1BP1;RAP2C
prerank,cellular response to hexose stimulus (GO:0071331),0.4227646932528178,0.9923640626288522,0.49295774647887325,0.8727178986628121,1.0,4/23,3.32%,UNC13B;SLC26A6;KCNB1;SLC39A14
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3105490896414536,-0.9920476736543313,0.44537815126050423,0.799462503360139,1.0,5/33,5.75%,PRKG1;APOD;OGN;IGFBP3;MEF2C
prerank,sensory perception of chemical stimulus (GO:0007606),0.4552425800894705,0.9920187624405659,0.479136690647482,0.8729724497654282,1.0,4/15,18.59%,GNAS;UBR3;ADCY3;MKKS
prerank,autophagosome assembly (GO:0000045),0.37712418305733025,0.9916584095417925,0.5006150061500615,0.8733034562808415,1.0,13/52,18.39%,ULK2;RAB43;BECN1;WDR45B;ATG3;TP53INP2;RB1CC1;ATG5;STX12;WIPI2;RAB1A;SMURF1;UBXN2B
prerank,cell cycle G2/M phase transition (GO:0044839),0.33370381103092084,0.991637256109546,0.4866023579849946,0.8727893488946349,1.0,30/129,19.14%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;CUL1;HAUS2;CCNB1;CEP63;PLK4;PCNT;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;PLK3;ARPP19;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,positive regulation of cell death (GO:0010942),0.3645848473639246,0.9914779094971812,0.4720873786407767,0.872609691998784,1.0,12/59,14.08%,BMP4;MAP3K5;GSK3B;LRP1;ZC3H12A;EGR1;RIPK2;EIF2S1;CLU;CDKN1B;CELF1;HTATIP2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.47184337427522816,0.9914383365185938,0.47874015748031495,0.872141116781191,1.0,3/13,11.62%,B3GNT2;B4GAT1;B3GNT9
prerank,response to interferon-gamma (GO:0034341),-0.2672092678766103,-0.9912120185978497,0.4473684210526316,0.8002605066334327,1.0,24/67,21.08%,WNT5A;SIRPA;IFITM1;IFITM3;GBP4;BST2;STAT1;GCH1;GBP7;GAPDH;IFITM2;AQP4;CX3CL1;GBP3;SHFL;CD40;CD74;CCL19;CD47;PDE12;NUB1;IRF8;CASP1;SNCA
prerank,modified amino acid transport (GO:0072337),0.46139171222511705,0.9908888882170854,0.4814264487369985,0.8729268138309214,1.0,4/15,8.49%,SLC5A6;FOLR2;SLC7A9;SLC25A32
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.35000715935787025,0.9908462545227127,0.49,0.8719107044229477,1.0,31/104,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,cellular response to lectin (GO:1990858),0.35000715935787025,0.9908462545227127,0.49,0.8719107044229477,1.0,31/104,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,epithelial structure maintenance (GO:0010669),-0.4105966971805247,-0.9907549297091287,0.489010989010989,0.799929685962251,1.0,6/11,32.19%,RBP4;NOD2;MUC13;PIWIL4;STRAP;MUC6
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.4275682212859825,-0.9907099833220032,0.4742547425474255,0.7986155236030317,1.0,2/10,1.18%,VTN;PRKCB
prerank,membrane lipid catabolic process (GO:0046466),0.4918210065830039,0.990595038670313,0.492436974789916,0.8719537855413715,1.0,2/10,8.26%,CYP1B1;PDXDC1
prerank,cell chemotaxis (GO:0060326),0.3678968765474451,0.9905430539166424,0.4847001223990208,0.8715147187276986,1.0,6/60,5.54%,CCN3;PRKCD;DEFB130A;NRP1;VEGFA;PARVA
prerank,membrane lipid biosynthetic process (GO:0046467),0.36880132523087156,0.9901102044095953,0.48429951690821255,0.871968574114896,1.0,4/58,3.52%,ST3GAL4;ACER3;PLPP3;SGMS2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.260882696000642,-0.9900241005658859,0.4774774774774775,0.7989672055416338,1.0,34/91,20.87%,CP;SLC30A10;APP;SLC39A10;TFRC;SLC39A8;SLC40A1;FTL;ABCB7;ATP6V1G1;SLC30A1;ATOX1;FTH1;SLC39A12;BOLA2;SLC31A1;COX19;FRRS1;ATP13A2;MT3;SOD1;CYB561A3;NDFIP1;MT2A;PRNP;MT1A;MT1M;MT1E;MT1F;MT1H;MT1X;MT1B;MT1G;ALAS2
prerank,cellular response to interferon-beta (GO:0035458),-0.3819143894322634,-0.9899395643472721,0.4859550561797753,0.7977584356617582,1.0,4/14,10.22%,NDUFA13;STAT1;AIM2;IFITM2
prerank,positive regulation of calcium ion import (GO:0090280),-0.40151696561139283,-0.989867620459879,0.4297520661157025,0.7965089197419435,1.0,2/12,3.42%,PDGFRB;CXCL12
prerank,response to histamine (GO:0034776),-0.4244188530908385,-0.9897335558179509,0.4319371727748691,0.7954662807943313,1.0,3/10,5.61%,GABRB3;GABRB1;GABRB2
prerank,microvillus organization (GO:0032528),0.46836513288052495,0.9897330943705118,0.5015290519877675,0.872342995737987,1.0,2/13,1.99%,FXYD5;EZR
prerank,bicellular tight junction assembly (GO:0070830),-0.2938505769730911,-0.9897322303090096,0.45023696682464454,0.7940508603658716,1.0,6/46,3.74%,PARD6G;PECAM1;OCLN;CLDN5;ESAM;F11R
prerank,regulation of fatty acid oxidation (GO:0046320),0.45232428055632584,0.9895360034929109,0.48615384615384616,0.8722793349651796,1.0,6/16,16.32%,SOX9;NR4A3;ABCD1;LONP2;TYSND1;ACADL
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.490234016254405,0.9894059235556493,0.5076219512195121,0.8720435120804989,1.0,2/10,9.97%,AOC3;ETFBKMT
prerank,prostaglandin metabolic process (GO:0006693),-0.32872154668491527,-0.9890827459177993,0.4962121212121212,0.7943851152928951,1.0,8/26,15.88%,PTGDS;PTGS1;EDN1;TBXAS1;GSTM1;MIF;HPGDS;CD74
prerank,apoptotic process (GO:0006915),0.33141852653968007,0.9889959561385965,0.49897119341563784,0.8724466103720503,1.0,54/203,21.82%,PLAGL1;CIT;PRKCD;CYFIP2;CASP6;PRKCE;PTK2B;EFNA5;CD2;PAWR;EGLN3;NOTCH2;RFK;MAGI3;MCM2;ZBTB16;TGFBR2;PLSCR3;CASP2;CDK11B;IKBKG;IRF1;FEM1B;SFRP5;PDCD4;CIB1;PARP1;MAP3K7;YARS1;MYD88;RAF1;BRAT1;PIDD1;PLSCR1;BNIP1;ADAM15;MAP3K10;PLK3;FAP;STK3;FAM162A;DAPK1;BCL2L13;JAK2;NUDT2;AIFM1;TRAF7;CDIP1;RELT;IAPP;DAP;IRF3;MRPS30;TRADD
prerank,development of primary male sexual characteristics (GO:0046546),0.3972416547719713,0.9880352334234976,0.5032509752925878,0.8741640048209393,1.0,6/34,9.60%,LHFPL2;SOX9;INHBA;KITLG;GATA4;SIX4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.34864953699237483,0.9876627820699084,0.5016722408026756,0.874516680896966,1.0,31/105,24.68%,PRKCD;NRAS;KRAS;PSMB2;PLCG2;TAB3;CREBBP;IKBKG;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;RAF1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;RELB;PSME3;PSMD3;PSMB6;PAK2;FBXW11;SRC
prerank,connective tissue development (GO:0061448),0.39643617614947746,0.9876600959308991,0.4816753926701571,0.8739658051297167,1.0,7/35,8.08%,PKD1;SOX9;ITGB8;ZBTB16;CD44;SULF1;SLC39A13
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4486028067825549,0.9876052379540756,0.4879432624113475,0.8735515801307894,1.0,2/18,1.67%,STK39;CAMK2D
prerank,negative regulation of autophagy (GO:0010507),0.3712673061771898,0.9874767454034594,0.5077288941736029,0.8733171230943083,1.0,24/54,25.36%,MET;EIF4G3;STAT3;TAB3;NRBP2;LZTS1;EIF4G2;KLHL22;TAB2;MCL1;RUBCN;SNRNP70;FOXK1;LRRK2;TLK2;EIF4G1;FOXK2;DAP;USP36;HTR2B;MTMR9;MTOR;SMCR8;TSC1
prerank,protein ubiquitination (GO:0016567),0.3191452639608086,0.9874313774800276,0.5505505505505506,0.8728757809225769,1.0,106/471,19.10%,WWP1;FBXL7;NEDD4;RNF144A;MKRN3;FBXO10;CBLC;NFE2L2;SH3RF3;WWP2;RNF126;PSMB2;UBE4B;TRIM55;RNF114;HERC2;UBR5;FANCL;SPSB2;TRIM47;UBE2A;RNF115;NPEPPS;WAC;BARD1;FBXL20;TRIM39;PSMD11;UVSSA;TSPAN17;RNF185;HIF3A;ARIH1;CUL3;PSMC1;VCP;CDC16;UBE4A;CUL1;ANAPC11;KLHL22;PEX13;ANKIB1;FBXW8;DTX2;FBXO27;ATG3;HECTD2;TRPC4AP;UBE3C;PSMC6;DDA1;DET1;KEAP1;TRIM44;FBXO31;TRIM41;ANAPC16;RNF138;RNF146;TRAF2;BRCA1;UBE2K;UBR3;TRIP12;MIB1;RNF122;RNF8;COMMD1;FBXO45;RNF41;PSMD1;UBE2B;NHLRC1;HERC6;UBE2D3;MKRN2;PRKDC;RNF111;TRAF6;PSMD4;RNF141;UBE2O;RNF11;FBXO17;CNOT4;TMEM129;RNF20;AREL1;RNF14;PSMA6;UBE2S;DTL;RBCK1;SMURF1;MYCBP2;PSMD14;SPOP;PSMD12;CHFR;RMND5A;TRIM35;ENC1;PSMD7;NFX1;VCPIP1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.41319939912722914,0.9871834146353431,0.49175824175824173,0.8728720308041478,1.0,7/26,13.32%,EFNA5;CLTRN;KLF7;TRPM4;CDK16;NR1D1;LRP5
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.3720675257692954,0.9871629180919321,0.49937421777221525,0.8723761344298208,1.0,12/50,16.26%,CCNA2;MNAT1;CCND1;CDKN2C;CCNB1;CDKN1C;CDKN1B;CDKN3;CCNG1;CDK7;CCNT2;CDKN1A
prerank,regulation of lipid metabolic process (GO:0019216),0.35150955023493924,0.9871036054528326,0.496551724137931,0.8719514892052236,1.0,22/88,19.88%,TNFAIP8L3;ID2;CREBBP;RORA;NCOR1;ABCA7;CHD9;NCOR2;RXRA;ACACA;TBL1X;GGPS1;NCOA6;NR1D1;SREBF1;NFYA;SQLE;SCD;HMGCR;PPARG;TGS1;NR1D2
prerank,positive regulation of developmental process (GO:0051094),0.33482253672357626,0.9870530679074847,0.5233050847457628,0.8715197479592386,1.0,39/164,16.80%,BMP4;FOXD1;BMP1;COBL;BMP5;NLRP5;SOX9;VEGFA;BMPR1A;PHLDB2;FGFR1;ZBTB16;LMNA;AGO2;AURKA;SHANK1;AGR2;FOXO6;TRPM4;CORO1C;TMEM119;PHLDB1;CDC20;MIEF1;NLGN1;MCU;FBXO5;NIBAN2;RPS6KA3;KMT5B;ZDHHC15;SORL1;ACVR1;DVL1;PTN;DLG5;GDNF;MIEF2;SYDE1
prerank,nervous system development (GO:0007399),0.3197505044056573,0.9870087511565877,0.5541082164328658,0.8710872788334335,1.0,47/429,7.69%,WWP1;PCDHB16;DCLK1;CRIM1;MET;PKD1;MBNL1;HES1;HDAC4;CDH1;ZIC4;RBFOX2;GSN;EFNA5;FGF13;FGF2;ECRG4;DMBX1;NGF;SOX14;PCDHB9;GRHL2;NELL1;ELP3;VEGFA;PCDHA1;SMO;ZIC1;NOTCH2;GLRB;PMP22;S100B;TGFBR1;NOG;PDGFC;STAT3;NF1;ZBTB16;DACT1;NBL1;SNTG2;ST8SIA2;GLIS2;INHBA;TENM1;FN1;SCRG1
prerank,plasma membrane repair (GO:0001778),0.4681172239424771,0.9869842280701809,0.5051851851851852,0.8705924808412951,1.0,2/13,3.72%,AHNAK2;SYTL4
prerank,protein mannosylation (GO:0035268),0.422868070036987,0.986860975504177,0.4857142857142857,0.87031790267905,1.0,9/22,23.33%,TMTC1;LARGE1;DPY19L3;B4GAT1;TMTC3;DPM1;LARGE2;POMT2;POMT1
prerank,regulation of interleukin-6 production (GO:0032675),0.3480302553406387,0.9864549746340177,0.4971687429218573,0.8707521583689527,1.0,18/96,13.32%,LBP;RAB7B;PLCG2;IRAK3;TLR1;IL33;TWIST1;STAT3;C5AR2;IL17RA;NLRP12;ZC3H12A;TLR4;MAVS;IFIH1;TLR8;MYD88;TIRAP
prerank,bile acid and bile salt transport (GO:0015721),-0.3358408562496585,-0.9858174363121309,0.46863468634686345,0.801519193718613,1.0,3/24,2.03%,SLCO2B1;SLCO1C1;NCOA1
prerank,extracellular transport (GO:0006858),0.4754896594337373,0.9856785110529305,0.48619631901840493,0.8720568211632558,1.0,4/12,20.82%,WWP2;DNAAF4;SPAG17;DNAAF2
prerank,peroxisome organization (GO:0007031),0.4235477707743546,0.9854907892178726,0.49043715846994534,0.8719598501462655,1.0,4/25,12.06%,ABCD3;ABCD1;LONP2;ACOT8
prerank,erythrocyte differentiation (GO:0030218),-0.286923280620831,-0.9851141645280376,0.4398148148148148,0.8019077614408479,1.0,16/44,18.29%,LYN;MFHAS1;KIT;TGFBR3;RPS14;RPS19;ALAS1;TAL1;ABCB10;MED1;CDK5RAP3;HIPK2;SH2B3;LYAR;IKZF1;JAK3
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.45811514428637784,0.9847568510749382,0.49147286821705427,0.8731304393794342,1.0,6/15,14.70%,CAMK2D;NR4A3;MEF2A;SLC9A1;PARP1;PRKCA
prerank,negative regulation of cellular component organization (GO:0051129),0.35747466629394503,0.9847417895524416,0.4976851851851852,0.8726235671940263,1.0,18/74,21.26%,TMEFF2;VEGFA;GSK3B;IRAK3;BMP6;ABCA7;TMC8;RDX;CLU;RAF1;SORL1;RUBCN;FAP;LRSAM1;XRCC5;LGALS3;DNAJB2;IAPP
prerank,chromatin remodeling (GO:0006338),0.3474859261097855,0.9846144880230735,0.4938684503901895,0.8723772021977709,1.0,26/100,20.51%,HDAC4;SOX9;ESR1;NUDT5;SRCAP;MYSM1;CHD3;CHD1L;TOP1;SMARCC1;NPM3;ZBTB1;EZH1;MBD3;ATRX;KDM5B;SMARCA5;CHD8;PBRM1;HCFC1;RB1;ACTR5;HDAC2;SATB2;ZBTB7A;BAZ1A
prerank,membrane depolarization (GO:0051899),-0.31384666605205647,-0.984484565023129,0.48523206751054854,0.8021217590994608,1.0,18/32,23.44%,SCN7A;CACNA1E;CACNB4;CACNA1B;CACNG4;YWHAH;SCN1A;P2RX7;SCN9A;CACNG2;SCN3A;SCN2A;CACNA1I;KCNH2;SCN5A;CHRNA4;CACNA1H;CAV1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3396040134886606,0.9844484477729986,0.4945770065075922,0.8722581569490307,1.0,26/113,20.19%,TRABD2B;MPP7;UNC13B;CLTRN;VEGFA;ESR1;GSK3B;ERCC5;SPIDR;TLR4;CHD1L;VCP;PARP1;PSMC6;SH3GLB1;CLU;MYD88;TIRAP;CDC42EP2;GTF2H3;MED25;ATR;EIF4G1;FERMT2;ERCC4;LGALS3
prerank,regulation of microtubule polymerization (GO:0031113),-0.2991999527102108,-0.9840944702047498,0.49130434782608695,0.8017478552950845,1.0,14/40,14.04%,OCLN;PAK1;MAP2;NAV3;RPS3;STMN1;CDK5RAP2;DYRK1A;RAC1;MAPT;CAMSAP2;CDH5;CLIP3;FES
prerank,mitochondrial membrane organization (GO:0007006),-0.3124391911284464,-0.9837011288023471,0.4664179104477612,0.801288120069352,1.0,7/32,17.53%,BCL2;BCL2L1;CHCHD6;APOOL;DNAJC11;MFN1;MTX1
prerank,sterol metabolic process (GO:0016125),-0.2671601685685196,-0.9831513731848959,0.5,0.8013332061400129,1.0,12/60,11.00%,CYP7B1;APOE;CYP27A1;CYP26B1;LIPA;ABCA5;ABCG1;INSIG2;PPARD;ARV1;MSMO1;OSBPL1A
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.44107101580728353,0.9828282326105088,0.4970501474926254,0.8755455907327762,1.0,12/18,37.98%,RNF185;MAN1B1;SEL1L;UBB;UBA52;RPS27A;RNF139;TRIM13;SYVN1;RNF5;EDEM2;AMFR
prerank,retinoic acid metabolic process (GO:0042573),-0.3801699458922708,-0.9826783666875146,0.5124223602484472,0.8011176074089925,1.0,2/14,2.27%,ALDH1A2;CYP26B1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4290307636715577,0.982453479803159,0.5007132667617689,0.8759005714690168,1.0,12/20,29.69%,ZC3H7A;AGO2;PUM2;MRPL44;PUM1;TRIM71;DICER1;PRKRA;DROSHA;AGO1;TSN;TSNAX
prerank,cellular protein localization (GO:0034613),0.3208774524063967,0.9822153011476832,0.5207280080889788,0.8759384900177846,1.0,65/285,18.59%,EGFR;CSRP3;PTPRU;ANK2;WNT11;SGSM2;TLK1;ID1;STX11;KIF13A;TMED5;TMED3;NIPBL;CNTLN;RRAGB;HERC2;RAB43;RIC3;RAB6A;RAB24;ARFIP2;SEC31A;AP3B1;VCL;ARFGAP3;WDR45B;COPA;SEC23IP;TM9SF4;PIGU;NSF;STX5;ARF4;STX12;CTTN;ZDHHC15;EHD1;TBC1D2B;RAB21;WIPI2;EVI5;DMD;ARCN1;SCFD2;AP3D1;BICD1;COPB2;NPHP1;USP4;RABGAP1;SNX8;RAB28;RAB1A;TBC1D8B;RAB5B;CPLANE2;STXBP1;PIGK;STX2;LRRK2;COG3;SMURF1;TBC1D5;TBC1D17;AP2A1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.3655475455163302,-0.9820435565571078,0.48286604361370716,0.8013974074300001,1.0,4/16,14.28%,HS3ST5;TRIM14;TRIM62;NECTIN2
prerank,negative regulation of organelle assembly (GO:1902116),0.3943644401383288,0.9820306804856508,0.4869451697127937,0.8758345388720721,1.0,9/35,17.76%,CDK10;RBM14;TMEM39A;STYXL1;LIMK2;BRCA1;SMAD4;YAP1;LRRK2
prerank,protein O-linked mannosylation (GO:0035269),0.43118487668065236,0.9820003597375876,0.5015151515151515,0.8753584294544602,1.0,8/18,23.33%,TMTC1;LARGE1;B4GAT1;TMTC3;DPM1;LARGE2;POMT2;POMT1
prerank,positive regulation of biosynthetic process (GO:0009891),0.3845451278469386,0.9818508830285867,0.5051413881748072,0.8751737590733456,1.0,6/40,10.85%,BMP4;TGFB3;PLCG2;MLXIPL;TLR4;CREB3L1
prerank,regulation of blood circulation (GO:1903522),0.3932034258655641,0.9816649390629565,0.5032765399737876,0.8750648159805942,1.0,3/34,6.16%,KCNMB2;CAMK2D;ECE1
prerank,negative regulation of JNK cascade (GO:0046329),0.404911147161665,0.9816233006538848,0.505249343832021,0.8746070506856474,1.0,6/31,10.44%,KLHL31;PER1;DACT1;NCOR1;PDCD4;DUSP19
prerank,receptor clustering (GO:0043113),0.41050887902040556,0.9813746977922134,0.4889196675900277,0.8746739084546398,1.0,10/27,19.89%,DLG2;NLGN1;SYNJ2BP;ITGB1BP1;DLG1;NRXN2;DVL1;PTN;SCRIB;ITGAL
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4821117243303778,0.9808447123029117,0.500768049155146,0.8753743060860903,1.0,6/12,28.87%,FDX1;TSPO;STAR;STARD3NL;FDX2;FDXR
prerank,plasma membrane invagination (GO:0099024),0.40217837229641823,0.9806169175679156,0.5013157894736842,0.8753759633840653,1.0,5/29,12.14%,GULP1;GSN;ALKBH4;RHOA;SNX18
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.2877359894052,-0.9804775848334826,0.4320388349514563,0.8040365258665445,1.0,5/41,5.78%,TJP1;ANK3;PODXL;PIEZO1;BMP7
prerank,microvillus assembly (GO:0030033),0.4577808320363974,0.9803114721181442,0.5037593984962406,0.8755714208357354,1.0,2/14,1.99%,FXYD5;EZR
prerank,regulation of MAP kinase activity (GO:0043405),0.3429064431594445,0.9801889576796683,0.5130533484676504,0.8753241131874328,1.0,13/92,7.26%,BMP4;EGFR;PRKCD;FGF2;CBLC;VEGFA;CDK12;IRAK3;PDGFC;FGFR1;NF1;ERBB2;TENM1
prerank,negative regulation of DNA replication (GO:0008156),0.4618814756376617,0.979653815079228,0.48657187993680884,0.8760436689085548,1.0,7/13,25.26%,RAD17;TSPYL2;ATR;S100A11;WAPL;GTPBP4;CDC6
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.48367522498559146,0.9796381848486517,0.5184,0.8755378264473177,1.0,1/11,2.94%,TAS1R3
prerank,positive regulation of cellular process (GO:0048522),0.31872837969749995,0.9794343145108712,0.5601202404809619,0.8754811930101711,1.0,83/565,12.69%,THBS1;BMP4;EGFR;ZFHX3;ACER3;LRP6;PGF;HES1;HDAC4;NTRK3;GRK5;LBP;PPP3CA;PRKCD;BMP5;PTK2B;FGF2;GAB2;SOX9;KRAS;IRS1;VEGFA;TGFB3;RAB25;CLCF1;FZD7;RARA;TIMP1;S100B;TGFBR1;PTHLH;FOLR2;LRP1;PDGFC;FGFR1;SHC1;DDX49;TCIRG1;CNOT8;PROK2;LMNA;BMP6;CTF1;ERBB2;TIAM1;TGFBR2;UBE2A;ABCA7;FN1;KITLG;DNPH1;CEP43;ZC3H12A;MLXIPL;CCND1;TLR4;TRPM4;EIF4G2;CUL3;SMC6;CHRD;CIB1;CDC123;ACACA;ITGAV;KLHL22;RIPK2;SMC5;CDK13;TTK;DHX36;GAREM1;NSMCE1;ANKRD17;MECP2;POFUT2;FBXO5;FXN;CDKN1B;RPS6KA3;PARD3;BRAT1;CELF1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.35597494577111377,0.9790634092509898,0.5168408826945412,0.8758060328067175,1.0,11/66,13.46%,FOXP1;CCL3;STAT3;NLRP12;ZC3H12A;TLR4;EGR1;RIPK2;TLR8;MYD88;CARD16
prerank,snRNA transcription (GO:0009301),0.3570926679788314,0.978981824514298,0.5088967971530249,0.8754681145793464,1.0,24/70,26.01%,NABP1;SNAPC2;INTS5;GTF2E1;INTS6;GTF2A2;POU2F1;CDK7;CCNT2;INTS7;TAF5;ELL2;POLR2C;CCNT1;ICE2;TAF8;TBP;INTS1;INTS14;TAF13;GTF2B;INTS8;INTS2;ELL
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4294463026475467,0.9783420578016799,0.4933530280649926,0.8764276552403513,1.0,8/19,28.12%,FOLR2;SLC25A32;SLC46A1;SLC19A1;MTHFS;GGH;SHMT1;FPGS
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.35684341324282176,0.9783292782304037,0.509367681498829,0.8759094077763409,1.0,8/73,4.96%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1;NR4A3
prerank,snRNA processing (GO:0016180),0.43855152087323734,0.9783257269013904,0.5014880952380952,0.8753762074434139,1.0,8/16,27.51%,INTS5;INTS6;INTS7;INTS1;INTS14;INTS8;INTS2;INTS9
prerank,regulation of type I interferon production (GO:0032479),0.34713886820955825,0.978313409960135,0.5074626865671642,0.8748704678420669,1.0,25/84,21.43%,TAX1BP1;CREBBP;IKBKE;IRF1;MAVS;IFIH1;GPATCH3;DHX36;CGAS;POLR3F;POLR3A;MYD88;TIRAP;POLR3K;POLR3E;PRKDC;POLR3D;PIN1;OTUD5;DHX9;XRCC5;NLRX1;TRAF3;NFKB2;IRF3
prerank,autophagy of peroxisome (GO:0030242),0.47143927723256174,0.9780392151531936,0.5007751937984496,0.8749453072719214,1.0,8/12,30.27%,ACBD5;RB1CC1;NBR1;USP30;ATM;MAP1LC3B;SQSTM1;PIK3R4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.31939097478071465,-0.9779441422088657,0.4940239043824701,0.8093342829250109,1.0,10/29,20.25%,ACSL1;ELOVL7;ACSL4;HACD1;HACD2;ACSBG1;ACSL5;ELOVL6;HSD17B12;CBR4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.37808899814861985,0.9777448302215515,0.5006435006435006,0.8750960061083657,1.0,5/43,4.65%,PID1;PRKCD;IRS1;GRB10;PTPN2
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3872433825096983,0.9777024201266742,0.49340369393139843,0.8746529682217519,1.0,13/38,18.53%,USP15;BMP6;ANKRD17;TLR8;POLR3F;IFI35;PRKCA;AKIRIN2;PLSCR1;POLR3D;SCIMP;DHX9;PUM2
prerank,regulation of macrophage cytokine production (GO:0010935),0.4615712704533024,0.9773326739793077,0.5152439024390244,0.8749883325567444,1.0,3/13,4.62%,TGFB3;PLCG2;IRAK3
prerank,positive regulation of JNK cascade (GO:0046330),0.35902000095460396,0.9772817839493134,0.5146198830409356,0.8745701406552095,1.0,6/70,3.82%,RASSF2;MAP3K5;PTK2B;SH3RF3;GADD45G;FZD7
prerank,cellular protein modification process (GO:0006464),0.31377324552129054,0.9772737934296402,0.607,0.8740530990126407,1.0,205/983,18.49%,THBS1;ST3GAL4;FBXL7;STK39;BMP4;DCLK1;MAP3K5;PLOD2;FSTL1;MARK1;PTP4A2;GRK5;PPP3CA;CCN1;PTPN3;WNK1;PRKCD;CAMK2D;PTPRU;WNT11;PRKCE;IGFBP5;GPC3;PTK2B;CCDC8;LOXL1;UST;COL3A1;B3GNT2;PTPRF;FBXO10;TLK1;BMPR1A;MSLN;DSP;DCAF6;EGLN3;WWP2;PPM1H;CLK2;GSK3B;CDK10;PSMB2;RARA;CDK12;TIMP1;HIPK1;TGFBR1;ABL1;IRAK3;LARGE1;FGFR1;ANXA1;PHKA2;DCAF4;FRK;CHEK2;USP25;NEK7;ZBTB16;SPSB2;MAN2A1;FAM20A;BCR;DCAF5;ST8SIA2;STRADA;ERBB2;TGFBR2;SIRT6;NRBP2;AURKA;LIMK2;ABCA7;FBXL20;CDK11B;FN1;PTPRA;IKBKE;PSMD11;CSNK1A1;CHST5;GRK4;PHEX;FEM1B;CKAP4;DUSP11;NLK;HIF3A;P3H1;MAST2;TGM5;TGM6;CUL3;PSMC1;WDR45B;PARP3;MAK;MIA3;PPP2R5C;CUL1;KLHL22;CDK16;RBBP7;RCN1;CDK13;FBXW8;AAK1;PARP1;PLK4;JMJD4;FBXO27;DNAJC3;CALU;ATG3;EIF2AK2;PDK3;LOX;PSMC6;DDA1;NPC1;CSNK1G3;KEAP1;SBF1;PIGT;KTN1;FBXO31;B3GNT9;PIGU;ATG5;SGK3;ARF4;MAP3K1;DUSP5;ILKAP;MARK2;COPS7B;PTPRS;UBE2M;PNPLA2;RET;CDKL2;MAN2B1;MXRA8;COP1;SIRT3;DCAF7;ACVR1;MORC3;COPS5;WIPI2;PTPN9;PIM2;COMMD1;PPP1R12A;MGAT1;PRKCA;ATG4B;RAB11B;PSMD1;PTPN21;MARK3;CDK7;UBLCP1;UBE2D3;PRKDC;PPP3CC;PSMD4;GGCX;PPP4R2;CDK2;OGA;RAB1A;PPP5C;LCK;UBL5;SIK1;FBXO17;IKBKB;PARP6;SHISA5;CEL;ERN2;DCUN1D1;TULP4;NEK4;SOCS3;PIGK;PSMA6;SDHAF2;UBE2S;LRRK2;DTL;STK24;STK3;COG3;MAPKAPK2;COPS8;DDOST;NUCB1;PARP2;NAA80;PSMD14;PPM1L;PSMD12
prerank,glutathione biosynthetic process (GO:0006750),0.4764208130387063,0.9771392546146788,0.48440065681444994,0.8738184641713035,1.0,1/11,1.99%,GCLC
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.39488640790413293,0.9768606683719635,0.5136897001303781,0.8739165774738832,1.0,13/37,21.18%,IGFBP5;FGF2;TGFB3;BMPR1A;NR4A3;PDCD4;CDKN1B;MEF2D;CDKN1A;ADAMTS1;PPARG;HTR1B;SOD2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3033944501758452,-0.9762289001740516,0.4828897338403042,0.8123781818209661,1.0,10/34,17.17%,LYN;MFHAS1;LGR4;GRAMD4;DAB2IP;CD300A;SARM1;NLRP2B;TYRO3;CACTIN
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3466644945350677,0.9760415484059498,0.5073779795686719,0.8753398755410088,1.0,23/85,18.97%,WNT11;PRICKLE1;FZD1;FZD7;PSMB2;AP2A2;TIAM1;PSMD11;PSMC1;RHOA;PSMC6;PARD6A;PSMD1;DAAM1;DVL1;PSMD4;AP2B1;PSMA6;SMURF1;PSMD14;PSMD12;AP2A1;PSMD7
prerank,cellular response to dsRNA (GO:0071359),0.4485063899745804,0.9758545887774344,0.5112994350282486,0.8751978084393599,1.0,7/15,19.69%,MAVS;IFIH1;CGAS;FLOT1;RALB;DHX9;COLEC12
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.27534910171198146,-0.9757703370441184,0.4696132596685083,0.8122296482788163,1.0,9/54,11.45%,NSA2;RPL7;NPM1;RPL23A;RPL26;RPL35A;RPL10A;RPL11;SNU13
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.39096664554052046,0.975606505257915,0.5077922077922078,0.8752100766037816,1.0,10/33,19.72%,HOXA5;RAB7B;STAT3;FOXO3;INHBA;ARNT;PITHD1;PRKDC;NCKAP1L;ANKRD54
prerank,cellular response to virus (GO:0098586),0.3991600854704145,0.9754693040143243,0.49933598937583,0.8749989638771573,1.0,9/30,22.05%,GBF1;ZC3H12A;IFIH1;VWCE;RRP1B;GSDME;CHUK;IRF3;FMR1
prerank,embryonic hemopoiesis (GO:0035162),-0.3918975835670807,-0.9750325256676797,0.4812680115273775,0.8128028322589703,1.0,4/12,9.77%,KIT;KDR;FLT3LG;TAL1
prerank,tight junction assembly (GO:0120192),-0.28667343332696144,-0.9748925167580499,0.4789473684210526,0.8117894625123246,1.0,6/49,3.74%,PARD6G;PECAM1;OCLN;CLDN5;ESAM;F11R
prerank,chromosome condensation (GO:0030261),0.3830008126184671,0.974842445448891,0.49081364829396323,0.8759357919155564,1.0,10/36,24.47%,SMC4;CCNB1;KMT5A;ERN2;RB1;NCAPH2;AIFM1;SMC2;PHF8;AKAP8L
prerank,brain morphogenesis (GO:0048854),-0.3952469382321454,-0.9744198005666527,0.4885057471264368,0.8117115664818509,1.0,2/12,2.59%,SHANK3;CTNNA2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4106738348529184,0.9738105421295908,0.5007235890014472,0.8778336768489702,1.0,4/24,10.11%,FGF13;MAP7D3;KATNB1;HDGFL3
prerank,regulation of chromosome segregation (GO:0051983),0.43652468316531506,0.9737806191732534,0.4947683109118087,0.8773724517994015,1.0,6/16,25.26%,SMC6;SMC5;RMI2;PUM2;PUM1;CDC6
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4297181081582435,0.9736947781285298,0.4733044733044733,0.8770451119556529,1.0,3/19,3.78%,EXT1;HS6ST2;XYLT1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.39779666117058093,0.9732969027875973,0.49132176234979974,0.8774287867940993,1.0,13/31,16.49%,EZR;DLG2;SYNE4;ERBIN;RHOA;PARD3;SYNJ2BP;MARK2;DLG1;PDCD6IP;MYO9A;SCRIB;CAMSAP3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3635347677030184,0.9731908863323576,0.49573690621193667,0.8771233887101398,1.0,18/51,25.90%,SMG6;NEK7;TEN1;STN1;NAT10;CCT5;TENT4B;NAF1;MAP3K4;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;GNL3L;CCT6A;SRC;PARN
prerank,cardiac muscle contraction (GO:0060048),0.39185479630623166,0.9728536752305507,0.5149863760217984,0.8773987302410009,1.0,4/34,1.98%,CSRP3;CAMK2D;GSN;ATP1B1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4631898971956314,0.9726717193619768,0.50231124807396,0.8772926020502527,1.0,6/13,17.81%,RGPD1;KPNA1;KPNA2;RANBP2;KPNA4;NUP35
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.3252197219254181,0.9724575820143867,0.54,0.8772499842393954,1.0,19/159,9.55%,PCDHB16;HMCN1;CDH11;GPC6;PKD1;FAT2;CDH1;MPZL2;PTPRF;PCDHB9;NECTIN3;DSG2;CEACAM5;TGFBR2;TENM1;ITGB1;EMB;SLITRK2;PCDHB3
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3306102332826065,-0.9722498681972394,0.5091575091575091,0.8158465318234813,1.0,4/24,15.34%,DACH1;RPS3;BLM;ACVRL1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.30203464824465615,-0.9721429618955317,0.5159817351598174,0.8147344235255187,1.0,12/37,15.82%,CEMIP;APP;SPRED1;BMP7;MAPK1;CADM4;CALM1;SPHK1;WNK3;SIRT2;PRKAG2;STOX1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.41889711694096443,0.9721427113665339,0.49359886201991465,0.8774552536676697,1.0,9/22,17.75%,CAMK2D;NR4A3;MEF2A;GLRX3;SLC9A1;PARP1;PRKCA;SMAD4;P2RX4
prerank,negative regulation of signaling (GO:0023057),0.40982202131637374,0.9720783757236869,0.49387755102040815,0.8770757868658218,1.0,6/25,16.08%,UBASH3B;SRMS;NLRP12;TRAT1;ACVR1;HHIP
prerank,regulation of neuron apoptotic process (GO:0043523),0.3410494076024209,0.9718556729329623,0.5267857142857143,0.8770499627465119,1.0,12/96,6.71%,SIX1;PTK2B;NGF;KCNB1;TGFB3;EGLN3;CLCF1;CCL3;FOXO3;NF1;NFATC4;NRBP2
prerank,folic acid metabolic process (GO:0046655),0.43289399652669713,0.9716610261152036,0.4888888888888889,0.8769805862841475,1.0,8/18,28.12%,FOLR2;SLC25A32;SLC46A1;SLC19A1;PM20D2;MTHFS;SHMT1;FPGS
prerank,heart process (GO:0003015),0.45682341550856687,0.971444275848761,0.5044117647058823,0.87693399292071,1.0,1/14,1.15%,SGCD
prerank,cellular response to metal ion (GO:0071248),0.3331284692343153,0.9713476260356372,0.5441810344827587,0.8766311760153497,1.0,22/123,17.76%,EGFR;SLC12A2;CLIC4;CDH1;CAMK2D;DLG2;PLCG2;MEF2A;BMP6;DMTN;NLGN1;CDKN1B;CPNE8;CPNE1;DPEP1;TIGAR;ADD1;ADCY8;CPNE3;IQGAP1;P2RX4;LRRK2
prerank,natural killer cell activation (GO:0030101),0.425575334709227,0.9713062500890035,0.4930167597765363,0.8761779927248445,1.0,3/23,5.98%,PBX1;CD2;NFIL3
prerank,regulation of steroid metabolic process (GO:0019218),-0.3317918750318097,-0.9711423727519667,0.5,0.8159949828037407,1.0,4/23,10.80%,APOE;ABCG1;ARV1;ASAH1
prerank,diacylglycerol metabolic process (GO:0046339),0.41067419660501764,0.9710580923986363,0.5141643059490085,0.876248932611652,1.0,5/23,14.41%,PLCE1;PLA2G15;DGKA;PNPLA2;MOGAT1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.40770985259176373,-0.9710059374030319,0.5093833780160858,0.8149531482826113,1.0,2/10,6.47%,LYN;GHR
prerank,positive regulation of signaling (GO:0023056),-0.29698473584665075,-0.9705497703232231,0.5159817351598174,0.8147156656111716,1.0,8/37,10.17%,WLS;GRIK2;RIMS1;RIMS2;SYT1;LGI1;KCTD13;EDN1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.34118263465477877,0.9704252846807586,0.5292134831460674,0.8771710732573755,1.0,11/86,8.37%,CDC42EP5;MET;BAIAP2L1;PRKCE;PTK2B;KATNB1;CLIP1;NCK2;TENM1;TOGARAM1;AKAP9
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.46147708746370736,0.970311759079023,0.49157733537519144,0.8769116598547323,1.0,4/11,13.32%,SOX9;TGFBR2;CHRD;LRP5
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.4694595957311034,0.9701197400333851,0.5139318885448917,0.8768212669002484,1.0,3/11,17.26%,ANXA1;ZC3H12A;SMAD7
prerank,nuclear pore complex assembly (GO:0051292),0.48620572886652036,0.9700514827821617,0.5070422535211268,0.8764340925759315,1.0,3/10,10.34%,NUP93;NUP153;AHCTF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3514127554039879,0.9698122864380989,0.5150115473441108,0.8764484958319521,1.0,13/72,16.78%,RBFOX2;FGF2;NOG;SHOC2;FGFR1;SPRED2;KIF16B;FGFRL1;TIA1;HNRNPH1;HNRNPM;FLRT2;FGFR3
prerank,striated muscle cell development (GO:0055002),-0.379450229121092,-0.9690933764740176,0.5029940119760479,0.8171198633899932,1.0,3/14,10.51%,PGM5;LMOD1;TMOD1
prerank,calcium ion homeostasis (GO:0055074),0.33689856722991707,0.9689481799587196,0.5374301675977654,0.8779620162410706,1.0,16/95,13.14%,SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;CCL3;CCL1;ATP2B4;FAM20A;SLC10A7;CCL7;DRD3;SLC8B1;CTRC;NPTN
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4267207173013896,0.9683436682840987,0.5207439198855508,0.878827342874752,1.0,3/21,10.90%,FOXP1;IKBKG;TRAT1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.35801478355727795,0.9683416555242991,0.5166270783847982,0.8783027749063873,1.0,10/59,8.63%,HMCN1;PKD1;FAT2;CDH1;MPZL2;NECTIN3;DSG2;CEACAM5;ITGB1;EMB
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.36781659647230547,-0.9677292486230791,0.4878048780487805,0.8192454039833449,1.0,10/16,35.21%,ATP5PF;ATP5F1E;ATP5F1A;ATP5F1B;ATP5MC1;ATP5MC2;ATP5MC3;ATP5F1D;DMAC2L;STOML2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4209117661105454,0.9677193244537197,0.5097222222222222,0.879219839866904,1.0,9/22,23.18%,GSK3B;STYXL1;CRY2;PTPA;MGAT5;IKBKB;NCKAP1L;LGALS3;BOD1L1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3823021904226262,0.967645208777737,0.5084087968952135,0.8788685320543047,1.0,11/37,21.80%,IFT46;WDR35;PCM1;IFT52;DYNC2I2;KIF3B;DYNC2I1;IFT43;CLUAP1;IFT22;DYNC2H1
prerank,negative regulation of gene expression (GO:0010629),0.3162963872537195,0.9674526396964355,0.5947315096251267,0.8787986872461412,1.0,43/302,11.66%,FOXP1;BMP4;SLC24A3;SAMD4A;IGFBP5;HDAC9;FGF2;ITGB8;VEGFA;ESR1;BMPR1A;ID2;WWP2;SMO;ZNF148;NOTCH2;KLF4;CCL3;PAIP2;CNOT8;EMILIN1;ATP2B4;AGO2;REL;AURKA;NLRP12;NCOR1;EED;ZC3H12A;NCOR2;DNMT3A;NUDT12;EPRS1;ANXA7;RBBP7;XDH;POU4F1;DHX36;EIF2AK2;CREB3L1;MECP2;ATOH8;CD46
prerank,activation of adenylate cyclase activity (GO:0007190),-0.30291507201066215,-0.9674426110936244,0.48132780082987553,0.8185595814584378,1.0,5/35,5.92%,ADCY5;ADCY1;LGR4;CAP2;ADCY7
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3362547653566265,-0.9674309328237535,0.5087108013937283,0.8171865969262478,1.0,6/21,11.83%,CHSY3;CSGALNACT1;DCN;CHSY1;CHST3;CSPG5
prerank,sodium ion homeostasis (GO:0055078),0.4201001219167566,0.9672056312003363,0.5109489051094891,0.8788906400352036,1.0,7/21,9.77%,SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,positive regulation of transport (GO:0051050),-0.24451212285379043,-0.9671376193487374,0.6173913043478261,0.8165511763801592,1.0,24/85,18.38%,CAMK1D;APOE;NEDD4L;MERTK;IL15RA;ACTB;SIRPA;HIP1R;NR1H3;DOCK2;GATA2;SGK1;GAS6;CLIP3;SMPD1;BOK;TULP1;MLC1;CCL19;CD47;LYAR;GSK3A;CD151;PYCARD
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.46316415186840537,0.9666127151701577,0.5078125,0.8797547165421352,1.0,3/13,4.80%,RAMP1;SOAT1;IL33
prerank,mRNA processing (GO:0006397),0.31572788774354654,0.9661792950108912,0.5786802030456852,0.8802157781882867,1.0,120/287,32.07%,RNMT;DDX5;SRSF11;U2AF2;SON;RBM14;THOC2;DBR1;SRSF5;MNAT1;SRSF6;SRRM2;SNRNP48;PABPC1;PRPF18;KIN;CDC40;SRSF2;CELF1;FUS;HNRNPH1;SNRNP35;U2SURP;RBMX;SCAF11;SRSF1;CHERP;WBP4;CDK7;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;GTF2H3;CPSF3;CHTOP;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;SARNP;GEMIN5;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;PNN;LSM4;TCERG1;AURKAIP1;RNGTT;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;ZC3H11A;FIP1L1;AKAP8L;YTHDC1;HNRNPF;USP39;RBM4;SUPT4H1;GTF2H4;SNRNP200;CSTF1;PTBP1;RBM17;CMTR2;RAMAC;CMTR1;ZCRB1;WDR33;DNAJC8;RBM5;THOC1;GCFC2;SMNDC1;SNRPB;SNRPB2;ALKBH5;DHX15;ELAVL1;ZRSR2;HNRNPC;ERCC2;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;WBP11;PPIL3;THOC5;TXNL4A;PRPF3;GTF2H5;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3130309959761993,0.9659399112944587,0.6042084168336673,0.8802448154632316,1.0,83/509,13.54%,F3;THBS1;EGFR;NR3C2;TNFAIP8L3;TCF7L2;MET;NTRK3;NEDD4;TCIM;ADRA1B;WNT11;NFAT5;FGF2;GAB2;PIK3AP1;ADRB2;AKAP13;SOX9;IRS1;VEGFA;ESR1;CCL3;ALPK1;LIMS1;TRAF3IP2;S100B;PLCG2;TGFBR1;USP15;PDGFC;FGFR1;SHC1;RRAGB;TAB3;MYOC;ERBB2;REL;MIER1;NLRP12;STRN;IRAK4;ROR1;STYXL1;FN1;IKBKG;ITGB1;KITLG;IKBKE;HTR6;TLR4;BECN1;CD80;MAVS;PDCD4;ITGAV;MYORG;RIPK2;RHOA;DUSP19;MAP3K7;DHX36;TAB2;EIF2AK2;MAP3K3;CGAS;TRAT1;ANKRD17;NLGN1;TRIM44;IFI35;BCAR3;MYD88;TRAF2;BCAP31;CPNE1;ITGB1BP1;RET;TIRAP;PLXNB1;MTDH;CARD16;ZDHHC13
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.37673686870402645,0.9659092600376963,0.5113350125944585,0.8797916614966633,1.0,6/41,8.34%,LBP;RARA;IRAK3;C5AR2;ZC3H12A;TLR4
prerank,positive regulation of protein secretion (GO:0050714),0.34937034833048936,0.9658998210408748,0.5361305361305362,0.8792857124527569,1.0,11/69,12.51%,TCF7L2;ADAM9;EZR;UNC13B;TGFB3;SYTL4;BMP6;TLR4;AACS;MCU;APBB3
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3879034010203528,-0.9658078699804836,0.49570200573065903,0.8187126833640239,1.0,4/13,8.41%,SLC8A1;ANK3;PDE4D;CALM1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4014096841226724,0.9654571159265275,0.5034867503486751,0.8797956218358046,1.0,4/27,3.09%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,regulation of protein polymerization (GO:0032271),-0.3039667279564233,-0.965407747839086,0.47843137254901963,0.8184091336582495,1.0,6/35,10.20%,ARHGAP28;ESAM;MAP2;PAK3;MAPT;CAMSAP2
prerank,lytic vacuole organization (GO:0080171),0.38853589956680706,0.9652700150654325,0.5215123859191656,0.8796759138766798,1.0,7/32,17.76%,HPS4;ACP3;ACP4;ARSB;HOOK3;GNPTAB;LRRK2
prerank,protein glycosylation (GO:0006486),0.33189435329031314,0.964821181781255,0.5540838852097131,0.8801795336360653,1.0,35/125,23.62%,ST3GAL4;PLOD2;FUT8;B3GNT2;MGAT4C;LARGE1;ST8SIA2;B4GALT1;ENTPD5;ALG12;B4GAT1;NPC1;B3GNT9;DPAGT1;POFUT1;MGAT1;GALNT10;MGAT5;OGA;GFPT1;COG3;DDOST;TMEM165;TUSC3;MPI;FUT2;DPM1;GCNT2;ALG8;LARGE2;FUT10;POMT2;POMT1;PGM3;OGT
prerank,myelination (GO:0042552),0.37120679910206567,0.9647193970576655,0.5188916876574308,0.8798759191362067,1.0,7/46,7.52%,ACER3;MARVELD1;PMP22;NF1;SKI;MYOC;ABCD1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3783654773154573,-0.9645403916573622,0.5091463414634146,0.8192135100033323,1.0,6/14,17.99%,PRKCZ;IL18;CD81;CD74;NOD2;CD86
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3417112381130313,0.9644009295154853,0.5402951191827469,0.8800712232571009,1.0,13/86,10.00%,EGFR;PRKCD;PTK2B;EFNA5;NRP1;VEGFA;PLCG2;ABL1;BMP6;CD44;DMTN;CD80;RIPK2
prerank,tRNA transport (GO:0051031),0.3845169973320865,0.9642559723414009,0.5347313237221494,0.8798670839961279,1.0,9/35,17.81%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.28532912069817756,-0.964196157862456,0.5246636771300448,0.8187347123521719,1.0,19/42,28.13%,IL6R;OPTN;DEFA6;RPS19;GSDMD;MR1;CHGA;ADGRB1;PYCARD;ROMO1;MPEG1;RARRES2;HMGB2;SERPINE1;TREM2;SELP;TNFRSF14;NOS2;AQP1
prerank,establishment of protein localization to organelle (GO:0072594),0.35098247743525335,0.9640738713149155,0.5355064027939465,0.8797712308160045,1.0,15/72,16.18%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;TSPAN17;NUP153;TNPO2;TNPO3;IPO7;NUP155;ZDHHC15;NUTF2;NUP88;CSE1L
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36456813796987414,0.9640520408706534,0.5445665445665445,0.8792936492158335,1.0,17/53,23.94%,PSMB2;NQO1;PSMD11;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.3852606179644639,-0.9639890368961673,0.518840579710145,0.8178778048777324,1.0,6/12,16.49%,PIK3R1;DAB2IP;BCL2L11;ERN1;BOK;XBP1
prerank,positive regulation of neuron migration (GO:2001224),-0.4076893777142722,-0.9636626676688318,0.4904632152588556,0.8173424104182629,1.0,3/11,7.11%,SEMA6A;RAPGEF2;DAB2IP
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.36608908927097733,-0.9630368533463809,0.4757834757834758,0.817511881139666,1.0,4/14,6.54%,KIT;WNT5A;SEMA7A;GPRC5B
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.40371828188475367,-0.9625652908811368,0.47883597883597884,0.8173632245835757,1.0,3/11,15.69%,ENPP3;SLC19A3;DCK
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.405117576893354,0.9625356234968838,0.5020463847203275,0.882274081857531,1.0,11/24,26.46%,TAB3;IKBKG;AAMP;RIPK2;MAP3K7;TAB2;TRAF6;UBB;UBE2V1;UBA52;RPS27A
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.31698367750430095,0.9625340833340853,0.5712830957230143,0.8817552093390916,1.0,58/248,18.49%,EGFR;TCF7L2;LRP6;MLLT3;CTNND2;WNK1;PTPRU;WNT11;GPC3;PRICKLE1;PLEKHA4;SOX9;SFRP4;GSK3B;FZD7;PSMB2;GLI3;INVS;TLE2;EMD;NOG;UBR5;DACT1;DKK3;PSMD11;CSNK1A1;TRPM4;CUL3;SFRP5;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;IGFBP6;CSNK1G1;PSMD1;UBE2B;DVL1;CAPRIN2;PSMD4;RBMS3;USP47;PIN1;NPHP3;CHD8;TLE6;PSMA6;SDHAF2;PRDM15;LRRK2;STK3;PSMD14;PSMD12
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.44146771970432774,0.9623161902044101,0.5,0.8817252979470495,1.0,6/15,20.00%,ABL1;MAD2L1;FBXO5;SMAD7;BAG5;BAG2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.34112362022108866,-0.9621713923048162,0.5171339563862928,0.8170020891550748,1.0,5/19,15.55%,SLCO1C1;APP;WFS1;PAX8;MTPN
prerank,regulation of intracellular signal transduction (GO:1902531),0.3100082098102227,0.9621670263240998,0.6148445336008024,0.8815546032841937,1.0,80/420,14.69%,RASSF2;EGFR;RHOJ;ARHGAP20;NTRK3;MOB3B;VAV2;ARAP1;USP2;EZR;CMKLR1;ARHGAP21;ARHGAP10;SRGAP2;SRGAP3;AKAP13;ARHGDIB;VEGFA;TELO2;EXO1;ITFG2;HIPK1;PLCG2;ARHGAP44;ARHGAP40;RRAGB;CHEK2;MYOC;BCR;ARHGAP17;TIAM1;SOS2;AURKA;NLRP12;EHMT1;STYXL1;BARD1;ENTPD5;IKBKG;WRN;TOPBP1;RHOQ;TIAM2;ZFAND6;ARHGAP31;CHD3;STARD13;GATA4;ARHGAP5;PPP2R5C;ITGAV;RBBP7;POU4F1;RHOA;NLGN1;FGD1;RAD50;PIP5K1A;TRAF2;TRIO;MDM4;RAD17;BRCA1;OCRL;CPNE1;TMBIM4;FGD3;DLG1;MBD3;PRMT5;PIP4K2A;CCNG1;TAF4;BRIP1;TRIP10;MYO9A;GNA13;DEPDC1B;PIDD1;RNF41
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.3560243221709471,-0.9618324427946171,0.5231607629427792,0.8164928401046745,1.0,1/16,0.16%,AUTS2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.39143279111002766,0.9616539126562133,0.5213333333333333,0.8821900306637313,1.0,6/30,7.77%,DSE;CHST13;HEXA;BGN;CHST11;ARSB
prerank,regulation of exit from mitosis (GO:0007096),0.37440478675486855,0.9615515625806252,0.5076923076923077,0.8818659887090062,1.0,9/38,11.96%,ANAPC5;CDC14A;ANAPC10;CDC16;ANAPC11;CDC20;MAD2L1;ANAPC16;ZW10
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.39802788517464294,-0.9615077799236929,0.5171428571428571,0.815907514612036,1.0,4/12,13.51%,LYN;CD300A;ELF2;PTPN22
prerank,regulation of metal ion transport (GO:0010959),-0.3658917639051633,-0.9610822515720443,0.48579545454545453,0.8156525229217791,1.0,7/16,14.55%,EPB41;SLC30A10;BCL2;CACNA2D1;ORAI1;CAMK2G;CAMK2B
prerank,regulation of superoxide anion generation (GO:0032928),0.4500622162559349,0.9609730864759283,0.5132743362831859,0.8826476510213788,1.0,1/14,1.64%,PRKCD
prerank,nuclear body organization (GO:0030575),-0.3750891759131204,-0.9609631085673895,0.5040431266846361,0.8146005909037197,1.0,3/12,14.15%,ETS1;WRAP53;HIPK2
prerank,neuron projection fasciculation (GO:0106030),-0.4131091840488115,-0.9609407651873078,0.5263157894736842,0.8133135370347995,1.0,4/10,10.23%,CNTN4;EPHA4;RTN4;SEMA5A
prerank,mesenchymal cell differentiation (GO:0048762),0.3655439859492095,0.9608987026308928,0.5226993865030675,0.8823057114388846,1.0,9/51,5.15%,LRP6;DDX5;SOX9;DDX17;GSK3B;LIMS1;TGFBR1;NOG;FGFR1
prerank,pseudouridine synthesis (GO:0001522),0.44944843698853176,0.9607200512431376,0.5125,0.8821993792879252,1.0,3/13,17.69%,PUS7L;RPUSD2;PUSL1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.3299922581633717,-0.9605686629845389,0.5036231884057971,0.8128323332245487,1.0,10/24,23.43%,BCL2;CXCL12;BCL2L1;TPT1;MIF;CD74;CDKN2D;TAF9;TRIAP1;SNAI2
prerank,selective autophagy (GO:0061912),0.3584330412112806,0.9604310765469127,0.5266343825665859,0.8823750075789054,1.0,23/56,29.17%,ULK2;BECN1;WDR81;TEX264;ACBD5;PCNT;RB1CC1;ATG5;UBA5;NBR1;USP30;WDFY3;ATM;UBB;AMBRA1;UBE2V1;UBA52;ATG2A;MAP1LC3B;RPS27A;ATG14;UBE2N;SQSTM1
prerank,positive regulation of histone acetylation (GO:0035066),-0.3282517267673231,-0.9600362054513183,0.5,0.8128669423077249,1.0,11/23,32.40%,RPS6KA5;PPARGC1A;RPS6KA4;BRD7;WBP2;GLYR1;KAT7;SPHK2;PIH1D1;MUC1;RUVBL2
prerank,glycoprotein biosynthetic process (GO:0009101),0.3416674797387046,0.9595127353764472,0.5371428571428571,0.8838538868468964,1.0,18/79,18.13%,ST3GAL4;FOXL1;B3GNT2;CHST13;XYLT1;LARGE1;ST8SIA2;CHST11;GAL3ST4;B3GALT6;NPC1;B3GNT9;MGAT1;TNIP1;GOLPH3;CHST12;COG3;DDOST
prerank,cellular response to nitrogen compound (GO:1901699),0.42684835982109653,0.9594413860669768,0.5296610169491526,0.8834874866175056,1.0,8/20,22.05%,ATP2B4;SPIDR;DDI2;DDX11;RTF2;ATRX;DDI1;FMR1
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.47467838474852364,0.9592367712811937,0.5,0.8828881959643594,1.0,1/10,1.64%,PRKCD
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.47467838474852364,0.9592367712811937,0.5,0.8828881959643594,1.0,1/10,1.64%,PRKCD
prerank,cholesterol homeostasis (GO:0042632),0.35241286283023443,0.9591854246609138,0.5196195005945303,0.8824799706941174,1.0,12/64,13.32%,SOAT1;HDAC9;LDLR;TSKU;LIMA1;RORA;NPC1;ANGPTL3;SOAT2;NR1D1;EHD1;LRP5
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.44759666733609477,0.9581314753058675,0.518910741301059,0.8843159144747066,1.0,4/15,13.94%,SRM;SMOX;TPH2;PAOX
prerank,"transcription, DNA-templated (GO:0006351)",0.3192923278768714,0.9575411022792619,0.5733471074380165,0.8851434625715138,1.0,70/207,26.45%,RNMT;MLLT3;DDX5;AFF4;FOXO3;NFIX;MEF2A;MNAT1;NR4A2;MBD1;SNAPC2;NFIC;PARP1;TFDP1;POLR3A;NCOA6;CEBPD;GTF2E1;DRG1;ELOA;E2F1;PRMT5;NFYA;RBMX;NELFE;DDX21;GTF2A2;TAF4;POLR3K;CDK7;CCNT2;RNPS1;HOXD3;SMARCA5;PPP5C;HSF2BP;GTF2H3;ZBTB7B;UBTF;MED20;TAF5;DEK;POLR2C;MED16;NFX1;EPC1;COPS2;CREBL2;CCNT1;TTF1;RNGTT;TBP;GTF3C1;GTF3C4;TAF12;TP53;TAF13;GTF2B;GTF3A;TAF7;RO60;RSF1;CBFB;SMN1;SUPT4H1;ELL;GTF2H4;BAZ2A;TOPORS;TTF2
prerank,ATP transport (GO:0015867),-0.4073949012956217,-0.9570020356985104,0.5306122448979592,0.8191148128607548,1.0,2/10,16.37%,ABCC6;CD47
prerank,peptidyl-lysine dimethylation (GO:0018027),0.43079366474009295,0.9566322958322451,0.5173852573018081,0.8866665147197675,1.0,9/18,32.86%,SETD2;EHMT1;KMT2D;ASH1L;SMYD2;SETD7;SETMAR;EHMT2;PRDM9
prerank,negative regulation of synaptic transmission (GO:0050805),-0.3234011257028143,-0.9560317283822258,0.5270758122743683,0.8201832050032826,1.0,5/23,11.28%,SLC24A2;SYT11;SHANK2;SLC30A1;PLK2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.4421995298189182,0.9559031481387984,0.5178849144634525,0.8877511589112179,1.0,3/14,8.37%,ANK2;ATP1B1;AKAP9
prerank,regulation of JNK cascade (GO:0046328),0.33636437072100667,0.955674201901319,0.5633958103638368,0.8877454311217874,1.0,11/101,7.25%,RASSF2;EGFR;MAP3K5;PTK2B;KLHL31;SH3RF3;GADD45G;FZD7;PER1;DACT1;NCOR1
prerank,regulation of axonogenesis (GO:0050770),0.3601090402701554,0.9554391217266947,0.5414634146341464,0.8877236246186775,1.0,11/51,13.39%,SLIT2;SIPA1L1;NGF;GSK3B;EPHB3;TIAM1;TIAM2;RHOA;MARK2;MAP6;PLXNB1
prerank,response to steroid hormone (GO:0048545),0.38734888394264033,0.9548879609246244,0.5084967320261438,0.8884502704323386,1.0,7/31,16.91%,THBS1;TGFB3;ATP1A3;ATP1A1;NR3C1;URI1;YAP1
prerank,translational termination (GO:0006415),0.3378662843149688,0.954742296074272,0.5558086560364465,0.8882703845784782,1.0,44/95,35.75%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;GSPT1;MRPS2;ETF1;MRPL36;MRPL19;MRPL15;APEH;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;ABCE1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,histone ubiquitination (GO:0016574),0.40987785242508323,0.953909675565305,0.5118694362017804,0.8895637975461645,1.0,5/21,17.43%,UBE2A;WAC;RNF8;UBE2B;RNF20
prerank,protein-DNA complex assembly (GO:0065004),0.3312119704535716,0.9538770308258544,0.5686059275521405,0.8891047152040279,1.0,40/116,26.46%,CHAF1B;SOX9;PSMB2;ERCC5;MCM2;RAD51;MNAT1;PSMD11;CHAF1A;CHD1L;PSMC1;PARP1;RAD23B;PSMC6;ORC3;ATRX;PSMD1;MCM7;CDK7;KAT6B;PSMD4;SMARCA5;GTF2H3;PSMA6;PSMD14;PSMD12;CETN2;PSMD7;NAA60;PSME3;NAP1L1;PSMD3;PSMB6;ASF1A;UBB;RSF1;CDC6;UBA52;GTF2H4;RPS27A
prerank,RNA processing (GO:0006396),0.3171919285585997,0.9538432866047987,0.5866388308977035,0.8886574587719674,1.0,72/176,30.14%,MBNL1;DDX17;CELF3;SRSF11;CDK12;U2AF2;SON;SRSF5;TUT7;RBM39;TUT4;SNRNP48;DUSP11;PRPF18;KIN;RBM3;SRSF2;TENT2;CELF1;FUS;HNRNPH1;SNRNP35;SCAF11;BICD1;SRSF1;WBP4;RNPS1;PRPF8;FASTKD5;RNPC3;TENT4B;PABPC4;HNRNPA2B1;NONO;SYNCRIP;RBM6;CSTF3;MRPL44;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;LSM4;TCERG1;AURKAIP1;LUC7L3;RNGTT;TARDBP;SRRM1;SRPK2;AKAP8L;HNRNPF;LSM1;USP39;RBM4;SUPT4H1;DICER1;SCNM1;PTBP1;DROSHA;ZCRB1;RBM5;THOC1;SNRPB;ALKBH5;DHX15;ZRSR2;HNRNPC;HNRNPR;PIWIL2;SRPK1
prerank,pentose-phosphate shunt (GO:0006098),0.4742793494481601,0.9537944814632427,0.5388349514563107,0.8882469410359948,1.0,7/11,29.07%,DERA;TKT;RPE;PGM2;PGLS;RPIA;SHPK
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3712342066802923,0.9533769179895151,0.5348837209302325,0.888683557753058,1.0,8/42,10.43%,VIT;FZD7;LIMS1;NF1;AGR2;DMTN;CORO1C;RHOA
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.39733849530902365,0.9533523209640806,0.5440340909090909,0.8882177681863443,1.0,5/26,8.37%,MET;KATNB1;CLIP1;TOGARAM1;AKAP9
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3607989899668366,-0.9531555389161671,0.5192307692307693,0.8261409983188841,1.0,2/16,3.89%,IGF1R;INSR
prerank,replication fork processing (GO:0031297),0.3723865151336426,0.9531381243641965,0.5256570713391739,0.888162613414672,1.0,15/38,30.15%,RAD51;WRN;SMARCAL1;DDX11;PRIMPOL;ATRX;FAM111A;BRCA2;ATR;BOD1L1;SETMAR;THOC1;ZGRF1;MMS22L;GEN1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.43479336917791234,0.9530042346960603,0.5178571428571429,0.8879286589872347,1.0,4/16,14.70%,SLC39A14;ACP3;PRMT5;PRKCA
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.4564917058893476,0.9526214923451194,0.5286821705426357,0.888285713816011,1.0,2/12,1.98%,WNK1;ATP1B1
prerank,cellular sodium ion homeostasis (GO:0006883),0.4410021510982564,0.9524631791900806,0.524812030075188,0.8881241331029816,1.0,7/15,9.77%,SLC12A2;ATP1B1;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.41357552820344307,0.9520468647963756,0.5444287729196051,0.888522041539382,1.0,8/21,20.15%,CCND1;CCNB1;MECP2;FBXO5;CDC7;DTL;BRD4;RAB11A
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3300904166044428,-0.9520204129481606,0.5104166666666666,0.8277354871837874,1.0,4/21,5.10%,MFHAS1;PPP1R16B;PPP4R4;YWHAB
prerank,mitotic cell cycle phase transition (GO:0044772),0.31554112376677446,0.9518754362332943,0.6008316008316008,0.8883941917963923,1.0,49/203,19.14%,FBXL7;CCNA2;PPP1R12B;CHEK2;MNAT1;PCM1;INHBA;AURKA;PAFAH1B1;E2F3;CEP43;CCND1;AKAP9;CUL3;CDKN2C;SDCCAG8;CDC16;CUL1;GSPT1;HAUS2;CCNB1;CEP63;PLK4;PPP2R2D;PCNT;CDKN1B;CDKN3;E2F1;ACVR1;CCNG1;HINFP;PIM2;PPP1R12A;KHDRBS1;CDK7;OFD1;CDK2;CDKN1A;CDC7;PLK3;ARPP19;RPS6KB1;RB1;UBE2S;CEP164;CETN2;WEE1;FBXL6;BORA
prerank,positive regulation of kinase activity (GO:0033674),0.3330404647027253,0.951734157691614,0.5580110497237569,0.8881785017551871,1.0,12/107,7.13%,RASSF2;EGFR;MET;NTRK3;DDR2;CCN1;LMO4;PTK2B;EPHB3;FGFR1;ERBB2;ROR1
prerank,regulation of cell division (GO:0051302),0.34401411208854615,0.9517137765914377,0.5514450867052023,0.8877134132138373,1.0,22/72,24.57%,MLLT3;NLRP5;KIF13A;SETD2;AURKA;RAB11FIP3;BECN1;CIB1;AHCTF1;PLK4;SH3GLB1;PIN1;PLK3;TLE6;PRDM15;CETN2;RAB11A;BIRC6;HTR2B;CALM2;ENTR1;PDXP
prerank,membrane repolarization (GO:0086009),0.44695506806649055,0.9517098055172363,0.5266955266955267,0.8872005003347436,1.0,2/15,1.98%,KCNJ2;ATP1B1
prerank,telomere organization (GO:0032200),0.36964084601346103,0.9515305846755521,0.5408163265306123,0.8870943525402828,1.0,13/43,23.47%,APEX1;WRN;STN1;PARP3;PARP1;RAD50;PRKDC;ATR;XRCC5;ERCC4;NBN;RAD51D;ATM
prerank,positive regulation of transmembrane transport (GO:0034764),0.4480568391606017,0.9507254069330492,0.5230769230769231,0.8883651904153744,1.0,5/13,15.17%,SLC26A6;ANO6;NR4A3;C2CD5;AZIN1
prerank,response to cytokine (GO:0034097),0.3235867329733171,0.9504895869430042,0.5686486486486486,0.8883839051035638,1.0,22/141,11.15%,DPYSL3;HDAC4;PID1;ADAM9;AFF3;NFAT5;COL3A1;TIMP1;IRAK3;PTPN2;STAT3;ANXA1;SETD2;REL;NLRP12;IKBKE;TIMP2;POU4F1;RHOA;EIF2AK2;MCL1;IGBP1
prerank,negative regulation of macrophage activation (GO:0043031),-0.3528601278392779,-0.9504379779525782,0.5365079365079365,0.8302714228038842,1.0,5/16,8.83%,IL31RA;NR1H3;LRFN5;SYT11;CD200
prerank,cellular response to cAMP (GO:0071320),0.3921544442276973,0.9502594359467139,0.5655080213903744,0.8883496355502633,1.0,6/30,11.12%,IGFBP5;EZR;SLC26A6;DMTN;AKAP9;RAP1A
prerank,regulation of cellular response to heat (GO:1900034),0.34064041710641163,0.9500206083269285,0.5606407322654462,0.8883677493768611,1.0,24/77,25.15%,CAMK2D;GSK3B;HSPB8;NUP93;BAG3;CREBBP;NUP214;HSPA1L;NUP153;CHORDC1;NUP155;RANBP2;NUP88;MLST8;NUP35;BAG5;MAPKAPK2;ATR;BAG2;HSPH1;YWHAE;ATM;MTOR;NUP98
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.338349857075215,0.9500042314210244,0.5559322033898305,0.887890337761223,1.0,26/85,22.37%,RNF144A;PRICKLE1;GSK3B;ZYG11B;USP13;CSNK1A1;RNF185;ARIH1;VCP;ANKIB1;PSMC6;DDA1;DET1;KEAP1;CLU;COP1;DVL1;TMTC3;SMAD7;RNF14;LRRK2;BAG2;DNAJB2;PIAS1;FMR1;TMEM259
prerank,regulation of nervous system development (GO:0051960),0.37709177974919283,0.9497902437319437,0.5508905852417303,0.8878505404863952,1.0,7/37,16.91%,HES1;DOCK7;BHLHE40;HES3;PTN;NPHP3;YAP1
prerank,proteasome assembly (GO:0043248),0.4654292731860574,0.9495105119846969,0.5317829457364341,0.8879487588621966,1.0,3/11,15.78%,ADRM1;PSMD11;PSMD4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.39664062799271876,0.9495094660137244,0.5242165242165242,0.8874360429909145,1.0,5/24,11.48%,TRAF3IP2;ZC3H12A;MAVS;CGAS;TRIM44
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.2940909525959042,-0.9494125979054617,0.5401785714285714,0.8315277309945523,1.0,4/35,5.43%,PAM;ACSS3;FAR2;GGT5
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.36789665742304833,0.9492430002625124,0.5286783042394015,0.8874974433176507,1.0,6/43,8.34%,LBP;RARA;IRAK3;C5AR2;ZC3H12A;TLR4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4022099807332486,0.9492370358857137,0.5265423242467718,0.8869932030968471,1.0,10/24,24.30%,PKD1;PTK2B;DNAAF4;NUDT15;PSMD14;ATP5IF1;TMF1;PSME3;RHBDF1;UBB
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.37455926120432137,-0.9491019803260803,0.5118343195266272,0.8309531221217334,1.0,9/13,43.18%,MR1;NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL12B;XCL1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.35133922867146944,-0.9484124266938219,0.517799352750809,0.8314096597874399,1.0,10/17,37.91%,ALK;ADRA2A;MFSD2A;AKT1;APOC1;PRKAA1;PDE3B;PLIN5;CIDEA;TNF
prerank,maturation of 5.8S rRNA (GO:0000460),0.4275374632056312,0.9476929370442486,0.5339105339105339,0.8898921253158277,1.0,9/17,23.69%,MPHOSPH6;C1D;URB1;EIF6;PRKDC;WDR12;PES1;RRP15;RPF1
prerank,mitochondrial translation (GO:0032543),0.33010038969377437,0.9475113467814591,0.5625,0.8897611545287442,1.0,47/104,35.75%,MTIF3;MRPL33;MRPL40;MRPL42;NOA1;MRPS27;MRPL11;EARS2;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;RARS2;MTIF2;TSFM;MRPL30;GFM2;GATC;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,peptidyl-lysine methylation (GO:0018022),0.40084879073068647,0.9473664512137632,0.5204216073781291,0.8895513517623219,1.0,9/26,26.83%,SETD2;EHMT1;ETFBKMT;EEF2KMT;KMT5A;SMYD3;SETD6;SMYD2;SETD7
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.33519081621971153,0.9472127467959418,0.5571587125416204,0.8893821378842292,1.0,21/93,17.92%,RASSF2;MAP3K5;PTK2B;VEGFA;SH3RF3;MID1;GADD45G;FZD7;ZC3H12A;XDH;DUSP19;EIF2AK2;TRAF2;ARL6IP5;TIRAP;TRAF6;MAP3K10;TRAF5;SCIMP;MAP3K4;TRAF4
prerank,protein secretion (GO:0009306),0.35660015964406483,0.9471789352776157,0.5649432534678437,0.8889425484059688,1.0,7/56,9.51%,PCSK5;TANGO6;ANXA1;LTBP2;ARFGAP3;COPG1;MIA3
prerank,UV-damage excision repair (GO:0070914),0.4502871582613437,0.9471374274755328,0.5285053929121726,0.8885221567088933,1.0,6/12,30.91%,ACTR5;INO80;DDB1;POLA1;DDB2;XPA
prerank,steroid biosynthetic process (GO:0006694),-0.26036787833059577,-0.9470646247145915,0.5760869565217391,0.8333989673854625,1.0,15/56,25.05%,CYP7B1;CYP27A1;INSIG2;MSMO1;OSBPL1A;PRKAG2;SCP2;OSBPL9;OSBPL3;OSBPL7;SRD5A1;CH25H;TM7SF2;FDFT1;SLC27A2
prerank,actomyosin structure organization (GO:0031032),0.3426380890926181,0.9470322400676248,0.5665137614678899,0.888238255660097,1.0,12/75,10.43%,EPB41L5;CIT;CSRP3;EPB41L2;ITGB5;PHACTR1;ALKBH4;FLII;ITGB1;CUL3;SIX4;RHOA
prerank,negative regulation of response to wounding (GO:1903035),0.4212453221059508,0.9470236723102268,0.527736131934033,0.8877487510252563,1.0,4/19,15.90%,FGF2;CD109;PTPRS;ALOX5
prerank,regulation of protein targeting to membrane (GO:0090313),0.3882979377487961,0.9466834537037534,0.532258064516129,0.8880165952719177,1.0,9/28,16.37%,KCNB1;ERBB2;DMTN;CIB1;MIEF1;C2CD5;CHP1;ITGB1BP1;MIEF2
prerank,negative regulation of response to external stimulus (GO:0032102),0.3288356566131748,0.9464894584660496,0.5802197802197803,0.887975881095666,1.0,11/105,7.12%,CCN3;PRKCD;FGF2;PTGIS;CD109;KLF4;TRAFD1;IRAK3;PTPN2;NLRP12;RORA
prerank,COPII-coated vesicle budding (GO:0090114),0.3477568457497743,0.946326364183146,0.5558139534883721,0.8878181582059091,1.0,26/68,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;MIA3;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;SEC23B;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4113317988754585,0.9459404317609144,0.5270655270655271,0.8882071440723787,1.0,4/21,10.54%,MED13;TWIST1;MED24;DHX36
prerank,protein autophosphorylation (GO:0046777),0.3169229664630513,0.9458206872110239,0.5855194123819517,0.8879441826970584,1.0,18/157,6.92%,STK39;EGFR;GRK5;DDR2;CAMK2D;ULK2;PTK2B;SRMS;CLK2;GSK3B;CDK12;ABL1;EPHB3;FGFR1;CHEK2;STK16;ERBB2;AURKA
prerank,production of siRNA involved in RNA interference (GO:0030422),0.4754114641927627,0.945643897459742,0.5420875420875421,0.887821631964518,1.0,7/10,29.69%,AGO2;MRPL44;DICER1;PRKRA;DROSHA;TSN;TSNAX
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.32060086212826205,0.9455517145688889,0.5797872340425532,0.8875005109910753,1.0,18/138,7.13%,EGFR;GUCY2C;MET;NTRK3;DDR2;PTPRU;ABI1;PTK2B;PTPRF;NGF;SRMS;EPHB3;POLR1G;FGFR1;SHC1;FRK;ERBB2;ROR1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3457054847539086,0.9455447548642474,0.5536130536130536,0.8870026477777248,1.0,7/70,4.52%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42629125564738224,0.9453983963577147,0.5328358208955224,0.8868013397825872,1.0,6/18,24.07%,ANXA1;KLF9;FAM107A;NR3C1;SSTR2;REST
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.42091002868733357,0.945333031945895,0.5271428571428571,0.8864378555642448,1.0,5/19,18.91%,ADA;AMPD3;DGUOK;GMPR2;AMPD2
prerank,protein oxidation (GO:0018158),0.4703495523008968,0.9450797728345391,0.5487256371814093,0.8864869504756804,1.0,4/11,21.56%,LOXL1;LOX;TMX3;LOXL4
prerank,telomere maintenance via telomerase (GO:0007004),0.38545630919382917,0.9447082689739127,0.5318302387267905,0.8868117649540658,1.0,8/28,22.26%,TELO2;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;PPP6C
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.31911077843362473,0.9446664435552607,0.6120331950207469,0.8863921548151494,1.0,22/161,9.09%,TCF7L2;LRP6;MLLT3;PTPRU;WNT11;PRICKLE1;SOX9;SFRP4;GSK3B;PSMB2;GLI3;INVS;TLE2;EMD;NOG;DACT1;DKK3;PSMD11;CSNK1A1;CUL3;SFRP5;PSMC1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3771016800286062,0.944587500509225,0.5527704485488126,0.8860661956146325,1.0,7/33,13.02%,ADAM9;CYP1B1;FOXC2;ADA;CIB1;ITGB1BP1;RET
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.38356456333180966,0.9444158340540819,0.5274869109947644,0.885920481458194,1.0,5/30,7.92%,FSTL1;SFRP4;LTBP4;DKK3;SMAD2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.39032026368565176,0.9443202965068846,0.5357142857142857,0.8856084598566045,1.0,4/29,3.09%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,positive regulation of actin nucleation (GO:0051127),0.46078797988825837,0.9441094313633828,0.5681114551083591,0.8855538736929776,1.0,5/11,25.04%,GSN;CYFIP1;FCHSD2;NCKAP1;WHAMM
prerank,COPII vesicle coating (GO:0048208),0.3507612084436119,0.9437698423486016,0.5566150178784267,0.8847491813506877,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3507612084436119,0.9437698423486016,0.5566150178784267,0.8847491813506877,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,vesicle coating (GO:0006901),0.3507612084436119,0.9437698423486016,0.5566150178784267,0.8847491813506877,1.0,24/61,25.28%,SEC16A;SEC31A;SEC24B;SEC23A;CUL3;ANKRD28;SEC24D;SEC23IP;PPP6R3;NSF;STX5;TRAPPC3;TRAPPC10;GOSR2;RAB1A;TRAPPC9;PPP6R1;TMED2;PPP6C;MCFD2;BET1;RAB1B;TRAPPC2L;USO1
prerank,cardiac muscle cell development (GO:0055013),-0.33698999336174373,-0.9437413557798485,0.5451612903225806,0.8402205148376507,1.0,5/20,8.55%,SORBS2;PDGFRB;SLC8A1;MYH11;HEY2
prerank,positive regulation of neuron death (GO:1901216),0.3600878539119998,0.9435716285380571,0.5403022670025189,0.8846773419334217,1.0,9/46,12.19%,MAP3K5;GSK3B;CCL3;FOXO3;NF1;TLR4;EGR1;EIF2S1;CLU
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.46939009270219134,0.9433412711298699,0.5104,0.8846608859975202,1.0,3/10,14.30%,ESR1;PSMC6;ATF7IP
prerank,receptor-mediated endocytosis (GO:0006898),0.3225542154398583,0.9433392454345894,0.589881593110872,0.884162563018051,1.0,15/132,8.04%,LRP6;RAMP1;NEDD4;ADRB2;CD9;IGF2R;LDLR;PDLIM7;COLEC11;AP2A2;SCARB2;LRP1;FCHO2;ITGB1;GRK4
prerank,regulation of lipid catabolic process (GO:0050994),0.41845056696963584,0.9433156653037212,0.5410557184750733,0.8837033595306397,1.0,4/19,13.75%,ABCD1;LONP2;ANGPTL3;TYSND1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3745974490819796,0.9431773262013023,0.5392535392535392,0.8834908105952027,1.0,15/36,23.71%,RAD51;EHMT1;EED;CBX5;RBBP7;TFDP1;BRCA1;E2F1;CDC7;EPC1;SUZ12;CHEK1;PCGF6;APAF1;RBBP8
prerank,heart looping (GO:0001947),0.36921999996621174,0.9430338465720032,0.5486725663716814,0.8832991943691945,1.0,4/39,8.40%,MICAL2;SMO;TGFBR2;GATA4
prerank,mitotic sister chromatid segregation (GO:0000070),0.32764428996152345,0.9420309863170595,0.5838926174496645,0.8849884488104794,1.0,38/98,31.95%,SMC4;NIPBL;KNSTRN;BECN1;CUL3;KLHL22;CCNB1;POGZ;ZW10;PDCD6IP;KMT5A;SMC1A;CHMP2B;RB1;RAD21L1;REC8;SPDL1;NCAPH2;SMC2;RAB11A;PIBF1;PHF8;KIF23;INO80;AKAP8L;RAD21;CHMP3;KIF22;MIS12;CENPK;PLK1;CENPE;NAA50;TUBG1;NCAPD3;ESPL1;TEX14;SEH1L
prerank,positive regulation of integrin activation (GO:0033625),-0.38609459424263426,-0.9419606907353288,0.53125,0.8433647810821588,1.0,2/11,5.28%,RASIP1;PIEZO1
prerank,regulation of potassium ion transport (GO:0043266),0.3813657403395512,0.941269399468415,0.5410691003911343,0.886124079166892,1.0,3/31,2.10%,FHL1;ANK2;PTK2B
prerank,tricarboxylic acid metabolic process (GO:0072350),0.44985514882697414,0.9410747097570636,0.5555555555555556,0.8860615394171278,1.0,4/12,24.46%,ACO2;IDH3B;IREB2;IDH3A
prerank,translation (GO:0006412),-0.2182980870955363,-0.9410187455383098,0.7575757575757576,0.844378037996871,1.0,62/208,20.46%,EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPS14;RPL18A;RPL38;RPS19;RPS8;RPS11;RPL34;RPL18;RPL7;EEF1G;EEF1B2;RPS25;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RPL11;RPS5;RPS16;MRPL3;RPL4;RPS7;RPS23;RPS15;TARS1;MRPS14;RPL36;MRPS33;RPS18;RPL37A;RPL32;RPS20;RPL29;RPL13;RPL36A;MRPL51;HARS1;RPL23;RPL17;DARS2;RPL9;EEF2;GTPBP1;RARS1;NDUFA7;MRPS11;MRPS5;AARS1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.40661929766088145,0.9406819447905368,0.5403899721448467,0.8863815568088727,1.0,3/22,5.44%,CACNA1C;PALM;NF1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.341618859073942,0.9403526123880239,0.5809859154929577,0.8865991962936968,1.0,15/75,14.03%,THBS1;HOXA5;SEMA3E;ISM1;KLF4;EMILIN1;ATP2B4;SULF1;KRIT1;FOXC1;MECP2;NIBAN2;SYNJ2BP;EFNA3;CD160
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.4448786984563283,0.940281218393827,0.5352112676056338,0.8862495245966346,1.0,3/13,8.64%,TWIST1;CD44;KDM1A
prerank,regulation of hydrolase activity (GO:0051336),0.34177004201254585,0.9400354411546561,0.5591016548463357,0.8862815126964737,1.0,18/71,14.94%,VAV2;SIPA1L1;EFNA5;EPHB3;ARHGAP44;SCARB2;NF1;PAFAH1B1;WRN;RDX;FGD1;OCRL;ITGB1BP1;FGD3;PLXNB1;ADAP1;FGD6;RABGAP1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.38216731773294105,0.9398857643581948,0.5489690721649485,0.8860960499790393,1.0,7/33,16.55%,EZR;UBASH3A;PTPN2;IKBKG;TRAT1;CD160;LCK
prerank,regulation of viral genome replication (GO:0045069),-0.25810175629051185,-0.9398832124492308,0.5754189944134078,0.8457246492050225,1.0,17/56,17.42%,PPARA;IFIT1;HACD3;IFITM1;OAS2;IFITM3;BST2;PROX1;RNASEL;IFITM2;DDX3X;ADAR;SHFL;NR5A2;PARP10;BANF1;PDE12
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3437111217436725,0.9397139872254912,0.563231850117096,0.8859576864087886,1.0,7/71,4.52%,PRKCD;VAV2;CYFIP2;PRKCE;ABI1;PLCG2;ABL1
prerank,cardiac myofibril assembly (GO:0055003),0.43395748476371526,0.9396871291308814,0.5384615384615384,0.8855108712817338,1.0,2/15,5.87%,CSRP3;MEF2A
prerank,glucose metabolic process (GO:0006006),-0.26170181064145076,-0.9395372651656435,0.5921787709497207,0.8452026799335801,1.0,11/58,10.90%,APOD;RBP4;SLC25A13;PGM1;PPARGC1A;PPARD;AKR1A1;GOT2;PGAM1;GAPDH;PCK2
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.402051729021367,-0.9392560984431574,0.5521978021978022,0.8445303015752674,1.0,7/11,24.08%,PAK1;STMN1;RAC1;SIRT2;HGF;MST1R;BCAR1
prerank,protein localization to lysosome (GO:0061462),0.38905443816043966,0.9391280083158613,0.56,0.886193199907759,1.0,5/28,13.58%,NEDD4;SCARB2;SZT2;AP3M1;SORL1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.39185259251119936,0.9390638168060239,0.561624649859944,0.8858175420823516,1.0,5/27,8.64%,DDX5;TWIST1;SPRED2;CD44;KDM1A
prerank,ncRNA transcription (GO:0098781),0.4474884069072625,0.9390357929652814,0.5488,0.8853755566727605,1.0,2/13,7.21%,POLR1G;SNAPC2
prerank,negative regulation of transferase activity (GO:0051348),0.39156440654742203,0.9390123750538129,0.5587431693989071,0.8849334999116548,1.0,11/28,24.68%,GSK3B;ABL1;FBXO5;CDKN1C;CDKN1B;SMAD7;BAG5;ERCC4;NPRL2;TP53;SRC
prerank,fibrinolysis (GO:0042730),-0.37777128001728083,-0.9381155355905328,0.5286103542234333,0.8460955785314859,1.0,9/13,43.11%,PLAT;PLAU;SERPINE1;HRG;PLAUR;PLG;CPB2;GP1BA;F2
prerank,triglyceride catabolic process (GO:0019433),0.4140222937216656,0.9379138911544174,0.5516265912305516,0.8867783195146691,1.0,3/19,12.98%,FABP12;PNPLA3;PNPLA2
prerank,positive regulation of growth (GO:0045927),0.34328289902657483,0.937868115677162,0.5678271308523409,0.8863849528556661,1.0,13/64,12.60%,EGFR;TGFBR1;DDX49;ERBB2;AGR2;DNPH1;CEP43;EIF4G2;CIB1;KLHL22;FXN;RPS6KA3;BRAT1
prerank,purine ribonucleotide transport (GO:0015868),0.4402294855363065,0.9378437380788034,0.5397301349325337,0.8859476285000386,1.0,1/16,1.13%,LRRC8D
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3160180061604595,0.9375852658696016,0.6044776119402985,0.886015430556117,1.0,39/151,22.43%,ST3GAL4;PCSK5;ACER3;PLPP3;SGMS2;LARGE1;CHKB;GSTT1;INHBA;GAL3ST4;GSTA2;SLC44A3;ARG1;TYW5;LPIN2;LPCAT1;NMRAL1;KDSR;MOCOS;SPTSSB;DMD;ELOVL5;PCTP;TNIP1;GOLPH3;LPCAT2;LCAT;NANP;GSTM4;PPM1L;CEPT1;GSTO1;TYW1;CHAT;MOCS1;CERS6;HACD4;ELOVL2;PLPP1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.4229600294161901,0.9373367839360899,0.5416058394160584,0.8860166298708606,1.0,9/16,29.80%,PARP3;KMT5B;PRKDC;KMT5C;KDM4D;PARP9;SMCHD1;SETMAR;DTX3L
prerank,negative regulation of protein kinase activity (GO:0006469),0.333380037591591,0.9371073659021412,0.5844594594594594,0.8860007793713651,1.0,20/88,17.24%,LRP6;UBASH3B;ABL1;NF1;ACP4;CEP43;CORO1C;DUSP19;QARS1;CHP1;CDKN1C;CDKN1B;ITGB1BP1;LRP5;SORL1;SRCIN1;DVL1;CDKN1A;CEP85;RB1
prerank,histone methylation (GO:0016571),0.39515062825977526,0.9370699920613581,0.5655737704918032,0.8855896446289105,1.0,9/26,23.89%,PRMT8;CREBBP;EHMT1;NSD1;PRMT5;SMYD3;PRMT6;SETD6;SMYD2
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.29205200943599874,-0.9370110446490502,0.5458515283842795,0.8475088974373175,1.0,4/34,3.89%,IGF1;TGFA;PDGFRB;INSR
prerank,chondroitin sulfate catabolic process (GO:0030207),0.44040529640984954,0.9369680306236545,0.5238095238095238,0.8853010152210684,1.0,4/13,15.34%,HEXA;BGN;ARSB;IDUA
prerank,embryonic digit morphogenesis (GO:0042733),0.4221104485909117,0.9368228499824016,0.5431400282885431,0.8851034819228729,1.0,5/18,7.03%,GLI3;NOG;TWIST1;ECE1;CREBBP
prerank,sympathetic nervous system development (GO:0048485),0.4361835964576677,0.9361199163756363,0.5736677115987461,0.886088379015899,1.0,2/15,5.44%,NRP1;NF1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.34026117017563173,0.9359950572881386,0.5620608899297423,0.885860591203148,1.0,23/73,25.55%,HDAC4;POLR1G;POLR1A;EED;DNMT3A;MTA1;RBBP7;MECP2;TAF1D;DDX21;SMARCA5;GLMN;POLR1F;DEK;TASOR;EPC1;SUZ12;IGF2;TBP;PPHLN1;TDG;KDM1B;PPM1D
prerank,positive regulation of insulin secretion (GO:0032024),0.3637590129030826,0.9358986723497774,0.5468549422336328,0.8855786871505686,1.0,5/36,11.52%,TCF7L2;CLTRN;TRPM4;AACS;MCU
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3255493338716803,-0.93518214104116,0.5620689655172414,0.8508853778950594,1.0,5/21,8.84%,EPHA7;GRIN2B;GRIN1;AIM2;BIRC2
prerank,positive regulation by host of viral transcription (GO:0043923),-0.35707557286003855,-0.9351027802993764,0.544891640866873,0.8497127738771761,1.0,1/15,0.53%,LEF1
prerank,male gonad development (GO:0008584),-0.29527040671333443,-0.93509997549121,0.5580357142857143,0.8483572764146329,1.0,4/34,5.06%,WNT4;KIT;WNT5A;MAMLD1
prerank,positive regulation of cellular senescence (GO:2000774),-0.4075581659366878,-0.9347964729985334,0.5512465373961218,0.8477049408489908,1.0,3/10,13.94%,B2M;YPEL3;ABI3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3036725244667504,0.9346393533216744,0.6827309236947792,0.8878216980801013,1.0,47/390,7.76%,ARHGEF28;EGFR;MET;PGF;UBASH3B;NTRK3;DDR2;RBFOX2;VAV2;CYFIP2;ABI1;SIPA1L1;PTK2B;EFNA5;FGF2;ADRB2;NGF;IRS1;NRP1;VEGFA;SRMS;SLC39A14;GSK3B;FOXC2;GRB10;AP2A2;PTPN2;EPHB3;SHOC2;POLR1G;NR4A3;PDGFC;FGFR1;SPRED2;STAT3;SHC1;TCIRG1;KIF16B;FRK;NFATC4;ERBB2;TIAM1;NCK2;ROR1;ATP6V0A4;RHOQ;SULF1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.2734872868933881,-0.9344606037386856,0.5891089108910891,0.8471616713116173,1.0,13/44,22.32%,CYP7B1;CYP27A1;INSIG2;MSMO1;OSBPL1A;ALOX12;PRKAG2;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H;TM7SF2
prerank,aggrephagy (GO:0035973),0.3863238771461308,0.9343422468530581,0.5503978779840849,0.8879452105985833,1.0,11/27,29.17%,WDR81;ACBD5;PCNT;ATG5;WDFY3;UBB;UBE2V1;UBA52;RPS27A;UBE2N;SQSTM1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3543227151238693,-0.9341253579148316,0.5292207792207793,0.8466309706167675,1.0,4/16,5.75%,MCTP1;RIMS1;MCTP2;MEF2C
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.3683383354648302,-0.9339877360377814,0.5327635327635327,0.8456398482609992,1.0,4/14,14.29%,IL18;IL17D;PAEP;CD84
prerank,hexose biosynthetic process (GO:0019319),-0.27587183383230784,-0.9338394434494228,0.5485436893203883,0.8446071283768498,1.0,15/42,23.63%,RBP4;SLC25A13;PGM1;PPARGC1A;GOT2;PGAM1;GAPDH;PCK2;MDH1;CRY1;ENO1;GAPDHS;GOT1;G6PC3;ALDOC
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.44286562982576483,0.9331657370852271,0.553680981595092,0.8899231627815855,1.0,4/13,11.45%,MDFIC;BARD1;NUP153;CHP1
prerank,energy reserve metabolic process (GO:0006112),0.4191591115328462,0.9330159041197119,0.5533707865168539,0.8897588541696915,1.0,4/19,8.00%,PID1;GSK3B;PPP1R3C;PHKB
prerank,heme catabolic process (GO:0042167),0.4367114374277067,0.9324265915259559,0.557427258805513,0.8900088074997851,1.0,3/14,15.68%,ABCG2;HMOX2;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.4367114374277067,0.9324265915259559,0.557427258805513,0.8900088074997851,1.0,3/14,15.68%,ABCG2;HMOX2;ABCC1
prerank,positive regulation of cell killing (GO:0031343),-0.36877468680349035,-0.9323963677968901,0.5612535612535613,0.8467806316998715,1.0,3/13,9.24%,WNT5A;NOX1;RAC1
prerank,membrane protein proteolysis (GO:0033619),0.36554759009251797,0.9323823440218023,0.5481481481481482,0.8895981895573198,1.0,7/37,15.75%,ADAM9;BACE2;SPPL2A;CLPP;RET;RBMX;TRAF6
prerank,cell-cell junction organization (GO:0045216),0.3325489840323877,0.9319224994924693,0.5750873108265425,0.8900698795139794,1.0,10/79,5.31%,CDH11;CDH1;CTNND2;PKP1;TGFB3;DSP;NECTIN3;DSG2;LIMS1;CTNNA1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.32340016604640826,0.9318083724778523,0.5891472868217055,0.8898191639573444,1.0,23/98,16.37%,EGFR;PRKCE;KCNB1;LRP1;RANGRF;ATP2B4;PLS1;ERBB2;AGR2;ITGB1;CIB1;MIEF1;C2CD5;EPHB2;CHP1;TFDP1;ITGB1BP1;DLG1;E2F1;PTPN9;PPP3CC;KIF5B;MIEF2
prerank,protein dephosphorylation (GO:0006470),0.31947549335227965,0.9316589478634296,0.6307363927427961,0.8896402560681466,1.0,28/135,16.31%,EYA2;UBASH3B;PPP3CA;PTPN3;PTPRU;PTPRF;EYA4;PPM1H;PTPN2;PTPRA;DUSP11;PPP2R5C;PPTC7;PPP2R2D;SBF1;DUSP5;EYA3;ILKAP;PTPRS;PTPN9;PPP1R12A;PTPN21;UBLCP1;NCK1;PPP3CC;PPP4R2;SSU72;PPP5C
prerank,positive regulation of endocytosis (GO:0045807),-0.27686735378079264,-0.931610103143316,0.5906976744186047,0.8473983023059933,1.0,5/45,2.14%,VTN;SGIP1;APOE;NEDD4L;B2M
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2307097108096491,-0.9314173796941015,0.67,0.846532026665591,1.0,29/109,18.89%,PLCB1;INPP4B;PIP5K1B;PDGFRB;LPGAT1;PIK3R1;INPP5D;PIK3C2A;PLEKHA2;PLAAT3;PIK3R6;PTPN13;BMX;PITPNM2;CDIPT;MTMR3;MTMR10;PIK3CA;PIK3R5;CSF1R;PIP4K2B;MTMR14;PLEK;PLCG1;MTMR6;MTMR7;PIGW;PLEKHA3;INPP5B
prerank,alpha-amino acid catabolic process (GO:1901606),-0.304602146685585,-0.9313904743447289,0.5576923076923077,0.8452682924797078,1.0,6/29,18.01%,DDO;ACADSB;GOT2;ALDH4A1;CBS;SARDH
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.42999385674740603,0.9309191257492567,0.5626865671641791,0.8907038680686947,1.0,3/16,3.28%,ZFPM2;FGF2;BMPR1A
prerank,adenine nucleotide transport (GO:0051503),0.4302054994283094,0.9307113586722876,0.5527488855869243,0.8906653134853956,1.0,1/17,1.13%,LRRC8D
prerank,positive regulation of lipid storage (GO:0010884),0.40285490286119846,0.9304825597207814,0.5536959553695955,0.8906667232393656,1.0,6/21,21.79%,IKBKE;ZC3H12A;PLIN3;EHD1;FITM2;OSBPL11
prerank,lysosome organization (GO:0007040),0.3659964758703676,0.9304669032956273,0.5595984943538268,0.8902090093677613,1.0,15/36,30.45%,HPS4;ACP3;ACP4;ARSB;HOOK3;GNPTAB;LRRK2;TMEM165;MTOR;CLN3;HOOK1;VPS33A;MBTPS1;ACP2;LAMTOR1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3412729637667808,0.9299913804520137,0.5820359281437125,0.8906970588234139,1.0,13/64,17.98%,MGLL;CYP1B1;ACSL3;SLC27A3;ABCD1;PNPLA3;ACOT8;ACOX1;ELOVL5;ALOX5;ACADL;GSTM4;DAGLB
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.39542193707234996,0.9298979293187946,0.5602941176470588,0.8903919588616136,1.0,3/21,1.84%,CACNA1C;CAMK2D;ANK2
prerank,regulation of protein processing (GO:0070613),0.4055050403589229,0.9298784723591359,0.5549132947976878,0.8899362820346503,1.0,6/21,20.00%,TNP2;GAS1;ACP4;SNX12;LRRK2;BAG2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33430429259030914,0.9297002956045562,0.6009334889148191,0.8898371640173428,1.0,9/76,12.31%,PLCE1;ADRA1B;CMKLR1;ESR1;C5AR2;GPR65;GPR4;DRD3;NMUR2
prerank,bile acid metabolic process (GO:0008206),-0.3057709869300759,-0.9293985891589402,0.5625,0.8487237105824101,1.0,8/27,21.99%,CYP7B1;CYP27A1;OSBPL1A;SCP2;OSBPL9;OSBPL3;OSBPL7;CH25H
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.33286818454862505,0.9291403435715794,0.5776255707762558,0.8905215986393576,1.0,28/76,27.83%,RNF144A;PRICKLE1;GSK3B;ZYG11B;CSNK1A1;ARIH1;VCP;ANKIB1;DDA1;DET1;KEAP1;CLU;COP1;DVL1;SMAD7;RNF14;LRRK2;SMURF1;BAG2;DNAJB2;PIAS1;DAB2;ARIH2;CSNK1E;AXIN1;SUMO1;RNF19A;PLK1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3301249387767476,0.9285952936667852,0.5948372615039281,0.8911918322602008,1.0,30/88,21.67%,VPS13A;EXOC4;VPS13C;GBF1;KIF16B;GOLGB1;STXBP6;SCAMP2;CLINT1;ARL3;ACBD3;DOP1B;SORL1;COMMD1;GOPC;VAMP2;SNAP23;GOLGA7;MON2;SH3D19;AP2A1;TXNDC5;AP1M1;EXOC2;SCAMP3;AP4E1;AP1S1;EXOC5;PUM1;ARFGEF2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.3654367089263255,0.9284767166815648,0.5736434108527132,0.8909416021485689,1.0,10/39,20.38%,TANGO6;LTBP2;ARFGAP3;COPG1;MIA3;SEL1L;TMEM167A;GOLPH3;TVP23B;TVP23A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.33699754819564653,0.9282922540510418,0.5874125874125874,0.8908354333469426,1.0,20/73,21.13%,PSMB2;ABL1;KITLG;PSMD11;FOXC1;PSMC1;DHX36;EIF2AK2;PSMC6;PDCD2;PSMD1;PRKDC;PSMD4;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12;PSME3
prerank,ribosomal subunit export from nucleus (GO:0000054),0.4439080202804109,0.9280553065353241,0.5644171779141104,0.8908456877460955,1.0,5/13,14.77%,LTV1;XPO1;EIF6;NUP88;NMD3
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4290033783472531,0.9277989741604044,0.5471976401179941,0.8908620781817159,1.0,1/15,1.31%,ADAM9
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3624790849408625,0.9276266923779735,0.5716129032258065,0.8907321120252787,1.0,9/41,18.40%,MGLL;CYP1B1;ABCD1;ACOT8;ACOX1;ELOVL5;ALOX5;DAGLB;SCD
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3734850066939617,0.9273786533057609,0.5595238095238095,0.8907825994458313,1.0,3/31,3.04%,CACNA1G;CLTRN;KCNB1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.36444046454383766,-0.9265244121524985,0.5459770114942529,0.8544884889059234,1.0,4/14,6.42%,RAPGEF2;PRKAR2B;PRKAR1B;PRKAR1A
prerank,positive regulation of peptidase activity (GO:0010952),0.3995614308333437,0.926453510402665,0.5560283687943263,0.8921977204248981,1.0,3/20,9.12%,TANK;MAPK12;VCP
prerank,chromatin assembly (GO:0031497),0.3622649434103514,0.9264224339776036,0.5576441102756893,0.8917795009094797,1.0,12/38,24.63%,CHAF1B;SOX9;CHAF1A;EZH1;ATRX;KAT6B;SMARCA5;NAA60;NAP1L1;TP53;ASF1A;RSF1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4007336548506204,0.9263227854079095,0.5552282768777614,0.8914988413730717,1.0,7/20,17.24%,TWIST1;FOXC1;POU4F1;NIBAN2;TRAF6;PAX6;RB1
prerank,negative regulation of immune system process (GO:0002683),0.4238145127621019,0.9262722005923318,0.5533428165007113,0.8911187875137597,1.0,2/16,2.75%,COL3A1;SOX9
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3943508821756903,0.9262491342617496,0.5546334716459198,0.8906717920663856,1.0,8/23,16.08%,GPC3;GLI3;GLIS2;VCP;ULK3;KIF7;MEGF8;HHIP
prerank,inorganic ion transmembrane transport (GO:0098660),-0.3794888409728514,-0.9260910726968192,0.5545454545454546,0.8541506427865071,1.0,5/12,22.15%,ABCC9;KCNJ8;PKD2L1;ABCC8;CACNA1H
prerank,cristae formation (GO:0042407),-0.3158638248488104,-0.9260878083786679,0.5505226480836237,0.8528143180222229,1.0,14/27,30.29%,CHCHD6;ATP5PF;ATP5F1E;APOOL;ATP5F1A;DNAJC11;ATP5F1B;LETM1;UQCC3;ATP5MC1;ATP5MC2;ATP5MC3;AFG3L2;ATP5F1D
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.42892765316268133,0.9235889771329482,0.5658307210031348,0.8957908661328177,1.0,6/14,22.06%,YBX3;ANGEL2;MYD88;TIRAP;MAPKAPK2;TARDBP
prerank,negative regulation of DNA binding (GO:0043392),0.3792308548785982,0.9235005599388614,0.5803452855245684,0.8954880416332368,1.0,5/28,13.24%,MDFI;SMO;KDM1A;CPNE1;E2F1
prerank,ncRNA export from nucleus (GO:0097064),0.3662791334800205,0.923309865800333,0.5705128205128205,0.8953995250789905,1.0,9/36,17.81%,NUP93;NUP214;NUP153;NOL6;NUP155;RANBP2;NUP88;SSB;NUP35
prerank,positive regulation of cell projection organization (GO:0031346),0.31974434668221147,0.923200614096326,0.6082698585418934,0.8951422420043619,1.0,28/115,15.70%,SLIT2;DPYSL3;NTRK3;CUX1;PTK2B;NGF;FZD1;KIDINS220;SCARB2;TIAM1;ROR1;STYXL1;TIAM2;ARSB;P3H1;FBXW8;RHOA;RAP1A;MARK2;RET;NPTN;MAP6;PLXNB1;SCN1B;ALKAL2;DVL1;CAPRIN2;PTN
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.44378373022047335,0.9231988184566702,0.5555555555555556,0.8946509607756247,1.0,4/12,22.75%,TK1;UPP2;DHODH;UMPS
prerank,acute-phase response (GO:0006953),0.44625592170196093,0.9227558894337282,0.5431309904153354,0.8951073704295452,1.0,1/12,1.41%,LBP
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.35658884045078876,0.9225764607450841,0.5748129675810474,0.8950031749356921,1.0,15/46,17.24%,ZNF423;NPR3;ID1;FOXC2;DOCK7;IP6K1;TLR4;ABHD6;ACOT11;NR1D1;ACOT13;ADAMTS5;RHEB;PCTP;RB1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.383367873903854,-0.9222002605343631,0.5491329479768786,0.8610146473047101,1.0,2/12,1.39%,DOCK10;DOCK11
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3295941757911902,-0.9221508014015457,0.5694444444444444,0.859799352504844,1.0,4/19,6.97%,TJP1;NEXMIF;NOTCH1;NOTCH4
prerank,mitotic spindle organization (GO:0007052),0.3120814424122372,0.9218957687113691,0.639412997903564,0.8959333323944512,1.0,45/153,25.34%,NDEL1;CLIP1;CHEK2;SPICE1;AURKA;STAG1;MISP;PAFAH1B1;TOGARAM1;XPO1;VCP;PTPA;CDC20;TTK;CCNB1;AHCTF1;RHOA;MECP2;CENPT;MAD2L1;PCNT;KIF3B;ZW10;RANBP2;CENPL;OFD1;ABRAXAS2;SMC1A;ZWILCH;SPDL1;STAG2;MAD1L1;NEK6;RAB11A;CCDC61;PPP1CC;PIBF1;BUB3;TAOK1;KIF23;ABRAXAS1;TBCE;CENPP;NUP98;GPSM2
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.255543846064426,-0.9218126409765848,0.6242774566473989,0.8592672680199978,1.0,20/57,24.61%,DCN;KDR;SPIRE1;HIP1R;PPARGC1A;PDCD5;PINK1;BCL2L11;TNFSF10;BOK;FIS1;GSK3A;PYCARD;BIK;MFF;GPER1;TREM2;FBXO7;RALBP1;CAMKK2
prerank,negative regulation of neurogenesis (GO:0050768),-0.28558626030969025,-0.9217247887106301,0.5634920634920635,0.8581826538636758,1.0,8/34,10.07%,B2M;RAPGEF2;RTN4;NOTCH1;MAG;YWHAH;RUFY3;ARHGDIA
prerank,lipid biosynthetic process (GO:0008610),0.32655475644951415,0.9215609129134916,0.5881683731513083,0.8961185144289111,1.0,18/77,19.13%,ABCD3;ACSM2A;ACSM2B;AGPS;PDSS2;MBOAT1;ACACA;GGPS1;LPCAT1;PIP5K1A;GNPAT;SREBF1;ALOX5;SCD;HMGCR;NDUFAB1;FITM2;STAR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.38024307761187953,0.9214144466273904,0.5898123324396782,0.8959176015926887,1.0,12/29,26.46%,CNOT8;EXOSC3;DCP1A;EXOSC1;DIS3;EXOSC2;LSM4;EXOSC7;EXOSC8;DDX6;LSM1;PATL1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.32218017076238686,0.921153439076823,0.6155555555555555,0.8959830671621458,1.0,18/101,11.58%,EGFR;PKD1;TCIM;FGF2;ADRB2;VEGFA;TELO2;PDGFC;FGFR1;ATP2B4;ERBB2;TENM1;CCND1;SYAP1;CIB1;RHOA;CCNYL1;CAB39
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35115215871146055,0.9208090822891857,0.5869017632241813,0.8961878273708989,1.0,10/44,10.43%,WNT11;SORBS3;NRP1;TGFB3;TGFBR1;ABL1;MYOC;GPR65;S100A10;RHOA
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.33489152357614427,0.9207092178075651,0.6058139534883721,0.8959192195259836,1.0,29/72,33.09%,ERCC5;MNAT1;UVSSA;COPS7B;COPS5;CDK7;GTF2H3;COPS8;POLR2C;COPS3;RFC1;COPS2;ERCC4;USP7;UBB;HMGN1;ERCC8;UBA52;POLK;GTF2H4;RPS27A;DDB1;ERCC2;POLD1;XPA;GTF2H5;COPS7A;GTF2H1;RFC2
prerank,myeloid cell differentiation (GO:0030099),-0.27241177418145085,-0.9206184026173424,0.6059113300492611,0.8595067263499511,1.0,6/47,6.08%,LYN;MFHAS1;KIT;SNRK;RPS14;RPS19
prerank,positive regulation of reproductive process (GO:2000243),0.374710171150458,0.9203152411216169,0.5659121171770972,0.8962331730952583,1.0,4/31,6.79%,LHFPL2;VEGFA;AGO2;INHBA
prerank,neural crest cell migration (GO:0001755),0.3678408094546994,0.9201950826153327,0.6088050314465409,0.8959963056847863,1.0,7/36,8.58%,SEMA3E;PITX2;NRP1;SEMA3C;SEMA3D;FN1;CORO1C
prerank,female gonad development (GO:0008585),-0.33568371369263716,-0.9200193409850964,0.5377049180327869,0.859590424354213,1.0,8/19,22.27%,NR2F2;KIT;CEBPB;NUP107;SOD1;FOXL2;COL9A3;LHCGR
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.34405027602805954,-0.9197927006868352,0.6086956521739131,0.8588208289626672,1.0,7/17,23.44%,PPARA;PRKAA2;PPARD;PRKAG2;PDK4;FABP3;CAV1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.383788209706058,-0.9197406966338024,0.5361111111111111,0.8576097069720311,1.0,7/11,43.92%,PRKCQ;NFKBID;IL12RB1;CARD9;IL23A;IL12B;CLEC6A
prerank,fluid transport (GO:0042044),0.45096088701253906,0.9193944267712656,0.5756172839506173,0.8971679740955262,1.0,1/12,2.44%,SLC26A6
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.42207230048899363,0.9193397603473499,0.5744047619047619,0.8967940752000649,1.0,5/15,24.07%,ANXA1;FAM107A;NR3C1;SSTR2;REST
prerank,sulfur compound catabolic process (GO:0044273),-0.27868650711428755,-0.9190183543891828,0.5816326530612245,0.8581421835385014,1.0,16/38,23.81%,FMOD;OGN;DCN;GGT5;OMD;LUM;CHAC2;CSPG5;HEXB;NCAN;GALNS;GGT1;CTH;MPST;ACAN;BCAN
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.43299545866295513,0.9186428204063399,0.5585023400936038,0.8977341668053226,1.0,7/13,28.28%,SMUG1;UPP2;TDG;NEIL1;DUT;DCTPP1;NT5C
prerank,peptidyl-tyrosine modification (GO:0018212),0.3441074442082834,0.9182703884544743,0.5949519230769231,0.898031950656276,1.0,8/56,6.57%,EGFR;DDR2;ABI1;PTK2B;SRMS;ABL1;FGFR1;ERBB2
prerank,regulation of wound healing (GO:0061041),0.35557992355551704,0.9181273929350867,0.570694087403599,0.8978338431174105,1.0,11/42,16.83%,PRKCE;FGF2;CD109;ANXA1;SRSF6;ITGB1;DMTN;EPHB2;ALOX5;ARFGEF1;TNFRSF12A
prerank,melanosome organization (GO:0032438),0.38277846698785417,0.9180973761677428,0.5863013698630137,0.8973971082038259,1.0,8/26,21.96%,KIF13A;HPS4;AP3B1;LYST;AP3D1;BLOC1S5;AP1M1;PMEL
prerank,regulation of proteolysis (GO:0030162),0.35137817252722175,0.9180400727687917,0.5739130434782609,0.897037302992218,1.0,16/48,27.88%,PERP;CYFIP2;LTBP4;DNAJC1;SPOPL;SPOP;HDAC2;ASPH;TRAF3;AURKAIP1;OGT;FBXW11;TBC1D10A;CLN3;PLK1;BAD
prerank,regulation of insulin secretion (GO:0050796),0.32209455586255853,0.9178260807843086,0.6299212598425197,0.8970132252502491,1.0,7/101,3.09%,CCN3;TCF7L2;CACNA1C;EFNA5;KCNB1;KCNS3;IRS1
prerank,Fc receptor signaling pathway (GO:0038093),0.32257690948002643,0.9177995927080269,0.6216814159292036,0.8965880882327837,1.0,30/110,21.13%,PPP3CA;VAV2;GAB2;PSMB2;PLCG2;SHC1;TAB3;IKBKG;NFATC3;PSMD11;PSMC1;CUL1;MAP3K7;TAB2;PSMC6;MAP2K4;MAP3K1;NFATC1;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;LAT;PSMD14;PSMD12;PSMD7;CHUK;FER;PSME3
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3179846175339992,0.91777215554025,0.6295884315906563,0.8961590202524985,1.0,21/107,16.55%,SLC24A3;CSRP3;ATP2C2;ANK2;ATP1B1;CASR;SLC39A14;CCL3;CCL1;ATP2B4;SLC10A7;SLC39A13;CCL7;DRD3;SLC8B1;CTRC;NPTN;CHERP;SLC30A9;RMDN3;LCK
prerank,mononuclear cell differentiation (GO:1903131),0.3916879548924924,0.9177698012870708,0.5761024182076814,0.895678279047979,1.0,2/24,3.17%,BMP4;VEGFA
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.31373866185529065,0.9177220033626287,0.6296296296296297,0.8952940538480293,1.0,33/129,19.59%,EGFR;WNK1;GPC3;PLEKHA4;SFRP4;PSMB2;UBR5;DACT1;PSMD11;TRPM4;PSMC1;VCP;USP34;TBL1X;PSMC6;CSNK1G3;JUP;RNF146;NRARP;CSNK1G1;PSMD1;UBE2B;CAPRIN2;PSMD4;USP47;PIN1;PSMA6;PRDM15;LRRK2;PSMD14;PSMD12;PSMD7;LGR6
prerank,regulation of ion transport (GO:0043269),0.33012862056309983,0.9176928032714561,0.6077537058152793,0.8948674829104634,1.0,6/76,5.87%,KCNJ2;NEDD4;KCNJ15;WNK1;WWP2;PER1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33238372068290123,0.9176589310853482,0.6151202749140894,0.8944435664006016,1.0,5/75,3.32%,PLCE1;MGLL;GRK5;PDE6A;SLC39A14
prerank,mitochondrial translational termination (GO:0070126),0.3247802739961732,0.9173342280894313,0.6146892655367232,0.8946384010406596,1.0,40/88,35.75%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;MRRF;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MTRF1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,cellular response to lipid (GO:0071396),0.30616243688935396,0.9171546506154356,0.6515463917525773,0.8945100888584016,1.0,35/191,16.93%,EGFR;WNT9A;PID1;ADAM9;LBP;WNT11;PTK2B;SOX9;IRS1;ESR1;CXCL2;FZD7;LCOR;RORA;ZC3H12A;TLR4;CD80;PDCD4;ATP1A3;ATP1A1;POU4F1;RHOA;PDK3;TRIM41;MYD88;NR1D1;RET;CARD16;NR3C1;URI1;ADAM15;TRAF6;PDCD1LG2;ADCY8;ADCY3
prerank,lipid droplet organization (GO:0034389),0.3942005287643001,0.9162946821994703,0.5842857142857143,0.8957796343888084,1.0,6/22,19.00%,ZFYVE1;SMIM22;PNPLA3;SQLE;CDS1;FITM2
prerank,negative regulation of interferon-gamma production (GO:0032689),0.3911081620719841,0.915910369502517,0.576662143826323,0.8960751264362431,1.0,4/23,8.34%,RARA;INHBA;ZC3H12A;TLR4
prerank,regulation of embryonic development (GO:0045995),-0.2938133518514253,-0.9156626552561256,0.6025641025641025,0.8648715845041061,1.0,8/34,10.11%,PLCB1;CLASP2;INSR;DAG1;SOX17;CFL1;WDPCP;RPS6KA6
prerank,regulation of amyloid fibril formation (GO:1905906),-0.3537816248021914,-0.9147324448707029,0.5710059171597633,0.8658031123518739,1.0,3/15,7.83%,APOE;APP;PFDN5
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.40472058187926785,0.9145274844425264,0.5505780346820809,0.8984730793602006,1.0,6/20,20.86%,DCUN1D5;TGFBR1;EGR1;DCUN1D2;DCUN1D1;DNAJB2
prerank,neuromuscular synaptic transmission (GO:0007274),0.41242179135455764,0.9142124943678371,0.5625899280575539,0.8986439088604892,1.0,6/18,21.08%,ERC1;ERC2;KIF1B;FCHSD2;CHRNB1;CHAT
prerank,second-messenger-mediated signaling (GO:0019932),-0.23495646189347816,-0.9140415406516532,0.6830985915492958,0.8661126262842596,1.0,13/82,10.17%,APOE;MCTP1;CCR9;NOS3;RYR2;GUCY1B1;MCTP2;DGKD;NDNF;GUCY1A1;CHRM3;SPHK1;EDN1
prerank,determination of heart left/right asymmetry (GO:0061371),0.3533023512176317,0.913867127955993,0.5924528301886792,0.8988773288506933,1.0,4/42,8.40%,MICAL2;SMO;TGFBR2;GATA4
prerank,positive regulation of cell growth (GO:0030307),0.3192148669643793,0.9137878225795895,0.6189944134078212,0.8985430983165974,1.0,16/96,13.51%,EGFR;NTN1;NGF;TGFBR1;DDX49;ERBB2;DNPH1;CEP43;EIF4G2;SHTN1;CIB1;KLHL22;FXN;RPS6KA3;BRAT1;DBN1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.39423704636929185,-0.91377506362867,0.5606060606060606,0.8654326799816306,1.0,2/10,3.29%,ZEB2;RAPGEF2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4037495321391905,0.9132587550901932,0.5617021276595745,0.8991176666827234,1.0,4/18,19.71%,COX16;SCO2;COA8;FASTKD3
prerank,post-translational protein modification (GO:0043687),0.2974105603904241,0.9128240028776741,0.7080366225839267,0.8994888801091442,1.0,68/332,19.18%,FBXL7;BMP4;FSTL1;PTP4A2;CCN1;IGFBP5;GPC3;CCDC8;FBXO10;MSLN;DCAF6;PSMB2;TIMP1;DCAF4;ZBTB16;SPSB2;DCAF5;FBXL20;FN1;DSCC1;PSMD11;FEM1B;CKAP4;HIF3A;CUL3;PSMC1;MIA3;CUL1;KLHL22;RBBP7;RCN1;FBXW8;FBXO27;DNAJC3;CALU;PSMC6;DDA1;KEAP1;KTN1;FBXO31;ESCO1;ATG5;COPS7B;UBE2M;PNPLA2;MXRA8;COP1;DCAF7;COPS5;COMMD1;RAB11B;PSMD1;PSMD4;RAB1A;FBXO17;SHISA5;DCUN1D1;TULP4;SOCS3;PSMA6;DTL;COPS8;NUCB1;PSMD14;PSMD12;COPS3;PSMD7;UBA3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.4400341387484505,0.9127961552057009,0.5659509202453987,0.8990726117740806,1.0,6/13,23.59%,RENBP;SLC35A3;GFPT1;GNPDA1;UAP1;PGM3
prerank,receptor signaling pathway via STAT (GO:0097696),0.3825993901533692,0.9125701157235584,0.5674931129476584,0.8990433157373651,1.0,3/25,5.26%,PKD1;CLCF1;STAT3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.2945892475410111,-0.9121922416211388,0.6150793650793651,0.8678529556206949,1.0,5/30,6.27%,IGF1;LYN;RASGRF1;TGM2;NOTCH1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3950771426049528,0.9121646431616847,0.556497175141243,0.8993971022030297,1.0,7/20,25.76%,MCU;SLC8B1;YME1L1;MICU2;MCUB;PMPCB;MICU3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.37426193466210345,0.9119186145642795,0.5750670241286864,0.8993959413644822,1.0,4/30,7.83%,FHIT;GIPC1;WAC;TRIM39
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3431996472608441,-0.911465460842244,0.5751633986928104,0.868309742137148,1.0,6/17,22.54%,BCL2;BCL2L1;BOK;FIS1;SFN;MFF
prerank,stress granule assembly (GO:0034063),0.40142572770279944,0.9114547263826208,0.5895953757225434,0.8998339468140601,1.0,5/20,15.49%,ATXN2;EIF2S1;UBAP2L;BICD1;CIRBP
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.38962608542007626,-0.9110384708386899,0.5771428571428572,0.8680278979153967,1.0,5/10,15.43%,LPGAT1;NR1H3;NR1H2;ABCD2;MID1IP1
prerank,regulation of kinase activity (GO:0043549),0.3229771597182753,0.9105295650363106,0.628668171557562,0.9012161562993671,1.0,10/89,7.13%,EGFR;PLCE1;MET;NTRK3;DDR2;LMO4;EPHB3;FGFR1;ERBB2;ROR1
prerank,lamellipodium assembly (GO:0030032),0.37831076986389367,0.9102356250073329,0.5683060109289617,0.9013329230682112,1.0,7/26,8.22%,ABLIM3;SRGAP2;ARFIP2;VCL;ITGB1;DMTN;ABLIM2
prerank,negative regulation of cholesterol transport (GO:0032375),-0.39373025771161374,-0.9100617127340271,0.5604395604395604,0.8689920599958716,1.0,3/10,26.73%,ABCA2;APOC1;SHH
prerank,insulin receptor signaling pathway (GO:0008286),0.33138291729408237,0.909792436371418,0.6131301289566237,0.9017724384190593,1.0,22/69,21.33%,IRS1;SLC39A14;GSK3B;FOXC2;GRB10;PTPN2;SHC1;TCIRG1;ATP6V0A4;RHOQ;PIK3R3;C2CD5;IDE;BCAR3;ATP6V1A;IRS4;AP3S1;ZNF106;ATP6V0D1;FER;SORBS1;IGF2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.3744225995086908,-0.9095298276203273,0.561046511627907,0.8689426797323673,1.0,7/12,20.09%,LMO2;CTSH;CTSB;MED1;CTSS;THRB;CTSL
prerank,oligosaccharide metabolic process (GO:0009311),0.35347551089542556,0.9094213768034967,0.5867665418227216,0.9020281662453319,1.0,6/46,9.10%,ST3GAL4;FUT8;ST8SIA2;B4GALT1;GAL3ST4;MAN1B1
prerank,regulation of endocytic recycling (GO:2001135),0.44437706321370796,0.909391239031252,0.6028708133971292,0.9016049566275637,1.0,4/11,14.80%,EHD2;EHD1;SORL1;RAB11B
prerank,negative regulation of RNA splicing (GO:0033119),0.40035307979683366,0.9093434835222389,0.5801186943620178,0.9012320439234166,1.0,5/19,17.54%,U2AF2;SRSF6;RBMX;RNPS1;PCBP4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.3875018423007671,0.9092469351042778,0.5826446280991735,0.900941836199039,1.0,6/24,9.11%,NRP1;VEGFA;LIMS1;ABL1;MYOC;S100A10
prerank,ganglioside metabolic process (GO:0001573),-0.32481533761103487,-0.9088627961232684,0.5986622073578596,0.8692204320886744,1.0,3/20,7.51%,ST6GALNAC3;ST8SIA4;ST8SIA6
prerank,positive regulation of cytokine production (GO:0001819),0.2977460903815396,0.9082497313010395,0.7191919191919192,0.9024654741767985,1.0,52/292,17.40%,F3;FOXP1;LBP;CYP1B1;CD2;RAB7B;RARA;CCL1;PLCG2;TLR1;IL33;TWIST1;STAT3;ANXA1;IL17RA;CREBBP;RORA;IRF1;SULF1;TLR4;EGR1;GATA4;CD80;MAVS;ARNT;IFIH1;RIPK2;MAP3K7;DHX36;EIF2AK2;CGAS;ZFPM1;TLR8;POLR3F;CD46;POLR3A;MYD88;TRAF2;BRCA1;TIRAP;SORL1;POLR3K;POLR3E;PRKDC;TRAF6;RAB1A;FLOT1;SCRIB;POLR3D;GLMN;ZBTB7B;SCIMP
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.27344718008780017,-0.9081673718588454,0.6748768472906403,0.8696007502701935,1.0,6/40,5.12%,VTN;SGIP1;B2M;CD63;INSR;DGKD
prerank,glycerophospholipid catabolic process (GO:0046475),-0.30200530334519715,-0.907640059253566,0.5845070422535211,0.8695786962186258,1.0,3/27,6.73%,ENPP2;GPCPD1;ENPP6
prerank,negative regulation of receptor binding (GO:1900121),0.44794497255428667,0.9071879886049851,0.5851735015772871,0.9041681422556367,1.0,2/10,4.74%,PTPRF;NOG
prerank,regulation of GTPase activity (GO:0043087),0.30313224167855235,0.9070966082004196,0.6935817805383023,0.903864935922044,1.0,38/177,15.18%,WNK1;VAV2;ARAP1;WNT11;SIPA1L1;EFNA5;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;EPHB3;ARHGAP44;NDEL1;NF1;ERBB2;ITGB1;RDX;S100A10;RGP1;RGS6;CCL7;RAP1A;FGD1;SNX18;BCAR3;OCRL;ITGB1BP1;FGD3;RRP1B;PLXNB1;EVI5;ADAP1;FGD6;RABGAP1;AFDN
prerank,mitochondrial translational elongation (GO:0070125),0.32201657129065214,0.9067967137378644,0.6228571428571429,0.9039845871672431,1.0,39/88,35.75%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;MRPL23;MRPL44;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;TSFM;MRPL30;GFM2;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,response to cAMP (GO:0051591),0.36080687179462,0.9067114629950681,0.6198453608247423,0.9036612817160902,1.0,6/37,11.12%,IGFBP5;EZR;SLC26A6;DMTN;AKAP9;RAP1A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.367436644275959,0.9066949898080032,0.5779816513761468,0.9032109414706085,1.0,8/29,22.26%,TELO2;ANKRD28;PPP6R3;RAD50;TNKS1BP1;CDK2;RFC1;PPP6C
prerank,protein targeting to membrane (GO:0006612),0.3223460101683137,0.9064515911976955,0.6131221719457014,0.9032093720845005,1.0,28/83,26.99%,ABCD3;PXMP2;SEC61A1;ZDHHC2;ABCD1;ZDHHC20;ACBD5;PEX13;ZDHHC12;ATG3;VPS37A;PARD3;ZDHHC15;VPS37B;SRP19;ZDHHC24;GOLGA7;PEX26;ZDHHC3;ATAD1;ZDHHC19;PEX3;RABGEF1;SRPRA;ZDHHC21;PEX11B;ALDH3A2;ZDHHC6
prerank,response to nutrient levels (GO:0031667),0.41061348786333524,0.9063002825294482,0.5970149253731343,0.9030244863695683,1.0,5/17,24.23%,KCNB1;FAM107A;RPS6KB1;EIF4G1;MTOR
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.4293062147130968,0.9061698460308042,0.6014705882352941,0.902792376158409,1.0,3/14,9.01%,RARA;ANXA1;CD80
prerank,regulation of inflammatory response (GO:0050727),0.2994341149367719,0.9059931558297971,0.6890495867768595,0.9026596150249454,1.0,36/190,19.19%,FOXP1;CCN3;MGLL;PRKCD;PIK3AP1;PTGIS;KLF4;CCL3;CCL1;PTPN2;IL33;ANXA1;IL17RA;NLRP12;RORA;TLR4;GPR4;PDCD4;IFI35;MYD88;CELF1;NR1D1;ABCC1;TNIP1;ALOX5;FFAR4;VAMP2;RB1;AREL1;PSMA6;DAGLB;CCN4;DHX9;PPARG;JAK2;BRD4
prerank,regulation of organelle organization (GO:0033043),0.3188608930776047,0.9052274484974488,0.6230859835100118,0.9037075066505345,1.0,20/80,17.53%,CLIC4;EZR;CAPN2;SCARB2;CLEC16A;DIAPH1;ARMH3;AKAP9;RDX;MAVS;STX5;MARK2;PLXNB1;TMEM33;GOLPH3;MIEF2;CAMSAP3;SYDE1;CPLANE2;SURF4
prerank,mesenchyme morphogenesis (GO:0072132),0.4059560380941613,0.9050686893699901,0.5809248554913294,0.9035249015698437,1.0,6/17,13.65%,SOX9;BMPR1A;NOG;SMAD2;MDM4;ACVR1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.35062661346242086,0.9049480606522023,0.6045340050377834,0.9032768870769159,1.0,10/41,19.88%,SCARB2;NUP93;NUP214;NUP153;EIF6;NUP155;RANBP2;NUP88;NUP35;ZBTB7A
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.3633991744063485,-0.9048983786101276,0.552,0.8749634365136439,1.0,3/12,10.31%,IL18;IL17D;PAEP
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3729193386857501,-0.9048836056271082,0.559228650137741,0.8736789108533973,1.0,4/11,15.17%,SLC30A10;PPARA;ABCB7;ABCD2
prerank,cytoplasmic translational initiation (GO:0002183),0.4030353312208613,0.9047686437472462,0.6056129985228951,0.9031371638474298,1.0,8/17,30.49%,EIF3A;EIF4B;EIF2S2;EIF2D;EIF4G1;RBM4;DHX29;EIF4A2
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.32677458067900245,-0.9047382007175394,0.56957928802589,0.8727389325030256,1.0,3/20,9.33%,APOE;KPNB1;ARV1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.3608821502310614,-0.9040507575061918,0.5644699140401146,0.8730524173555068,1.0,7/13,24.02%,PPP1R15B;WFS1;DNAJB9;RACK1;DDRGK1;UFL1;HSPA5
prerank,muscle tissue morphogenesis (GO:0060415),0.412601387971129,0.9039774289039715,0.5960665658093798,0.9042217862018798,1.0,1/16,0.35%,BMP4
prerank,cardiac ventricle morphogenesis (GO:0003208),0.34815455374602394,0.9035788523513697,0.603112840466926,0.9045514782419887,1.0,4/41,8.40%,BMP4;BMPR1A;TGFBR2;GATA4
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.24476822271854576,-0.9032907942023594,0.6751592356687898,0.8735391648904709,1.0,21/63,21.92%,BCL2;VCAM1;TFRC;MEF2C;VAV3;CD38;IL18;NFATC2;CD81;MIF;CD40;CD74;CCL19;CD86;SLC7A1;JAK3;FGF10;CD276;GPR183;IL7;CD274
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3756597789394638,0.9030663692915595,0.588477366255144,0.9051104821550467,1.0,5/27,8.34%,IRAK3;C5AR2;NLRP12;ZC3H12A;TLR4
prerank,polyol metabolic process (GO:0019751),0.34673543912165494,0.9030527633384542,0.6093552465233881,0.904648833385114,1.0,10/46,13.19%,PLCE1;PLCZ1;PLCB3;PLCG2;IP6K1;IP6K2;PPIP5K1;INPP4A;OCRL;INPPL1
prerank,response to insulin (GO:0032868),-0.24417453763962924,-0.9029952451210279,0.7401574803149606,0.8729193777637745,1.0,13/80,9.23%,TBC1D4;PIK3R1;SORT1;CPEB2;FOXO1;ENPP1;INSR;INSIG2;SLC25A33;MYO5A;LPIN3;RAB31;DENND4C
prerank,regulation of small molecule metabolic process (GO:0062012),-0.28588338522977236,-0.9027182486593631,0.6210526315789474,0.8723043737241136,1.0,3/28,3.27%,APOE;PPARA;PDK1
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3186624174028815,-0.9025447733681766,0.572463768115942,0.87140412030534,1.0,8/20,15.97%,APOE;SHANK3;CPEB3;CUX2;LRP8;CAMK2B;DBNL;RELN
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.32235265526962936,-0.9023006725016155,0.6112956810631229,0.8706709989692549,1.0,8/20,26.04%,HSP90AB1;HOPX;LONP1;HSPA1A;PTGES3L;HSPD1;BBS10;TMEM35A
prerank,regulation of AMPA receptor activity (GO:2000311),-0.306103725874338,-0.9020674997207829,0.6060606060606061,0.8699502434533198,1.0,9/25,17.57%,SHANK3;MEF2C;CACNG7;CACNG4;CACNG3;CACNG2;RELN;GSG1L;CACNG8
prerank,positive regulation of phospholipase activity (GO:0010518),0.38987476526814113,0.902014069163101,0.5860597439544808,0.9062674485010266,1.0,4/22,5.15%,NTRK3;FGF2;ESR1;FGFR1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.4405020874050596,0.9019096859816368,0.6,0.9060017566867978,1.0,6/11,27.06%,STAT3;DHX9;PUM2;PUM1;FMR1;LIMD1
prerank,retinal metabolic process (GO:0042574),0.42967896714529663,0.9010861065794511,0.5778120184899846,0.90723241088081,1.0,2/12,12.07%,CYP1B1;DHRS13
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3640986353890237,0.9007513805742783,0.6037483266398929,0.9074288784673017,1.0,16/33,33.91%,LSM11;SCAF8;SSU72;CPSF3;CSTF3;CLP1;MAZ;FIP1L1;TTF2;CSTF1;WDR33;SNRPB;CSTF2T;NUDT21;MED18;SNRPF
prerank,protein tetramerization (GO:0051262),0.33103810877809264,0.9007467584603782,0.6157517899761337,0.9069618754308302,1.0,7/67,10.61%,KCNJ2;PKD1;TRPM4;CUTC;ACACA;TDO2;TK1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.43456348004275897,0.9003257860490692,0.5865834633385335,0.9073191947193601,1.0,2/12,8.34%,SOX9;TLR4
prerank,JNK cascade (GO:0007254),0.35553886580233013,0.9003093343751312,0.6209068010075567,0.9068719792530237,1.0,9/40,16.38%,MAP3K5;TAB3;IKBKG;RIPK2;MAP3K7;TAB2;MAP2K4;TRAF6;MAP3K10
prerank,negative regulation of developmental growth (GO:0048640),-0.28835206285054044,-0.9002811431303873,0.6245210727969349,0.8727440443449576,1.0,6/30,6.99%,NKD1;MAP2;DCC;PTCH1;RTN4;MAG
prerank,import into nucleus (GO:0051170),0.3229313565645007,0.8999171748738349,0.6086956521739131,0.9071616791647218,1.0,14/73,16.18%,PRICKLE1;STAT3;NUP93;E2F3;NUP214;NUP153;TNPO2;TNPO3;IPO7;NUP155;NUTF2;HTATIP2;NUP88;CSE1L
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.2911126958974794,-0.8997625098278204,0.6317991631799164,0.8726438131286212,1.0,7/32,11.27%,MCTP1;RIMS1;RIMS2;MCTP2;MEF2C;SYT11;SLC30A1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3741644208530777,0.899715351114484,0.6208333333333333,0.9071009271266418,1.0,6/28,12.82%,MET;CLIP1;TOGARAM1;AKAP9;MECP2;DRG1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.44306048563830713,0.8995430498709248,0.5888888888888889,0.9064634820435234,1.0,4/12,12.97%,EFNA5;DMTN;CORO1C;ITGB1BP1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.44306048563830713,0.8995430498709248,0.5888888888888889,0.9064634820435234,1.0,4/12,12.97%,EFNA5;DMTN;CORO1C;ITGB1BP1
prerank,regulation of viral release from host cell (GO:1902186),0.388121599480071,0.8989273242582929,0.5909090909090909,0.9072286787855267,1.0,9/21,29.51%,VPS37B;CHMP2B;TRIM35;MID2;PML;CHMP3;DDB1;TRIM26;TSG101
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.40136608595105805,0.8988322106806282,0.6063829787234043,0.9069421829364287,1.0,7/18,24.41%,EMD;NF1;SKI;MORC3;MED25;TP53;NLRC3
prerank,regulation of response to cytokine stimulus (GO:0060759),0.3908508852359308,0.8988183925741365,0.5985401459854015,0.9064904272443874,1.0,4/19,9.54%,ELF1;KLF4;MAVS;IFIH1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.33925632069078127,0.8986331529991706,0.6093366093366094,0.9063844623962488,1.0,6/54,5.90%,THBS1;FGF2;VEGFA;FGFR1;NF1;ATP2B4
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.4437773004862835,0.8984203371088926,0.5978260869565217,0.9063397652247052,1.0,1/11,0.92%,SCARA3
prerank,neutrophil mediated immunity (GO:0002446),0.2904027944657243,0.8983817352360156,0.7713139418254764,0.9059528208788696,1.0,99/432,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;IRAK4;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;KMT2E;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,negative regulation of developmental process (GO:0051093),0.32937971253400544,0.898356303876779,0.6436107854630715,0.9055317532512267,1.0,8/69,9.40%,BMP4;NFIB;WNT11;SOX9;KLF7;FOXC1;SFRP5;PARP3
prerank,negative regulation of anoikis (GO:2000811),-0.36297644827148884,-0.8980742923131698,0.5945121951219512,0.8754816852747003,1.0,6/14,17.24%,TLE1;BCL2;NOTCH1;PIK3CA;PTK2;PDK4
prerank,lamellipodium organization (GO:0097581),0.3693198818363118,0.8980575812387558,0.6035182679296346,0.9056500465924257,1.0,10/29,15.96%,ABLIM3;SNX2;ARFIP2;VCL;ITGB1;DMTN;ABLIM2;CTTN;CYFIP1;GOLPH3
prerank,amino sugar biosynthetic process (GO:0046349),0.43975825325382467,0.8975950803915832,0.5705329153605015,0.9061163386491836,1.0,6/12,23.59%,RENBP;NANP;GFPT1;GNPDA1;UAP1;PGM3
prerank,neutrophil degranulation (GO:0043312),0.2894881045128591,0.8965542241970245,0.7763289869608826,0.907744240317992,1.0,97/425,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.31993670969050303,0.8964914344649109,0.6571753986332574,0.9073978631705072,1.0,16/88,16.79%,TRABD2B;MPP7;VEGFA;GSK3B;EMILIN1;SLX4;SPIDR;VCP;SH3GLB1;CLU;TIRAP;PDCD6IP;PRKCA;CDC42EP2;FLOT1;SNF8
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.38315527963284046,0.896392054938152,0.6062767475035663,0.9071101317396534,1.0,2/22,1.98%,ANK2;ATP1B1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.33333787297969897,-0.8963515269208905,0.6036585365853658,0.8781435691699674,1.0,6/16,23.56%,CECR2;KPNB1;HMGB1;FOXL2;HMGB2;CASP3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.35658460212802845,0.8963293160067926,0.6138107416879796,0.9067475040053657,1.0,5/36,7.83%,FHIT;GIPC1;USP25;WAC;TRIM39
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.37916908043460834,-0.896192391329714,0.5835616438356165,0.8772310234401577,1.0,6/10,18.81%,CORO2B;MAPT;TERF1;SNX3;PPM1F;NDFIP1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.2685307345394228,-0.8959195540726209,0.6181818181818182,0.8765890336503929,1.0,13/37,20.41%,BCL2;BCL2L1;RPS3;BCL2L11;RACK1;RPS7;NUPR1;BOK;SFPQ;FIS1;SOD1;EIF5A;MSX1
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30309172333991435,-0.8956677002192804,0.5936395759717314,0.8758669851773174,1.0,4/23,14.48%,IGF1;GAS6;NLRP2B;CX3CL1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.40252801970642327,0.895377079565332,0.6006240249609984,0.9081080799475741,1.0,5/17,17.40%,CD55;BMP6;CARD16;PRKCA;SCIMP
prerank,neutrophil activation involved in immune response (GO:0002283),0.2889770711548729,0.8952795724056449,0.7773319959879639,0.9078273057165386,1.0,97/428,20.64%,CD55;PRKCD;ANXA2;GSN;TMC6;PYGB;NRAS;PKP1;DSP;STOM;IGF2R;ANO6;VNN1;BRI3;AP2A2;SPTAN1;PTGES2;TCIRG1;ACP3;FRK;RAB6A;DIAPH1;CLEC5A;RAB24;TMEM179B;CD44;B4GALT1;CRACR2A;VCL;PAFAH1B2;ARSB;PSMD11;TIMP2;CKAP4;ARG1;DERA;ANXA3;GPI;VCP;ILF2;ITGAV;RAB4B;CMTM6;CDK13;AMPD3;UBR4;RHOA;NDUFC2;DNAJC3;HMOX2;LPCAT1;RAP1A;CAB39;JUP;ATP11A;RNASE3;CPNE1;MAN2B1;NBEAL2;GDI2;RAP2C;CYFIP1;PSMD1;PGM2;KCMF1;C3AR1;ALOX5;GHDC;VAMP2;ACTR2;RAB5B;CPNE3;IQGAP1;SNAP23;GOLGA7;SURF4;APEH;NCKAP1L;DDOST;GLB1;ATP8B4;PSMD14;PSMD12;CAT;PSMD7;AGPAT2;TXNDC5;RAP2B;STK11IP;XRCC5;S100A11;ITGAL;CAPN1;LGALS3;AP1M1;FRMPD3;SLPI
prerank,vasoconstriction (GO:0042310),-0.37427639304381405,-0.8951251808752942,0.5813333333333334,0.8757658954182159,1.0,4/11,10.17%,SLC8A1;PIK3C2A;ACTA2;EDN1
prerank,lymphocyte differentiation (GO:0030098),0.32585190860155183,0.8950476438137963,0.6321303841676368,0.9077990302132628,1.0,8/68,7.67%,HDAC4;HDAC9;PBX1;CLCF1;PLCG2;PTPN2;NFIL3;ITGB1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.37769974323005684,-0.8948623608533485,0.6058823529411764,0.8750973740664357,1.0,3/11,10.14%,FOXO1;FAS;ATP6V1G1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4294053249629506,0.8940955952197032,0.584251968503937,0.9091458238470005,1.0,4/12,21.58%,BRCA1;ACADL;PIBF1;ACADVL
prerank,negative regulation of protein localization to membrane (GO:1905476),0.38263919012706976,0.8936341075213603,0.5975773889636609,0.9095906648875739,1.0,9/24,27.41%,PID1;RHOQ;DMTN;ITGB1BP1;LZTFL1;TMBIM1;DAB2;NUMB;GDI1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3527027300800995,-0.8935236950415336,0.597667638483965,0.8768057623196561,1.0,6/14,17.22%,IGF1;SYT11;CD200;CX3CL1;CD200R1;GRN
prerank,long-term memory (GO:0007616),-0.3238549807291528,-0.8928043508218614,0.6105263157894737,0.8771968931864128,1.0,4/19,7.04%,APOE;RASGRF1;CPEB3;SGK1
prerank,peptide catabolic process (GO:0043171),0.3801516896644155,0.8927987073906143,0.599721059972106,0.9107561561413603,1.0,6/23,12.95%,CPQ;ECE1;XPNPEP1;NPEPPS;IDE;DPEP1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.29256973422706534,-0.8925471414289684,0.61003861003861,0.8764892513427742,1.0,6/31,8.94%,BCL2;TFDP2;YWHAB;HIP1R;PPP1R13B;YWHAH
prerank,cobalamin metabolic process (GO:0009235),0.39453613258408843,0.8922549046678185,0.6115819209039548,0.9113632560610592,1.0,4/17,19.23%,MMACHC;CTRC;ABCC1;MMAB
prerank,axonal transport of mitochondrion (GO:0019896),-0.3730513730887024,-0.8920289515703574,0.6080691642651297,0.876343807565966,1.0,2/11,17.41%,MAPT;HIF1A
prerank,regulation of exocytosis (GO:0017157),-0.2594770781626121,-0.8919065762063738,0.6358974358974359,0.875319282692985,1.0,12/46,18.86%,IL1RAPL1;CLASP2;CADPS;RIMS2;SYT1;STXBP5L;RAB3C;RAB13;RAB3A;LGI3;RAB15;STX4
prerank,regulation of G0 to G1 transition (GO:0070316),0.350160661459291,0.8918706888967546,0.6150895140664961,0.9116053222957125,1.0,15/38,23.71%,RAD51;EHMT1;EED;CBX5;RBBP7;TFDP1;BRCA1;E2F1;CDC7;EPC1;SUZ12;CHEK1;PCGF6;APAF1;RBBP8
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3489845839481306,0.8917724740347889,0.6229508196721312,0.9113079366959662,1.0,14/42,26.46%,WRN;VCP;ZBTB1;POLI;PRIMPOL;PCLAF;DTL;RFC1;USP10;SPRTN;UBB;UBA52;POLK;RPS27A
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.2641347922221324,-0.8911631387339881,0.6446700507614214,0.8757913001585321,1.0,10/39,12.34%,RPS14;RPS19;RPS25;NPM1;RPS5;RPS16;SNU13;RPS7;DDX52;RPS15
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.41348599011114673,0.8908412699871755,0.608955223880597,0.9125981147844673,1.0,8/15,31.05%,CHEK2;RAD17;MDC1;ATF2;RAD9A;RAD9B;TIPIN;HUS1
prerank,protein sumoylation (GO:0016925),0.3369746516036008,0.8907694206179725,0.6211562115621156,0.9122620852881077,1.0,24/49,32.93%,NUP93;SAE1;NUP214;TRPM4;NUP153;IFIH1;NUP155;RANBP2;NUP88;NUP35;PIAS2;PIAS1;NUP98;TOPORS;SUMO1;PIAS3;POM121;UBE2I;PIAS4;STX1A;SEH1L;NUP54;TPR;AAAS
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3310400666109951,0.890699417853826,0.6332138590203107,0.9119148282571277,1.0,23/62,29.26%,STAT3;NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;DHX9;PUM2;POLR2C;PPARG;EIF4G1;PUM1;FMR1;TRIM71;NUP98;LIMD1;POM121;AGO1;ELAVL1;SEC13
prerank,erythrocyte development (GO:0048821),-0.37337035634937576,-0.8905671709879716,0.5909090909090909,0.8757950896726856,1.0,6/10,20.87%,ALAS1;ABCB10;MED1;SH2B3;LYAR;ALAS2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3523771533259727,0.8904030838342029,0.6164199192462988,0.9120365800732855,1.0,13/35,25.90%,NEK7;DHX36;CCT5;NAF1;MAP3K4;HNRNPA2B1;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;CCT6A;PARN
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.29941846061182203,-0.8901194467611517,0.6405693950177936,0.8755452396744722,1.0,17/25,42.49%,PDCD5;PINK1;BCL2L11;TNFSF10;PYCARD;BIK;MFF;GPER1;PMAIP1;PLAUR;DNM1L;BMF;CIDEB;BBC3;HRK;MMP9;MOAP1
prerank,positive regulation of bone resorption (GO:0045780),-0.3781701538319994,-0.8900599083587667,0.5763157894736842,0.87437929321194,1.0,5/11,29.23%,TNFRSF11A;SPP1;PLEKHM1;ATP6AP1;MC4R
prerank,cellular response to amino acid starvation (GO:0034198),0.3221441971358618,0.8898461127449003,0.6394009216589862,0.9126323914317898,1.0,19/71,21.88%,MAP3K5;NPRL3;ITFG2;TCIRG1;RRAGB;SZT2;EIF2AK2;EIF2S1;SH3GLB1;ATP6V1A;RHEB;MLST8;CDKN1A;ATF2;ATP6V0D1;SESN3;NPRL2;DAP;LARS1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.38320481324091915,-0.8897330050876316,0.6105263157894737,0.8738892308916046,1.0,3/10,10.01%,PCGF5;ZFP57;PRMT7
prerank,regulation of microglial cell activation (GO:1903978),0.4143118116415594,0.8897202228962713,0.5898617511520737,0.9124005531807814,1.0,5/15,19.29%,LDLR;CCL3;NR1D1;CST7;TAFA3
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3069671895923327,-0.889028927256386,0.6206896551724138,0.8742611447417398,1.0,3/22,7.36%,APOE;PPARA;PPARD
prerank,primary alcohol metabolic process (GO:0034308),0.3806146345129143,0.8888614877996083,0.6192468619246861,0.9135727056368274,1.0,3/25,4.82%,CYP1B1;ADH7;RDH12
prerank,positive regulation of stem cell differentiation (GO:2000738),0.4033342556078748,0.8886516591442342,0.5935672514619883,0.9134949362891706,1.0,6/16,10.54%,SOX9;LTBP3;HOXB4;GATA4;FOXC1;DHX36
prerank,fatty acid metabolic process (GO:0006631),0.3076060302802687,0.8886340764121605,0.6768558951965066,0.9130557889609283,1.0,25/115,19.06%,ABCD3;PLA2G15;ACSM2A;ACSM2B;ACSL3;SLC27A3;ACOT12;PNPLA3;ACBD5;ACOT11;ACACA;LPIN2;ANGPTL3;CPT1B;ACOT8;GNPAT;CPT1C;ACOX1;ALOX5;CEL;CROT;CRAT;NDUFAB1;PPARG;PON2
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.41584225832975896,0.8885833519439511,0.5876288659793815,0.9126831644210737,1.0,4/14,16.74%,PARP1;WDR48;FUS;ACTR2
prerank,cellular response to interleukin-1 (GO:0071347),0.3036870841910943,0.8882179291260439,0.6865037194473964,0.9129136061713762,1.0,34/143,20.03%,TANK;PTGIS;SOX9;PSMB2;CCL3;CCL1;IRAK3;TAB3;IRAK4;IKBKG;PSMD11;ZC3H12A;EGR1;PSMC1;CUL1;CCL7;RIPK2;MAP3K7;TAB2;MAP3K3;PSMC6;MYD88;NR1D1;RBMX;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;USP10
prerank,positive regulation of protein kinase activity (GO:0045860),0.3012437376841331,0.8875926301607792,0.6691331923890064,0.9137257482080594,1.0,31/148,18.20%,RASSF2;DDR2;CCN1;PRKCD;PTK2B;ADRB2;VEGFA;TELO2;STRADA;TGFBR2;EGR1;SYAP1;CLSPN;CIB1;RHOA;DUSP19;TAB2;TOM1L1;RAP1A;CAB39;CLU;MARK2;ITGB3;SRCIN1;TRAF6;CDKN1A;IQGAP1;STK3;TRAF4;LAT;RALB
prerank,regulation of mitotic nuclear division (GO:0007088),0.3303696510511424,0.8872676230876616,0.6222493887530562,0.9138674585462498,1.0,17/55,22.41%,BMP4;CCDC8;AURKA;CDK13;CCNB1;TOM1L1;FBXO5;DRD3;PRMT5;LRP5;PIN1;BORA;EDN3;EGF;IGF2;AURKAIP1;CHEK1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.38827903904106703,0.8870841023880185,0.6144927536231884,0.913753673595111,1.0,4/21,13.49%,ANK2;SNTA1;AKAP9;SCN1B
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.40766704018969857,0.8870110920339989,0.6133333333333333,0.913427674800557,1.0,5/14,16.31%,PPP3CA;PPTC7;PPP2R2D;NCK1;PPP5C
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3948043377215835,0.8869998226325184,0.6017191977077364,0.9129770847150535,1.0,10/19,34.50%,TEN1;STN1;NAT10;TENT4B;GNL3L;SRC;HNRNPC;EXOSC10;TERF2;XRN1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.3866200285002202,-0.8864730930658828,0.6124031007751938,0.8786960576324383,1.0,3/10,14.01%,PRKCH;MED1;ETV4
prerank,DNA dealkylation (GO:0035510),0.437706814127825,0.886044126119266,0.5667215815485996,0.9139002093757572,1.0,4/10,23.19%,MPG;FTO;ASCC2;ALKBH1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.437706814127825,0.886044126119266,0.5667215815485996,0.9139002093757572,1.0,4/10,23.19%,MPG;FTO;ASCC2;ALKBH1
prerank,nucleoside salvage (GO:0043174),0.44251780385378253,0.8858578319077748,0.5953947368421053,0.9137945299305428,1.0,2/10,12.29%,TK1;UPP2
prerank,T cell mediated immunity (GO:0002456),0.4360577840514557,0.8855727288806359,0.5900900900900901,0.9139012647754542,1.0,3/13,12.02%,CD55;CD46;JAG1
prerank,regulation of protein localization to cell surface (GO:2000008),-0.2800262190638228,-0.8851363644773838,0.6986301369863014,0.8804342252563423,1.0,13/33,18.86%,NEDD4L;ACTN2;PICALM;HSP90AB1;LEPROTL1;GPM6B;MAP1A;TAX1BP3;CTNNB1;TYROBP;ABCA2;BDNF;STX4
prerank,neuron projection organization (GO:0106027),0.4113608861217242,0.8846878574924371,0.5928792569659442,0.9151340382419283,1.0,4/15,9.70%,GSK3B;PLS1;ABCD1;ATP1A3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4451249824248271,0.8843655913571927,0.6195286195286195,0.9152795754877782,1.0,4/10,25.27%,BAG3;NCK1;HIF1AN;JUN
prerank,cellular response to ATP (GO:0071318),-0.3471489537253728,-0.8839684924684096,0.598159509202454,0.8819159358293193,1.0,8/14,33.54%,P2RY1;P2RX7;CIB2;TAF1;HSP90B1;P2RX3;P2RY2;RYR3
prerank,regulation of pH (GO:0006885),0.4356090397330663,0.8838635102984945,0.6148969889064976,0.9157265219230566,1.0,3/11,9.77%,ATP6V0A4;ATP1A4;SLC9A1
prerank,cellular response to radiation (GO:0071478),0.3419483801106588,0.8836967251388321,0.6162642947903431,0.9155571861123744,1.0,11/40,25.37%,TANK;RAD51;SPIDR;TNKS1BP1;CDKN1A;INTS7;TP53;INO80;RAD9A;RAD9B;KDM4D
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.3444137414969081,-0.8836920700324918,0.6657142857142857,0.8813133293912735,1.0,3/14,12.25%,ABCG1;DYRK1A;APH1B
prerank,regulation of protein kinase C signaling (GO:0090036),0.4207887694564795,0.8829917907535748,0.5979073243647235,0.9164525406929224,1.0,2/14,3.17%,WNT11;VEGFA
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3789371554323983,0.8826915550389675,0.6185852981969486,0.9165549778289573,1.0,4/24,10.85%,VEGFA;NFE2L2;ATF6;CREB3L1
prerank,response to thyroid hormone (GO:0097066),-0.35732650589721143,-0.8825629919196525,0.6119402985074627,0.8825079822772385,1.0,7/13,20.09%,LMO2;CTSH;CTSB;MED1;CTSS;THRB;CTSL
prerank,tRNA modification (GO:0006400),0.32391220448603075,0.8822844540970753,0.66270783847981,0.9168735280813183,1.0,26/62,33.25%,TRMT10A;ALKBH8;TYW5;MTO1;ELP5;METTL2A;METTL2B;TARBP1;SSB;PUSL1;TRMT61B;THUMPD1;TRDMT1;TYW1;FTSJ1;ALKBH1;CDKAL1;THADA;TRMT44;THUMPD2;WDR4;PUS10;QTRT1;TRMT13;TPRKB;ANKRD16
prerank,nitric oxide biosynthetic process (GO:0006809),0.4128080401284674,0.8819762676183828,0.6123680241327301,0.9169881111686179,1.0,2/13,7.28%,CYP1B1;NQO1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4371546145220374,0.8816443667148581,0.6178861788617886,0.917140998909484,1.0,2/10,11.54%,GALNT13;POGLUT3
prerank,response to muscle stretch (GO:0035994),0.4026622505247709,0.881578404466904,0.6006240249609984,0.9168230372677006,1.0,2/15,1.97%,CSRP3;GSN
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.409770603422809,0.8815701801081652,0.6017830609212481,0.9163679495540556,1.0,2/13,7.70%,BMP5;DKK3
prerank,negative regulation of translation (GO:0017148),0.31311170822969037,0.8815277976266754,0.6601382488479263,0.9159734658614289,1.0,29/87,26.50%,SAMD4A;IGFBP5;PAIP2;CNOT8;AGO2;EIF3E;EPRS1;DHX36;EIF2AK2;CELF1;MEX3D;FTO;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;PUM1;FMR1;MALSU1;CNOT1;TRIM71;DDX6;TSC1;RBM4;METTL16;SHMT1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3742129707571455,0.8812594620034785,0.6136363636363636,0.9160193018658036,1.0,8/24,16.37%,KCNB1;ERBB2;CIB1;MIEF1;C2CD5;CHP1;ITGB1BP1;MIEF2
prerank,phosphorylation (GO:0016310),0.2862644317186184,0.8811066001221108,0.7993951612903226,0.9158527554969338,1.0,78/385,18.10%,STK39;DCLK1;MAP3K5;MARK1;GRK5;WNK1;PRKCD;CAMK2D;WNT11;PRKCE;PTK2B;TLK1;BMPR1A;CLK2;GSK3B;CDK10;RARA;CDK12;HIPK1;TGFBR1;ABL1;IRAK3;FGFR1;STAT3;FRK;CHEK2;NEK7;FAM20A;NADK;BCR;STRADA;ERBB2;TGFBR2;NRBP2;AURKA;DGKA;LIMK2;CDK11B;IKBKE;CSNK1A1;GRK4;NLK;MAST2;TOP1;MAK;CDK16;CDK13;AAK1;PLK4;EIF2AK2;PDK3;EPHB2;SGK3;MAP3K1;AGK;MARK2;RET;CDKL2;ACVR1;MORC3;PIM2;PRKCA;MARK3;CDK7;PRKDC;CDK2;LCK;SIK1;IKBKB;ERN2;GNPTAB;NEK4;GNPTG;LRRK2;STK24;STK3;MAPKAPK2;COPS8
prerank,regulation of gluconeogenesis (GO:0006111),0.3635185943885961,0.8810659559952535,0.6172185430463576,0.9154606948894728,1.0,3/27,5.71%,CLK2;PTPN2;NNMT
prerank,cellular response to interleukin-7 (GO:0098761),0.4006738870195069,0.8810372653202085,0.626099706744868,0.9145753925253539,1.0,2/17,5.26%,IRS1;STAT3
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4006738870195069,0.8810372653202085,0.626099706744868,0.9145753925253539,1.0,2/17,5.26%,IRS1;STAT3
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.28725465325922006,-0.8810004951898547,0.6692307692307692,0.8847746724478769,1.0,6/26,17.41%,APOE;NUS1;GCH1;NOS1AP;TERT;HIF1A
prerank,histone H2B ubiquitination (GO:0033523),0.43214879175398746,0.8809879565803758,0.6157804459691252,0.9142083611798509,1.0,5/10,29.80%,WAC;RNF8;RNF20;CTR9;DTX3L
prerank,protein targeting (GO:0006605),0.3060301772070733,0.8808877688690768,0.6870229007633588,0.9139362369439198,1.0,42/118,27.42%,GIPC1;HPS4;KATNB1;LTBP2;SRPRB;SEC61A1;ZDHHC2;ZFAND6;ZDHHC20;LONP2;TIMM23;ZDHHC12;ATG3;NLGN1;VPS37A;BCAP31;PARD3;ZDHHC15;VPS37B;SORL1;TIMM9;ZDHHC24;TSPO;GOLGA7;PEX1;ZDHHC3;AP4E1;TIMM17B;PITRM1;AIP;FUT10;ZDHHC19;TIMM44;TOMM34;RABGEF1;SRPRA;ZDHHC21;KIF13B;TOMM20;AP4M1;ZDHHC6;TIMM13
prerank,nucleic acid-templated transcription (GO:0097659),0.350033538357835,0.880655891076967,0.6341463414634146,0.9139349337794223,1.0,12/42,19.83%,MEF2A;NR4A2;POLR3A;DRG1;E2F1;RNPS1;HOXD3;PPP5C;MED20;POLR2C;EPC1;CREBL2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.38800461100524913,0.8805765882774518,0.6096181046676096,0.9136013023890087,1.0,8/18,27.83%,MISP;ZDHHC2;SPTBN1;VTI1B;STX8;MMP14;CLN3;PLK1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.393002103510245,0.8800230502263221,0.6231454005934718,0.914168556971059,1.0,8/17,27.57%,TTK;ZW10;RB1;ZWILCH;SPDL1;BUB3;MTBP;MIS12
prerank,lysine metabolic process (GO:0006553),0.41874411523617217,0.8799869730305059,0.6172106824925816,0.9133119493853299,1.0,5/12,24.55%,HYKK;SLC25A21;PHYKPL;OGDH;DLD
prerank,lysine catabolic process (GO:0006554),0.41874411523617217,0.8799869730305059,0.6172106824925816,0.9133119493853299,1.0,5/12,24.55%,HYKK;SLC25A21;PHYKPL;OGDH;DLD
prerank,heart morphogenesis (GO:0003007),0.33020897693363593,0.8796967336430361,0.6299019607843137,0.9134191151306137,1.0,7/50,5.18%,HES1;SOX9;VEGFA;BMPR1A;TGFBR1;NOG;NIPBL
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.38155750129266786,0.879608182653336,0.6272855133614628,0.9131401277385209,1.0,6/21,10.43%,EFNA5;PTPRA;VCL;CORO1C;SLC9A1;RHOA
prerank,nitric oxide metabolic process (GO:0046209),0.40802130920797464,0.8793441031313681,0.6396946564885496,0.9131793626983531,1.0,2/14,7.28%,CYP1B1;NQO1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.34938033894236153,-0.8792365809319919,0.6426512968299711,0.8875320049421401,1.0,5/13,10.72%,NOS3;PPARA;TMSB4X;PPARGC1A;PINK1
prerank,response to amino acid starvation (GO:1990928),0.31798734869324763,0.8792315730246054,0.6528735632183909,0.912958371828368,1.0,19/72,21.88%,MAP3K5;NPRL3;ITFG2;TCIRG1;RRAGB;SZT2;EIF2AK2;EIF2S1;SH3GLB1;ATP6V1A;RHEB;MLST8;CDKN1A;ATF2;ATP6V0D1;SESN3;NPRL2;DAP;LARS1
prerank,Rho protein signal transduction (GO:0007266),0.3296809097191017,0.8785404889773385,0.6502994011976048,0.9138194491101426,1.0,4/53,3.12%,NTN1;CDC42EP5;RHOJ;ARHGDIB
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.417366712617493,0.878042903147679,0.6085578446909667,0.9143339452060399,1.0,1/12,1.67%,CAMK2D
prerank,neuromuscular process controlling balance (GO:0050885),-0.35786645233948416,-0.877557591505138,0.6077922077922078,0.8899941419430563,1.0,2/12,3.61%,NRXN1;PCDH15
prerank,mammary gland epithelium development (GO:0061180),-0.339145474308562,-0.8772598354909719,0.6149253731343284,0.8893035019984823,1.0,2/14,3.82%,WNT4;ERBB4
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.38710431074391755,0.8771181887166166,0.5977496483825597,0.9156565510528961,1.0,2/18,5.81%,DDR2;EMILIN1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.3052527332519554,-0.8770492517159734,0.6310344827586207,0.8885161133987501,1.0,3/22,9.47%,ALDH1A2;LGMN;CUBN
prerank,cyclooxygenase pathway (GO:0019371),-0.3674671778201503,-0.876671007690496,0.6082191780821918,0.8881156032207208,1.0,5/10,17.60%,PTGDS;PTGS1;TBXAS1;HPGDS;CBR1
prerank,actin cytoskeleton reorganization (GO:0031532),0.3232716160225901,0.876615110690166,0.6571767497034401,0.9161485521117425,1.0,19/63,18.07%,GSN;EZR;SIPA1L1;NRP1;PHACTR1;ANXA1;PARVA;GPR65;DMTN;ANTXR1;RHOA;MCU;PIP5K1A;CTTN;PDLIM4;SYDE1;FARP2;S1PR2;CXADR
prerank,regulation of protein acetylation (GO:1901983),0.4170364222051437,0.8762652013290549,0.60625,0.9163677057440094,1.0,2/12,5.49%,GSK3B;FAM161A
prerank,activation of protein kinase activity (GO:0032147),0.3056827363720893,0.876045998985838,0.6769570011025359,0.9162995607964224,1.0,26/106,19.14%,CARD14;NTRK3;PRKCD;PTK2B;ADRB2;VEGFA;ABL1;ADCY9;STRADA;TGFBR2;CLSPN;MAP3K7;TOM1L1;TRAF2;MARK2;ITGB1BP1;TIRAP;ITGB3;TRAF6;MLST8;ADCY8;ADCY3;STK3;COPS8;JAK2;BORA
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3244182663424669,0.8760176774210132,0.6588957055214724,0.915887680586789,1.0,3/57,1.74%,MAP3K5;PERP;CYFIP2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3505049045755799,-0.8758784299284244,0.6035502958579881,0.888631364423585,1.0,4/13,15.39%,AXL;IL18;GAS6;TYROBP
prerank,positive regulation of ion transport (GO:0043270),0.3335085269650522,0.8754170518680158,0.625609756097561,0.9165767560872247,1.0,11/48,17.75%,FHL1;ANK2;ANO6;CCL3;CRACR2A;DLG1;SCN1B;SCN3B;KIF5B;GDNF;P2RX4
prerank,synapse organization (GO:0050808),0.30163285359065095,0.8751065113492106,0.7029379760609358,0.916703114458586,1.0,9/125,3.03%,PCDHB16;GPC6;NEDD4;CDH1;CTNND2;SEMA3E;UNC13B;PTPRF;PCDHB9
prerank,phosphate ion transport (GO:0006817),0.4014248572663545,0.875051250339465,0.6242331288343558,0.916346908123829,1.0,2/16,13.56%,SLC34A2;SLC37A1
prerank,membrane lipid metabolic process (GO:0006643),0.3753994165857945,0.8749214721505365,0.6460431654676259,0.9161388392692387,1.0,5/22,14.16%,CYP1B1;TEX2;AGMO;AGK;TECR
prerank,regulation of dendrite development (GO:0050773),0.34890965910228466,0.8748145116655845,0.6241699867197875,0.9158814061174948,1.0,5/37,3.75%,MARK1;NEDD4;COBL;BMP5;GSK3B
prerank,fatty acid transmembrane transport (GO:1902001),0.3901837729492524,0.8745571487674538,0.62882096069869,0.9159113151656179,1.0,5/19,16.15%,ABCD3;ABCD1;ACACA;CPT1B;SLC25A20
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31537874516430886,0.8745327564755697,0.656140350877193,0.9155051725268394,1.0,11/70,12.41%,CRADD;NGF;GSK3B;HIPK1;BAG3;INHBA;CASP2;CIB1;ITGAV;MCL1;TRAF2
prerank,negative regulation of cell activation (GO:0050866),0.4100956760448339,0.8743205826566417,0.6324655436447167,0.9154393038695826,1.0,3/14,5.81%,THBD;LDLR;EMILIN1
prerank,cellular amide metabolic process (GO:0043603),0.30567252723832716,0.8742413024054878,0.6883408071748879,0.9151281684754337,1.0,12/102,9.73%,SLC5A6;PLPP3;VNN1;PLA2G15;FOLR2;ACSM2A;ACSM2B;NNMT;ACOT12;ACOT9;SLC25A32;ACOT11
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.3156560710979361,0.8738381873031098,0.6650660264105642,0.915442350771775,1.0,17/69,24.00%,UBE4B;RNF185;MAN1B1;VCP;UBE4A;FBXO27;PSMC6;HERPUD1;SEL1L;FBXO17;TMEM129;ANKZF1;USP19;UBXN4;DNAJB2;RHBDD2;SEC61B
prerank,ribonucleoprotein complex assembly (GO:0022618),0.29608706755944,0.8738057137481191,0.7009646302250804,0.9150459259503935,1.0,45/132,28.70%,RPSA;CELF3;LUC7L2;SRSF5;SRSF6;EIF6;EIF3A;PRPF18;CELF4;CELF1;PRMT5;SCAF11;SRSF1;PRKDC;NAF1;EIF4B;DHX9;EIF2S2;EIF2D;GEMIN5;TRAF7;CLP1;XRCC5;TGS1;LSM4;LUC7L3;RPL10;SRPK2;KHDC4;BRIX1;YTHDC1;USP39;SMN1;DICER1;SNRNP200;DHX29;GEMIN8;RPS27L;SNUPN;RAMAC;CELF6;RPL5;RBM5;GCFC2;SNRPB
prerank,dendrite morphogenesis (GO:0048813),0.3568404148058126,0.8736559032505168,0.6397919375812744,0.9148668527817746,1.0,11/35,15.70%,CTNND2;PHACTR1;EPHB3;KLF7;MEF2A;SHANK1;FARP1;EPHB2;MAP6;DVL1;PTN
prerank,phospholipid catabolic process (GO:0009395),-0.3023669646563,-0.8735519840004828,0.662962962962963,0.8924935641931987,1.0,3/24,6.73%,ENPP2;GPCPD1;ENPP6
prerank,isotype switching (GO:0045190),0.43230398380587115,0.8731312660986431,0.599009900990099,0.9153837910701889,1.0,2/10,14.24%,EXOSC3;RNF8
prerank,negative regulation of viral life cycle (GO:1903901),-0.344202999369817,-0.8728212182339997,0.6485714285714286,0.892896541534054,1.0,6/15,14.63%,LY6E;IFITM1;IFITM3;BST2;IFITM2;SNX3
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.29793938230926076,-0.8724074355167479,0.6744186046511628,0.892532117704019,1.0,3/24,4.88%,AGBL4;TTLL7;TTLL11
prerank,regulation of mRNA polyadenylation (GO:1900363),0.38820035040565093,0.8722323000279668,0.6071428571428571,0.916628759111869,1.0,6/17,21.60%,ZC3H14;NELFE;RNF20;VIRMA;CCNT1;ZC3H3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3565494920714314,0.8721371940786289,0.6317934782608695,0.9163637303459959,1.0,6/28,10.55%,TAB3;IKBKG;AAMP;RIPK2;MAP3K7;TAB2
prerank,cellular response to starvation (GO:0009267),0.29724038930484153,0.8719981911003103,0.7174603174603175,0.9161726648016788,1.0,34/147,18.85%,MAP3K5;NPRL3;ITFG2;CLEC16A;FOXO3;TCIRG1;RRAGB;KLF10;VPS41;ZFYVE1;WRN;ZC3H12A;BECN1;WDR45B;SZT2;EIF2AK2;GAS2L1;EIF2S1;ATG5;SH3GLB1;SREBF1;RRP8;WIPI2;ATP6V1A;RHEB;INHBB;MLST8;CDKN1A;SIK1;LRRK2;STK24;ATF2;RALB;ATP6V0D1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3830034532726102,0.8719822591798233,0.6368794326241135,0.9157430328675791,1.0,5/21,15.09%,DERA;GPI;TKT;RPE;PGM2
prerank,axonal fasciculation (GO:0007413),-0.3584475382822926,-0.8718363199302099,0.6302083333333334,0.892445843447107,1.0,4/12,10.23%,CNTN4;EPHA4;RTN4;SEMA5A
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3812810899595268,0.8717346941265403,0.6351550960118169,0.9157479517575264,1.0,3/20,9.27%,BMP4;TGFBR1;PDCD4
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3510933596939081,0.8715347360563784,0.6526717557251909,0.9156615181289889,1.0,20/36,30.19%,NECTIN3;GORASP2;KIF13A;NSF;AFDN;GOLPH3;VAMP2;GOLGA7;GOLGA4;SPTBN1;GOLPH3L;BBS2;RAB26;GCC2;GGA1;RILPL1;GGA2;SYS1;TRARG1;BLZF1
prerank,regulated exocytosis (GO:0045055),0.29136538028323034,0.8715208094837742,0.7339743589743589,0.9152282247446627,1.0,18/173,9.60%,THBS1;PCDH7;LHFPL2;CLTRN;CD9;FAM3C;VEGFA;TGFB3;CD109;SYTL4;TIMP1;ARHGAP17;FN1;VCL;PHACTR2;PCLO;TEX264;MAGED2
prerank,gene expression (GO:0010467),-0.19289013796089216,-0.8713360306288976,1.0,0.8923019915978371,1.0,80/348,17.69%,RBPMS;NOVA1;TSPAN5;ATXN1;RBMS1;EEF1A1;RPL37;RPL27A;RPL19;RPS13;EIF4EBP2;RPS9;RPS3;RPS14;RPL18A;RPL38;PTMA;RPS19;RPS8;DTX1;RPS11;APOBEC1;RPL34;RPL18;ELAVL4;RPL7;TSPAN14;RPS25;ADARB2;RPL21;RPL23A;RPLP2;RPS21;RPL26;RPS4X;RPL41;RPS29;RPL35A;RPL10A;RNASEL;RPL11;MAGOH;RPS5;RPS16;MRPL3;RPL4;SMG7;PAX8;POLR2G;RPS7;RPS23;RPS15;DDX20;ADAR;MRPS14;RPL36;ANGPT2;THOC3;MRPS33;NOX4;NUP37;RPS18;RPL37A;RPL32;HHEX;RPS20;TSPAN15;HNRNPL;RPL29;THRB;NUP50;RPL13;TFIP11;NUP210;RPL36A;MRPL51;HARS1;RPL23;RPL17;NUP107
prerank,secondary alcohol metabolic process (GO:1902652),0.3361613269281169,0.8712434801317935,0.6662515566625156,0.9153028504247511,1.0,12/42,18.89%,SOAT1;FDX1;TSKU;RXRA;ANGPTL3;SOAT2;IDH3B;GBA2;LCAT;SQLE;EBP;APOF
prerank,intermediate filament organization (GO:0045109),0.39694074662431345,0.8711009440986157,0.6179941002949852,0.9151265733594539,1.0,2/17,3.39%,PKP1;DSP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3638617848896964,0.8709614741344938,0.6494708994708994,0.9149464212608269,1.0,4/27,10.52%,MAP3K5;IKBKG;CUL1;MAP3K7
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.30071527924768476,0.8709433459142187,0.6948051948051948,0.9145189104024184,1.0,23/108,19.38%,F3;MAP3K5;GSN;CRADD;NGF;EGLN3;NLRP12;CASP2;VCP;XDH;PDCD2;TRAF2;BCAP31;ARL6IP5;PIDD1;MTCH1;LCK;FAM162A;DAPK1;BCL2L13;PPARG;JAK2;AIFM1
prerank,regulation of transport (GO:0051049),-0.2703354146243516,-0.8707946333625993,0.7108433734939759,0.892241033604729,1.0,8/36,14.04%,LEPR;EPB41;ICA1;ACTB;PINK1;ICA1L;MYO6;FES
prerank,regulation of programmed cell death (GO:0043067),0.2929564397619354,0.8707256472678686,0.7196652719665272,0.9144637096157942,1.0,26/161,14.83%,ACER3;PERP;CASP6;CRADD;SOX9;FBXO10;NDRG1;GAS1;ABL1;PLSCR3;CREBBP;CASP2;APEX1;WRN;VCP;BRMS1;POU4F1;CLU;TRAF2;RAF1;RBM25;TIGAR;HTATIP2;SRA1;PIDD1;TMEM219
prerank,outer dynein arm assembly (GO:0036158),0.4098223788373726,0.8705530186367976,0.6116207951070336,0.9143332135097708,1.0,5/14,20.51%,DNAAF4;ODAD2;ODAD3;DNAL1;DNAH17
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.27519660093757814,-0.8704627409616369,0.7,0.8916572006298845,1.0,18/33,30.22%,TGFA;AFAP1L2;DGKD;HIP1R;ADRA2A;HBEGF;HIP1;CCDC88A;FBXW7;CNOT9;NUP62;AKT1;GPER1;BTC;AGT;PDE6G;NCF1;PLAUR
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.39782334665899377,0.8703949959818948,0.6166419019316494,0.9141659497078491,1.0,4/16,5.06%,NRP1;ABL1;NR4A3;PDGFC
prerank,peripheral nervous system development (GO:0007422),0.3727439890669363,0.8700505827815803,0.625,0.9143176361689965,1.0,5/23,16.35%,NGF;PMP22;NF1;GFRA3;GDNF
prerank,regulation of mRNA processing (GO:0050684),0.3534978812857308,0.8700256420720202,0.6339165545087483,0.9139081711514575,1.0,12/32,24.78%,SLTM;SON;RBM39;CDK11B;TIA1;KHDRBS1;DHX9;SRSF3;SRPK2;JMJD6;LARP7;YTHDC1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3174771295704241,0.8699917178037881,0.7007211538461539,0.9135076950584861,1.0,21/74,24.30%,VEGFA;NFE2L2;EGLN3;PSMB2;CREBBP;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;PSMD1;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;HIF1AN;PSME3;PSMD3;PSMB6;UBB
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3479511570898498,0.8699205203768269,0.6389261744966444,0.9131802590920272,1.0,4/33,8.90%,TCF7L2;NFE2L2;CAST;KRIT1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3015253047551362,-0.8697527289549883,0.6774193548387096,0.8920428644355425,1.0,5/22,17.83%,WNT5A;SLC7A5;LACC1;NOD2;BTK
prerank,cellular response to interferon-gamma (GO:0071346),0.30817919785664327,0.8692743164036066,0.6912599318955732,0.9139386805857935,1.0,11/88,9.92%,PRKCD;CAMK2D;SLC26A6;MID1;CCL3;CCL1;CD44;IRF1;TLR4;EPRS1;CCL7
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.34890850291703585,-0.8692678385133971,0.6544943820224719,0.8917977208908829,1.0,6/12,21.87%,BCL2;RPL26;MIF;CD74;TAF9;TRIAP1
prerank,macrophage migration (GO:1905517),0.4180695201974353,0.8690099766966691,0.6212121212121212,0.9139701636950829,1.0,4/13,25.02%,CCL3;P2RX4;LGALS3;P2RY12
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3984222188977319,0.8687307402649229,0.6318840579710145,0.9140318369219971,1.0,4/15,17.26%,SKI;DACT1;ACVR1;SMAD7
prerank,histone exchange (GO:0043486),0.34444361981237176,0.8686668272702479,0.6350649350649351,0.9136957304519757,1.0,15/37,29.38%,SRCAP;RBBP7;CENPT;HJURP;DMAP1;CENPL;RNF8;SMARCA5;VPS72;CENPW;CENPP;RSF1;CENPK;NASP;ANP32E
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2971230987677716,-0.8685226110378844,0.7167235494880546,0.8921916695941683,1.0,7/21,18.13%,BCL2L1;CREB3;BCL2L11;BOK;XBP1;HSPA1A;SELENOS
prerank,serine family amino acid metabolic process (GO:0009069),0.40120980824472213,0.8683436564765683,0.6238532110091743,0.9138314478647052,1.0,1/16,1.99%,GCLC
prerank,inhibitory synapse assembly (GO:1904862),-0.35557025485302274,-0.868191671972454,0.6121883656509696,0.8916330322943035,1.0,6/11,14.15%,WNT5A;GABRB3;GABRA2;GABRB2;GABRA1;GABRG2
prerank,N-glycan processing (GO:0006491),0.3840587206120045,0.8681409001100072,0.6433878157503715,0.9137542867074221,1.0,5/18,12.53%,FUT8;MAN2A1;ST8SIA2;MAN1B1;GANAB
prerank,positive regulation of T cell activation (GO:0050870),-0.23793774996639733,-0.8680557299590729,0.7243589743589743,0.8906888190251142,1.0,22/62,24.38%,VCAM1;TFRC;SIRPA;PRKCQ;RHOH;DOCK8;CD81;CCL19;CD47;XBP1;NOD2;CD86;SLC7A1;JAK3;THY1;PYCARD;HSPD1;CD276;IL7;CD274;CCL2;CYRIB
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3146090387756357,0.8679857122487765,0.6713124274099884,0.913590739749848,1.0,9/69,10.40%,SIX1;PTK2B;NGF;TGFB3;CLCF1;NFATC4;NRBP2;SIX4;POU4F1
prerank,cellular response to interleukin-6 (GO:0071354),0.3645789971756805,0.8679460766239052,0.6469038208168643,0.913211306487781,1.0,8/26,20.79%,PID1;PTGIS;STAT3;SMAD4;YAP1;SOCS3;JAK2;FER
prerank,tetrapyrrole metabolic process (GO:0033013),0.3810084585271393,0.8675412920481078,0.6444759206798867,0.9135051846116082,1.0,4/18,19.23%,MMACHC;CTRC;ABCC1;MMAB
prerank,phospholipid translocation (GO:0045332),0.361402569229542,0.8673415471489286,0.6510989010989011,0.9133927011011089,1.0,10/28,18.40%,ANO6;TMEM30B;PLSCR3;ABCA7;ATP11A;ATP9B;ATP10A;PLSCR1;ABCC1;ATP8B4
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.40611930856671885,0.8673148541165033,0.6308623298033282,0.9129883451218557,1.0,2/13,5.16%,DDX5;SPRED2
prerank,negative regulation of metabolic process (GO:0009892),0.3294074534861736,0.8672610304603098,0.6630303030303031,0.9126360390182142,1.0,15/54,17.24%,ZNF423;NPR3;ID1;FOXC2;DOCK7;IP6K1;TLR4;ABHD6;ACOT11;NR1D1;ACOT13;ADAMTS5;RHEB;PCTP;RB1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.3801289475617593,0.867226311804073,0.6380090497737556,0.9122444881535,1.0,3/18,8.37%,CCL3;TLR4;TCTA
prerank,transport along microtubule (GO:0010970),0.41332697119771766,0.8671775050406952,0.6109422492401215,0.9118798756150048,1.0,5/13,16.49%,ARHGAP21;BAG3;COPG1;SPG11;CAMSAP3
prerank,regulation of response to external stimulus (GO:0032101),0.2926068085813191,0.8669705572472497,0.7130620985010707,0.911812036813476,1.0,34/121,25.10%,FOXP1;MGLL;CD55;PDE6A;PIK3AP1;ANXA1;IRF1;GRK4;EPHB2;MYD88;CELF1;TIRAP;PDE6B;ALOX5;AREL1;PSMA6;P2RX4;STK24;DAGLB;JAK2;BRD4;NR1D2;TRAF3;FNTA;ERAP1;PPEF1;METAP2;PTGES;SETD6;CNGB1;APPL2;SBNO2;P2RY12;NLRP6
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.325635279342411,0.8668921082070805,0.639549436795995,0.9115010471976777,1.0,19/53,24.30%,PKD1;DNAAF4;XPO1;DESI1;RAD23B;PSMC6;NUDT15;COMMD1;TMTC3;PSME3IP1;GLMN;PSMD14;TMF1;USP19;BAG2;PSME3;FMR1;RHBDF1;UBB
prerank,ribosome biogenesis (GO:0042254),-0.20550265536721277,-0.8668631952417497,0.8055555555555556,0.8920641449375017,1.0,48/187,18.80%,RPL37;RPL27A;RPL19;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;NPM1;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;SNU13;RPL4;RPS7;DDX52;RPS15;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RRS1;RPL36A;RPL23;RPL17;RPL9;DDX27;SDAD1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3728623953229306,0.8667455544689983,0.6557142857142857,0.9113249195191634,1.0,2/22,3.89%,NFE2L2;PSMB2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.30781965351465196,0.8666128803300507,0.7041619797525309,0.911114469357649,1.0,15/101,13.46%,ADAM9;LBP;PRKCE;CXCL2;CCL3;ZC3H12A;TLR4;CD80;PDCD4;RHOA;TRIM41;MYD88;NR1D1;MTDH;CARD16
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3140182406524165,0.8662761677666505,0.6732558139534883,0.911326478997954,1.0,18/73,19.38%,F3;CRADD;NGF;EGLN3;NLRP12;CASP2;VCP;XDH;PDCD2;TRAF2;PIDD1;MTCH1;LCK;FAM162A;BCL2L13;PPARG;JAK2;AIFM1
prerank,negative regulation of macroautophagy (GO:0016242),0.36221283876362786,0.8662168548098784,0.6390870185449358,0.9109858773052409,1.0,11/26,25.36%,CLEC16A;TMEM39A;NRBP2;LZTS1;RUBCN;LRRK2;USP36;MTOR;SMCR8;MTM1;TSC1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2913752301299173,-0.8660279229888174,0.662962962962963,0.8925914503808335,1.0,4/25,9.24%,APP;PICALM;ANKRD13A;RAC1
prerank,synaptic vesicle recycling (GO:0036465),0.3513294425658995,0.8660098809241109,0.635752688172043,0.9109052025734454,1.0,8/31,17.62%,STON2;STON1;FCHO2;NLGN1;VAMP2;SYNJ2;CEL;SYNJ1
prerank,regulation of defense response to virus by host (GO:0050691),0.35115114390575175,0.8659969283940893,0.6461748633879781,0.9104748325091687,1.0,12/30,29.80%,TRAF3IP2;ZC3H12A;MAVS;CGAS;TRIM44;IFNLR1;DHX9;LILRB1;PARP9;IL4;IL23R;DTX3L
prerank,mesoderm development (GO:0007498),-0.3164964223381441,-0.8653228044322037,0.627177700348432,0.8928525746677599,1.0,8/18,18.30%,TIE1;TBX3;TBX1;BMX;GDF11;IKZF1;BTK;HCK
prerank,negative regulation of double-strand break repair (GO:2000780),0.3546379535857562,0.8651643961244928,0.6259946949602122,0.9115754574312446,1.0,5/30,13.29%,TWIST1;UBR5;HELB;CGAS;TRIP12
prerank,cellular response to chemical stress (GO:0062197),-0.22096399108121037,-0.8650355767468269,0.8584905660377359,0.8922359146896294,1.0,31/96,18.86%,PRR5L;PRKD1;MSRA;CPEB2;FOXO1;PRKAA2;SOD3;PPARGC1A;NOX1;FAS;DDX3X;PINK1;FANCC;PIK3CA;ALDH3B1;SIRT2;NOX4;NCF2;CYCS;STOX1;ERO1A;LONP1;TRPV4;ATP13A2;MT3;SRXN1;HSPA1A;SOD1;ETV5;SELENOS;STX4
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4224038402622366,0.8646926415958569,0.6059113300492611,0.912006543479397,1.0,3/10,14.61%,KDM1A;BRCA1;ATRX
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.4284341703881037,0.8646158865921505,0.6248012718600954,0.9116988309951016,1.0,1/10,3.22%,NFE2L2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.39315968265915036,0.8644553758001053,0.6472346786248132,0.9115288648878251,1.0,5/16,19.23%,CREBBP;NAA15;NAA40;NAA80;NAA60
prerank,axonal transport (GO:0098930),0.3456907598260465,0.86443667662963,0.6529032258064517,0.9111161706767041,1.0,9/36,18.54%,KIF1B;AP3B1;PAFAH1B1;KIF3B;AP3M1;RAB21;AP3D1;BLOC1S5;AP3S1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4235242474110613,0.8644314136610379,0.6359375,0.910681993224566,1.0,5/11,17.75%,ATP2B4;LMNA;GLRX3;SMAD4;P2RX4
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3894176133932924,0.8642997984752541,0.6343612334801763,0.9104695179834013,1.0,3/17,11.32%,LTBP3;KDM1A;PDCD2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.39837236993532,0.8641593868239558,0.6384615384615384,0.910289059916594,1.0,6/14,21.29%,CHKB;ETNK1;LPIN2;ETNPPL;CEPT1;ETNK2
prerank,neurotransmitter uptake (GO:0001504),0.42035035962373657,0.8636971966690915,0.6479099678456591,0.9106820379841464,1.0,1/12,0.16%,SLC38A1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2926485124411796,-0.8634744671213531,0.6843971631205674,0.8943012633011295,1.0,7/23,24.95%,CECR2;KPNB1;HMGB1;FOXL2;HMGB2;CASP3;MUS81
prerank,protein-containing complex subunit organization (GO:0043933),0.3047051417133385,0.86345626245526,0.7074235807860262,0.9106873490225086,1.0,23/109,18.03%,HES1;REPS2;PTK2B;SOX9;SLC7A9;MNAT1;CREBBP;SHANK1;IKBKG;DMTN;EPRS1;DET1;TEAD1;ZW10;TRAF2;PARD3;MDM4;CAPZA1;TUBGCP2;VAMP2;YAP1;NUP35;NCKAP1L
prerank,positive regulation of double-strand break repair (GO:2000781),0.3361891371138699,0.8631809667965041,0.6521197007481296,0.9107358303330103,1.0,17/39,27.84%,SPIDR;PARP3;PARP1;WDR48;KMT5B;FUS;DDX11;PRKDC;ACTR2;KMT5C;SLF1;ZCWPW1;KDM4D;MRNIP;PARP9;SMCHD1;SETMAR
prerank,cellular response to interleukin-12 (GO:0071349),-0.248282992180367,-0.8627297540716513,0.7264150943396226,0.8946562444748538,1.0,18/48,21.64%,PLCB1;SIRPA;CFL1;CNN2;LMNB1;TALDO1;MIF;MSN;LCP1;BOLA2;P4HB;CD47;SOD1;PSME2;JAK1;HNRNPDL;MTAP;PPIA
prerank,ceramide metabolic process (GO:0006672),0.32682936360639203,0.8622479630390049,0.6645408163265306,0.9119995286339395,1.0,4/49,4.55%,ACER3;PLPP3;SGMS2;PLA2G15
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3929524668232792,0.8621013043026552,0.6471428571428571,0.9118172752102012,1.0,2/18,4.45%,LBP;PLCG2
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.35749411007409454,0.8619693637174205,0.6222527472527473,0.9116223165184746,1.0,4/27,13.66%,GSR;CTPS2;AK4;AK1
prerank,positive regulation of neuron projection development (GO:0010976),0.3101017239555373,0.8616219376380493,0.6950517836593786,0.9117950592723069,1.0,21/85,13.83%,DPYSL3;NTRK3;COBL;BMP5;PTK2B;FZD1;KIDINS220;SCARB2;ROR1;STYXL1;ARSB;P3H1;DHX36;RAP1A;MARK2;ZDHHC15;RET;NPTN;SCN1B;DBN1;ALKAL2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.357959375008629,0.8610280546454832,0.6440443213296398,0.912401795321554,1.0,4/27,8.57%,MARK1;GSK3B;NDEL1;MBOAT1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3573760329119846,0.8608851673518529,0.6238159675236806,0.9122098056749701,1.0,3/29,5.26%,PKD1;CLCF1;STAT3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.410939788992951,0.8607957235863061,0.6216216216216216,0.9119324434354786,1.0,3/13,5.95%,FSTL1;NOG;NBL1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.32824524461940374,-0.8603174394503906,0.6390728476821192,0.8986172126871486,1.0,2/17,5.77%,LPGAT1;PLAAT3
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.281504639751616,-0.8601761472361329,0.6810035842293907,0.8976724423852486,1.0,10/27,18.60%,IGF1;WNT5A;CDK6;SPHK1;GAS6;CDK4;MIF;CD74;BMI1;PDGFRA
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2960040953493323,0.8598704312222311,0.7142857142857143,0.9132164392851551,1.0,16/117,12.88%,ME1;SLC5A6;ADH7;SLC16A1;VNN1;CYP2S1;ACSL3;ACOT12;ACOT11;PDHA1;CKB;NPC1;ANGPTL3;CPT1B;GNPAT;CPT1C
prerank,substantia nigra development (GO:0021762),-0.263502309182495,-0.8598658910173993,0.7260869565217392,0.8971489519956934,1.0,10/37,13.20%,GNB4;MBP;MAOB;ACTB;PLP1;CALM1;YWHAH;BASP1;ATP5PF;SIRT2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.285822657732035,0.8598031814576624,0.7700312174817898,0.9128919179009659,1.0,55/208,20.27%,TANK;AKAP13;ESR1;ALPK1;TRAF3IP2;S100B;PLCG2;PER1;TAB3;REL;MIER1;NLRP12;IRAK4;RORA;ROR1;IKBKG;IKBKE;ZFAND6;TRIM39;ZC3H12A;MAVS;RIPK2;RHOA;MAP3K7;DHX36;TAB2;MAP3K3;ANKRD17;MYD88;TRAF2;NR1D1;CPNE1;TIRAP;MTDH;CARD16;ZDHHC13;DDX21;PIM2;PIDD1;TRAF6;TNIP1;PPP5C;TRAF5;IKBKB;SHISA5;MAP3K14;TRAF4;RBCK1;TICAM1;BRD4;NLRX1;CHUK;USP10;NEK6;MID2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.399297418713496,0.8595680057340414,0.6316568047337278,0.9128763665104643,1.0,3/15,14.66%,ZC3H12C;ZC3H12A;ZC3H12B
prerank,regulation of fat cell differentiation (GO:0045598),0.3104218070757991,0.859369140377429,0.7022988505747126,0.9127808665996453,1.0,20/74,19.83%,ZFPM2;CMKLR1;ID2;ZBTB16;RORA;ZC3H12A;TRPM4;SYAP1;ZFPM1;TRIO;NR1D1;E2F1;LRP5;ALOX5;FTO;YAP1;CDS1;PPARG;FERMT2;CREBL2
prerank,cellular response to glucose stimulus (GO:0071333),0.3527431968732704,0.85936644912054,0.6516393442622951,0.912339119714403,1.0,6/30,10.80%,UNC13B;CLTRN;KCNB1;SLC39A14;MLXIPL;PDK3
prerank,regulation of developmental growth (GO:0048638),0.3525952092187396,0.8591866313082489,0.6260162601626016,0.9122212916358357,1.0,6/29,9.60%,SIX1;GSK3B;ABL1;NIPBL;AGR2;SIX4
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.32208002743162045,-0.8590535660265916,0.6737160120845922,0.8976606834373219,1.0,2/17,3.20%,CTNNA2;WASF3
prerank,regulation of gene silencing by RNA (GO:0060966),0.32843713233707533,0.8589793548652863,0.6786600496277916,0.9116953222674659,1.0,22/50,32.93%,NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;PUM2;POLR2C;EIF4G1;PUM1;FMR1;TRIM71;NUP98;POM121;AGO1;SEC13;SEH1L;NUP54;TPR;AAAS
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.32843713233707533,0.8589793548652863,0.6786600496277916,0.9116953222674659,1.0,22/50,32.93%,NUP93;AGO2;NUP214;NUP153;NUP155;RANBP2;NUP88;NUP35;PUM2;POLR2C;EIF4G1;PUM1;FMR1;TRIM71;NUP98;POM121;AGO1;SEC13;SEH1L;NUP54;TPR;AAAS
prerank,pre-replicative complex assembly (GO:0036388),0.31657955797362475,0.85879657028488,0.6810551558752997,0.9115888130032976,1.0,22/64,28.26%,PSMB2;MCM2;PSMD11;PSMC1;PSMC6;ORC3;PSMD1;MCM7;PSMD4;PSMA6;PSMD14;PSMD12;PSMD7;PSME3;PSMD3;PSMB6;UBB;CDC6;UBA52;RPS27A;ORC6;PSMA5
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.42699923911234927,0.8584167976237944,0.6323076923076923,0.9118347944852615,1.0,2/10,6.10%,VEGFA;BMP6
prerank,negative regulation of biomineral tissue development (GO:0070168),0.3682054678736093,0.8580757375081394,0.6212765957446809,0.9120092079098326,1.0,5/21,10.56%,PTK2B;SOX9;CCL3;TRPM4;BCOR
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.34189390901755434,-0.858043135472935,0.6895522388059702,0.8985361449344477,1.0,3/13,15.90%,ENPP1;TPST1;SULT4A1
prerank,negative regulation of interferon-beta production (GO:0032688),0.4285914991186173,0.8577848513016793,0.6387959866220736,0.9120742982721677,1.0,7/10,26.88%,REL;PTPRS;RELB;YY1;LILRB1;NLRC3;PPM1B
prerank,negative regulation of immune effector process (GO:0002698),0.40379264082733984,0.8577366185868123,0.6425269645608629,0.9117102960472644,1.0,1/13,1.19%,CD55
prerank,response to retinoic acid (GO:0032526),0.3192533197195685,0.8575598094384373,0.67018779342723,0.9116050208054329,1.0,6/59,4.08%,WNT9A;WNT11;PTK2B;SOX9;FZD7;RARA
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.2749392987789099,-0.857004583327376,0.6589147286821705,0.8993756732053203,1.0,1/31,0.06%,PLCB1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3214033260865734,0.8566674622774344,0.6783042394014963,0.9127964860941461,1.0,10/51,10.43%,WNT11;SORBS3;NRP1;TGFB3;TGFBR1;ABL1;MYOC;GPR65;S100A10;RHOA
prerank,mRNA destabilization (GO:0061157),0.3326832270062157,0.8562686753837193,0.6602067183462532,0.9131059401311374,1.0,15/38,29.07%,TUT7;TUT4;ZC3H12A;DHX36;CELF1;MEX3D;MOV10;FTO;PUM1;TARDBP;CNOT1;TRIM71;METTL16;ROCK1;YTHDF2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.3292441532016804,-0.8561937106282702,0.6590909090909091,0.8998206335794854,1.0,5/14,18.13%,BCL2L1;CREB3;XBP1;HSPA1A;SELENOS
prerank,regulation of cell projection organization (GO:0031344),-0.3372944791100898,-0.8559454009372,0.6638888888888889,0.8991119604713514,1.0,6/13,24.13%,CCL19;MFSD2A;SEMA4D;NTNG1;NTNG2;TREM2
prerank,positive regulation of hormone secretion (GO:0046887),-0.31154449666445416,-0.8559450482756203,0.6430868167202572,0.8978778878690871,1.0,3/17,10.17%,SPP1;C1QTNF3;EDN1
prerank,response to organonitrogen compound (GO:0010243),0.33615207930629226,0.8558220624496947,0.6760925449871465,0.913461690106819,1.0,6/38,14.84%,GLRB;IRAK3;RNF185;VCP;DRD3;SEL1L
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.35510280831408947,0.8557404134276304,0.6458333333333334,0.9131650620694888,1.0,16/30,28.09%,KIF13A;KRT18;SEC16A;NSF;GOLPH3;VAMP2;GOLGA7;GOLGA4;SPTBN1;GOLPH3L;BBS2;RAB26;GCC2;GGA1;GGA2;SYS1
prerank,regulation of axon extension (GO:0030516),0.34123063348786536,0.8556678215217031,0.6578599735799208,0.9128613715542395,1.0,7/37,13.51%,NTN1;GSK3B;ABL1;SHTN1;CTTN;PTPRS;DBN1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4225994236524211,0.85557535810286,0.6451104100946372,0.9125800153277258,1.0,2/11,9.12%,RNF185;VCP
prerank,cytokine-mediated signaling pathway (GO:0019221),0.27649411367025245,0.8554103279269146,0.8736208625877633,0.9124276801343116,1.0,90/532,17.80%,F3;CARD14;LBP;PRKCD;CAMK2D;ANXA2;TNFRSF11B;PTK2B;FGF2;GAB2;IL22RA1;EDA;IRS1;VEGFA;IL20RB;CXCL2;CLCF1;MID1;PITPNA;GRB10;PSMB2;CCL3;IL17RE;LIMS1;CCL1;TIMP1;TRAF3IP2;IRAK3;IL33;TWIST1;STAT3;SHC1;ANXA1;FOXO3;TAB3;CTF1;IL17RA;CD44;IRAK4;RORA;FN1;IKBKG;IP6K2;GSTA2;ITGB1;IRF1;PSMD11;CCND1;EGR1;CD80;FOXC1;PSMC1;PDCD4;CUL1;CCL7;RIPK2;MAP3K7;TAB2;MAP3K3;MCL1;PSMC6;COL1A2;IFI35;MYD88;CDKN1B;TRAF2;CEBPD;INPPL1;IFNLR1;TXLNA;CNTF;CAPZA1;PSMD1;POU2F1;TRAF6;PSMD4;ALOX5;CDKN1A;SMAD4;TRAF5;LCK;IKBKB;TNFRSF12A;YAP1;MAP3K14;SOCS3;SERPINB2;PSMA6;HNRNPA2B1;TNFSF13B
prerank,regulation of transposition (GO:0010528),0.4081607954928008,0.8549395943152389,0.6444444444444445,0.9128548243707417,1.0,1/13,5.55%,TEX15
prerank,negative regulation of intracellular protein transport (GO:0090317),0.37181189283701416,0.8548445571618903,0.6532951289398281,0.9125821939490742,1.0,6/22,17.76%,MDFIC;BARD1;DMTN;CHP1;ITGB1BP1;LRRK2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.38332529840464796,0.854405718794722,0.6398852223816356,0.912918417112778,1.0,5/17,15.16%,BMP4;ATP1A3;ATP1A1;NR3C1;URI1
prerank,nuclear membrane organization (GO:0071763),0.380150485328353,0.8539630215895571,0.6434782608695652,0.9133109916378019,1.0,7/19,27.83%,EMD;TOR1B;UBXN2B;TOR1AIP1;TARDBP;AKAP8L;PLK1
prerank,modulation by symbiont of host process (GO:0044003),-0.3632109555047595,-0.8539621368259164,0.6586666666666666,0.900856203460313,1.0,3/10,18.47%,B2M;MRC1;ENO1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.30591550576490273,-0.8537292425759478,0.6445993031358885,0.9001237296011577,1.0,4/18,10.72%,DCN;KDR;SPIRE1;PINK1
prerank,axonogenesis (GO:0007409),0.2823087877685938,0.853625971769225,0.786734693877551,0.9134844038119547,1.0,43/237,14.94%,SLIT3;SLIT2;SEMA3E;ULK2;EZR;EFNA5;GAB2;UNC5C;SLIT1;NRP1;PDLIM7;NOTCH2;GRB10;SEMA3C;S100B;EPHB3;KLF7;SPTAN1;LYPLA2;SHC1;DOCK7;SEMA3D;GLI2;PTPRA;SHTN1;EMB;SLITRK2;MAP1B;POU4F1;EPHB2;NIBAN2;SEMA4B;PARD3;RET;NPTN;SCN1B;EFNA3;SPG11;MAP1S;GFRA3;CYFIP1;PRKCA;ATL1
prerank,RNA metabolic process (GO:0016070),0.2914311509117308,0.8530192969608237,0.7152103559870551,0.9141330760490461,1.0,35/127,21.91%,RBFOX2;SIDT2;DDX17;FASTKD1;AGO2;RBM39;DDX24;ZC3H12A;DUSP11;ATXN2;DHX36;RBM3;TENT2;RNASE3;HNRNPH1;WTAP;RNASEH2A;RBMX;BICD1;HNRNPM;LSM8;FTO;PABPC4;HNRNPA2B1;DHX9;POLR2C;SYNCRIP;RBM6;MRPL44;SNRNP40;CLP1;DHX8;EXOSC7;RNGTT;HNRNPH2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.354383791122745,0.8529215025935568,0.6527777777777778,0.9138590229732604,1.0,6/27,16.55%,NFAT5;NR4A3;CD44;RHOA;TRAF6;LCK
prerank,regulation of protein metabolic process (GO:0051246),0.32601199030614564,0.8526950618220432,0.6624525916561315,0.913821255836837,1.0,13/44,21.02%,CNDP1;LDLR;KLF4;CHEK2;ABCA7;ZDHHC2;LTBP4;ODC1;SPOPL;SNF8;SPOP;PM20D2;TRAF3
prerank,positive regulation of cilium assembly (GO:0045724),-0.3099121769642369,-0.8526730802357201,0.6762820512820513,0.9011509598774584,1.0,4/18,15.17%,TAPT1;WRAP73;CEP120;CCDC88A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.38421516434167036,0.8523724470466832,0.6426426426426426,0.9139526572065312,1.0,5/18,21.18%,NFE2L2;VNN1;BAG5;NONO;SOD2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3950459529814028,0.8520025794201833,0.6344410876132931,0.9141945211084433,1.0,4/16,17.98%,LDLR;PNPLA2;SREBF1;DAGLB
prerank,nuclear pore organization (GO:0006999),0.4020413042675732,0.8519107306472339,0.6412884333821376,0.9139083062104737,1.0,4/14,17.81%,NUP93;NUP153;AHCTF1;NUP35
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.2794019955624415,0.8519004614632325,0.7857868020304568,0.913488035655372,1.0,107/264,32.42%,DDX5;DDX17;SRSF11;U2AF2;RBM14;DBR1;SRSF5;SRSF6;SRRM2;SNRNP48;CDK13;PABPC1;CDC40;SRSF2;CELF4;FUS;HNRNPH1;SNRNP35;PRMT5;U2SURP;RBMX;SCAF11;SRSF1;CHERP;WBP4;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;CPSF3;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;GEMIN5;SNRNP40;CLP1;TGS1;PDCD7;SF3B3;DHX8;PNN;LSM4;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;SRPK2;FIP1L1;YTHDC1;HNRNPF;USP39;RBM4;SMN1;SCNM1;SNRNP200;GEMIN8;CSTF1;SNUPN;PTBP1;RBM17;ZCRB1;WDR33;DNAJC8;RBM5;GCFC2;SMNDC1;SNRPB;SNRPB2;DHX15;ELAVL1;ZRSR2;HNRNPC;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;SRPK1;WBP11;PPIL3;TXNL4A;PRPF3;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B;SRSF7;SNRPA
prerank,regulation of T cell mediated immunity (GO:0002709),0.43021880177225263,0.8516859729044657,0.6534810126582279,0.9134174578474042,1.0,2/10,11.56%,TRPM4;ZBTB1
prerank,intracellular lipid transport (GO:0032365),0.3748317700278893,0.851238327266755,0.6657223796033994,0.9137427469296108,1.0,5/21,16.15%,ABCD3;ABCD1;ACACA;CPT1B;SLC25A20
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.2772932687767213,0.8509301027148587,0.8210313447927199,0.9138558246291179,1.0,68/306,19.83%,ST3GAL4;EXT1;RPSA;EXO1;LARGE1;TBRG1;ABCF1;CDC45;MCM2;MEF2A;TICRR;AGO2;NR4A2;INHBA;BARD1;GAL3ST4;WRN;TOPBP1;MRPL42;EIF4G2;HELB;TOP1;MRPL11;CLSPN;POLE2;GSPT1;RRBP1;KIN;RAD50;POLR3A;ORC3;RAD17;BRCA1;DRG1;E2F1;RNASEH2A;SRBD1;COPS5;MRPL36;BRIP1;MCM7;EEF2K;RNPS1;HOXD3;TNIP1;GTPBP2;PCLAF;FAM111A;GOLPH3;CDK2;PPP5C;CDC7;PABPC4;RECQL5;MED20;DONSON;MCM9;RMI2;MRPL23;POLA2;POLR2C;IGF2BP3;ATR;EIF4G1;MRRF;EPC1;ASMT;CREBL2
prerank,renal absorption (GO:0070293),0.41976660669178545,0.850689575283916,0.6454689984101749,0.9138502652387654,1.0,2/10,9.60%,GSN;MAGED2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.29071923267064637,-0.850614834519736,0.7013888888888888,0.9043143938773333,1.0,11/22,20.41%,PLA2R1;RPL37;SPRED1;RPS7;RPS15;CDK5RAP3;HIC1;RPS20;RPL23;EIF5A;MSX1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.321905269912282,0.8505649250090859,0.7016908212560387,0.9136291320794029,1.0,17/54,29.17%,NXN;U2AF2;HDAC8;CHP1;SPOPL;USP4;SMAD7;BAG5;BAG2;GTPBP4;OGT;GNL3L;SENP2;PIAS3;RPL5;DNAJA1;SQSTM1
prerank,positive regulation of histone deacetylation (GO:0031065),0.42105927915980074,0.850387375663518,0.6557911908646004,0.9134984781357267,1.0,4/12,17.32%,VEGFA;NIPBL;SAP30BP;ZBTB7B
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3804253285939234,0.8501586870279241,0.6553254437869822,0.9134528373009783,1.0,2/17,3.91%,NFE2L2;VNN1
prerank,protein ADP-ribosylation (GO:0006471),0.3544774266014879,0.8497117260308804,0.6613545816733067,0.9138072329281145,1.0,9/28,19.48%,SIRT6;PARP3;PARP1;PARP12;ARF4;SIRT3;PARP6;PARP2;PARP4
prerank,regulation of translational initiation (GO:0006446),0.3169236750955899,0.8496330902374614,0.7070217917675545,0.9135007691958663,1.0,17/63,23.19%,EIF4G3;PAIP2;AGO2;NCK2;EIF4G2;EIF3E;CDC123;DNAJC3;EIF5B;KHDRBS1;NCK1;RPS6KB1;EIF4B;EIF4G1;FMR1;MTIF2;ALKBH1
prerank,Ras protein signal transduction (GO:0007265),0.28651140775160094,0.8496315306236728,0.7454350161117078,0.9130686618608896,1.0,14/137,6.59%,PLCE1;NTN1;CDC42EP5;CCNA2;FGF2;NRAS;KRAS;ARHGDIB;MRAS;SHOC2;G3BP2;SHC1;NF1;TIAM1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.2868362657335517,-0.8495128986143471,0.671280276816609,0.9053158553204484,1.0,3/24,3.31%,ERRFI1;PRKCH;ROCK2
prerank,macrophage chemotaxis (GO:0048246),0.43441483052827634,0.8492226827354578,0.6395534290271132,0.9133443010264485,1.0,1/10,4.14%,CCL3
prerank,carnitine shuttle (GO:0006853),-0.3572927302839523,-0.8491021289094657,0.6597938144329897,0.9048805484847698,1.0,4/11,15.43%,PRKAA2;ACACB;PRKAG2;MID1IP1
prerank,positive regulation of transferase activity (GO:0051347),0.290426178837006,0.8488890473763527,0.7529665587918015,0.9135093445126039,1.0,16/142,7.80%,EGFR;MET;NTRK3;DDR2;LMO4;GRHL2;KLF4;DCUN1D5;CHTF18;EPHB3;FGFR1;NEK7;ERBB2;CHTF8;ROR1;DSCC1
prerank,positive regulation of protein processing (GO:0010954),0.3806463193777645,0.8487714168988152,0.6446991404011462,0.913266004800949,1.0,2/19,2.92%,GSN;TNP2
prerank,glycerol metabolic process (GO:0006071),-0.3563579375030795,-0.8486860385575705,0.6657963446475196,0.9044689073602417,1.0,2/10,7.49%,GK;COQ2
prerank,negative regulation of histone methylation (GO:0031061),0.4151272358070675,0.848684924250732,0.6442307692307693,0.9129793876568356,1.0,3/10,12.66%,KDM1A;BCOR;BRCA1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4123304358113888,0.8486025332276497,0.6451104100946372,0.9126809642438155,1.0,2/10,6.03%,PLS1;TSKU
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.3884475494249854,0.8477157960829687,0.649546827794562,0.9138341976109391,1.0,6/15,16.49%,FGFR1;CELF4;BRCA1;CELF1;UBR3;CAMSAP3
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2915528562276042,-0.8476338551111813,0.7043189368770764,0.9053709928464665,1.0,7/20,16.99%,BCL2;DCC;BCL2L1;FAS;ERBB3;BOK;GSK3A
prerank,response to reactive oxygen species (GO:0000302),0.3206166761186915,0.8471793611021674,0.7091775923718713,0.914351506484008,1.0,2/54,1.31%,EGFR;ADAM9
prerank,filopodium assembly (GO:0046847),0.38747157436012875,0.8469461805418098,0.6473214285714286,0.9143192087154082,1.0,6/16,17.88%,EZR;SRGAP2;FGD1;FGD3;FGD6;S1PR2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.3379998774675087,-0.8466741167134262,0.6564245810055865,0.9061136974914367,1.0,5/13,21.03%,AAR2;SRSF10;DDX20;PRPF31;SART3
prerank,ERAD pathway (GO:0036503),0.2984647387632072,0.8464420052418513,0.7106481481481481,0.9147557314426378,1.0,19/83,24.00%,UBE4B;USP13;RNF185;MAN1B1;VCP;UBE4A;FBXO27;PSMC6;HERPUD1;SEL1L;FBXO17;TMEM129;ANKZF1;USP19;UBXN4;DNAJB2;POMT2;RHBDD2;SEC61B
prerank,regulation of microtubule depolymerization (GO:0031114),0.35085031323737026,0.8463251989071311,0.6737891737891738,0.9145188765903289,1.0,7/25,16.49%,FGF13;KATNB1;MAP1B;CIB1;HDGFL3;MAP1S;CAMSAP3
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.24960932521681672,-0.8456387333319848,0.7523809523809524,0.9069794965399353,1.0,15/46,27.29%,DGKB;DGKD;DGKG;GPAM;AGPAT4;PLD2;DGKZ;ABHD8;AGPAT5;ABHD4;LIPH;PLA2G4B;PLA2G5;LPCAT4;GPD1L
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.41345892784918403,0.8450774884026839,0.6702290076335878,0.9163252234023167,1.0,3/12,16.55%,WNK1;MIA3;LCK
prerank,histone H3-K4 methylation (GO:0051568),0.36060805851042793,0.8447940417299142,0.692090395480226,0.9163710295466971,1.0,11/26,32.86%,KMT2C;WDR82;KMT2D;DPY30;OGT;SETMAR;CTR9;TET3;PAXIP1;MEN1;PRDM9
prerank,Notch signaling pathway (GO:0007219),0.3119492654163766,0.8447138278816141,0.7118012422360248,0.9160904199317353,1.0,13/59,13.70%,HES1;PBX1;ZNF423;NOTCH2;GMDS;CREBBP;HES3;DTX2;GALNT11;JAG1;POFUT1;NRARP;MIB1
prerank,mitochondrial protein processing (GO:0034982),-0.3553932880719821,-0.8440650779898136,0.6676056338028169,0.9089660973158096,1.0,1/11,1.81%,IMMP2L
prerank,artery development (GO:0060840),0.36732331479064834,0.8432224600836079,0.6657303370786517,0.9182586273840703,1.0,5/23,5.44%,HES1;NRP1;VEGFA;TGFBR1;NF1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.38830049244687015,0.8428089149950959,0.6559766763848397,0.9185511199228259,1.0,5/16,20.17%,SCARB2;RORA;PDK3;FOXK1;FOXK2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.33106509120386823,0.8426673232031459,0.6800535475234271,0.918349187129676,1.0,7/39,13.82%,PIK3C2B;TTC7A;IP6K1;IP6K2;PIK3R3;PI4KB;PIP4K2A
prerank,receptor recycling (GO:0001881),0.419015103253024,0.8426392398374412,0.6523125996810207,0.9179567040757235,1.0,4/10,21.67%,PHETA2;SORL1;RAB11B;ARFGEF2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3340144904493487,0.842462005298674,0.6758793969849246,0.9178373652258388,1.0,16/38,28.77%,RBBP7;CENPT;HJURP;HIRA;CENPL;ATRX;SMARCA5;CABIN1;IPO4;CENPW;ASF1A;CENPP;RSF1;HAT1;CENPK;NASP
prerank,steroid metabolic process (GO:0008202),-0.2281728949930314,-0.8422558397702588,0.8164556962025317,0.9112454593533789,1.0,8/72,9.89%,CYP7B1;CYP27A1;CYP26B1;LIPA;LGMN;ARV1;CUBN;MSMO1
prerank,regulation of histone modification (GO:0031056),0.40279768330702204,0.8421978792216671,0.6413373860182371,0.9178338204149568,1.0,8/13,34.19%,NNMT;IGF2;AKAP8L;SETD5;UBE2N;PARK7;FLCN;PARG
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.3838833227348736,0.8420286551679457,0.6404160475482912,0.9176954622551217,1.0,1/15,1.64%,PRKCD
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.35482540319616457,0.8419530638892891,0.6676056338028169,0.917388914401219,1.0,4/24,10.99%,CCL3;FOXO3;NF1;MCL1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.2491332491941032,-0.8417938382677091,0.8206521739130435,0.9109413528460887,1.0,14/49,16.64%,BCL2;SGMS1;BCL2L1;DAPK2;NDUFA13;DDX3X;PINK1;BCL2L11;RACK1;NUPR1;UBQLN1;BOK;P4HB;FIS1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.34084816763775977,0.8414748763978174,0.6857142857142857,0.9178016367797962,1.0,4/34,3.09%,TNFAIP8L3;PTK2B;FGF2;IRS1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.22317943832605405,-0.8412993175471218,0.8347107438016529,0.9107101081811785,1.0,6/75,6.73%,PLCB1;PDGFRB;GPCPD1;PLA1A;SERINC5;ENPP6
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.3111648397295535,0.8411365747520335,0.7132867132867133,0.9179725052375475,1.0,11/70,10.43%,TMEFF2;SRGAP2;GRHL2;NRP1;RAB25;EPHB3;PARVA;FN1;ANTXR1;ITGAV;RHOA
prerank,mRNA polyadenylation (GO:0006378),0.34973744022621056,0.8408862481690099,0.6827195467422096,0.917548892307483,1.0,10/26,23.87%,SCAF8;PABPC1;TENT2;SSU72;CPSF3;TENT4B;CSTF3;CLP1;FIP1L1;PAPOLG
prerank,RNA polyadenylation (GO:0043631),0.34973744022621056,0.8408862481690099,0.6827195467422096,0.917548892307483,1.0,10/26,23.87%,SCAF8;PABPC1;TENT2;SSU72;CPSF3;TENT4B;CSTF3;CLP1;FIP1L1;PAPOLG
prerank,regulation of defense response (GO:0031347),0.2974747334562151,0.8402960365479494,0.7161066048667439,0.9181210252178091,1.0,22/76,25.10%,FOXP1;MGLL;PIK3AP1;ANXA1;IRF1;MYD88;CELF1;TIRAP;ALOX5;AREL1;PSMA6;DAGLB;JAK2;BRD4;NR1D2;TRAF3;ERAP1;PTGES;SETD6;APPL2;SBNO2;NLRP6
prerank,defense response to bacterium (GO:0042742),0.2921700080092114,0.8401303280299157,0.7513935340022296,0.9179906404576724,1.0,12/105,13.32%,LBP;PRKCD;DEFB130A;SHC1;TLR4;ANXA3;MAVS;ANKRD17;MYD88;RNASE3;LYST;TIRAP
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.3091761754343786,-0.8399470021630132,0.6797583081570997,0.912189136724902,1.0,7/18,24.99%,CORO2B;WRAP53;CEP120;CCT8;CCT3;TREM2;TCP1
prerank,response to leucine (GO:0043201),0.4171194822077564,0.8397949627317696,0.6698564593301436,0.9177111314955286,1.0,4/10,24.23%,KLHL22;SESN3;LARS1;MTOR
prerank,cellular response to leucine (GO:0071233),0.4171194822077564,0.8397949627317696,0.6698564593301436,0.9177111314955286,1.0,4/10,24.23%,KLHL22;SESN3;LARS1;MTOR
prerank,Golgi inheritance (GO:0048313),0.41213096966550467,0.83930129381853,0.647887323943662,0.9181507916557938,1.0,4/11,19.10%,GBF1;STX5;PLK3;VCPIP1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.323572031573125,0.8391734570676049,0.6853658536585366,0.9179227964107759,1.0,5/45,7.74%,PRKCD;CAMK2D;MID1;CD44;IRF1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.30456762303234813,0.8387148785827641,0.7076566125290024,0.9182484020183841,1.0,8/67,6.57%,EGFR;DDR2;ABI1;PTK2B;SRMS;ABL1;FGFR1;ERBB2
prerank,nuclear membrane reassembly (GO:0031468),0.31584087311647546,0.8384638164705952,0.6909975669099757,0.9182523159530454,1.0,12/54,18.39%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35;UBXN2B
prerank,regulation of macroautophagy (GO:0016241),0.291289043421441,0.838306453728388,0.7302118171683389,0.9180913203588975,1.0,24/105,20.20%,NEDD4;EXOC4;CLEC16A;RRAGB;NRBP2;WAC;IKBKG;PAFAH1B2;LZTS1;SNX32;MAP3K7;SCOC;RB1CC1;SH3GLB1;EXOC7;ATP6V1A;RHEB;MLST8;LRRK2;ATP6V0D1;GPSM1;CAPN1;EPM2A;SESN3
prerank,regulation of interleukin-17 production (GO:0032660),-0.2678865856955125,-0.8380948277697439,0.7579365079365079,0.9147053141582606,1.0,5/31,9.52%,RFTN1;SLC7A5;PRKCQ;IL18;SPHK1
prerank,lipid modification (GO:0030258),0.3292009770758356,0.8380558209540088,0.6697009102730819,0.9180886353185232,1.0,5/37,8.57%,PLPP3;PLPPR2;MBOAT4;DGKA;MBOAT1
prerank,positive regulation of heart rate (GO:0010460),-0.3117033197331812,-0.8380086428731411,0.6708860759493671,0.9136167635286839,1.0,6/17,11.33%,RYR2;PDE4D;ATP2A2;EDN1;ADM;KCNQ1
prerank,cellular response to unfolded protein (GO:0034620),-0.2705861912185672,-0.8377548272170584,0.7311827956989247,0.9129297933432593,1.0,10/26,24.02%,OPTN;HSPA8;DAB2IP;HSPA13;ABCB10;ERN1;HSPA1A;HSPD1;HSPA2;HSPA5
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3691631569565297,0.8372460454505417,0.6928571428571428,0.9189958893301451,1.0,2/20,4.17%,MET;ADA
prerank,pre-miRNA processing (GO:0031054),0.39348463577293463,0.8367451684631483,0.6890243902439024,0.9194082702246493,1.0,8/14,28.65%,AGO2;TUT7;TUT4;MRPL44;DICER1;PRKRA;DROSHA;AGO1
prerank,negative regulation of hippo signaling (GO:0035331),0.4016925237736026,0.836699929201193,0.652241112828439,0.9190667399161434,1.0,6/12,27.06%,CIT;MARK3;DLG5;WWC2;MAP2K3;LIMD1
prerank,lipid translocation (GO:0034204),0.3680410892171337,0.8366277395846359,0.6887608069164265,0.9187678492161907,1.0,8/21,18.40%,TMEM30B;ABCA7;ATP11A;ATP9B;ATP10A;ABCC1;RFT1;ATP8B4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.2701216124768863,-0.8365246225225001,0.7298387096774194,0.9141559191906458,1.0,4/29,5.60%,APOE;LPGAT1;PPARA;NR1H3
prerank,protein transport (GO:0015031),0.2738161021260568,0.836363849118398,0.8699596774193549,0.9187895658657956,1.0,108/332,27.00%,RAMP1;TANGO6;SGSM2;TLK1;STX11;KIF13A;LRP1;TMED5;TMED3;TCIRG1;LTBP2;HERC2;RAB43;RAB6A;LMAN2L;RUFY1;RAB24;ARFIP2;SEC31A;AP3B1;SLC10A7;ATP6V0A4;ARFGAP3;COPG1;SCAMP2;COPA;MIA3;CMTM6;SEC23IP;KIF3B;NSF;STX5;ARF4;CLU;STX12;CTTN;ARL6IP5;EHD1;TBC1D2B;RAB21;EVI5;ATP6V1A;ARCN1;SCFD2;AP3D1;COPB2;RAB11B;SEL1L;RABGAP1;SNX8;TMEM167A;CHMP2B;GOLPH3;RAB28;RAB1A;VAMP2;TBC1D8B;RAB5B;STXBP1;GOLGA7;GOLGA4;STX2;TBC1D5;TBC1D17;AP2A1;ATP6V0D1;TVP23B;PPARG;EIF2D;LRSAM1;TVP23A;SPTBN1;IFT22;SCAMP3;TMED2;TBC1D15;STX17;GOLPH3L;STX8;ARF3;TOM1;SNX13;SCAMP1;BBS2;RABL3;ATP6V0A2;RAB26;FAM91A1;GCC2;TBCK;RAB1B;COPZ1;RIC1;ARL5C;USO1;NECAB3;CEP290;GGA1;RAB14;CHMP3;VPS26B;SYNRG;STXBP3;TBC1D10A;RCN3;AP4M1;GGA2;ATP6V0B
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3174984504590368,0.836320553766266,0.7062423500611995,0.9180096092266886,1.0,11/51,17.81%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35
prerank,mitotic nuclear membrane organization (GO:0101024),0.3174984504590368,0.836320553766266,0.7062423500611995,0.9180096092266886,1.0,11/51,17.81%,EMD;CC2D1B;LMNA;NUP93;LEMD2;CCNB1;AHCTF1;NUP155;CHMP2B;LBR;NUP35
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.3421984006372158,0.836189135147519,0.6826666666666666,0.9178052711885311,1.0,12/31,26.46%,CNOT8;EXOSC3;DCP1A;EXOSC1;DIS3;EXOSC2;LSM4;EXOSC7;EXOSC8;DDX6;LSM1;PATL1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.2529852712495954,-0.8360906726836503,0.7633928571428571,0.9137533174855963,1.0,10/38,17.54%,GEMIN2;AAR2;PRMT7;SRSF10;SNRPD3;DDX20;PRPF31;CLNS1A;SNRPG;COIL
prerank,cellular response to pH (GO:0071467),0.3803241124825088,0.8354431888430873,0.6753445635528331,0.9186428390657069,1.0,5/17,23.08%,SLC9A1;CHP1;RAB11B;GPR68;HYAL1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.3940915070888892,0.8352829527024869,0.6755905511811023,0.9184886551574158,1.0,6/15,22.54%,ZC3H12A;VCP;DHX36;GSTO1;MKNK2;ZFAND1
prerank,negative regulation of viral process (GO:0048525),-0.2296161273867111,-0.8352709376126851,0.8103448275862069,0.9141004955088087,1.0,16/57,20.09%,IFIT1;TRIM14;IFITM1;OAS2;IFITM3;BST2;PROX1;STAT1;RNASEL;IFITM2;TRIM62;SHFL;PARP10;BANF1;N4BP1;ZFP36
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.32431180002276655,-0.8350785978081003,0.672782874617737,0.9132662299809383,1.0,1/16,0.67%,CADM1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.36094516902732293,0.8347655234645505,0.6866096866096866,0.9189009549183511,1.0,9/23,22.78%,NABP1;ZW10;ZFYVE19;PLK3;ZWILCH;CHFR;WEE1;CHEK1;PRCC
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.32379027360473633,0.8344556267369774,0.6928934010152284,0.9189831717122235,1.0,9/40,18.27%,PTK2B;TRIM39;XPO1;DESI1;RAD23B;CLU;COMMD1;GLMN;SMURF1
prerank,dephosphorylation (GO:0016311),0.28486078425566375,0.8343477251941751,0.772823779193206,0.9187414513297247,1.0,25/147,16.31%,ALPL;PPP3CA;PTPN3;PTPRU;PLPP3;PLPPR2;PTPRF;PPM1H;ACP3;ACP4;PTPRA;DUSP11;PPP2R5C;SBF1;DUSP28;DUSP5;ILKAP;PTPRS;PTPN9;PPP1R12A;PTPN21;UBLCP1;PPP3CC;PPP4R2;PPP5C
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.31363058639501296,0.8342509868267826,0.7095588235294118,0.9184848131290864,1.0,11/52,16.60%,ABLIM3;HPS4;NPEPPS;SAE1;HSPA1L;TFDP1;SH3GLB1;E2F1;UBE2D3;PPP3CC;UBL5
prerank,"base-excision repair, gap-filling (GO:0006287)",0.33732219944842584,0.8342117929841185,0.6842105263157895,0.9181276584779247,1.0,6/35,19.19%,MPG;SMUG1;APEX1;PARP1;POLB;RFC1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29294079412710544,0.8335611066360632,0.7494356659142212,0.9188512204109671,1.0,9/85,10.22%,PIEZO2;COL11A1;NIPBL;CDC14A;ROR1;POU3F4;ATP6V0A4;SLC52A3;TBL1X
prerank,regulation of response to oxidative stress (GO:1902882),-0.3386398082516322,-0.8335203775771319,0.7055837563451777,0.915014662613388,1.0,3/11,15.82%,MCTP1;PINK1;STOX1
prerank,myofibril assembly (GO:0030239),-0.24392193285254218,-0.8327729205876411,0.7942583732057417,0.9152670141114513,1.0,3/42,2.26%,PGM5;PDGFRB;ACTN2
prerank,T cell receptor signaling pathway (GO:0050852),-0.20627205531169182,-0.8325061294356937,0.9285714285714286,0.9145894068222571,1.0,28/138,16.36%,PDE4B;RFTN1;PAK1;PIK3R1;TEC;FYB1;INPP5D;PAK3;TNFRSF21;PDE4D;PRKCQ;THEMIS;BTRC;PSMD8;PSMC3;PSMB4;PTPRJ;PAG1;MOG;PSMB3;PIK3CA;ICOSLG;PTPN22;PSMB8;BTN3A3;PSMA8;EIF2B1;PLCG1
prerank,membrane assembly (GO:0071709),0.3390661418005785,0.8324123680054153,0.6945169712793734,0.9203642824428847,1.0,11/34,18.39%,DMKN;ANXA2;S100A10;GAK;TLCD1;NLGN1;NRXN2;FLOT1;CEL;STX2;UBXN2B
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.3350676785381683,0.8320500175089168,0.7066666666666667,0.9205230536579766,1.0,7/36,10.53%,CRADD;TGFBR1;NR4A2;STYXL1;TRIM39;GATA4;QARS1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.31827732250205787,-0.8318631287556602,0.6878980891719745,0.9146251069900281,1.0,1/17,0.67%,CADM1
prerank,regulation of protein kinase A signaling (GO:0010738),0.3641995315023791,0.8317400250370244,0.672514619883041,0.9206117979635079,1.0,2/20,2.59%,TCIM;ADRB2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3517289996433446,0.8316364150251089,0.6994459833795014,0.9203658598159927,1.0,13/25,31.73%,DBR1;SCAF11;PRPF8;WDR83;SNRNP40;SF3B3;SRRM1;LSM1;SMNDC1;TRA2B;TXNL4A;PRPF3;SF3B1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.30044678460487745,0.831616808646911,0.7426556991774383,0.9199706188059537,1.0,25/72,31.09%,ERCC5;ZC3H12A;CHD1L;PARP1;RAD50;DCP1A;GTF2H3;RFC1;ERCC4;UBB;UBA52;POLK;GTF2H4;DICER1;RPS27A;DXO;SETMAR;MEI4;DDB1;ERCC2;DCP1B;DDB2;POLD1;XPA;GTF2H5
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.36524540787225507,0.8311889299939413,0.7025495750708215,0.9202806260497017,1.0,4/20,7.40%,NT5E;ANO6;PSTPIP1;ENTPD5
prerank,regulation of interleukin-2 production (GO:0032663),0.32854530933634396,0.8305532152811655,0.7081218274111675,0.9209183489439793,1.0,9/43,16.99%,EZR;PLCG2;ANXA1;CD80;MAP3K7;TRAF2;HOMER2;TRAF6;GLMN
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.3418324677232433,-0.8304893578396512,0.6737400530503979,0.9161230326998393,1.0,4/11,23.44%,PTPRT;NF2;SH2B3;CAV1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.403127403236697,0.8304282179875228,0.6692307692307692,0.920703344862804,1.0,4/11,22.09%,STAT3;JAK2;STAT4;IL27RA
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4092360021679664,0.8300150173983671,0.6737481031866465,0.9209829148711973,1.0,5/11,25.30%,PTGIS;ZC3H12A;FAP;TP53;DLC1
prerank,regulation of cellular component size (GO:0032535),0.3351876414581297,0.8299280302238833,0.6724598930481284,0.9206965478535492,1.0,4/30,9.02%,VAV2;EZR;RAP1GAP2;RDX
prerank,positive regulation of interleukin-2 production (GO:0032743),0.35666268481082025,0.8298667175084637,0.6814404432132964,0.9203746975494087,1.0,8/25,20.41%,PLCG2;ANXA1;CD80;MAP3K7;TRAF2;TRAF6;GLMN;SPTBN1
prerank,C4-dicarboxylate transport (GO:0015740),0.39316404995604115,0.8298474074606277,0.6718266253869969,0.9199713363603463,1.0,1/14,1.13%,LRRC8D
prerank,positive regulation of TOR signaling (GO:0032008),0.3215840789067988,0.829358702608893,0.7223650385604113,0.9203447179357397,1.0,10/40,19.12%,TELO2;CLEC16A;RRAGB;HTR6;KLHL22;RHEB;GOLPH3;MLST8;NCKAP1L;GPR137B
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.35805071777797376,0.8292954655679443,0.6831275720164609,0.9200380419494144,1.0,4/24,10.35%,PID1;COQ10B;NR4A3;COX15
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29456698154735284,0.8291553749311786,0.770193401592719,0.9198354147606332,1.0,27/91,23.82%,STON2;NRP1;RAB25;GAS1;ABL1;STON1;RUFY1;ARFGAP1;ITGAV;RAB4B;NSF;RAB21;RAB11B;VAMP2;RAB5B;CPLANE2;SNX12;LRRK2;STXBP5;RAB33B;RAB11A;BET1L;MAP2K2;CPLX2;RAB4A;RAB26;USP7
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3448383634747598,0.8288689528731822,0.6941015089163237,0.9198774817778864,1.0,3/24,7.67%,EZR;NT5E;ITGB1
prerank,phospholipid dephosphorylation (GO:0046839),0.33154622022271935,0.8287801018651015,0.6983914209115282,0.9196014711718317,1.0,11/37,22.85%,PLPP3;PLPPR2;MTMR12;OCRL;PIP4P2;SYNJ2;SYNJ1;MTMR1;SACM1L;PLPP1;MTMR9
prerank,negative regulation of viral genome replication (GO:0045071),-0.24487824184693668,-0.8284581900569267,0.7431192660550459,0.91872127677792,1.0,11/40,17.36%,IFIT1;IFITM1;OAS2;IFITM3;BST2;PROX1;RNASEL;IFITM2;SHFL;PARP10;BANF1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.2938366997667783,0.8282160604276448,0.744920993227991,0.9201391988097471,1.0,15/87,16.78%,RBFOX2;FGF2;SHOC2;FGFR1;SPRED2;KIF16B;CD44;FGFRL1;TIA1;HNRNPH1;ITGB1BP1;NR4A1;HNRNPM;FLRT2;FGFR3
prerank,iron ion transport (GO:0006826),-0.24412488486501582,-0.8280058418356379,0.8100558659217877,0.9183893246221561,1.0,7/47,10.14%,CP;TFRC;SLC40A1;LMTK2;ABCB7;ATP6V0A1;ATP6V1G1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3801158766837001,0.8278069271705092,0.6806596701649176,0.9204303872782275,1.0,4/16,13.61%,PID1;VCP;PARP1;AK4
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2896314816660959,-0.8276519334199174,0.6872727272727273,0.9178505408094328,1.0,2/23,6.25%,CADM1;PIK3R6
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.32553350750779003,0.827606544084062,0.7209595959595959,0.9203339133019971,1.0,9/46,10.43%,TMEFF2;SRGAP2;NRP1;EPHB3;PARVA;FN1;ANTXR1;ITGAV;RHOA
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.38465814805254583,0.8275384125707481,0.6671974522292994,0.9200324510264523,1.0,4/14,21.66%,USP15;ANKRD17;PUM2;PUM1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.35095179268294435,-0.8272354205189859,0.699724517906336,0.917434822369158,1.0,5/10,23.72%,SACS;DNAJA4;HSPA1A;DNAJB6;HSPA2
prerank,cellular iron ion homeostasis (GO:0006879),0.3094737652204845,0.8271559090345484,0.7310012062726177,0.9202727406373428,1.0,14/55,20.01%,SCARA5;ABCG2;SLC39A14;BMP6;GLRX3;CUL1;HMOX2;FXN;ATP6V1A;SMAD4;SLC46A1;ATP6V0D1;FLVCR1;IREB2
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.29134013800153,-0.827085130423572,0.717391304347826,0.9164869506924608,1.0,5/22,9.52%,SASH1;MFHAS1;RELL1;BMP2;SPHK1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.35616836936682167,0.8270701540108043,0.6858345021037868,0.9199977815176213,1.0,6/22,24.23%,ERBB2;WDR43;DDX11;UBTF;PHF8;MTOR
prerank,regulation of cellular respiration (GO:0043457),-0.3090795857953882,-0.8268705655843918,0.7134670487106017,0.9156961014501973,1.0,3/17,5.08%,CBFA2T3;IFNAR1;PRDM16
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32892002169931417,0.8266799045148823,0.6943734015345269,0.9202467484994711,1.0,12/42,19.38%,SRCAP;CHD3;SMARCC1;MBD3;DMAP1;RNF8;SMARCA5;CHD8;VPS72;PBRM1;ACTR5;HDAC2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.2763211410923669,-0.8266552747546628,0.720754716981132,0.9149213601986333,1.0,7/26,17.24%,LPGAT1;PRKAA2;NR1H3;NR1H2;PRKAG2;MID1IP1;PDK4
prerank,GPI anchor metabolic process (GO:0006505),0.341301430085711,0.8265025186734858,0.6961690885072656,0.9201281498862935,1.0,10/26,27.93%,PGAP2;PIGU;PIGO;DPM1;MPPE1;PIGG;PGAP3;PIGB;PIGQ;PIGV
prerank,fatty acid elongation (GO:0030497),-0.33387280692368576,-0.826231209141221,0.6981132075471698,0.9145562489503668,1.0,5/13,15.51%,ELOVL7;HACD3;HACD1;HACD2;ELOVL6
prerank,leukocyte tethering or rolling (GO:0050901),-0.29992838921075865,-0.8259160185729015,0.7267267267267268,0.9139376807689292,1.0,4/17,14.26%,VCAM1;JAM2;GCNT1;ITGA4
prerank,regulation of cell adhesion (GO:0030155),0.28318631975301883,0.8250054657762653,0.7774193548387097,0.9221575321419059,1.0,20/129,14.70%,ZFHX3;PPP3CA;PTK2B;EFNA5;ARHGDIB;VEGFA;ABL1;EPHB3;ERBB2;ZDHHC2;GPR4;CHRD;MIA3;ITGAV;EPHB2;ITGB1BP1;RET;PLXNB1;PPP1R12A;PRKCA
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.386263517914958,0.8249658534394819,0.6838905775075987,0.9217962977891156,1.0,4/15,17.04%,VCP;HERPUD1;SEL1L;TMEM129
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.30147080825543054,0.8245311331212177,0.744131455399061,0.9221149124765741,1.0,20/70,24.88%,PSMB2;ABL1;PSMD11;FOXC1;PSMC1;EIF2AK2;PSMC6;PSMD1;PRKDC;PSMD4;YAP1;PSMA6;PSMD14;PSMD12;PSMD7;TCF12;PSME3;PSMD3;PSMB6;CBFB
prerank,regulation of centriole replication (GO:0046599),0.3765927858175956,0.8241542220362857,0.6846715328467153,0.9223250085340927,1.0,4/17,12.66%,RBM14;SPICE1;PLK4;BRCA1
prerank,positive regulation of behavior (GO:0048520),-0.35025466151553,-0.8240290020198656,0.672316384180791,0.9162274181940768,1.0,3/10,10.36%,SGIP1;MEF2C;NPAS2
prerank,regulation of macrophage differentiation (GO:0045649),0.38426335531054034,0.8238395415964214,0.679160419790105,0.9224043552658482,1.0,3/15,6.79%,ID2;PTPN2;INHBA
prerank,arachidonate transport (GO:1903963),0.418768158989619,0.8237101487251859,0.7129032258064516,0.9217895357984159,1.0,3/10,12.31%,ANXA1;DRD3;NMUR2
prerank,arachidonic acid secretion (GO:0050482),0.418768158989619,0.8237101487251859,0.7129032258064516,0.9217895357984159,1.0,3/10,12.31%,ANXA1;DRD3;NMUR2
prerank,sarcomere organization (GO:0045214),0.3414043492722372,0.8235581892579319,0.7035040431266847,0.9216306197249418,1.0,2/27,9.60%,CSRP3;SIX4
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2707145405456756,0.8230887954685977,0.8295918367346938,0.9219572729652766,1.0,105/241,34.17%,DDX5;SRSF11;U2AF2;RBM14;DBR1;SRSF5;SRSF6;SRRM2;SNRNP48;PABPC1;CDC40;SRSF2;FUS;HNRNPH1;SNRNP35;U2SURP;RBMX;SRSF1;CHERP;WBP4;HNRNPM;SNRNP70;LSM8;RNPS1;PRPF8;UBL5;RNPC3;CPSF3;SYF2;GPKOW;HNRNPA2B1;USP49;WDR83;DHX9;POLR2C;NONO;SYNCRIP;RBM6;CSTF3;GEMIN5;SNRNP40;CLP1;PDCD7;SF3B3;DHX8;PNN;LSM4;HNRNPH2;DHX38;SRSF3;SRRM1;SUGP1;PRCC;CCAR1;FIP1L1;YTHDC1;HNRNPF;USP39;RBM4;SNRNP200;CSTF1;PTBP1;RBM17;ZCRB1;WDR33;DNAJC8;RBM5;GCFC2;SMNDC1;SNRPB;SNRPB2;DHX15;ELAVL1;ZRSR2;HNRNPC;CSTF2T;TRA2A;UPF3B;DDX42;HNRNPR;TRA2B;WBP11;PPIL3;TXNL4A;PRPF3;ELAVL2;PPIH;NUDT21;SNW1;SF3B2;SF3B1;DDX39A;DDX39B;SRSF7;SNRPA;SF3B6;PUF60;ALYREF;ESS2;PPIL1;EFTUD2;ZCCHC8;SNRPF;SRRT;SF3A2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.35518769099992875,0.8229817724311732,0.6647887323943662,0.9217239946369753,1.0,7/21,19.78%,PDZD8;MCU;BCAP31;SLC8B1;MICU2;MCUB;ANXA6
prerank,granulocyte chemotaxis (GO:0071621),0.31163146259222185,0.8229762554557611,0.7249698431845597,0.9213091230858576,1.0,5/55,5.34%,CXCL2;CCL3;CCL1;GBF1;ANXA1
prerank,cellular glucose homeostasis (GO:0001678),0.32534286132234164,0.8229589915578259,0.7276214833759591,0.9209141534586701,1.0,4/41,3.32%,LRRC8D;UNC13B;KCNB1;SLC39A14
prerank,negative regulation of protein transport (GO:0051224),0.34717326539714566,0.822482676797635,0.6857541899441341,0.9212986046604615,1.0,9/25,24.09%,WWP2;DPH3;SERGEF;DRD3;SNX12;HMGCR;CSK;PKDCC;RHBDF1
prerank,positive regulation of MAPK cascade (GO:0043410),0.2717381360938172,0.82205919871934,0.8299180327868853,0.9216051575833977,1.0,23/245,7.33%,BMPER;EGFR;TNFAIP8L3;NTRK3;ADRA1B;PTK2B;FGF2;ADRB2;NRP1;VEGFA;MID1;NOTCH2;CCL3;CCL1;PLCG2;PDGFC;FGFR1;SHC1;ERBB2;CD44;ROR1;TENM1;ABCA7
prerank,cochlea morphogenesis (GO:0090103),0.41058225142063526,0.8217217490873732,0.7017828200972447,0.9217369169141709,1.0,2/10,7.46%,SOX9;POU3F4
prerank,negative regulation of cilium assembly (GO:1902018),0.40494260557759443,0.8215847177956698,0.6619273301737757,0.9215447429578502,1.0,3/12,16.91%,CDK10;LIMK2;YAP1
prerank,regulation of coagulation (GO:0050818),-0.34502939176781744,-0.821160341068022,0.7364130434782609,0.9204168231650667,1.0,5/11,27.62%,HS3ST5;F2R;CAV1;HRG;PROCR
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.3891793206235233,0.8208748651419282,0.6842105263157895,0.9223019424855878,1.0,4/14,12.97%,LIMS1;TIMP1;DMTN;ITGB1BP1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.362975628341268,0.8204562576472889,0.672316384180791,0.9225550984388242,1.0,2/20,7.72%,PID1;RHOQ
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2690313038553367,-0.8203298990186314,0.756198347107438,0.9207978273794069,1.0,7/29,12.54%,CXCL12;LGMN;JAM2;CREB3;GAS6;PLA2G7;HMGB1
prerank,negative regulation of viral release from host cell (GO:1902187),0.3921139391921472,0.8200285141763306,0.7025796661608498,0.9228705645516141,1.0,5/13,29.10%,TRIM35;MID2;PML;CHMP3;TRIM26
prerank,regulation of neurogenesis (GO:0050767),0.3088441480696683,0.8199926749831364,0.7427536231884058,0.9225027220741138,1.0,15/55,24.12%,HES1;DOCK7;BHLHE40;PCM1;HOOK3;HES3;SORL1;PAX6;YAP1;FAIM;NUMBL;NAP1L1;HEYL;REST;APPL2
prerank,lymphocyte migration (GO:0072676),0.33459745561320076,0.8197709027272988,0.7236842105263158,0.9224684699727234,1.0,4/32,13.02%,CCL3;CCL1;CCL7;RET
prerank,regulation of cell-cell adhesion (GO:0022407),0.3247430316296765,0.8196935717271927,0.7237008871989861,0.9221811851720257,1.0,5/39,7.41%,CDH1;EFNA5;ADA;EPHB3;ZDHHC2
prerank,dendritic cell migration (GO:0036336),-0.3183069540025948,-0.819426042631881,0.7055214723926381,0.9212980545093425,1.0,6/16,22.73%,EPS8;HMGB1;CCL19;CCR5;GPR183;PIK3CG
prerank,lipid oxidation (GO:0034440),-0.3377817586785117,-0.8193252338912129,0.6908077994428969,0.9202715866464612,1.0,3/12,12.99%,PPARGC1A;PLA2G7;ALOX12
prerank,positive regulation of hydrolase activity (GO:0051345),0.2819985507050381,0.8188957029694619,0.7905982905982906,0.923100638608621,1.0,23/137,12.16%,ARAP1;WNT11;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;NDEL1;NF1;MAPK12;ERBB2;WRN;ITGB1;S100A10;RGP1;RGS6;CCL7;RHOA;RAP1A;SNX18;BCAR3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3626348295900294,0.818757321002083,0.6896551724137931,0.9228979131146925,1.0,5/20,16.33%,CNOT8;AGO2;EIF6;CELF1;MOV10
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.3397172701066562,0.8186186442554414,0.7088948787061995,0.9226972210335666,1.0,7/25,19.88%,TWIST1;NSD1;POU4F1;NIBAN2;TRAF6;RB1;ZBTB7A
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.35308943429792133,0.8184568211871645,0.7025862068965517,0.9225276526116075,1.0,7/22,26.46%,EDEM3;RNF185;MAN1B1;SEL1L;UBB;UBA52;RPS27A
prerank,negative regulation of cell division (GO:0051782),-0.34265890357165435,-0.8180248800735975,0.6862244897959183,0.921476736028903,1.0,6/11,28.64%,TXNIP;BLM;CHMP4C;E2F7;MYC;E2F8
prerank,positive regulation of GTPase activity (GO:0043547),0.27387602487382956,0.8179383445466926,0.828125,0.9229375260781785,1.0,44/188,18.48%,NTRK3;ARAP1;WNT11;SIPA1L1;SGSM2;SRGAP2;GSK3B;BCAS3;CCL3;LIMS1;CCL1;RAP1GAP2;NDEL1;DOCK7;NF1;BCR;GPR65;ERBB2;TIAM1;ITGB1;TIAM2;CORO1C;S100A10;RGP1;RGS6;CCL7;RAP1A;SNX18;BCAR3;PIP5K1A;PLXNB1;TBC1D2B;EVI5;SIPA1L2;RABGAP1;AFDN;SCRIB;PIN1;TBC1D8B;SYDE1;MTSS2;TBC1D5;CCDC125;TBC1D17
prerank,positive regulation of immune effector process (GO:0002699),0.33847868880709026,0.8175846297387122,0.7058823529411765,0.9230881952770489,1.0,3/27,11.66%,LBP;ANKRD17;CD46
prerank,positive regulation of cellular respiration (GO:1901857),-0.3393529247410527,-0.8175259010966355,0.7072538860103627,0.9211964005667994,1.0,4/11,16.57%,IFNAR1;PINK1;NUPR1;IL10RB
prerank,interstrand cross-link repair (GO:0036297),0.30837652440529095,0.817408891989977,0.7198067632850241,0.9229638744543172,1.0,15/53,26.46%,RAD51;FANCL;SLX4;VCP;USP1;NEIL3;WDR48;RNF8;MCM9;ATR;ERCC4;DCLRE1A;UBB;UBA52;RPS27A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3235754173172654,0.8166270202541938,0.7211413748378729,0.9238403927842572,1.0,2/35,1.65%,HES1;CYP1B1
prerank,iron ion homeostasis (GO:0055072),0.3025843485734177,0.8159189851738736,0.7377830750893921,0.9245797323067553,1.0,15/58,20.01%,SCARA5;BDH2;ABCG2;NEO1;BMP6;GLRX3;CUL1;HMOX2;FXN;ATP6V1A;SMAD4;SLC46A1;ATP6V0D1;FLVCR1;IREB2
prerank,phosphatidic acid metabolic process (GO:0046473),-0.23797515795792962,-0.8158507390116861,0.8067632850241546,0.9231462523205382,1.0,15/48,27.29%,DGKB;DGKD;DGKG;GPAM;AGPAT4;PLD2;DGKZ;ABHD8;AGPAT5;ABHD4;LIPH;PLA2G4B;PLA2G5;LPCAT4;GPD1L
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.29298833806223545,0.8155789391931954,0.7733644859813084,0.9246948384651781,1.0,20/72,22.68%,ELF1;HIPK1;IRAK3;PTPN2;TAX1BP1;SPPL2A;PALM3;IKBKG;TRIM44;TRAF2;IKBKB;SOCS3;RBCK1;JAK2;AGPAT2;CHUK;TRADD;PIAS1;VRK2;SPPL2B
prerank,regulation of TORC1 signaling (GO:1903432),0.3296390672856992,0.8154572351665704,0.702523240371846,0.9244770272953466,1.0,6/33,10.24%,TELO2;ITFG2;CLEC16A;RRAGB;KLHL22;SZT2
prerank,rRNA pseudouridine synthesis (GO:0031118),0.40105618427156575,0.8154190663789809,0.6929133858267716,0.9241112584688683,1.0,3/10,17.36%,RPUSD4;RPUSD2;NAF1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3443241961274883,0.8151761881045513,0.7375690607734806,0.9240944286776454,1.0,3/28,6.69%,CRADD;NGF;BAG3
prerank,positive regulation of response to stimulus (GO:0048584),0.3177413031256406,0.8149937549452423,0.7352572145545797,0.9239810786234435,1.0,14/40,27.90%,PRKCD;CD80;MAVS;IFIH1;CGAS;NSMCE1;HOMER1;DHX9;CDKN2AIP;FMR1;HMGA1;EEF1E1;ACOX2;BCLAF1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.3991335712363586,0.8146454312789727,0.6936236391912908,0.9241334135153028,1.0,3/11,17.86%,SMARCAL1;FBXO5;DONSON
prerank,endoderm development (GO:0007492),0.3840248250989702,0.8136471775329248,0.6706231454005934,0.9253125495353057,1.0,3/13,12.24%,KIF16B;GATA4;DUSP5
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2277808897126813,-0.8130134707869892,0.8502994011976048,0.9271353249533778,1.0,4/59,3.36%,ALDH1A2;CYP7B1;CYP27A1;GATM
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3410836359640663,0.8129174726364744,0.6932599724896836,0.9260421059806698,1.0,7/25,17.40%,CD55;PLCG2;MAP3K7;TRAF2;CD160;TRAF6;SCIMP
prerank,glutamate metabolic process (GO:0006536),0.35364784329276006,0.812547685607807,0.6850507982583455,0.9262332180133647,1.0,1/19,1.99%,GCLC
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.29609838315867937,0.812540056744904,0.7470449172576832,0.9258237838412614,1.0,23/71,26.46%,CAPN2;ZYG11B;VCP;IDE;DDI2;NR1D1;RNF123;CLPP;PDCD6IP;ZRANB1;RNF41;YME1L1;FAP;PSMA6;CHFR;DDI1;USP9X;CTSK;CTSO;OMA1;UBB;UBA52;RPS27A
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.32934568438209755,-0.8125198131799428,0.7154696132596685,0.9268462459451381,1.0,1/12,1.99%,PCGF5
prerank,ruffle organization (GO:0031529),0.36305030350633705,0.8124473831725829,0.6786786786786787,0.9255504199760567,1.0,4/16,14.63%,LIMA1;ARFIP2;PIP5K1A;CYFIP1
prerank,cellular response to alkaloid (GO:0071312),0.3661088855688561,0.812258781640973,0.6928783382789317,0.9254395188530559,1.0,3/17,7.31%,CASP6;RAD51;SPIDR
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3668986170114443,0.8118949675764403,0.6976047904191617,0.9256159006756437,1.0,5/16,10.50%,CAMK2D;NR4A3;MEF2A;SLC9A1;PARP1
prerank,protein homotetramerization (GO:0051289),0.3142326465835916,0.8118036962718701,0.7313054499366286,0.9253274367564573,1.0,6/49,13.08%,KCNJ2;TRPM4;ACACA;TDO2;TK1;ACOT13
prerank,pore complex assembly (GO:0046931),0.35801822613632034,0.8114787802457089,0.7245762711864406,0.9254071535949593,1.0,5/19,15.18%,ANO6;NUP93;NUP153;AHCTF1;AFDN
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.2705604812080543,-0.8110197147783492,0.7330827067669173,0.9283323116852782,1.0,5/25,5.81%,AFAP1L2;RBPJ;DGKD;HIP1R;RTN4
prerank,negative regulation of inflammatory response (GO:0050728),0.27116706053729794,0.8109391949457952,0.8319502074688797,0.9258769639739332,1.0,15/182,8.15%,CCN3;RAMP1;PTGDR;PRKCD;PTGIS;ADRB2;KLF4;PLCG2;PTHLH;PTPN2;ADCY9;NLRP12;RORA;GPR27;HTR6
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.35092398469686825,0.8107725778657181,0.7075862068965517,0.9256957576397873,1.0,6/24,13.74%,NEDD4;GRB10;EMILIN1;ARNT;NIBAN2;ITGB3
prerank,epithelial cell development (GO:0002064),0.3571702535296358,0.8107338976468627,0.7229916897506925,0.9253351180046129,1.0,2/20,3.31%,GRHL2;RAB25
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3641683955078507,0.8105141787576925,0.7034277198211625,0.9252639485725171,1.0,5/18,21.66%,USP15;GPATCH3;ANKRD17;PUM2;PUM1
prerank,inner dynein arm assembly (GO:0036159),0.39999448945868465,0.8100699097428097,0.6909090909090909,0.9255868697235544,1.0,1/10,5.28%,DNAAF4
prerank,regulation of secretion (GO:0051046),-0.3247231029749021,-0.8099573181950039,0.7225433526011561,0.9290343138471137,1.0,5/13,13.95%,OAS2;SGK1;KCNQ1;MYO6;ERBB3
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.277495620752707,0.8098998692220846,0.7980022197558269,0.9254494770575942,1.0,39/119,25.92%,PIK3C2B;FGF2;PLEKHA4;PLCG2;TTC7A;IP6K1;RUFY1;IP6K2;MTMR12;PIK3R3;PGAP2;PI4KB;INPP4A;SBF1;PIGU;PIP5K1A;OCRL;INPPL1;PIGO;PIP4K2A;SYNJ2;SOCS3;SYNJ1;CDS1;MTMR1;DPM1;MPPE1;ARF3;SACM1L;PIGG;MTMR9;RAB4A;TTC7B;PGAP3;PIGB;MBOAT7;MTM1;PIGQ;RAB14
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.36625757576684576,0.8098183619393357,0.691044776119403,0.9251621301293658,1.0,6/16,27.43%,HELB;CGAS;RMI2;POLQ;KLHL15;SMCHD1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3019669170494026,0.8097345871956446,0.7644927536231884,0.9248878093985821,1.0,15/61,18.97%,PSMB2;NQO1;PSMD11;NCOR2;PSMC1;ODC1;PSMC6;PSMD1;AZIN1;PSMD4;OAZ2;PSMA6;PSMD14;PSMD12;PSMD7
prerank,P-body assembly (GO:0033962),0.38834627566728297,0.8095192523747586,0.6874003189792663,0.9248083429197618,1.0,8/12,36.83%,ATXN2;LSM4;DDX6;PATL1;LIMD1;LSM14A;LSM3;DYNC1H1
prerank,glycerolipid metabolic process (GO:0046486),0.400027599210232,0.8094683384527013,0.7045454545454546,0.924454252587968,1.0,4/11,12.38%,PLA2G15;DGKA;PNPLA3;PIP5K1A
prerank,regulation of neuron migration (GO:2001222),0.3332947213748186,0.8094119207262278,0.7041499330655957,0.9241209718268343,1.0,5/26,8.59%,COL3A1;SRGAP2;PHACTR1;NIPBL;SHTN1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.36812987309789746,0.8093947624761547,0.714078374455733,0.9237329196564529,1.0,4/17,17.04%,VCP;HERPUD1;SEL1L;TMEM129
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.40059869608664034,0.8090289311692525,0.6713615023474179,0.9238724840164676,1.0,5/11,23.59%,RENBP;GFPT1;GNPDA1;UAP1;PGM3
prerank,electron transport chain (GO:0022900),0.37356431166618426,0.8087996151724257,0.6896046852122987,0.9238218464356475,1.0,4/15,19.45%,ENOX2;ETFDH;ETFA;UQCRFS1
prerank,pinocytosis (GO:0006907),-0.34723741989227386,-0.8086560995173216,0.7002724795640327,0.9301272451839627,1.0,5/10,28.67%,DOCK2;PYCARD;AHSG;PPT1;MAPKAPK3
prerank,regulation of presynapse assembly (GO:1905606),0.3623112988808665,0.8081568811569326,0.7160839160839161,0.9239982968630186,1.0,1/18,0.61%,GPC6
prerank,regulation of presynapse organization (GO:0099174),0.3623112988808665,0.8081568811569326,0.7160839160839161,0.9239982968630186,1.0,1/18,0.61%,GPC6
prerank,regulation of cell motility (GO:2000145),0.27814895131246137,0.8080648301069203,0.7817982456140351,0.9237296958496145,1.0,10/121,6.57%,EGFR;NTN1;LMO4;FGF2;ABL1;CCDC25;TWIST1;LMNA;DIAPH1;ERBB2
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3431761622909656,0.8076097481704851,0.7181303116147308,0.9240632220437941,1.0,7/23,24.07%,PDE6A;GRK4;PDE6B;FNTA;PPEF1;METAP2;CNGB1
prerank,negative regulation of neuron death (GO:1901215),0.2851275765409064,0.8074563964112882,0.7875417130144605,0.9238878430537137,1.0,11/93,10.40%,SIX1;PTK2B;NGF;TGFB3;CLCF1;GSK3B;NFATC4;NRBP2;IKBKG;SIX4;POU4F1
prerank,snRNA metabolic process (GO:0016073),0.35752151291656203,0.8072173429074638,0.6859259259259259,0.9238586496086586,1.0,7/17,27.51%,INTS5;INTS6;INTS7;INTS1;INTS8;INTS2;INTS9
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3447486311637306,0.8071886721559808,0.7233727810650887,0.9234845210568191,1.0,4/21,10.11%,FGF13;KATNB1;CIB1;HDGFL3
prerank,regulation of oxidative phosphorylation (GO:0002082),0.3678933389797779,0.8071734486836999,0.7268445839874411,0.9230980413379046,1.0,4/16,13.61%,ABCD1;MLXIPL;VCP;AK4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3584310892972334,0.8062102634686644,0.6905444126074498,0.9241856239751967,1.0,7/20,25.64%,PID1;RHOQ;CSK;TMBIM1;PKDCC;DAB2;NUMB
prerank,negative regulation of innate immune response (GO:0045824),0.3194690465205047,0.8058307716120618,0.7291941875825627,0.9243840528694878,1.0,4/34,5.04%,TRAFD1;IRAK3;PTPN2;USP15
prerank,defense response to tumor cell (GO:0002357),0.4116817160936729,0.8055475137479796,0.6885758998435054,0.924419408359912,1.0,4/10,20.46%,KLF4;RBMS3;DAPK1;PRDX2
prerank,lipoprotein transport (GO:0042953),-0.35004506612623054,-0.8051836211179649,0.7299465240641712,0.9350122800842502,1.0,3/10,11.59%,PRKCB;ZDHHC17;VMP1
prerank,regulation of autophagosome assembly (GO:2000785),0.320426520780954,0.8049557201285723,0.7150610583446404,0.9249382253478412,1.0,12/33,25.30%,NPRL3;TMEM39A;SH3GLB1;PIP4K2A;LRRK2;RALB;LRSAM1;NPRL2;RAB1B;RAB3GAP1;SMCR8;MTM1
prerank,mitochondrial genome maintenance (GO:0000002),-0.33331962426410006,-0.8042890652312158,0.7313019390581718,0.9353736375759154,1.0,2/11,6.98%,AKT3;SLC25A33
prerank,genitalia development (GO:0048806),0.38690753160200025,0.804118324897146,0.7074380165289256,0.9257956403864211,1.0,1/12,1.00%,PKD1
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28813897007689243,0.8041137253054397,0.7882623705408516,0.9253897332586332,1.0,27/88,27.05%,SAMD4A;IGFBP5;NELL1;PAIP2;CNOT8;DNAJC1;EPRS1;RGP1;DHX36;EIF2AK2;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;FMR1;MALSU1;CNOT1;TRIM71;RIC1;DDX6;TSC1;RBM4;SHMT1;CLN3
prerank,negative regulation of GTPase activity (GO:0034260),0.34852601432448277,0.8037650761949678,0.7174887892376681,0.9254828425413345,1.0,8/22,20.57%,WNK1;BCAS3;RDX;RRP1B;ARFGEF1;LRRK2;GPSM1;TMED2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.40664140195115095,0.8037235321036997,0.7095238095238096,0.9251257459686455,1.0,4/11,19.10%,ATL2;ATL1;BNIP1;VCPIP1
prerank,positive regulation of cell cycle process (GO:0090068),0.285262015650589,0.8034483185126462,0.7997787610619469,0.9251570652501974,1.0,29/91,25.34%,CIT;PRKCE;GIPC1;CDC14A;AURKA;CUL3;CCNB1;RHOA;PLK4;MAD2L1;DRD3;LRP5;DDX11;ATRX;PLSCR1;CDC7;CXCR5;PCID2;UBXN2B;EDN3;USP19;EGF;IGF2;KIF23;PKN2;INO80;RAD21;CDC6;GPSM2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3696871070747619,0.8031225378463606,0.7033132530120482,0.925247447258766,1.0,4/15,16.22%,ADAM9;EHD2;EHD1;FLOT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.34238392983604865,0.8026069648021504,0.7400275103163686,0.9256411859268792,1.0,7/26,24.07%,NFE2L2;VNN1;GATA4;LRRK2;BAG5;SOD2;REST
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3828268186698644,0.8024234336851098,0.7124802527646129,0.9255248637888711,1.0,3/13,15.75%,NFAT5;RHOA;TRAF6
prerank,protein K48-linked deubiquitination (GO:0071108),0.3486926937429655,0.8013642909924008,0.728021978021978,0.9267843827837002,1.0,11/23,32.38%,USP25;USP34;OTUD5;OTUD4;OTUD3;VCPIP1;USP33;USP5;ATXN3;OTUD7B;USP8
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3578636966461121,0.80008351090652,0.713859910581222,0.9283818324631545,1.0,3/18,9.03%,MET;MYOC;CUL3
prerank,fatty acid biosynthetic process (GO:0006633),0.29552915730948404,0.7997764671811245,0.7800480769230769,0.9284291703728711,1.0,11/63,18.96%,ABCD3;ACSM2A;ACSM2B;ABCD1;ACACA;TECR;ELOVL5;ALOX5;GSTM4;SCD;NDUFAB1
prerank,cellular response to hypoxia (GO:0071456),0.2742016725080464,0.7995086138973608,0.806243272335845,0.9284413763499757,1.0,27/126,18.97%,PTGIS;VEGFA;EGLN3;PSMB2;NDRG1;TWIST1;LMNA;NPEPPS;CREBBP;RORA;PSMD11;HIF3A;PSMC1;ARNT;PSMC6;MDM4;CARD16;AK4;TIGAR;PSMD1;PSMD4;PLK3;PSMA6;PSMD14;PSMD12;FAM162A;PSMD7
prerank,glycine metabolic process (GO:0006544),0.37852711647961557,0.7992469957393841,0.7117263843648208,0.9284657125193475,1.0,4/12,26.50%,SDSL;GLYAT;DLD;SHMT1
prerank,regulation of microtubule-based movement (GO:0060632),-0.32717346496194805,-0.7987290995866982,0.7226890756302521,0.9439822075630412,1.0,4/11,25.46%,MAP2;CFAP298;NEFH;CCDC65
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.2953207474359421,-0.7985815590949247,0.7415730337078652,0.9429934674221017,1.0,4/15,17.79%,HECW2;CDC23;ANAPC7;TACC3
prerank,organophosphate catabolic process (GO:0046434),-0.33818861145318246,-0.798430706948745,0.7344632768361582,0.9420408135701765,1.0,1/11,1.30%,ENPP2
prerank,cellular response to fluid shear stress (GO:0071498),0.3847547859079719,0.7975753951180526,0.7096273291925466,0.9306636578110142,1.0,2/12,4.13%,NFE2L2;KLF4
prerank,regulation of mitochondrial translation (GO:0070129),0.34709114996918455,0.7971147893389081,0.7091172214182344,0.9309502557803431,1.0,6/21,23.19%,MRPS27;RPUSD4;FASTKD3;MALSU1;TSFM;ALKBH1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2950724852882771,0.7969932983644409,0.7858851674641149,0.9307282526600591,1.0,17/67,21.13%,ITGB5;PSMB2;IKBKG;PSMD11;PSMC1;ITGAV;PSMC6;PSMD1;PSMD4;IKBKB;SNAP23;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;PSME3
prerank,negative regulation of biosynthetic process (GO:0009890),-0.30399146338748984,-0.7967197679122427,0.7922077922077922,0.9436933145725721,1.0,3/16,9.20%,SLC30A10;PPARA;ABCB7
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.30697896187955476,-0.7956629682240524,0.768025078369906,0.9442458079705217,1.0,9/16,37.20%,AHR;PTPN22;TNFSF8;FGF10;LST1;IKZF3;IL12A;CD22;TNFSF9
prerank,regulation of multicellular organismal development (GO:2000026),0.33398457141804844,0.7953367787478279,0.7228260869565217,0.9328464045533219,1.0,6/25,15.70%,NIPBL;MYSM1;EHMT1;DHX36;TRIP12;PTN
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3036605284389579,0.7952471017804872,0.7487745098039216,0.9325775435600664,1.0,22/48,34.51%,ELOF1;POLR1G;POLR1A;TAF1D;DDX21;SMARCA5;POLR1F;DEK;TBP;CHEK1;HMGA1;ASF1A;KAT2B;ZMIZ1;SF3B1;KAT2A;TAF1C;MYBBP1A;BAZ1B;PADI2;TAF1A;PHF2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.37181542993509,0.7951376041288565,0.7180685358255452,0.9323169937184481,1.0,3/13,18.60%,GLRX3;ISCA1;NFU1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3142600417265549,0.7946350816487531,0.7218543046357616,0.9326631874507947,1.0,11/32,25.36%,PRKCD;FOXO3;ATXN2;RBM3;TIGAR;CYFIP1;GEMIN5;PUM3;RPL10;MAPKAPK5;TSC1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.3571795646635594,0.7937695690978632,0.726207906295754,0.9335861927830875,1.0,3/17,8.64%,TWIST1;CD44;KDM1A
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.22797474101507925,-0.79359092473212,0.8743961352657005,0.946589510982945,1.0,5/48,8.02%,IL1R1;PDE4B;SLC7A5;PDE4D;IL18
prerank,regulation of cellular localization (GO:0060341),0.3028957930286633,0.7931261752917482,0.7465145754119138,0.9341850141933221,1.0,13/46,19.25%,CAMK2D;GSN;EFNA5;KDM1A;CDK16;PARP1;NR1D1;LRP5;PARD6A;DVL1;LRRK2;TTL;MAD1L1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.2611447411096784,-0.7930362812651515,0.8120300751879699,0.9463455988481236,1.0,11/28,24.13%,CTSC;DAB2IP;PSMC3;CDK5RAP3;PTK2;NUPR1;ECSCR;FBXW7;OSBPL7;DDRGK1;TREM2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.29933527384220665,-0.7930138695569282,0.7477203647416414,0.9451761725146665,1.0,8/15,28.93%,SORT1;FRS2;NTRK2;BDNF;CASP3;BCAR1;DDIT4;NGFR
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.3910384927654832,0.7929498610276785,0.7185534591194969,0.9340410574474912,1.0,2/10,17.26%,ZC3H12A;SMAD7
prerank,mitotic cytokinesis (GO:0000281),0.31092323585698206,0.7928345659284548,0.7846715328467153,0.9338063901417849,1.0,8/47,13.35%,CIT;SON;TTC19;CNTROB;RAB35;ARL3;SNX18;PDCD6IP
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.278803959631096,0.7927581463989165,0.8072687224669604,0.9335079695466124,1.0,9/110,6.83%,RAMP1;ADGRL2;ADRA1B;GNAS;ADRB2;PTHLH;ADCY9;GPR65;PTGER1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.38335751263982115,0.7926781512097841,0.702660406885759,0.933220095930359,1.0,5/12,21.33%,IRS1;SORL1;ZBTB7B;SORBS1;IGF2
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.27974418532187434,0.7926445533862538,0.7946725860155383,0.9328627629853037,1.0,15/95,16.17%,ADAM9;LBP;CXCL2;ZC3H12A;TLR4;CD80;PDCD4;RHOA;TRIM41;MYD88;NR1D1;TIRAP;CARD16;TRAF6;PDCD1LG2
prerank,acylglycerol homeostasis (GO:0055090),0.34995112346605217,0.7926299537484839,0.7245337159253945,0.9324731378428912,1.0,4/20,11.47%,ACSM2A;RORA;MLXIPL;ANGPTL3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3126102236450567,-0.792045225212154,0.7574850299401198,0.9455722805034993,1.0,5/14,18.27%,RFFL;CCDC3;GAS6;NLRP2B;TRAIP
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.27003470031059323,0.7919473730904755,0.8356164383561644,0.9331496274433526,1.0,10/152,6.83%,RAMP1;ADGRL2;GRK5;ADRA1B;GNAS;ADRB2;PTHLH;ADCY9;GPR65;PTGER1
prerank,apical junction assembly (GO:0043297),0.30466483603647765,0.7918387581882825,0.7893432465923172,0.9329141906195486,1.0,13/53,16.30%,MPP7;GRHL2;CTNNA1;STRN;VCL;PATJ;RHOA;PARD3;DLG1;PDCD6IP;PARD6A;AFDN;CLDN11
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2929457505402761,0.7917047022265227,0.7849462365591398,0.9327155414960916,1.0,12/65,14.05%,PTGIS;VEGFA;EGLN3;NDRG1;TWIST1;LMNA;NPEPPS;RORA;MDM4;CARD16;AK4;TIGAR
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.32658873695975976,0.7912599429070118,0.7213793103448276,0.9330030969244509,1.0,2/28,2.01%,MAP3K5;TMEM117
prerank,neurotrophin signaling pathway (GO:0038179),-0.2727596003318873,-0.7904513552395313,0.7622377622377622,0.9469502895778918,1.0,11/21,25.72%,SORT1;RAPGEF2;FRS2;NTRK2;MAGI2;NTF3;BDNF;CASP3;BCAR1;RAPGEF1;DDIT4
prerank,B cell activation (GO:0042113),0.287922334784394,0.7903733942757837,0.7606132075471698,0.9339549398659012,1.0,6/68,7.67%,HDAC4;HDAC9;CLCF1;PLCG2;PTPN2;ITGB1
prerank,icosanoid secretion (GO:0032309),0.38371420776313986,0.7901848566517461,0.7219662058371735,0.9338460866640099,1.0,3/12,12.31%,ANXA1;DRD3;NMUR2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.352647348141473,0.7899222495852314,0.7132243684992571,0.9338477659965941,1.0,2/18,5.71%,CMKLR1;C5AR2
prerank,innate immune response (GO:0045087),0.2628884837151647,0.7893410951818964,0.8711018711018711,0.9343177023515541,1.0,42/217,20.89%,LBP;PTK2B;SRMS;COLEC11;VNN1;ALPK1;S100B;PLCG2;FRK;ANKHD1;CLEC5A;SETD2;REL;CLPB;IRAK4;IKBKG;TRIM39;TLR4;MAVS;IFIH1;RIPK2;ANKRD17;TLR8;POLR3A;MYD88;RNASE3;IFNLR1;CAPZA1;ADAM15;LCK;IKBKB;TTC4;TRIM35;PPARG;COLEC12;CHUK;YES1;MID2;RELB;SLPI;FER;PML
prerank,sphingoid metabolic process (GO:0046519),0.37912970628072035,0.7888809106797326,0.7183734939759037,0.9346501905210428,1.0,2/12,12.28%,PLPP3;KDSR
prerank,nuclear transport (GO:0051169),-0.29564856980713833,-0.7887519517221208,0.7616099071207431,0.9485683755416785,1.0,6/16,19.16%,ANP32A;NPM1;PSIP1;NXT2;BANF1;RSRC1
prerank,heart contraction (GO:0060047),0.3086635433463255,0.7884967734242468,0.7833981841763943,0.9348231759537445,1.0,3/41,1.98%,SGCD;CSRP3;ATP1B1
prerank,lipoprotein catabolic process (GO:0042159),0.3876376590964847,0.7883653986328343,0.7226502311248074,0.9346239416133718,1.0,3/11,10.38%,LYPLA2;ABHD17B;LYPLAL1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3664448930870886,0.7883146214755935,0.7535612535612536,0.9342835856613705,1.0,2/17,4.31%,ANK2;SNTA1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.34101924418546037,0.7882758237899977,0.7006896551724138,0.9339302048921456,1.0,7/23,17.44%,MAP3K5;DUSP19;MAP3K7;TRAF2;TRAF6;MAP3K10;MAP3K4
prerank,cortical actin cytoskeleton organization (GO:0030866),0.35029763392420465,0.7878707461051245,0.7452135493372607,0.934124511729785,1.0,5/20,18.03%,FMNL2;RHOQ;DLG1;IKBKB;NCKAP1L
prerank,regulation of DNA damage checkpoint (GO:2000001),0.3905548846196127,0.787816826386985,0.7178683385579937,0.9337994671023051,1.0,6/10,33.74%,FEM1B;WDR76;THOC1;THOC5;DDX39B;RFWD3
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3242285567514814,0.7875969425973133,0.7445945945945946,0.9337146681177259,1.0,11/29,26.78%,ESR1;DNAAF4;UBA5;BRCA1;STRN3;YAP1;KMT2D;CNOT1;CBFB;AXIN1;KANK2
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.36885115172026145,0.7869958577842078,0.7427258805513017,0.934199654532973,1.0,4/14,13.66%,SMPDL3A;AK4;AK3;AK1
prerank,establishment of mitotic spindle localization (GO:0040001),0.32485539430405846,0.7864300423593165,0.7516778523489933,0.9346257183492668,1.0,8/28,18.39%,NDEL1;MISP;PAFAH1B1;ITGB1;MAD2L1;ZW10;SPDL1;UBXN2B
prerank,regulation of telomerase activity (GO:0051972),0.302115100604668,0.7862807817897333,0.7748756218905473,0.9344418872182423,1.0,14/45,25.90%,GRHL2;KLF4;SMG6;NEK7;NAF1;MAP3K4;PARP4;XRCC5;ERCC4;ATM;MAPKAPK5;TP53;SRC;PARN
prerank,magnesium ion transport (GO:0015693),-0.3232704746927748,-0.7860948432824117,0.7676470588235295,0.9516382490540984,1.0,5/12,23.29%,NIPA1;NIPAL4;MMGT1;SLC41A1;NIPA2
prerank,cardiac muscle cell differentiation (GO:0055007),0.3447218315333453,0.7860860677619566,0.7362482369534555,0.9343343739851853,1.0,6/21,18.07%,AKAP13;VEGFA;ALPK3;ACVR1;SIK1;CXADR
prerank,positive regulation of receptor internalization (GO:0002092),0.340061202692839,0.7857206811384517,0.7596153846153846,0.9344809947424634,1.0,2/22,3.17%,SFRP4;VEGFA
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.32557453795557273,0.7855274756399777,0.7187060478199718,0.9343580750817971,1.0,6/26,11.60%,ANAPC5;CUL3;CDC16;ANAPC11;CCNB1;FBXO5
prerank,regulation of protein ubiquitination (GO:0031396),0.27583341331589184,0.7854525475748948,0.8203991130820399,0.9340769587461553,1.0,19/108,18.27%,NXN;PRICKLE1;U2AF2;TGFBR1;HDAC8;FAM107A;CUL3;RIPK2;CHP1;BRCA1;SPOPL;COMMD1;USP4;TRAF6;SMAD7;DCUN1D1;LRRK2;BAG5;MYCBP2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.3336087172971287,-0.785176917103518,0.7300771208226221,0.9518867558905948,1.0,5/11,24.99%,WRAP53;TERF1;CCT8;CCT3;TCP1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.36223795169835593,0.7848818273645323,0.7378497790868925,0.9345567656158388,1.0,2/15,5.02%,DDR2;LRP1
prerank,cellular response to gamma radiation (GO:0071480),0.3535349509178323,0.784860871940247,0.726457399103139,0.9341794949727652,1.0,8/17,23.55%,WRN;KDM1A;YAP1;ATR;TLK2;XRCC5;ATM;TP53
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.33982630869405706,-0.78439701658524,0.7272727272727273,0.9519520369426974,1.0,1/10,1.30%,ENPP2
prerank,ncRNA processing (GO:0034470),-0.17678636739383927,-0.7841480552560366,1.0,0.9511603910327884,1.0,46/200,17.54%,RPL37;RPL27A;RPL19;LIN28B;RPS9;RPS14;RPL18A;RPL38;RPS19;RPL34;MTREX;RPL18;RPL7;RPS25;RPL21;RPL23A;RPLP2;RPL26;RPL41;RPL35A;RPL10A;RPL11;RPS16;EXOSC5;AGO4;SNU13;RPL4;RPS7;DDX52;RPS15;ADAR;RPL36;POP4;EXOSC9;RPL37A;RPL32;RPL29;DDX10;HEATR1;LYAR;RPL13;FBL;RCL1;RPL36A;RPL23;RPL17
prerank,microtubule nucleation (GO:0007020),0.344488602884695,0.7836168504106272,0.7418899858956276,0.9355893117489431,1.0,10/19,33.18%,NDEL1;AKAP9;TUBGCP6;TUBGCP2;TUBGCP5;TUBGCP3;TUBG1;NDE1;CSNK1D;CCDC57
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3339417470594026,0.7835271798400324,0.738191632928475,0.9353068245140294,1.0,8/25,17.76%,CMKLR1;CCL3;PLCG2;TRAT1;TMBIM4;P2RX5;P2RX4;LRRK2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.30997930220877024,0.781778150911169,0.7628865979381443,0.9375108879823253,1.0,4/37,7.83%,FHIT;GIPC1;WAC;TRIM39
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3823355780761605,0.7817711250726087,0.7145214521452146,0.9371135811582294,1.0,2/11,10.54%,BARD1;DHX36
prerank,negative regulation of cation channel activity (GO:2001258),-0.25800403351547974,-0.781687597568394,0.7813620071684588,0.9539719433678826,1.0,6/26,18.37%,KCNAB1;SLC6A9;CALM1;UBQLN1;CASQ2;GNB5
prerank,neuromuscular process (GO:0050905),0.3546254539961552,0.7813693544313329,0.7310030395136778,0.937307346871456,1.0,6/16,22.61%,SHANK1;PAFAH1B1;UBA5;STRA6;MYCBP2;PRRT2
prerank,gene silencing by miRNA (GO:0035195),0.3153972595480387,0.7812251313387958,0.762532981530343,0.9371052417374794,1.0,15/32,29.53%,ZC3H7A;CNOT8;AGO2;EIF6;MOV10;PUM2;PUM1;CNOT1;TRIM71;RBM4;DICER1;PRKRA;LIMD1;AGO1;TNRC6C
prerank,regulation of protein dephosphorylation (GO:0035304),-0.2333808748112148,-0.7812145864512764,0.8492462311557789,0.9534727563515608,1.0,10/37,15.31%,MFHAS1;PPP1R16B;YWHAB;CALM1;ANKLE2;CDH5;TIPRL;SMPD1;PPP1R2;PPP2R5A
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3387101531869338,0.7811988829450419,0.7232524964336662,0.9367363800424158,1.0,6/22,16.22%,LBP;RAB7B;IFI35;NR1D1;TIRAP;FLOT1
prerank,regulation of protein neddylation (GO:2000434),0.39368277197907886,0.780979240743573,0.7227414330218068,0.9366747037496687,1.0,3/10,17.27%,DCUN1D5;DCUN1D2;DCUN1D1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.21973575495638095,-0.7809316027977716,0.9021739130434783,0.9527333955791484,1.0,15/53,26.79%,HTR2C;CALCRL;CHRM2;CHRM3;OPRM1;HTR2A;TSHR;LHCGR;HTR1F;CCL2;LPAR3;CHRM1;NPY;HRH1;AGT
prerank,presynapse organization (GO:0099172),0.38662909496938297,0.7809155521602559,0.7238562091503268,0.9363653205500613,1.0,3/10,15.27%,FZD1;NLGN1;DVL1
prerank,mammary gland development (GO:0030879),0.3383940758446299,0.7807488254528296,0.7576177285318559,0.936210164935311,1.0,3/21,6.46%,VEGFA;TGFB3;GLI2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3963859665122043,0.7806944624746192,0.7439222042139384,0.9358907006079159,1.0,3/10,23.84%,TLR4;NCKAP1L;DDIT3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3236044313827066,0.7805295067057824,0.7476635514018691,0.9357481923576079,1.0,12/28,29.80%,PARP3;KMT5B;PRKDC;ACTR2;KMT5C;KDM4D;MRNIP;PARP9;SMCHD1;SETMAR;NUDT16L1;DTX3L
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.2954312373392961,0.7798358358110342,0.785012285012285,0.9364391730790022,1.0,11/48,19.88%,NUP93;NUP214;NOA1;NUP153;EIF6;NUP155;RANBP2;TIGAR;NUP88;NUP35;ZBTB7A
prerank,renal filtration (GO:0097205),0.3951580566161308,0.7797215348349333,0.7085271317829457,0.9362047751077563,1.0,4/10,18.12%,XPNPEP3;SULF1;TBC1D8B;MYO1E
prerank,negative regulation of TOR signaling (GO:0032007),-0.23628615206057185,-0.7787096989796344,0.8675213675213675,0.9550818039905442,1.0,10/36,19.80%,RNF152;PRKAA2;SPAAR;TNFAIP8L1;TSC2;CASTOR1;DEPTOR;GSK3A;SH3BP4;FNIP1
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3059628457418128,-0.7786597663490554,0.7714285714285715,0.9539688827606869,1.0,2/13,6.29%,EPS8;EPS8L2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.37446146480974934,0.778659373801867,0.7465224111282844,0.9373448554387452,1.0,4/12,21.19%,CD44;FLOT1;LCK;GCNT2
prerank,Golgi ribbon formation (GO:0090161),0.3709351299533819,0.7780540690223585,0.7189952904238619,0.9378583101974338,1.0,5/13,23.42%,TMED5;PRMT5;GOLPH3;VTI1A;GCC2
prerank,intestinal absorption (GO:0050892),-0.3096920698785294,-0.7754897429508602,0.7774566473988439,0.9578234513465606,1.0,4/13,11.55%,UGCG;F11R;KCNQ1;ADRA2A
prerank,homocysteine metabolic process (GO:0050667),-0.3262456365037525,-0.7752899192990478,0.7120418848167539,0.9569124958795737,1.0,4/11,22.63%,NOX4;CBS;CTH;MPST
prerank,presynapse assembly (GO:0099054),0.35495563931570856,0.7752872357409512,0.7473200612557427,0.9415599737045246,1.0,6/16,16.98%,FZD1;BSN;PCLO;NLGN1;DVL1;CEL
prerank,regulation of urine volume (GO:0035809),0.38409094600520266,0.7750745636502118,0.7277227722772277,0.9414627190734439,1.0,1/10,3.34%,NPR3
prerank,copper ion homeostasis (GO:0055070),-0.28335447266173575,-0.7749372882210227,0.74375,0.956247371077696,1.0,6/17,19.93%,APP;ATOX1;SLC31A1;COX19;MT2A;PRNP
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3448220379496636,0.7748169287985932,0.7652050919377652,0.9414203192654881,1.0,5/18,16.42%,ITGB8;FN1;ITGAV;CD46;SMAD4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3708103388424499,0.774382128339875,0.7374392220421394,0.9416823480501357,1.0,6/12,29.53%,STX11;SNAP23;STX2;PRRT2;STX3;STX1A
prerank,negative regulation of JUN kinase activity (GO:0043508),0.38940338665836005,0.7740157871383703,0.7268588770864947,0.9418206946572317,1.0,2/10,10.44%,PDCD4;DUSP19
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.394820237410288,0.773443578814151,0.7480798771121352,0.9422481713970291,1.0,2/10,10.31%,KNSTRN;CCNB1
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.2904571562938251,0.7732152607353923,0.7907845579078456,0.942164388909781,1.0,18/52,23.18%,SHC1;LMNA;SRPRB;SEC31A;ARFGAP1;DNAJC3;DDX11;GOSR2;ADD1;ERN2;TSPYL2;GFPT1;ATP6V0D1;MYDGF;ACADVL;KDELR3;ZBTB17;KLHDC3
prerank,positive regulation of viral genome replication (GO:0045070),-0.25127619623416,-0.772890256110565,0.8387096774193549,0.9581459218671265,1.0,10/29,22.00%,PPARA;IFIT1;HACD3;DDX3X;ADAR;NR5A2;PDE12;TARBP2;PPIA;TOP2B
prerank,carbohydrate derivative transport (GO:1901264),0.3491037581932218,0.7725882340138019,0.7296898079763663,0.9426503711113525,1.0,2/18,7.41%,LBP;SLC10A7
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.37242348427160554,0.7725755544955171,0.7480559875583204,0.9422553241365573,1.0,4/12,23.81%,ATF7IP;TASOR;PPHLN1;RESF1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.37001229331818286,0.7713854338714349,0.7441860465116279,0.9435695280064317,1.0,2/12,8.34%,PLCG2;TLR4
prerank,regulation of interferon-gamma production (GO:0032649),-0.19927486231485295,-0.7711362460928046,0.9379310344827586,0.9596396629877821,1.0,21/71,24.38%,IL1R1;PDE4B;SLC7A5;PDE4D;SIRPA;AXL;IL18;GAS6;HMGB1;TLR7;PTPN22;CD47;PYCARD;PRNP;HSPD1;CD276;FZD5;CD274;NR1H4;VSIR;CYRIB
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3816902974817535,0.7705566800160255,0.7393364928909952,0.9444053386865839,1.0,4/11,23.84%,ATF6;CREB3L1;TP53;DDIT3
prerank,negative regulation of reproductive process (GO:2000242),0.3511375693293538,0.770399357248026,0.7485632183908046,0.9442269663587406,1.0,3/17,7.76%,ARHGDIB;TIMP1;SULF1
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.2769807013431209,-0.769257125275197,0.7934426229508197,0.9612866244173776,1.0,3/19,8.59%,DDO;ASPA;GOT2
prerank,positive regulation of interleukin-10 production (GO:0032733),0.3189608389283797,0.7691182964877656,0.7771739130434783,0.9456812774872585,1.0,4/30,11.66%,PLCG2;STAT3;TLR4;CD46
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.35136896872787277,0.768715332388925,0.7415565345080763,0.9458762320878771,1.0,2/18,9.51%,WNK1;MIA3
prerank,lipoprotein localization (GO:0044872),-0.3199962080152753,-0.7686784190582591,0.7698630136986301,0.9609931381963122,1.0,3/11,11.59%,PRKCB;ZDHHC17;VMP1
prerank,Golgi to plasma membrane transport (GO:0006893),0.2930776621105094,0.7685741342461114,0.7816229116945107,0.9456939688963402,1.0,19/47,23.42%,EXOC4;KIF13A;STXBP6;ARL3;NSF;COMMD1;GOLPH3;GOPC;VAMP2;GOLGA7;GOLGA4;SPTBN1;EXOC2;EXOC5;GOLPH3L;ARFGEF2;BBS2;RAB26;GCC2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.33942463856178084,0.7685403867322312,0.7593880389429764,0.9453349656491774,1.0,3/20,5.78%,SEMA3E;SEMA3C;SEMA3D
prerank,ribosomal small subunit assembly (GO:0000028),0.3519381248704356,0.7685338773263282,0.7616191904047976,0.944934026476718,1.0,1/16,1.40%,RPSA
prerank,ethanol metabolic process (GO:0006067),0.3754602988593617,0.768132633844105,0.7378335949764521,0.9450958818094292,1.0,3/12,13.96%,ADH7;SULT1A1;ADH5
prerank,cellular response to insulin stimulus (GO:0032869),0.26421045439983265,0.7681097163394185,0.8628509719222462,0.9447245456276157,1.0,29/124,19.02%,HDAC9;IRS1;SLC39A14;GSK3B;FOXC2;GRB10;PTPN2;SHC1;TCIRG1;ATP6V0A4;RHOQ;EPRS1;SYAP1;PIK3R3;C2CD5;PARP1;IDE;LPIN2;BCAR3;ATP6V1A;INHBB;PRKDC;VAMP2;IRS4;RPS6KB1;AP3S1;ZNF106;ATP6V0D1;PPARG
prerank,negative regulation of hydrolase activity (GO:0051346),0.29075757588551104,0.7674634079287798,0.7906683480453972,0.9452282281891983,1.0,13/49,20.57%,WNK1;SLC39A14;BCAS3;RDX;CHP1;RRP1B;URI1;ARFGEF1;CST7;LRRK2;ATP5IF1;GPSM1;TMED2
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3734783318554298,0.7673333756457792,0.7578125,0.9450262801934497,1.0,5/11,25.90%,EXOSC3;TENT4B;EXOSC2;LARP7;PARN
prerank,establishment of melanosome localization (GO:0032401),-0.2781595808862094,-0.7673294071547031,0.8131147540983606,0.9618889306649603,1.0,4/19,12.19%,SHROOM2;BBS5;MYO5A;MREG
prerank,regulation of vasculogenesis (GO:2001212),0.35622001325014563,0.7670387699915843,0.7538699690402477,0.9450665687020066,1.0,3/14,11.12%,TMEM100;XDH;RAP1A
prerank,regulation of fibroblast proliferation (GO:0048145),0.2956003528478568,0.7669346006423192,0.8139240506329114,0.9448010076009918,1.0,6/45,7.38%,DDR2;EMD;PDGFC;NF1;SKI;FN1
prerank,zinc ion transport (GO:0006829),0.33338467679260203,0.7668582978135621,0.7604017216642754,0.9444935564136084,1.0,4/21,8.45%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.32083237954892346,0.766712316488084,0.7602256699576869,0.9442896668497932,1.0,1/24,0.50%,PLCE1
prerank,mitochondrial transport (GO:0006839),-0.21509129570855143,-0.7666648300734765,0.90625,0.9617084804557564,1.0,16/53,27.20%,BCL2;BCL2L1;SLC25A13;TIMM17A;ABCB10;TOMM5;TOMM7;FIS1;TOMM22;TOMM40;TIMM10B;MFF;FBXO7;STARD3;PMAIP1;COX18
prerank,positive regulation of protein ubiquitination (GO:0031398),0.27566028667755443,0.7662377930228569,0.8227848101265823,0.9445453854519316,1.0,16/80,18.27%,PRICKLE1;DCUN1D5;FAM107A;KDM1A;CUL3;MTA1;RIPK2;BRCA1;COMMD1;DCUN1D2;TRAF6;PIN1;SMAD7;DCUN1D1;LRRK2;MYCBP2
prerank,negative regulation of viral transcription (GO:0032897),-0.30583417766164145,-0.7660771595028948,0.7701492537313432,0.9613687140607259,1.0,3/13,12.02%,TRIM14;IFITM3;TRIM62
prerank,sterol transport (GO:0015918),0.33506782651120615,0.7660408347357442,0.765867418899859,0.9444253432060349,1.0,3/19,16.45%,LDLR;NPC1;LCAT
prerank,proton transmembrane transport (GO:1902600),0.29921606829023817,0.7654489871642775,0.796895213454075,0.9448754097477033,1.0,13/36,22.01%,ATP6V0A4;ATP12A;ATP1A3;ATP1A4;ATP1A1;SLC9A1;COX15;ATP6V1A;UCP3;SLC46A1;ATP6V0D1;ATP5PO;SLC25A27
prerank,regulation of extracellular matrix organization (GO:1903053),0.35198649992958997,0.7647876982477949,0.7609682299546142,0.9453818497945166,1.0,6/15,18.17%,DDR2;LRP1;FAP;RB1;ANGPTL7;DDR1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.33956153390582156,0.7647236020133777,0.7641242937853108,0.9450519864179676,1.0,7/18,24.14%,GSK3B;RAP1A;NLGN1;SLC4A8;LRRK2;FMR1;RAB3GAP1
prerank,protein lipidation (GO:0006497),0.2836737316730137,0.7641618196358844,0.8193473193473193,0.9454397331427339,1.0,22/59,27.93%,ZDHHC2;HHAT;ZDHHC20;WDR45B;PGAP2;ZDHHC12;PIGU;ATG5;ZDHHC15;ZDHHC13;PIGO;WIPI2;ZDHHC3;DPM1;MPPE1;PIGG;PGAP3;PIGB;ZDHHC21;PIGQ;ZDHHC6;PIGV
prerank,histone monoubiquitination (GO:0010390),0.3225794149262933,0.7639274470286996,0.781021897810219,0.9453719242816725,1.0,9/24,30.67%,WAC;BCOR;RNF20;PCGF1;CTR9;DDB1;RNF168;DTX3L;DDB2
prerank,homologous chromosome segregation (GO:0045143),-0.2716526981033696,-0.7639034281411016,0.7986348122866894,0.9633776779715184,1.0,9/20,41.87%,FMN2;FANCD2;SGO1;MEIOB;IHO1;SIRT7;RNF212B;MEIKIN;TERB2
prerank,protein localization to phagophore assembly site (GO:0034497),0.376865952801037,0.7633994454203084,0.7503974562798092,0.945733682407216,1.0,3/11,21.16%,WDR45B;WIPI2;STX17
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.3353483388198363,0.7624367257690734,0.7690100430416069,0.9467207437145545,1.0,4/18,22.81%,ERBB2;WDR43;UBTF;PHF8
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3414892954414525,0.7620938441388841,0.7838235294117647,0.94676743029104,1.0,6/21,16.98%,PLA2G15;ACBD5;LPIN2;ACOT8;ACOX1;CEL
prerank,retrograde axonal transport (GO:0008090),0.3470333656234438,0.7620634291953251,0.7621861152141802,0.9464045580904803,1.0,4/16,16.06%,DLG2;PAFAH1B1;KIF1C;KIF5B
prerank,regulation of mast cell degranulation (GO:0043304),-0.29977977354546653,-0.7620292933938705,0.7840531561461794,0.964939524124107,1.0,4/14,14.29%,LYN;CD300A;FES;CD84
prerank,cellular respiration (GO:0045333),0.30221441470672133,0.7619850112621886,0.7903225806451613,0.9460994250791889,1.0,9/41,20.20%,COQ10B;NR4A3;ETFDH;COX15;ETFA;SIRT3;MTFR1;UQCRFS1;COQ10A
prerank,myoblast fusion (GO:0007520),0.3655975810638191,0.7619683399408888,0.7376543209876543,0.9457216101807687,1.0,3/12,14.01%,CD9;ADAM12;ADAMTS5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2537944126804139,0.7618626910944292,0.8764397905759163,0.9454864893522699,1.0,45/172,23.22%,PIK3C2B;FGF2;PLEKHA4;PLCG2;CHKB;RUFY1;DGKA;SLC44A3;ETNK1;PNPLA3;MTMR12;PIK3R3;LPIN2;PI4KB;LPCAT1;INPP4A;SBF1;HDHD5;PIP5K1A;AGK;GNPAT;OCRL;CPNE1;INPPL1;PIP4K2A;PLSCR1;TAMM41;PCTP;ETNPPL;LPCAT2;LCAT;SYNJ2;CPNE3;SYNJ1;CDS1;CEPT1;AGPAT2;MTMR1;CHAT;ETNK2;ARF3;SACM1L;MTMR9;RAB4A;PLA2G12A
prerank,activation of GTPase activity (GO:0090630),0.26937874710082704,0.7612879342771196,0.8405466970387244,0.9459208605820588,1.0,23/89,18.48%,NTRK3;SIPA1L1;SGSM2;BCAS3;RAP1GAP2;DOCK7;BCR;GPR65;TIAM1;TIAM2;CORO1C;PIP5K1A;TBC1D2B;EVI5;SIPA1L2;RABGAP1;SCRIB;TBC1D8B;SYDE1;MTSS2;TBC1D5;CCDC125;TBC1D17
prerank,RNA methylation (GO:0001510),0.2777185985270597,0.7608902326396009,0.8315282791817088,0.9460819999208925,1.0,20/60,29.90%,TRMT10A;ALKBH8;MTO1;WTAP;METTL2A;METTL2B;TARBP1;VIRMA;TRMT61B;TGS1;TRDMT1;FTSJ1;MTERF4;FTSJ3;METTL16;THADA;TRMT44;CMTR1;THUMPD2;METTL5
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.34721038386156505,0.7608315276357694,0.7395833333333334,0.9457604199992,1.0,2/15,9.03%,PLCG2;CUL3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.3302434912075629,0.7604976239491638,0.7655367231638418,0.9458439656191002,1.0,3/22,7.32%,NOTCH2;KLF9;SRSF6
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.34866013247477895,0.7603035920753495,0.7511811023622047,0.9457229480519017,1.0,3/15,12.32%,TLR4;EIF2AK2;MYD88
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.38333172575847096,0.7602814244077793,0.7806451612903226,0.9453515837709222,1.0,2/10,8.34%,IL33;TLR4
prerank,long-chain fatty acid transport (GO:0015909),0.31115336742293265,0.7598176187120458,0.7819650067294751,0.9455939194733004,1.0,9/30,19.97%,ABCD3;ACSL3;ABCD1;ACACA;CPT1B;SLC25A20;RPS6KB1;PPARG;SPX
prerank,response to axon injury (GO:0048678),0.340603829720215,0.7593533938523214,0.7597597597597597,0.945851097528103,1.0,1/18,0.80%,DPYSL3
prerank,linoleic acid metabolic process (GO:0043651),-0.28037054713674897,-0.7593278508443059,0.7941176470588235,0.9677936323397839,1.0,3/17,12.99%,ACSL1;FADS2;ALOX12
prerank,regulation of aerobic respiration (GO:1903715),0.3450659732310328,0.7592531935179815,0.7809076682316118,0.9455918946363717,1.0,4/15,13.61%,ABCD1;VCP;IDE;AK4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.38251325523744306,0.7590842990603998,0.7649769585253456,0.9454304300526095,1.0,2/10,5.02%,PTPN2;LRP1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.2704306162887728,-0.7590558265263029,0.7833333333333333,0.9669998055032477,1.0,8/22,20.22%,PDE4B;CACNB4;CACNB2;CACNB1;NOS1AP;GNB5;STAC;STAC2
prerank,ketone body metabolic process (GO:1902224),0.37292827237614723,0.7587476164511622,0.7624223602484472,0.9455031320805142,1.0,3/10,17.06%,BDH2;AACS;HMGCS2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.2864303218104427,-0.7586092632694701,0.7880597014925373,0.9664252097965436,1.0,5/15,19.43%,SAMHD1;USP18;NLRC5;CACTIN;STAT2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.25399091136444707,-0.758513219028471,0.8448275862068966,0.9653786549182659,1.0,7/23,16.69%,PARP14;NR1H3;STAT1;HSP90AB1;NR1H2;IFNGR1;NLRC5
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.29948328000715274,0.758458513206495,0.8122605363984674,0.9455036618220364,1.0,8/40,18.67%,PID1;ABL1;ABCD1;VCP;ARL6IP5;RNF122;LRRK2;ATP5IF1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3801145211899586,0.7583367430990263,0.7512437810945274,0.9452815157167256,1.0,2/10,11.85%,CREBBP;ESCO1
prerank,positive regulation of inflammatory response (GO:0050729),0.2670583241292944,0.758267186719376,0.838452787258248,0.9449776449946725,1.0,9/86,9.27%,LBP;CCL3;CCL1;IL33;IL17RA;NLRP12;TLR4;GPR4;PDCD4
prerank,cardiac atrium morphogenesis (GO:0003209),0.3443542140827887,0.7582019184649768,0.7692307692307693,0.9446697452884936,1.0,4/16,11.24%,NOTCH2;NOG;GATA4;ZFPM1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28976232509468247,0.7580573139630534,0.8178484107579462,0.9444752310382007,1.0,8/45,12.32%,CCL3;STAT3;NLRP12;TLR4;EGR1;RIPK2;TLR8;MYD88
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.3407570928085222,0.7575462885522805,0.7606060606060606,0.9448012898941109,1.0,4/18,8.90%,PTK2B;BCAS3;SHTN1;KRIT1
prerank,axonemal dynein complex assembly (GO:0070286),0.3187081790116528,0.7574678111263586,0.7773224043715847,0.9445075567289116,1.0,8/27,21.78%,DNAAF4;ODAD2;DNAAF3;ODAD3;DNAL1;DNAH17;DNAAF2;DRC1
prerank,glycogen biosynthetic process (GO:0005978),0.3646164624202561,0.7574121866262827,0.7377300613496932,0.9437856594911772,1.0,4/12,15.40%,PPP1R3C;NR1D1;PGM2;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.3646164624202561,0.7574121866262827,0.7377300613496932,0.9437856594911772,1.0,4/12,15.40%,PPP1R3C;NR1D1;PGM2;NHLRC1
prerank,endothelial cell differentiation (GO:0045446),0.3642422287935702,0.7569817797027444,0.7511380880121397,0.944015677068489,1.0,1/12,1.02%,FSTL1
prerank,regulation of cellular catabolic process (GO:0031329),0.2740437138456439,0.7565744752033565,0.8200238379022646,0.9441647188788787,1.0,15/62,20.03%,ABL1;SCARB2;CISD2;RRAGB;USP13;WDR41;ABCD1;LONP2;KEAP1;TYSND1;PIP4K2A;LRRK2;DAPK1;GPR137B;USP10
prerank,cellular response to calcium ion (GO:0071277),0.27312518872580444,0.7565553081518273,0.8269896193771626,0.9437936922647192,1.0,13/67,17.21%,CLIC4;CAMK2D;PLCG2;MEF2A;DMTN;NLGN1;CPNE8;CPNE1;DPEP1;ADD1;ADCY8;CPNE3;IQGAP1
prerank,lysosome localization (GO:0032418),0.3060879808312806,0.7565072686745773,0.8023255813953488,0.9434708091382833,1.0,6/37,16.06%,SYTL4;NR4A3;NDEL1;PLEKHM2;MAP6;KIF5B
prerank,regulation of Golgi organization (GO:1903358),-0.2820003422457729,-0.7563746599667431,0.7954545454545454,0.9671964181108663,1.0,6/17,14.98%,USP6NL;MAPK1;MYO5A;CAMSAP2;MAP2K1;PDE4DIP
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3060390537649802,0.7562282450535168,0.7851351351351351,0.9434465822655799,1.0,8/32,21.08%,CHKB;SLC44A3;LPIN2;LPCAT1;PCTP;LCAT;CEPT1;CHAT
prerank,regulation of microtubule nucleation (GO:0010968),-0.3300418534901738,-0.7557449846582414,0.7966573816155988,0.9670066960967444,1.0,4/10,17.82%,PAK1;CKAP5;ARHGEF7;HSPA1A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.337800637806038,0.755615592511101,0.7525925925925926,0.9438951501448047,1.0,2/17,4.34%,ANO6;CCL1
prerank,regulation of secretion by cell (GO:1903530),0.28274328906237656,0.7551762672787643,0.8007246376811594,0.9441300835845143,1.0,16/54,24.09%,SNCAIP;DISP1;ANXA1;DNAJC1;P3H1;NSF;RAB21;VAMP2;CPLANE2;HCRT;STXBP5;FMR1;CPLX2;RAB26;RIC1;RHBDF1
prerank,rRNA catabolic process (GO:0016075),0.34615299302630886,0.7551421428563356,0.7786032689450223,0.9437850079006658,1.0,6/16,24.31%,EXOSC3;ERN2;DIS3;EXOSC2;EXOSC7;EXOSC8
prerank,response to peptide (GO:1901652),0.31228574032928885,0.7549724375735304,0.7975871313672922,0.943623894683844,1.0,4/33,10.04%,IRS1;STAT3;ANXA1;ERBIN
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.3175136468927412,0.7546554867106687,0.7810734463276836,0.9436665319528668,1.0,6/24,12.45%,SEC31A;SEC24B;SEC23A;SEC24D;IDE;BCAP31
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.21244031461908458,-0.7538775929083115,0.9130434782608695,0.9684841910342841,1.0,11/57,12.34%,RPL38;RPS19;RPL7;RPS25;NPM1;RPL26;RPL35A;RPL11;RPS16;RPS7;RPS15
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3716755029874488,0.7534561906421412,0.768621236133122,0.9449341384307917,1.0,2/11,16.70%,CLK2;SIK1
prerank,cellular protein catabolic process (GO:0044257),0.2790248582689837,0.7533550113289512,0.8329238329238329,0.9446718744378669,1.0,12/59,18.59%,CAPN2;AP2A2;TCIRG1;CHEK2;IDE;RNF123;CLPP;YME1L1;AP2B1;FAP;PSMA6;AP2A1
prerank,mesoderm formation (GO:0001707),0.3427132289143884,0.7532737840285644,0.7600574712643678,0.9443838798260404,1.0,6/17,26.98%,ITGB1;SMAD2;ITGB3;SNAI1;CRB2;ITGA2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.282400971333787,0.7528741719884193,0.8241626794258373,0.9445392432662563,1.0,14/54,22.68%,HIPK1;PTPN2;TAX1BP1;SPPL2A;IKBKG;TRAF2;UBE2K;CPNE1;CARD16;IKBKB;RBCK1;CHUK;TRADD;SPPL2B
prerank,regulation of JUN kinase activity (GO:0043506),0.30820693776248764,0.7524916479349146,0.7741935483870968,0.9446562191422558,1.0,8/33,17.44%,MAP3K5;PDCD4;DUSP19;MAP3K7;TRAF2;TRAF6;MAP3K10;MAP3K4
prerank,regulation of biosynthetic process (GO:0009889),-0.3211600959174078,-0.7519085051715744,0.7620320855614974,0.969956886975262,1.0,4/11,26.31%,SLC25A33;MID1IP1;SNCA;SPHK2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.30256234391313946,0.7516718502485445,0.7801899592944369,0.9453925968530268,1.0,11/32,25.90%,NEK7;CCT5;NAF1;MAP3K4;ATR;XRCC5;TNKS2;ATM;MAPKAPK5;CCT6A;PARN
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.27025024034549916,-0.7515515280796243,0.8278145695364238,0.9692845276297644,1.0,7/19,24.61%,PINK1;ATP13A2;GSK3A;FBXW7;FZD5;FBXO7;CAMKK2
prerank,membrane organization (GO:0061024),0.24864935305755168,0.7506047837440679,0.9229979466119097,0.9464855438957537,1.0,41/227,17.62%,EGFR;REPS2;ANK2;STON2;ADRB2;IGF2R;LDLR;STX11;AP2A2;EMD;SCARB2;NUP93;FCHO2;CORO1C;GAK;TLCD1;LEMD2;AAK1;NPC1;CHP1;SH3GLB1;CTTN;NUP155;OCRL;PDCD6IP;TMEM33;EPN1;AP3D1;TOR1B;TRIP10;EPS15L1;CHMP2B;MTCH1;AP2B1;GAPVD1;LPCAT2;VAMP2;SYNJ2;ACTR2;SNAP23;SYNJ1
prerank,male meiosis I (GO:0007141),0.3437910703363236,0.7504914773110571,0.7572519083969466,0.9462576769786389,1.0,3/16,21.55%,SYCP3;HSF2BP;FOXJ3
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.29641404026098267,0.7503930880317916,0.795071335927367,0.9460058128371516,1.0,8/37,12.32%,STAT3;PER1;IL17RA;ABCD1;ZC3H12A;TLR4;PDCD4;MYD88
prerank,amide biosynthetic process (GO:0043604),0.282852829634484,0.74993529090935,0.8122653316645807,0.9462322152596688,1.0,7/47,14.19%,PCSK5;SGMS2;ARG1;NMRAL1;AGK;SPTSSB;DMD
prerank,endocytic recycling (GO:0032456),0.2851213367387873,0.7494706179866071,0.8206724782067247,0.9464452834893051,1.0,12/50,19.48%,RAB11FIP3;EHD2;RAB35;CMTM6;VPS39;EHD1;ANKRD27;RAB11B;SNF8;SNX12;PTPN23;VPS52
prerank,cellular macromolecule catabolic process (GO:0044265),0.28705447956491614,0.7491306470608361,0.8151476251604621,0.9465157667975337,1.0,9/49,17.46%,SIDT2;CHEK2;IDE;FBXO27;RNASE3;RNASEH2A;OGA;FBXO17;PABPC4
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.30288578294526486,-0.7485190406976704,0.770949720670391,0.9722973129907104,1.0,2/12,10.29%,ACTB;LAMA5
prerank,protein destabilization (GO:0031648),0.2944718723977121,0.748506126215511,0.7772020725388601,0.9469653579202215,1.0,4/32,12.71%,GSN;CREBBP;CUL3;NR1D1
prerank,protein N-linked glycosylation (GO:0006487),0.2714742795963403,0.7483374117813536,0.8403869407496977,0.9468102767376733,1.0,18/66,23.59%,FUT8;MGAT4C;ALG13;B4GALT1;ENTPD5;ALG12;DPAGT1;MGAT1;MGAT5;GFPT1;DDOST;TMEM165;ALG14;TUSC3;DPM1;ALG8;MCFD2;PGM3
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.3563920445720363,0.7482284667358631,0.7542768273716952,0.9465609306580225,1.0,5/13,21.33%,IRS1;SORL1;ZBTB7B;SORBS1;IGF2
prerank,microtubule-based transport (GO:0099111),0.35258597444371265,0.7481596473481092,0.7674772036474165,0.9462593267831452,1.0,3/12,20.82%,DNAAF4;SPAG17;DNAAF2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2947086981559029,0.747907616727273,0.806949806949807,0.9462172381462888,1.0,6/35,11.24%,HOXA5;STAT3;FOXO3;INHBA;ARNT;ZFPM1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.27508170004502,0.7475002177795254,0.8488095238095238,0.9464106642181322,1.0,17/70,21.13%,ITGB5;PSMB2;IKBKG;PSMD11;PSMC1;ITGAV;PSMC6;PSMD1;PSMD4;IKBKB;SNAP23;PSMA6;PSMD14;PSMD12;PSMD7;CHUK;PSME3
prerank,negative regulation of axonogenesis (GO:0050771),0.30977932439655836,0.7461059897861716,0.7721854304635761,0.9479274712223724,1.0,2/27,2.21%,ULK2;FGF13
prerank,regulation of ATP metabolic process (GO:1903578),0.27765731214762196,0.7460991338549641,0.8292978208232445,0.9475400510921629,1.0,12/54,19.88%,NUP93;ABCD1;NUP214;NUP153;EIF6;NUP155;RANBP2;AK4;NUP88;NUP35;ATP5IF1;ZBTB7A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3010988635826156,0.7460628203402708,0.8207171314741036,0.9471939114439601,1.0,9/32,19.19%,ID2;CDC45;CDK16;FBXO5;TFDP1;E2F1;HINFP;RB1;BRD4
prerank,organelle fusion (GO:0048284),0.3195610226687813,0.7459234744749389,0.7940761636107193,0.9469873399499996,1.0,7/22,27.91%,EEA1;MIEF1;MIEF2;MIGA1;USP30;CHCHD3;BAX
prerank,regulation of actin filament-based movement (GO:1903115),0.36969283647570617,0.7457278261702412,0.773524720893142,0.9468357855267554,1.0,1/10,1.84%,ANK2
prerank,negative regulation of protein depolymerization (GO:1901880),0.3109118223731276,0.7452773091295951,0.8084795321637427,0.9470651574217798,1.0,5/24,10.11%,FGF13;KATNB1;LIMA1;CIB1;HDGFL3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.33185117932561287,0.7450746741118797,0.7762237762237763,0.9469373026275457,1.0,5/19,15.53%,CUX1;FBXW8;DHX36;DBN1;CAPRIN2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.3144339465191445,0.7441075239346202,0.8271604938271605,0.9478418705529575,1.0,5/26,16.22%,LBP;TLR1;IFI35;TIRAP;FLOT1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.28884025979824823,0.744037787855969,0.7969348659003831,0.9475373250571559,1.0,6/38,12.19%,PTGIS;KLF4;ATP2B4;ZC3H12A;TLR4;CLU
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.28108674585309934,0.743997705181115,0.8388324873096447,0.9471997741615468,1.0,10/48,15.55%,HIPK1;ABL1;CHEK2;CASP2;IKBKE;MCL1;BRCA1;E2F1;USP28;PRKDC
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.3478912711229589,0.7435928612205036,0.7554179566563467,0.947362026127721,1.0,7/15,25.40%,ATL2;RTN3;TMEM33;ATL1;ZFYVE27;REEP3;REEP4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.26272713480289894,0.7435605790541912,0.8862343572241184,0.9470113684120568,1.0,12/90,10.73%,GNAS;CMKLR1;ADRB2;VEGFA;GADD45G;GRB10;PDGFC;SIRT6;EHMT1;KDM1A;DECR1;TRPM8
prerank,chromatin disassembly (GO:0031498),0.3512126721726085,0.7430938673275371,0.7854889589905363,0.9468636251294873,1.0,7/14,34.64%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,nucleosome disassembly (GO:0006337),0.3512126721726085,0.7430938673275371,0.7854889589905363,0.9468636251294873,1.0,7/14,34.64%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,melanosome localization (GO:0032400),-0.26334096833078535,-0.742451397801424,0.8688524590163934,0.9792063959634121,1.0,4/21,12.19%,SHROOM2;BBS5;MYO5A;MREG
prerank,stress-activated MAPK cascade (GO:0051403),0.27420191203016125,0.7424373439312036,0.8472385428907168,0.9473437832321555,1.0,20/61,26.46%,MAP3K5;TAB3;IKBKG;CUL1;RIPK2;MAP3K7;TAB2;MAP2K4;TRAF6;MAP3K10;IKBKB;CHUK;SH2D3C;MAP2K3;UBB;FBXW11;ARHGEF6;UBE2V1;UBA52;RPS27A
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.32945149676203095,0.742270491317467,0.7533039647577092,0.9471742956436768,1.0,2/18,7.14%,GSK3B;MPV17L
prerank,sensory perception of smell (GO:0007608),0.36654245747705216,0.7414987480367725,0.7614814814814815,0.9477974897927407,1.0,5/11,28.45%,UBR3;ADCY3;MKKS;BEST2;BBS4
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3646694124446488,0.7414253091896418,0.7746913580246914,0.9475016538454751,1.0,2/11,12.02%,ADRB2;DRD3
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.25593009607847617,-0.740385543992495,0.8631178707224335,0.9808548885433033,1.0,6/24,15.71%,AKAP6;PDE4D;JPH1;CALM1;JPH2;CASQ2
prerank,histone H2A monoubiquitination (GO:0035518),-0.26578457575721426,-0.7395847773321838,0.8372781065088757,0.9807586826900796,1.0,4/17,19.05%,PCGF5;RING1;BMI1;KDM2B
prerank,N-terminal protein amino acid modification (GO:0031365),0.3476754476308499,0.7393992282856517,0.801762114537445,0.9497926853293932,1.0,7/14,31.46%,NAA15;NAA40;NAA60;METAP2;NAA50;METAP1D;NTMT1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.3018680828671325,-0.7393620435437559,0.8169398907103825,0.9798452479883252,1.0,5/11,21.87%,BCL2;MIF;CD74;TAF9;TRIAP1
prerank,cellular response to acid chemical (GO:0071229),0.30753183942867646,0.7390367701816716,0.8048780487804879,0.9498488608644939,1.0,3/27,5.42%,VEGFA;CAPN2;RRAGB
prerank,vesicle organization (GO:0016050),-0.2161962809743871,-0.7386320014294808,0.9540816326530612,0.9796057931251866,1.0,6/46,7.94%,SORT1;DNM1;FNBP1L;SRGN;RAB22A;CD34
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2487776221920624,0.7382893228204318,0.9111111111111111,0.9504858368778852,1.0,39/158,20.27%,AKAP13;ALPK1;TRAF3IP2;S100B;TAB3;REL;MIER1;IRAK4;ROR1;IKBKG;IKBKE;MAVS;RIPK2;RHOA;MAP3K7;DHX36;TAB2;MAP3K3;ANKRD17;MYD88;TRAF2;TIRAP;MTDH;CARD16;ZDHHC13;DDX21;PIM2;TRAF6;PPP5C;TRAF5;IKBKB;SHISA5;MAP3K14;RBCK1;TICAM1;BRD4;CHUK;NEK6;MID2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.29696571134337646,0.7379679060876918,0.8045515394912985,0.9505190574334768,1.0,5/35,11.41%,MET;ARHGAP44;MYOC;CUL3;EPHB2
prerank,"phototransduction, visible light (GO:0007603)",0.34501737517852704,0.7378889821700613,0.7781109445277361,0.9502197754738513,1.0,1/14,2.13%,PDE6A
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2867793806933884,0.7378340685147002,0.8254777070063695,0.949901069113183,1.0,9/41,19.88%,NUP93;NUP214;NUP153;EIF6;NUP155;RANBP2;NUP88;NUP35;ZBTB7A
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.34534375658064287,0.7376126583426406,0.7693498452012384,0.9498001881679318,1.0,3/12,21.95%,TICRR;WDR18;NBN
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.29231172707976605,-0.737004015072633,0.8084507042253521,0.980671220885092,1.0,1/13,0.40%,RNF152
prerank,positive regulation of exocytosis (GO:0045921),-0.22347477552676684,-0.7367780900660916,0.8717948717948718,0.9797964142913016,1.0,3/35,5.01%,CLASP2;CADPS;SMPD3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.35314818189211783,0.735579221744024,0.796923076923077,0.9520602103496675,1.0,3/12,17.07%,SRM;ODC1;OAZ2
prerank,MAPK cascade (GO:0000165),0.24186314141471976,0.7355783912034324,0.9471544715447154,0.9516671448143162,1.0,36/295,11.07%,EGFR;MET;MAP3K5;PTPN3;FGF13;FGF2;SOX9;NRAS;KRAS;IRS1;DLG2;PSMB2;CCL3;MRAS;SPTAN1;SHOC2;PDE6D;FGFR1;SHC1;NF1;MEF2A;MAPK12;ERBB2;PTPRA;IKBKG;ABHD17B;KITLG;PSMD11;IL17RD;CUL3;PSMC1;CUL1;ITGAV;MAP3K7;MAP3K3;PSMC6
prerank,positive regulation of viral transcription (GO:0050434),0.3068562849183365,0.7343775512157619,0.8104667609618105,0.9528602148346319,1.0,8/25,28.96%,MDFIC;NELFE;DHX9;POLR2C;CCNT1;RSF1;SUPT4H1;NELFA
prerank,regulation of immunoglobulin production (GO:0002637),0.3122241744497345,0.7341532791792048,0.819538670284939,0.9527586951063145,1.0,3/23,11.41%,CLCF1;GPI;EPHB2
prerank,positive regulation of autophagy (GO:0010508),0.2643380711721416,0.7339636356257978,0.8836405529953917,0.9526025637632763,1.0,23/81,21.06%,GSK3B;TPCN1;FOXO3;WAC;IKBKG;PAFAH1B2;ZC3H12A;ATF6;PLEKHF1;MAP3K7;SCOC;SH3GLB1;MTDH;PIM2;PLK3;LRRK2;TICAM1;DAPK1;GPSM1;EPM2A;SESN3;MID2;NPRL2
prerank,peptide hormone secretion (GO:0030072),0.3071015362009012,0.7337695344795593,0.8160112359550562,0.9524728544863139,1.0,6/26,19.46%,ANXA1;LTBP4;CDK16;FFAR4;RAB1A;EDN3
prerank,ovarian follicle development (GO:0001541),0.34752014732066616,0.7337434561043863,0.7791411042944786,0.9521108840376069,1.0,2/13,6.79%,VEGFA;INHBA
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3032296033327997,0.7335213235321886,0.803347280334728,0.952002335050956,1.0,4/27,6.64%,CHST13;XYLT1;BGN;CHST11
prerank,cardiac ventricle development (GO:0003231),0.3177302874271893,0.7333818693717661,0.7974137931034483,0.9517946691256424,1.0,5/20,16.94%,HES1;GATA4;MDM4;TMEM65;STRA6
prerank,mitotic cytokinetic process (GO:1902410),0.3205295054955874,0.732749302423104,0.7873563218390804,0.9522284175131634,1.0,4/20,15.95%,CNTROB;RHOA;PDCD6IP;CHMP2B
prerank,vasodilation (GO:0042311),0.3439254885673294,0.7316282718126843,0.7774343122102009,0.9532748821817661,1.0,1/13,2.59%,ADRB2
prerank,zinc ion transmembrane transport (GO:0071577),0.31123753151255884,0.7314716094078801,0.8138888888888889,0.9530915114303777,1.0,4/22,8.45%,SLC39A14;SLC39A13;SLC39A11;SLC30A3
prerank,positive regulation of chemokine production (GO:0032722),0.2832594753660454,0.7311376384327984,0.8414948453608248,0.953132595133425,1.0,8/44,13.32%,IL33;TWIST1;IL17RA;TLR4;EGR1;MAVS;EIF2AK2;TIRAP
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.33167017658153225,0.7303002059667982,0.782991202346041,0.9538704048080502,1.0,6/17,21.18%,TGFB3;PDCD4;CDKN1B;CDKN1A;PPARG;SOD2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2606173438108708,0.7302486139311524,0.8860759493670886,0.95354065207403,1.0,26/84,25.56%,SAMD4A;IGFBP5;PAIP2;CNOT8;ABCA7;EPRS1;DHX36;EIF2AK2;RTN3;CLU;SORL1;PIN1;TOB1;SYNCRIP;ENC1;DAPK1;IGF2BP3;CAPRIN1;SAMD4B;FMR1;MALSU1;CNOT1;TRIM71;DDX6;TSC1;RBM4
prerank,response to peptide hormone (GO:0043434),0.2838995402605339,0.7302220461508566,0.8509316770186336,0.9531887264060365,1.0,4/43,5.34%,IGFBP5;IRS1;STAT3;ANXA1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.26016633069780215,0.7295478887145899,0.8886363636363637,0.9536505664525281,1.0,24/94,19.76%,PSMB2;IRAK3;TAB3;IRAK4;IKBKG;PSMD11;EGR1;PSMC1;CUL1;RIPK2;MAP3K7;TAB2;MAP3K3;PSMC6;MYD88;PSMD1;TRAF6;PSMD4;IKBKB;PSMA6;PSMD14;PSMD12;PSMD7;CHUK
prerank,cellular response to oxidative stress (GO:0034599),0.25236072444902313,0.7291121474689214,0.8970427163198248,0.953818000038785,1.0,34/118,25.98%,EGFR;PRKCD;NFE2L2;GSR;ABL1;FOXO3;PRDX5;GPX8;ZC3H12A;ARNT;PARP1;KEAP1;EIF2S1;CCS;VKORC1L1;STX2;LRRK2;CAT;DAPK1;NUDT2;CHUK;PRDX2;FER;SOD2;VRK2;ZFAND1;RAD52;TP53;WNT16;RBM11;JUN;MPV17;TXNRD1;AIF1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.32839888609322393,0.7290919372251767,0.7757142857142857,0.9534464683540701,1.0,1/18,1.99%,EZR
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.30047005710630476,0.7290062443056858,0.8120713305898491,0.9531582320303205,1.0,7/27,21.29%,PLA2G15;CHKB;ETNK1;LPIN2;ETNPPL;CEPT1;ETNK2
prerank,maturation of LSU-rRNA (GO:0000470),-0.24328061270919416,-0.7289727795352174,0.864,0.9885370093463566,1.0,5/26,11.45%,NSA2;RPL7;RPL10A;RPL7L1;SNU13
prerank,negative regulation of immune response (GO:0050777),0.24683118438695983,0.7281826151162721,0.9125395152792413,0.9538665355140543,1.0,11/154,8.15%,RAMP1;PTGDR;COL3A1;ADRB2;PLCG2;TRAFD1;PTHLH;IRAK3;ADCY9;GPR27;HTR6
prerank,positive regulation of telomerase activity (GO:0051973),0.2921929543621983,0.7273092184571911,0.807277628032345,0.9545684531599515,1.0,3/33,5.82%,GRHL2;KLF4;NEK7
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.3498142965493841,0.7271633916474426,0.776,0.9543717026378867,1.0,5/12,22.02%,ANKRD13C;KDELR2;RER1;KDELR3;GPAA1
prerank,regulation of intracellular transport (GO:0032386),0.28782195585023207,0.7268966852570663,0.8524804177545692,0.9543064371953078,1.0,6/38,17.76%,GAS1;NDEL1;NUP214;GRIPAP1;RAB11B;LRRK2
prerank,protein acetylation (GO:0006473),0.29662753129900965,0.7265934096204965,0.8240740740740741,0.9543240453885757,1.0,13/30,29.23%,CREBBP;DSCC1;NAA15;ESCO1;NAT10;NAA40;NAA80;NAA60;KAT6A;GTF2B;HAT1;KAT2B;NAA50
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.27874290956002906,0.7258605510803365,0.8542413381123058,0.954861122627629,1.0,9/56,13.35%,CIT;SON;TTC19;ALKBH4;RAB35;ARL3;RHOA;SNX18;PDCD6IP
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.32400870155456396,0.7254932918743157,0.7776141384388807,0.954965792942721,1.0,7/19,23.59%,RENBP;GFPT1;SLC35D1;GNPDA1;UAP1;MPI;PGM3
prerank,B cell activation involved in immune response (GO:0002312),0.34135041885620904,0.725484508855917,0.7746031746031746,0.954587301898163,1.0,2/13,14.24%,EXOSC3;RNF8
prerank,regulation of cilium assembly (GO:1902017),0.26604768653893546,0.7245483867945739,0.8614457831325302,0.9553844820465072,1.0,15/62,20.95%,CDK10;RABEP2;LIMK2;SDCCAG8;ATG3;ATG5;TBC1D2B;EVI5;RABGAP1;YAP1;TBC1D5;TBC1D17;ODAD3;CDKL1;TBC1D15
prerank,centromere complex assembly (GO:0034508),0.28924784497506945,0.7237576987952551,0.8541666666666666,0.9559933928494867,1.0,16/36,32.12%,RBBP7;CENPT;POGZ;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;MIS12;CENPK;NASP;CENPE;HELLS;CENPN;CENPV
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.25056362167034746,0.7232373068592493,0.902465166130761,0.9562502705066038,1.0,19/125,14.06%,NDEL1;CLIP1;SETD2;AURKA;PAFAH1B1;XPO1;PTPA;CDC20;TTK;CCNB1;AHCTF1;MECP2;CENPT;MAD2L1;PCNT;KIF3B;ZW10;RANBP2;CENPL
prerank,macroautophagy (GO:0016236),0.25075495434519557,0.7232198252740989,0.9112814895947426,0.9558834348957588,1.0,41/118,29.73%,TCIRG1;VPS41;LIX1L;ZFYVE1;BECN1;VCP;ACBD5;VPS39;ATG3;SNX14;ULK3;RB1CC1;ATG5;VPS37A;VTA1;VPS37B;PIP4K2A;WIPI2;NBR1;ATG4B;CHMP2B;SNF8;TBC1D5;TMEM74;STX17;VTI1B;PRKAB1;SRC;AMBRA1;ARL8B;CHMP3;MAP1LC3B;TOMM20;CLN3;ATG14;VPS33A;HGS;SQSTM1;ATG12;TSG101;UBXN6
prerank,amyloid-beta metabolic process (GO:0050435),0.3231183093713796,0.7231695452629114,0.802710843373494,0.9555573482351206,1.0,4/16,17.77%,BACE2;ABCA7;IDE;APEH
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.3569534442444232,0.7230179638302583,0.7777777777777778,0.955358189595762,1.0,2/11,13.05%,LDLR;SREBF1
prerank,indolalkylamine catabolic process (GO:0046218),0.35257994333275455,0.7218947421244669,0.7848484848484848,0.9564005491127415,1.0,2/10,18.32%,TDO2;IDO2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3281225917679734,0.7217409550616192,0.7981927710843374,0.9561958498133516,1.0,5/16,23.64%,ZC3H12A;DHX36;MOV10;TARDBP;TRIM71
prerank,multivesicular body organization (GO:0036257),0.29232783102668175,0.7214595256744293,0.8285714285714286,0.9561742783812902,1.0,11/31,30.23%,VPS37A;VTA1;VPS37B;PDCD6IP;CHMP2B;SNF8;RAB11A;CHMP3;HGS;TSG101;IST1
prerank,positive regulation of cellular component organization (GO:0051130),0.25076615541386793,0.7214489650414759,0.9078947368421053,0.9557980733710231,1.0,22/107,17.53%,TRABD2B;MPP7;GPC3;VEGFA;TGFB3;GSK3B;TGFBR1;LRP1;SPIDR;PLEKHM2;VCP;CDC20;SH3GLB1;CLU;ATP10A;TIRAP;CDC42EP2;FLOT1;ADD1;RB1;PTPN23;SURF4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3623173906561771,0.7212850118107478,0.7832512315270936,0.9556218680249492,1.0,2/10,7.38%,TSKU;FN1
prerank,necroptotic process (GO:0070266),0.3357925570547608,0.7212726477151423,0.7908689248895434,0.9552507217858058,1.0,2/16,8.34%,TRPM7;TLR4
prerank,positive regulation of viral life cycle (GO:1903902),-0.2520870795265974,-0.7203108583374359,0.8711864406779661,0.9980163634770712,1.0,5/22,16.32%,LGALS1;AXL;CD74;P4HB;TYRO3
prerank,regulation of steroid biosynthetic process (GO:0050810),0.35292604146991624,0.7202857378765403,0.7888888888888889,0.9560881683161722,1.0,2/11,8.34%,BMP5;EGR1
prerank,multivesicular body assembly (GO:0036258),0.2929745882805166,0.7201077675839361,0.8285714285714286,0.9559346780025576,1.0,11/30,30.23%,VPS37A;VTA1;VPS37B;PDCD6IP;CHMP2B;SNF8;RAB11A;CHMP3;HGS;TSG101;IST1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.31489012701361274,0.7196498028533066,0.827972027972028,0.9561093450248045,1.0,5/20,19.00%,ACSM2A;ACSL3;ACACA;SCD;FITM2
prerank,regulation of receptor internalization (GO:0002090),0.29307161314497787,0.7194410877055734,0.8571428571428571,0.955976515991818,1.0,11/35,24.96%,SFRP4;VEGFA;ATXN2;FLOT1;TBC1D5;EGF;ATAD1;FMR1;RIN3;SCYL2;MKLN1
prerank,insulin secretion (GO:0030073),0.31664009575054447,0.7192157347581243,0.8147612156295224,0.9558799395441655,1.0,2/19,5.34%,CLTRN;ANXA1
prerank,defense response to fungus (GO:0050832),0.3210637107134736,0.7187523634934193,0.8115727002967359,0.9560716597061579,1.0,1/17,4.45%,PLCG2
prerank,granulocyte differentiation (GO:0030851),0.3275035291434949,0.7182954428936461,0.8265734265734266,0.9562427041063837,1.0,8/18,20.89%,RARA;RXRA;E2F1;CDK2;CDKN1A;LBR;DEK;PML
prerank,maintenance of protein localization in organelle (GO:0072595),-0.26119551215238446,-0.7178247675986535,0.8517350157728707,0.999786510066196,1.0,7/19,24.02%,PINK1;TAF3;TAPT1;ARL2BP;HK2;AKT1;HSPA5
prerank,DNA conformation change (GO:0071103),0.32664988211386853,0.7174013286216896,0.8064992614475628,0.9569735786713142,1.0,2/17,9.18%,ABL1;TOP1
prerank,phagosome-lysosome fusion (GO:0090385),0.3521892593074973,0.7170269626498201,0.7910216718266254,0.9570530832688571,1.0,1/10,3.81%,RAB7B
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.25577092008019975,0.7165580281726562,0.8723897911832946,0.9568554298568404,1.0,19/78,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.25577092008019975,0.7165580281726562,0.8723897911832946,0.9568554298568404,1.0,19/78,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,regulation of interleukin-10 production (GO:0032653),-0.20997280405496102,-0.716499290386768,0.9264705882352942,1.0,1.0,13/44,21.92%,PRKCZ;TNFRSF21;TRIB2;CD34;HMGB1;TYROBP;CD47;NOD2;JAK3;PYCARD;HSPD1;AGER;CD274
prerank,regulation of mitochondrion organization (GO:0010821),0.2748927873873815,0.716403702406599,0.8456712672521958,0.9566682565145491,1.0,11/47,23.72%,PID1;GSK3B;PLSCR3;SREBF1;GOLPH3;MIEF2;LRRK2;PRMT6;IAPP;USP36;OMA1
prerank,acylglycerol metabolic process (GO:0006639),0.2833183507268413,0.7161657417620741,0.8504551365409623,0.9565557461319878,1.0,7/37,14.84%,MGLL;LYPLA2;DGKA;PNPLA3;ABHD6;PNPLA2;SEL1L
prerank,positive regulation of defense response (GO:0031349),0.2509182280377812,0.7157978278690841,0.8906426155580609,0.9566283019294505,1.0,19/89,19.40%,CCL3;CCL1;IL33;IL17RA;NLRP12;TLR4;GPR4;PDCD4;TLR8;POLR3F;IFI35;AKIRIN2;PLSCR1;ABCC1;TNIP1;POLR3D;CCN4;DHX9;LRSAM1
prerank,cholesterol metabolic process (GO:0008203),0.2614580472708554,0.7154536697599317,0.8778801843317973,0.9566345294534453,1.0,15/68,18.89%,SOAT1;FDX1;TSKU;RXRA;GGPS1;ANGPTL3;SOAT2;GBA2;LCAT;SQLE;LBR;CEL;EBP;HMGCR;APOF
prerank,regulation of p38MAPK cascade (GO:1900744),0.28696507335829563,0.7153583885459046,0.8318002628120894,0.9563774167395929,1.0,7/35,13.19%,EZR;VEGFA;GADD45G;PER1;ZC3H12A;XDH;DLG1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2321228085070133,-0.7152795055086724,0.8872180451127819,1.0,1.0,13/29,34.22%,CADM1;NECTIN2;TYROBP;CYRIB;SPI1;FADD;NOS2;SLAMF6;ITGAM;CD226;IL12A;CRTAM;IL12RB1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.2695368972161031,0.7148958540163243,0.8775757575757576,0.9565554115877635,1.0,8/51,12.32%,CCL3;STAT3;NLRP12;TLR4;EGR1;RIPK2;TLR8;MYD88
prerank,regulation of platelet aggregation (GO:0090330),0.32826153073443615,0.7145564053688517,0.8137829912023461,0.9565661553553901,1.0,3/17,7.87%,PRKCD;CD9;DMTN
prerank,cilium-dependent cell motility (GO:0060285),-0.24626029647640307,-0.7141108548021939,0.9117647058823529,1.0,1.0,11/22,33.90%,CFAP44;CFAP54;CCDC39;DNAH3;EFHC1;EFHC2;CCDC65;RFX3;DNAH2;TEKT5;DNAH1
prerank,hexose metabolic process (GO:0019318),-0.2177750104133589,-0.7138805764255969,0.9308755760368663,0.9995696663194661,1.0,5/39,9.19%,APOD;PGM1;PPARD;AKR1A1;PMM2
prerank,neutrophil chemotaxis (GO:0030593),0.2724024916844131,0.7124947345772062,0.8681318681318682,0.9586953117719427,1.0,4/53,5.09%,CXCL2;CCL3;CCL1;GBF1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.2208671699155502,-0.7124232022048691,0.908,1.0,1.0,10/31,26.54%,LYN;TNFRSF21;CD300A;CEBPB;TYROBP;CD86;CD274;LST1;RC3H1;IL4I1
prerank,regulation of autophagy (GO:0010506),0.2354071096774363,0.7123413576037985,0.9406952965235174,0.9584855465876971,1.0,46/216,20.27%,MET;NEDD4;EXOC4;EIF4G3;GSK3B;TPCN1;ABL1;STAT3;CISD2;FOXO3;RRAGB;USP13;TAB3;WDR41;ZC3H12A;EIF4G2;SNX32;KLHL22;ATF6;PLEKHF1;TAB2;MCL1;KEAP1;RB1CC1;SH3GLB1;SREBF1;EXOC7;MTDH;PIP4K2A;ATP6V1A;PIM2;RUBCN;RHEB;MLST8;FOXK1;LRRK2;TICAM1;ATP6V0D1;DAPK1;GPR137B;TLK2;EIF4G1;USP10;CAPN1;FOXK2;MID2
prerank,positive regulation of catalytic activity (GO:0043085),0.28085284368046026,0.7112838711233644,0.8427109974424553,0.9594104128188192,1.0,8/37,21.33%,BCAS3;ABL1;WRN;CIB1;FXN;CHTOP;XRCC5;IGF2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.29234778916560983,0.7110455495534866,0.8428184281842819,0.9593078099798246,1.0,7/27,26.06%,ZC3H12C;ZC3H12A;ZC3H12B;CPSF3;CSTF3;PARN;DICER1
prerank,ESCRT complex disassembly (GO:1904896),0.3457677009189915,0.7101905869529844,0.7965571205007824,0.9595666855067332,1.0,2/10,15.95%,VTA1;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.3457677009189915,0.7101905869529844,0.7965571205007824,0.9595666855067332,1.0,2/10,15.95%,VTA1;CHMP2B
prerank,negative regulation by host of viral transcription (GO:0043922),0.3403644273776676,0.7098080568919722,0.7917933130699089,0.9596540022618448,1.0,4/12,25.27%,CCL3;TARDBP;REST;JUN
prerank,histone H3-K36 demethylation (GO:0070544),-0.3091138451361008,-0.7092989572596077,0.8166666666666667,1.0,1.0,1/10,2.66%,KDM7A
prerank,inner mitochondrial membrane organization (GO:0007007),-0.20713251719767312,-0.7091851070571534,0.958139534883721,1.0,1.0,19/47,30.29%,NDUFA13;CHCHD6;ATP5PF;ATP5F1E;APOOL;ATP5F1A;DNAJC11;ATP5F1B;MTX1;ROMO1;TIMM10B;MTX3;LETM1;UQCC3;ATP5MC1;ATP5MC2;ATP5MC3;AFG3L2;ATP5F1D
prerank,neutrophil migration (GO:1990266),0.268510135518828,0.7089645246833207,0.8810096153846154,0.9602710905550345,1.0,6/58,9.92%,CXCL2;CCL3;CCL1;GBF1;IRAK4;CCL7
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.275143672933318,0.7089205977780798,0.8622448979591837,0.9599330476838797,1.0,1/39,0.67%,TCF7L2
prerank,long-term synaptic potentiation (GO:0060291),0.3095554256257907,0.7086725864315648,0.8432203389830508,0.9598479802566425,1.0,3/21,6.09%,PTK2B;MPP2;NFATC4
prerank,cellular response to inorganic substance (GO:0071241),0.3141663383049084,0.7086677883884005,0.8220338983050848,0.9594656356820742,1.0,9/21,22.05%,SPIDR;DDI2;DPEP1;DDX11;RTF2;ATRX;CDK2;DDI1;FMR1
prerank,T cell differentiation in thymus (GO:0033077),0.33465782566657093,0.7081990506251401,0.8009118541033434,0.9596638197301205,1.0,1/14,4.18%,GLI3
prerank,regulation of dephosphorylation (GO:0035303),-0.27263708743683485,-0.7081330269140582,0.8357348703170029,1.0,1.0,4/15,13.55%,PPP1R16B;MTMR3;SMG7;CDK5RAP3
prerank,striated muscle cell differentiation (GO:0051146),0.33253011391111903,0.7074937336692281,0.8256333830104322,0.9601447254198109,1.0,2/16,5.66%,AKAP13;SKI
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.32400777543247083,0.7068343594551888,0.8236151603498543,0.9605484584158026,1.0,6/17,17.88%,VEGFA;VCL;PPP1R12A;ADD1;IKBKB;S1PR2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.3271351094611997,0.7065685914140316,0.806966618287373,0.960503925754118,1.0,4/15,19.00%,LDLR;SREBF1;SIK1;FITM2
prerank,RNA destabilization (GO:0050779),0.30922719430974815,0.7064504380118158,0.8022440392706872,0.9602528011127405,1.0,9/18,29.07%,ZC3H18;CELF1;MEX3D;FTO;PUM1;METTL16;DXO;ROCK1;YTHDF2
prerank,tryptophan catabolic process (GO:0006569),0.3424848502291272,0.7060515877332095,0.8038922155688623,0.960324883374494,1.0,2/11,18.32%,TDO2;IDO2
prerank,leukotriene biosynthetic process (GO:0019370),-0.2757535113195981,-0.7055885601850554,0.8481375358166189,1.0,1.0,6/14,27.24%,GGT5;LTA4H;GGT1;PLA2G5;ALOX5AP;MGST2
prerank,toxin transport (GO:1901998),0.3552087829282352,0.7054301886237507,0.8172920065252854,0.9606727310772162,1.0,2/10,14.99%,ANTXR1;RAB40B
prerank,positive regulation of vasculogenesis (GO:2001214),0.351007231983607,0.7041922615227736,0.821939586645469,0.961732692393342,1.0,2/10,11.12%,TMEM100;RAP1A
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.28482463121147567,-0.7041856726821502,0.8438356164383561,1.0,1.0,1/12,1.18%,PRKCB
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3139371335109935,0.7029566385489662,0.8230088495575221,0.9627755914749119,1.0,3/18,9.02%,EZR;DACT1;RDX
prerank,negative regulation of cell development (GO:0010721),0.29360338719545537,0.7025137036174919,0.8365384615384616,0.9628939473324275,1.0,10/25,24.40%,GSK3B;PTHLH;PCM1;HOOK3;SORL1;PAX6;RFLNA;REST;APPL2;LILRB1
prerank,negative regulation of nervous system development (GO:0051961),0.31382746107331655,0.7022551853755852,0.829971181556196,0.9628222763416954,1.0,5/17,16.03%,SLIT1;PCM1;HOOK3;SORL1;PAX6
prerank,neuron projection extension (GO:1990138),0.28922144564107555,0.702175372212125,0.8647214854111406,0.9625357086817877,1.0,7/32,17.21%,ULK2;NRP1;MAP1B;CPNE1;SPG11;CYFIP1;IQGAP1
prerank,positive regulation of response to wounding (GO:1903036),0.29945953311888435,0.7019201993362819,0.8302687411598303,0.9624371271578306,1.0,7/24,16.07%,PRKCE;ANXA1;ITGB1;DMTN;CNTF;PTN;ARFGEF1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.3563831283250094,0.7018692359772162,0.8123028391167192,0.9621121124751146,1.0,2/10,8.37%,DLGAP4;AKAP9
prerank,cardiocyte differentiation (GO:0035051),0.3585643858865072,0.701520650180381,0.800658978583196,0.9621306289933323,1.0,1/10,2.61%,AKAP13
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2898632136474671,0.7010927044035385,0.8293333333333334,0.9622352172642231,1.0,10/30,24.68%,TEN1;STN1;NIBAN2;NAT10;CDKN1A;TENT4B;ERCC4;TP53;GNL3L;SRC
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2930010229727746,0.7005419730892535,0.8236877523553163,0.9625158661948202,1.0,7/25,19.72%,STAT3;FOXO3;INHBA;ARNT;PRKDC;NCKAP1L;ANKRD54
prerank,regulation of response to interferon-gamma (GO:0060330),0.33080153640984067,0.7004204751129586,0.8103186646433991,0.9622870495421931,1.0,6/14,26.95%,PTPN2;SOCS3;JAK2;PIAS1;SUMO1;PARP9
prerank,plasma membrane tubulation (GO:0097320),-0.27449804946215867,-0.7002735448204714,0.8426966292134831,1.0,1.0,2/13,10.75%,FNBP1L;MICALL1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.33209546614448915,0.699860769027916,0.8108527131782945,0.9625335445737958,1.0,3/14,19.71%,MRPS27;RPUSD4;FASTKD3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3033832814722922,0.6997947597352315,0.8237822349570201,0.9622209721578787,1.0,2/23,8.57%,PLA2G4F;MBOAT1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.23733309435736583,-0.6990619595234022,0.90625,1.0,1.0,12/26,26.89%,INSR;HSP90AB1;EDN1;NOS1AP;DDAH1;DDAH2;TMEM106A;AKT1;PTGS2;ASS1;CD36;TLR6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.29111526771293983,-0.6990337064950559,0.8257142857142857,1.0,1.0,5/11,21.58%,ENPP2;PDPN;ARHGEF7;CORO1B;KANK1
prerank,protein K48-linked ubiquitination (GO:0070936),0.26106642640163813,0.6983879505373737,0.8923076923076924,0.9634438206002832,1.0,10/54,15.49%,RNF126;UBR5;UBE2A;RNF115;CUL3;RNF146;UBE2K;RNF8;UBE2B;UBE2D3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.26418529188715845,0.6978111766021898,0.8849009900990099,0.9637185889576864,1.0,13/47,23.49%,CNDP1;KLF4;FOXO3;INHBA;ATXN2;RBM3;CYFIP1;EIF4G1;GEMIN5;PM20D2;PUM3;RPL10;MAPKAPK5
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.2863348371649992,0.6977739439062343,0.8571428571428571,0.9633728691166498,1.0,11/31,20.71%,SIPA1L1;ARHGAP44;DHX36;NLGN1;ZDHHC15;DBN1;SRCIN1;CAPRIN2;LRRK2;PDLIM5;CAPRIN1
prerank,cardiac cell development (GO:0055006),0.3354862946512867,0.6974126592867756,0.8284389489953632,0.9634101544021857,1.0,4/11,18.07%,VEGFA;ALPK3;JAG1;CXADR
prerank,positive regulation of ATPase activity (GO:0032781),-0.2110893306667907,-0.6969860641076857,0.9365853658536586,1.0,1.0,5/41,11.59%,ATP1B3;RYR2;ATP1B2;DYNLL2;VMP1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.23965292812797706,0.6966441371638922,0.9415584415584416,0.963914153772655,1.0,8/116,8.15%,RAMP1;PTGDR;ADRB2;PLCG2;PTHLH;ADCY9;GPR27;HTR6
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.27352135973638253,-0.6965214104616628,0.8588957055214724,1.0,1.0,4/14,23.23%,TFRC;NECTIN2;SHLD2;SHLD3
prerank,synaptic vesicle membrane organization (GO:0048499),0.31047818949478967,0.6954386022666991,0.833578792341679,0.9649036319019562,1.0,5/17,22.61%,STX11;AP3D1;SNAP23;STX2;PRRT2
prerank,regulation of endocytosis (GO:0030100),0.25921658715663887,0.694697257747641,0.8856799037304453,0.965390941786701,1.0,9/61,9.94%,GPC3;STON2;ABL1;LRP1;STON1;RUFY1;ABCA7;ARFGAP1;RAB4B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2517089669330287,-0.694640821650665,0.898989898989899,1.0,1.0,1/20,0.78%,NR2F2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.23806840704558974,0.6941726144561307,0.9366952789699571,0.9656067596079392,1.0,8/117,8.15%,RAMP1;PTGDR;ADRB2;PLCG2;PTHLH;ADCY9;GPR27;HTR6
prerank,T cell activation (GO:0042110),0.24735478598970484,0.6931045114442288,0.8926096997690531,0.9664351626482731,1.0,6/69,6.77%,PPP3CA;CD2;ADA;PTPN2;NCK2;CD44
prerank,negative regulation of hormone secretion (GO:0046888),-0.30950895122527616,-0.6925100215593429,0.8363636363636363,1.0,1.0,2/10,13.05%,GJA1;RAB11FIP1
prerank,steroid hormone biosynthetic process (GO:0120178),0.28761146642144814,0.6917431901317136,0.8716216216216216,0.9675655460737336,1.0,8/29,29.93%,FDX1;TSPO;STAR;STARD3NL;HSD17B2;FDX2;FDXR;DHCR7
prerank,histone lysine methylation (GO:0034968),0.2847762275505345,0.6917329788577922,0.8577291381668947,0.9671948894747389,1.0,14/33,32.86%,WDR82;SMYD3;PRDM5;KMT2D;DPY30;SETD6;SMYD2;SETMAR;PAXIP1;DOT1L;SETDB1;MEN1;EHMT2;PRDM9
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.29975679029927876,0.6915011143201499,0.8452554744525548,0.9670630732178443,1.0,9/23,25.30%,MTMR12;OCRL;PIP4P2;SYNJ2;SYNJ1;MTMR1;SACM1L;MTMR9;MTM1
prerank,ncRNA catabolic process (GO:0034661),0.2862319726870023,0.6907729707860322,0.844207723035952,0.9674773099559707,1.0,11/28,29.56%,TUT4;EXOSC3;ERN2;TENT4B;DIS3;EXOSC2;EXOSC7;EXOSC8;PARN;NUDT16L1;SND1
prerank,peptidyl-asparagine modification (GO:0018196),0.27955383816453433,0.6903060162538167,0.876010781671159,0.9676147404976001,1.0,9/31,22.54%,FUT8;MGAT1;MGAT5;DDOST;TUSC3;HIF1AN;DPM1;ALG8;MCFD2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.29348265772158255,0.6893675411925555,0.8544668587896254,0.9682795265923219,1.0,2/23,3.95%,ID2;DSG2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.30111790352042245,0.6893554017295934,0.8518518518518519,0.9679041096871122,1.0,7/19,27.11%,HIPK1;USP28;CDIP1;PML;TP53;AEN;RPS27L
prerank,cranial nerve development (GO:0021545),0.3306734332818979,0.6887445671168886,0.8194888178913738,0.9682175574512417,1.0,3/11,11.92%,ATOH7;POU4F1;TMEM126A
prerank,cell junction maintenance (GO:0034331),-0.26491364633196873,-0.6884080486806621,0.8776758409785933,1.0,1.0,5/14,23.65%,CLDN1;CSF1R;CBLN2;F2R;PRTN3
prerank,regulation of cardiac muscle contraction (GO:0055117),0.27170765567847366,0.6877896234053672,0.8849673202614379,0.9688700959111819,1.0,4/34,9.77%,ANK2;ATP1B1;ZC3H12A;SLC9A1
prerank,defense response to protozoan (GO:0042832),-0.2831802385648491,-0.6877362682785141,0.8380681818181818,1.0,1.0,3/12,15.37%,GBP4;GBP7;CD40
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3043379821262978,0.6874563651999821,0.853021978021978,0.968844508518471,1.0,4/20,15.75%,CD55;MAP3K7;TRAF2;TRAF6
prerank,negative regulation of viral entry into host cell (GO:0046597),0.3366696378384697,0.6871136180289968,0.8404423380726699,0.968850166299933,1.0,1/12,1.97%,GSN
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3380627490283131,0.6866806413602556,0.8357723577235773,0.9685506666697264,1.0,6/11,29.53%,AGO2;EIF6;TRIM71;RBM4;AGO1;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3380627490283131,0.6866806413602556,0.8357723577235773,0.9685506666697264,1.0,6/11,29.53%,AGO2;EIF6;TRIM71;RBM4;AGO1;TNRC6C
prerank,positive regulation of T cell differentiation (GO:0045582),0.27616543472996274,0.6862050501910143,0.8746666666666667,0.9686911814319498,1.0,7/36,18.03%,VNN1;GLI3;GLI2;ZBTB1;CD46;NKAP;NCKAP1L
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2893704530585788,-0.6852198719302683,0.8519553072625698,1.0,1.0,1/10,2.90%,RAPGEF3
prerank,oogenesis (GO:0048477),-0.25597610093135104,-0.6848713320913211,0.8771428571428571,1.0,1.0,1/15,2.64%,FMN2
prerank,secretory granule organization (GO:0033363),-0.295242162169718,-0.6848557543721445,0.8725961538461539,1.0,1.0,6/10,37.66%,SRGN;ABCA1;F2R;BLOC1S1;F2RL3;BLOC1S3
prerank,protein palmitoylation (GO:0018345),0.27824927434227154,0.6847426798441832,0.8789473684210526,0.9699387146939863,1.0,10/30,22.44%,ZDHHC2;HHAT;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC13;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19
prerank,regulation of amyloid-beta clearance (GO:1900221),0.31039947274873453,0.6847247358998658,0.8333333333333334,0.9695759635598846,1.0,4/16,18.62%,LRP1;ABCA7;CLU;HMGCR
prerank,translational elongation (GO:0006414),0.23976075256847368,0.6846688167155763,0.9271300448430493,0.9692530368000345,1.0,42/101,35.75%,MRPL33;MRPL40;MRPL42;MRPS27;MRPL11;MRPS2;MRPL36;MRPL19;MRPL15;EEF2K;GTPBP2;MRPL23;MRPL44;GADD45GIP1;MRPS21;AURKAIP1;MRPS30;MRPL35;MRPL52;TSFM;MRPL30;GFM2;LTN1;MRPL10;MRPL48;MRPS18A;MRPS31;MRPL1;MRPL13;MRPL22;MRPS16;MRPL37;MRPS28;MRPS35;ERAL1;MRPL28;CHCHD1;MRPS7;MRPL14;MRPL32;MRPS9;MRPS18C
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.342783458808105,0.6844038315567226,0.8391167192429022,0.969153524754307,1.0,3/10,21.32%,VPS9D1;ATP5PD;ATP5PO
prerank,DNA catabolic process (GO:0006308),-0.2785135898562551,-0.6840296254925681,0.8444444444444444,1.0,1.0,11/11,72.17%,MUS81;ISG20;REXO4;XRN2;DNASE1;FBH1;DNASE1L3;DNASE1L1;DNASE1L2;DFFB;SETMAR
prerank,regulation of necroptotic process (GO:0060544),0.2952972483273211,0.683421093087421,0.8559077809798271,0.9698494067014646,1.0,3/23,16.22%,YBX3;PDCD6IP;FLOT1
prerank,pigment granule transport (GO:0051904),0.30217428470445884,0.6829884585973727,0.8698830409356725,0.9695512601625554,1.0,6/18,23.15%,MLPH;RAB11B;BLOC1S5;MKKS;RAB11A;BBS2
prerank,melanosome transport (GO:0032402),0.30217428470445884,0.6829884585973727,0.8698830409356725,0.9695512601625554,1.0,6/18,23.15%,MLPH;RAB11B;BLOC1S5;MKKS;RAB11A;BBS2
prerank,regulation of centrosome cycle (GO:0046605),0.3020534529839186,0.6828546644655881,0.8604651162790697,0.9693202553921183,1.0,4/21,15.95%,AURKA;NAT10;PDCD6IP;CHMP2B
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.242912824004623,0.6827390147784043,0.9112903225806451,0.9690627383296647,1.0,19/79,24.22%,AP2A2;SEC31A;SEC24B;SEC23A;SEC24D;DCTN5;KIF3B;DCTN4;CTSE;CAPZA1;KLC1;AP2B1;LAG3;AP2A1;AP1M1;AP1S1;KIF23;KIF15;KIFAP3
prerank,regulation of histone methylation (GO:0031060),0.32592804564594585,0.6824844955289177,0.8113496932515337,0.9689444197790124,1.0,3/13,17.18%,NNMT;NSD1;CHTOP
prerank,regulation of cell aging (GO:0090342),0.3294333393856158,0.6818471792518196,0.8343949044585988,0.9692521732296252,1.0,4/11,23.76%,LMNA;NEK4;NEK6;RSL1D1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3154860035705504,0.681713873147462,0.8284389489953632,0.9686341786371456,1.0,5/15,23.22%,AGO2;PABPC1;DHX36;TOB1;CNOT1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3154860035705504,0.681713873147462,0.8284389489953632,0.9686341786371456,1.0,5/15,23.22%,AGO2;PABPC1;DHX36;TOB1;CNOT1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.32538702237295775,0.680160883065087,0.8224582701062215,0.9699071631099735,1.0,3/14,16.55%,IKBKG;TRAT1;LCK
prerank,programmed necrotic cell death (GO:0097300),0.3111790745537177,0.6798125524397679,0.8503597122302158,0.9699155426660088,1.0,2/18,8.34%,TRPM7;TLR4
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3209825578984547,0.6796100668869312,0.8455538221528861,0.9697502831928334,1.0,7/13,32.75%,CCNB1;MAD2L1;PCID2;GEN1;DUSP1;LCMT1;TPR
prerank,negative regulation of centrosome duplication (GO:0010826),0.33399057644322006,0.6792480809390525,0.8636363636363636,0.9697666612688621,1.0,2/11,12.66%,RBM14;BRCA1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.27126363674717435,0.6788371466754441,0.8746736292428199,0.9698207429934662,1.0,5/34,13.24%,ZFPM2;RORA;ZFPM1;TRIO;E2F1
prerank,Notch signaling involved in heart development (GO:0061314),0.3303850403885259,0.6787903848999061,0.8210862619808307,0.9694818907788215,1.0,3/11,12.02%,NOTCH2;GALNT11;JAG1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.22645657341109343,-0.6778820297327868,0.910394265232975,1.0,1.0,13/29,30.77%,NR1H3;PLAAT3;NR1H2;DBI;TMEM86B;PNPLA8;PLA2G4B;PLA2G5;LPCAT4;MBOAT2;PLA2G4C;PLBD1;PLB1
prerank,Golgi to lysosome transport (GO:0090160),-0.2811828442514971,-0.6778354813075156,0.8666666666666667,1.0,1.0,1/11,2.40%,SORT1
prerank,positive regulation of DNA recombination (GO:0045911),0.285157531739349,0.6778107884475282,0.8908594815825375,0.9701092794715218,1.0,14/27,34.34%,PARP1;WDR48;KMT5B;FUS;ACTR2;KMT5C;ZCWPW1;MRNIP;PAXIP1;ERCC2;ARID2;PRDM9;SHLD1;HMCES
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.21600649870838484,-0.6775408228518464,0.924812030075188,1.0,1.0,10/29,22.66%,RPS14;RPS19;RPS8;RPS21;RPS16;HEATR1;RRS1;MRPS11;WDR46;NOP9
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.24664915623965142,0.6774473984374884,0.9125295508274232,0.9701175599719457,1.0,19/67,22.62%,RABEP2;DMTN;RDX;SDCCAG8;ATG3;ATG5;TBC1D2B;EVI5;RABGAP1;P2RX4;TBC1D5;TBC1D17;ODAD3;CDKL1;ABITRAM;FER;TBC1D15;FMR1;TRPM2
prerank,intracellular sterol transport (GO:0032366),0.3232754647698284,0.6771680144508143,0.8401253918495298,0.9700184114780626,1.0,6/13,24.55%,NPC1;STARD4;STAR;SERAC1;RELCH;OSBP
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.30478463973687026,0.6766751230780929,0.8613569321533924,0.9701725365297266,1.0,5/17,19.43%,SPRED2;DMTN;PARD3;SMAD7;EIF4G1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.28719054430866225,0.6766341514317468,0.869625520110957,0.9698421322106504,1.0,7/26,17.84%,FGF2;PLCG2;IBTK;SLC8B1;CHERP;LCK;ITPR2
prerank,histone H3 acetylation (GO:0043966),0.269858743139497,0.6765181936989775,0.8762755102040817,0.9695884007400455,1.0,18/40,28.80%,PER1;TADA3;MAP3K7;JADE2;KAT6B;TAF5;BRCA2;NAA60;PHF14;BRPF3;TAF12;YEATS2;KAT6A;TRIM16;SGF29;TADA2A;KAT2B;BRD1
prerank,serine family amino acid catabolic process (GO:0009071),-0.29307168883935164,-0.6762805873235127,0.8596491228070176,1.0,1.0,5/10,32.10%,CBS;GLDC;GCSH;THNSL2;DAO
prerank,positive regulation of protein maturation (GO:1903319),0.33155199847929523,0.6760146707288286,0.829073482428115,0.9697575524475238,1.0,1/11,2.92%,TNP2
prerank,establishment of spindle localization (GO:0051293),0.31472818806475217,0.6759681101804623,0.8500749625187406,0.9694257206298277,1.0,1/14,2.23%,NLRP5
prerank,positive regulation of cell aging (GO:0090343),-0.28892203018106066,-0.6756466235027205,0.8728813559322034,1.0,1.0,3/11,13.94%,B2M;YPEL3;ABI3
prerank,positive regulation of leukocyte migration (GO:0002687),0.28162015559178255,0.6753010566530425,0.8612244897959184,0.9697237242495732,1.0,6/27,20.19%,VEGFA;MIA3;PTN;NCKAP1L;EDN3;LGALS3
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.24840012510251328,-0.6750049827109937,0.8856209150326797,1.0,1.0,8/17,27.78%,MMGT1;EMC7;SGTA;BAG6;EMC6;EMC1;GET1;EMC10
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.320045200577563,0.6747459313044789,0.8434108527131783,0.9699266209147266,1.0,13/13,68.02%,FIP1L1;CSTF2T;NUDT21;CPSF4L;NCBP2;NCBP1;CPSF4;CPSF7;TUT1;CPSF1;CPSF6;CSTF2;CPSF2
prerank,mitochondrion distribution (GO:0048311),-0.2801207501894704,-0.674414560686077,0.8775510204081632,1.0,1.0,4/12,16.77%,MAPT;ARMC1;ATCAY;CLUH
prerank,maturation of SSU-rRNA (GO:0030490),-0.20802864169213667,-0.674084283016212,0.9634146341463414,1.0,1.0,6/34,11.97%,RPS14;RPS19;RPS8;RPS16;SNU13;DDX52
prerank,nuclear membrane disassembly (GO:0051081),-0.26337673149884855,-0.6733737995678443,0.8706896551724138,1.0,1.0,1/14,1.18%,PRKCB
prerank,glycoprotein catabolic process (GO:0006516),-0.24911515146417051,-0.6727679606061046,0.9159663865546218,1.0,1.0,1/17,1.47%,ADAMTS9
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.2689748975821459,-0.672299161015705,0.8559077809798271,1.0,1.0,4/13,11.88%,TNRC6B;CPEB3;POLR2G;BTG2
prerank,mitochondrial fusion (GO:0008053),0.30037964112506793,0.6720464342414968,0.8492753623188406,0.972292820446554,1.0,6/18,27.91%,MIEF1;MIEF2;MIGA1;USP30;CHCHD3;BAX
prerank,regulation of T cell proliferation (GO:0042129),0.25088242217770484,0.6706496601274899,0.9125295508274232,0.9733584154630482,1.0,18/61,28.14%,ANXA1;NCK2;ARG1;CD80;CD46;NCK1;PDCD1LG2;DLG5;GLMN;NCKAP1L;IL27;LGALS3;SDC4;LILRB1;AIF1;PTPRC;IL4;IL23R
prerank,protein import into peroxisome matrix (GO:0016558),-0.27350492267167503,-0.6704179025297585,0.8818443804034583,1.0,1.0,2/12,9.17%,PEX5L;PEX5
prerank,regulation of defense response to virus (GO:0050688),0.31516980995713795,0.6697906831069266,0.8421052631578947,0.97384473125141,1.0,7/14,33.41%,IFNLR1;DHX9;TRAF3;PPM1B;TRAF3IP1;RNF26;C1QBP
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3346403977727181,0.6691381023148912,0.8432601880877743,0.97413213817253,1.0,1/10,7.39%,APEX1
prerank,response to muramyl dipeptide (GO:0032495),0.32044225231454715,0.6688590666389824,0.8562300319488818,0.9740460899555037,1.0,3/12,11.69%,RIPK2;ERBIN;TRIM41
prerank,alpha-amino acid metabolic process (GO:1901605),-0.19389310798464424,-0.6679783328677398,0.9590909090909091,1.0,1.0,16/45,26.53%,ASPA;SLC25A13;ASPG;GOT2;NOX4;CBS;ASNS;FOLH1;GPT2;GOT1;DDAH1;DDAH2;ASS1;KYAT3;NAT8L;PYCR1
prerank,vitamin D metabolic process (GO:0042359),-0.26705927361141624,-0.6673924629333914,0.8902077151335311,1.0,1.0,2/13,9.47%,LGMN;CUBN
prerank,mitochondrial transcription (GO:0006390),0.3308331768920152,0.6673219887142375,0.8325508607198748,0.9751842694505217,1.0,2/10,18.35%,FOXO3;MTERF2
prerank,regulation of myelination (GO:0031641),-0.21911368000052472,-0.6664481105488085,0.95703125,1.0,1.0,5/25,17.16%,TNFRSF21;TENM4;JAM2;SIRT2;NSUN5
prerank,peptidyl-amino acid modification (GO:0018193),0.33126939222171775,0.6664113669295321,0.8567119155354449,0.9757463825079543,1.0,2/10,22.31%,FKBP10;METAP2
prerank,acetyl-CoA metabolic process (GO:0006084),0.3125001555798839,0.666334724262678,0.8441176470588235,0.9754391239581232,1.0,8/15,33.77%,ACACA;TDO2;HMGCS2;MVD;MVK;HMGCS1;ACAT1;PMVK
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23226132275544445,0.6661351520141185,0.9555808656036446,0.9752506750120636,1.0,34/94,32.27%,PCM1;PAFAH1B1;CEP43;AKAP9;SDCCAG8;HAUS2;CEP63;PLK4;PCNT;NPHP1;OFD1;CEP164;CETN2;IQCB1;C2CD3;RAB11A;SFI1;CEP89;TCTN1;YWHAE;CEP76;RPGRIP1L;CSNK1E;CEP290;CEP162;PLK1;ACTR1A;CEP72;CEP131;CEP97;CEP57;TUBG1;NDE1;CSNK1D
prerank,glycosphingolipid metabolic process (GO:0006687),0.25692206868313827,0.6645513608875585,0.9009779951100244,0.9764728457564581,1.0,3/42,4.64%,ESYT3;HEXA;LARGE1
prerank,cardiolipin metabolic process (GO:0032048),0.311458554222241,0.6631507365144373,0.8576,0.977465768487929,1.0,4/13,25.44%,PLSCR3;TAMM41;HADHA;LCLAT1
prerank,carboxylic acid catabolic process (GO:0046395),0.31970761697085104,0.6631333730007235,0.8649068322981367,0.977103234568087,1.0,3/12,18.55%,RENBP;ACOT8;GNPDA1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.24419188747959314,-0.6629162203292526,0.9,1.0,1.0,16/16,75.61%,AGER;CYRIB;FADD;IL12A;IL12RB1;IL23A;CEACAM1;KLRD1;IL12B;RIPK3;XCL1;KLRC1;STX7;IL23R;PTPRC;LILRB1
prerank,icosanoid biosynthetic process (GO:0046456),-0.28170223357248425,-0.6628182527721007,0.8877005347593583,1.0,1.0,4/10,27.24%,LTA4H;PLA2G5;ALOX5AP;MGST2
prerank,photoreceptor cell development (GO:0042461),0.3064200769269332,0.662669242889159,0.8663729809104258,0.9771834532693466,1.0,2/14,10.41%,VEGFA;ARL3
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.26824953765788667,0.6624936819093823,0.8983957219251337,0.9769742482216793,1.0,4/30,12.66%,BMP5;GSK3B;TRAF2;BRCA1
prerank,chromatin remodeling at centromere (GO:0031055),0.271623450605888,0.6619706759173759,0.895364238410596,0.977095719800321,1.0,13/31,32.12%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP;HELLS;CENPN;CENPV
prerank,microtubule anchoring (GO:0034453),0.31173482929147006,0.661718370965862,0.8668639053254438,0.9769613527103195,1.0,5/12,23.42%,PCM1;BICD1;CAMSAP3;BICD2;GCC2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.243275495091654,0.6614869906053117,0.925,0.9768070625901323,1.0,11/62,17.97%,YBX3;NFE2L2;VNN1;NDUFS3;CREB3L1;MCL1;HERPUD1;CLU;URI1;LRRK2;BAG5
prerank,regulation of spindle assembly (GO:0090169),0.2762318298313027,0.660642099957852,0.8844086021505376,0.9772287529464038,1.0,10/25,32.75%,DRG1;PDCD6IP;CHMP2B;SENP6;GPSM2;CHMP3;PLK1;CEP97;RNF4;TPR
prerank,regulation of phosphatase activity (GO:0010921),0.2806943089392398,0.6604830659379713,0.8602442333785617,0.9770077724225311,1.0,9/24,27.59%,PTPA;PPP6R3;CHP1;URI1;PPP6R1;PPP6R2;MTMR9;TSC1;ZCCHC9
prerank,regulation of cytokine production (GO:0001817),0.2270979215496091,0.6603527400326749,0.9524838012958964,0.9767500930729498,1.0,20/126,19.11%,FOXP1;HDAC9;IL33;ANXA1;C5AR2;PER1;NLRP12;MAST2;IFIH1;EIF2AK2;NPTN;ALOX5;FFAR4;FLOT1;GLMN;TWSG1;MAPKAPK2;CCN4;IGF2BP3;AGPAT2
prerank,gas transport (GO:0015669),0.329539286066871,0.6603052137786277,0.8354430379746836,0.9764138044150313,1.0,1/10,6.12%,CYGB
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.24598603929654356,-0.6602378088491255,0.9174311926605505,1.0,1.0,10/17,35.21%,ATP5PF;ATP5F1E;ATP5F1A;ATP5F1B;ATP5MC1;ATP5MC2;ATP5MC3;ATP5F1D;DMAC2L;STOML2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.33217508061537937,0.6596496518522035,0.8454258675078864,0.9766840984567686,1.0,1/11,4.08%,ELOF1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.28363925263101886,0.6594058793545848,0.8774104683195593,0.9765541734947247,1.0,9/24,22.85%,FGF2;PLCG2;IBTK;CHERP;LCK;ITPR2;ANXA6;TRPM2;HTR2B
prerank,heterochromatin assembly (GO:0031507),0.2969835962428776,0.6590650844960815,0.8778735632183908,0.9765089413550656,1.0,8/20,32.12%,EZH1;RRP8;HMGA1;BAZ2A;SMCHD1;ZNFX1;HELLS;CENPV
prerank,regulation of lymphocyte migration (GO:2000401),0.3281732095743183,0.6573098885603424,0.8768233387358185,0.9777947707629315,1.0,2/10,12.50%,MIA3;SLC8B1
prerank,regulation of cilium movement (GO:0003352),0.33385542995333567,0.6573047663982307,0.8503184713375797,0.9774199873726397,1.0,4/10,24.73%,CFAP43;ODAD2;DRC1;DNAH11
prerank,female gamete generation (GO:0007292),-0.21155803724057337,-0.6571547180963595,0.9477911646586346,1.0,1.0,2/29,3.65%,FMN2;DIAPH2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.24972270523507523,-0.6561896997982469,0.9085173501577287,1.0,1.0,5/15,21.87%,BCL2;MIF;CD74;TAF9;TRIAP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.3012796702316884,0.6561487210431752,0.8705882352941177,0.9781474348889947,1.0,4/17,23.22%,PLA2G4F;LPCAT1;SERAC1;PLA2G12A
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.23504788169325927,-0.6555890448181432,0.9390243902439024,1.0,1.0,5/18,24.68%,LIG3;MCMDC2;RFC4;PCNA;LIG1
prerank,sulfur amino acid metabolic process (GO:0000096),0.2777938877938169,0.6552472907637832,0.8792401628222524,0.9785955193398678,1.0,4/24,19.35%,GCLC;DPEP1;ADO;GADL1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.28269153105791467,0.6550306341261898,0.8793604651162791,0.978429587108936,1.0,3/20,12.45%,CAMK2D;HERPUD1;BCAP31
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.2815495558307572,0.6548545062151646,0.8984485190409027,0.9782235388985234,1.0,3/24,11.03%,PLA2G4F;PLA2G15;LPCAT1
prerank,cellular response to oxygen levels (GO:0071453),-0.27519334898078307,-0.6545802575773133,0.8736263736263736,1.0,1.0,2/10,10.14%,CPEB4;ATP6V1G1
prerank,regulation of actomyosin structure organization (GO:0110020),0.30336876866408125,0.6545337872841498,0.8449848024316109,0.9781426325208712,1.0,2/13,9.77%,AKAP13;SLC9A1
prerank,non-motile cilium assembly (GO:1905515),0.26717256145113377,0.6541442515294746,0.8985313751668892,0.9781363587946913,1.0,10/30,30.22%,PCM1;TOGARAM1;DISC1;C2CD3;PIBF1;CEP89;RPGRIP1L;CEP290;BBS4;GORAB
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.32683744384157165,0.6537422431104912,0.8912337662337663,0.9781457006635552,1.0,1/10,3.59%,ANO6
prerank,error-free translesion synthesis (GO:0070987),0.2875337019663425,0.6535833949696171,0.8762446657183499,0.9779112115486144,1.0,11/22,35.30%,VCP;RFC1;SPRTN;UBB;UBA52;RPS27A;POLD1;RFC2;RPA1;RCHY1;REV1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2823878802350057,-0.6533084241063287,0.8829787234042553,1.0,1.0,4/10,18.01%,SLC44A1;COMT;ALDH7A1;SARDH
prerank,protein acylation (GO:0043543),0.2597537674256014,0.6529280008226944,0.9143222506393862,0.9781238061518369,1.0,8/38,13.54%,CREBBP;ZDHHC2;HHAT;ZDHHC20;ZDHHC12;NAT10;ZDHHC15;ZDHHC13
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.2807707251573738,0.6528085683728851,0.8866120218579235,0.977855982153521,1.0,5/23,16.06%,KIF1B;HOOK3;KIF1C;MAP6;KIF5B
prerank,ribosomal large subunit assembly (GO:0000027),-0.21389426151625995,-0.6525665128356561,0.9530685920577617,1.0,1.0,13/24,40.15%,RPL23A;RPL11;RRS1;NLE1;DDX28;RPF2;FASTKD2;RPL24;RSL24D1;RPL6;NOP2;PPAN;RPL3L
prerank,cellular response to glucose starvation (GO:0042149),0.25705683624375114,0.6524491146369128,0.9171974522292994,0.9778287890717844,1.0,7/41,13.44%,ITFG2;FOXO3;ZC3H12A;BECN1;SZT2;SH3GLB1;RRP8
prerank,tryptophan metabolic process (GO:0006568),0.3157307310825419,0.6520757992778778,0.8433179723502304,0.9778031750220351,1.0,2/11,18.32%,TDO2;IDO2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.288965900772751,0.6515276125156194,0.8744588744588745,0.9779212569000206,1.0,2/19,7.28%,RIC3;NQO1
prerank,detection of visible light (GO:0009584),0.294148686152724,0.6509100329033967,0.8806404657933042,0.9781205940276795,1.0,1/16,2.89%,CACNA1F
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26824587566410835,0.6493082077347853,0.9086092715231788,0.979197900734547,1.0,5/30,15.15%,ABCD3;ABCD1;ACOX1;TECR;ELOVL5
prerank,negative regulation of catalytic activity (GO:0043086),-0.21971457484788043,-0.6490890520230029,0.9629629629629629,1.0,1.0,3/24,6.27%,NES;IFIT1;NOTCH1
prerank,positive regulation of chromatin organization (GO:1905269),0.3153506748925179,0.6487973725709892,0.8547140649149922,0.9792698061542623,1.0,2/12,14.61%,MIER1;ATRX
prerank,microtubule bundle formation (GO:0001578),0.24961772659345344,0.6481270859739596,0.9147496617050067,0.9794858888363625,1.0,7/42,16.20%,CLIP1;TOGARAM1;NAV1;GAS2L1;CHP1;MAP1S;CCDC66
prerank,tRNA 5'-end processing (GO:0099116),-0.24188379792707373,-0.6471070265182707,0.889589905362776,1.0,1.0,7/15,38.78%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.2849403000467579,0.6469033784173456,0.8879310344827587,0.9802419837344922,1.0,4/20,16.70%,BMP5;BRCA1;ACADL;SIK1
prerank,tRNA 5'-leader removal (GO:0001682),-0.24966967935225926,-0.646593274451508,0.9005847953216374,1.0,1.0,7/13,38.78%,POP4;RPP14;POP7;RPP40;RPP21;POP1;RPP25
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2319135425109915,-0.6460450629443159,0.9153605015673981,1.0,1.0,7/18,22.21%,PIK3R1;BCL2L11;ERN1;BOK;XBP1;BAG6;RNFT1
prerank,replicative senescence (GO:0090399),-0.2684970286486397,-0.6459004458744043,0.9073569482288828,1.0,1.0,2/12,5.73%,PLA2R1;MME
prerank,cellular response to UV-A (GO:0071492),0.31213458136837613,0.6449590274438216,0.8526645768025078,0.9816260387393143,1.0,1/11,4.35%,TIMP1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.26094673668417295,-0.644838939369102,0.8994413407821229,1.0,1.0,2/13,11.38%,NOS3;ALDH4A1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.26769249014222696,0.6444560809296981,0.9153225806451613,0.9813290759427511,1.0,10/29,28.77%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP
prerank,CENP-A containing chromatin organization (GO:0061641),0.26769249014222696,0.6444560809296981,0.9153225806451613,0.9813290759427511,1.0,10/29,28.77%,RBBP7;CENPT;HJURP;CENPL;SMARCA5;CENPW;CENPP;RSF1;CENPK;NASP
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.26155718189796284,0.6431809423370755,0.9129251700680272,0.982082525534389,1.0,8/30,22.54%,FUT8;MGAT1;MGAT5;DDOST;TUSC3;DPM1;ALG8;MCFD2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.3033911177710047,0.6422216064220144,0.8687022900763359,0.9825565169304132,1.0,2/14,7.50%,DDX18;URB1
prerank,response to amino acid (GO:0043200),0.26243304505061504,0.6418732963438757,0.9039473684210526,0.9824757009058893,1.0,3/31,5.42%,CAPN2;GLRB;RRAGB
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.22890141191480864,0.641778534468658,0.9638009049773756,0.9821860444357121,1.0,17/87,19.71%,COX16;NDUFS3;TTC19;NDUFC2;NDUFB4;TMEM126A;SCO2;ECSIT;COA8;NUBPL;NDUFA12;SDHAF2;NDUFAB1;AIFM1;UQCRFS1;NDUFA9;FASTKD3
prerank,piRNA metabolic process (GO:0034587),0.2827600295038244,0.6416851793831726,0.9073033707865169,0.9818919609887349,1.0,1/19,5.55%,TEX15
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.27596330784898226,0.6416559411490614,0.8947368421052632,0.9811654909734542,1.0,10/22,26.99%,ZDHHC2;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19;ZDHHC21;ZDHHC6
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.27596330784898226,0.6416559411490614,0.8947368421052632,0.9811654909734542,1.0,10/22,26.99%,ZDHHC2;ZDHHC20;ZDHHC12;ZDHHC15;ZDHHC24;GOLGA7;ZDHHC3;ZDHHC19;ZDHHC21;ZDHHC6
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.2607476262819819,-0.6412978832596873,0.9088397790055248,1.0,1.0,2/12,7.83%,APOE;PFDN5
prerank,organonitrogen compound catabolic process (GO:1901565),0.23770796242309442,0.6412518309504566,0.9419035846724351,0.9811561798703057,1.0,10/57,19.40%,CPQ;PLA2G15;NPEPPS;RENBP;PDXDC1;IDE;ADO;GNPDA1;GADL1;LRSAM1
prerank,positive regulation of secretion (GO:0051047),0.31795861214272003,0.6409358972223859,0.8569157392686805,0.9810462995249867,1.0,1/11,5.85%,ACSL3
prerank,negative regulation of histone modification (GO:0031057),0.3011981609187,0.6409249313626787,0.8902255639097745,0.9806774248971353,1.0,5/14,24.01%,TWIST1;BRCA1;THAP7;PRMT6;TAF7
prerank,motile cilium assembly (GO:0044458),-0.25867578650822326,-0.6408035838556373,0.9010152284263959,1.0,1.0,7/12,38.31%,BBS5;CCDC39;SPATA6;BBOF1;CCDC40;RSPH6A;DNAAF1
prerank,TOR signaling (GO:0031929),-0.21426273183202946,-0.6406911563772631,0.94140625,1.0,1.0,5/26,15.17%,PRR5L;EIF4EBP2;PINK1;TIPRL;CCDC88A
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.31206816406277865,0.6400810228937924,0.8835098335854765,0.9810270168129935,1.0,4/12,15.15%,ABCD1;ACOT8;ACOX1;ELOVL5
prerank,phagolysosome assembly (GO:0001845),0.3072239381119641,0.6400304557302384,0.8523076923076923,0.9806947521920413,1.0,1/12,3.81%,RAB7B
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.30104343841948245,0.6394272557064603,0.8939157566302652,0.98082932037627,1.0,5/13,19.11%,MAVS;IFIH1;TRIM44;DHX9;AGPAT2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.2582772940729361,0.6387519620004789,0.9205298013245033,0.9810359851329384,1.0,3/31,8.57%,HSPB8;BAG3;HSPA1L
prerank,positive regulation of interleukin-13 production (GO:0032736),0.3233413552973515,0.6377628078220707,0.8925750394944708,0.9815072507233277,1.0,1/10,4.08%,RARA
prerank,triglyceride homeostasis (GO:0070328),0.26626220820117175,0.6375176646242668,0.9177897574123989,0.9813354164923256,1.0,4/26,11.47%,ACSM2A;RORA;MLXIPL;ANGPTL3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.22330085322724036,-0.6374946994137152,0.9679715302491103,1.0,1.0,1/22,0.78%,NR2F2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.2543788059514094,-0.6365134260802108,0.9142857142857143,1.0,1.0,13/13,74.59%,BCL2L11;RHOT2;PMAIP1;BMF;MOAP1;BNIP3;BLOC1S2;VDAC2;RTL10;BNIP3L;BAX;BAD;RHOT1
prerank,regulation of anoikis (GO:2000209),0.28096532130765434,0.6361182112802515,0.8963068181818182,0.9821367109853296,1.0,7/19,18.39%,CEACAM5;ITGB1;BRMS1;ANKRD13C;MCL1;SIK1;ITGA5
prerank,mRNA modification (GO:0016556),0.2700403828380106,0.6359078320879625,0.8987517337031901,0.9819346984114712,1.0,6/22,27.92%,RPUSD2;WTAP;VIRMA;TRMT61B;METTL16;CMTR1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.30203429266232107,0.6358536721403918,0.8953846153846153,0.9816072135897104,1.0,2/13,8.34%,IL33;TLR4
prerank,regulation of sister chromatid cohesion (GO:0007063),0.31026335200395,0.635682936231275,0.8798751950078003,0.9813755105384279,1.0,5/12,24.69%,HDAC8;DDX11;RB1;WAPL;RAD21
prerank,T cell homeostasis (GO:0043029),0.313855452455384,0.6347461458198075,0.8705501618122977,0.9817851142331219,1.0,1/10,4.70%,PPP2R3C
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2429083521085968,0.6340023908164536,0.924812030075188,0.9820261973565549,1.0,10/44,17.96%,CNOT8;AGO2;ZC3H12A;PABPC1;DHX36;CELF1;MEX3D;MOV10;FTO;TOB1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.24026736316903266,0.6329313486995582,0.9419753086419753,0.9825491331890452,1.0,5/47,8.15%,PTGIS;CLK2;ATP2B4;MPV17L;ZC3H12A
prerank,kinetochore organization (GO:0051383),0.29748084701122673,0.6325673586681939,0.891640866873065,0.9824728122453305,1.0,5/13,28.95%,CENPT;POGZ;CENPW;MIS12;CENPE
prerank,regulation of protein localization (GO:0032880),-0.17784065004987695,-0.6318629170569262,0.9764705882352941,1.0,1.0,18/58,24.74%,MAP2;PICALM;TRIM14;WDPCP;MMD2;HSP90AB1;ATCAY;RACK1;RABGAP1L;FBXW7;TRIM46;PPM1F;MMD;TRIM67;UFL1;DNAJB6;TRIM17;ADCYAP1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2612241659964921,0.6309557661616865,0.9272727272727272,0.9834119532891591,1.0,3/30,7.87%,PRKCD;PTPN2;DMTN
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.28750164981865717,0.6303975100564505,0.8801213960546282,0.9834856355602117,1.0,4/17,17.40%,MID1;EIF2AK2;ARL6IP5;SCIMP
prerank,eye photoreceptor cell development (GO:0042462),0.2899715443442616,0.630037065973298,0.9007407407407407,0.983394446572295,1.0,6/15,28.45%,VEGFA;CRB2;RPGRIP1L;CEP290;TOPORS;BBS4
prerank,negative regulation of B cell activation (GO:0050869),0.2769986525651703,0.6297622784538248,0.9070100143061517,0.9832522497620633,1.0,3/21,9.40%,ID2;INHBA;PARP3
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.2678150516094657,-0.6295175123669772,0.896,1.0,1.0,5/11,21.48%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.2678150516094657,-0.6295175123669772,0.896,1.0,1.0,5/11,21.48%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,prostanoid metabolic process (GO:0006692),-0.25132265944263205,-0.6289174695274202,0.9131736526946108,1.0,1.0,3/13,15.40%,PTGS1;GSTM1;HPGDS
prerank,negative regulation of autophagosome assembly (GO:1902902),0.2883371988964901,0.6287847894504942,0.8837209302325582,0.9836476108460909,1.0,9/13,36.61%,TMEM39A;LRRK2;SMCR8;MTM1;SEC22B;PHF23;CHMP4A;CHMP4B;SCFD1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.25374274867931024,-0.6287597793297042,0.9407008086253369,1.0,1.0,1/12,2.27%,CYP26B1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.27988529063052586,0.6286933332128388,0.9136904761904762,0.9833496246374416,1.0,6/18,24.61%,DNAAF4;OFD1;NPHP3;SPAG17;DNAAF2;CFAP53
prerank,protein mono-ADP-ribosylation (GO:0140289),0.30957310423907813,0.6286050938328033,0.9065849923430321,0.9830422746588018,1.0,4/11,19.48%,PARP3;PARP12;PARP6;PARP4
prerank,protein prenylation (GO:0018342),0.3086241526487573,0.628177760083792,0.8894230769230769,0.9829985920114159,1.0,10/10,69.16%,FNTA;PGGT1B;RABGGTB;RCE1;RABGGTA;CHM;FNTB;AIPL1;PTAR1;CHML
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.19732160389607423,-0.627201660586571,0.967479674796748,1.0,1.0,17/32,38.78%,DEFA6;RPS19;PGLYRP1;GAPDH;ROMO1;RPL39;HRG;CCL13;CXCL14;CXCL5;CXCL1;RPL30;PF4;PPBP;CAMP;CXCL10;PGLYRP3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.2795067806958672,0.6260154656984508,0.9068702290076336,0.9843283429751112,1.0,5/18,16.72%,DERA;FBXO27;BPGM;OGA;FBXO17
prerank,regulation of innate immune response (GO:0045088),0.23233633462191364,0.6258156736999257,0.9478908188585607,0.9841079499271342,1.0,11/57,18.46%,TRAFD1;IRAK3;IRF1;TLR8;POLR3F;IFI35;TIRAP;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,response to gamma radiation (GO:0010332),0.26417152033434793,0.6258153208345629,0.9095966620305981,0.983734899150058,1.0,8/24,23.55%,WRN;KDM1A;YAP1;ATR;TLK2;XRCC5;ATM;TP53
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.2689455179261415,-0.6244904784495867,0.865,1.0,1.0,4/10,24.99%,WRAP53;CCT8;CCT3;TCP1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.22805475323370591,-0.6242064706070716,0.933933933933934,1.0,1.0,16/16,77.22%,PIGW;PIGM;PIGZ;PIGL;PIGN;PIGF;PIGC;PIGX;DPM2;PIGH;PIGP;PIGA;PIGV;PIGQ;PIGB;PIGG
prerank,regulation of lamellipodium organization (GO:1902743),0.2903995418240907,0.6237705609895146,0.9113737075332349,0.9849338307572133,1.0,2/14,7.87%,CD44;DMTN
prerank,negative regulation of T cell proliferation (GO:0042130),0.2551519267193446,0.6231696948804176,0.9262734584450402,0.985008160467797,1.0,6/28,16.99%,ARG1;CD80;PDCD1LG2;DLG5;SCRIB;GLMN
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.30221066130775986,0.6223541269039594,0.881203007518797,0.9852557446744034,1.0,1/13,4.08%,ELOF1
prerank,glycolytic process (GO:0006096),-0.19713088414048044,-0.6211141167738511,0.948936170212766,1.0,1.0,14/28,34.79%,PGM1;PGAM1;PGAM4;GAPDH;HK2;ENO1;GAPDHS;ALDOC;PFKM;PFKL;HKDC1;ALDOB;ENO4;HK3
prerank,regulation of acute inflammatory response (GO:0002673),-0.22933936196935442,-0.6206329668812128,0.9437086092715232,1.0,1.0,18/18,77.10%,OSMR;NLRP3;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;IL6ST;F12;C2CD4A;DNASE1L3;ADAM8;KLKB1;IL4;PTGES
prerank,negative regulation of defense response to virus (GO:0050687),-0.2688927943760984,-0.620574960985816,0.925,1.0,1.0,10/10,73.13%,TSPAN6;TARBP2;PCBP2;MUL1;ITCH;ILRUN;C1QBP;RNF26;TRAF3IP1;PPM1B
prerank,positive regulation of immunoglobulin production (GO:0002639),0.24890229265869518,0.6197031424834154,0.9238709677419354,0.9869453215900362,1.0,4/31,12.75%,CLCF1;GPI;EPHB2;KMT5B
prerank,positive regulation of nervous system process (GO:0031646),0.2788777998762388,0.6196635967102665,0.8961988304093568,0.9866036334900556,1.0,4/18,17.41%,UNC13B;PARD3;CST7;HCRT
prerank,defense response to Gram-positive bacterium (GO:0050830),0.24128362618149496,0.6194099491276838,0.9361147327249022,0.9864123889670199,1.0,4/40,13.32%,LBP;MYD88;RNASE3;TIRAP
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.27027994445082704,0.6191636939233469,0.9097525473071325,0.9862113568979617,1.0,2/20,7.25%,CLK2;NCOR1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.25439663750426006,0.6191365681373404,0.9322268326417704,0.9858581140158568,1.0,5/30,12.19%,TWIST1;CD44;KDM1A;FBXO5;CLU
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.2915305397006494,0.6187300506323047,0.8907435508345979,0.9858063129869282,1.0,3/13,16.33%,CNOT8;ZC3H12A;MOV10
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.266576979181019,0.6182242236787918,0.9182561307901907,0.9858007214338717,1.0,6/25,21.99%,GPI;PFKP;ADPGK;FOXK1;FOXK2;PKM
prerank,placenta development (GO:0001890),-0.25465866090717937,-0.617715246851401,0.8885941644562334,1.0,1.0,4/12,21.27%,PTK2;SOD1;ADAM19;E2F7
prerank,regulation of T cell differentiation (GO:0045580),0.24725015928772537,0.6171937169742467,0.9252336448598131,0.9861948718059766,1.0,2/33,4.52%,CD2;ABL1
prerank,protein import into mitochondrial matrix (GO:0030150),0.2782590550038867,0.6170816311329771,0.912781954887218,0.9859001236874424,1.0,7/18,28.52%,TIMM23;TIMM17B;GRPEL2;TIMM44;DNLZ;TOMM20;GRPEL1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2640613339439326,-0.6166633740109885,0.9295039164490861,1.0,1.0,7/10,32.40%,ZNHIT6;ZNHIT3;TAF9;NUFIP1;RUVBL1;PIH1D1;RUVBL2
prerank,intracellular pH reduction (GO:0051452),-0.19507007134135257,-0.6162775934383906,0.9581589958158996,1.0,1.0,11/33,26.39%,DMXL2;CLCN3;ATP6V0A1;ATP6V1G1;RAB39A;ATP6V0E2;ATP6V0D2;RAB38;ATP6V0C;RAB20;ATP6V1E1
prerank,regulation of immune response (GO:0050776),0.21182371395093527,0.6157869021644128,0.9772727272727273,0.9864841287342938,1.0,7/135,8.41%,FOXP1;COL3A1;RAET1E;SPPL2A;ITGB1;IRF1;COL17A1
prerank,positive regulation of telomere capping (GO:1904355),0.27721364686112737,0.6155540989998779,0.913946587537092,0.9862988401466959,1.0,4/17,23.49%,NEK7;MAP3K4;TNKS2;MAPKAPK5
prerank,maintenance of protein location in nucleus (GO:0051457),0.27272045349983504,0.6139405657269462,0.911144578313253,0.9870913434989912,1.0,9/20,30.51%,BARD1;MORC3;PML;TAF8;SUN1;TOPORS;SUN2;BBS4;SUPT7L
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.21779917777950986,0.6138724096786426,0.9781609195402299,0.9867654835692824,1.0,30/82,32.27%,PCM1;AURKA;PAFAH1B1;CEP43;AKAP9;SDCCAG8;HAUS2;CEP63;PLK4;PCNT;OFD1;CDK2;CEP164;CETN2;SFI1;YWHAE;CEP76;TP53;CSNK1E;CEP290;PLK1;NEK10;ACTR1A;CEP72;GTSE1;CEP131;CEP57;TUBG1;NDE1;CSNK1D
prerank,positive regulation of signaling receptor activity (GO:2000273),0.24769528358268172,0.6135759718463729,0.943864229765013,0.9866057963726533,1.0,4/36,11.41%,ADRB2;NRP1;ITGB1;EPHB2
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.2969040417007516,0.6125086046346218,0.8827258320126783,0.987027136616812,1.0,3/11,28.67%,DDX11;MTOR;SMARCA4
prerank,'de novo' posttranslational protein folding (GO:0051084),0.25219850457911713,0.6115861821471684,0.9262295081967213,0.987318484002416,1.0,4/30,15.69%,ENTPD5;HSPA1L;GAK;SDF2
prerank,positive regulation of isotype switching (GO:0045830),0.28117084013716853,0.6110472182392227,0.9185185185185185,0.9873359131032705,1.0,2/15,12.75%,CLCF1;KMT5B
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.23807132094424915,-0.6100568525728607,0.9371428571428572,1.0,1.0,14/14,76.22%,ERN1;CPSF2;CSTF2;CPSF6;CPSF1;TUT1;CPSF7;CPSF4;NCBP1;NCBP2;CPSF4L;NUDT21;CSTF2T;FIP1L1
prerank,mRNA methylation (GO:0080009),0.2769660631172009,0.608848077132078,0.909221902017291,0.9884777331844559,1.0,5/15,27.92%,WTAP;VIRMA;TRMT61B;METTL16;CMTR1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.2627635613655146,0.6078125721723335,0.9236016371077762,0.9888198664861767,1.0,8/24,25.55%,EED;DNMT3A;RBBP7;TASOR;EPC1;SUZ12;PPHLN1;PPM1D
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2556804175978638,0.6075610622401146,0.9294781382228491,0.9886267326319415,1.0,2/26,4.62%,TRAFD1;IRAK3
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.24408650046624053,-0.607219961171784,0.9391534391534392,1.0,1.0,9/13,43.93%,BRSK2;UBAC2;ERLEC1;UBE2J1;SVIP;DERL2;DERL3;OS9;YOD1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2303245897343185,0.6068850022318822,0.9569620253164557,0.9887214551978837,1.0,12/46,21.72%,ANXA2;PITPNA;GSTA2;PDCD4;CAPZA1;SERPINB2;HNRNPA2B1;JAK2;GSTO1;SOD2;AIP;STAT4
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.22892296000977982,0.6053688900062408,0.9605911330049262,0.9893666506251798,1.0,19/55,27.91%,CRADD;TGFBR1;STYXL1;TRIM39;BECN1;TRAF2;BCAP31;GSDME;LCK;TNFRSF12A;TRAF7;PML;TP53;DDIT3;PAK2;BID;BAD;BCLAF1;BAX
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.21276518553103463,-0.6043786105328788,0.9545454545454546,1.0,1.0,4/20,15.52%,BIRC2;ASAH1;MLKL;NUPR1
prerank,regulation of cytoplasmic translation (GO:2000765),0.2870154150684761,0.6029743952180655,0.9086892488954345,0.9906470373314614,1.0,5/14,22.05%,YBX3;DHX36;DHX9;PKM;FMR1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.27769231128620075,0.6025114063014836,0.9180576631259484,0.9905835524530868,1.0,2/15,7.28%,SRPRB;SEC61A1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.25719605957590147,-0.6007870943736995,0.948509485094851,1.0,1.0,4/10,24.93%,PRKAR1A;PRNP;CD274;RC3H1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.18155814658033215,-0.6004516559711883,0.9956521739130435,1.0,1.0,14/38,28.62%,NDUFB9;NDUFA4;NDUFA13;NDUFC1;NDUFV3;NDUFB11;NDUFA7;NDUFA11;NDUFB6;NDUFB8;NDUFA3;NDUFA1;NDUFB10;NDUFA2
prerank,positive regulation of histone modification (GO:0031058),0.24345965835660147,0.599675910944299,0.9496688741721855,0.9920262488324425,1.0,12/33,29.29%,NIPBL;KDM1A;BRCA1;SAP30BP;CHTOP;ZBTB7B;FMR1;TADA2B;AKAP8L;TADA2A;UBE2N;PAXIP1
prerank,regulation of glucose metabolic process (GO:0010906),0.24132111125702982,0.5991612741808358,0.9473684210526315,0.9919751754846846,1.0,7/34,23.82%,IRS1;RORA;PDK3;FOXK1;FOXK2;OGT;USP7
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2385160921888321,0.5984613305416232,0.9493506493506494,0.9920627493010794,1.0,7/37,13.77%,NCOR1;ATXN2;ITGAV;TRAT1;BRCA1;ITGB3;AATF
prerank,regulation of mitotic spindle assembly (GO:1901673),0.2621570829686739,0.5981864595619023,0.927170868347339,0.9918682221821807,1.0,7/19,32.75%,DRG1;PDCD6IP;CHMP2B;CHMP3;PLK1;CEP97;TPR
prerank,rRNA transcription (GO:0009303),0.2665312708562198,0.5974540966234966,0.9252199413489736,0.9919746919127383,1.0,4/17,23.90%,POLR1G;GTF3C1;GTF3C4;GTF3A
prerank,intracellular protein transmembrane transport (GO:0065002),0.23666206926759534,0.5967575617143417,0.940337224383917,0.992053466938776,1.0,15/42,30.74%,SEC61A1;TIMM23;C2CD5;PEX26;PEX1;AIFM1;TIMM17B;GRPEL2;TIMM44;DNLZ;SEC61B;TOMM20;GRPEL1;PEX2;PEX7
prerank,regulation of TOR signaling (GO:0032006),0.21750313395772597,0.5964665617505235,0.9722222222222222,0.9918731530963468,1.0,15/67,25.36%,NPRL3;TELO2;ITFG2;RRAGB;HTR6;RHEB;GOLPH3;MLST8;EPM2A;NPRL2;LARS1;MAPKAPK5;TBCK;SMCR8;TSC1
prerank,spermatid development (GO:0007286),0.24307204575205188,0.5960561749597739,0.9428191489361702,0.9917761351320786,1.0,5/32,18.59%,CIB1;RFX2;SYCP3;RNF8;MKKS
prerank,regulation of viral transcription (GO:0046782),0.23047429053261517,0.5955321083053097,0.9465648854961832,0.9917241554305535,1.0,11/39,25.88%,MDFIC;NELFE;UBP1;DHX9;POLR2C;HEXIM1;CCNT1;MID2;LARP7;RSF1;SUPT4H1
prerank,myelin maintenance (GO:0043217),0.2988334500211318,0.5943679345614628,0.9131832797427653,0.9920510695157267,1.0,2/10,12.19%,ABCD1;CLU
prerank,organelle fission (GO:0048285),0.25591362268781737,0.5943458050141784,0.9394347240915208,0.9916958286952123,1.0,5/24,14.26%,CORO1C;MIEF1;WASHC5;ACOT8;MTFR1
prerank,regulation of hemopoiesis (GO:1903706),0.2930070232355257,0.5932594133653649,0.8919354838709678,0.992016470089806,1.0,5/10,24.88%,MYSM1;CREBBP;PTN;LGALS3;CBFB
prerank,phosphatidylcholine metabolic process (GO:0046470),0.21552729318713393,0.5924616995401861,0.9714285714285714,0.9921478454127247,1.0,10/70,16.45%,PLA2G4F;PLA2G15;CHKB;SLC44A3;MBOAT1;LPIN2;LPCAT1;PCTP;LPCAT2;LCAT
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.19967408002331613,-0.5913398488518666,0.97,1.0,1.0,7/25,24.02%,HSPA8;HSPA13;ERO1A;HSPA1A;HSPE1;HSPA2;HSPA5
prerank,transcription preinitiation complex assembly (GO:0070897),0.28390793644479606,0.5895127697490218,0.9256965944272446,0.9935516530204369,1.0,5/12,24.01%,GTF2A2;TBP;TAF12;GTF2B;TAF7
prerank,protein targeting to mitochondrion (GO:0006626),0.22264079823890834,0.5885627518987736,0.9817739975698664,0.993753236678643,1.0,21/52,29.24%,TIMM23;BCAP31;AGK;TIMM9;TSPO;AIFM1;TIMM17B;PITRM1;AIP;PMPCB;GRPEL2;TIMM44;TOMM34;DNLZ;TOMM20;MIPEP;SAMM50;TIMM13;GRPEL1;TIMM10;IMMP1L
prerank,positive regulation of dephosphorylation (GO:0035306),0.2511470059030142,0.5881321247017797,0.9513797634691196,0.9936478925451734,1.0,9/27,25.30%,PRKCD;PTPA;NSMF;PIN1;MTMR9;CALM2;SRC;CNEP1R1;DLC1
prerank,transcription by RNA polymerase III (GO:0006383),0.24298551679891311,0.5875728142469782,0.9468085106382979,0.9936179741495293,1.0,9/27,26.01%,SNAPC2;POLR3K;ICE2;TBP;GTF3C1;GTF3C4;GTF3A;RO60;ELL
prerank,mitochondrial gene expression (GO:0140053),0.22593504982568455,0.5857743548668726,0.9732484076433121,0.9942934414111106,1.0,9/42,24.87%,FOXO3;NOA1;MRPS2;FASTKD5;MRPL23;MRPS21;RARS2;GFM2;GATC
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.2653773167764906,0.5846189464474879,0.9361702127659575,0.9945968440813014,1.0,7/18,24.68%,STAT3;SMAD4;YAP1;SOCS3;JAK2;FER;SRC
prerank,regulation of hormone secretion (GO:0046883),0.2728085027374906,0.5841862582573201,0.9204368174726989,0.9944744085185956,1.0,3/15,19.46%,ANXA1;VAMP2;EDN3
prerank,inositol phosphate catabolic process (GO:0071545),-0.2459297042994456,-0.5835768473158736,0.9344262295081968,1.0,1.0,5/12,21.48%,INPP1;IMPA2;INPP5B;INPP5A;INPP5J
prerank,glutathione derivative metabolic process (GO:1901685),-0.20967339432439971,-0.5832658814611569,0.9688473520249221,1.0,1.0,9/20,27.57%,AKR1A1;MGST1;GSTA4;GSTM1;HPGDS;GSTK1;GSTM5;MGST2;GSTM2
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.20967339432439971,-0.5832658814611569,0.9688473520249221,1.0,1.0,9/20,27.57%,AKR1A1;MGST1;GSTA4;GSTM1;HPGDS;GSTK1;GSTM5;MGST2;GSTM2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.26490759303316114,0.580886851697296,0.9355345911949685,0.9959666066669848,1.0,3/14,13.93%,AGR2;TMEM33;COPS5
prerank,negative regulation of histone acetylation (GO:0035067),0.2830639281405246,0.579867959884695,0.9175738724727839,0.9961547333018388,1.0,3/11,24.01%,BRCA1;THAP7;TAF7
prerank,RNA modification (GO:0009451),0.21532818967646197,0.5797776290106229,0.9791666666666666,0.9958281197355955,1.0,13/54,26.82%,PUS7L;TYW5;NAT10;ELP5;SSB;THUMPD1;TRDMT1;FTSJ1;JMJD6;ALKBH1;PARN;FTSJ3;CDKAL1
prerank,myeloid dendritic cell activation (GO:0001773),0.27793206671187626,0.5761104288565863,0.9273570324574961,0.9974361368073952,1.0,2/12,12.90%,TGFBR2;BATF3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.2745555085321634,0.5759405259465579,0.9255813953488372,0.9971513586546659,1.0,3/13,20.23%,NRP1;PLXNB1;PLXNA4
prerank,protein autoprocessing (GO:0016540),0.25861573289644607,0.574929785604668,0.9450222882615156,0.9973064744574957,1.0,5/17,23.72%,FXN;PIDD1;FAM111A;SPRTN;OMA1
prerank,copper ion transport (GO:0006825),0.2812752257257484,0.5741760370713912,0.9206349206349206,0.9973398660109394,1.0,2/11,13.86%,CUTC;SLC31A2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.26452982775535394,0.5732982603595981,0.9431988041853513,0.9974373914641564,1.0,3/16,20.49%,SLX4;ERCC4;MSH4
prerank,negative regulation of DNA recombination (GO:0045910),0.222014783942311,0.5721262243338923,0.9723618090452262,0.997704370639277,1.0,6/43,18.58%,HELB;PARP3;CGAS;ATRX;RMI2;POLR2C
prerank,mitochondrion organization (GO:0007005),0.19475992797780212,0.5720292476282581,0.9968085106382979,0.9973851538693163,1.0,48/165,28.97%,PID1;VPS13C;MEF2A;NRF1;GABPB1;WDR81;PPRC1;VPS13D;TIMM23;MIEF1;PARP1;BCAP31;SIRT3;RAB5IF;MTFR1;TIMM9;YME1L1;NUBPL;MIEF2;TSPO;HCFC1;POLG2;LRRK2;MIGA1;CXADR;AIFM1;TIMM17B;PITRM1;AIP;USP30;TIMM44;TOMM34;SLC25A36;OMA1;BID;MTM1;RHOT1;MPV17;MGME1;TOMM20;CHCHD3;SAMM50;TIMM13;MTX2;BAX;PISD;HIGD1A;TIMM10
prerank,regulation of axon regeneration (GO:0048679),0.2763821008292069,0.5694028784470904,0.9339622641509434,0.9983602877394437,1.0,4/12,17.91%,PTPRS;CNTF;PTN;STK24
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.2703282828292513,0.5687395314360529,0.9327073552425665,0.9983231688600018,1.0,4/13,22.09%,STAT3;IL27;JAK2;IL27RA
prerank,V(D)J recombination (GO:0033151),-0.23526116923402923,-0.5674411519112887,0.9544235924932976,1.0,1.0,4/11,24.68%,HMGB1;LIG3;HMGB2;LIG1
prerank,regulation of lipid kinase activity (GO:0043550),0.2771613289223207,0.5669379578312445,0.9390243902439024,0.9988512006267589,1.0,3/11,17.24%,WDR81;PIK3R3;RB1
prerank,cellular protein-containing complex assembly (GO:0034622),0.19308404215488856,0.5662847785007812,0.9968253968253968,0.9987989528465222,1.0,42/159,25.15%,ADRB2;CLTRN;NUP93;TIAM1;NCK2;FCHO2;ADRM1;PSMD11;SMAD2;STXBP6;NUP153;AHCTF1;CENPT;POGZ;CLU;TRAF2;RAB5IF;DMD;SRP19;NCK1;PSMD4;SMAD4;VAMP2;STXBP1;EIF4B;DNAAF3;DHX9;MKKS;TBCD;AIFM1;CLTB;DNAAF2;CALY;DRC1;TBCC;GTF2B;OMA1;TBCE;CENPW;BBS12;SRC;NUP98
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.24409992467988953,-0.563099961138159,0.9481268011527377,1.0,1.0,10/10,75.61%,ARRB2;CEACAM1;KLRD1;KLRC1;LGALS9;FCGR2B;CLEC12B;CX3CR1;PTPRC;LILRB1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.25355582187954373,0.5614774275006784,0.9499263622974963,1.0,1.0,1/16,3.00%,PLCB3
prerank,regulation of cytoplasmic transport (GO:1903649),0.27954362612766587,0.560945701715426,0.9351851851851852,1.0,1.0,5/11,26.14%,LRRK2;MAP2K2;USP7;SRC;CHMP3
prerank,mitotic metaphase plate congression (GO:0007080),0.20983999222039842,0.5599460397666013,0.9826732673267327,1.0,1.0,10/51,20.70%,BECN1;CUL3;CCNB1;ZW10;PDCD6IP;CHMP2B;SPDL1;MAD1L1;RAB11A;PIBF1
prerank,phagosome maturation (GO:0090382),0.22268306602934101,0.5597209010214756,0.9703989703989704,1.0,1.0,3/35,7.53%,TCIRG1;RAB43;ATP6V0A4
prerank,regulation of neuron projection arborization (GO:0150011),0.25401832400410246,0.5585060775557631,0.9473684210526315,1.0,1.0,8/15,30.10%,MYO9A;DVL1;MOV10;FZD4;DVL2;DLG4;DVL3;GRIP1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.2735404444587831,0.5578841256258614,0.9425837320574163,1.0,1.0,4/11,27.78%,JAK2;HDAC2;TAF7;IL4
prerank,lipid homeostasis (GO:0055088),0.2043039014347248,0.5563953074295643,0.9842424242424243,1.0,1.0,12/57,19.88%,ACOX3;ABCD1;MLXIPL;PNPLA3;TLCD1;RBP1;ANGPTL3;PNPLA2;ACOX1;FITM2;PPARG;NR1D2
prerank,regulation of isotype switching (GO:0045191),0.25451905740708153,0.5560589302662597,0.9397590361445783,1.0,1.0,7/14,34.34%,PARP3;KMT5B;KMT5C;IL4;PAXIP1;SHLD1;HMCES
prerank,negative regulation by host of viral process (GO:0044793),-0.2380710594372163,-0.5560150590562427,0.9484536082474226,1.0,1.0,2/10,11.77%,PSMC3;VAPA
prerank,dendritic cell chemotaxis (GO:0002407),-0.22571175607420244,-0.5556743524172795,0.9653179190751445,1.0,1.0,10/14,40.12%,HMGB1;CCL19;CCR5;GPR183;PIK3CG;CCL5;CCR1;CCR2;CCR6;CXCR2
prerank,synaptonemal complex organization (GO:0070193),0.2532694877893439,0.5550240595904888,0.9474474474474475,1.0,1.0,5/15,27.49%,RAD21L1;REC8;P3H4;RAD21;SYCE2
prerank,synaptonemal complex assembly (GO:0007130),0.2532694877893439,0.5550240595904888,0.9474474474474475,1.0,1.0,5/15,27.49%,RAD21L1;REC8;P3H4;RAD21;SYCE2
prerank,phospholipid homeostasis (GO:0055091),0.27627038366469825,0.5549281989541593,0.9412673879443586,1.0,1.0,2/11,11.47%,TLCD1;ANGPTL3
prerank,vacuolar acidification (GO:0007035),0.24010631511425398,0.5539256192605754,0.9707520891364902,1.0,1.0,2/21,7.53%,TCIRG1;ATP6V0A4
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.2765647013298428,0.5527149827889358,0.9417322834645669,1.0,1.0,3/10,20.70%,PTPN2;SOCS3;PIBF1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.23065285309057051,-0.5524573327438632,0.9460916442048517,1.0,1.0,2/11,15.71%,CALM1;CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.23065285309057051,-0.5524573327438632,0.9460916442048517,1.0,1.0,2/11,15.71%,CALM1;CASQ2
prerank,cilium movement (GO:0003341),0.20828651368866494,0.5522838541463562,0.9798994974874372,1.0,1.0,11/47,24.73%,DNAAF4;CAMSAP3;ODAD2;SPAG17;ODAD3;DNAH17;DNAAF2;TEKT2;RSPH9;CFAP53;DNAH11
prerank,glutamine family amino acid metabolic process (GO:0009064),0.22250339622512447,0.5519163248994263,0.9683195592286501,0.9998552654659593,1.0,1/33,1.99%,GCLC
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2352112390121288,0.5509535126928801,0.9634317862165963,0.9999160914364881,1.0,3/21,13.01%,VEGFA;KDM1A;DISC1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.2362540798393171,-0.5508443818052444,0.949438202247191,1.0,1.0,10/10,76.40%,SELENOS;ZNF692;SIRT7;DGKQ;PDK2;FBP1;SDHAF3;GNMT;USP7;OGT
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.2368379923446944,0.5492296835935064,0.957004160887656,1.0,1.0,11/22,32.17%,DUSP5;PPP5C;PPM1D;PPM1B;PPM1A;DUSP7;DUSP10;DUSP16;DUSP4;PPP2CB;DUSP1
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.17627097341796016,-0.548449455656371,0.9803921568627451,1.0,1.0,29/29,82.41%,FANCD2;TEX11;BAG6;TRIP13;SYCP2;MEIOB;TEX12;STAG3;IHO1;SIRT7;RNF212B;HORMAD1;TERB2;SYCP1;MAJIN;RNF212;SYCE3;KASH5;SYCE1;TERB1;PRDM9;ANKRD31;MEI4;SYCE2;ZCWPW1;RAD21;P3H4;REC8;RAD21L1
prerank,heterocycle biosynthetic process (GO:0018130),0.25579558770422617,0.546308212151669,0.9494470774091627,1.0,1.0,4/14,27.12%,MOCOS;ALOX5;MOCS1;LIAS
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22290052679241304,-0.5461423982391578,0.9637883008356546,1.0,1.0,1/12,5.74%,PRKCQ
prerank,regulation of establishment of protein localization (GO:0070201),-0.21345895271485377,-0.5455294383230453,0.975609756097561,1.0,1.0,1/13,2.95%,CORO2B
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.22940069005513697,-0.5449178481667305,0.984984984984985,1.0,1.0,1/11,5.11%,AHR
prerank,protein catabolic process (GO:0030163),0.19946720584444116,0.5427939080929806,0.992638036809816,1.0,1.0,11/59,19.40%,CHEK2;VCP;IDE;FBXO27;DDI2;NR1D1;RNF41;OGA;FBXO17;DDI1;LRSAM1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.26049363924550434,0.5410975239366452,0.9566563467492261,1.0,1.0,1/11,4.96%,NR4A3
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.20961994173304516,0.5404196709384671,0.9887218045112782,1.0,1.0,17/46,28.97%,TIMM23;BCAP31;TIMM9;TSPO;AIFM1;TIMM17B;PITRM1;AIP;GRPEL2;TIMM44;TOMM34;DNLZ;TOMM20;TIMM13;HK1;GRPEL1;TIMM10
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.22717982103911433,0.5401433520021556,0.9782903663500678,1.0,1.0,4/25,17.75%,KLF4;TLR4;CLU;P2RX4
prerank,phasic smooth muscle contraction (GO:0014821),-0.23290450822487047,-0.5399794759069972,0.9656084656084656,1.0,1.0,2/10,10.90%,EDN1;PTGER3
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.27625491540649083,0.5383297431339493,0.946875,1.0,1.0,3/10,24.88%,ZBTB7B;NCKAP1L;CBFB
prerank,peptidyl-arginine modification (GO:0018195),0.24912129339642547,0.5377350417129032,0.9522342064714946,1.0,1.0,2/15,13.30%,PRMT8;PRMT5
prerank,positive regulation of organelle assembly (GO:1902117),0.20773129603335375,0.5357988083805145,0.9886075949367089,1.0,1.0,20/44,30.93%,G3BP2;PLK4;SH3GLB1;PDCD6IP;PIP4K2A;RALB;LRSAM1;CNOT1;ENTR1;RAB3GAP1;SDC4;GPSM2;STX18;BBS4;ARHGAP35;KCTD17;FSCN1;RAB3GAP2;PIP4K2C;SDC1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.25514256384461753,0.5331686339912939,0.957613814756672,1.0,1.0,7/12,36.54%,MAD1L1;MIS12;CENPE;RMDN1;SEH1L;CHAMP1;CENPC
prerank,protein insertion into ER membrane (GO:0045048),0.212861098123183,0.5326137249304688,0.9765013054830287,1.0,1.0,6/37,16.76%,TRAM2;EMD;STX5;EMC8;VAMP2;EMC2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2672654616993102,0.532419803860271,0.9509803921568627,1.0,1.0,3/10,24.01%,BRCA1;THAP7;TAF7
prerank,regulation of myoblast fusion (GO:1901739),0.25751265516518057,0.5310584476716383,0.9600638977635783,1.0,1.0,3/11,16.22%,EHD2;EHD1;FLOT1
prerank,B cell mediated immunity (GO:0019724),0.26421324528857837,0.5309454673585547,0.952076677316294,1.0,1.0,1/10,11.28%,TLR8
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.26759290121188395,0.5287808505825685,0.948051948051948,1.0,1.0,3/10,23.54%,DRD3;FMR1;CBARP
prerank,branched-chain amino acid catabolic process (GO:0009083),0.23088404254185146,0.5279752554997535,0.9717114568599717,1.0,1.0,2/20,8.05%,AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.23088404254185146,0.5279752554997535,0.9717114568599717,1.0,1.0,2/20,8.05%,AUH;HIBCH
prerank,regulation of spindle organization (GO:0090224),-0.18978546431735094,-0.5264953834371501,0.9819277108433735,1.0,1.0,5/18,21.65%,MAP9;GNAI1;TACC3;TPX2;NUP62
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.2296617542732562,0.5258304622669887,0.9672619047619048,1.0,1.0,4/19,18.03%,PPP2R3C;ZBTB1;PRKDC;NCKAP1L
prerank,hydrogen peroxide metabolic process (GO:0042743),0.2352559075430235,0.5249544442156212,0.9705014749262537,1.0,1.0,7/19,30.42%,PRDX5;ACOX1;CAT;PRDX2;PRDX1;GPX1;PXDN
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.24845582458933457,0.5207127031008575,0.9572107765451664,1.0,1.0,1/12,7.28%,SEC61A1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.23562623594883478,0.5172604947657834,0.9607558139534884,1.0,1.0,5/15,32.35%,TDO2;IDO2;HGD;GSTZ1;KYNU
prerank,lipoxygenase pathway (GO:0019372),-0.20492451386700986,-0.5168940975278016,0.9827089337175793,1.0,1.0,5/14,27.61%,ALOX12;GPX4;PTGS2;ALOX5AP;ALOXE3
prerank,immunoglobulin mediated immune response (GO:0016064),-0.22465681715025115,-0.5165925373985424,0.968,1.0,1.0,5/10,36.78%,CD81;CD74;FCER1G;CD27;CARD9
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.20520116289407214,-0.5159353983439028,0.9886363636363636,1.0,1.0,1/14,3.58%,CSF1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.2229753656301982,-0.5156209338454161,0.967479674796748,1.0,1.0,3/10,20.98%,RNF125;DHX58;TSPAN6
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.24191165716073443,0.5156031828926827,0.9633587786259542,1.0,1.0,4/15,17.96%,AGO2;PABPC1;TENT4B;TOB1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.19314530283254214,-0.5148518308932115,0.9876543209876543,1.0,1.0,5/16,25.64%,LEPROTL1;VPS36;CHMP4C;CHMP5;CHMP6
prerank,innate immune response in mucosa (GO:0002227),-0.2192496487100791,-0.5144520568582478,0.9676616915422885,1.0,1.0,1/10,6.02%,DEFA6
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.25169949070223413,0.5121543373700924,0.9618320610687023,1.0,1.0,2/11,14.43%,AGK;TIMM9
prerank,alanine transport (GO:0032328),0.2542593216264377,0.5119788194558478,0.9510135135135135,1.0,1.0,2/10,20.17%,SLC38A3;SLC36A4
prerank,protein-DNA complex disassembly (GO:0032986),0.234991405377051,0.5118230727734409,0.9722650231124808,1.0,1.0,7/16,34.64%,SMARCC1;HMGA1;SMARCA4;SMARCE1;ARID2;SMARCD3;SMARCC2
prerank,mitochondrion transport along microtubule (GO:0047497),0.24039257911211773,0.5112444677313228,0.9726443768996961,1.0,1.0,4/13,25.94%,MAP1S;UBB;RHOT1;SYBU
prerank,protein localization to mitochondrion (GO:0070585),-0.2078000896423339,-0.5109353054366964,0.9922077922077922,1.0,1.0,4/11,27.20%,PINK1;HK2;AKT1;COX18
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.19708670810573242,-0.5077260188360015,0.975,1.0,1.0,15/15,80.32%,ERN1;FAM98B;TSEN15;CSTF2;TSEN34;TSEN2;CPSF1;RTCB;DDX1;CPSF4;ZBTB8OS;TRPT1;TSEN54;RTRAF;CLP1
prerank,tRNA metabolic process (GO:0006399),0.23416838693969916,0.5077240793450406,0.9814550641940085,1.0,1.0,5/17,30.59%,DTD2;SSB;YARS2;FARS2;RPP30
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.17137831385852492,-0.505646401741934,0.9931506849315068,1.0,1.0,24/24,82.89%,LIG3;RFC4;RPA3;PCNA;LIG1;UBC;XRCC1;POLD2;RFC5;POLE;RPA2;LIG4;RFC3;POLD3;POLD4;RPA1;RFC2;POLD1;RPS27A;POLK;UBA52;UBB;RFC1;POLB
prerank,regulation of lymphocyte activation (GO:0051249),-0.20933401782372668,-0.505577589793419,0.9685863874345549,1.0,1.0,6/12,33.69%,PAG1;DCAF15;IKZF3;THEMIS2;CCL5;CRTAM
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.210199129844344,0.5050410588968862,0.9836065573770492,1.0,1.0,15/31,34.36%,TIMM23;PEX26;PEX1;AIFM1;TIMM17B;GRPEL2;TIMM44;DNLZ;TOMM20;GRPEL1;PEX2;PEX7;PEX10;TIMM21;DNAJC15
prerank,sterol biosynthetic process (GO:0016126),-0.16115862191874922,-0.5044455965001626,0.99581589958159,1.0,1.0,9/33,24.55%,INSIG2;ARV1;MSMO1;PRKAG2;NSDHL;CH25H;TM7SF2;FDFT1;ACAT2
prerank,cellular response to amino acid stimulus (GO:0071230),0.20463655226322414,0.5041979840719824,0.9867021276595744,1.0,1.0,4/33,12.56%,CAPN2;RRAGB;KLHL22;NSMF
prerank,modulation by host of symbiont process (GO:0051851),0.20374154551125864,0.503272575907329,0.9838926174496644,1.0,1.0,8/31,25.27%,CCL3;RRP1B;SAP30BP;CHD1;CCNT1;TARDBP;REST;JUN
prerank,negative regulation of ATPase activity (GO:0032780),0.22666249713889658,0.501882770356439,0.9764359351988218,1.0,1.0,6/16,27.49%,ATP5IF1;PXK;TP53;TSC1;THADA;TNNI3
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.19707433450527376,-0.5014225138979815,0.9786585365853658,1.0,1.0,14/14,80.32%,FAM98B;TSEN15;CSTF2;TSEN34;TSEN2;CPSF1;RTCB;DDX1;CPSF4;ZBTB8OS;TRPT1;TSEN54;RTRAF;CLP1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.23566133475439155,0.49983171990004027,0.9894259818731118,1.0,1.0,4/13,25.15%,BMS1;KRI1;NOP14;TBL3
prerank,nucleus organization (GO:0006997),0.18832417907267923,0.49937497778624895,0.9914738124238733,1.0,1.0,13/47,26.54%,NUP93;LEMD2;NUP155;PDCD6IP;CHMP2B;NUP35;USP36;SUN1;REEP3;NUP98;REEP4;CHMP3;SUN2
prerank,T cell activation involved in immune response (GO:0002286),-0.1989956057752668,-0.4979430393982589,0.9888888888888889,1.0,1.0,12/12,80.12%,LCP1;CD74;FCER1G;MDK;F2RL1;IFNK;TNFSF18;ICAM1;SLC11A1;EIF2AK4;LILRB1;ITGAL
prerank,autophagosome maturation (GO:0097352),0.20408319894180119,0.49672784049402446,0.9895150720838795,1.0,1.0,12/32,29.51%,LIX1L;VCP;SNX14;WIPI2;STX17;VTI1B;CHMP3;MAP1LC3B;CLN3;ATG14;VPS33A;TSG101
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.21110400048042843,-0.4961424675651463,0.9801699716713881,1.0,1.0,5/10,27.78%,MMGT1;EMC7;EMC6;EMC1;EMC10
prerank,RNA catabolic process (GO:0006401),0.1921323645019169,0.49579932838253593,0.9889162561576355,1.0,1.0,12/46,29.56%,SIDT2;NUDT12;RNASE3;RNASEH2A;PABPC4;EXOSC7;METTL16;DXO;YTHDF2;NUDT16L1;ZPR1;SND1
prerank,DNA strand elongation (GO:0022616),0.215394140930174,0.49522230453795024,0.9738372093023255,1.0,1.0,6/18,30.28%,RAD50;MCM7;NBN;GINS3;POLA1;GINS1
prerank,glucose catabolic process to pyruvate (GO:0061718),0.21392756281398093,0.4947536752905572,0.989100817438692,1.0,1.0,5/24,21.99%,GPI;PFKP;FOXK1;FOXK2;PKM
prerank,canonical glycolysis (GO:0061621),0.21392756281398093,0.4947536752905572,0.989100817438692,1.0,1.0,5/24,21.99%,GPI;PFKP;FOXK1;FOXK2;PKM
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1847868565210219,0.4943228518284779,0.9963768115942029,1.0,1.0,13/56,26.55%,NDUFS3;NDUFC2;NDUFB4;TMEM126A;ECSIT;NUBPL;NDUFA12;NDUFAB1;NDUFA9;NDUFB2;NDUFAF7;NDUFS2;NDUFV1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1847868565210219,0.4943228518284779,0.9963768115942029,1.0,1.0,13/56,26.55%,NDUFS3;NDUFC2;NDUFB4;TMEM126A;ECSIT;NUBPL;NDUFA12;NDUFAB1;NDUFA9;NDUFB2;NDUFAF7;NDUFS2;NDUFV1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.2054126795183839,-0.4923101999854344,0.9743589743589743,1.0,1.0,3/11,23.84%,HMGB1;CD274;VSIR
prerank,coenzyme A metabolic process (GO:0015936),0.22815751926230715,0.488166336579232,0.9762258543833581,1.0,1.0,5/14,31.96%,PPCDC;CROT;DCAKD;COASY;ACAT1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.16746899279860475,-0.4878311278100648,1.0,1.0,1.0,7/23,27.20%,NDUFA13;BCL2L11;TOMM22;ROMO1;TIMM10B;PMAIP1;COX18
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.22426696649111733,0.4878160679954355,0.9690721649484536,1.0,1.0,6/16,30.62%,SRSF1;WBP4;PRPF39;SFSWAP;SNRNP200;WBP11
prerank,negative regulation of receptor internalization (GO:0002091),-0.1941882607370085,-0.4875906101682729,0.9830985915492958,1.0,1.0,4/12,25.19%,ANKRD13A;ANKRD13B;NECAB2;UBQLN2
prerank,regulation of T cell activation (GO:0050863),0.18875419430554324,0.485406845537094,0.9948652118100129,1.0,1.0,2/42,4.52%,CD2;ABL1
prerank,phagosome acidification (GO:0090383),0.202907717546701,0.4847132693620426,0.9846582984658299,1.0,1.0,4/26,18.85%,TCIRG1;ATP6V0A4;ATP6V1A;ATP6V0D1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.17412097952124486,-0.4834998009968075,0.9937304075235109,1.0,1.0,6/19,32.96%,POLR2G;TERF1;POLR2J;POLR2H;POLR2K;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.17412097952124486,-0.4834998009968075,0.9937304075235109,1.0,1.0,6/19,32.96%,POLR2G;TERF1;POLR2J;POLR2H;POLR2K;POLR2F
prerank,regulation of rRNA processing (GO:2000232),0.2181759674497313,0.483334787287798,0.9799691833590138,1.0,1.0,6/16,31.82%,WDR43;USP36;KAT2B;YTHDF2;RIOK1;UTP15
prerank,DNA biosynthetic process (GO:0071897),0.21889964092553263,0.4817836052650535,0.9833080424886191,1.0,1.0,1/16,7.50%,WRN
prerank,positive regulation of viral process (GO:0048524),0.17838697448301827,0.4812308553173081,0.9963898916967509,1.0,1.0,13/60,25.88%,MDFIC;TMEM39A;STAU1;PABPC1;KPNA2;NELFE;DHX9;POLR2C;CCNT1;SRPK2;PKN2;RSF1;SUPT4H1
prerank,positive regulation of myelination (GO:0031643),0.23702081583305246,0.48072435152228116,0.973186119873817,1.0,1.0,4/11,29.70%,PARD3;CST7;DICER1;TNFRSF1B
prerank,ribosome assembly (GO:0042255),0.18348071566849505,0.4803998821980811,0.9950062421972534,1.0,1.0,3/47,10.74%,RPSA;EIF6;MRPS2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.17515952064257095,-0.4788531473870241,0.9851632047477745,1.0,1.0,10/18,37.57%,DCP2;CCT8;CCT3;TCP1;RUVBL1;NHP2;NOP10;RUVBL2;SHQ1;CCT4
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.20913884007029876,-0.47807350191681863,0.9806629834254144,1.0,1.0,10/10,79.11%,MTHFD2;SHMT2;MTHFD1L;MTHFD2L;DHFR;MTHFD1;MTHFR;TYMS;SHMT1;MTHFS
prerank,sulfur amino acid catabolic process (GO:0000098),0.23542707020776846,0.4775707531898588,0.9845201238390093,1.0,1.0,2/10,19.35%,ADO;GADL1
prerank,peptidyl-methionine modification (GO:0018206),0.22926898026798284,0.47584643398739085,0.9714285714285714,1.0,1.0,3/12,22.31%,NAA15;NAA60;METAP2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.2407373585700927,0.4752721402241222,0.9666666666666667,1.0,1.0,2/10,17.83%,PFKP;GFPT1
prerank,tRNA processing (GO:0008033),0.17400613346657984,0.4721120845742059,0.9976359338061466,1.0,1.0,17/61,32.12%,TRMT10A;TYW5;ELP5;SSB;CLP1;THUMPD1;TRDMT1;FTSJ1;PTCD1;CDKAL1;FARS2;RTRAF;TRNT1;WDR4;RPP30;QTRT1;TSEN54
prerank,antibacterial humoral response (GO:0019731),-0.17571482174482722,-0.47071687371694193,0.9883720930232558,1.0,1.0,1/16,6.02%,DEFA6
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.20411749937233242,-0.4705447985498943,0.9893617021276596,1.0,1.0,10/10,79.61%,MTMR3;MFSD2A;MTMR2;DNAJC19;ABCA3;PHB2;GNB3;MTMR4;MTMR9;MTMR1
prerank,regulation of stem cell population maintenance (GO:2000036),0.2145730187611975,0.46756740779813055,0.9868421052631579,1.0,1.0,7/18,33.09%,WDR43;PTN;CNOT1;REST;ELAVL1;KAT2A;CNOT3
prerank,cellular amino acid catabolic process (GO:0009063),0.16529558007009212,0.46745586819641205,1.0,1.0,1.0,8/87,10.96%,UROC1;AUH;HIBCH;ARG1;SDSL;TDO2;HYKK;SLC25A21
prerank,positive regulation of cellular protein localization (GO:1903829),0.16893547736165174,0.46719301410089753,1.0,1.0,1.0,11/69,19.57%,GSK3B;RANGRF;RIC3;LIMK2;ABCA7;TM9SF4;PARD6A;BICD1;YAP1;GPR137B;FERMT2
prerank,regulation of centrosome duplication (GO:0010824),0.192125857817126,0.46677035079779855,0.9932249322493225,1.0,1.0,9/29,30.41%,SPICE1;NAT10;PDCD6IP;CHMP2B;CEP76;CHMP3;CCNF;GEN1;CEP131
prerank,transferrin transport (GO:0033572),0.18718542292543122,0.4664248097912887,0.9920212765957447,1.0,1.0,5/33,18.85%,TCIRG1;ATP6V0A4;ATP6V1A;RAB11B;ATP6V0D1
prerank,mucosal immune response (GO:0002385),0.2165456586912799,0.465699246744585,0.9858490566037735,1.0,1.0,2/15,13.76%,RNASE3;IFNLR1
prerank,positive regulation of rRNA processing (GO:2000234),0.2257617740479878,0.4655845444068229,0.9773462783171522,1.0,1.0,1/10,10.75%,WDR43
prerank,methylguanosine-cap decapping (GO:0110156),0.2263493146311613,0.4616072339037277,0.9790996784565916,1.0,1.0,4/10,29.67%,DCP1A;LSM1;PATL1;DCP1B
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.1996651263178712,0.4594221431607416,0.9929577464788732,1.0,1.0,3/22,17.15%,IRF1;CD46;LAG3
prerank,regulation of lysosomal lumen pH (GO:0035751),0.21916059309123856,0.4557950440003771,0.9860681114551083,1.0,1.0,4/12,28.51%,LRRK2;TMEM165;CLN3;VPS33A
prerank,leukotriene metabolic process (GO:0006691),0.19847863533228666,0.4552608479207686,0.9941944847605225,1.0,1.0,5/19,22.98%,DPEP1;ABCC1;ALOX5;MAPKAPK2;ABCC10
prerank,regulation of mitotic spindle organization (GO:0060236),0.17984151367214846,0.45495814113630334,0.9974126778783958,1.0,1.0,10/35,30.52%,PARP3;DRG1;PDCD6IP;CHMP2B;BORA;GPSM2;CHMP3;PLK1;FSD1;CEP97
prerank,negative regulation of T cell activation (GO:0050868),0.18350778375014795,0.4534836303271836,0.9949044585987261,1.0,1.0,9/35,24.40%,ARG1;CD80;PDCD1LG2;DLG5;GLMN;NCKAP1L;LGALS3;SDC4;LILRB1
prerank,meiosis I (GO:0007127),0.1909707041703297,0.4528474430514881,0.9958791208791209,1.0,1.0,7/23,34.21%,SYCP3;HSF2BP;FOXJ3;ZCWPW1;BRDT;ZSCAN21;PTTG1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.18881430202322982,0.4512410608203067,0.991701244813278,1.0,1.0,4/25,15.95%,VCP;VTA1;LYST;CHMP2B
prerank,response to unfolded protein (GO:0006986),0.16931504994311936,0.4481561073058526,1.0,1.0,1.0,14/48,30.60%,HSPB8;BAG3;HSPA1L;HERPUD1;TOR1B;DNAJC4;DNAJB2;HSPH1;DDIT3;ERP44;BAX;DNAJA1;HSPA14;BAK1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.22452175104966693,0.4479155214055447,0.9809220985691574,1.0,1.0,3/10,22.85%,PARD3;PLPP1;HTR2B
prerank,positive regulation of exosomal secretion (GO:1903543),0.2078975014206836,0.4449608595480634,0.9939024390243902,1.0,1.0,6/15,30.93%,PDCD6IP;SNF8;SDC4;HGS;TSG101;SDC1
prerank,rRNA methylation (GO:0031167),-0.15238693467336684,-0.44264688091225335,0.996742671009772,1.0,1.0,22/22,84.79%,ZCCHC4;BUD23;FBL;NSUN5;MRM2;TFB2M;TRMT112;FDXACB1;FBLL1;NOP2;NSUN4;MRM1;DIMT1;TFB1M;EMG1;NSUN3;METTL5;METTL16;FTSJ3;MTERF4;MRM3;METTL15
prerank,rRNA modification (GO:0000154),-0.15449193641678502,-0.4412496649010871,1.0,1.0,1.0,10/21,36.54%,ZCCHC4;BUD23;FBL;MRM2;NHP2;TFB2M;NOP10;TRMT112;TSR3;FBLL1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.2074931676318147,0.4395438053290851,0.9918300653594772,1.0,1.0,3/11,24.17%,CCT5;LARP7;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.2074931676318147,0.4395438053290851,0.9918300653594772,1.0,1.0,3/11,24.17%,CCT5;LARP7;CCT6A
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.18173679323959283,0.43789456712954816,0.9985358711566618,1.0,1.0,4/26,17.87%,IRAK3;IRF1;FLOT1;OTUD4
prerank,modulation by host of viral genome replication (GO:0044827),0.2103985658021298,0.435155534291658,0.9911504424778761,1.0,1.0,1/13,8.15%,ZC3H12A
prerank,positive regulation of immune response (GO:0050778),0.15988743309646422,0.4347496963906637,1.0,1.0,1.0,8/64,18.46%,TLR8;POLR3F;CD46;IFI35;AKIRIN2;PLSCR1;POLR3D;DHX9
prerank,coenzyme A biosynthetic process (GO:0015937),-0.18180531683172252,-0.43316686521909237,0.9860724233983287,0.9997651049212125,1.0,1/11,7.71%,PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.18180531683172252,-0.43316686521909237,0.9860724233983287,0.9997651049212125,1.0,1/11,7.71%,PANK1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.18180531683172252,-0.43316686521909237,0.9860724233983287,0.9997651049212125,1.0,1/11,7.71%,PANK1
prerank,positive regulation of translational initiation (GO:0045948),0.19398938342923866,0.4292961528703354,0.9941176470588236,1.0,1.0,7/18,32.06%,CDC123;KHDRBS1;RPS6KB1;MTOR;YTHDF2;HABP4;EIF2B5
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.19969712157192546,0.4247795088258745,0.9902755267423015,1.0,1.0,4/12,24.90%,CCT5;GNL3L;CCT6A;GNL3
prerank,carbohydrate catabolic process (GO:0016052),0.16917757261567962,0.4227088470115069,0.9974651457541192,1.0,1.0,7/38,21.99%,PFKFB1;DERA;GPI;MAN2B1;LDHA;NEU3;PKM
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.1931728908070341,0.42190123683975733,0.992548435171386,1.0,1.0,5/16,28.81%,PTPN2;SOCS3;PIBF1;ADIPOR1;HGS
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.20433940798301875,0.42148611288370275,0.9909638554216867,1.0,1.0,2/11,18.33%,MAVS;TICAM1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.17135762662314624,0.41910537847529333,0.9959731543624161,0.9998847677293898,1.0,10/30,30.66%,GGPS1;SQLE;LBR;EBP;HMGCR;MVD;MVK;LSS;DHCR7;HMGCS1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.20594445684649837,0.4174516431656663,0.995398773006135,0.999667885331499,1.0,3/11,24.07%,GATA4;LANCL1;REST
prerank,regulation of exosomal secretion (GO:1903541),0.1877413594949034,0.4162106674971431,0.9940828402366864,0.9994118102016248,1.0,7/19,30.93%,PDCD6IP;SNF8;SDC4;CHMP3;HGS;TSG101;SDC1
prerank,midbody abscission (GO:0061952),-0.15676074234711962,-0.41462126435837937,1.0,0.9997477301769012,1.0,8/17,33.57%,CHMP4C;CEP55;CHMP5;CHMP6;KIF20A;VPS4B;CHMP7;CHMP2A
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.18252024863439448,0.4069267674081441,0.9902439024390244,0.9997329318107535,1.0,15/15,81.77%,CCT5;NAF1;CCT6A;DKC1;CCT2;CCT7;CCT4;SHQ1;RUVBL2;NOP10;NHP2;RUVBL1;TCP1;CCT3;CCT8
prerank,cholesterol biosynthetic process (GO:0006695),0.16541959931564787,0.40625078687313676,0.9973297730307076,0.9994268747855122,1.0,10/31,30.66%,GGPS1;SQLE;LBR;EBP;HMGCR;MVD;MVK;LSS;DHCR7;HMGCS1
prerank,axoneme assembly (GO:0035082),0.1672664881133515,0.40431771981247966,0.9986376021798365,0.9991913535297633,1.0,6/30,21.78%,TOGARAM1;DNAAF3;SPAG17;DNAAF2;RSPH9;DRC1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.1997669102428809,0.3913770194510864,0.9919224555735057,0.9996091773243813,1.0,3/10,24.41%,ATRX;CDC7;INO80
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.1967986706710516,0.386203088171726,0.9951456310679612,0.9995024019944205,1.0,1/10,10.54%,DHX36
prerank,covalent chromatin modification (GO:0016569),-0.1498618784530387,-0.38297333338085043,0.996875,0.9996215312114664,1.0,14/14,85.03%,HLCS;MT3;UFL1;SIRT1;MBD2;AURKB;SIRT7;AURKC;HDAC1;PARK7;HELLS;SETD5;PARP2;CHD1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.15334889064705287,0.37758180370372424,1.0,0.999492600883619,1.0,8/31,30.84%,MOCOS;ALOX5;STAR;MOCS1;LIAS;FDXR;LSS;DHRS11
prerank,acyl-CoA biosynthetic process (GO:0071616),0.1705748066034306,0.3710437645976446,0.9969924812030075,0.9993654182129723,1.0,2/16,18.40%,ACACA;SCD
prerank,phosphate ion transmembrane transport (GO:0035435),0.1701192718141869,0.3501333678239301,0.995260663507109,0.9995309730563279,1.0,12/12,83.00%,SLC37A1;SLC25A3;SLC25A30;SLC20A1;SLC25A14;SLC25A11;SLC37A4;SLC37A2;XPR1;SLC25A10;SLC37A3;SLC20A2
